data_2kkz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kkz _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.567 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 74.7 ttt180 . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -121.96 121.17 36.47 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 175.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.405 HG23 ' HB2' ' A' ' 92' ' ' ASP . 49.0 mm -91.25 112.9 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.5 p -98.75 65.54 1.56 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 170.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 132' ' ' ALA . 27.5 t70 -67.61 -41.07 84.6 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 113.489 -1.687 . . . . 0.0 110.361 -177.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -109.84 151.02 27.55 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 173.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.5 m -86.82 154.23 21.05 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.593 0.357 . . . . 0.0 111.126 -170.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 49.8 mm -63.13 -35.91 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 123.157 0.583 . . . . 0.0 110.424 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -47.66 -46.64 29.27 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.859 1.264 . . . . 0.0 112.743 174.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.38 -20.11 20.02 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.204 -175.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.496 ' HG ' HD22 ' A' ' 146' ' ' LEU . 8.7 tt -69.03 -35.77 76.98 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.739 0.815 . . . . 0.0 109.812 174.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.8 m -97.84 12.01 35.38 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.84 0.856 . . . . 0.0 110.753 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -79.41 131.58 36.13 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.533 0.733 . . . . 0.0 109.868 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -81.47 140.64 34.48 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 38.4 p-90 -158.7 176.22 12.64 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.086 0.954 . . . . 0.0 109.044 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -151.88 166.68 30.69 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.636 0.775 . . . . 0.0 109.259 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 74.4 mtm -102.07 127.8 48.81 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.066 0.546 . . . . 0.0 109.788 170.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.43 HD21 ' H ' ' A' ' 105' ' ' LEU . 1.2 pt? -78.31 -33.3 49.43 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.11 0.564 . . . . 0.0 110.638 178.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 23.5 mmt -120.0 80.7 26.65 Favored Pre-proline 0 N--CA 1.485 1.287 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 168.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -73.23 129.23 13.75 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.669 2.246 . . . . 0.0 112.579 -173.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -134.81 121.84 21.23 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 174.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -109.65 110.24 21.23 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -174.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.447 ' HG2' HG12 ' A' ' 180' ' ' VAL . 22.1 tptm -100.79 133.6 45.02 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 169.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.8 t -103.61 126.92 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 171.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -131.46 88.65 2.61 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.29 -124.16 13.1 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.315 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -91.07 13.55 2.11 Favored 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 123.113 2.542 . . . . 0.0 112.476 176.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.1 mt -128.83 114.84 17.04 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.695 0.798 . . . . 0.0 108.916 -171.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 161' ' ' SER . 25.6 p -89.8 114.14 25.82 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.062 0.458 . . . . 0.0 110.364 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.425 ' HB ' ' HB3' ' A' ' 110' ' ' LYS . 12.0 mm -86.07 121.0 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 124.812 1.245 . . . . 0.0 110.607 -175.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -94.18 118.44 31.57 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 33.1 mm -118.26 121.84 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -102.41 114.33 28.43 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 169.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -71.01 -16.8 62.64 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -176.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.13 -26.04 25.43 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 118.169 0.441 . . . . 0.0 111.954 -174.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.551 HG13 ' HB ' ' A' ' 157' ' ' VAL . 29.2 mm -70.55 104.08 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 122.493 0.317 . . . . 0.0 110.46 -176.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 48.1 mtt -134.41 152.38 51.76 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.376 1.07 . . . . 0.0 109.702 -176.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.3 t70 71.89 7.84 5.92 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.608 1.163 . . . . 0.0 112.129 174.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -93.03 151.27 19.98 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.778 0.831 . . . . 0.0 110.532 -175.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -95.22 108.64 20.78 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 171.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.567 ' HB ' HG12 ' A' ' 192' ' ' VAL . 66.5 mt -115.52 149.15 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.405 0.682 . . . . 0.0 110.167 -170.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 55.8 tpp -125.31 134.36 52.28 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.149 0.979 . . . . 0.0 109.504 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -94.3 103.38 15.39 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.47 ' HG3' ' CE1' ' A' ' 150' ' ' PHE . 25.1 mmmt -114.52 149.94 35.66 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.62 1.168 . . . . 0.0 109.229 -173.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.518 ' HB3' ' HG ' ' A' ' 147' ' ' LEU . . . -153.49 144.12 22.57 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -104.92 133.68 49.31 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 167.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.49 ' HA ' HG13 ' A' ' 145' ' ' ILE . 28.4 p90 -162.16 164.19 28.02 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.182 0.515 . . . . 0.0 111.569 -172.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.1 t -88.53 157.4 18.63 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.614 172.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' A' ' 88' ' ' ARG . 74.1 t -136.31 140.01 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.303 1.041 . . . . 0.0 109.028 -174.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 7.9 tp -145.95 140.55 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 172.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 58.82 26.96 15.44 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.753 0.821 . . . . 0.0 112.34 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.0 t70 72.29 14.41 5.48 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.338 1.455 . . . . 0.0 111.895 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -123.54 160.71 26.42 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.12 0.568 . . . . 0.0 109.764 175.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.432 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 8.7 tt -62.87 119.04 8.61 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 177.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -82.67 -69.38 0.63 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.158 0.983 . . . . 0.0 109.135 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 93.8 m -137.17 129.71 30.01 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.647 0.779 . . . . 0.0 109.271 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.46 HD22 ' HB2' ' A' ' 147' ' ' LEU . 52.2 tp -73.13 123.51 23.74 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.641 0.776 . . . . 0.0 109.449 176.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.49 HG13 ' HA ' ' A' ' 134' ' ' PHE . 69.0 mt -83.79 -48.56 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.496 HD22 ' HG ' ' A' ' 98' ' ' LEU . 49.2 tp -161.98 149.57 14.42 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.899 0.88 . . . . 0.0 109.503 172.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.714 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 7.7 tt -126.52 142.74 51.44 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 172.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.541 HH11 HG21 ' A' ' 156' ' ' ILE . 46.6 ttm-85 -135.0 137.57 43.15 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.772 1.229 . . . . 0.0 110.53 -177.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.573 ' HB3' HD21 ' A' ' 181' ' ' LEU . . . -111.67 118.6 36.1 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 171.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.47 ' CE1' ' HG3' ' A' ' 131' ' ' LYS . 29.2 p90 -143.39 160.41 40.6 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 40.8 p -80.83 170.82 15.79 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.003 -174.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.27 -11.39 60.87 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 120.735 0.302 . . . . 0.0 111.11 171.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -71.03 -30.19 66.32 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.852 0.861 . . . . 0.0 110.066 168.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 106.6 -4.93 37.24 Favored Glycine 0 C--N 1.352 1.447 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.443 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -77.66 122.34 25.19 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.388 0.675 . . . . 0.0 110.493 -174.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.541 HG21 HH11 ' A' ' 148' ' ' ARG . 39.3 mt -76.53 103.99 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.212 0.605 . . . . 0.0 110.651 -175.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.551 ' HB ' HG13 ' A' ' 123' ' ' ILE . 27.2 m -99.27 -9.49 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 123.74 0.816 . . . . 0.0 112.061 -172.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -167.79 173.03 42.75 Favored Glycine 0 C--N 1.34 0.785 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 147' ' ' LEU . 37.5 tt0 -164.08 157.79 18.64 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.714 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 93.6 mt -123.53 103.87 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 167.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.629 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 2.7 m -93.7 109.47 41.41 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.563 -177.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -64.34 119.11 6.06 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.624 2.216 . . . . 0.0 111.307 172.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 CA--C 1.545 0.751 0 O-C-N 124.051 0.844 . . . . 0.0 110.411 178.858 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 16.0 p-80 . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 5.0 m -102.17 162.25 13.06 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.618 0.767 . . . . 0.0 110.199 -173.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.449 HD11 ' HA ' ' A' ' 202' ' ' ALA . 17.8 tt -56.78 -28.98 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 C-N-CA 124.95 1.3 . . . . 0.0 111.819 173.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -54.86 -42.79 72.44 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.721 1.208 . . . . 0.0 111.607 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.01 -44.0 90.64 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.809 0.844 . . . . 0.0 110.482 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.477 ' O ' HG13 ' A' ' 178' ' ' ILE . 50.9 t -65.58 -48.66 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.633 -172.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -58.15 -36.08 72.47 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.595 0.758 . . . . 0.0 111.757 -175.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.415 ' O ' HG22 ' A' ' 180' ' ' VAL . 16.2 m120 -74.02 -43.09 59.14 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.618 0.767 . . . . 0.0 110.142 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -59.56 -42.15 91.77 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.185 0.928 . . . . 0.0 111.562 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 174' ' ' VAL . 62.0 mt -57.71 -42.8 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 123.734 0.813 . . . . 0.0 109.171 177.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -76.9 -22.43 71.79 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-N 114.662 -1.154 . . . . 0.0 114.431 -175.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.447 HG12 ' HG2' ' A' ' 110' ' ' LYS . 97.6 t -73.5 -43.43 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 172.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.627 HD23 HG13 ' A' ' 160' ' ' ILE . 33.0 tp -58.97 -48.85 80.06 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.656 173.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.504 ' O ' ' HG2' ' A' ' 186' ' ' GLU . 70.0 mt -60.46 -44.66 96.81 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.997 0 C-N-CA 123.856 0.862 . . . . 0.0 110.61 176.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.438 ' O ' ' HG3' ' A' ' 187' ' ' ARG . . . -56.67 -39.31 85.89 Favored Glycine 0 C--N 1.342 0.869 0 O-C-N 123.512 0.508 . . . . 0.0 113.268 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -67.01 -41.21 93.3 Favored Glycine 0 C--N 1.353 1.489 0 N-CA-C 112.058 -0.417 . . . . 0.0 112.058 174.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 76.9 mt -62.96 -34.32 77.26 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.012 0.925 . . . . 0.0 111.043 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 31.1 mm-40 -68.41 -42.63 78.71 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 123.922 0.889 . . . . 0.0 109.827 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 183' ' ' GLY . 74.0 mtp180 -60.35 -38.38 83.62 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.299 0.64 . . . . 0.0 110.65 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -72.72 -14.21 61.51 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.951 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 36.6 t70 64.12 67.22 0.6 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.977 0.911 . . . . 0.0 110.819 -177.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -104.63 -162.82 0.91 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 170.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.1 m -135.0 101.0 4.74 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 169.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.567 HG12 ' HB ' ' A' ' 128' ' ' ILE . 8.2 m -111.02 153.26 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 121.784 0.802 . . . . 0.0 111.02 -172.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 52.2 ttm-85 -139.58 142.23 37.14 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.032 -1.44 . . . . 0.0 107.895 174.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 3.4 t -88.14 145.65 7.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 34.3 t -57.68 144.32 38.3 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.581 0.352 . . . . 0.0 111.272 178.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . 0.572 ' HZ1' ' HB3' ' A' ' 196' ' ' LYS . 0.2 OUTLIER -45.8 -37.78 6.45 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 124.429 1.081 . . . . 0.0 112.062 174.086 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 70.5 p -69.29 -55.54 10.18 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 123.525 0.73 . . . . 0.0 110.271 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.426 HD22 ' HB2' ' A' ' 132' ' ' ALA . 73.3 mt -62.17 -31.99 72.55 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.261 0.624 . . . . 0.0 111.413 -175.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.552 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 49.7 mt-30 -62.1 -50.38 72.15 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.496 0.718 . . . . 0.0 111.131 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.25 -20.11 35.13 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -175.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -87.38 -62.31 1.53 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.8 0.44 . . . . 0.0 111.285 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.449 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -111.05 -51.95 2.82 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.315 0.646 . . . . 0.0 111.679 -162.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.552 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 57.5 t-105 . . . . . 0 CA--C 1.554 1.116 0 C-N-CA 125.37 1.468 . . . . 0.0 110.675 -173.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.405 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 41.3 ttm180 . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -119.36 109.95 16.39 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.781 0.833 . . . . 0.0 108.928 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.8 mm -87.09 131.69 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 123.457 0.703 . . . . 0.0 109.413 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.461 ' HA ' HD21 ' A' ' 133' ' ' ASN . 50.9 p -118.48 81.06 1.62 Allowed 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 172.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -74.56 -27.45 60.51 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.606 -174.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.472 ' HB2' ' HG3' ' A' ' 97' ' ' GLU . 23.4 ptt? -102.89 134.14 46.81 Favored 'General case' 0 C--O 1.245 0.86 0 C-N-CA 123.361 0.664 . . . . 0.0 109.553 174.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.419 ' O ' ' HB2' ' A' ' 98' ' ' LEU . 9.8 t -81.84 171.72 14.17 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.337 0.655 . . . . 0.0 110.908 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -55.7 -43.02 71.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 126.024 1.73 . . . . 0.0 111.384 -176.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 100' ' ' ARG . 27.0 mm-40 -52.38 -40.64 62.3 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.126 0.97 . . . . 0.0 113.454 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.472 ' HG3' ' HB2' ' A' ' 93' ' ' MET . 12.7 pt-20 -97.73 -22.1 16.61 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.22 0.608 . . . . 0.0 111.291 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 94' ' ' THR . 2.2 tt -73.91 -59.93 2.49 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.634 0.773 . . . . 0.0 109.077 -176.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 39.7 m -80.67 -7.5 59.33 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.378 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.431 ' HB2' ' O ' ' A' ' 96' ' ' GLU . 9.2 tpm_? -58.81 122.33 13.31 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 123.416 0.687 . . . . 0.0 110.501 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -92.9 145.9 24.04 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 173.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 30.7 p-90 -154.16 178.65 9.75 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.828 0.851 . . . . 0.0 109.921 -166.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -136.84 151.17 48.82 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.093 0.957 . . . . 0.0 109.618 -177.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 65.6 mtp -93.17 95.16 9.23 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 172.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -57.14 -37.95 72.78 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.54 0.525 . . . . 0.0 111.312 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.589 ' HB3' ' HB2' ' A' ' 121' ' ' GLN . 8.7 mmt -124.77 97.06 39.41 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 168.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -82.82 127.06 4.71 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.965 2.444 . . . . 0.0 114.202 -170.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.53 ' HB3' ' HB ' ' A' ' 119' ' ' ILE . 87.5 tttt -123.19 116.29 23.17 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 162.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.489 ' NE2' ' SG ' ' A' ' 116' ' ' CYS . 50.8 tp60 -106.91 111.59 24.16 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -176.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.43 ' HG2' HG13 ' A' ' 180' ' ' VAL . 50.5 tptt -117.12 135.83 53.46 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 124.858 1.263 . . . . 0.0 108.58 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.1 t -112.06 118.67 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 170.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -110.15 88.52 2.78 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.79 -115.96 7.77 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.343 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -85.49 -1.43 9.07 Favored 'Trans proline' 0 C--N 1.367 1.52 0 C-N-CA 122.898 2.398 . . . . 0.0 113.694 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.467 HD13 ' HB3' ' A' ' 177' ' ' ALA . 45.0 mt -116.23 152.07 34.5 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.187 0.595 . . . . 0.0 110.743 -171.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.489 ' SG ' ' NE2' ' A' ' 109' ' ' GLN . 37.9 t -106.55 110.79 23.09 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.234 1.014 . . . . 0.0 109.824 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.8 mm -95.92 142.5 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.803 0.841 . . . . 0.0 109.317 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -128.52 121.76 29.57 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.53 ' HB ' ' HB3' ' A' ' 108' ' ' LYS . 37.3 mm -116.8 127.18 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.43 1.092 . . . . 0.0 109.762 -176.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -79.55 141.02 37.02 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 170.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.589 ' HB2' ' HB3' ' A' ' 106' ' ' MET . 58.8 mt-30 -103.4 3.19 34.82 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.919 172.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -108.14 -46.41 3.75 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -170.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.424 HG13 HG13 ' A' ' 157' ' ' VAL . 30.1 mm -81.98 106.63 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 121.295 0.569 . . . . 0.0 109.99 -163.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 63.0 mtt -127.82 161.45 28.98 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.527 1.131 . . . . 0.0 109.76 -172.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 66.43 6.39 4.31 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 124.311 1.045 . . . . 0.0 112.822 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -103.91 153.61 20.59 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.594 0.757 . . . . 0.0 110.393 -171.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -88.14 107.62 18.86 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 172.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.624 HD12 HG21 ' A' ' 157' ' ' VAL . 47.5 mt -105.62 117.9 52.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.625 0.726 . . . . 0.0 109.251 -175.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 13.4 tpt -102.47 133.86 46.73 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.423 -173.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 15.2 mt -108.36 104.04 13.32 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -176.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.404 ' HA ' ' OG ' ' A' ' 195' ' ' SER . 68.2 mttm -116.7 149.78 39.27 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.329 0.652 . . . . 0.0 110.501 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -141.08 161.94 36.66 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 122.146 0.974 . . . . 0.0 113.02 -174.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.461 HD21 ' HA ' ' A' ' 91' ' ' THR . 8.8 m120 -108.47 133.24 52.9 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 160.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -160.53 160.85 32.4 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.254 0.55 . . . . 0.0 111.6 -177.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.0 m -87.82 154.72 20.32 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.428 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.405 ' HB ' ' HB3' ' A' ' 88' ' ' ARG . 79.4 t -128.7 131.35 68.63 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 C-N-CA 123.938 0.895 . . . . 0.0 109.427 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 6.7 tp -142.99 141.51 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 171.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 58.2 37.92 26.23 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.832 0.853 . . . . 0.0 112.115 176.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 63.18 16.62 9.54 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 125.036 1.335 . . . . 0.0 112.446 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 16.1 ptt-85 -132.6 167.22 20.42 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.15 0.58 . . . . 0.0 110.856 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.6 tt -67.81 115.85 7.82 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -78.21 -61.9 1.85 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 122.789 0.436 . . . . 0.0 110.468 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 97.3 m -147.2 125.89 12.58 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.569 0.748 . . . . 0.0 110.12 -171.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.441 HD11 ' HB2' ' A' ' 147' ' ' LEU . 47.9 tp -73.51 129.53 38.18 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.191 0.596 . . . . 0.0 109.784 176.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 85.3 mt -88.27 -51.05 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.699 0.8 . . . . 0.0 109.283 174.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 54.3 tp -162.23 148.06 13.02 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 175.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.604 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 7.7 tt -137.28 149.45 47.11 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 175.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.493 ' HD3' HD13 ' A' ' 156' ' ' ILE . 46.8 mtt-85 -133.87 145.52 49.74 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.491 0.717 . . . . 0.0 110.729 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.541 ' HB2' HD21 ' A' ' 181' ' ' LEU . . . -109.76 123.52 49.68 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 168.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.497 ' HB3' ' HA ' ' A' ' 156' ' ' ILE . 18.8 p90 -150.22 168.51 23.79 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.64 0.776 . . . . 0.0 110.186 -176.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 79.1 p -85.69 165.87 16.61 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 173.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.05 -9.46 39.5 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 120.691 0.282 . . . . 0.0 111.675 174.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -79.83 -23.7 41.85 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.018 1.327 . . . . 0.0 110.973 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 106.18 -1.48 37.84 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-N 115.637 -0.711 . . . . 0.0 113.003 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.24 106.9 6.1 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.216 0.606 . . . . 0.0 109.911 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.497 ' HA ' ' HB3' ' A' ' 150' ' ' PHE . 25.6 mt -77.46 118.51 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -177.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.624 HG21 HD12 ' A' ' 128' ' ' ILE . 18.9 m -106.89 -15.31 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 124.595 1.158 . . . . 0.0 111.994 -170.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -165.25 177.23 40.72 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 111.826 -0.51 . . . . 0.0 111.826 -172.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -166.17 153.94 10.28 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.739 0.416 . . . . 0.0 111.046 -173.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.604 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 67.9 mt -127.61 116.49 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 166.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 33.4 t -128.03 118.74 20.84 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.108 0.563 . . . . 0.0 109.898 -174.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -62.14 121.45 9.49 Favored 'Trans proline' 0 C--N 1.382 2.328 0 C-N-CA 122.798 2.332 . . . . 0.0 111.91 176.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.4 mt . . . . . 0 CA--C 1.548 0.903 0 C-N-CA 122.862 0.465 . . . . 0.0 110.217 -178.92 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 10.1 p80 . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.0 m -107.27 161.86 14.41 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.269 1.027 . . . . 0.0 110.82 -169.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.594 HD12 ' HA ' ' A' ' 202' ' ' ALA . 14.8 tt -56.05 -29.99 28.06 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.308 0 C-N-CA 124.235 1.014 . . . . 0.0 112.307 172.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -56.21 -52.65 63.65 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.059 0.944 . . . . 0.0 111.835 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -73.63 -25.2 60.19 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.978 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 178' ' ' ILE . 63.4 t -65.78 -40.92 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 122.643 0.377 . . . . 0.0 110.185 172.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -72.1 -30.7 65.36 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.477 0.311 . . . . 0.0 111.005 178.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.433 ' O ' HG21 ' A' ' 180' ' ' VAL . 94.8 m-20 -62.79 -46.16 89.27 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 169.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.467 ' HB3' HD13 ' A' ' 115' ' ' LEU . . . -61.87 -48.21 81.53 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.766 1.226 . . . . 0.0 112.339 -174.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 174' ' ' VAL . 45.6 mt -68.32 -32.36 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -65.31 -38.74 95.39 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-N 116.086 -0.506 . . . . 0.0 113.364 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.433 HG21 ' O ' ' A' ' 176' ' ' ASN . 95.8 t -72.45 -42.81 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.066 0.546 . . . . 0.0 109.847 177.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.541 HD21 ' HB2' ' A' ' 149' ' ' ALA . 35.4 tp -54.15 -55.97 22.69 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.027 0.931 . . . . 0.0 110.536 176.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.493 ' O ' ' HG2' ' A' ' 186' ' ' GLU . 24.7 mt -55.0 -45.27 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 124.152 0.907 . . . . 0.0 110.74 172.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -55.24 -41.86 80.45 Favored Glycine 0 CA--C 1.533 1.189 0 O-C-N 123.793 0.683 . . . . 0.0 114.268 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.35 -33.26 64.53 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-O 121.302 0.39 . . . . 0.0 112.134 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.422 ' HB3' ' OD1' ' A' ' 190' ' ' ASN . 88.9 mt -72.2 -28.82 63.44 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 124.618 1.167 . . . . 0.0 111.403 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 18.2 mm-40 -60.55 -38.45 84.56 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.703 0.801 . . . . 0.0 110.044 175.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 67.4 mtp85 -69.42 -30.83 68.86 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.24 -1.345 . . . . 0.0 110.821 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -83.09 4.81 24.76 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.516 0.727 . . . . 0.0 112.652 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 36.9 t70 59.33 26.96 15.92 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.986 0.898 . . . . 0.0 111.124 173.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.422 ' OD1' ' HB3' ' A' ' 185' ' ' LEU . 28.8 p30 -105.09 161.48 14.2 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -177.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 35.4 m -91.27 113.79 26.15 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.28 0.632 . . . . 0.0 109.827 -172.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.48 HG21 HG22 ' A' ' 182' ' ' ILE . 35.2 m -89.83 134.43 28.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-O 121.324 0.583 . . . . 0.0 109.986 -177.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -140.76 129.78 23.33 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.755 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 4.7 t -105.34 152.62 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.404 ' OG ' ' HA ' ' A' ' 131' ' ' LYS . 63.5 m -59.06 145.84 40.64 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 118.222 0.464 . . . . 0.0 111.037 176.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 200' ' ' ARG . 0.2 OUTLIER -69.26 -28.08 66.0 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.294 0.371 . . . . 0.0 110.222 -178.216 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 62.6 p -67.34 -50.15 61.12 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 171.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 33.6 mt -58.58 -30.61 67.32 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.464 0.705 . . . . 0.0 111.26 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.639 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 45.6 mt-30 -70.58 -55.18 9.43 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.161 0.585 . . . . 0.0 110.897 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 196' ' ' LYS . 0.0 OUTLIER -81.61 -11.78 58.99 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -173.213 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -97.37 -39.51 9.17 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.038 0.535 . . . . 0.0 111.13 175.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.594 ' HA ' HD12 ' A' ' 171' ' ' ILE . . . -121.67 -61.55 1.5 Allowed 'General case' 0 N--CA 1.479 0.993 0 O-C-N 122.15 -0.344 . . . . 0.0 111.287 -172.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.639 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 51.2 t-105 . . . . . 0 CA--C 1.545 0.757 0 C-N-CA 124.584 1.153 . . . . 0.0 110.445 -165.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 120.5 0.19 . . . . 0.0 110.625 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -99.1 98.73 9.71 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.954 0.901 . . . . 0.0 109.197 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.8 mm -77.22 137.44 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.994 0.918 . . . . 0.0 109.018 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.2 p -127.35 85.92 2.43 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.107 0.563 . . . . 0.0 109.534 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -72.55 -25.52 61.39 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 122.824 0.45 . . . . 0.0 111.319 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.54 ' HB2' ' HG3' ' A' ' 97' ' ' GLU . 9.1 ptp -106.04 131.7 53.01 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 172.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 77.1 p -70.05 169.24 13.81 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.415 0.686 . . . . 0.0 109.946 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 45.0 mm -62.16 -35.66 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 122.593 0.357 . . . . 0.0 110.582 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 100' ' ' ARG . 43.2 mt-10 -53.72 -44.13 69.61 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.803 0.841 . . . . 0.0 112.294 176.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.54 ' HG3' ' HB2' ' A' ' 93' ' ' MET . 13.7 pt-20 -96.7 -13.23 22.89 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.076 0.55 . . . . 0.0 110.996 -177.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.563 HD11 HD23 ' A' ' 146' ' ' LEU . 53.2 tp -68.9 -50.21 51.5 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.919 0.888 . . . . 0.0 110.768 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.1 p -103.42 14.33 31.63 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.659 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 96' ' ' GLU . 59.5 ttt85 -72.15 141.38 49.11 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.237 0.615 . . . . 0.0 111.279 -174.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -84.28 152.28 24.26 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.344 0.592 . . . . 0.0 109.812 173.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . 0.468 ' HE1' HH12 ' A' ' 148' ' ' ARG . 7.9 p-90 -149.6 167.51 26.14 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.389 1.076 . . . . 0.0 109.396 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -129.19 145.08 51.4 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.685 0.794 . . . . 0.0 109.605 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.549 ' SD ' ' HD2' ' A' ' 118' ' ' ARG . 69.7 mtp -116.9 150.92 37.68 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.662 0.785 . . . . 0.0 109.886 178.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -126.93 -23.73 3.6 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.672 0.789 . . . . 0.0 110.552 -177.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 25.6 mmt -130.12 72.72 81.83 Favored Pre-proline 0 N--CA 1.49 1.563 0 C-N-CA 123.119 0.568 . . . . 0.0 109.627 167.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.93 135.66 35.85 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.867 2.378 . . . . 0.0 113.61 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -129.88 118.9 22.44 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.032 0.933 . . . . 0.0 109.133 173.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.413 ' NE2' ' SG ' ' A' ' 116' ' ' CYS . 0.0 OUTLIER -108.33 103.8 13.04 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.715 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.7 tptt -120.79 126.36 49.91 Favored 'General case' 0 C--O 1.206 -1.207 0 C-N-CA 124.957 1.303 . . . . 0.0 107.911 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 81.3 t -96.4 133.85 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 173.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -126.12 92.65 3.62 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 175.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.61 -133.25 25.3 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.909 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -75.65 3.78 5.64 Favored 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 123.716 2.944 . . . . 0.0 113.697 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 5.3 mp -125.23 156.67 38.14 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.267 0.627 . . . . 0.0 109.71 -177.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.413 ' SG ' ' NE2' ' A' ' 109' ' ' GLN . 42.6 t -116.87 132.75 56.62 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.002 0.921 . . . . 0.0 108.825 -177.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.41 HD11 ' HB2' ' A' ' 177' ' ' ALA . 12.6 mm -106.03 143.71 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.472 1.109 . . . . 0.0 109.184 -176.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.613 ' HB3' ' HB3' ' A' ' 159' ' ' GLU . 71.3 ttp85 -129.3 120.64 25.99 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 176.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.552 HD13 ' HA3' ' A' ' 184' ' ' GLY . 44.2 mt -128.68 139.17 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -176.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -107.86 121.92 45.73 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 171.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.445 ' HA ' ' ND2' ' A' ' 188' ' ' ASN . 70.2 mt-30 -82.96 -9.29 59.36 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -173.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.27 -32.18 26.53 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.798 0.439 . . . . 0.0 111.5 178.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.419 HG12 ' CG1' ' A' ' 157' ' ' VAL . 1.8 mp -71.02 108.57 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.758 0.789 . . . . 0.0 109.117 -178.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.413 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 58.4 mtt -132.08 163.19 29.01 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 113.684 -1.598 . . . . 0.0 108.988 -175.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 71.35 5.33 5.39 Favored 'General case' 0 N--CA 1.502 2.126 0 C-N-CA 124.543 1.137 . . . . 0.0 112.998 171.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -97.08 151.13 20.06 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.653 0.781 . . . . 0.0 112.143 -170.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -91.98 108.33 19.85 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 164.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.531 HG12 HG23 ' A' ' 151' ' ' THR . 34.0 mt -110.92 147.91 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 123.598 0.759 . . . . 0.0 110.397 -172.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 15.4 tpt -130.67 120.76 24.39 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.544 1.138 . . . . 0.0 109.768 -169.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -88.21 103.63 15.95 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -117.25 138.14 51.92 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.487 0.715 . . . . 0.0 109.26 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -134.8 147.03 49.86 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.512 0.931 . . . . 0.0 113.512 -171.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.449 ' OD1' ' HG2' ' A' ' 93' ' ' MET . 5.2 m-20 -102.07 122.92 45.03 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 165.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -159.73 158.7 31.78 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 122.901 0.48 . . . . 0.0 111.645 -171.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.9 t -88.02 155.11 19.99 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.008 0.923 . . . . 0.0 109.914 173.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.9 t -130.5 145.6 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 124.901 1.281 . . . . 0.0 109.297 -177.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.499 HG21 ' HB2' ' A' ' 142' ' ' GLU . 11.0 tp -157.95 144.01 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 171.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 55.5 27.59 10.49 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 123.64 0.776 . . . . 0.0 112.858 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 66.18 23.19 10.95 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.97 1.308 . . . . 0.0 112.661 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 137' ' ' ILE . 28.8 ptt180 -117.66 160.96 20.44 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.945 0.498 . . . . 0.0 109.78 175.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.8 tt -71.2 112.99 7.78 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 166.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.499 ' HB2' HG21 ' A' ' 137' ' ' ILE . 11.9 tp10 -81.43 -58.46 3.02 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.67 0.388 . . . . 0.0 110.186 177.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 96.4 m -141.78 120.94 12.97 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.249 0.22 . . . . 0.0 110.808 -174.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 43.6 tp -77.2 119.3 20.69 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.057 0.543 . . . . 0.0 109.577 172.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 72.0 mt -80.56 -53.68 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 174.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.563 HD23 HD11 ' A' ' 98' ' ' LEU . 65.0 tp -156.61 146.09 20.66 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.888 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.551 HD12 HD13 ' A' ' 160' ' ' ILE . 8.2 tt -133.2 145.59 50.72 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 171.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.653 HH11 HG21 ' A' ' 156' ' ' ILE . 84.4 mtt-85 -140.52 143.69 35.54 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.227 1.011 . . . . 0.0 108.845 178.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -101.61 112.43 24.99 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 176.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -106.58 125.31 50.84 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.382 1.073 . . . . 0.0 109.74 -175.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.531 HG23 HG12 ' A' ' 128' ' ' ILE . 43.7 p -71.64 -174.07 1.06 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.034 0.534 . . . . 0.0 111.583 175.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -19.2 65.5 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.462 0.705 . . . . 0.0 112.833 175.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -98.3 -1.2 42.37 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.728 0.811 . . . . 0.0 111.358 172.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 76.38 26.3 63.91 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 116.396 -0.365 . . . . 0.0 113.343 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -77.7 131.63 37.79 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.653 HG21 HH11 ' A' ' 148' ' ' ARG . 22.9 mt -83.02 86.86 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 121.649 0.738 . . . . 0.0 109.181 -177.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.419 ' CG1' HG12 ' A' ' 123' ' ' ILE . 19.3 m -100.09 -12.89 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.519 1.128 . . . . 0.0 111.185 -169.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.406 ' HA3' HD11 ' A' ' 181' ' ' LEU . . . -142.84 164.76 27.05 Favored Glycine 0 C--O 1.245 0.836 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.613 ' HB3' ' HB3' ' A' ' 118' ' ' ARG . 32.8 tt0 -167.89 150.05 5.56 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 117.437 0.618 . . . . 0.0 110.428 -173.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.551 HD13 HD12 ' A' ' 147' ' ' LEU . 57.6 mt -136.0 125.67 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 170.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 14.4 m -138.46 122.88 11.7 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.574 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 88.1 Cg_exo -48.51 142.44 17.78 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 123.257 2.638 . . . . 0.0 113.175 173.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 90.4 mt . . . . . 0 CA--C 1.559 1.307 0 C-N-CA 123.623 0.769 . . . . 0.0 111.09 178.873 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.8 m -122.51 154.96 37.15 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.447 HD11 ' HA ' ' A' ' 202' ' ' ALA . 10.7 tt -51.88 -34.96 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 C-N-CA 124.726 1.21 . . . . 0.0 113.001 177.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -61.97 -44.15 97.35 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.221 1.008 . . . . 0.0 112.784 -177.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -82.75 -25.62 32.67 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.647 0.379 . . . . 0.0 111.276 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 178' ' ' ILE . 91.4 t -64.49 -48.64 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 122.809 0.444 . . . . 0.0 110.858 172.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -65.96 -28.22 68.74 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.61 0.364 . . . . 0.0 110.905 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.417 ' O ' HG22 ' A' ' 180' ' ' VAL . 13.7 m120 -68.53 -43.56 76.48 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 123.144 0.578 . . . . 0.0 109.495 171.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.41 ' HB2' HD11 ' A' ' 117' ' ' ILE . . . -61.3 -40.52 94.46 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.842 0.857 . . . . 0.0 111.36 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 174' ' ' VAL . 57.6 mt -65.0 -39.91 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.19 -36.98 94.16 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.476 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 176' ' ' ASN . 80.9 t -66.2 -47.59 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.218 0.607 . . . . 0.0 110.613 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.406 HD11 ' HA3' ' A' ' 158' ' ' GLY . 32.7 tp -59.46 -46.76 87.85 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.879 0.737 . . . . 0.0 110.344 178.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.787 HG23 HG22 ' A' ' 192' ' ' VAL . 47.8 mt -57.12 -46.19 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.37 1.068 . . . . 0.0 111.447 176.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -63.41 -34.58 90.34 Favored Glycine 0 C--N 1.341 0.841 0 O-C-N 123.675 0.609 . . . . 0.0 113.104 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.552 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -71.12 -27.61 71.67 Favored Glycine 0 C--N 1.35 1.343 0 O-C-N 123.751 0.324 . . . . 0.0 113.0 177.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.406 HD21 ' CD1' ' A' ' 128' ' ' ILE . 64.2 mt -77.28 -47.35 20.29 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.832 0.853 . . . . 0.0 110.076 175.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -67.14 -34.11 76.89 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.316 0.646 . . . . 0.0 112.417 -174.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -66.89 -29.05 68.85 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 122.432 0.293 . . . . 0.0 111.365 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.445 ' ND2' ' HA ' ' A' ' 121' ' ' GLN . 49.5 m-20 -80.38 8.19 8.11 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.207 0.603 . . . . 0.0 110.86 174.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 34.4 t70 65.49 64.2 0.6 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.776 1.23 . . . . 0.0 110.207 177.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -124.46 172.96 8.76 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.153 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 70.2 m -122.93 102.55 8.08 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.787 HG22 HG23 ' A' ' 182' ' ' ILE . 31.8 m -89.99 150.97 3.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 CA-C-O 121.898 0.856 . . . . 0.0 111.574 -174.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -141.22 131.23 24.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 113.8 -1.545 . . . . 0.0 107.701 173.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 5.8 t -89.75 152.7 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 38.6 t -62.95 141.6 58.66 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 118.179 0.445 . . . . 0.0 109.929 176.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -57.94 -33.73 69.13 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.258 0.623 . . . . 0.0 111.888 -177.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 15.0 p -66.79 -49.6 65.34 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.433 0.458 . . . . 0.0 110.242 174.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 72.5 mt -58.63 -34.65 71.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 122.697 0.399 . . . . 0.0 110.775 178.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.553 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 75.5 mt-30 -61.35 -41.53 97.21 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.092 0.957 . . . . 0.0 112.666 -175.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.26 -21.09 14.41 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -178.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -79.49 -48.69 13.47 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 118.745 0.702 . . . . 0.0 111.107 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.447 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -114.82 -50.89 2.76 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.498 0.666 . . . . 0.0 111.221 -174.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.553 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 35.4 t-105 . . . . . 0 CA--C 1.555 1.136 0 C-N-CA 124.97 1.308 . . . . 0.0 111.391 -171.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -116.4 113.54 23.02 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.888 0.875 . . . . 0.0 109.345 174.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 32.5 mm -78.38 132.85 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 36.1 p -128.25 87.93 2.67 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.923 0.889 . . . . 0.0 109.305 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -71.33 -22.9 61.86 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 173.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.426 ' SD ' ' HB2' ' A' ' 148' ' ' ARG . 56.9 mtm -119.63 139.89 51.47 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 125.15 1.38 . . . . 0.0 109.027 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 72.2 p -88.88 165.67 14.48 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 172.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.504 ' HA ' HD12 ' A' ' 98' ' ' LEU . 2.2 mp -53.93 -30.73 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 124.609 1.164 . . . . 0.0 111.736 -171.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -53.33 -62.69 1.49 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.355 1.062 . . . . 0.0 111.984 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.714 ' HA ' ' HB2' ' A' ' 100' ' ' ARG . 14.9 pm0 -77.21 -22.56 52.14 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.834 0.453 . . . . 0.0 111.74 -177.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.61 HD13 ' ND2' ' A' ' 133' ' ' ASN . 32.7 mt -58.53 -39.17 79.4 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.089 0.556 . . . . 0.0 110.491 169.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.3 m -108.32 20.96 17.98 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.278 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.714 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 6.5 tpt180 -71.29 143.05 50.46 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.75 0.42 . . . . 0.0 110.861 -174.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -96.12 104.99 16.98 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.113 0.965 . . . . 0.0 109.563 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . 0.401 ' HE1' ' NH1' ' A' ' 148' ' ' ARG . 46.0 p-90 -137.04 172.66 12.67 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.216 1.006 . . . . 0.0 110.496 -177.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -138.38 166.22 24.8 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.611 0.764 . . . . 0.0 110.657 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.415 ' HG2' ' HB2' ' A' ' 120' ' ' ASP . 55.9 mtm -122.16 129.19 52.08 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.286 1.034 . . . . 0.0 109.105 172.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 56.3 tp -71.38 -40.62 70.45 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.023 0.929 . . . . 0.0 110.034 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 24.1 mmt -125.0 77.97 66.48 Favored Pre-proline 0 N--CA 1.483 1.194 0 C-N-CA 124.404 1.082 . . . . 0.0 109.451 174.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.43 111.93 3.43 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.627 2.218 . . . . 0.0 112.352 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -87.04 111.2 20.65 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 172.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -89.21 116.8 27.72 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.547 0.339 . . . . 0.0 110.271 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.406 ' HG2' HG13 ' A' ' 180' ' ' VAL . 14.4 tppt? -127.47 140.23 52.29 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.983 1.313 . . . . 0.0 109.332 174.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.56 HG12 HD12 ' A' ' 163' ' ' LEU . 79.5 t -123.24 99.5 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 166.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.496 ' HG2' HG21 ' A' ' 180' ' ' VAL . 9.1 tp10 -104.3 95.56 6.04 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -175.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.16 -125.91 19.19 Favored Glycine 0 CA--C 1.536 1.362 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.39 -176.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -85.75 6.38 5.59 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 123.246 2.63 . . . . 0.0 112.875 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.42 HD11 ' HB3' ' A' ' 177' ' ' ALA . 73.6 mt -123.51 144.32 49.62 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.345 0.658 . . . . 0.0 109.666 -171.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 46.4 t -107.66 115.58 30.4 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.322 0.649 . . . . 0.0 109.458 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.0 mm -99.72 133.71 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.2 mtm180 -134.42 120.98 20.47 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.66 0.784 . . . . 0.0 108.946 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.546 HG12 HD12 ' A' ' 181' ' ' LEU . 49.6 mt -126.06 132.47 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.391 1.077 . . . . 0.0 108.988 -173.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.421 ' OD2' HG12 ' A' ' 123' ' ' ILE . 16.7 t70 -89.29 120.09 30.34 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 118.064 0.393 . . . . 0.0 109.958 176.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.466 ' HA ' ' ND2' ' A' ' 188' ' ' ASN . 82.2 mt-30 -91.35 2.21 56.56 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.74 0.816 . . . . 0.0 113.118 -175.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.11 -27.82 16.04 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 174.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.421 HG12 ' OD2' ' A' ' 120' ' ' ASP . 22.5 mm -78.49 95.03 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.685 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.488 ' HE1' ' HA ' ' A' ' 188' ' ' ASN . 37.4 mtt -122.74 149.33 44.24 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.045 -178.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.0 t70 65.55 52.1 1.41 Allowed 'General case' 0 N--CA 1.484 1.23 0 O-C-N 124.529 1.143 . . . . 0.0 110.928 175.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -130.03 156.1 45.05 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.068 0.947 . . . . 0.0 110.691 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -95.64 108.27 20.54 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 170.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.528 ' HB ' HG12 ' A' ' 192' ' ' VAL . 58.7 mt -113.66 143.56 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.761 0.824 . . . . 0.0 111.186 -171.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.548 ' HE2' ' HA ' ' A' ' 195' ' ' SER . 12.4 tpt -118.41 122.85 43.79 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.324 1.05 . . . . 0.0 108.912 -177.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.412 HD12 HG22 ' A' ' 194' ' ' VAL . 12.1 mt -94.79 103.87 15.77 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -175.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -118.37 140.74 49.37 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.948 0.899 . . . . 0.0 109.974 -170.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -135.6 154.12 51.44 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 122.581 1.181 . . . . 0.0 114.141 -171.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.61 ' ND2' HD13 ' A' ' 98' ' ' LEU . 3.3 m-20 -108.06 127.63 53.96 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 162.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -156.21 159.6 39.09 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.682 0.614 . . . . 0.0 110.556 -176.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.2 t -86.3 162.85 18.04 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 173.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.8 t -135.02 133.87 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.625 1.17 . . . . 0.0 109.132 -174.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.6 tp -148.88 145.81 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 172.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 59.21 30.47 20.24 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.741 0.816 . . . . 0.0 111.3 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 64.06 17.74 10.81 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.057 1.343 . . . . 0.0 112.096 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -127.36 175.39 8.23 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.899 0.88 . . . . 0.0 110.0 176.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.484 HD23 ' HA ' ' A' ' 171' ' ' ILE . 9.1 tt -67.33 123.46 20.42 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.545 0.738 . . . . 0.0 109.119 175.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -82.99 -70.19 0.57 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.137 0.575 . . . . 0.0 109.886 174.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 61.4 m -147.92 129.34 14.85 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.88 0.872 . . . . 0.0 109.656 -174.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 59.3 tp -72.3 134.55 45.59 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.768 0.827 . . . . 0.0 110.46 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 66.1 mt -96.16 -43.48 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.924 0.89 . . . . 0.0 110.102 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.428 HD21 ' NH2' ' A' ' 148' ' ' ARG . 40.9 tp -169.5 149.12 3.9 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.922 0.889 . . . . 0.0 109.253 174.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.667 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 7.5 tt -136.0 144.93 45.59 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.691 ' HD3' HD12 ' A' ' 156' ' ' ILE . 71.7 mtt-85 -142.54 146.75 34.98 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.224 1.01 . . . . 0.0 109.939 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.73 118.72 37.47 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.239 1.016 . . . . 0.0 108.844 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -110.25 128.94 55.77 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.277 1.031 . . . . 0.0 110.397 -174.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 31.4 p -76.8 179.27 6.21 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.022 0.529 . . . . 0.0 111.022 172.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -61.97 -21.02 64.48 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.884 0.874 . . . . 0.0 112.02 174.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -83.04 -1.54 52.98 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.801 1.24 . . . . 0.0 111.569 176.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 69.0 18.23 72.51 Favored Glycine 0 C--N 1.357 1.709 0 CA-C-N 116.456 -0.338 . . . . 0.0 112.847 -173.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -92.57 129.47 38.49 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.383 0.673 . . . . 0.0 109.419 -174.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.691 HD12 ' HD3' ' A' ' 148' ' ' ARG . 24.4 mt -79.97 109.26 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.1 m -117.08 -0.55 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.974 0.91 . . . . 0.0 111.397 -173.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -150.22 164.47 29.71 Favored Glycine 0 C--N 1.34 0.76 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -165.57 144.39 6.23 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 117.149 0.475 . . . . 0.0 110.595 -174.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.667 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 73.8 mt -127.05 102.84 10.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.1 t -106.79 112.62 63.39 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 123.366 0.666 . . . . 0.0 109.579 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -58.96 128.26 27.26 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.749 2.299 . . . . 0.0 111.983 174.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.56 HD12 HG12 ' A' ' 111' ' ' VAL . 88.8 mt . . . . . 0 CA--C 1.548 0.873 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.202 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 42.3 p-80 . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 120.993 0.425 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 19.2 m -106.56 158.16 17.14 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.269 1.027 . . . . 0.0 110.064 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.484 ' HA ' HD23 ' A' ' 141' ' ' LEU . 2.8 tt -48.22 -39.78 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 125.563 1.545 . . . . 0.0 113.024 174.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -63.54 -34.17 77.21 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.55 0.74 . . . . 0.0 111.687 -174.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -65.98 -37.05 84.96 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.861 0.864 . . . . 0.0 110.546 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 25.5 t -68.63 -34.95 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 123.865 0.728 . . . . 0.0 110.611 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -64.24 -38.27 90.47 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 120.486 0.184 . . . . 0.0 110.707 176.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -63.16 -47.21 83.64 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 123.992 0.808 . . . . 0.0 109.568 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.42 ' HB3' HD11 ' A' ' 115' ' ' LEU . . . -60.41 -48.78 80.27 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 114.29 -1.323 . . . . 0.0 112.2 -175.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 68.5 mt -67.42 -38.73 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 123.779 0.674 . . . . 0.0 109.418 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.26 -30.07 76.42 Favored Glycine 0 CA--C 1.536 1.372 0 O-C-N 123.328 0.392 . . . . 0.0 113.677 176.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.496 HG21 ' HG2' ' A' ' 112' ' ' GLU . 43.2 t -76.45 -43.73 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.663 0.785 . . . . 0.0 110.32 175.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.546 HD12 HG12 ' A' ' 119' ' ' ILE . 36.6 tp -56.53 -49.04 75.92 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.727 0.811 . . . . 0.0 110.509 175.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.459 ' O ' ' HG2' ' A' ' 186' ' ' GLU . 77.3 mt -61.54 -52.18 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.14 0.976 . . . . 0.0 110.272 174.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -54.99 -36.26 60.41 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 124.153 0.908 . . . . 0.0 114.141 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.13 -41.34 47.69 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 112.235 -0.346 . . . . 0.0 112.235 174.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.456 HD13 HG13 ' A' ' 192' ' ' VAL . 35.5 mt -69.79 -16.49 63.3 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.304 1.042 . . . . 0.0 111.944 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 20.5 mm-40 -70.81 -39.27 73.18 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 171.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -77.83 -34.48 51.89 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.451 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.488 ' HA ' ' HE1' ' A' ' 124' ' ' MET . 7.9 m-20 -72.59 -13.63 61.43 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.692 170.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 38.6 t70 57.57 67.63 0.95 Allowed 'General case' 0 C--N 1.355 0.842 0 C-N-CA 125.556 1.542 . . . . 0.0 111.367 176.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -124.92 139.2 54.05 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.484 -1.235 . . . . 0.0 107.843 175.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 86.7 m -79.54 102.44 8.84 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.528 HG12 ' HB ' ' A' ' 128' ' ' ILE . 34.0 m -107.57 147.58 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 121.505 0.669 . . . . 0.0 110.983 -173.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -135.79 139.93 43.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 113.957 -1.474 . . . . 0.0 107.779 175.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.412 HG22 HD12 ' A' ' 130' ' ' LEU . 16.5 t -89.42 155.96 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.548 ' HA ' ' HE2' ' A' ' 129' ' ' MET . 28.8 t -56.1 151.75 11.68 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.186 0.595 . . . . 0.0 112.172 -178.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.78 -44.73 82.15 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 124.04 0.838 . . . . 0.0 109.861 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 63.7 p -65.83 -49.3 68.69 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 113.93 -1.486 . . . . 0.0 110.516 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 54.9 mt -62.56 -35.06 78.28 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.321 0.649 . . . . 0.0 110.868 -177.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.537 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 42.0 mt-30 -62.39 -34.06 75.98 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.775 0.83 . . . . 0.0 111.775 -176.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.16 -30.54 10.14 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -76.48 -33.42 58.67 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.218 0.607 . . . . 0.0 111.562 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.418 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -121.13 -58.18 1.81 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.174 0.59 . . . . 0.0 110.643 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.537 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 27.7 t-105 . . . . . 0 CA--C 1.555 1.167 0 C-N-CA 125.026 1.33 . . . . 0.0 111.225 -166.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -100.82 100.98 11.71 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.536 0.734 . . . . 0.0 109.658 -175.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 50.8 mm -78.41 120.5 29.45 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.088 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 174.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 62.2 p -114.49 97.38 6.27 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -88.84 -25.56 22.12 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.513 0.325 . . . . 0.0 110.301 -178.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.507 ' HB3' ' HG3' ' A' ' 97' ' ' GLU . 2.7 mpp? -101.44 144.24 30.47 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.897 0.879 . . . . 0.0 108.945 172.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.3 m -72.94 161.05 31.17 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.328 0.651 . . . . 0.0 109.533 171.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.0 mp -55.69 -39.26 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.612 0.765 . . . . 0.0 111.373 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -65.37 -52.37 54.09 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.446 0.699 . . . . 0.0 111.699 -175.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.507 ' HG3' ' HB3' ' A' ' 93' ' ' MET . 11.3 pt-20 -70.25 -26.73 63.97 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 122.903 0.481 . . . . 0.0 111.532 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.1 tt -66.56 -44.29 82.73 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.732 0.813 . . . . 0.0 109.787 174.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 39.1 t -99.66 20.63 13.68 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.95 0.9 . . . . 0.0 110.734 -177.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.435 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 20.4 tpt180 -80.09 136.46 36.55 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.532 0.733 . . . . 0.0 111.657 -176.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -84.94 136.15 33.74 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 170.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 16.6 p-90 -144.14 137.74 27.68 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.229 1.012 . . . . 0.0 109.52 -175.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -94.73 138.19 32.86 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.505 ' HE1' ' HA ' ' A' ' 107' ' ' PRO . 18.1 ptm -123.97 124.11 41.86 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 173.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.431 ' H ' HD22 ' A' ' 105' ' ' LEU . 1.6 pt? -82.55 -25.21 33.55 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.114 0.566 . . . . 0.0 111.571 -171.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 23.4 mmt -123.23 80.87 52.3 Favored Pre-proline 0 N--CA 1.475 0.816 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 175.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.505 ' HA ' ' HE1' ' A' ' 104' ' ' MET . 3.8 Cg_exo -76.04 110.66 3.12 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.493 2.129 . . . . 0.0 112.12 -177.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -95.96 112.28 24.05 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 165.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.499 ' NE2' ' SG ' ' A' ' 116' ' ' CYS . 0.0 OUTLIER -91.95 98.82 11.81 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 179.068 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.52 ' HG2' HG13 ' A' ' 180' ' ' VAL . 51.2 tptt -107.65 147.2 31.0 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.243 1.017 . . . . 0.0 108.906 177.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 51.5 t -130.68 129.18 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 172.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -135.88 104.83 5.87 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.43 -148.62 42.49 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 119.507 -0.607 . . . . 0.0 111.958 -175.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -73.89 13.11 0.84 Allowed 'Trans proline' 0 CA--C 1.555 1.552 0 C-N-CA 123.37 2.713 . . . . 0.0 114.097 173.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.2 mp -125.35 152.28 44.96 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.754 0.822 . . . . 0.0 108.802 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.499 ' SG ' ' NE2' ' A' ' 109' ' ' GLN . 23.5 t -109.07 140.45 42.6 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.328 0.651 . . . . 0.0 110.029 175.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.7 mm -111.34 147.57 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.625 0.77 . . . . 0.0 109.518 178.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -124.86 119.98 30.38 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.405 HD13 ' HA ' ' A' ' 181' ' ' LEU . 27.6 mm -116.05 123.9 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 175.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -90.96 116.68 28.95 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 168.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -75.18 -16.63 60.49 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.552 0.741 . . . . 0.0 112.484 -173.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.44 -35.58 19.6 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.428 0.691 . . . . 0.0 112.128 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.85 109.95 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-O 121.994 0.902 . . . . 0.0 109.304 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.435 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 51.2 mtt -135.17 156.22 49.37 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 113.908 -1.496 . . . . 0.0 109.602 -177.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.3 t70 61.61 24.08 14.26 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 124.713 1.205 . . . . 0.0 112.228 174.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 54.3 mmtt -104.55 146.13 29.33 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 121.657 -0.652 . . . . 0.0 111.466 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.548 ' HA ' ' HB ' ' A' ' 191' ' ' THR . 0.8 OUTLIER -83.96 102.41 12.42 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 174.586 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.485 HD12 HD21 ' A' ' 185' ' ' LEU . 59.4 mt -114.95 141.07 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 123.681 0.793 . . . . 0.0 110.496 -172.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 14.0 tpt -117.59 131.42 56.68 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.304 1.042 . . . . 0.0 109.326 -174.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 2.9 mm? -91.4 104.4 16.92 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -118.45 136.1 53.98 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.365 1.066 . . . . 0.0 109.613 -171.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.448 ' HB1' ' HG ' ' A' ' 147' ' ' LEU . . . -142.22 152.52 43.16 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 -177.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -110.79 131.11 55.32 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 114.138 -1.392 . . . . 0.0 107.267 167.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.473 ' HA ' HG13 ' A' ' 145' ' ' ILE . 44.1 p90 -161.93 164.69 28.34 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.13 0.572 . . . . 0.0 111.4 -171.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.6 p -92.91 161.27 14.54 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.852 0.861 . . . . 0.0 109.667 173.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 54.8 t -128.27 133.36 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 124.288 1.035 . . . . 0.0 109.854 -176.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 8.7 tp -143.83 144.98 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 60.34 32.77 20.78 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.003 0.921 . . . . 0.0 112.447 174.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.7 t70 76.41 -0.07 3.13 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 124.555 1.142 . . . . 0.0 111.982 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -126.73 179.94 5.11 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.377 1.071 . . . . 0.0 110.136 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.521 ' HB3' HG13 ' A' ' 171' ' ' ILE . 9.9 tt -70.09 136.3 50.09 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.853 0.461 . . . . 0.0 109.877 177.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -91.48 -66.72 0.9 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.736 0.814 . . . . 0.0 110.517 174.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 75.9 m -145.96 130.0 17.41 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.513 0.725 . . . . 0.0 109.713 -174.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.445 HD22 ' HB2' ' A' ' 147' ' ' LEU . 40.6 tp -72.34 129.83 39.3 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 173.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.473 HG13 ' HA ' ' A' ' 134' ' ' PHE . 66.1 mt -87.14 -51.1 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 174.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 59.0 tp -163.77 147.42 10.11 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.225 1.01 . . . . 0.0 109.227 175.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.651 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 7.0 tt -131.8 148.15 52.54 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 173.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.498 HH11 HG21 ' A' ' 156' ' ' ILE . 55.2 mtt-85 -142.92 148.23 36.58 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.18 0.992 . . . . 0.0 109.857 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.438 ' HB2' HD22 ' A' ' 181' ' ' LEU . . . -105.63 112.39 25.45 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.354 1.062 . . . . 0.0 108.499 175.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -106.2 130.16 54.12 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.403 0.681 . . . . 0.0 110.347 -177.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 28.3 p -71.29 174.01 7.03 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.069 0.548 . . . . 0.0 110.991 170.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.42 -18.26 64.4 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.433 0.693 . . . . 0.0 111.349 171.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -64.08 -29.7 70.82 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.952 0.901 . . . . 0.0 110.76 168.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 91.91 20.6 36.1 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.747 -173.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -103.31 134.48 46.62 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.815 0.846 . . . . 0.0 110.668 -175.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.498 HG21 HH11 ' A' ' 148' ' ' ARG . 16.2 mt -73.87 116.03 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.43 -1.06 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.685 0.794 . . . . 0.0 110.787 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -157.13 161.86 31.42 Favored Glycine 0 C--N 1.334 0.417 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -162.0 150.46 15.11 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 117.482 0.641 . . . . 0.0 109.968 -172.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.651 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 67.5 mt -129.34 103.71 9.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 167.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.5 t -107.34 106.45 58.4 Favored Pre-proline 0 C--O 1.243 0.757 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.45 117.59 4.31 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.997 2.465 . . . . 0.0 112.258 175.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.7 mt . . . . . 0 CA--C 1.548 0.879 0 C-N-CA 123.738 0.815 . . . . 0.0 111.985 -173.029 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 . . . . . 0 C--O 1.243 0.747 0 CA-C-O 121.377 0.608 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 27.9 m -99.58 164.46 12.06 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.279 1.031 . . . . 0.0 109.385 174.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.521 HG13 ' HB3' ' A' ' 141' ' ' LEU . 7.7 tt -49.83 -36.41 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 124.613 1.165 . . . . 0.0 112.051 174.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -60.59 -39.63 88.81 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.348 1.059 . . . . 0.0 111.308 -177.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -66.31 -36.6 83.36 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.461 0.705 . . . . 0.0 110.969 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.505 ' O ' HG13 ' A' ' 178' ' ' ILE . 46.3 t -65.19 -39.68 86.27 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.687 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.245 175.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.435 ' HE2' ' O ' ' A' ' 202' ' ' ALA . 88.1 mttt -58.79 -45.54 89.63 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.117 0.567 . . . . 0.0 110.775 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.475 ' O ' HG22 ' A' ' 180' ' ' VAL . 53.6 m-80 -64.15 -43.29 95.66 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.182 177.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.2 -50.27 74.11 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.209 0.943 . . . . 0.0 111.568 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 174' ' ' VAL . 39.9 mt -62.84 -40.27 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -58.69 -32.99 70.66 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 115.474 -0.785 . . . . 0.0 113.88 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.52 HG13 ' HG2' ' A' ' 110' ' ' LYS . 41.0 t -73.09 -46.38 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 117.041 0.421 . . . . 0.0 110.039 177.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.471 HD21 HG13 ' A' ' 160' ' ' ILE . 21.7 tp -61.77 -46.37 89.87 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 123.79 0.682 . . . . 0.0 110.825 -177.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 75.4 mt -61.41 -50.39 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.547 0.739 . . . . 0.0 110.078 175.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 187' ' ' ARG . . . -53.99 -47.85 64.87 Favored Glycine 0 C--N 1.346 1.13 0 O-C-N 124.201 0.938 . . . . 0.0 113.629 -177.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.19 -40.86 99.16 Favored Glycine 0 C--N 1.344 0.974 0 C-N-CA 123.164 0.411 . . . . 0.0 112.23 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.485 HD21 HD12 ' A' ' 128' ' ' ILE . 96.7 mt -63.7 -39.58 94.66 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.421 0.688 . . . . 0.0 111.084 176.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -67.75 -35.29 78.46 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.487 0.715 . . . . 0.0 110.984 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' ' 183' ' ' GLY . 12.6 mmp_? -75.04 -27.48 60.05 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.81 0.444 . . . . 0.0 110.63 177.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.435 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 6.1 m-20 -81.02 -7.12 59.49 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.304 0.641 . . . . 0.0 110.898 170.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 38.7 t70 63.33 67.18 0.67 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.051 1.341 . . . . 0.0 111.328 -176.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -119.0 145.95 45.42 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.847 0.859 . . . . 0.0 109.074 175.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.548 ' HB ' ' HA ' ' A' ' 127' ' ' ASN . 28.2 m -76.99 107.51 9.39 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -178.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 18.0 m -101.85 134.85 41.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 121.265 0.555 . . . . 0.0 110.865 -172.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -143.9 133.87 24.06 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.321 1.048 . . . . 0.0 108.273 169.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.501 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 5.2 t -90.87 151.51 3.49 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 48.0 t -59.06 139.14 57.16 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 175.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -62.44 -25.29 67.89 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.985 0.514 . . . . 0.0 111.19 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 67.0 p -76.33 -44.59 36.02 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.213 0.605 . . . . 0.0 109.378 175.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.401 HD22 ' HB3' ' A' ' 132' ' ' ALA . 28.4 mt -58.65 -33.37 70.01 Favored 'General case' 0 C--O 1.2 -1.524 0 C-N-CA 122.713 0.405 . . . . 0.0 111.493 172.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.492 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 50.6 mt-30 -76.92 -41.2 44.44 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.999 0.52 . . . . 0.0 110.412 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 41.6 tpt85 -62.73 -43.23 99.35 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.282 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -100.72 -49.07 4.29 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.446 -169.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.435 ' O ' ' HE2' ' A' ' 175' ' ' LYS . . . -97.19 -57.4 2.27 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -167.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.492 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 49.4 t-105 . . . . . 0 N--CA 1.48 1.042 0 C-N-CA 124.621 1.168 . . . . 0.0 112.271 -164.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 . . . . . 0 N--CA 1.473 0.692 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -104.71 101.71 11.32 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 177.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 133' ' ' ASN . 38.5 mm -75.93 129.59 36.93 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 68.6 p -122.14 80.7 1.74 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.844 0.858 . . . . 0.0 108.783 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.454 ' HB2' ' HB3' ' A' ' 131' ' ' LYS . 37.8 m-20 -69.84 -31.25 69.0 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 121.855 0.836 . . . . 0.0 109.55 172.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.581 ' HG3' ' HG3' ' A' ' 97' ' ' GLU . 25.1 ttp -102.69 121.81 43.17 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.142 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.4 m -72.97 155.65 39.63 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.832 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.8 mp -53.59 -34.3 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 C-N-CA 123.958 0.903 . . . . 0.0 111.084 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -50.9 -68.39 0.17 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.878 1.271 . . . . 0.0 112.108 173.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.581 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 9.9 pt-20 -71.13 -22.64 62.05 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.329 1.052 . . . . 0.0 112.063 -178.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.543 ' HG ' HD22 ' A' ' 146' ' ' LEU . 9.8 tt -66.72 -45.37 78.92 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.221 1.008 . . . . 0.0 110.347 174.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.9 t -98.94 1.63 45.76 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.39 0.676 . . . . 0.0 111.323 -175.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -61.01 140.88 57.72 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.554 0.742 . . . . 0.0 111.121 175.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -86.24 142.27 28.69 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.125 0.57 . . . . 0.0 109.751 171.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 28.7 p-90 -152.85 156.83 39.75 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.34 -170.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -111.26 155.24 23.3 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.265 1.026 . . . . 0.0 110.579 -175.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.517 ' HE3' ' HA ' ' A' ' 107' ' ' PRO . 93.8 mtp -128.43 109.23 11.22 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.113 0.965 . . . . 0.0 108.464 166.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.4 tp -67.92 -49.5 61.51 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.637 0.775 . . . . 0.0 110.261 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.46 ' HG2' ' HB2' ' A' ' 122' ' ' ALA . 97.7 mmm -119.95 82.19 28.19 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 124.151 0.98 . . . . 0.0 109.54 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.517 ' HA ' ' HE3' ' A' ' 104' ' ' MET . 69.1 Cg_endo -71.9 125.72 11.26 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.506 2.138 . . . . 0.0 112.675 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -95.76 110.18 22.37 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 166.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 20.4 tm0? -80.43 106.08 12.17 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 176.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.454 ' HG2' HG11 ' A' ' 180' ' ' VAL . 22.7 tptm -130.01 143.99 51.09 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.817 0.847 . . . . 0.0 108.745 170.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.446 HG11 HD11 ' A' ' 163' ' ' LEU . 63.1 t -131.72 122.16 49.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 168.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -109.18 97.56 7.15 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.29 -126.14 8.07 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 119.083 -0.843 . . . . 0.0 111.724 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.589 ' HG2' ' HB3' ' A' ' 169' ' ' HIS . 42.3 Cg_endo -98.26 31.88 0.13 Allowed 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 123.408 2.739 . . . . 0.0 111.74 172.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 162' ' ' PRO . 90.4 mt -131.17 123.97 29.67 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.177 0.991 . . . . 0.0 109.448 -178.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 16.6 p -83.78 122.69 29.01 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.445 0.698 . . . . 0.0 109.92 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.4 mm -103.11 106.65 20.48 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 C-N-CA 123.69 0.796 . . . . 0.0 109.3 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.606 ' HD2' ' HB3' ' A' ' 159' ' ' GLU . 77.2 mtt85 -95.93 119.92 35.29 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.76 0.824 . . . . 0.0 108.834 176.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.5 HD12 ' HA3' ' A' ' 184' ' ' GLY . 82.3 mt -129.76 123.79 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 124.401 1.08 . . . . 0.0 108.307 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -92.65 128.37 38.48 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.322 0.582 . . . . 0.0 110.029 177.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.484 ' HA ' ' ND2' ' A' ' 188' ' ' ASN . 75.1 mt-30 -91.13 -11.45 38.49 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.233 -174.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.46 ' HB2' ' HG2' ' A' ' 106' ' ' MET . . . -79.41 -49.43 12.35 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 120.997 0.427 . . . . 0.0 110.589 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.543 HG12 HG12 ' A' ' 157' ' ' VAL . 1.7 mp -71.34 109.73 3.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.288 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 50.3 mtt -131.61 159.2 38.97 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 113.693 -1.594 . . . . 0.0 109.554 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.4 t70 67.97 18.36 9.53 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 125.288 1.435 . . . . 0.0 112.295 174.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -103.61 151.99 22.28 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.585 0.754 . . . . 0.0 111.162 -176.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -84.31 102.2 12.51 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 168.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.5 HD13 HD22 ' A' ' 185' ' ' LEU . 44.3 mt -103.28 124.12 57.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -176.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.5 ' HG3' ' HG3' ' A' ' 131' ' ' LYS . 14.0 tpt -98.61 126.65 44.27 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.435 1.094 . . . . 0.0 109.069 -175.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.432 HD13 HG21 ' A' ' 194' ' ' VAL . 12.4 mt -105.79 103.43 12.93 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -174.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.5 ' HG3' ' HG3' ' A' ' 129' ' ' MET . 45.1 mtmt -126.5 150.95 48.44 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.037 0.535 . . . . 0.0 109.981 -176.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -136.91 153.68 50.67 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.907 0.86 . . . . 0.0 112.304 -174.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 4.6 m-20 -107.5 120.77 43.11 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 162.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -156.4 160.18 39.4 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.264 0.626 . . . . 0.0 111.02 -170.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 53.5 p -86.28 151.22 23.78 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.749 0.819 . . . . 0.0 109.226 174.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.0 t -130.55 132.75 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.381 1.073 . . . . 0.0 108.477 -177.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.3 tp -140.78 140.68 33.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 174.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 58.19 31.04 20.29 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.933 0.893 . . . . 0.0 111.946 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 63.31 30.88 15.59 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 124.97 1.308 . . . . 0.0 112.338 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 7.8 ppt_? -143.65 165.68 26.95 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.226 0.61 . . . . 0.0 109.687 173.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.462 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 10.5 tt -66.48 121.56 15.59 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.313 0.645 . . . . 0.0 109.742 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -82.31 -67.14 0.81 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.257 0.623 . . . . 0.0 110.281 173.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 62.2 m -141.96 127.4 18.87 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.885 0.474 . . . . 0.0 109.843 -173.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.639 HD12 ' HB2' ' A' ' 147' ' ' LEU . 51.9 tp -77.37 114.56 16.33 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.716 0.807 . . . . 0.0 109.545 178.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 57.1 mt -77.82 -52.65 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 175.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.543 HD22 ' HG ' ' A' ' 98' ' ' LEU . 50.2 tp -158.82 145.12 16.92 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.452 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.639 ' HB2' HD12 ' A' ' 144' ' ' LEU . 8.2 tt -139.26 152.25 47.13 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 176.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.715 HH11 HG22 ' A' ' 156' ' ' ILE . 6.8 ptp180 -150.73 157.44 42.96 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 122.046 0.927 . . . . 0.0 112.503 174.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.658 ' HB2' HD22 ' A' ' 181' ' ' LEU . . . -117.55 117.78 30.36 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 113.346 -1.752 . . . . 0.0 107.317 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -145.64 145.1 30.8 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.049 0.452 . . . . 0.0 111.709 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 80.5 p -65.13 163.28 15.29 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.457 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -64.82 -19.6 65.94 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -84.59 -1.46 55.98 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.164 0.586 . . . . 0.0 111.4 176.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 97.45 -5.25 62.5 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-O 119.931 -0.372 . . . . 0.0 114.005 172.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.99 105.97 6.26 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.991 0.395 . . . . 0.0 110.085 -175.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.715 HG22 HH11 ' A' ' 148' ' ' ARG . 13.8 mt -79.51 126.65 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.543 HG12 HG12 ' A' ' 123' ' ' ILE . 24.2 m -134.63 5.41 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 123.902 0.881 . . . . 0.0 110.964 -174.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -153.27 156.06 26.52 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.606 ' HB3' ' HD2' ' A' ' 118' ' ' ARG . 40.5 tt0 -164.83 141.64 6.01 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.802 0.441 . . . . 0.0 110.368 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.5 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 72.2 mt -120.62 121.64 65.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 172.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 15.5 m -137.52 148.13 60.32 Favored Pre-proline 0 N--CA 1.469 0.509 0 C-N-CA 123.272 0.629 . . . . 0.0 109.898 -177.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.449 ' HA ' HD23 ' A' ' 115' ' ' LEU . 18.1 Cg_endo -61.01 134.46 53.19 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 121.864 1.709 . . . . 0.0 110.302 165.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.446 HD11 HG11 ' A' ' 111' ' ' VAL . 66.2 mt . . . . . 0 CA--C 1.548 0.901 0 C-N-CA 123.266 0.626 . . . . 0.0 110.886 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.589 ' HB3' ' HG2' ' A' ' 114' ' ' PRO . 25.4 p-80 . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 121.181 0.515 . . . . 0.0 110.663 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 65.2 p -98.43 -178.62 4.08 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.471 169.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.462 ' HB ' ' O ' ' A' ' 141' ' ' LEU . 5.8 tt -54.6 -41.85 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.152 171.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.546 ' HA ' ' HD3' ' A' ' 175' ' ' LYS . 14.7 mm-40 -56.91 -41.35 77.99 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.366 1.066 . . . . 0.0 111.613 -176.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -64.05 -40.17 95.7 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.372 0.669 . . . . 0.0 111.018 178.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 46.2 t -68.1 -32.65 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.175 0.59 . . . . 0.0 110.604 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.546 ' HD3' ' HA ' ' A' ' 172' ' ' GLU . 27.3 mtpp -62.08 -42.92 99.7 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.564 0.745 . . . . 0.0 110.684 176.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.485 ' O ' HG22 ' A' ' 180' ' ' VAL . 60.7 m-80 -68.58 -41.27 79.9 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.143 175.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.99 -53.28 60.01 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 124.416 1.073 . . . . 0.0 112.008 -175.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 49.9 mt -63.19 -35.43 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 O-C-N 123.604 0.565 . . . . 0.0 109.756 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.19 -32.09 81.15 Favored Glycine 0 C--N 1.347 1.155 0 CA-C-N 116.159 -0.473 . . . . 0.0 114.082 177.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 176' ' ' ASN . 98.0 t -73.0 -44.66 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.658 HD22 ' HB2' ' A' ' 149' ' ' ALA . 48.9 tp -54.44 -49.76 69.27 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.261 1.025 . . . . 0.0 110.674 176.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.457 HD11 ' CH2' ' A' ' 203' ' ' TRP . 17.8 mt -63.88 -45.66 96.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.929 0.891 . . . . 0.0 110.979 176.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -55.1 -36.87 62.15 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 123.893 0.746 . . . . 0.0 113.811 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.5 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -70.07 -48.75 38.0 Favored Glycine 0 C--N 1.347 1.142 0 N-CA-C 111.793 -0.523 . . . . 0.0 111.793 174.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.5 HD22 HD13 ' A' ' 128' ' ' ILE . 97.7 mt -64.19 -31.97 73.37 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.985 0.914 . . . . 0.0 112.419 -176.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -66.24 -41.99 89.23 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.419 0.688 . . . . 0.0 111.121 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -74.84 -34.65 62.34 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.216 0.607 . . . . 0.0 110.417 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.484 ' ND2' ' HA ' ' A' ' 121' ' ' GLN . 6.0 m-20 -67.28 -15.14 63.52 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.344 0.657 . . . . 0.0 110.297 169.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 21.9 t70 64.49 65.99 0.62 Allowed 'General case' 0 C--N 1.349 0.577 0 C-N-CA 125.799 1.64 . . . . 0.0 110.223 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -121.95 139.69 53.36 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 175.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 74.0 m -78.46 104.81 9.3 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 23.9 m -80.77 130.23 36.24 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.591 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.4 ' HG2' ' SD ' ' A' ' 129' ' ' MET . 38.5 ttp180 -133.36 123.07 24.74 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 173.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.432 HG21 HD13 ' A' ' 130' ' ' LEU . 4.3 t -101.82 150.05 6.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 -175.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 34.0 t -58.68 143.48 46.54 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.867 0.467 . . . . 0.0 111.146 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -57.01 -32.96 66.67 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.939 0.896 . . . . 0.0 111.25 -178.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 67.8 p -72.02 -48.49 44.24 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.582 175.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 58.3 mt -62.67 -36.45 82.92 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.107 0.563 . . . . 0.0 110.389 -177.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.472 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 42.2 mt-30 -55.51 -33.79 64.05 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.596 1.159 . . . . 0.0 112.426 -177.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -101.25 -39.53 7.58 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -73.97 -38.03 64.3 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -168.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.428 ' O ' ' HG2' ' A' ' 175' ' ' LYS . . . -120.64 -57.7 1.88 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.896 0.478 . . . . 0.0 110.074 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.472 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 69.5 t-105 . . . . . 0 CA--C 1.556 1.188 0 C-N-CA 125.272 1.429 . . . . 0.0 114.057 -168.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 29.8 ttp-105 . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -99.65 109.52 22.0 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.834 0.853 . . . . 0.0 109.945 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.7 mm -78.85 121.68 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 123.783 0.833 . . . . 0.0 109.352 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.1 p -108.38 66.19 0.64 Allowed 'General case' 0 C--O 1.244 0.781 0 CA-C-O 122.672 1.225 . . . . 0.0 108.112 173.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.536 ' HB3' ' O ' ' A' ' 132' ' ' ALA . 19.1 t70 -68.95 -35.54 76.88 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 112.91 -1.95 . . . . 0.0 110.963 -177.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.569 ' HB3' ' HB3' ' A' ' 131' ' ' LYS . 26.2 ptt? -110.93 146.24 36.92 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 171.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.1 m -91.85 158.02 16.55 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.308 0.643 . . . . 0.0 111.069 -167.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.2 mp -58.53 -34.97 52.54 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 C-N-CA 124.122 0.969 . . . . 0.0 110.385 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -48.91 -43.02 38.94 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.358 1.063 . . . . 0.0 113.094 176.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.52 -24.45 15.56 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 122.847 0.459 . . . . 0.0 111.102 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.441 ' HA ' HH21 ' A' ' 148' ' ' ARG . 9.0 tt -67.46 -45.81 74.89 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.616 0.766 . . . . 0.0 110.128 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 26.4 t -96.32 10.93 36.46 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.561 1.144 . . . . 0.0 110.316 -175.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -74.23 136.02 42.72 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.049 0.54 . . . . 0.0 110.517 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -77.42 133.56 38.62 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 174.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 17.9 p-90 -150.76 171.35 17.33 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.661 0.784 . . . . 0.0 110.406 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -148.2 165.33 31.24 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.728 1.211 . . . . 0.0 108.665 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 62.3 mtp -110.37 127.77 55.24 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 36.2 tp -73.39 -40.84 64.01 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.411 0.684 . . . . 0.0 109.642 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.497 ' HG2' ' HB3' ' A' ' 122' ' ' ALA . 23.8 mmt -124.77 88.96 53.11 Favored Pre-proline 0 N--CA 1.482 1.134 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 169.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.18 112.38 2.74 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 122.995 2.464 . . . . 0.0 112.236 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.434 ' HB2' ' NE2' ' A' ' 121' ' ' GLN . 58.7 tptt -115.61 118.39 32.99 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 169.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -100.96 115.37 30.29 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.47 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 16.7 tppt? -120.9 159.84 24.7 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.429 1.092 . . . . 0.0 108.377 175.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.5 t -137.68 140.8 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -122.84 84.7 2.3 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 171.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.5 -116.71 7.2 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.883 175.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -85.25 8.84 4.39 Favored 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 123.227 2.618 . . . . 0.0 112.739 -177.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.8 mt -131.87 121.95 24.89 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.977 0.911 . . . . 0.0 109.021 -171.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.574 ' SG ' HD22 ' A' ' 163' ' ' LEU . 90.0 m -90.51 120.61 31.75 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.964 0.506 . . . . 0.0 111.252 -178.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.47 ' HB ' ' HB3' ' A' ' 110' ' ' LYS . 17.2 mm -86.64 155.3 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.358 0 C-N-CA 124.298 1.039 . . . . 0.0 110.034 -176.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -134.66 121.27 20.61 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.42 HD11 ' HA3' ' A' ' 184' ' ' GLY . 50.5 mm -123.7 122.85 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 123.416 0.686 . . . . 0.0 109.686 -177.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -98.64 115.45 28.7 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 172.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.434 ' NE2' ' HB2' ' A' ' 108' ' ' LYS . 44.4 mt-30 -84.08 -6.91 59.49 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.02 0.928 . . . . 0.0 113.327 -174.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.497 ' HB3' ' HG2' ' A' ' 106' ' ' MET . . . -87.7 -45.45 10.35 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.963 0.505 . . . . 0.0 110.301 177.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.448 HG12 HG11 ' A' ' 157' ' ' VAL . 1.8 mp -70.67 110.7 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-O 122.038 0.923 . . . . 0.0 110.006 -177.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.572 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 51.3 mtt -131.72 158.43 41.19 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.224 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.5 t70 67.82 13.47 9.2 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.757 1.223 . . . . 0.0 112.739 174.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -97.55 146.82 24.9 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.43 -0.793 . . . . 0.0 110.611 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.548 ' HB2' ' HB3' ' A' ' 152' ' ' GLU . 39.4 m-80 -82.73 97.74 8.72 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 174.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.45 HD12 HD22 ' A' ' 185' ' ' LEU . 53.4 mt -105.82 130.12 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.462 0.705 . . . . 0.0 110.111 -171.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 12.2 tpt -105.12 134.11 48.77 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.163 0.985 . . . . 0.0 110.026 -175.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 2.2 mm? -100.2 109.15 21.4 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.569 ' HB3' ' HB3' ' A' ' 93' ' ' MET . 40.9 mttm -127.56 152.0 48.18 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.049 0.939 . . . . 0.0 110.682 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.573 ' HB3' HD23 ' A' ' 198' ' ' LEU . . . -146.63 149.42 33.47 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -105.5 132.69 51.36 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 165.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.487 ' HA ' HG13 ' A' ' 145' ' ' ILE . 39.6 p90 -158.79 159.27 34.95 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.761 0.824 . . . . 0.0 109.979 -171.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.8 p -86.57 160.69 18.86 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.391 0.676 . . . . 0.0 109.695 173.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 77.7 t -128.0 135.79 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.36 1.064 . . . . 0.0 109.135 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 8.2 tp -142.08 139.46 30.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 170.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 57.25 33.8 23.84 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.776 0.83 . . . . 0.0 111.72 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 36.0 t70 67.35 8.82 6.54 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.892 1.277 . . . . 0.0 112.636 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 44.5 ptt85 -116.57 165.25 13.46 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.647 0.779 . . . . 0.0 110.033 176.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.418 ' HB3' HG13 ' A' ' 171' ' ' ILE . 8.5 tt -64.26 108.63 1.64 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.507 0.723 . . . . 0.0 109.204 175.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -68.18 -68.73 0.37 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.341 0.656 . . . . 0.0 110.334 177.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.6 m -143.68 130.56 20.44 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.418 -175.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.7 tp -73.16 124.88 26.46 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 175.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.487 HG13 ' HA ' ' A' ' 134' ' ' PHE . 70.1 mt -84.54 -49.86 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 176.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 48.2 tp -164.8 147.53 8.48 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.75 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.765 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 6.7 tt -134.06 153.52 51.75 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 176.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.486 ' N ' HD22 ' A' ' 147' ' ' LEU . 45.1 ttm-85 -143.23 147.25 34.54 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.546 0.738 . . . . 0.0 111.284 -173.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.593 ' HB1' HD23 ' A' ' 181' ' ' LEU . . . -120.69 111.3 17.44 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.791 1.237 . . . . 0.0 107.856 169.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 40.5 p90 -127.67 157.27 40.74 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.166 0.986 . . . . 0.0 108.756 -178.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.45 ' HG1' ' HB3' ' A' ' 155' ' ' ALA . 63.0 p -86.02 176.65 7.91 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.39 0.614 . . . . 0.0 111.122 -174.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.548 ' HB3' ' HB2' ' A' ' 127' ' ' ASN . 11.0 pt-20 -54.38 -35.78 63.19 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.912 1.285 . . . . 0.0 112.144 174.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -88.32 -9.22 53.52 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.115 0.966 . . . . 0.0 111.618 -177.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 100.63 -3.36 56.17 Favored Glycine 0 C--N 1.352 1.43 0 CA-C-O 120.016 -0.324 . . . . 0.0 113.471 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.45 ' HB3' ' HG1' ' A' ' 151' ' ' THR . . . -69.82 104.9 2.59 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.433 HD11 ' HD3' ' A' ' 148' ' ' ARG . 26.3 mt -69.87 124.28 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.178 0.591 . . . . 0.0 109.53 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.448 HG11 HG12 ' A' ' 123' ' ' ILE . 35.0 m -126.41 -3.68 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.737 0.815 . . . . 0.0 111.382 -174.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -155.31 164.96 32.19 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.651 -175.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -167.43 153.86 8.05 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.245 0.618 . . . . 0.0 109.528 -176.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.765 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 78.6 mt -125.75 102.99 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 165.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 84.0 p -99.0 110.42 57.66 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 123.61 0.764 . . . . 0.0 110.014 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.06 123.95 14.59 Favored 'Trans proline' 0 C--N 1.367 1.513 0 C-N-CA 122.921 2.414 . . . . 0.0 112.921 174.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.574 HD22 ' SG ' ' A' ' 116' ' ' CYS . 89.5 mt . . . . . 0 CA--C 1.544 0.723 0 C-N-CA 123.789 0.836 . . . . 0.0 110.714 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 44.5 p -84.57 160.58 20.43 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.493 0.663 . . . . 0.0 112.081 -174.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.418 HG13 ' HB3' ' A' ' 141' ' ' LEU . 11.4 tt -57.58 -32.1 41.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.648 170.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -72.85 -30.54 64.09 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.539 0.736 . . . . 0.0 111.353 -177.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -60.76 -39.72 89.82 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 122.843 0.457 . . . . 0.0 110.499 173.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 178' ' ' ILE . 38.5 t -64.88 -39.13 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 O-C-N 124.471 1.107 . . . . 0.0 110.2 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -59.26 -48.76 80.43 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.525 0.73 . . . . 0.0 111.459 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.447 ' O ' HG23 ' A' ' 180' ' ' VAL . 65.0 m-80 -65.71 -38.86 90.37 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.935 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.4 -43.4 97.65 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 124.137 0.898 . . . . 0.0 111.451 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 174' ' ' VAL . 60.5 mt -67.52 -34.1 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.9 -33.38 87.09 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 116.625 -0.262 . . . . 0.0 113.596 176.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 176' ' ' ASN . 97.8 t -78.71 -43.25 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.48 0.712 . . . . 0.0 110.353 177.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.593 HD23 ' HB1' ' A' ' 149' ' ' ALA . 38.6 tp -57.34 -54.79 42.81 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.819 0.848 . . . . 0.0 111.035 176.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.602 HG21 HG23 ' A' ' 192' ' ' VAL . 61.8 mt -58.06 -40.12 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 123.821 0.848 . . . . 0.0 110.225 170.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.4 -21.82 54.88 Favored Glycine 0 N--CA 1.475 1.28 0 N-CA-C 115.151 0.82 . . . . 0.0 115.151 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.42 ' HA3' HD11 ' A' ' 119' ' ' ILE . . . -95.74 -16.11 40.45 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 117.004 0.402 . . . . 0.0 112.751 173.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.45 HD22 HD12 ' A' ' 128' ' ' ILE . 81.9 mt -91.76 -32.66 15.31 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.408 1.083 . . . . 0.0 111.825 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 182' ' ' ILE . 0.4 OUTLIER -77.84 -31.8 51.76 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.136 0.574 . . . . 0.0 111.132 -173.439 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 8.7 ptm85 -70.23 -24.77 63.15 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.669 0.787 . . . . 0.0 110.942 173.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.572 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 4.2 m-20 -81.48 -10.88 59.39 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.79 0.836 . . . . 0.0 110.293 172.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 19.5 t70 57.63 65.79 1.26 Allowed 'General case' 0 C--N 1.358 0.975 0 C-N-CA 125.414 1.486 . . . . 0.0 110.2 -171.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -107.57 145.71 32.85 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.635 169.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.1 m -83.47 100.31 10.66 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.602 HG23 HG21 ' A' ' 182' ' ' ILE . 18.7 m -99.27 134.63 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 123.645 0.778 . . . . 0.0 110.571 -171.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -135.66 129.82 33.35 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.411 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 2.9 t -90.01 143.03 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 23.2 t -69.11 156.58 38.44 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -172.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -50.23 -49.5 52.73 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.312 1.045 . . . . 0.0 111.812 -176.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 38.1 p -61.18 -50.84 71.52 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 123.967 0.792 . . . . 0.0 110.19 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.573 HD23 ' HB3' ' A' ' 132' ' ' ALA . 62.9 mt -60.07 -36.47 77.43 Favored 'General case' 0 C--O 1.215 -0.735 0 O-C-N 123.882 0.739 . . . . 0.0 111.752 -176.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.506 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 48.3 mt-30 -66.0 -51.7 55.99 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.472 0.709 . . . . 0.0 110.776 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.26 -24.79 51.08 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -175.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.415 ' O ' HD13 ' A' ' 171' ' ' ILE . 25.3 m-85 -82.04 -57.37 3.43 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.819 0.448 . . . . 0.0 110.698 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -116.82 -57.77 2.14 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.24 0.616 . . . . 0.0 110.408 -166.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.506 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 51.4 t-105 . . . . . 0 CA--C 1.546 0.826 0 C-N-CA 124.857 1.263 . . . . 0.0 111.103 -168.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 . . . . . 0 N--CA 1.476 0.832 0 CA-C-O 120.897 0.379 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -97.54 111.74 23.89 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 168.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.6 mm -77.42 140.43 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.749 0.82 . . . . 0.0 109.76 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.6 p -141.34 61.12 1.49 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.183 0.993 . . . . 0.0 109.326 -173.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.9 -15.01 60.27 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.493 172.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 69.2 mtm -110.66 133.71 53.09 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 165.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 74.8 p -71.6 159.65 34.05 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 167.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.72 -34.76 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 123.195 0.598 . . . . 0.0 110.249 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -56.6 -61.51 2.37 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.375 1.07 . . . . 0.0 112.053 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -73.51 -26.5 60.91 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -176.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.8 tt -63.18 -51.98 64.2 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.62 0.768 . . . . 0.0 109.785 176.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.9 t -91.94 2.28 56.64 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.583 -174.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -69.71 132.46 46.16 Favored 'General case' 0 C--N 1.356 0.858 0 C-N-CA 122.717 0.407 . . . . 0.0 111.262 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -89.15 148.77 23.48 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.665 0.786 . . . . 0.0 109.729 176.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . 0.438 ' HE1' ' NH1' ' A' ' 148' ' ' ARG . 12.2 p-90 -151.93 164.45 37.12 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 124.337 1.055 . . . . 0.0 110.373 -171.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -115.19 158.17 22.63 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.526 1.13 . . . . 0.0 110.135 -176.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.477 ' SD ' ' HD2' ' A' ' 118' ' ' ARG . 70.2 mtp -122.02 145.53 48.05 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.386 0.674 . . . . 0.0 110.454 178.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.7 tp -91.97 -42.49 9.97 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.856 0.862 . . . . 0.0 109.926 177.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 24.9 mmt -126.49 85.69 59.79 Favored Pre-proline 0 N--CA 1.482 1.159 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 173.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -70.47 113.27 3.44 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 123.125 2.55 . . . . 0.0 111.676 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.483 ' HD3' ' NE2' ' A' ' 121' ' ' GLN . 55.9 tptt -98.23 118.49 34.99 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 172.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -82.76 105.68 13.98 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 170.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -125.98 145.49 50.27 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.907 0.883 . . . . 0.0 108.91 174.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.0 t -136.77 139.53 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 173.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -126.82 86.08 2.46 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 174.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.38 -121.52 8.22 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.48 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -89.54 15.96 1.86 Allowed 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 123.339 2.693 . . . . 0.0 113.225 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.638 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 5.4 mp -129.11 137.4 51.2 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.658 0.783 . . . . 0.0 108.976 176.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 53.5 t -92.03 130.46 37.77 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 173.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.1 mm -100.76 155.9 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.962 0.905 . . . . 0.0 108.802 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.477 ' HD2' ' SD ' ' A' ' 104' ' ' MET . 20.2 tpp180 -138.61 120.54 15.48 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.443 HD11 ' HA ' ' A' ' 181' ' ' LEU . 38.8 mm -123.56 134.84 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.555 1.142 . . . . 0.0 108.703 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -101.65 115.19 29.97 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 169.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.483 ' NE2' ' HD3' ' A' ' 108' ' ' LYS . 85.5 mt-30 -78.73 -2.07 37.61 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.557 0.743 . . . . 0.0 112.912 -172.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.59 -32.75 10.94 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.359 0.664 . . . . 0.0 110.395 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 31.2 mm -71.23 110.88 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 121.468 0.651 . . . . 0.0 110.739 -176.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.469 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 57.9 mtt -136.34 161.91 34.48 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.218 -173.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 62.62 19.66 11.47 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.739 1.215 . . . . 0.0 113.351 171.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -102.3 149.94 23.83 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.336 0.654 . . . . 0.0 110.016 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -87.23 102.87 14.9 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 167.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 57.3 mt -104.2 142.31 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 123.607 0.763 . . . . 0.0 109.038 -172.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.47 ' HE2' ' HA ' ' A' ' 195' ' ' SER . 11.4 tpt -126.65 125.13 41.36 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.274 1.029 . . . . 0.0 108.636 -173.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 14.6 mt -90.46 102.73 15.47 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -176.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.475 ' HD3' ' CD1' ' A' ' 150' ' ' PHE . 25.0 mtpp -113.71 129.84 56.51 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.528 1.131 . . . . 0.0 108.771 -171.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.478 ' HB3' ' HG ' ' A' ' 147' ' ' LEU . . . -134.67 154.98 51.29 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.797 0.808 . . . . 0.0 113.017 -172.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -116.48 134.9 54.32 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 114.061 -1.427 . . . . 0.0 107.774 165.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.515 ' HA ' HG13 ' A' ' 145' ' ' ILE . 37.6 p90 -162.96 165.05 25.46 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.508 0.505 . . . . 0.0 111.581 -176.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 44.7 p -85.98 148.76 25.6 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.462 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 90.1 t -126.44 151.81 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.252 1.021 . . . . 0.0 109.148 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.3 tp -158.4 144.87 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 170.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 57.41 26.52 12.64 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 176.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 67.83 15.03 9.57 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 124.758 1.223 . . . . 0.0 112.701 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -120.82 160.7 22.87 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.715 0.806 . . . . 0.0 109.457 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.491 HD12 ' HB1' ' A' ' 202' ' ' ALA . 9.8 tt -66.6 123.27 19.62 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 174.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -78.93 -69.38 0.57 Allowed 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 176.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 99.0 m -145.8 129.5 17.13 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.368 0.667 . . . . 0.0 109.418 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.546 HD22 HG12 ' A' ' 174' ' ' VAL . 53.3 tp -71.52 115.83 11.15 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 123.894 0.746 . . . . 0.0 109.966 176.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.515 HG13 ' HA ' ' A' ' 134' ' ' PHE . 73.5 mt -74.29 -53.83 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 57.7 tp -160.18 149.74 17.81 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.134 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.632 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 7.1 tt -134.51 148.78 50.6 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 174.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.447 ' N ' HD23 ' A' ' 147' ' ' LEU . 43.5 mtt-85 -141.95 159.48 42.14 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.994 0.918 . . . . 0.0 110.329 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -115.77 112.15 21.59 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.121 0.968 . . . . 0.0 109.166 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.475 ' CD1' ' HD3' ' A' ' 131' ' ' LYS . 56.9 m-85 -107.99 136.01 48.4 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.232 1.013 . . . . 0.0 109.93 -177.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 66.9 p -81.43 -172.93 4.08 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.955 0.502 . . . . 0.0 110.648 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -53.76 -37.56 63.53 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.446 0.698 . . . . 0.0 111.882 170.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -80.5 -5.5 56.76 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.121 0.968 . . . . 0.0 111.91 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 75.46 23.05 74.39 Favored Glycine 0 C--N 1.347 1.19 0 N-CA-C 112.102 -0.399 . . . . 0.0 112.102 -174.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -82.69 121.25 26.61 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 12.2 mt -75.6 110.3 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.6 m -120.41 1.86 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.337 1.055 . . . . 0.0 111.047 -175.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -157.23 166.59 33.69 Favored Glycine 0 C--O 1.242 0.634 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -165.26 150.17 9.09 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -174.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.632 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 63.9 mt -128.43 102.69 8.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 164.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 48.1 t -112.06 113.35 52.07 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.638 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 19.0 Cg_endo -57.79 136.21 73.95 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.291 1.994 . . . . 0.0 111.787 178.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 83.2 mt . . . . . 0 CA--C 1.552 1.036 0 C-N-CA 123.968 0.907 . . . . 0.0 112.402 -171.741 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 . . . . . 0 C--O 1.245 0.839 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 34.5 p -83.94 156.26 22.43 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.467 HG13 ' HB3' ' A' ' 141' ' ' LEU . 7.2 tt -58.37 -31.89 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 124.178 0.991 . . . . 0.0 110.593 171.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -67.15 -38.08 84.9 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.474 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -62.71 -33.93 76.12 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.834 0.454 . . . . 0.0 110.833 176.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.546 HG12 HD22 ' A' ' 144' ' ' LEU . 60.9 t -66.56 -52.53 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 124.009 0.818 . . . . 0.0 111.618 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -63.04 -33.98 76.6 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 122.225 0.21 . . . . 0.0 111.456 -176.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -69.82 -40.36 75.95 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.161 0.584 . . . . 0.0 110.185 174.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -59.91 -40.44 88.82 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 124.084 0.865 . . . . 0.0 110.805 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 174' ' ' VAL . 67.5 mt -68.2 -38.86 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.352 0.661 . . . . 0.0 109.671 177.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.36 -35.29 91.44 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 116.003 -0.544 . . . . 0.0 113.612 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.2 t -76.09 -38.67 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.112 0.565 . . . . 0.0 110.194 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.443 ' HA ' HD11 ' A' ' 119' ' ' ILE . 30.1 tp -57.01 -48.09 79.31 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.354 0.661 . . . . 0.0 110.276 173.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.412 ' O ' ' HG2' ' A' ' 186' ' ' GLU . 47.6 mt -60.82 -48.9 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.82 0.848 . . . . 0.0 110.492 176.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -55.93 -44.61 87.64 Favored Glycine 0 C--N 1.347 1.154 0 O-C-N 123.796 0.685 . . . . 0.0 113.438 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -66.79 -28.57 73.83 Favored Glycine 0 C--N 1.35 1.343 0 O-C-N 123.959 0.446 . . . . 0.0 113.676 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 33.9 mt -83.21 -33.27 26.16 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.296 1.038 . . . . 0.0 111.711 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 52.3 mm-40 -68.62 -39.3 80.88 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.541 0.737 . . . . 0.0 110.873 -177.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -73.8 -16.47 61.15 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.894 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.469 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 8.1 m-20 -77.09 -15.44 59.57 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.386 0.674 . . . . 0.0 111.743 169.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 66.72 64.31 0.48 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.408 1.083 . . . . 0.0 110.138 -172.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -137.06 154.6 50.3 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.755 167.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 20.7 m -98.95 105.98 18.18 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.744 0.818 . . . . 0.0 109.483 -169.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 13.7 m -97.93 150.3 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-O 121.714 0.769 . . . . 0.0 112.095 -178.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 19.6 tpp85 -133.37 139.1 46.61 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.9 t -98.69 146.77 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -178.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.47 ' HA ' ' HE2' ' A' ' 129' ' ' MET . 27.9 t -55.08 145.54 20.53 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.286 0.634 . . . . 0.0 111.943 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -51.86 -37.8 53.52 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.005 0.922 . . . . 0.0 111.284 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 53.3 p -73.2 -51.86 16.22 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.726 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 62.2 mt -57.02 -39.02 73.98 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.09 0.556 . . . . 0.0 111.241 -177.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.436 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 46.7 mt-30 -58.81 -39.4 81.06 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.958 0.903 . . . . 0.0 112.246 -176.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.01 -32.54 10.9 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -176.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.456 ' O ' HD13 ' A' ' 171' ' ' ILE . 35.0 m-85 -74.97 -52.29 11.52 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 117.951 0.341 . . . . 0.0 111.25 -175.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.491 ' HB1' HD12 ' A' ' 141' ' ' LEU . . . -109.63 -50.62 2.96 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.056 0.542 . . . . 0.0 111.346 -172.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.436 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 70.7 t-105 . . . . . 0 N--CA 1.477 0.924 0 C-N-CA 124.369 1.068 . . . . 0.0 111.156 -170.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -98.78 110.49 23.09 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 168.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.8 mm -77.47 118.7 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.608 0.763 . . . . 0.0 109.025 173.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 38.5 p -102.47 68.02 1.04 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.537 ' HB3' ' O ' ' A' ' 132' ' ' ALA . 32.4 t70 -72.77 -25.17 61.08 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 114.439 -1.255 . . . . 0.0 111.059 -175.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 60.7 mtm -92.92 136.98 32.77 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 162.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 77.0 p -67.37 163.82 19.92 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 167.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 29.8 mm -57.04 -36.06 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 173.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -58.94 -42.07 88.9 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.313 175.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -77.43 -35.94 53.58 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 122.873 0.469 . . . . 0.0 111.549 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.418 HD11 ' ND2' ' A' ' 133' ' ' ASN . 6.7 tt -64.03 -40.23 95.85 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.974 1.31 . . . . 0.0 109.826 -177.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.0 t -113.34 22.05 14.61 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.348 1.059 . . . . 0.0 109.91 -176.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -66.33 137.5 56.96 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.481 0.712 . . . . 0.0 111.14 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -79.03 136.14 37.1 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 175.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . 0.426 ' CG ' ' HB ' ' A' ' 156' ' ' ILE . 38.3 p-90 -156.06 164.86 37.9 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.932 0.893 . . . . 0.0 110.33 176.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -136.93 149.58 47.67 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.763 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.533 ' HE3' ' HA ' ' A' ' 107' ' ' PRO . 13.2 ptm -129.78 129.66 44.37 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 173.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.448 HD21 ' H ' ' A' ' 105' ' ' LEU . 0.9 OUTLIER -94.75 -19.41 20.39 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.297 0.639 . . . . 0.0 110.857 -173.169 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 94.1 mmm -127.37 72.44 77.33 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.187 0.995 . . . . 0.0 109.375 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.533 ' HA ' ' HE3' ' A' ' 104' ' ' MET . 12.3 Cg_exo -71.03 110.39 2.8 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 122.63 2.22 . . . . 0.0 111.741 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.485 ' HB3' ' HB ' ' A' ' 119' ' ' ILE . 57.7 tptt -82.83 117.07 22.44 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 173.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 20.6 tm0? -77.3 102.24 6.65 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.459 ' HA ' ' HE3' ' A' ' 110' ' ' LYS . 0.1 OUTLIER -137.09 130.63 31.55 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.383 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 91.0 t -134.43 138.01 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 173.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -123.61 102.96 8.14 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.154 0.582 . . . . 0.0 109.44 175.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.17 -125.18 26.71 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.007 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -86.31 13.79 2.63 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 123.397 2.732 . . . . 0.0 113.289 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.504 HD21 ' HA ' ' A' ' 162' ' ' PRO . 86.7 mt -130.97 130.85 43.93 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.567 0.747 . . . . 0.0 110.381 -175.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 53.3 t -83.83 137.27 33.78 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.502 0.721 . . . . 0.0 110.266 173.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.3 mm -106.08 151.93 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 C-N-CA 123.924 0.89 . . . . 0.0 108.763 175.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -130.79 124.29 31.04 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 173.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.547 HD13 ' HA3' ' A' ' 184' ' ' GLY . 55.3 mt -132.3 122.69 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.506 ' HB3' ' HB ' ' A' ' 157' ' ' VAL . 23.7 t70 -93.85 121.42 35.28 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.453 ' HA ' ' ND2' ' A' ' 188' ' ' ASN . 81.9 mt-30 -84.29 -7.83 59.21 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -174.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.83 -47.45 11.09 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 118.287 0.494 . . . . 0.0 110.4 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.503 HG22 ' HG3' ' A' ' 126' ' ' LYS . 1.7 mp -71.74 102.47 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-O 122.32 1.057 . . . . 0.0 109.499 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 38.6 mtt -124.55 170.14 11.2 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-N 113.613 -1.63 . . . . 0.0 109.773 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 70.47 11.67 7.38 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 124.762 1.225 . . . . 0.0 112.573 173.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.503 ' HG3' HG22 ' A' ' 123' ' ' ILE . 74.7 mmtt -100.64 156.67 17.18 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.708 0.803 . . . . 0.0 112.227 -171.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.417 ' HB2' ' HG2' ' A' ' 152' ' ' GLU . 90.4 m-20 -89.77 108.91 19.97 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 166.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.543 ' HB ' HG11 ' A' ' 192' ' ' VAL . 64.4 mt -112.55 137.33 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.261 0.624 . . . . 0.0 110.355 -176.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.488 ' HG3' ' HG2' ' A' ' 131' ' ' LYS . 37.2 tpp -113.84 132.81 55.75 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.912 1.285 . . . . 0.0 109.774 -175.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.502 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 2.4 mm? -93.18 102.49 14.79 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.56 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 9.1 mmpt? -105.53 143.2 34.03 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 175.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.537 ' O ' ' HB3' ' A' ' 92' ' ' ASP . . . -145.58 136.58 24.65 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.418 ' ND2' HD11 ' A' ' 98' ' ' LEU . 4.9 m-20 -89.62 118.68 29.42 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 163.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -148.58 157.5 43.5 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.094 0.558 . . . . 0.0 110.728 -174.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.5 t -86.43 160.19 19.11 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.756 174.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.6 t -134.41 143.92 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.371 1.068 . . . . 0.0 109.071 -176.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.4 tp -150.26 140.9 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 168.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 58.02 31.75 21.07 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 175.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 64.34 24.02 13.16 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.448 1.099 . . . . 0.0 112.589 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.475 ' HB2' HD11 ' A' ' 171' ' ' ILE . 2.9 ptp180 -133.09 165.53 24.55 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 173.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.577 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 10.3 tt -65.84 126.23 27.83 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 176.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -81.7 -74.05 0.35 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.3 m -139.17 125.68 20.49 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -175.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 60.0 tp -70.49 132.98 46.37 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.411 0.685 . . . . 0.0 110.167 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.5 mp -89.15 -52.38 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 173.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 40.4 tp -164.6 142.42 6.62 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.655 0.782 . . . . 0.0 109.142 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.587 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 9.3 tt -130.72 139.58 50.3 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 176.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 61.3 mtp85 -141.69 132.8 26.22 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.382 1.073 . . . . 0.0 109.117 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -116.71 126.69 53.54 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.881 1.272 . . . . 0.0 108.829 -173.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.56 ' CZ ' ' HG3' ' A' ' 131' ' ' LYS . 3.7 p90 -143.75 166.81 23.85 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.28 0.562 . . . . 0.0 111.852 -173.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 68.0 p -82.29 175.35 10.34 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.373 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.417 ' HG2' ' HB2' ' A' ' 127' ' ' ASN . 35.9 mm-40 -57.42 -29.51 64.2 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 121.198 0.523 . . . . 0.0 111.125 171.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -74.04 -16.86 61.03 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.155 0.982 . . . . 0.0 111.052 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 92.01 5.41 66.08 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 116.327 -0.397 . . . . 0.0 112.521 -177.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.63 102.72 6.26 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -178.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.512 HG12 ' HB3' ' A' ' 150' ' ' PHE . 16.8 mt -72.19 122.54 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -177.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.506 ' HB ' ' HB3' ' A' ' 120' ' ' ASP . 27.4 m -130.08 6.09 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.228 1.011 . . . . 0.0 110.592 -175.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -150.81 156.95 26.95 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -165.75 145.55 6.48 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.854 0.462 . . . . 0.0 110.078 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.587 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 63.7 mt -124.92 106.32 16.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 168.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 88.0 p -115.59 134.97 22.57 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.504 ' HA ' HD21 ' A' ' 115' ' ' LEU . 52.3 Cg_exo -53.85 140.99 67.45 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 122.743 2.295 . . . . 0.0 111.873 172.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 80.0 mt . . . . . 0 CA--C 1.547 0.859 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.765 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 . . . . . 0 N--CA 1.476 0.83 0 CA-C-O 120.747 0.308 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 22.7 m -96.66 158.34 15.48 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 123.898 0.879 . . . . 0.0 109.395 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.577 ' HB ' ' O ' ' A' ' 141' ' ' LEU . 4.7 tt -48.52 -38.61 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 125.378 1.471 . . . . 0.0 112.836 174.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -62.21 -40.36 95.86 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.846 0.858 . . . . 0.0 111.517 -175.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -62.85 -41.1 99.23 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.984 0.914 . . . . 0.0 110.005 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.473 ' O ' HG13 ' A' ' 178' ' ' ILE . 44.3 t -63.24 -54.46 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 O-C-N 124.398 1.061 . . . . 0.0 111.603 -177.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -61.3 -35.09 76.38 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 124.05 0.844 . . . . 0.0 110.991 -175.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.43 ' O ' HG21 ' A' ' 180' ' ' VAL . 76.9 m-20 -69.69 -41.88 74.83 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.9 -36.28 82.8 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.163 0.914 . . . . 0.0 111.036 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 174' ' ' VAL . 66.6 mt -65.68 -39.18 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 175.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -71.06 -24.64 76.89 Favored Glycine 0 C--N 1.341 0.852 0 O-C-N 123.668 0.605 . . . . 0.0 113.551 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.43 HG21 ' O ' ' A' ' 176' ' ' ASN . 71.1 t -76.04 -43.15 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.441 0.697 . . . . 0.0 109.711 175.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 19.9 tp -60.92 -46.59 90.07 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.43 0.692 . . . . 0.0 110.473 173.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.456 ' O ' ' HG2' ' A' ' 186' ' ' GLU . 57.5 mt -60.56 -50.07 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 123.967 0.907 . . . . 0.0 110.254 175.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -60.9 -33.15 82.39 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 123.447 0.467 . . . . 0.0 113.639 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.547 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -67.79 -43.81 82.56 Favored Glycine 0 C--N 1.347 1.19 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 171.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.444 HD23 HD11 ' A' ' 128' ' ' ILE . 53.4 mt -68.7 -23.9 64.43 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.521 1.129 . . . . 0.0 111.705 177.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 52.4 mm-40 -74.73 -41.9 59.28 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.947 0.499 . . . . 0.0 109.947 178.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -64.23 -41.72 96.88 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.128 171.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.453 ' ND2' ' HA ' ' A' ' 121' ' ' GLN . 6.2 m-20 -68.05 -10.66 55.51 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.552 0.741 . . . . 0.0 111.39 173.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 16.6 t70 63.52 64.49 0.8 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.475 1.11 . . . . 0.0 110.031 174.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -126.22 134.17 51.3 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.8 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 127' ' ' ASN . 59.2 m -80.92 99.25 8.27 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.543 HG11 ' HB ' ' A' ' 128' ' ' ILE . 24.5 m -104.87 148.38 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.668 0.747 . . . . 0.0 111.553 -172.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 44.0 ttt180 -137.76 135.48 36.39 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 114.25 -1.341 . . . . 0.0 107.937 173.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.502 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 4.1 t -87.33 155.27 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -178.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.516 ' HB3' ' HE2' ' A' ' 131' ' ' LYS . 88.6 p -62.45 149.15 43.46 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.446 0.566 . . . . 0.0 111.083 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -55.35 -34.68 64.47 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.188 0.995 . . . . 0.0 110.448 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 52.1 p -64.08 -58.65 6.03 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.436 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.419 ' HB2' HG12 ' A' ' 194' ' ' VAL . 69.7 mt -62.72 -37.45 86.58 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.148 0.579 . . . . 0.0 110.912 -174.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -55.79 -37.54 68.75 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.712 0.805 . . . . 0.0 112.085 -176.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -102.22 -25.33 13.73 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -82.73 -54.32 5.22 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 118.403 0.547 . . . . 0.0 111.519 -176.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -102.56 -56.72 2.19 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.811 0.844 . . . . 0.0 110.694 -171.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 44.3 t-105 . . . . . 0 N--CA 1.476 0.842 0 C-N-CA 125.383 1.473 . . . . 0.0 109.601 -177.303 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.535 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 8.1 ttm180 . . . . . 0 N--CA 1.473 0.698 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -121.74 101.42 7.57 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 172.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.9 mm -81.76 132.89 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 123.617 0.767 . . . . 0.0 109.787 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 34.2 p -121.96 83.55 2.11 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 171.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -70.19 -31.37 68.8 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.174 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.461 ' HE2' HD13 ' A' ' 98' ' ' LEU . 25.0 ptt? -111.07 141.92 43.92 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 174.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 81.6 p -65.4 152.97 42.6 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.091 0.472 . . . . 0.0 110.569 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.52 -29.34 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.951 173.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -65.97 -49.61 67.25 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.644 1.177 . . . . 0.0 111.946 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.511 ' HA ' ' HB2' ' A' ' 100' ' ' ARG . 12.5 pt-20 -75.58 -22.32 57.07 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 120.801 0.334 . . . . 0.0 110.334 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.53 ' HG ' HD21 ' A' ' 146' ' ' LEU . 9.2 tt -69.15 -33.73 73.9 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.885 0.874 . . . . 0.0 109.542 170.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.3 t -103.12 13.75 33.4 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.7 0.8 . . . . 0.0 110.983 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.511 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 71.2 ttt180 -65.39 150.16 48.79 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.661 0.784 . . . . 0.0 111.723 -174.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -80.45 125.41 29.9 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 170.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -154.14 173.21 16.38 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.66 0.784 . . . . 0.0 110.488 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -138.78 146.74 41.73 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.158 0.583 . . . . 0.0 110.714 175.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.541 ' SD ' ' HB3' ' A' ' 107' ' ' PRO . 14.3 ptp -99.76 108.43 20.75 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 167.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 48.0 tp -71.58 -38.16 70.94 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.032 0.533 . . . . 0.0 110.552 -175.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 24.9 mmt -121.12 84.81 40.42 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 123.779 0.832 . . . . 0.0 109.088 173.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.541 ' HB3' ' SD ' ' A' ' 104' ' ' MET . 56.5 Cg_endo -67.81 117.86 5.19 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.144 2.563 . . . . 0.0 113.088 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.417 ' HD2' HE21 ' A' ' 121' ' ' GLN . 61.6 tttp -118.66 131.98 56.17 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 167.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -122.84 120.84 34.71 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 176.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.79 106.6 9.8 Favored 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 124.676 1.19 . . . . 0.0 107.997 176.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.421 HG11 HD11 ' A' ' 163' ' ' LEU . 79.3 t -75.35 128.54 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -122.57 85.24 2.38 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 124.864 1.266 . . . . 0.0 108.363 -176.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 68.01 -113.13 5.2 Favored Glycine 0 CA--C 1.539 1.531 0 CA-C-N 114.966 -1.016 . . . . 0.0 113.239 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -89.97 9.21 3.39 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 123.624 2.883 . . . . 0.0 113.227 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 162' ' ' PRO . 60.1 mt -129.95 158.27 40.02 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -175.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.423 ' HB3' HD22 ' A' ' 163' ' ' LEU . 23.7 p -125.51 119.04 27.11 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 176.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.0 mm -86.72 140.94 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.378 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -122.36 129.97 52.65 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 170.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.568 HD12 ' HA3' ' A' ' 184' ' ' GLY . 60.4 mt -128.08 122.86 59.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -178.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -94.28 114.72 26.85 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 174.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.417 HE21 ' HD2' ' A' ' 108' ' ' LYS . 76.2 mt-30 -82.72 -10.49 58.88 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.097 0.959 . . . . 0.0 111.51 -175.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.71 -41.57 53.25 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.019 0.527 . . . . 0.0 111.881 -174.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.85 113.14 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.866 0.841 . . . . 0.0 109.834 -176.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 44.8 mtt -131.2 166.16 21.75 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.321 -1.309 . . . . 0.0 109.501 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.5 t70 57.69 32.72 22.29 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.828 0.851 . . . . 0.0 111.313 177.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -120.71 153.94 36.27 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.878 0.871 . . . . 0.0 110.507 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -90.78 106.97 18.88 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 173.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.54 HG12 HG23 ' A' ' 151' ' ' THR . 48.2 mt -108.14 130.77 60.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 123.478 0.711 . . . . 0.0 110.315 -173.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.606 ' HE1' ' HD2' ' A' ' 193' ' ' ARG . 52.1 tpp -110.0 126.47 53.98 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.28 1.032 . . . . 0.0 108.752 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 25.1 mt -87.77 103.0 15.22 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -110.55 132.39 54.23 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.313 1.045 . . . . 0.0 109.988 -172.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.547 ' HB2' ' HG ' ' A' ' 147' ' ' LEU . . . -136.99 154.93 50.29 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -175.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -112.84 128.44 56.45 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 167.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.41 ' HB3' HD12 ' A' ' 144' ' ' LEU . 33.0 p90 -157.37 163.57 38.46 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.351 0.596 . . . . 0.0 112.393 -170.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 46.6 t -85.14 156.99 20.79 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.425 -1.261 . . . . 0.0 109.417 173.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.535 ' HB ' ' HB3' ' A' ' 88' ' ' ARG . 79.1 t -140.27 142.96 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.378 1.071 . . . . 0.0 109.935 -174.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.414 ' O ' ' HG2' ' A' ' 140' ' ' ARG . 11.3 tp -150.3 145.6 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 168.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 60.62 22.8 12.61 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 123.632 0.773 . . . . 0.0 112.119 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 58.77 39.61 23.98 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.316 1.046 . . . . 0.0 111.658 -172.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 137' ' ' ILE . 5.8 ptp180 -144.85 163.35 34.35 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.509 0.724 . . . . 0.0 109.694 172.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.471 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 10.5 tt -63.85 117.25 6.68 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.952 0.501 . . . . 0.0 110.08 -176.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -79.8 -60.63 2.27 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.839 0.856 . . . . 0.0 109.121 175.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 80.5 m -147.75 132.13 17.59 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.632 0.773 . . . . 0.0 109.366 177.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.41 HD12 ' HB3' ' A' ' 134' ' ' PHE . 51.3 tp -76.7 131.59 38.87 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.557 0.743 . . . . 0.0 110.156 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.9 mp -87.15 -46.88 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 173.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.53 HD21 ' HG ' ' A' ' 98' ' ' LEU . 57.7 tp -167.94 149.08 5.22 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.573 0.749 . . . . 0.0 109.585 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.651 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 6.6 tt -134.19 140.08 46.27 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 177.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 58.7 mtp85 -145.48 147.63 32.38 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.32 1.048 . . . . 0.0 108.991 -175.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.01 109.2 21.1 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.009 0.923 . . . . 0.0 109.269 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -106.29 124.15 49.15 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.424 0.69 . . . . 0.0 110.187 -175.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.54 HG23 HG12 ' A' ' 128' ' ' ILE . 33.7 p -73.0 -174.45 1.51 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.372 0.669 . . . . 0.0 110.955 169.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.95 -25.51 63.68 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 122.257 -0.277 . . . . 0.0 111.243 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -83.85 -8.1 59.29 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.748 0.819 . . . . 0.0 110.381 173.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 78.99 23.02 64.63 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 116.331 -0.395 . . . . 0.0 113.391 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.26 127.62 32.57 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.7 mp -81.8 101.39 6.58 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.9 m -111.16 24.33 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.305 1.042 . . . . 0.0 109.991 -172.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 176.05 151.28 8.66 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 114.119 -1.401 . . . . 0.0 110.28 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -158.39 130.55 6.89 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.069 0.935 . . . . 0.0 111.047 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.651 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 67.3 mt -107.43 102.99 14.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 173.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 27.7 t -104.17 120.73 49.97 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 123.427 0.691 . . . . 0.0 109.37 -177.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.419 ' HA ' HD23 ' A' ' 115' ' ' LEU . 74.8 Cg_exo -54.22 123.79 14.43 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.666 2.244 . . . . 0.0 112.492 172.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.423 HD22 ' HB3' ' A' ' 116' ' ' CYS . 67.2 mt . . . . . 0 CA--C 1.55 0.961 0 C-N-CA 123.268 0.627 . . . . 0.0 111.261 -177.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 34.9 p-80 . . . . . 0 N--CA 1.476 0.871 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 27.3 m -93.03 159.01 15.49 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.363 0.665 . . . . 0.0 109.866 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 141' ' ' LEU . 7.6 tt -50.99 -37.77 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.728 1.211 . . . . 0.0 111.997 173.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -64.24 -35.41 80.72 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.417 1.087 . . . . 0.0 111.445 -175.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -64.38 -38.83 92.4 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.89 0.876 . . . . 0.0 110.488 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.451 ' O ' HG13 ' A' ' 178' ' ' ILE . 43.7 t -67.79 -37.11 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.297 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -62.14 -40.28 95.42 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.034 0.534 . . . . 0.0 110.747 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.414 ' O ' HG22 ' A' ' 180' ' ' VAL . 79.6 m-20 -61.0 -48.04 83.64 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 123.906 0.754 . . . . 0.0 109.568 174.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.55 -48.64 78.62 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 114.066 -1.424 . . . . 0.0 112.681 -173.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 174' ' ' VAL . 69.8 mt -59.66 -41.8 86.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -61.18 -34.37 87.79 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 115.301 -0.863 . . . . 0.0 114.005 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 176' ' ' ASN . 93.1 t -70.77 -44.08 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 122.956 0.502 . . . . 0.0 110.307 177.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 32.3 tp -59.91 -43.81 94.65 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.822 176.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.513 HG21 HG23 ' A' ' 192' ' ' VAL . 86.6 mt -59.83 -51.58 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.575 0.75 . . . . 0.0 110.267 175.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.22 -42.38 97.21 Favored Glycine 0 C--N 1.344 1.006 0 O-C-N 123.804 0.69 . . . . 0.0 113.779 -176.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.568 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -68.9 -24.81 75.62 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 115.502 -0.349 . . . . 0.0 113.116 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.431 HD21 HD13 ' A' ' 128' ' ' ILE . 32.6 mt -86.54 -25.69 24.92 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.878 0.871 . . . . 0.0 111.564 176.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 182' ' ' ILE . 50.2 mt-10 -70.78 -31.26 67.97 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 122.084 -0.385 . . . . 0.0 110.789 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -81.09 -20.66 41.04 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.161 0.585 . . . . 0.0 111.092 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -65.53 -20.82 66.49 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.011 0.525 . . . . 0.0 110.466 165.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 33.6 t70 63.4 67.47 0.65 Allowed 'General case' 0 C--N 1.355 0.833 0 C-N-CA 124.418 1.087 . . . . 0.0 110.195 -178.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -138.01 178.65 6.96 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.125 175.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 85.3 m -102.51 103.52 13.88 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -174.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.513 HG23 HG21 ' A' ' 182' ' ' ILE . 35.5 m -101.47 146.54 9.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 C-N-CA 123.388 0.675 . . . . 0.0 110.897 -178.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.606 ' HD2' ' HE1' ' A' ' 129' ' ' MET . 30.2 ttm180 -143.84 145.37 32.28 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.522 171.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 4.6 t -89.9 137.6 21.11 Favored 'Isoleucine or valine' 0 C--O 1.245 0.818 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 173.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 78.9 p -56.96 148.29 21.62 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 118.819 0.736 . . . . 0.0 111.045 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -57.06 -27.03 61.34 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.545 0.738 . . . . 0.0 111.808 -177.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 65.1 p -70.49 -54.25 13.02 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 123.387 0.675 . . . . 0.0 109.847 174.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 33.5 mt -63.45 -26.98 68.98 Favored 'General case' 0 C--O 1.208 -1.079 0 CA-C-O 119.004 -0.522 . . . . 0.0 111.577 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -67.76 -49.71 61.03 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.886 0.474 . . . . 0.0 110.856 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -77.27 -36.54 54.23 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.341 0.401 . . . . 0.0 111.62 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -85.41 -54.94 4.26 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 122.257 -0.277 . . . . 0.0 111.152 -171.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -95.08 -60.37 1.7 Allowed 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.185 0.517 . . . . 0.0 111.447 -170.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 43.5 t-105 . . . . . 0 N--CA 1.475 0.814 0 C-N-CA 126.026 1.73 . . . . 0.0 111.039 -169.967 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -115.38 111.11 20.34 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 171.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.4 mm -81.83 130.42 35.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 123.597 0.759 . . . . 0.0 109.382 175.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.7 p -117.51 81.91 1.73 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -76.89 -13.46 59.99 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.582 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.529 ' HB3' ' HG3' ' A' ' 97' ' ' GLU . 63.2 mtm -114.97 143.94 44.37 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.139 1.376 . . . . 0.0 107.321 161.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 69.3 p -72.29 152.21 42.29 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 167.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 57.0 mt -57.41 -27.68 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 122.606 0.362 . . . . 0.0 111.13 178.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -54.67 -62.36 1.71 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.07 0.948 . . . . 0.0 111.801 170.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.529 ' HG3' ' HB3' ' A' ' 93' ' ' MET . 11.0 pt-20 -73.54 -22.07 60.2 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 122.924 0.49 . . . . 0.0 112.152 -177.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.567 ' HG ' HD21 ' A' ' 146' ' ' LEU . 10.0 tt -63.19 -36.44 83.65 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.007 0.923 . . . . 0.0 109.32 171.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.3 m -109.47 16.91 21.94 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.659 0.784 . . . . 0.0 111.601 -177.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.425 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 62.0 ttt180 -75.03 140.01 43.27 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.671 0.788 . . . . 0.0 110.828 -177.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -75.22 136.52 40.97 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.564 0.745 . . . . 0.0 111.248 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 28.0 p-90 -161.14 171.54 18.34 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.654 1.182 . . . . 0.0 109.666 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -141.0 165.08 28.54 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.244 0.618 . . . . 0.0 111.171 -175.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.461 ' HE3' ' HA ' ' A' ' 107' ' ' PRO . 63.6 mtp -118.11 131.08 56.46 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.046 0.939 . . . . 0.0 108.466 172.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.416 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.5 pt? -109.29 -29.21 8.59 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.289 0.636 . . . . 0.0 110.829 -175.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.479 ' HA ' ' HE3' ' A' ' 106' ' ' MET . 7.7 mmt -123.24 70.31 42.51 Favored Pre-proline 0 N--CA 1.486 1.375 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 166.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.461 ' HA ' ' HE3' ' A' ' 104' ' ' MET . 91.5 Cg_endo -73.9 145.09 35.54 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 122.243 1.962 . . . . 0.0 113.014 -170.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.455 ' HB3' ' HB ' ' A' ' 119' ' ' ILE . 25.0 ttmm -134.94 120.31 19.06 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 168.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -96.81 100.04 11.59 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -178.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.549 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 17.7 tppt? -96.66 148.78 22.52 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 174.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 68.6 t -128.03 133.62 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 175.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -137.3 95.32 3.06 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 68.37 -131.25 27.0 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.289 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -82.19 18.21 1.45 Allowed 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 123.356 2.704 . . . . 0.0 113.421 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -134.42 170.66 15.41 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.8 0.84 . . . . 0.0 109.655 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 17.9 p -136.33 143.61 44.22 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.033 0.933 . . . . 0.0 109.341 177.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.549 ' HB ' ' HB3' ' A' ' 110' ' ' LYS . 9.3 mm -111.09 147.35 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 124.371 1.069 . . . . 0.0 109.681 -173.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.521 ' HG3' ' HB3' ' A' ' 159' ' ' GLU . 36.3 mmt180 -109.87 118.52 36.7 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 173.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.492 HD13 ' HA3' ' A' ' 184' ' ' GLY . 46.1 mm -119.81 122.29 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 175.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -115.05 118.98 34.93 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -80.23 -9.18 59.72 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.695 0.798 . . . . 0.0 112.789 -170.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -79.66 -36.01 38.39 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 120.654 0.264 . . . . 0.0 110.787 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.6 mp -80.12 99.62 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 45.3 mtt -131.66 156.7 45.39 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-N 114.132 -1.395 . . . . 0.0 109.249 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.3 t70 72.03 2.17 4.2 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 124.384 1.074 . . . . 0.0 112.718 175.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -85.95 148.65 25.67 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 121.635 -0.665 . . . . 0.0 112.087 -173.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -91.16 105.38 17.77 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 172.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.606 ' HB ' HG13 ' A' ' 192' ' ' VAL . 56.8 mt -115.39 146.37 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 123.71 0.804 . . . . 0.0 110.257 -172.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.448 ' SD ' ' HB3' ' A' ' 193' ' ' ARG . 15.7 tpt -129.23 128.63 43.67 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 125.481 1.512 . . . . 0.0 107.781 177.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 35.7 mt -81.39 145.6 30.73 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -142.55 133.96 26.36 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 173.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.518 ' HB1' ' HG ' ' A' ' 147' ' ' LEU . . . -141.45 142.94 33.63 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -170.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -101.9 133.6 46.42 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 171.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.496 ' HA ' HD12 ' A' ' 145' ' ' ILE . 37.3 p90 -161.1 161.62 31.27 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 123.79 0.681 . . . . 0.0 111.057 -175.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.1 p -86.35 161.32 18.77 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.099 0.96 . . . . 0.0 109.41 172.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 53.9 t -139.25 139.39 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.258 1.423 . . . . 0.0 108.467 -175.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 9.8 tp -130.87 132.85 63.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 169.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 62.4 -84.59 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.914 1.286 . . . . 0.0 110.459 -173.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -158.98 23.42 0.21 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.13 0.972 . . . . 0.0 109.897 -176.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.504 ' HB2' HD11 ' A' ' 171' ' ' ILE . 11.1 ptp180 -127.47 163.06 24.92 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.584 0.754 . . . . 0.0 109.797 176.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.48 HD23 ' HA ' ' A' ' 171' ' ' ILE . 9.0 tt -67.7 125.41 26.13 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 171.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -81.35 -59.7 2.54 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 123.876 0.87 . . . . 0.0 108.811 174.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 95.6 m -149.71 136.68 19.58 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.98 0.912 . . . . 0.0 109.293 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.473 HD22 HG12 ' A' ' 174' ' ' VAL . 50.1 tp -77.73 121.47 24.08 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 134' ' ' PHE . 1.6 mp -77.14 -52.14 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.516 0.727 . . . . 0.0 109.161 176.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.567 HD21 ' HG ' ' A' ' 98' ' ' LEU . 39.3 tp -165.69 150.2 8.47 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.735 0.814 . . . . 0.0 109.358 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.664 HD13 HD13 ' A' ' 160' ' ' ILE . 7.4 tt -133.16 145.85 51.02 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.474 ' HD3' HD12 ' A' ' 156' ' ' ILE . 45.5 mtt-85 -141.28 148.3 39.59 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.906 0.882 . . . . 0.0 110.189 176.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.1 110.35 22.25 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.468 1.107 . . . . 0.0 108.441 176.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -104.45 127.95 52.24 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.555 0.742 . . . . 0.0 109.347 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.452 HG21 HG12 ' A' ' 128' ' ' ILE . 41.6 p -70.97 -175.81 1.22 Allowed 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.267 0.556 . . . . 0.0 111.191 176.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -27.13 68.71 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.55 0.74 . . . . 0.0 111.971 173.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -83.26 -4.08 58.08 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.451 0.7 . . . . 0.0 111.243 171.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 77.45 27.07 60.07 Favored Glycine 0 C--N 1.348 1.241 0 CA-C-N 116.441 -0.345 . . . . 0.0 112.944 178.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -92.66 129.45 38.59 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.013 0.525 . . . . 0.0 110.221 -176.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.474 HD12 ' HD3' ' A' ' 148' ' ' ARG . 17.0 mt -72.59 102.93 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.463 0.705 . . . . 0.0 109.141 177.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.9 m -113.83 -2.14 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.287 1.035 . . . . 0.0 111.514 -176.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -157.18 167.43 33.88 Favored Glycine 0 C--N 1.338 0.648 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.521 ' HB3' ' HG3' ' A' ' 118' ' ' ARG . 27.2 tt0 -166.61 149.03 6.6 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.256 0.622 . . . . 0.0 109.627 -174.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.664 HD13 HD13 ' A' ' 147' ' ' LEU . 71.6 mt -130.06 117.69 41.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 169.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.0 t -128.0 138.04 32.09 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.77 139.96 83.21 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 122.951 2.434 . . . . 0.0 111.644 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 88.1 mt . . . . . 0 CA--C 1.548 0.899 0 C-N-CA 123.0 0.52 . . . . 0.0 110.781 178.469 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 31.2 p-80 . . . . . 0 N--CA 1.473 0.692 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.625 HG21 HG21 ' A' ' 171' ' ' ILE . 4.9 m -99.35 171.73 7.79 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.915 0.886 . . . . 0.0 109.789 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.625 HG21 HG21 ' A' ' 170' ' ' THR . 11.2 tt -48.6 -41.84 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 125.84 1.656 . . . . 0.0 113.754 176.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -56.7 -35.83 68.94 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.187 1.395 . . . . 0.0 111.961 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -73.0 -38.02 66.75 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.26 0.624 . . . . 0.0 111.581 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.473 HG12 HD22 ' A' ' 144' ' ' LEU . 58.1 t -65.19 -51.4 65.86 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.88 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.931 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.485 ' HB2' ' HZ1' ' A' ' 175' ' ' LYS . 0.1 OUTLIER -63.27 -24.43 67.86 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 123.826 0.704 . . . . 0.0 112.026 -175.707 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.401 ' O ' HG23 ' A' ' 180' ' ' VAL . 15.4 m120 -70.77 -50.67 33.43 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.992 0.517 . . . . 0.0 109.624 169.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.21 -40.29 81.25 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.236 1.014 . . . . 0.0 111.817 -177.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 174' ' ' VAL . 61.5 mt -60.5 -46.33 95.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.716 0.806 . . . . 0.0 109.478 178.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.05 -25.67 72.18 Favored Glycine 0 C--N 1.343 0.934 0 CA-C-N 115.293 -0.867 . . . . 0.0 113.427 -177.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 176' ' ' ASN . 91.8 t -74.67 -43.53 47.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.04 0.536 . . . . 0.0 110.135 176.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 57.0 tp -59.35 -47.13 86.59 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.861 0.464 . . . . 0.0 110.453 175.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.456 ' O ' ' HG3' ' A' ' 186' ' ' GLU . 93.3 mt -59.01 -48.5 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.817 0.847 . . . . 0.0 110.167 177.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -62.24 -30.55 76.25 Favored Glycine 0 C--N 1.348 1.248 0 O-C-N 123.578 0.549 . . . . 0.0 113.385 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.492 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -75.76 -27.36 63.03 Favored Glycine 0 C--N 1.348 1.22 0 N-CA-C 112.345 -0.302 . . . . 0.0 112.345 175.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.473 ' HB3' HG11 ' A' ' 192' ' ' VAL . 61.0 mt -80.97 -31.54 34.76 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.239 1.015 . . . . 0.0 110.842 176.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 182' ' ' ILE . 49.2 mt-10 -72.05 -40.58 68.25 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.866 0.866 . . . . 0.0 110.765 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -70.07 -32.49 70.6 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.836 0.454 . . . . 0.0 110.46 176.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -76.35 -1.77 28.47 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.231 0.613 . . . . 0.0 111.394 170.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 23.4 t70 64.11 49.38 2.71 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.436 1.094 . . . . 0.0 111.011 170.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -109.95 140.36 44.03 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.622 1.169 . . . . 0.0 109.145 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 29.4 m -84.46 100.85 11.6 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.606 HG13 ' HB ' ' A' ' 128' ' ' ILE . 33.2 m -116.83 152.4 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-O 121.703 0.763 . . . . 0.0 112.822 -168.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.448 ' HB3' ' SD ' ' A' ' 129' ' ' MET . 63.4 ttt180 -134.99 142.96 46.58 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 114.043 -1.435 . . . . 0.0 108.307 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.454 HG22 HD11 ' A' ' 182' ' ' ILE . 13.2 t -82.37 154.38 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 5.4 m -50.53 132.48 25.38 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.423 0.689 . . . . 0.0 111.537 178.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -53.43 -30.74 42.03 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 124.218 1.007 . . . . 0.0 111.704 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 68.7 p -79.47 -47.06 16.28 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.983 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 90.6 mt -68.21 -33.68 74.87 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.948 0.499 . . . . 0.0 110.759 -177.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -51.06 -30.46 15.79 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.456 1.102 . . . . 0.0 112.624 -176.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -102.49 -47.92 4.31 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 171.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -67.89 -44.42 77.03 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -166.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -113.72 -54.26 2.62 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.33 0.652 . . . . 0.0 111.173 -175.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 . . . . . 0 CA--C 1.544 0.732 0 C-N-CA 125.114 1.366 . . . . 0.0 111.511 -172.637 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 66.9 ttt180 . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -92.36 97.73 11.05 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.699 0.8 . . . . 0.0 109.401 -178.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.9 mm -81.84 122.66 37.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.968 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.9 p -117.18 97.38 5.89 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.93 0.892 . . . . 0.0 110.292 -174.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -79.34 -27.74 42.03 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.828 0.851 . . . . 0.0 111.002 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.453 ' HB2' ' HG3' ' A' ' 97' ' ' GLU . 24.4 ptt? -119.02 141.43 48.7 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.776 0.83 . . . . 0.0 109.188 -177.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.8 m -68.69 160.23 30.64 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.067 0.947 . . . . 0.0 110.599 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 61.1 mt -62.43 -31.84 53.14 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 C-N-CA 122.809 0.443 . . . . 0.0 111.47 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.23 -54.14 49.29 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.511 0.324 . . . . 0.0 111.328 175.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.647 ' HA ' ' HB2' ' A' ' 100' ' ' ARG . 14.8 pt-20 -77.19 -18.31 57.85 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.029 0.531 . . . . 0.0 111.874 -177.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.497 HD12 ' ND2' ' A' ' 133' ' ' ASN . 6.0 tt -59.92 -43.75 94.73 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.37 1.068 . . . . 0.0 108.89 167.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.1 t -105.76 21.11 17.81 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.745 -176.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.647 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 30.8 tpt180 -67.45 133.1 48.91 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.802 0.441 . . . . 0.0 110.639 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -72.1 136.99 46.75 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 123.692 0.62 . . . . 0.0 109.8 174.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 20.4 p-90 -157.59 166.3 33.25 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.837 0.855 . . . . 0.0 109.485 176.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -142.62 144.02 32.63 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 123.547 0.739 . . . . 0.0 109.033 -176.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.543 ' SD ' ' HD2' ' A' ' 118' ' ' ARG . 67.4 mtp -85.48 105.51 16.15 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.2 tp -62.51 -36.36 82.3 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.192 0.997 . . . . 0.0 110.331 177.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.455 ' HG2' ' HB2' ' A' ' 122' ' ' ALA . 20.7 mmt -134.38 92.48 20.62 Favored Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 123.736 0.814 . . . . 0.0 109.153 168.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.49 ' HA ' ' HE2' ' A' ' 104' ' ' MET . 55.7 Cg_endo -67.24 112.95 2.69 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 123.165 2.577 . . . . 0.0 114.394 -176.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -109.54 117.96 35.35 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 161.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -107.72 113.44 26.71 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -125.88 103.31 7.71 Favored 'General case' 0 C--O 1.214 -0.767 0 C-N-CA 123.485 0.714 . . . . 0.0 109.516 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . 84.8 t -75.6 137.89 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 174.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -133.25 93.13 3.11 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-O 120.993 0.425 . . . . 0.0 109.963 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.15 -128.71 37.01 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.743 176.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -72.05 1.36 6.01 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 123.37 2.713 . . . . 0.0 114.126 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 4.3 mp -127.04 175.49 8.06 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.795 0.838 . . . . 0.0 109.411 -178.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.487 ' SG ' ' NH1' ' A' ' 118' ' ' ARG . 49.6 t -136.53 146.47 46.24 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 174.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.8 mm -116.22 147.32 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.309 1.044 . . . . 0.0 109.394 -174.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.543 ' HD2' ' SD ' ' A' ' 104' ' ' MET . 68.7 mmt-85 -119.54 127.31 52.88 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.049 0.939 . . . . 0.0 108.688 172.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.453 HD11 ' HA ' ' A' ' 181' ' ' LEU . 41.6 mm -122.84 125.59 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 173.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -93.45 116.86 29.4 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.402 ' HA ' HD22 ' A' ' 188' ' ' ASN . 80.3 mt-30 -78.51 -13.45 59.82 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.383 0.673 . . . . 0.0 112.257 -174.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.455 ' HB2' ' HG2' ' A' ' 106' ' ' MET . . . -82.86 -49.4 9.71 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.099 0.56 . . . . 0.0 110.791 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.405 HG12 HG11 ' A' ' 157' ' ' VAL . 1.8 mp -69.91 108.81 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-O 122.01 0.91 . . . . 0.0 109.731 -174.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.421 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 50.0 mtt -132.23 156.8 45.84 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 113.192 -1.822 . . . . 0.0 109.624 -177.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.0 t70 63.19 29.07 16.06 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.463 1.105 . . . . 0.0 111.801 173.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -115.0 149.56 37.21 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.569 0.748 . . . . 0.0 111.408 -179.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 152' ' ' GLU . 43.9 m-80 -83.52 107.29 15.9 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.506 HD12 HD22 ' A' ' 185' ' ' LEU . 50.2 mt -112.44 123.84 68.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-O 121.943 0.878 . . . . 0.0 111.105 -174.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 5.6 tpt -102.61 119.24 38.49 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 126.926 2.09 . . . . 0.0 108.905 -176.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 20.4 mt -95.25 104.9 16.8 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -115.43 144.8 43.27 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.192 0.597 . . . . 0.0 109.834 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -138.76 156.55 47.28 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.6 0.714 . . . . 0.0 112.479 -175.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.497 ' ND2' HD12 ' A' ' 98' ' ' LEU . 70.7 m-20 -113.6 119.38 37.28 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 165.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -153.1 157.96 41.18 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.416 0.686 . . . . 0.0 110.403 -167.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.0 p -89.66 156.8 18.32 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.345 0.658 . . . . 0.0 109.425 175.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.9 t -131.44 129.0 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.569 1.148 . . . . 0.0 109.325 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.5 tp -133.69 140.27 46.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 175.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 63.23 25.83 14.94 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.077 0.951 . . . . 0.0 111.604 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 66.13 15.73 10.19 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 124.986 1.314 . . . . 0.0 112.398 -176.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -127.27 171.19 11.69 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.471 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 7.0 tt -68.83 128.79 37.92 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -175.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -85.58 -69.61 0.65 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.757 0.823 . . . . 0.0 110.481 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 63.6 m -147.91 136.68 21.85 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.761 0.824 . . . . 0.0 109.05 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.434 HD21 HG11 ' A' ' 174' ' ' VAL . 47.6 tp -82.63 114.99 21.39 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.269 0.627 . . . . 0.0 109.58 177.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.0 mp -74.57 -50.8 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 175.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 49.4 tp -161.03 144.46 13.07 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.252 0.621 . . . . 0.0 109.464 178.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.605 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 7.6 tt -135.17 142.44 46.11 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 173.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.415 ' HB2' ' CE1' ' A' ' 150' ' ' PHE . 44.3 mtp85 -138.74 139.46 38.34 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -177.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.45 ' HB2' HD23 ' A' ' 181' ' ' LEU . . . -97.18 100.61 12.08 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -177.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.415 ' CE1' ' HB2' ' A' ' 148' ' ' ARG . 87.6 m-85 -96.56 124.55 40.58 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -177.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.508 ' HG1' ' HB3' ' A' ' 155' ' ' ALA . 58.6 p -67.5 178.84 1.47 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.266 0.555 . . . . 0.0 110.752 173.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.469 ' HB3' ' HB2' ' A' ' 127' ' ' ASN . 10.3 pt-20 -60.84 -22.21 63.99 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.371 1.068 . . . . 0.0 112.076 174.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -91.23 -1.35 57.71 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.075 0.95 . . . . 0.0 111.327 176.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 79.79 9.69 86.51 Favored Glycine 0 C--N 1.348 1.222 0 O-C-N 123.375 0.422 . . . . 0.0 113.148 -177.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.508 ' HB3' ' HG1' ' A' ' 151' ' ' THR . . . -87.25 120.8 28.91 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.69 0.796 . . . . 0.0 109.51 -174.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 16.1 mt -77.95 121.89 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -175.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.405 HG11 HG12 ' A' ' 123' ' ' ILE . 33.7 m -123.56 5.9 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.979 0.912 . . . . 0.0 110.948 -177.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -164.12 163.12 35.79 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -178.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -160.36 144.76 14.32 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.605 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 53.9 mt -123.71 115.54 45.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 172.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 18.4 p -138.84 132.34 16.1 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 122.902 0.481 . . . . 0.0 110.434 -175.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 31.1 Cg_endo -62.12 133.75 45.63 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.577 2.184 . . . . 0.0 111.875 176.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.2 mt . . . . . 0 CA--C 1.549 0.925 0 C-N-CA 123.699 0.8 . . . . 0.0 111.256 177.553 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 6.3 m -96.15 162.33 13.58 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.533 0.733 . . . . 0.0 109.218 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 141' ' ' LEU . 9.2 tt -50.15 -33.74 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 124.606 1.162 . . . . 0.0 112.13 171.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -52.73 -48.25 66.81 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.48 1.112 . . . . 0.0 111.458 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -69.16 -36.33 77.26 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.741 -176.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.434 HG11 HD21 ' A' ' 144' ' ' LEU . 46.0 t -64.12 -48.88 83.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 O-C-N 123.948 0.78 . . . . 0.0 111.002 178.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -59.81 -40.72 89.34 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.638 0.775 . . . . 0.0 110.982 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.458 ' O ' HG22 ' A' ' 180' ' ' VAL . 89.4 m-20 -64.04 -46.26 85.21 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.871 176.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -61.76 -40.8 96.42 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.717 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 174' ' ' VAL . 66.6 mt -68.05 -37.5 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -65.72 -26.61 72.12 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 116.046 -0.524 . . . . 0.0 113.447 177.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.458 HG22 ' O ' ' A' ' 176' ' ' ASN . 98.3 t -75.59 -45.96 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.209 0.604 . . . . 0.0 109.916 175.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.453 ' HA ' HD11 ' A' ' 119' ' ' ILE . 42.6 tp -55.93 -52.5 63.92 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.342 0.657 . . . . 0.0 110.816 176.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.4 HG21 HG23 ' A' ' 192' ' ' VAL . 79.8 mt -60.13 -46.65 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.79 0.836 . . . . 0.0 110.595 176.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -52.65 -45.71 59.86 Favored Glycine 0 C--N 1.345 1.045 0 O-C-N 124.097 0.873 . . . . 0.0 114.156 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -68.14 -38.11 87.74 Favored Glycine 0 C--N 1.347 1.14 0 O-C-N 123.917 0.422 . . . . 0.0 112.538 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.506 HD22 HD12 ' A' ' 128' ' ' ILE . 97.5 mt -67.29 -34.12 76.73 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.484 0.713 . . . . 0.0 111.226 178.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -69.12 -38.81 79.07 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.59 0.756 . . . . 0.0 110.407 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -61.56 -41.35 97.24 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.191 174.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.421 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 6.7 m-20 -80.19 -2.86 46.64 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.965 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 61.68 57.03 2.33 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.054 0.941 . . . . 0.0 111.298 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -111.81 143.37 42.86 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.756 0.822 . . . . 0.0 109.146 174.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 96.0 m -78.64 102.84 8.2 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.4 HG23 HG21 ' A' ' 182' ' ' ILE . 26.7 m -86.7 143.0 12.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.418 -173.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -147.7 129.72 15.4 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 171.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 3.7 t -96.99 146.35 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 31.2 t -57.53 139.15 54.15 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 118.913 -0.565 . . . . 0.0 110.072 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -54.89 -37.89 66.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 123.497 0.498 . . . . 0.0 110.609 -177.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 41.1 p -62.02 -52.55 63.53 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.596 0.758 . . . . 0.0 109.541 176.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 68.9 mt -58.71 -28.09 65.49 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.61 0.764 . . . . 0.0 111.489 177.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.532 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 46.5 mt-30 -73.46 -42.74 61.56 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 119.021 -0.514 . . . . 0.0 112.191 -176.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.33 -20.78 20.05 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 119.541 1.064 . . . . 0.0 111.574 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -80.51 -41.78 23.65 Favored 'General case' 0 C--N 1.35 0.602 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.47 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -114.4 -60.59 1.87 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.059 0.543 . . . . 0.0 111.617 -176.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.532 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 46.1 t-105 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -161.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 110.523 -0.177 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -85.58 105.58 16.26 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 169.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.0 mm -77.6 120.45 28.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 175.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.4 p -100.85 66.54 1.18 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 132' ' ' ALA . 22.6 t70 -67.84 -29.15 68.22 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.755 176.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.711 ' HG3' ' HG3' ' A' ' 97' ' ' GLU . 32.7 ttp -104.84 129.42 53.16 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.724 1.61 . . . . 0.0 107.141 170.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 48.0 p -67.1 156.16 36.85 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 121.309 -0.87 . . . . 0.0 109.94 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -59.64 -35.3 58.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -57.87 -58.29 9.02 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.01 0.924 . . . . 0.0 112.175 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.711 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 12.5 pt-20 -71.15 -27.09 63.3 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 122.703 0.401 . . . . 0.0 111.05 -178.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.545 ' HG ' HD23 ' A' ' 146' ' ' LEU . 9.5 tt -60.71 -39.91 90.31 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.207 1.003 . . . . 0.0 110.201 171.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 81.1 p -107.07 19.96 19.69 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.277 0.631 . . . . 0.0 111.219 -177.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.533 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 2.5 tpm_? -69.78 140.15 53.34 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.879 0.871 . . . . 0.0 111.203 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -78.89 128.26 33.1 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 173.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 40.2 p-90 -150.65 168.13 25.25 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.064 0.946 . . . . 0.0 110.088 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -126.85 136.51 52.44 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.39 0.676 . . . . 0.0 109.795 178.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.531 ' HG2' ' HA ' ' A' ' 107' ' ' PRO . 43.7 ttp -94.31 93.06 7.51 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 167.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.2 tp -55.62 -53.73 52.93 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.718 1.207 . . . . 0.0 111.367 -168.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.488 ' HA ' ' HE3' ' A' ' 106' ' ' MET . 27.5 mmt -101.95 93.75 3.97 Favored Pre-proline 0 C--O 1.244 0.779 0 C-N-CA 124.145 0.978 . . . . 0.0 108.581 171.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.531 ' HA ' ' HG2' ' A' ' 104' ' ' MET . 7.0 Cg_exo -73.02 111.73 3.35 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 122.573 2.182 . . . . 0.0 112.345 -172.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -114.63 112.32 22.71 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 171.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -94.92 101.5 13.29 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -177.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.439 ' HE2' HG12 ' A' ' 180' ' ' VAL . 55.2 tptt -101.93 146.23 28.15 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 170.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 93.2 t -131.01 129.29 63.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 167.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -123.78 95.11 4.44 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.35 -137.12 21.42 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.549 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -82.08 20.4 1.1 Allowed 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 123.705 2.937 . . . . 0.0 113.075 173.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.465 HD11 HG22 ' A' ' 174' ' ' VAL . 87.5 mt -127.86 122.69 33.24 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.358 0.663 . . . . 0.0 109.618 -175.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 49.4 t -85.44 115.41 23.15 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.038 0.935 . . . . 0.0 110.099 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.6 mm -100.47 121.88 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.588 0.755 . . . . 0.0 109.363 -175.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 51.3 mtt-85 -103.09 119.84 39.58 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 34.9 mm -114.56 122.04 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.522 ' HB2' ' HG3' ' A' ' 104' ' ' MET . 18.8 t70 -97.04 113.09 24.61 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 170.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -77.25 -11.56 59.84 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.716 0.806 . . . . 0.0 112.127 -175.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.66 -62.51 1.56 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.321 0.649 . . . . 0.0 111.765 -174.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.7 mp -71.23 115.0 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-O 122.014 0.911 . . . . 0.0 110.883 -174.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 59.1 mtt -133.11 167.25 20.67 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 113.83 -1.532 . . . . 0.0 109.879 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.9 t70 55.17 42.15 30.88 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.636 1.174 . . . . 0.0 111.374 177.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 190' ' ' ASN . 45.5 mmtm -124.75 153.39 42.49 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.209 1.004 . . . . 0.0 110.145 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -88.3 106.36 18.17 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 172.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.471 HG12 HG21 ' A' ' 151' ' ' THR . 56.0 mt -107.88 136.08 44.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 124.702 1.201 . . . . 0.0 110.031 -174.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 11.8 tpt -115.41 138.16 51.29 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.422 1.089 . . . . 0.0 110.057 -175.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.524 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 3.4 mm? -92.64 117.71 30.26 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.975 0.91 . . . . 0.0 108.92 177.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.458 ' HB3' ' HB2' ' A' ' 93' ' ' MET . 73.5 mmtt -123.6 125.47 44.9 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.668 1.187 . . . . 0.0 109.211 176.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.509 ' HB1' ' HG ' ' A' ' 147' ' ' LEU . . . -137.49 144.43 42.22 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -175.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -106.29 130.77 54.08 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 169.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.403 ' HA ' HD12 ' A' ' 145' ' ' ILE . 4.9 p90 -162.87 157.46 21.32 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 124.15 0.906 . . . . 0.0 109.38 -172.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 22.2 p -85.65 152.1 23.36 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 172.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 87.6 t -121.84 138.51 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.847 0.859 . . . . 0.0 109.738 -177.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.0 tp -145.05 142.43 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 170.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 60.39 17.87 7.58 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.714 0.806 . . . . 0.0 112.757 177.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 73.87 21.08 2.75 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 126.566 1.947 . . . . 0.0 112.155 -177.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.413 ' HB2' HD11 ' A' ' 171' ' ' ILE . 10.8 ptp180 -125.39 172.19 9.82 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.938 0.895 . . . . 0.0 109.863 175.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.2 tt -69.32 119.56 13.78 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.365 0.666 . . . . 0.0 109.669 174.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -83.41 -65.93 0.95 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.319 1.047 . . . . 0.0 108.947 176.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 69.4 m -141.55 130.94 23.7 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.608 0.763 . . . . 0.0 109.028 175.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 52.9 tp -77.6 121.31 23.76 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.993 0.917 . . . . 0.0 109.812 174.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 134' ' ' PHE . 1.7 mp -81.94 -44.49 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.579 0.752 . . . . 0.0 109.458 176.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.545 HD23 ' HG ' ' A' ' 98' ' ' LEU . 34.0 tp -167.72 148.89 5.37 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.943 0.897 . . . . 0.0 108.714 173.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.7 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 8.3 tt -129.17 150.13 50.68 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 174.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.718 HH11 HG23 ' A' ' 156' ' ' ILE . 44.0 ttm-85 -143.1 143.57 31.89 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.379 0.672 . . . . 0.0 110.8 -173.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -124.22 118.8 27.65 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.437 1.095 . . . . 0.0 108.308 174.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -145.92 144.66 30.31 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.198 0.523 . . . . 0.0 111.018 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.471 HG21 HG12 ' A' ' 128' ' ' ILE . 55.3 p -65.41 171.51 3.9 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.616 -1.174 . . . . 0.0 112.197 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -65.3 -23.22 66.96 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.003 0.521 . . . . 0.0 110.821 172.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -66.12 -30.04 70.46 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.226 1.01 . . . . 0.0 110.234 174.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 107.3 -5.36 35.74 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.039 -174.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -70.26 105.14 2.87 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.434 0.694 . . . . 0.0 110.681 -175.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.718 HG23 HH11 ' A' ' 148' ' ' ARG . 33.3 mt -73.92 118.9 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.45 ' HB ' ' HB3' ' A' ' 120' ' ' ASP . 35.6 m -130.98 15.3 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.833 0.853 . . . . 0.0 110.648 -175.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -164.39 151.78 21.14 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -163.54 141.58 7.68 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.7 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 69.1 mt -113.13 102.74 14.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 170.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 20.7 t -98.93 108.49 49.4 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.135 0.974 . . . . 0.0 108.85 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.19 134.55 62.53 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.514 2.143 . . . . 0.0 111.318 175.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 CA--C 1.551 1.001 0 O-C-N 123.531 0.52 . . . . 0.0 109.859 -179.614 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.403 ' O ' HG21 ' A' ' 174' ' ' VAL . 80.7 p -87.69 151.4 22.96 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.064 0.546 . . . . 0.0 110.385 -174.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.434 ' O ' ' HG3' ' A' ' 175' ' ' LYS . 8.3 tt -58.52 -38.76 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 O-C-N 123.99 0.806 . . . . 0.0 111.129 175.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 47.2 mp0 -55.54 -41.57 73.4 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.086 0.955 . . . . 0.0 110.461 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -67.38 -47.19 71.08 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.556 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.48 ' O ' HG13 ' A' ' 178' ' ' ILE . 57.4 t -61.53 -34.28 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 122.974 0.509 . . . . 0.0 110.959 -176.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 171' ' ' ILE . 39.2 mtpt -61.05 -34.7 75.3 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.247 0.619 . . . . 0.0 111.781 177.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -68.0 -47.65 67.94 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.35 -45.11 84.68 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 124.374 1.046 . . . . 0.0 112.249 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.509 ' HB ' ' HZ3' ' A' ' 203' ' ' TRP . 23.2 mt -72.06 -37.57 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -64.8 -27.47 72.12 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 116.126 -0.488 . . . . 0.0 113.003 177.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.439 HG12 ' HE2' ' A' ' 110' ' ' LYS . 54.1 t -83.15 -39.91 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.746 0.818 . . . . 0.0 110.203 177.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.471 HD22 HG13 ' A' ' 160' ' ' ILE . 58.7 tp -58.52 -53.03 62.95 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.084 0.554 . . . . 0.0 110.406 174.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.618 HG22 HG21 ' A' ' 192' ' ' VAL . 70.4 mt -59.28 -43.48 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.44 1.096 . . . . 0.0 110.278 173.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -58.53 -35.0 78.16 Favored Glycine 0 CA--C 1.533 1.203 0 O-C-N 123.886 0.741 . . . . 0.0 113.83 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -72.39 -35.49 59.91 Favored Glycine 0 C--N 1.349 1.292 0 N-CA-C 111.847 -0.501 . . . . 0.0 111.847 175.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.411 HD21 HD13 ' A' ' 128' ' ' ILE . 75.3 mt -71.06 -25.25 62.56 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 124.297 1.039 . . . . 0.0 111.252 175.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 26.9 mm-40 -70.85 -37.78 73.13 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.713 0.805 . . . . 0.0 110.06 174.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -73.83 -31.68 63.33 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.293 177.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -72.6 -14.72 61.68 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.088 169.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 15.6 t70 57.3 64.85 1.5 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.629 1.172 . . . . 0.0 110.313 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 10.5 p30 -131.84 165.73 23.18 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.671 174.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 42.3 m -87.78 106.39 18.04 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.507 -172.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.618 HG21 HG22 ' A' ' 182' ' ' ILE . 34.3 m -94.81 141.98 14.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.763 0 C-N-CA 122.918 0.487 . . . . 0.0 110.689 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -144.76 131.3 19.87 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.233 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.524 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 5.2 t -95.69 149.51 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.401 ' HB2' ' HG ' ' A' ' 198' ' ' LEU . 69.9 m -67.44 144.59 55.66 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 118.95 0.795 . . . . 0.0 110.947 177.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -60.22 -26.29 66.28 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.079 0.952 . . . . 0.0 111.797 -177.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.0 p -67.68 -53.18 29.74 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 172.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.489 ' HB2' HG13 ' A' ' 194' ' ' VAL . 68.1 mt -62.91 -25.61 68.41 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.881 0.873 . . . . 0.0 111.506 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.586 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 78.3 mt-30 -69.24 -44.12 72.65 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.224 0.61 . . . . 0.0 110.824 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.08 -30.0 20.22 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.662 -175.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -83.3 -57.89 3.07 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.548 0.339 . . . . 0.0 110.803 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -98.73 -37.37 9.51 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.16 0.584 . . . . 0.0 111.703 -165.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.586 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 43.4 t-105 . . . . . 0 N--CA 1.481 1.103 0 C-N-CA 124.275 1.03 . . . . 0.0 109.415 -170.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 . . . . . 0 N--CA 1.47 0.526 0 CA-C-O 120.76 0.314 . . . . 0.0 111.465 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -86.47 105.03 16.49 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 175.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 49.9 mm -78.73 125.89 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 62.4 p -114.26 91.42 3.62 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.641 -176.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -75.51 -17.84 59.99 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.182 0.593 . . . . 0.0 110.703 177.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.506 ' SD ' ' HB3' ' A' ' 148' ' ' ARG . 61.1 mtm -117.22 128.72 55.38 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.456 1.103 . . . . 0.0 108.943 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.4 m -77.82 162.15 27.11 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 171.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -48.55 -35.41 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 124.402 1.081 . . . . 0.0 111.763 -177.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -51.58 -71.14 0.07 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.211 1.404 . . . . 0.0 112.207 177.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -69.11 -29.84 67.99 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.528 0.731 . . . . 0.0 111.744 -176.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.8 tt -62.5 -43.1 99.63 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.235 1.014 . . . . 0.0 109.263 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.2 m -105.23 15.18 27.85 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.738 0.815 . . . . 0.0 111.815 -175.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -80.88 135.47 35.92 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.159 0.583 . . . . 0.0 110.222 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -88.22 144.87 26.19 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.776 0.83 . . . . 0.0 109.306 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 18.5 p-90 -152.42 154.29 35.26 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.192 0.997 . . . . 0.0 110.465 -173.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -96.42 160.47 14.39 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.538 0.735 . . . . 0.0 110.791 -177.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 65.9 mtp -128.74 116.88 20.21 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 170.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.3 tt -70.71 -54.78 10.51 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.466 ' HE2' ' HA ' ' A' ' 106' ' ' MET . 21.5 mmt -119.22 86.56 33.03 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 124.126 0.97 . . . . 0.0 109.378 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -76.67 113.61 3.69 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 122.837 2.358 . . . . 0.0 112.493 -175.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.533 ' HE3' ' HB2' ' A' ' 110' ' ' LYS . 51.4 tptt -90.59 106.69 18.68 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 169.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 51.2 tp60 -90.92 107.27 19.09 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.146 -0.933 . . . . 0.0 108.698 176.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.533 ' HB2' ' HE3' ' A' ' 108' ' ' LYS . 58.7 tttm -140.12 143.44 36.23 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.992 172.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 68.0 t -105.67 147.24 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 169.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -134.66 90.75 2.69 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 174.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.3 -136.37 21.21 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 114.823 -1.08 . . . . 0.0 112.687 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -81.43 17.9 1.42 Allowed 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 123.687 2.925 . . . . 0.0 113.148 176.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.3 mp -134.87 136.42 42.39 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.745 0.818 . . . . 0.0 108.91 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 26.4 p -100.82 138.83 37.35 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.105 0.562 . . . . 0.0 110.085 177.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.2 mm -106.72 133.94 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.326 1.05 . . . . 0.0 110.637 -171.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -108.84 118.18 36.12 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 173.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.496 ' HB ' ' HB3' ' A' ' 108' ' ' LYS . 87.0 mt -126.97 125.63 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -97.03 117.73 31.85 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 118.78 0.718 . . . . 0.0 109.331 173.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -78.5 -8.31 58.41 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.303 1.041 . . . . 0.0 112.506 -172.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.41 -26.33 23.36 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.676 0.39 . . . . 0.0 110.292 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 41.2 mm -81.89 102.15 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 121.997 0.904 . . . . 0.0 110.995 -173.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.511 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 52.1 mtt -134.09 160.47 37.67 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 114.253 -1.34 . . . . 0.0 108.763 -178.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.8 t70 65.34 24.56 12.1 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.719 0.771 . . . . 0.0 111.64 174.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 190' ' ' ASN . 74.9 mmtt -117.45 148.61 41.65 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.236 1.014 . . . . 0.0 110.66 -179.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.8 106.48 17.73 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 171.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.503 HD11 HD23 ' A' ' 185' ' ' LEU . 50.1 mt -102.28 128.63 54.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.893 0.877 . . . . 0.0 111.25 -174.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.544 ' HG3' ' HG3' ' A' ' 131' ' ' LYS . 4.0 tpt -98.99 116.38 31.1 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.064 1.746 . . . . 0.0 109.636 -176.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -98.57 104.7 16.76 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.544 ' HG3' ' HG3' ' A' ' 129' ' ' MET . 47.3 mtmt -127.17 149.58 49.91 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.166 0.586 . . . . 0.0 110.975 -177.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.468 ' HB2' HD21 ' A' ' 198' ' ' LEU . . . -141.4 149.93 41.7 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -173.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -100.25 118.88 37.46 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 163.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -151.91 159.18 43.89 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.157 0.583 . . . . 0.0 110.964 -171.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.8 m -86.36 150.52 24.27 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.787 1.235 . . . . 0.0 109.703 177.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 98.2 t -122.4 145.62 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 175.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.43 HG21 ' HB2' ' A' ' 142' ' ' GLU . 9.7 tp -162.67 145.48 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 167.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 56.29 25.68 9.61 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 124.043 0.937 . . . . 0.0 112.606 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 69.72 25.52 5.12 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 125.781 1.632 . . . . 0.0 112.487 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.521 ' HB2' HD11 ' A' ' 171' ' ' ILE . 1.2 ptp85 -132.56 171.65 13.54 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.325 0.65 . . . . 0.0 110.902 175.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.7 tt -74.44 114.07 12.41 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 114.904 -1.043 . . . . 0.0 108.662 172.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.43 ' HB2' HG21 ' A' ' 137' ' ' ILE . 9.4 tp10 -73.45 -61.84 1.69 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.902 0.881 . . . . 0.0 110.247 175.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 65.4 m -146.32 127.53 14.76 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.99 0.916 . . . . 0.0 109.438 -175.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.465 HD12 ' HB1' ' A' ' 132' ' ' ALA . 36.7 tp -74.06 125.23 27.84 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 172.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.9 mp -83.35 -48.51 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 172.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.54 HD22 ' NH2' ' A' ' 148' ' ' ARG . 46.5 tp -165.26 147.42 7.8 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.687 0.795 . . . . 0.0 109.626 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.632 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 8.9 tt -129.62 156.75 43.7 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 171.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.748 ' HD3' HD13 ' A' ' 156' ' ' ILE . 48.4 ttm-85 -154.07 141.16 19.39 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.082 0.553 . . . . 0.0 110.733 -175.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.98 121.14 44.51 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.627 1.171 . . . . 0.0 109.411 -177.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -110.99 155.94 21.98 Favored 'General case' 0 C--O 1.208 -1.087 0 C-N-CA 124.74 1.216 . . . . 0.0 108.541 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 24.9 p -100.18 168.3 9.9 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 118.852 0.751 . . . . 0.0 109.833 168.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.8 -21.17 62.51 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 172.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -61.7 -30.27 70.64 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.103 0.961 . . . . 0.0 111.422 169.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 99.21 14.31 36.36 Favored Glycine 0 C--N 1.346 1.116 0 O-C-N 123.714 0.634 . . . . 0.0 112.84 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -101.1 135.11 43.09 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.41 0.684 . . . . 0.0 109.957 176.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.748 HD13 ' HD3' ' A' ' 148' ' ' ARG . 47.1 mt -78.93 127.13 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 174.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.6 m -127.01 1.41 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.636 0.774 . . . . 0.0 112.435 -171.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -164.81 170.03 39.73 Favored Glycine 0 C--N 1.344 0.973 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 34.6 tt0 -167.67 153.75 7.63 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.04 0.936 . . . . 0.0 109.139 -177.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.632 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 70.6 mt -129.4 104.23 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 167.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 5.4 p -109.95 121.84 40.71 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 123.85 0.86 . . . . 0.0 109.627 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -62.53 140.11 79.81 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.752 2.301 . . . . 0.0 111.824 175.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 CA--C 1.548 0.874 0 C-N-CA 123.744 0.818 . . . . 0.0 110.543 179.297 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 59.1 p -98.23 166.08 11.57 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 123.31 0.644 . . . . 0.0 110.268 174.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.571 HD12 ' HA ' ' A' ' 202' ' ' ALA . 12.7 tt -52.78 -35.84 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 124.189 0.996 . . . . 0.0 110.882 170.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -59.72 -44.71 93.61 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.55 1.14 . . . . 0.0 111.469 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -63.34 -43.69 97.01 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 124.105 0.878 . . . . 0.0 111.093 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.477 ' O ' HG13 ' A' ' 178' ' ' ILE . 67.3 t -64.07 -42.91 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.944 -178.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -62.14 -36.84 83.03 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.028 0.531 . . . . 0.0 111.634 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -66.29 -43.99 84.77 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 175.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -59.33 -44.69 92.58 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.232 1.013 . . . . 0.0 111.719 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 174' ' ' VAL . 51.3 mt -70.38 -35.99 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.27 0.628 . . . . 0.0 109.661 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.96 -27.17 73.31 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 116.22 -0.445 . . . . 0.0 113.723 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 45.5 t -75.2 -47.03 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.499 0.72 . . . . 0.0 110.614 175.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 30.0 tp -60.89 -52.76 63.66 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 123.748 0.655 . . . . 0.0 110.573 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.411 HG22 HG13 ' A' ' 192' ' ' VAL . 65.3 mt -65.85 -46.8 87.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.77 0.828 . . . . 0.0 111.149 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -58.13 -34.48 73.35 Favored Glycine 0 C--N 1.345 1.075 0 O-C-N 123.599 0.562 . . . . 0.0 113.396 177.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.5 -47.04 92.35 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 172.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.503 HD23 HD11 ' A' ' 128' ' ' ILE . 93.8 mt -64.54 -29.25 70.28 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.787 1.235 . . . . 0.0 111.92 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -69.68 -41.55 75.29 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.519 0.728 . . . . 0.0 110.493 177.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 20.6 mtm180 -74.53 -26.88 60.26 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.891 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.511 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 16.0 m120 -71.99 -20.07 61.78 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.237 0.615 . . . . 0.0 111.152 172.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 65.66 66.3 0.52 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.528 1.131 . . . . 0.0 110.831 -173.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 11.6 p30 -136.57 158.26 44.86 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.156 168.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 86.2 m -83.65 105.93 14.96 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.616 0.766 . . . . 0.0 110.588 -170.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.411 HG13 HG22 ' A' ' 182' ' ' ILE . 33.0 m -83.18 145.41 8.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 C-N-CA 123.153 0.581 . . . . 0.0 110.308 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -146.16 125.13 12.76 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 170.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 3.0 t -93.46 149.16 4.37 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -177.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 43.0 t -59.7 141.45 55.1 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.736 0.414 . . . . 0.0 110.235 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -52.61 -38.66 60.59 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.06 0.944 . . . . 0.0 111.443 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 68.6 p -67.54 -49.73 61.92 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.331 1.052 . . . . 0.0 110.647 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.468 HD21 ' HB2' ' A' ' 132' ' ' ALA . 71.5 mt -59.67 -34.81 73.33 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.714 0.805 . . . . 0.0 110.922 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.57 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 50.5 mt-30 -63.65 -54.53 34.26 Favored 'General case' 0 C--N 1.348 0.543 0 O-C-N 123.88 0.737 . . . . 0.0 110.974 178.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.39 -12.81 53.77 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -172.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -96.0 -40.43 9.27 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 118.058 0.39 . . . . 0.0 111.764 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.571 ' HA ' HD12 ' A' ' 171' ' ' ILE . . . -121.82 -61.49 1.5 Allowed 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -172.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.57 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 60.3 t-105 . . . . . 0 N--CA 1.484 1.226 0 C-N-CA 124.378 1.071 . . . . 0.0 112.323 -164.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 45.0 ttm180 . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 120.97 0.414 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -96.85 111.05 23.41 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 170.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 133' ' ' ASN . 48.2 mm -83.05 117.69 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 170.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 37.7 p -113.5 88.49 2.85 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.017 0.927 . . . . 0.0 109.06 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -68.81 -31.06 69.78 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.456 177.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.443 ' HE3' ' HG ' ' A' ' 98' ' ' LEU . 24.5 ptt? -121.31 142.88 49.53 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.816 0.847 . . . . 0.0 108.934 178.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 68.5 p -78.96 163.07 25.53 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.767 0.318 . . . . 0.0 110.297 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.46 -31.42 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.291 0 C-N-CA 124.863 1.265 . . . . 0.0 111.995 -176.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -54.34 -69.58 0.12 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.269 1.027 . . . . 0.0 112.363 178.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.9 pm0 -69.02 -25.19 64.37 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.007 0.523 . . . . 0.0 111.758 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.443 ' HG ' ' HE3' ' A' ' 93' ' ' MET . 6.4 tt -59.67 -48.79 80.27 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.479 0.712 . . . . 0.0 109.386 176.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.8 t -106.77 19.24 20.76 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.203 0.601 . . . . 0.0 111.202 -175.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -77.58 140.59 39.71 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.689 0.796 . . . . 0.0 110.242 174.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -91.67 145.72 24.36 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.545 0.738 . . . . 0.0 110.459 174.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . 0.548 ' HH2' ' HG2' ' A' ' 118' ' ' ARG . 42.3 p-90 -158.41 179.77 8.83 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.929 1.292 . . . . 0.0 109.78 -172.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -139.72 158.36 44.23 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.333 0.653 . . . . 0.0 110.513 177.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.513 ' HE1' ' HA ' ' A' ' 107' ' ' PRO . 71.0 mtm -105.99 145.62 31.12 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.741 0.816 . . . . 0.0 109.334 171.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.9 tp -82.2 -40.15 22.11 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.189 0.596 . . . . 0.0 110.177 -175.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 19.7 mmt -122.68 88.74 49.95 Favored Pre-proline 0 N--CA 1.484 1.236 0 C-N-CA 124.562 1.145 . . . . 0.0 108.666 169.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.513 ' HA ' ' HE1' ' A' ' 104' ' ' MET . 17.4 Cg_exo -68.27 131.96 24.69 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.622 2.215 . . . . 0.0 113.307 -178.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.452 ' HD2' HE21 ' A' ' 121' ' ' GLN . 86.9 tttt -135.57 135.91 40.69 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.404 1.082 . . . . 0.0 108.372 171.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -112.82 124.15 51.93 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.11 0.564 . . . . 0.0 110.144 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -125.53 150.06 47.76 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 168.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 12.9 t -126.81 142.51 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 172.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -138.68 98.12 3.5 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 68.69 -127.25 22.56 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 119.351 -0.694 . . . . 0.0 112.162 -177.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -89.45 14.75 2.12 Favored 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 123.483 2.789 . . . . 0.0 112.803 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.518 HD22 ' HA ' ' A' ' 162' ' ' PRO . 93.9 mt -128.03 122.44 32.21 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.931 0.492 . . . . 0.0 110.096 -172.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 40.2 t -83.05 116.9 22.5 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.345 1.058 . . . . 0.0 109.702 177.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 10.4 mm -90.81 115.96 31.09 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 C-N-CA 123.777 0.831 . . . . 0.0 109.287 -177.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.548 ' HG2' ' HH2' ' A' ' 102' ' ' TRP . 7.9 tpt180 -94.7 118.53 31.88 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 43.9 mm -123.3 134.39 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.531 0.732 . . . . 0.0 109.509 -176.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -117.97 120.87 39.13 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.445 0.698 . . . . 0.0 109.153 174.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.452 HE21 ' HD2' ' A' ' 108' ' ' LYS . 82.4 mt-30 -82.98 -1.24 52.0 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.949 0.9 . . . . 0.0 112.893 -177.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.13 -56.92 3.12 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 117.934 0.334 . . . . 0.0 111.455 -173.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.458 HG22 ' HG3' ' A' ' 126' ' ' LYS . 2.0 mp -70.14 104.07 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-O 121.938 0.875 . . . . 0.0 110.314 -175.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.41 ' HE3' ' O ' ' A' ' 121' ' ' GLN . 51.9 mtt -126.56 159.42 33.53 Favored 'General case' 0 C--N 1.348 0.508 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.964 178.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.71 33.84 21.94 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.608 0.763 . . . . 0.0 112.294 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.458 ' HG3' HG22 ' A' ' 123' ' ' ILE . 74.1 mmtt -114.49 155.23 26.79 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.461 0.705 . . . . 0.0 110.594 176.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.436 ' HB2' ' HB3' ' A' ' 152' ' ' GLU . 0.8 OUTLIER -89.73 101.63 14.32 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 170.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.486 ' HB ' HG13 ' A' ' 192' ' ' VAL . 66.5 mt -101.77 139.73 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.535 0.734 . . . . 0.0 109.431 -172.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 14.2 tpt -123.0 127.03 48.24 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.822 0.849 . . . . 0.0 109.649 -175.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 22.8 mt -99.15 104.59 16.58 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -176.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.431 ' HB2' ' HE1' ' A' ' 150' ' ' PHE . 2.8 mtpm? -117.23 130.72 56.76 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -175.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -133.52 152.69 51.94 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 122.016 0.912 . . . . 0.0 112.782 -170.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.428 ' ND2' HD13 ' A' ' 98' ' ' LEU . 5.2 m-20 -108.22 125.35 51.55 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 168.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -155.48 159.09 39.51 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.297 0.639 . . . . 0.0 111.083 -172.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.485 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . 37.9 m -90.12 161.69 15.66 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.985 0.914 . . . . 0.0 110.94 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 70.9 t -139.88 130.81 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 124.263 1.025 . . . . 0.0 110.075 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.559 HG21 ' HG2' ' A' ' 142' ' ' GLU . 9.1 tp -146.89 144.7 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 170.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 57.55 24.69 10.66 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.622 0.769 . . . . 0.0 111.628 -178.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 63.4 30.36 15.46 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.824 1.25 . . . . 0.0 112.28 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -131.9 165.45 23.86 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.615 0.766 . . . . 0.0 109.458 171.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.471 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 9.8 tt -70.9 129.39 38.91 Favored 'General case' 0 CA--C 1.554 1.096 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.559 ' HG2' HG21 ' A' ' 137' ' ' ILE . 31.8 mt-10 -83.88 -67.52 0.79 Allowed 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.698 0.761 . . . . 0.0 109.736 173.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 27.6 m -144.85 138.75 27.24 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.9 -170.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.423 HD23 HG13 ' A' ' 174' ' ' VAL . 56.5 tp -84.2 112.36 20.2 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.077 0.551 . . . . 0.0 109.577 175.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.13 -51.42 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 174.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.413 HD23 ' NH2' ' A' ' 148' ' ' ARG . 35.2 tp -170.6 149.13 3.15 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.321 177.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.522 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 10.0 tt -124.0 150.97 44.24 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 172.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.476 ' HD3' HD13 ' A' ' 156' ' ' ILE . 32.5 ttm-85 -143.31 135.09 26.61 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 122.671 0.388 . . . . 0.0 110.265 -178.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.06 113.73 27.44 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.431 ' HE1' ' HB2' ' A' ' 131' ' ' LYS . 17.4 m-85 -103.62 166.0 10.69 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 57.6 p -93.98 -179.44 4.97 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 120.949 0.404 . . . . 0.0 110.125 166.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.436 ' HB3' ' HB2' ' A' ' 127' ' ' ASN . 13.3 pt-20 -61.94 -26.64 68.31 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.343 1.057 . . . . 0.0 110.913 172.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -77.57 -29.42 52.08 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.854 1.262 . . . . 0.0 110.815 174.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 103.96 11.03 33.29 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.908 -178.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.32 124.35 27.38 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.143 0.577 . . . . 0.0 109.503 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.476 HD13 ' HD3' ' A' ' 148' ' ' ARG . 54.9 mt -75.47 107.18 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -178.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.6 m -117.21 4.01 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.303 1.041 . . . . 0.0 111.869 -173.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -168.45 172.34 42.94 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-N 116.509 -0.314 . . . . 0.0 112.453 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -166.78 153.58 8.84 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.738 0.815 . . . . 0.0 109.394 -175.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.568 HD13 ' HB2' ' A' ' 181' ' ' LEU . 40.3 mm -124.95 103.58 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 164.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 55.9 p -102.68 126.95 31.35 Favored Pre-proline 0 N--CA 1.474 0.733 0 C-N-CA 123.146 0.578 . . . . 0.0 110.545 -177.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.518 ' HA ' HD22 ' A' ' 115' ' ' LEU . 56.4 Cg_endo -67.3 150.01 81.21 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 122.163 1.908 . . . . 0.0 112.015 175.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 77.0 mt . . . . . 0 CA--C 1.543 0.686 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.547 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.437 ' CE1' HD21 ' A' ' 115' ' ' LEU . 27.2 p-80 . . . . . 0 N--CA 1.477 0.908 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 42.6 m -110.99 161.83 15.47 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.596 0.758 . . . . 0.0 110.315 -174.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 141' ' ' LEU . 6.8 tt -45.94 -39.14 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.996 1.318 . . . . 0.0 112.498 173.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.583 ' HA ' ' NZ ' ' A' ' 175' ' ' LYS . 22.9 mm-40 -53.41 -48.87 68.32 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.262 1.025 . . . . 0.0 112.085 -176.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -61.11 -40.24 93.01 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 124.653 1.221 . . . . 0.0 110.813 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.423 HG13 HD23 ' A' ' 144' ' ' LEU . 41.1 t -66.8 -40.13 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.242 -175.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.583 ' NZ ' ' HA ' ' A' ' 172' ' ' GLU . 25.9 mtmm -60.39 -42.02 95.01 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 120.984 0.421 . . . . 0.0 110.009 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.488 ' O ' HG21 ' A' ' 180' ' ' VAL . 13.4 m120 -62.92 -48.51 78.64 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.653 175.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -59.68 -48.01 83.36 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.997 0.811 . . . . 0.0 112.616 -173.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.8 mt -63.57 -37.8 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.283 175.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.44 -30.82 77.22 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 115.578 -0.737 . . . . 0.0 114.432 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.488 HG21 ' O ' ' A' ' 176' ' ' ASN . 44.9 t -76.03 -43.15 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 117.79 0.795 . . . . 0.0 108.994 176.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.568 ' HB2' HD13 ' A' ' 160' ' ' ILE . 37.8 tp -53.38 -53.19 54.75 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.339 176.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.415 HD13 ' CH2' ' A' ' 203' ' ' TRP . 43.1 mt -64.1 -39.76 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.898 0.879 . . . . 0.0 110.716 174.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -53.12 -35.56 49.62 Favored Glycine 0 CA--C 1.533 1.214 0 O-C-N 123.466 0.478 . . . . 0.0 114.088 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -83.43 -39.45 9.8 Favored Glycine 0 C--N 1.348 1.235 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 175.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 46.1 mt -66.21 -31.67 72.65 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.168 0.987 . . . . 0.0 112.437 -176.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -69.57 -33.58 72.94 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.743 0.417 . . . . 0.0 110.329 176.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -71.32 -32.83 69.07 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.181 176.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -63.31 -16.99 62.04 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.141 0.576 . . . . 0.0 111.767 171.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 63.5 65.78 0.73 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.976 0.91 . . . . 0.0 110.136 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -141.0 175.9 9.24 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.069 176.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 90.9 m -109.91 101.91 10.71 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.106 0.563 . . . . 0.0 109.582 -173.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.486 HG13 ' HB ' ' A' ' 128' ' ' ILE . 12.7 m -99.82 153.87 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 121.535 0.683 . . . . 0.0 111.357 -177.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -136.56 143.91 43.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.174 -1.375 . . . . 0.0 108.305 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 3.3 t -111.06 145.88 16.79 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 47.4 m -57.93 140.66 51.62 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 118.014 0.37 . . . . 0.0 111.043 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -57.94 -29.91 65.53 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.291 0.636 . . . . 0.0 110.802 177.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 41.3 p -67.98 -52.64 33.52 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.784 0.834 . . . . 0.0 109.561 176.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 32.5 mt -54.58 -38.29 66.52 Favored 'General case' 0 C--O 1.208 -1.106 0 C-N-CA 123.871 0.868 . . . . 0.0 111.057 176.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.636 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 49.4 mt-30 -71.14 -39.74 71.8 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.258 0.623 . . . . 0.0 111.962 -176.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.29 -12.03 44.74 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -177.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -101.59 -42.53 6.19 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 178.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.439 ' HB2' HD11 ' A' ' 141' ' ' LEU . . . -123.42 -61.58 1.39 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.159 0.584 . . . . 0.0 112.243 -172.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.636 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 52.6 t-105 . . . . . 0 N--CA 1.475 0.804 0 C-N-CA 124.841 1.257 . . . . 0.0 111.084 -171.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.466 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 22.4 ttm-85 . . . . . 0 N--CA 1.471 0.6 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -92.76 101.97 14.36 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.942 0.897 . . . . 0.0 108.68 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.7 mm -78.96 114.33 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.491 0.716 . . . . 0.0 109.979 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.7 p -100.2 67.4 1.37 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 122.424 1.107 . . . . 0.0 108.752 174.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.45 ' HB3' ' O ' ' A' ' 132' ' ' ALA . 11.4 t70 -83.37 -33.31 25.84 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.76 -176.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 34.4 ttp -99.46 131.36 45.52 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 170.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.8 m -70.63 153.15 43.14 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 120.81 0.338 . . . . 0.0 110.4 177.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.43 -34.8 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.561 1.144 . . . . 0.0 110.406 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -54.44 -41.4 69.37 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.882 0.873 . . . . 0.0 111.627 174.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -80.69 -41.95 22.83 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.646 0.778 . . . . 0.0 110.451 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.541 ' HG ' HD22 ' A' ' 146' ' ' LEU . 10.4 tt -58.58 -46.65 86.48 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.565 1.146 . . . . 0.0 110.556 -176.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.5 t -100.22 19.28 16.8 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.764 0.826 . . . . 0.0 110.986 -175.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -84.74 128.11 34.44 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.033 0.533 . . . . 0.0 110.186 176.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -91.84 149.03 21.79 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.842 0.857 . . . . 0.0 108.949 174.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 24.2 p-90 -159.58 162.49 35.33 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.91 0.884 . . . . 0.0 110.463 -169.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -113.38 152.38 30.08 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.268 0.627 . . . . 0.0 109.974 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 66.2 mtp -104.79 123.2 47.25 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 175.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 42.7 tp -76.03 -40.28 53.8 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.502 0.721 . . . . 0.0 110.082 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 21.8 mmt -129.7 81.08 70.33 Favored Pre-proline 0 N--CA 1.482 1.173 0 C-N-CA 123.871 0.869 . . . . 0.0 108.926 171.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.81 113.39 3.19 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.7 2.266 . . . . 0.0 112.716 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.541 ' HB3' ' HB ' ' A' ' 119' ' ' ILE . 60.5 tttm -100.4 103.56 14.94 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 163.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.0 104.06 15.26 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -171.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.446 ' HG2' HG12 ' A' ' 180' ' ' VAL . 22.7 tptm -114.24 142.06 46.76 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.638 0.775 . . . . 0.0 109.451 177.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 97.6 t -125.82 126.4 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 170.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -115.06 83.96 2.0 Allowed 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 62.11 -114.95 7.3 Favored Glycine 0 CA--C 1.539 1.558 0 CA-C-N 114.875 -1.057 . . . . 0.0 113.468 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -84.93 5.93 5.99 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 123.702 2.935 . . . . 0.0 113.546 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.484 HD23 ' HA ' ' A' ' 162' ' ' PRO . 35.2 mt -133.93 111.91 10.82 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -173.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 44.5 t -84.19 127.96 34.26 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.201 0.6 . . . . 0.0 110.063 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.5 mm -102.91 137.22 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.353 0.661 . . . . 0.0 110.126 -174.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.497 ' HG3' ' HB3' ' A' ' 159' ' ' GLU . 29.1 mmt180 -107.56 116.83 32.65 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 173.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.541 ' HB ' ' HB3' ' A' ' 108' ' ' LYS . 43.3 mm -113.87 120.01 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 172.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -103.01 116.29 32.24 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 174.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -75.75 -22.15 56.77 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.066 0.947 . . . . 0.0 111.848 -174.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.27 -46.99 37.88 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.062 0.545 . . . . 0.0 111.477 -175.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.48 HG23 HG11 ' A' ' 157' ' ' VAL . 1.9 mp -71.25 108.52 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-O 121.928 0.87 . . . . 0.0 110.08 -177.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.472 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 45.9 mtt -130.56 160.67 33.47 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.415 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.4 t70 63.73 38.6 9.16 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 124.338 1.055 . . . . 0.0 112.126 172.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -123.61 151.38 43.05 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.266 0.626 . . . . 0.0 110.774 177.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -85.03 103.05 13.71 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 169.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.529 HD12 HG22 ' A' ' 157' ' ' VAL . 48.0 mt -107.64 129.97 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.65 0.738 . . . . 0.0 110.515 -172.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.49 ' HG3' ' HG3' ' A' ' 131' ' ' LYS . 2.4 tpt -97.51 123.29 41.32 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 125.47 1.508 . . . . 0.0 109.644 -174.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.513 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 3.5 mm? -94.73 103.75 15.66 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.49 ' HG3' ' HG3' ' A' ' 129' ' ' MET . 62.5 mttm -124.44 153.32 42.12 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.054 0.542 . . . . 0.0 111.242 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.521 ' HB3' ' HG ' ' A' ' 147' ' ' LEU . . . -147.07 160.67 42.12 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.549 -176.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -112.13 131.63 55.34 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 163.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -160.25 154.7 23.7 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.752 0.658 . . . . 0.0 110.931 -172.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.7 t -86.11 153.67 21.92 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.375 1.07 . . . . 0.0 108.325 175.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.466 ' HB ' ' HB3' ' A' ' 88' ' ' ARG . 79.6 t -134.88 139.73 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.516 0.726 . . . . 0.0 110.432 -175.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.9 tp -143.89 139.28 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 172.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 61.48 27.61 17.12 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 124.394 1.078 . . . . 0.0 112.354 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 61.14 29.96 19.11 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.669 1.187 . . . . 0.0 111.866 -177.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 7.5 ppt_? -135.3 158.22 44.91 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 173.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.6 tt -61.55 113.97 2.99 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.244 0.618 . . . . 0.0 110.288 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -75.28 -61.74 1.8 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.447 0.699 . . . . 0.0 110.462 176.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 40.5 m -147.09 129.03 15.41 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.516 0.726 . . . . 0.0 109.304 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 57.3 tp -78.11 120.6 23.15 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.894 0.878 . . . . 0.0 109.51 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.8 mp -77.91 -47.54 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 175.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.541 HD22 ' HG ' ' A' ' 98' ' ' LEU . 55.2 tp -167.22 147.41 5.43 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.007 0.923 . . . . 0.0 109.079 175.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.739 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 6.6 tt -127.09 154.02 45.25 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 175.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.503 HH11 HG21 ' A' ' 156' ' ' ILE . 39.2 ttm-85 -150.58 143.82 24.89 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.094 0.558 . . . . 0.0 111.316 -171.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.43 ' HB1' HD23 ' A' ' 181' ' ' LEU . . . -117.27 111.84 19.94 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.765 1.226 . . . . 0.0 107.878 173.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.468 ' HZ ' ' HD2' ' A' ' 131' ' ' LYS . 46.5 p90 -131.55 142.58 49.95 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 72.3 p -62.95 169.4 3.31 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.524 0.729 . . . . 0.0 112.133 -177.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -51.9 -28.63 16.91 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.965 1.306 . . . . 0.0 112.317 174.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -84.18 -29.49 26.59 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.009 0.924 . . . . 0.0 111.313 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 114.03 8.37 17.77 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 116.482 -0.327 . . . . 0.0 113.593 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -79.92 114.29 18.73 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.503 HG21 HH11 ' A' ' 148' ' ' ARG . 23.9 mt -71.29 124.14 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 122.626 0.37 . . . . 0.0 110.188 -177.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.529 HG22 HD12 ' A' ' 128' ' ' ILE . 26.6 m -124.8 -5.67 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.243 1.017 . . . . 0.0 111.236 -176.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -158.97 164.96 34.0 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -178.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.497 ' HB3' ' HG3' ' A' ' 118' ' ' ARG . 26.2 tt0 -168.28 150.52 5.29 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.257 0.623 . . . . 0.0 109.346 -176.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.739 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 83.7 mt -121.75 104.13 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 168.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 35.3 t -96.08 107.96 38.1 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 123.933 0.893 . . . . 0.0 110.233 -177.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.484 ' HA ' HD23 ' A' ' 115' ' ' LEU . 51.5 Cg_exo -58.47 113.65 1.64 Allowed 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.526 2.151 . . . . 0.0 111.681 172.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 CA--C 1.542 0.65 0 C-N-CA 124.11 0.964 . . . . 0.0 111.377 -174.114 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 . . . . . 0 C--O 1.242 0.69 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 14.7 m -88.31 152.4 21.96 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 6.7 tt -59.12 -35.91 59.9 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 124.933 1.293 . . . . 0.0 112.029 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.22 -31.91 73.3 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.753 0.821 . . . . 0.0 110.413 177.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.433 ' HA ' ' ND2' ' A' ' 176' ' ' ASN . 18.4 t70 -83.6 -30.01 27.3 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.712 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.508 ' O ' HG13 ' A' ' 178' ' ' ILE . 79.5 t -62.14 -38.82 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 171.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -52.0 -43.23 63.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 124.079 0.862 . . . . 0.0 110.85 173.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.439 ' O ' HG21 ' A' ' 180' ' ' VAL . 53.5 m-20 -66.18 -45.29 81.37 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.989 0.805 . . . . 0.0 109.996 -177.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.5 -46.38 88.71 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.751 0.82 . . . . 0.0 111.908 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 174' ' ' VAL . 40.8 mt -63.37 -36.33 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 177.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.49 -35.52 91.86 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 115.433 -0.803 . . . . 0.0 113.403 176.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.446 HG12 ' HG2' ' A' ' 110' ' ' LYS . 60.2 t -68.39 -48.88 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.572 HD22 HG13 ' A' ' 160' ' ' ILE . 24.4 tp -59.77 -50.37 74.08 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.256 -178.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 70.4 mt -62.11 -47.47 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.48 0.712 . . . . 0.0 110.757 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -58.51 -35.15 78.72 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 123.938 0.774 . . . . 0.0 114.128 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.461 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -69.37 -38.21 80.48 Favored Glycine 0 C--N 1.347 1.156 0 C-N-CA 122.947 0.308 . . . . 0.0 112.488 176.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.427 HD12 ' O ' ' A' ' 181' ' ' LEU . 8.9 mp -71.37 -32.58 68.66 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.679 0.792 . . . . 0.0 111.702 178.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -69.83 -38.24 76.46 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.1 0.56 . . . . 0.0 111.896 -177.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -79.02 -16.6 56.64 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.71 0.404 . . . . 0.0 111.406 177.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.472 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 7.0 m-20 -76.32 -11.49 59.91 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.062 0.545 . . . . 0.0 110.876 165.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 25.5 t70 65.43 59.87 0.77 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.483 1.113 . . . . 0.0 109.424 -176.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -110.57 151.29 27.79 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.349 169.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 49.9 m -83.43 102.67 12.22 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 171.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 35.4 m -88.3 140.79 15.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 123.701 0.8 . . . . 0.0 109.351 -175.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 24.7 ttm-85 -145.09 127.32 15.75 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.51 175.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.513 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 2.6 t -87.85 143.02 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 26.5 t -63.76 147.8 50.82 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 118.519 0.599 . . . . 0.0 111.035 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -54.19 -35.59 62.51 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.031 0.932 . . . . 0.0 111.591 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 60.9 p -65.38 -53.15 47.58 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.945 0.898 . . . . 0.0 110.029 176.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.422 HD21 ' HB2' ' A' ' 132' ' ' ALA . 73.9 mt -62.93 -26.41 68.8 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.261 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.542 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 49.2 mt-30 -75.48 -46.68 30.93 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.29 0.636 . . . . 0.0 110.702 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.21 -12.29 47.25 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -175.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -106.5 -45.3 4.29 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 122.932 0.493 . . . . 0.0 112.283 178.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -114.87 -36.24 4.54 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -164.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.542 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 72.5 t-105 . . . . . 0 N--CA 1.486 1.33 0 C-N-CA 123.826 0.851 . . . . 0.0 110.551 -167.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -123.91 105.83 9.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.597 0.759 . . . . 0.0 109.656 174.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 50.6 mm -79.91 139.86 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 174.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.8 p -137.64 93.05 2.75 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.555 0.742 . . . . 0.0 109.546 176.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -80.93 -21.06 40.77 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.157 0.583 . . . . 0.0 111.106 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.47 ' HE1' ' HG3' ' A' ' 148' ' ' ARG . 4.3 mpp? -100.67 126.82 47.22 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 175.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.61 177.28 8.78 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.88 0.872 . . . . 0.0 109.295 173.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -63.43 -43.16 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 123.88 0.872 . . . . 0.0 112.116 -167.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -62.46 -49.17 76.46 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.997 0.519 . . . . 0.0 111.931 -178.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.642 ' HA ' ' HB2' ' A' ' 100' ' ' ARG . 14.7 pt-20 -74.85 -19.82 60.01 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 123.475 0.485 . . . . 0.0 111.469 -178.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.8 tp -68.2 -32.3 72.43 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.29 1.036 . . . . 0.0 110.212 172.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.2 t -117.07 18.25 14.66 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.417 1.087 . . . . 0.0 110.849 -178.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.642 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 26.5 tpt180 -66.79 142.88 57.21 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.749 0.419 . . . . 0.0 112.107 -174.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -77.62 121.16 23.57 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.741 174.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . 0.401 ' HH2' ' HG3' ' A' ' 118' ' ' ARG . 6.3 p-90 -140.12 149.25 42.82 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.402 1.081 . . . . 0.0 109.933 178.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -134.16 135.51 43.15 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.922 0.889 . . . . 0.0 109.179 178.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.52 ' HE2' ' HA ' ' A' ' 107' ' ' PRO . 92.1 mtp -101.69 112.45 25.03 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.63 0.772 . . . . 0.0 109.324 -178.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 45.4 tp -65.93 -39.12 90.22 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.675 0.79 . . . . 0.0 110.206 -178.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.478 ' HE2' ' HA ' ' A' ' 106' ' ' MET . 11.3 mmt -124.25 86.41 54.53 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 124.322 1.049 . . . . 0.0 108.407 173.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.52 ' HA ' ' HE2' ' A' ' 104' ' ' MET . 56.1 Cg_endo -67.37 131.36 24.64 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.253 1.969 . . . . 0.0 111.663 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.506 ' HB3' ' HB ' ' A' ' 119' ' ' ILE . 60.4 tptt -131.75 119.96 22.04 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 173.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.42 ' NE2' ' HB2' ' A' ' 116' ' ' CYS . 58.9 tp60 -108.63 106.06 15.95 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -176.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.51 97.96 5.9 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 123.677 0.791 . . . . 0.0 109.006 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . 55.9 t -78.75 124.79 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -122.45 94.33 4.26 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.8 -127.11 30.48 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.259 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -86.07 21.32 1.09 Allowed 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 123.054 2.503 . . . . 0.0 112.615 175.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 4.3 mp -129.63 167.57 17.77 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.973 0.909 . . . . 0.0 109.002 174.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 20.3 p -140.23 130.74 25.49 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 176.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 17.6 mm -105.83 132.63 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.285 1.034 . . . . 0.0 109.87 -170.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.401 ' HG3' ' HH2' ' A' ' 102' ' ' TRP . 15.9 mmt85 -99.99 122.93 43.65 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.76 1.224 . . . . 0.0 108.917 172.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.506 ' HB ' ' HB3' ' A' ' 108' ' ' LYS . 42.5 mm -122.69 121.59 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 172.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -95.5 111.83 23.66 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 168.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -78.86 -3.43 44.59 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.254 -174.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.3 -27.81 20.29 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.138 0.575 . . . . 0.0 110.505 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 39.5 mm -79.49 101.69 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-O 121.667 0.746 . . . . 0.0 111.145 -172.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.453 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 36.4 mtt -129.48 147.11 51.26 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.898 -174.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.0 t70 62.23 42.11 9.79 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.128 0.971 . . . . 0.0 111.765 175.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -119.76 147.91 44.06 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.195 0.998 . . . . 0.0 110.371 176.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.423 ' HA ' ' HB ' ' A' ' 191' ' ' THR . 44.2 m-80 -83.56 110.0 17.87 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 171.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 61.6 mt -117.54 134.13 62.12 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 123.382 0.673 . . . . 0.0 111.23 -171.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 37.7 tpp -111.59 125.61 54.12 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.513 1.925 . . . . 0.0 108.763 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.468 ' HB3' HD21 ' A' ' 147' ' ' LEU . 18.5 mt -97.23 102.59 14.39 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -98.5 149.18 22.99 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.667 0.787 . . . . 0.0 109.365 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -142.56 144.44 32.9 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 122.239 1.018 . . . . 0.0 113.723 175.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -99.52 122.51 42.69 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 163.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.513 ' HB3' HD12 ' A' ' 144' ' ' LEU . 49.7 p90 -153.15 159.78 42.77 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.268 0.556 . . . . 0.0 111.763 -175.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.7 t -90.94 156.36 18.04 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.982 177.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 72.0 t -130.72 136.03 59.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.906 1.282 . . . . 0.0 108.575 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.3 tp -145.19 144.09 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 170.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 62.39 24.18 14.38 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.661 0.785 . . . . 0.0 111.348 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.5 t70 71.03 5.46 5.49 Favored 'General case' 0 CA--C 1.564 1.511 0 C-N-CA 124.931 1.292 . . . . 0.0 111.954 -176.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -114.58 172.2 7.17 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.343 -0.848 . . . . 0.0 109.78 176.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.591 ' HB2' ' HB3' ' A' ' 201' ' ' PHE . 6.8 tt -69.39 125.49 26.84 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -83.7 -66.61 0.87 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.299 0.64 . . . . 0.0 110.247 177.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 65.9 m -149.88 131.12 14.56 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.808 1.243 . . . . 0.0 108.49 -173.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.513 HD12 ' HB3' ' A' ' 134' ' ' PHE . 44.7 tp -71.96 131.91 43.58 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 175.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.38 -50.06 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 172.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 54.4 tp -164.95 151.25 10.29 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.016 0.926 . . . . 0.0 109.358 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.696 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 7.2 tt -136.62 145.82 45.32 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 172.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.47 ' HG3' ' HE1' ' A' ' 93' ' ' MET . 17.5 mtp180 -141.32 144.23 34.48 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.697 0.799 . . . . 0.0 109.599 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.11 111.86 24.77 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.399 1.08 . . . . 0.0 108.927 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.405 ' CE1' ' HB2' ' A' ' 148' ' ' ARG . 65.0 m-85 -106.6 137.2 45.04 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.191 0.996 . . . . 0.0 109.207 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 47.2 p -76.01 -179.9 5.2 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-O 121.286 0.565 . . . . 0.0 110.142 172.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -61.71 -20.44 63.49 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.515 0.726 . . . . 0.0 111.048 169.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -88.51 -1.75 58.22 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.962 1.305 . . . . 0.0 111.604 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 74.33 15.08 80.34 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-N 116.448 -0.342 . . . . 0.0 112.971 -178.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -86.01 125.0 33.08 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.426 0.69 . . . . 0.0 109.852 -176.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.449 HD11 ' HB3' ' A' ' 100' ' ' ARG . 22.6 mt -78.84 100.99 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -177.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.2 m -105.36 -0.16 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.138 0.975 . . . . 0.0 111.433 -173.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -162.96 167.07 37.19 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.329 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -163.47 153.36 15.28 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.696 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 63.1 mt -128.88 102.92 8.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 170.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 3.1 p -112.83 110.05 52.28 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 123.901 0.881 . . . . 0.0 109.605 -177.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.539 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 20.7 Cg_endo -60.04 127.85 24.62 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.641 2.227 . . . . 0.0 111.515 171.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.1 mt . . . . . 0 CA--C 1.55 0.943 0 C-N-CA 123.812 0.845 . . . . 0.0 110.366 177.195 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 . . . . . 0 CA--C 1.541 0.631 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 35.8 p -126.91 171.08 11.59 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.022 0.929 . . . . 0.0 110.36 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.46 ' O ' ' HG3' ' A' ' 175' ' ' LYS . 15.1 tt -50.69 -37.14 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.406 170.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -52.32 -51.29 59.53 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.338 1.455 . . . . 0.0 111.019 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -59.33 -41.1 88.34 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.949 0.9 . . . . 0.0 111.851 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 178' ' ' ILE . 25.9 t -64.07 -40.72 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 O-C-N 124.117 0.885 . . . . 0.0 110.52 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 171' ' ' ILE . 56.5 mtpt -61.66 -42.52 99.02 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.746 0.818 . . . . 0.0 111.165 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.465 ' O ' HG22 ' A' ' 180' ' ' VAL . 24.4 m120 -66.68 -43.24 84.97 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 123.591 0.557 . . . . 0.0 109.645 176.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -60.9 -45.08 96.03 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 124.584 1.177 . . . . 0.0 112.279 -175.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 174' ' ' VAL . 25.8 mt -69.27 -32.83 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.96 -30.64 78.31 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.433 174.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 176' ' ' ASN . 61.3 t -74.84 -51.08 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 122.813 0.445 . . . . 0.0 109.819 175.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.467 ' HA ' HD12 ' A' ' 119' ' ' ILE . 47.9 tp -54.18 -51.13 65.33 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 123.933 0.77 . . . . 0.0 111.26 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.498 ' O ' ' HG3' ' A' ' 186' ' ' GLU . 10.4 tt -62.27 -37.2 78.0 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.934 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.613 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -62.19 -42.53 99.72 Favored Glycine 0 C--N 1.351 1.366 0 O-C-N 123.287 0.367 . . . . 0.0 113.903 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -65.98 -35.85 91.23 Favored Glycine 0 C--N 1.348 1.208 0 O-C-N 123.843 0.378 . . . . 0.0 112.294 175.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 86.4 mt -68.33 -42.25 79.58 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.17 0.988 . . . . 0.0 111.49 177.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 182' ' ' ILE . 49.3 mt-10 -67.72 -38.41 83.53 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.494 0.718 . . . . 0.0 110.269 -176.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.11 -24.32 59.44 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.351 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.453 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 97.6 m-20 -68.93 -18.87 64.16 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 122.667 0.387 . . . . 0.0 111.059 170.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 35.9 t70 65.9 65.69 0.52 Allowed 'General case' 0 C--N 1.354 0.784 0 C-N-CA 124.116 0.967 . . . . 0.0 109.662 -174.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -131.14 169.09 16.38 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.694 173.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.423 ' HB ' ' HA ' ' A' ' 127' ' ' ASN . 89.5 m -84.17 114.72 22.0 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 30.0 m -97.52 136.37 28.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -145.04 128.09 16.56 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 176.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 4.8 t -103.07 150.58 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -175.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 45.8 t -60.91 141.07 57.51 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.86 -28.02 63.76 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.825 0.85 . . . . 0.0 112.249 -177.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 37.6 p -70.95 -45.25 64.48 Favored 'General case' 0 C--N 1.348 0.516 0 C-N-CA 123.544 0.738 . . . . 0.0 109.903 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 78.7 mt -65.1 -39.97 93.89 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.174 0.59 . . . . 0.0 110.52 176.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.614 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 49.5 mt-30 -60.06 -31.33 69.89 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.807 0.843 . . . . 0.0 111.101 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -83.87 -61.04 1.92 Allowed 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 123.887 0.875 . . . . 0.0 110.717 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.591 ' HB3' ' HB2' ' A' ' 141' ' ' LEU . 61.5 m-85 -71.44 -47.1 57.93 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.178 0.991 . . . . 0.0 112.84 -167.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.487 ' HB2' HD12 ' A' ' 141' ' ' LEU . . . -109.25 -58.15 2.07 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 122.944 0.497 . . . . 0.0 110.771 -170.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.614 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 40.4 t-105 . . . . . 0 N--CA 1.479 1.025 0 C-N-CA 124.751 1.221 . . . . 0.0 111.532 -175.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -90.2 108.99 20.09 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 174.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.0 mm -77.25 117.72 22.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 176.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.2 p -98.0 75.31 2.34 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -73.51 -32.02 64.03 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 113.726 -1.579 . . . . 0.0 109.966 -178.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.435 ' HB3' ' HB3' ' A' ' 131' ' ' LYS . 21.2 ptt? -109.74 138.67 45.77 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 165.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 66.7 p -65.3 157.32 29.39 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.726 0.41 . . . . 0.0 110.128 177.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.9 mp -58.07 -35.85 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -56.56 -60.3 3.73 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.092 1.357 . . . . 0.0 112.481 176.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.401 ' HG3' ' HB2' ' A' ' 93' ' ' MET . 11.9 pt-20 -70.71 -24.99 62.75 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 122.631 0.372 . . . . 0.0 111.18 -176.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.482 ' HA ' ' HE ' ' A' ' 148' ' ' ARG . 7.8 tt -65.36 -48.26 73.58 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.818 0.847 . . . . 0.0 109.622 172.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 90.5 p -84.3 -3.08 58.01 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.192 0.597 . . . . 0.0 112.389 -173.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.1 tpt85 -61.51 126.89 28.96 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.584 0.754 . . . . 0.0 110.915 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -82.42 155.07 24.86 Favored 'General case' 0 C--O 1.239 0.535 0 O-C-N 123.976 0.797 . . . . 0.0 109.801 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -161.3 169.05 22.85 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.65 0.78 . . . . 0.0 110.84 -173.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -125.89 151.82 46.38 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.201 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.518 ' HE2' ' HA ' ' A' ' 107' ' ' PRO . 72.9 mtp -109.86 105.05 14.1 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 171.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.9 tt -62.64 -44.1 97.12 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 80.4 mmm -119.58 88.37 38.8 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 123.904 0.882 . . . . 0.0 109.416 171.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.518 ' HA ' ' HE2' ' A' ' 104' ' ' MET . 79.1 Cg_endo -73.71 124.54 9.34 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.69 2.26 . . . . 0.0 112.355 -178.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.456 ' HD2' ' NE2' ' A' ' 121' ' ' GLN . 59.5 tttp -123.15 124.76 43.78 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.39 101.31 7.1 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -102.82 129.11 49.38 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.103 0.961 . . . . 0.0 108.815 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 72.7 t -86.76 133.8 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 173.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -128.36 85.3 2.32 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 62.31 -121.43 25.37 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.666 176.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.473 ' HB2' ' HB3' ' A' ' 169' ' ' HIS . 3.7 Cg_exo -78.92 8.48 3.75 Favored 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 123.728 2.952 . . . . 0.0 114.199 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.5 mp -133.62 163.5 29.28 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.375 0.67 . . . . 0.0 109.506 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.474 ' SG ' ' HB2' ' A' ' 161' ' ' SER . 31.5 p -126.86 136.02 51.78 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 10.2 mm -110.43 124.91 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.304 1.042 . . . . 0.0 109.542 -169.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -108.65 121.99 46.18 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.428 1.091 . . . . 0.0 108.347 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.528 HD12 ' HA3' ' A' ' 184' ' ' GLY . 53.0 mt -131.29 121.92 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.432 ' HB3' ' HB ' ' A' ' 157' ' ' VAL . 23.8 t70 -94.49 115.28 27.42 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 175.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.456 ' NE2' ' HD2' ' A' ' 108' ' ' LYS . 83.6 mt-30 -81.22 -10.64 59.57 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.715 0.806 . . . . 0.0 112.016 -174.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.2 -41.68 63.53 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.266 0.626 . . . . 0.0 110.963 -176.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.6 mp -76.91 115.83 19.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.882 177.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 48.6 mtt -132.89 154.97 49.88 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.567 1.147 . . . . 0.0 110.102 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.7 t70 62.34 23.95 14.23 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.354 1.062 . . . . 0.0 112.105 176.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 190' ' ' ASN . 73.9 mmtt -105.76 149.95 25.98 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.202 0.601 . . . . 0.0 110.079 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.535 ' HB2' ' HG2' ' A' ' 152' ' ' GLU . 75.8 m-20 -83.06 106.56 14.97 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 173.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 80.5 mt -106.29 121.86 59.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 123.39 0.676 . . . . 0.0 110.147 -174.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 36.7 tpp -96.33 130.44 43.44 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.879 1.272 . . . . 0.0 109.322 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 19.2 mt -100.07 104.27 15.83 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 93' ' ' MET . 32.7 mmtp -98.8 155.4 17.38 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.998 0.919 . . . . 0.0 109.507 173.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.496 ' HB2' HD13 ' A' ' 144' ' ' LEU . . . -155.49 145.69 21.73 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 168.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -108.18 134.35 51.15 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 172.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.444 ' HA ' HD12 ' A' ' 145' ' ' ILE . 37.9 p90 -160.01 160.62 33.5 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.735 0.814 . . . . 0.0 110.589 -169.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 43.7 p -85.47 155.24 21.32 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.866 0.866 . . . . 0.0 108.81 171.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 91.0 t -116.5 154.05 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.959 0.904 . . . . 0.0 110.308 -177.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.466 ' O ' ' HG3' ' A' ' 140' ' ' ARG . 11.0 tp -156.09 134.44 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 164.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 58.14 24.76 11.66 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.961 0.904 . . . . 0.0 113.024 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.535 ' HB3' HH22 ' A' ' 200' ' ' ARG . 1.6 m-20 65.5 35.03 7.52 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.869 1.268 . . . . 0.0 111.832 -176.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 137' ' ' ILE . 7.6 ppt_? -136.24 162.93 31.61 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.679 0.792 . . . . 0.0 109.048 169.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.465 ' HB3' HG13 ' A' ' 171' ' ' ILE . 9.7 tt -68.14 110.05 3.81 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.658 0.783 . . . . 0.0 109.765 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -70.78 -64.87 0.82 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.893 0.877 . . . . 0.0 109.558 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 53.1 m -142.54 131.31 22.78 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.515 HD21 ' HB2' ' A' ' 147' ' ' LEU . 53.6 tp -73.07 129.22 37.6 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.391 0.676 . . . . 0.0 109.455 173.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.444 HD12 ' HA ' ' A' ' 134' ' ' PHE . 1.6 mp -84.9 -52.86 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 174.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 39.9 tp -162.04 148.6 13.63 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.028 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.683 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 8.9 tt -125.76 149.13 48.81 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 174.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.602 HH11 HG22 ' A' ' 156' ' ' ILE . 21.7 ttm-85 -141.93 139.75 32.61 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.025 0.93 . . . . 0.0 110.583 -176.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.505 ' HB1' ' HA3' ' A' ' 158' ' ' GLY . . . -123.87 122.46 38.05 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.487 1.115 . . . . 0.0 108.023 176.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -142.05 166.36 24.92 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.241 0.616 . . . . 0.0 110.861 -177.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.415 ' HG1' ' HB3' ' A' ' 155' ' ' ALA . 82.4 p -85.67 179.0 7.17 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.735 0.814 . . . . 0.0 110.301 -177.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.535 ' HG2' ' HB2' ' A' ' 127' ' ' ASN . 24.3 mm-40 -63.44 -21.84 66.54 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 122.16 -0.338 . . . . 0.0 111.889 172.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -78.78 -13.7 59.67 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.014 0.525 . . . . 0.0 111.059 176.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 88.84 -2.72 84.51 Favored Glycine 0 C--N 1.349 1.254 0 N-CA-C 112.044 -0.422 . . . . 0.0 112.044 -173.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.415 ' HB3' ' HG1' ' A' ' 151' ' ' THR . . . -67.92 108.18 2.93 Favored 'General case' 0 C--N 1.353 0.721 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -178.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.602 HG22 HH11 ' A' ' 148' ' ' ARG . 23.6 mt -77.91 128.43 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 O-C-N 123.56 0.538 . . . . 0.0 110.415 -170.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' A' ' 120' ' ' ASP . 34.6 m -130.62 8.06 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 123.883 0.873 . . . . 0.0 111.228 -174.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.505 ' HA3' ' HB1' ' A' ' 149' ' ' ALA . . . -161.23 157.53 29.13 Favored Glycine 0 C--N 1.339 0.703 0 N-CA-C 111.856 -0.498 . . . . 0.0 111.856 -177.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -168.35 140.96 2.96 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.562 0.745 . . . . 0.0 109.765 -178.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.683 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 70.9 mt -123.7 112.66 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 175.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.474 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 20.3 m -112.53 118.32 45.51 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.094 0.958 . . . . 0.0 109.919 -177.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -63.94 124.55 13.74 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 122.855 2.37 . . . . 0.0 112.59 176.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 CA--C 1.549 0.936 0 C-N-CA 124.343 1.057 . . . . 0.0 112.207 -177.121 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 114' ' ' PRO . 20.2 p-80 . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 76.5 p -84.27 160.44 20.75 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 173.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.498 HD13 ' HA ' ' A' ' 202' ' ' ALA . 9.4 tt -54.64 -32.96 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 123.215 0.606 . . . . 0.0 110.712 168.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.669 ' HA ' ' HE2' ' A' ' 175' ' ' LYS . 35.6 mt-10 -64.71 -33.47 76.03 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.108 -178.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -70.62 -33.16 70.71 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.408 0.683 . . . . 0.0 111.55 175.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 56.4 t -69.76 -36.04 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 122.493 0.317 . . . . 0.0 110.33 174.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.669 ' HE2' ' HA ' ' A' ' 172' ' ' GLU . 48.6 mtmt -62.3 -38.04 87.89 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 120.77 0.319 . . . . 0.0 110.389 175.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -64.02 -44.23 93.2 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.221 174.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.87 -51.09 68.34 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.742 -175.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 49.5 mt -64.46 -33.37 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.15 0.58 . . . . 0.0 109.821 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -59.4 -39.72 95.16 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-N 115.653 -0.703 . . . . 0.0 113.649 175.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 97.2 t -72.42 -44.02 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 122.767 0.427 . . . . 0.0 110.395 176.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.447 HD11 HG12 ' A' ' 119' ' ' ILE . 59.5 tp -52.59 -57.3 10.43 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.802 0.841 . . . . 0.0 111.309 177.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.581 HG22 HG21 ' A' ' 192' ' ' VAL . 50.6 mt -58.88 -45.27 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 O-C-N 124.013 0.821 . . . . 0.0 110.598 174.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -53.54 -38.13 57.6 Favored Glycine 0 C--N 1.346 1.122 0 O-C-N 123.949 0.78 . . . . 0.0 114.066 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.528 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -81.0 -28.81 44.12 Favored Glycine 0 C--N 1.348 1.195 0 N-CA-C 112.577 -0.209 . . . . 0.0 112.577 176.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.462 ' HB3' HD22 ' A' ' 190' ' ' ASN . 68.6 mt -71.83 -21.45 61.68 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.237 0.615 . . . . 0.0 110.715 174.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 19.5 mm-40 -68.76 -36.56 78.5 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.354 0.662 . . . . 0.0 110.853 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -76.97 -24.77 52.27 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 122.939 0.149 . . . . 0.0 110.824 176.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -63.95 -22.55 66.97 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.57 0.348 . . . . 0.0 110.437 167.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 13.4 t70 53.19 67.33 1.01 Allowed 'General case' 0 C--N 1.356 0.85 0 C-N-CA 124.893 1.277 . . . . 0.0 111.252 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 8.5 p30 -124.5 -161.31 1.0 Allowed 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.825 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 31.9 m -120.07 101.49 7.88 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.581 HG21 HG22 ' A' ' 182' ' ' ILE . 26.7 m -93.28 147.28 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 121.145 0.497 . . . . 0.0 110.386 -177.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 40.1 ttt180 -142.22 132.96 25.54 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.13 172.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.452 HG21 HD11 ' A' ' 182' ' ' ILE . 3.2 t -90.41 134.26 29.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 N-CA-C 104.802 -2.295 . . . . 0.0 104.802 175.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 27.9 t -60.35 151.74 27.04 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.142 0.428 . . . . 0.0 111.654 -173.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -51.44 -40.15 58.8 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.755 1.222 . . . . 0.0 112.241 -175.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 75.8 p -68.82 -49.29 59.7 Favored 'General case' 0 C--N 1.345 0.393 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.467 HD21 ' HB3' ' A' ' 132' ' ' ALA . 41.1 mt -61.22 -29.96 70.14 Favored 'General case' 0 C--O 1.21 -0.976 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.151 -177.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.599 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 48.9 mt-30 -68.17 -57.03 6.69 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.487 0.715 . . . . 0.0 110.956 178.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.535 HH22 ' HB3' ' A' ' 139' ' ' ASP . 0.0 OUTLIER -72.75 -21.55 61.0 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -176.196 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -83.99 -59.79 2.3 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.13 0.572 . . . . 0.0 111.034 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.498 ' HA ' HD13 ' A' ' 171' ' ' ILE . . . -114.39 -60.66 1.86 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.255 0.622 . . . . 0.0 111.546 -165.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.599 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 67.8 t-105 . . . . . 0 N--CA 1.483 1.217 0 C-N-CA 124.479 1.112 . . . . 0.0 112.685 -168.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 . . . . . 0 N--CA 1.477 0.885 0 CA-C-O 120.517 0.198 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 19.3 m-85 -96.3 108.95 21.52 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.641 0.776 . . . . 0.0 109.166 175.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 50.0 mm -78.31 116.43 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 174.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 36.8 p -98.35 72.96 2.12 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.521 ' HB3' ' O ' ' A' ' 132' ' ' ALA . 31.0 t70 -72.8 -30.76 64.33 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.056 -174.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.567 ' SD ' ' HB3' ' A' ' 148' ' ' ARG . 59.5 mtm -98.12 151.15 20.69 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 166.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 64.6 p -69.93 158.84 34.84 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 173.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 69.1 mt -59.23 -31.39 46.01 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 173.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -57.87 -55.98 27.87 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.434 171.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -61.41 -38.67 87.94 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.012 0.525 . . . . 0.0 111.311 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.9 tt -63.89 -38.91 92.85 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.128 0.971 . . . . 0.0 109.378 -177.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.8 t -108.9 20.38 18.52 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 123.875 0.87 . . . . 0.0 111.066 -176.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.506 ' HD3' HD12 ' A' ' 156' ' ' ILE . 76.8 ttt180 -78.3 142.57 37.68 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.762 0.825 . . . . 0.0 111.696 -174.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -82.73 138.02 34.21 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.939 0.895 . . . . 0.0 110.524 176.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . 0.512 ' CZ3' ' SD ' ' A' ' 104' ' ' MET . 11.3 p-90 -157.33 160.28 38.36 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.842 1.257 . . . . 0.0 109.825 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -110.89 159.65 17.5 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.431 0.692 . . . . 0.0 111.693 -173.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.512 ' SD ' ' CZ3' ' A' ' 102' ' ' TRP . 99.2 mmm -120.65 93.06 3.91 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.237 1.015 . . . . 0.0 108.758 172.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.422 HD23 ' HB2' ' A' ' 122' ' ' ALA . 50.4 tp -71.8 -43.34 65.81 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.3 mmt -129.17 81.41 70.6 Favored Pre-proline 0 N--CA 1.479 1.002 0 C-N-CA 123.94 0.896 . . . . 0.0 109.353 175.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.75 145.56 46.46 Favored 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 122.104 1.869 . . . . 0.0 111.652 177.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -124.93 120.89 32.91 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 172.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.36 104.64 11.04 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.459 0.704 . . . . 0.0 109.624 -174.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -132.73 135.83 46.0 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.992 0.917 . . . . 0.0 109.467 172.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.2 t -125.4 142.79 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 166.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -123.34 91.6 3.51 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 176.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.37 -112.76 5.26 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.999 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -91.75 8.36 3.07 Favored 'Trans proline' 0 C--N 1.368 1.593 0 C-N-CA 123.27 2.647 . . . . 0.0 113.273 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.504 HD22 ' HA ' ' A' ' 162' ' ' PRO . 61.4 mt -130.44 116.45 18.25 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.516 0.727 . . . . 0.0 109.656 -170.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 41.9 t -83.34 127.23 33.49 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.231 0.612 . . . . 0.0 110.256 -177.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.8 mm -106.94 110.03 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.232 0 C-N-CA 124.034 0.933 . . . . 0.0 110.58 -173.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -92.81 125.89 37.63 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.487 0.715 . . . . 0.0 109.858 173.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.553 HD12 ' HA3' ' A' ' 184' ' ' GLY . 73.2 mt -131.89 123.73 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.237 1.015 . . . . 0.0 108.561 176.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -99.49 120.76 40.14 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.44 0.696 . . . . 0.0 109.498 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -84.99 -14.96 45.82 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.619 1.168 . . . . 0.0 111.734 -174.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.422 ' HB2' HD23 ' A' ' 105' ' ' LEU . . . -68.57 -38.4 80.68 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.01 0.524 . . . . 0.0 111.106 -176.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.454 HG23 ' HG3' ' A' ' 126' ' ' LYS . 1.8 mp -87.07 112.79 23.63 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 CA-C-O 121.969 0.89 . . . . 0.0 109.7 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 48.0 mtt -129.23 159.5 35.9 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.859 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.8 t70 76.21 12.14 2.78 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 124.667 1.187 . . . . 0.0 112.365 172.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.454 ' HG3' HG23 ' A' ' 123' ' ' ILE . 75.1 mmtt -99.79 151.99 20.63 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.48 0.712 . . . . 0.0 111.976 -173.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -90.38 112.19 23.7 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 168.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.433 HD13 HD21 ' A' ' 185' ' ' LEU . 65.3 mt -114.01 135.23 54.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.965 0.888 . . . . 0.0 111.325 -171.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.529 ' HG3' ' HG3' ' A' ' 131' ' ' LYS . 8.0 tpt -102.81 121.65 42.92 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.203 1.801 . . . . 0.0 109.643 -172.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 3.7 mm? -96.25 104.75 16.73 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.529 ' HG3' ' HG3' ' A' ' 129' ' ' MET . 90.8 mttt -125.58 149.4 48.4 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.455 0.702 . . . . 0.0 110.497 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.578 ' HB1' HD22 ' A' ' 198' ' ' LEU . . . -149.37 152.99 36.72 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -174.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -102.77 128.44 49.5 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 169.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -154.97 155.44 34.22 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.544 0.738 . . . . 0.0 109.871 -170.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 58.1 p -87.48 169.58 12.09 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.246 0.618 . . . . 0.0 109.775 172.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 79.5 t -132.15 136.3 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 123.564 0.746 . . . . 0.0 110.595 -173.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 7.5 tp -146.18 139.6 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 169.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 60.94 33.11 19.93 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 124.195 0.998 . . . . 0.0 111.936 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.3 t70 65.75 18.66 11.22 Favored 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 125.341 1.456 . . . . 0.0 111.644 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -132.54 172.9 11.9 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.815 -0.553 . . . . 0.0 109.643 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.455 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 10.3 tt -64.63 126.77 28.94 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -88.99 -77.8 0.37 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.991 0.516 . . . . 0.0 109.951 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.1 m -125.64 137.62 53.88 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.773 0.829 . . . . 0.0 109.321 -173.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 50.3 tp -82.96 126.64 32.74 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 174.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.43 -51.7 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 172.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 50.9 tp -164.19 146.73 9.13 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.833 0.853 . . . . 0.0 109.121 177.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.712 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 8.0 tt -125.5 154.75 41.63 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.676 HH11 HG23 ' A' ' 156' ' ' ILE . 47.3 ttm-85 -150.18 138.75 20.66 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 123.131 0.573 . . . . 0.0 110.971 -173.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -115.57 115.58 26.68 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 175.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.417 ' HD1' ' HG2' ' A' ' 148' ' ' ARG . 31.6 p90 -136.08 145.98 46.53 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.543 0.737 . . . . 0.0 109.59 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 54.5 p -69.32 175.84 3.71 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.79 0.836 . . . . 0.0 111.01 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -54.69 -32.38 59.36 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.687 0.795 . . . . 0.0 111.617 172.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -70.98 -29.24 65.16 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.944 1.298 . . . . 0.0 110.801 179.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 100.05 8.57 50.55 Favored Glycine 0 C--N 1.345 1.064 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.565 -173.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -73.16 104.56 4.26 Favored 'General case' 0 C--N 1.352 0.713 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 177.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.676 HG23 HH11 ' A' ' 148' ' ' ARG . 24.1 mt -75.93 122.72 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -175.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.4 m -130.74 9.53 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.636 0.774 . . . . 0.0 111.065 -175.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -159.89 159.26 30.51 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.428 -178.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -165.67 150.99 8.92 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.353 0.661 . . . . 0.0 109.457 -177.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.712 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 71.0 mt -131.4 106.85 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 170.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 78.9 p -109.18 119.05 49.7 Favored Pre-proline 0 C--O 1.24 0.556 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.504 ' HA ' HD22 ' A' ' 115' ' ' LEU . 11.1 Cg_endo -55.48 134.78 65.88 Favored 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 122.254 1.969 . . . . 0.0 111.384 168.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 90.0 mt . . . . . 0 CA--C 1.546 0.803 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 175.303 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 57.9 p -82.48 173.15 12.26 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.64 0.376 . . . . 0.0 110.902 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.474 HD11 ' HA ' ' A' ' 202' ' ' ALA . 7.7 tt -51.67 -40.84 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.088 171.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -65.12 -36.57 84.68 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.842 0.857 . . . . 0.0 111.216 -173.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -62.74 -42.08 99.5 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 123.694 0.621 . . . . 0.0 110.604 174.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.516 ' O ' HG13 ' A' ' 178' ' ' ILE . 40.6 t -63.17 -41.9 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 123.829 0.706 . . . . 0.0 109.921 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 171' ' ' ILE . 57.7 mtpt -57.55 -42.69 83.47 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.815 0.846 . . . . 0.0 111.206 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.444 ' O ' HG21 ' A' ' 180' ' ' VAL . 63.0 m-80 -66.15 -47.44 74.05 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.993 0.517 . . . . 0.0 110.123 176.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.42 -42.28 86.9 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.462 1.101 . . . . 0.0 112.053 -175.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 174' ' ' VAL . 53.1 mt -60.75 -41.45 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 177.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -68.05 -26.68 73.94 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.66 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.444 HG21 ' O ' ' A' ' 176' ' ' ASN . 69.5 t -72.56 -50.06 37.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 123.414 0.686 . . . . 0.0 109.926 176.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 15.7 tp -59.41 -46.08 89.7 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.708 177.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.509 HD12 HG23 ' A' ' 194' ' ' VAL . 32.2 mt -56.76 -49.17 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.588 1.155 . . . . 0.0 111.299 174.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.43 ' O ' ' HG3' ' A' ' 187' ' ' ARG . . . -55.28 -42.14 81.63 Favored Glycine 0 C--N 1.343 0.923 0 O-C-N 124.149 0.905 . . . . 0.0 113.618 -178.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.553 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -71.29 -34.84 63.89 Favored Glycine 0 C--N 1.347 1.189 0 O-C-N 123.787 0.345 . . . . 0.0 113.084 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.433 HD21 HD13 ' A' ' 128' ' ' ILE . 95.0 mt -64.02 -40.74 97.0 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.372 0.669 . . . . 0.0 110.556 175.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -63.37 -35.34 80.08 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.607 0.763 . . . . 0.0 111.012 178.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 183' ' ' GLY . 83.0 mtp180 -64.99 -39.0 92.82 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.302 0.641 . . . . 0.0 110.451 175.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -70.92 -3.92 21.79 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.987 0.915 . . . . 0.0 112.082 175.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.9 t70 65.95 46.39 2.24 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 122.646 1.212 . . . . 0.0 109.089 -176.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -111.08 138.37 47.59 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.088 177.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 26.6 m -79.79 114.02 18.39 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -177.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 27.3 m -92.65 139.01 18.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.612 -174.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -149.18 146.38 27.61 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.948 171.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.509 HG23 HD12 ' A' ' 182' ' ' ILE . 2.8 t -109.06 147.27 13.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 -175.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 27.2 t -61.0 152.3 28.24 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 118.158 0.435 . . . . 0.0 111.292 -174.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.37 -41.05 62.76 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 124.297 0.998 . . . . 0.0 110.988 179.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 57.9 p -70.49 -52.2 23.64 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.083 0.953 . . . . 0.0 110.01 178.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.578 HD22 ' HB1' ' A' ' 132' ' ' ALA . 34.9 mt -58.9 -29.68 67.22 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.751 0.82 . . . . 0.0 112.128 -176.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.555 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 47.5 mt-30 -72.09 -54.65 9.14 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.26 0.624 . . . . 0.0 110.554 177.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.81 -9.22 59.38 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -174.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -100.82 -50.46 3.84 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.008 0.523 . . . . 0.0 111.556 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.474 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -113.6 -62.47 1.59 Allowed 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -168.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.555 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 65.9 t-105 . . . . . 0 N--CA 1.481 1.08 0 C-N-CA 124.891 1.276 . . . . 0.0 111.246 -165.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.9 ttp180 . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -123.21 109.12 13.58 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.122 0.969 . . . . 0.0 109.322 173.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 36.1 mm -82.35 133.95 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 171.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 37.8 p -126.96 93.43 3.76 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.104 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -77.9 -25.88 48.76 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.73 177.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.664 ' SD ' ' HG2' ' A' ' 148' ' ' ARG . 40.1 mtm -104.83 129.16 53.18 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 124.199 0.999 . . . . 0.0 108.495 178.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 69.9 p -87.61 175.16 8.03 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 170.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 83.5 mt -56.43 -32.36 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 123.709 0.804 . . . . 0.0 111.116 -177.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -48.76 -55.5 11.32 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.152 1.381 . . . . 0.0 113.547 177.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -95.66 -25.73 16.01 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 118.039 0.382 . . . . 0.0 111.009 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.5 tt -66.72 -49.49 65.85 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -176.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.7 m -95.63 16.25 17.76 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.824 0.849 . . . . 0.0 110.86 -177.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -82.28 126.84 32.59 Favored 'General case' 0 C--N 1.35 0.604 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -80.43 128.17 33.26 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 169.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -137.18 164.82 27.57 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.261 0.624 . . . . 0.0 110.293 -174.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -134.84 149.99 50.42 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.286 0.634 . . . . 0.0 109.676 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 10.8 ptm -126.0 128.57 47.66 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.4 tp -69.88 -41.22 75.06 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.719 0.807 . . . . 0.0 111.316 -170.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.519 ' HE1' ' HA ' ' A' ' 106' ' ' MET . 4.0 mmt -116.67 88.1 23.66 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 123.792 0.837 . . . . 0.0 109.864 173.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -74.8 137.58 22.4 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.678 2.252 . . . . 0.0 113.201 -177.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -130.67 135.43 47.83 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.058 0.943 . . . . 0.0 108.469 166.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -121.82 123.75 42.51 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 173.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -144.24 121.53 11.59 Favored 'General case' 0 C--O 1.217 -0.623 0 C-N-CA 123.374 0.669 . . . . 0.0 109.241 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 97.1 t -79.23 137.67 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.029 0.531 . . . . 0.0 110.501 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -125.12 85.42 2.41 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 171.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.89 -119.42 6.41 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.279 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -89.74 16.73 1.69 Allowed 'Trans proline' 0 CA--C 1.552 1.411 0 C-N-CA 123.531 2.821 . . . . 0.0 113.044 177.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.537 HD21 ' HA ' ' A' ' 162' ' ' PRO . 96.1 mt -128.85 151.91 49.09 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.844 0.858 . . . . 0.0 109.965 -176.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 36.1 t -115.28 131.2 57.0 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.177 0.991 . . . . 0.0 108.897 177.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.4 mm -106.34 139.6 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.562 0.745 . . . . 0.0 109.219 -177.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -119.29 119.73 34.9 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 175.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.415 HD13 ' HA3' ' A' ' 184' ' ' GLY . 69.9 mt -126.05 124.08 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -178.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 106' ' ' MET . 24.4 t70 -97.59 123.27 41.42 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.837 0.455 . . . . 0.0 110.24 174.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -88.35 -11.2 46.94 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.21 -50.32 14.81 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.156 0.503 . . . . 0.0 111.454 -174.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.8 mp -72.34 112.67 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.706 1.202 . . . . 0.0 109.523 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.2 mtt -130.3 162.71 28.4 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.481 1.112 . . . . 0.0 109.974 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 73.78 18.96 3.28 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 125.037 1.335 . . . . 0.0 112.915 176.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -111.43 149.58 31.05 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.449 0.7 . . . . 0.0 111.716 -173.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -87.99 102.78 15.07 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 171.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.477 HG12 HG23 ' A' ' 151' ' ' THR . 54.8 mt -106.56 131.14 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.003 0.521 . . . . 0.0 109.92 -173.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 14.7 tpt -106.08 127.1 52.95 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.209 1.004 . . . . 0.0 109.688 -172.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.45 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 25.7 mt -99.16 105.08 17.11 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -177.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -130.42 145.56 51.84 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.42 0.688 . . . . 0.0 111.13 -175.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.49 155.43 46.66 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -170.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -109.02 122.19 46.72 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 166.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -155.84 161.07 40.67 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.692 0.797 . . . . 0.0 110.546 -170.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.7 p -86.56 163.77 17.28 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.688 173.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 90.0 t -139.04 137.26 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.667 1.187 . . . . 0.0 109.109 -174.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.2 tp -152.04 144.17 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 172.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 57.99 26.5 13.54 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 124.248 1.019 . . . . 0.0 111.767 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 57.63 44.32 20.98 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.655 1.182 . . . . 0.0 111.345 -174.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -146.74 166.79 25.55 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.162 169.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.507 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 9.6 tt -64.21 123.55 19.38 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -79.38 -70.28 0.52 Allowed 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 175.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 99.8 m -143.71 135.4 26.27 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.064 0.946 . . . . 0.0 109.185 177.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.47 ' HB3' ' NE2' ' A' ' 169' ' ' HIS . 62.7 tp -77.98 126.67 31.18 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.828 0.851 . . . . 0.0 109.716 178.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.58 -49.96 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 174.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.436 HD23 ' NH2' ' A' ' 148' ' ' ARG . 51.0 tp -162.66 147.59 12.03 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.408 0.683 . . . . 0.0 109.664 -178.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.623 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 8.8 tt -138.88 154.67 48.41 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.664 ' HG2' ' SD ' ' A' ' 93' ' ' MET . 10.8 ptp180 -153.7 158.33 40.87 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.78 0.8 . . . . 0.0 111.738 173.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.519 ' HB2' HD23 ' A' ' 181' ' ' LEU . . . -111.29 116.1 30.43 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.294 1.438 . . . . 0.0 107.748 176.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.476 ' HD1' ' HG3' ' A' ' 148' ' ' ARG . 44.6 p90 -134.69 136.78 43.0 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.067 0.547 . . . . 0.0 110.333 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.477 HG23 HG12 ' A' ' 128' ' ' ILE . 52.7 p -63.96 177.49 0.77 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.484 1.114 . . . . 0.0 112.364 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -64.99 -17.55 64.52 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.479 0.712 . . . . 0.0 112.384 173.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -81.7 -24.04 36.44 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 122.819 0.448 . . . . 0.0 109.826 172.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 101.23 3.56 54.01 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.576 -175.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -68.7 103.38 1.72 Allowed 'General case' 0 C--N 1.352 0.717 0 C-N-CA 123.489 0.716 . . . . 0.0 109.776 -178.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.565 HD13 HH11 ' A' ' 148' ' ' ARG . 14.5 mt -73.14 116.72 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -178.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' A' ' 120' ' ' ASP . 35.3 m -123.08 3.48 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.167 0.987 . . . . 0.0 111.17 -176.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -154.84 161.69 30.42 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.602 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 38.8 tt0 -166.0 144.65 5.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 122.687 0.395 . . . . 0.0 110.267 -177.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.623 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 68.8 mt -126.77 116.38 44.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 173.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 19.3 m -126.4 141.52 40.23 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 123.465 0.706 . . . . 0.0 109.954 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.537 ' HA ' HD21 ' A' ' 115' ' ' LEU . 32.0 Cg_exo -58.87 147.22 90.21 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.672 2.248 . . . . 0.0 112.171 173.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 76.3 mt . . . . . 0 CA--C 1.546 0.804 0 C-N-CA 122.777 0.431 . . . . 0.0 110.454 179.559 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.47 ' NE2' ' HB3' ' A' ' 144' ' ' LEU . 51.6 p-80 . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 121.073 0.463 . . . . 0.0 110.484 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 14.8 m -107.95 162.92 13.58 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.284 1.033 . . . . 0.0 109.692 -177.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.575 HD13 ' HA ' ' A' ' 202' ' ' ALA . 14.9 tt -54.63 -35.08 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 125.743 1.617 . . . . 0.0 113.465 178.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -63.12 -29.43 70.79 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.377 0.671 . . . . 0.0 111.331 -176.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -71.6 -38.86 70.8 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.159 0.584 . . . . 0.0 110.295 175.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 44.7 t -67.4 -41.72 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 124.067 0.854 . . . . 0.0 111.373 -175.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -65.32 -33.58 76.31 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 122.949 0.155 . . . . 0.0 110.854 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -70.23 -39.91 74.79 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.911 0.484 . . . . 0.0 109.719 175.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.58 -47.59 80.87 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.338 1.055 . . . . 0.0 111.353 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 73.2 mt -63.44 -35.05 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.532 0.733 . . . . 0.0 109.477 176.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -60.77 -36.3 91.58 Favored Glycine 0 C--N 1.349 1.278 0 O-C-N 123.586 0.554 . . . . 0.0 113.986 176.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 98.8 t -72.04 -45.99 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.135 0.574 . . . . 0.0 110.015 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.519 HD23 ' HB2' ' A' ' 149' ' ' ALA . 41.0 tp -58.23 -45.2 88.14 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.725 0.81 . . . . 0.0 111.168 178.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.477 ' O ' ' HG2' ' A' ' 186' ' ' GLU . 49.0 mt -62.05 -50.86 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.996 0.918 . . . . 0.0 110.169 175.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.408 ' O ' ' HG2' ' A' ' 187' ' ' ARG . . . -53.69 -37.81 57.66 Favored Glycine 0 C--N 1.346 1.089 0 O-C-N 124.067 0.854 . . . . 0.0 113.964 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.415 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -71.64 -38.43 61.38 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 123.676 0.28 . . . . 0.0 112.937 175.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.464 HD21 HD13 ' A' ' 128' ' ' ILE . 95.0 mt -72.36 -21.75 61.26 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.427 0.691 . . . . 0.0 111.469 176.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 11.6 mm-40 -74.76 -32.48 62.08 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.291 0.636 . . . . 0.0 109.64 176.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 183' ' ' GLY . 17.8 mmt180 -63.55 -39.12 93.59 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.375 172.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -75.47 -5.6 45.9 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.582 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 26.9 t70 63.6 21.86 12.9 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 123.977 0.911 . . . . 0.0 110.748 -177.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -80.95 138.15 36.11 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.129 0.972 . . . . 0.0 110.412 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 41.1 m -79.78 103.04 9.41 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.427 HG21 HG22 ' A' ' 182' ' ' ILE . 25.5 m -85.17 143.81 10.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.023 -177.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -143.87 127.32 16.88 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 168.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.45 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 7.8 t -88.27 146.53 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 27.7 t -57.32 144.32 36.33 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 118.429 0.558 . . . . 0.0 111.02 -176.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -55.76 -31.52 62.63 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.209 0.603 . . . . 0.0 111.11 -178.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 37.7 p -67.65 -57.53 6.24 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.808 172.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 56.3 mt -59.47 -25.32 64.31 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.07 0.948 . . . . 0.0 112.02 -174.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.582 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 49.9 mt-30 -74.63 -55.22 6.13 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.093 0.557 . . . . 0.0 110.242 178.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.82 -24.34 60.89 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 116.81 -0.177 . . . . 0.0 111.379 -174.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -84.56 -52.19 6.31 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.322 0.649 . . . . 0.0 110.764 177.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.575 ' HA ' HD13 ' A' ' 171' ' ' ILE . . . -114.64 -42.8 3.22 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -165.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.582 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 27.9 t-105 . . . . . 0 N--CA 1.488 1.437 0 C-N-CA 122.908 0.483 . . . . 0.0 111.972 -168.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 26.3 ttt . . . . . 0 N--CA 1.477 0.878 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.515 ' HG2' HD11 ' A' ' 137' ' ' ILE . 34.0 Cg_endo -63.96 151.47 85.09 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.287 1.991 . . . . 0.0 111.077 168.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.89 124.22 20.18 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.587 0.755 . . . . 0.0 111.239 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 55.8 p -88.31 126.63 35.28 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.451 0.7 . . . . 0.0 109.413 175.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.567 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 74.7 ttt180 -95.93 153.33 17.82 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.544 0.737 . . . . 0.0 109.21 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -121.96 121.17 36.47 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 175.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.405 HG23 ' HB2' ' A' ' 92' ' ' ASP . 49.0 mm -91.25 112.9 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.5 p -98.75 65.54 1.56 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 170.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 132' ' ' ALA . 27.5 t70 -67.61 -41.07 84.6 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 113.489 -1.687 . . . . 0.0 110.361 -177.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -109.84 151.02 27.55 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 173.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.5 m -86.82 154.23 21.05 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.593 0.357 . . . . 0.0 111.126 -170.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 49.8 mm -63.13 -35.91 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 123.157 0.583 . . . . 0.0 110.424 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -47.66 -46.64 29.27 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.859 1.264 . . . . 0.0 112.743 174.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.38 -20.11 20.02 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.204 -175.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.496 ' HG ' HD22 ' A' ' 146' ' ' LEU . 8.7 tt -69.03 -35.77 76.98 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.739 0.815 . . . . 0.0 109.812 174.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.8 m -97.84 12.01 35.38 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.84 0.856 . . . . 0.0 110.753 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -79.41 131.58 36.13 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.533 0.733 . . . . 0.0 109.868 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -81.47 140.64 34.48 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 38.4 p-90 -158.7 176.22 12.64 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.086 0.954 . . . . 0.0 109.044 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -151.88 166.68 30.69 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.636 0.775 . . . . 0.0 109.259 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 74.4 mtm -102.07 127.8 48.81 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.066 0.546 . . . . 0.0 109.788 170.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.43 HD21 ' H ' ' A' ' 105' ' ' LEU . 1.2 pt? -78.31 -33.3 49.43 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.11 0.564 . . . . 0.0 110.638 178.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 23.5 mmt -120.0 80.7 26.65 Favored Pre-proline 0 N--CA 1.485 1.287 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 168.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -73.23 129.23 13.75 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.669 2.246 . . . . 0.0 112.579 -173.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -134.81 121.84 21.23 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 174.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -109.65 110.24 21.23 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -174.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.447 ' HG2' HG12 ' A' ' 180' ' ' VAL . 22.1 tptm -100.79 133.6 45.02 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 169.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.8 t -103.61 126.92 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 171.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -131.46 88.65 2.61 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.29 -124.16 13.1 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.315 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -91.07 13.55 2.11 Favored 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 123.113 2.542 . . . . 0.0 112.476 176.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.1 mt -128.83 114.84 17.04 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.695 0.798 . . . . 0.0 108.916 -171.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 161' ' ' SER . 25.6 p -89.8 114.14 25.82 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.062 0.458 . . . . 0.0 110.364 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.425 ' HB ' ' HB3' ' A' ' 110' ' ' LYS . 12.0 mm -86.07 121.0 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 124.812 1.245 . . . . 0.0 110.607 -175.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -94.18 118.44 31.57 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 33.1 mm -118.26 121.84 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -102.41 114.33 28.43 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 169.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -71.01 -16.8 62.64 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -176.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.13 -26.04 25.43 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 118.169 0.441 . . . . 0.0 111.954 -174.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.551 HG13 ' HB ' ' A' ' 157' ' ' VAL . 29.2 mm -70.55 104.08 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 122.493 0.317 . . . . 0.0 110.46 -176.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 48.1 mtt -134.41 152.38 51.76 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.376 1.07 . . . . 0.0 109.702 -176.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.3 t70 71.89 7.84 5.92 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.608 1.163 . . . . 0.0 112.129 174.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -93.03 151.27 19.98 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.778 0.831 . . . . 0.0 110.532 -175.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -95.22 108.64 20.78 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 171.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.567 ' HB ' HG12 ' A' ' 192' ' ' VAL . 66.5 mt -115.52 149.15 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.405 0.682 . . . . 0.0 110.167 -170.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 55.8 tpp -125.31 134.36 52.28 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.149 0.979 . . . . 0.0 109.504 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -94.3 103.38 15.39 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.47 ' HG3' ' CE1' ' A' ' 150' ' ' PHE . 25.1 mmmt -114.52 149.94 35.66 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.62 1.168 . . . . 0.0 109.229 -173.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.518 ' HB3' ' HG ' ' A' ' 147' ' ' LEU . . . -153.49 144.12 22.57 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -104.92 133.68 49.31 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 167.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.49 ' HA ' HG13 ' A' ' 145' ' ' ILE . 28.4 p90 -162.16 164.19 28.02 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.182 0.515 . . . . 0.0 111.569 -172.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.1 t -88.53 157.4 18.63 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.614 172.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' A' ' 88' ' ' ARG . 74.1 t -136.31 140.01 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.303 1.041 . . . . 0.0 109.028 -174.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.515 HD11 ' HG2' ' A' ' 85' ' ' PRO . 7.9 tp -145.95 140.55 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 172.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 58.82 26.96 15.44 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.753 0.821 . . . . 0.0 112.34 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.0 t70 72.29 14.41 5.48 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.338 1.455 . . . . 0.0 111.895 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -123.54 160.71 26.42 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.12 0.568 . . . . 0.0 109.764 175.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.432 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 8.7 tt -62.87 119.04 8.61 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 177.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -82.67 -69.38 0.63 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.158 0.983 . . . . 0.0 109.135 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 93.8 m -137.17 129.71 30.01 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.647 0.779 . . . . 0.0 109.271 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.46 HD22 ' HB2' ' A' ' 147' ' ' LEU . 52.2 tp -73.13 123.51 23.74 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.641 0.776 . . . . 0.0 109.449 176.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.49 HG13 ' HA ' ' A' ' 134' ' ' PHE . 69.0 mt -83.79 -48.56 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.496 HD22 ' HG ' ' A' ' 98' ' ' LEU . 49.2 tp -161.98 149.57 14.42 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.899 0.88 . . . . 0.0 109.503 172.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.714 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 7.7 tt -126.52 142.74 51.44 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 172.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.541 HH11 HG21 ' A' ' 156' ' ' ILE . 46.6 ttm-85 -135.0 137.57 43.15 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.772 1.229 . . . . 0.0 110.53 -177.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.573 ' HB3' HD21 ' A' ' 181' ' ' LEU . . . -111.67 118.6 36.1 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 171.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.47 ' CE1' ' HG3' ' A' ' 131' ' ' LYS . 29.2 p90 -143.39 160.41 40.6 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 40.8 p -80.83 170.82 15.79 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.003 -174.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.27 -11.39 60.87 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 120.735 0.302 . . . . 0.0 111.11 171.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -71.03 -30.19 66.32 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.852 0.861 . . . . 0.0 110.066 168.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 106.6 -4.93 37.24 Favored Glycine 0 C--N 1.352 1.447 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.443 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -77.66 122.34 25.19 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.388 0.675 . . . . 0.0 110.493 -174.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.541 HG21 HH11 ' A' ' 148' ' ' ARG . 39.3 mt -76.53 103.99 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.212 0.605 . . . . 0.0 110.651 -175.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.551 ' HB ' HG13 ' A' ' 123' ' ' ILE . 27.2 m -99.27 -9.49 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 123.74 0.816 . . . . 0.0 112.061 -172.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -167.79 173.03 42.75 Favored Glycine 0 C--N 1.34 0.785 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 147' ' ' LEU . 37.5 tt0 -164.08 157.79 18.64 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.714 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 93.6 mt -123.53 103.87 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 167.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.629 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 2.7 m -93.7 109.47 41.41 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.563 -177.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -64.34 119.11 6.06 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.624 2.216 . . . . 0.0 111.307 172.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.453 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 94.7 mt -58.36 124.51 71.57 Favored Pre-proline 0 CA--C 1.545 0.751 0 O-C-N 124.051 0.844 . . . . 0.0 110.411 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 163' ' ' LEU . 16.8 Cg_exo -66.31 -24.18 50.81 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 123.397 2.732 . . . . 0.0 112.045 -172.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 77.7 p -74.05 -4.21 34.05 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.981 0.913 . . . . 0.0 111.809 177.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -123.96 81.39 56.51 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 124.251 1.02 . . . . 0.0 109.332 176.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -85.92 -6.05 8.65 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.329 2.019 . . . . 0.0 112.716 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -121.63 63.71 0.51 Allowed Glycine 0 C--N 1.344 0.984 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -175.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 16.0 p-80 -108.0 157.62 18.08 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 175.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 5.0 m -102.17 162.25 13.06 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.618 0.767 . . . . 0.0 110.199 -173.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.449 HD11 ' HA ' ' A' ' 202' ' ' ALA . 17.8 tt -56.78 -28.98 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 C-N-CA 124.95 1.3 . . . . 0.0 111.819 173.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -54.86 -42.79 72.44 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.721 1.208 . . . . 0.0 111.607 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.01 -44.0 90.64 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.809 0.844 . . . . 0.0 110.482 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.477 ' O ' HG13 ' A' ' 178' ' ' ILE . 50.9 t -65.58 -48.66 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.633 -172.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -58.15 -36.08 72.47 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.595 0.758 . . . . 0.0 111.757 -175.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.415 ' O ' HG22 ' A' ' 180' ' ' VAL . 16.2 m120 -74.02 -43.09 59.14 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.618 0.767 . . . . 0.0 110.142 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -59.56 -42.15 91.77 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.185 0.928 . . . . 0.0 111.562 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 174' ' ' VAL . 62.0 mt -57.71 -42.8 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 123.734 0.813 . . . . 0.0 109.171 177.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.638 ' HA3' ' HB2' ' A' ' 208' ' ' GLU . . . -76.9 -22.43 71.79 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-N 114.662 -1.154 . . . . 0.0 114.431 -175.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.447 HG12 ' HG2' ' A' ' 110' ' ' LYS . 97.6 t -73.5 -43.43 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 172.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.627 HD23 HG13 ' A' ' 160' ' ' ILE . 33.0 tp -58.97 -48.85 80.06 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.656 173.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.504 ' O ' ' HG2' ' A' ' 186' ' ' GLU . 70.0 mt -60.46 -44.66 96.81 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.997 0 C-N-CA 123.856 0.862 . . . . 0.0 110.61 176.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.438 ' O ' ' HG3' ' A' ' 187' ' ' ARG . . . -56.67 -39.31 85.89 Favored Glycine 0 C--N 1.342 0.869 0 O-C-N 123.512 0.508 . . . . 0.0 113.268 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -67.01 -41.21 93.3 Favored Glycine 0 C--N 1.353 1.489 0 N-CA-C 112.058 -0.417 . . . . 0.0 112.058 174.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 76.9 mt -62.96 -34.32 77.26 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.012 0.925 . . . . 0.0 111.043 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 31.1 mm-40 -68.41 -42.63 78.71 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 123.922 0.889 . . . . 0.0 109.827 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 183' ' ' GLY . 74.0 mtp180 -60.35 -38.38 83.62 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.299 0.64 . . . . 0.0 110.65 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -72.72 -14.21 61.51 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.951 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 36.6 t70 64.12 67.22 0.6 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.977 0.911 . . . . 0.0 110.819 -177.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -104.63 -162.82 0.91 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 170.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.1 m -135.0 101.0 4.74 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 169.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.567 HG12 ' HB ' ' A' ' 128' ' ' ILE . 8.2 m -111.02 153.26 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 121.784 0.802 . . . . 0.0 111.02 -172.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 52.2 ttm-85 -139.58 142.23 37.14 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.032 -1.44 . . . . 0.0 107.895 174.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 3.4 t -88.14 145.65 7.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 34.3 t -57.68 144.32 38.3 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.581 0.352 . . . . 0.0 111.272 178.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . 0.572 ' HZ1' ' HB3' ' A' ' 196' ' ' LYS . 0.2 OUTLIER -45.8 -37.78 6.45 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 124.429 1.081 . . . . 0.0 112.062 174.086 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 70.5 p -69.29 -55.54 10.18 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 123.525 0.73 . . . . 0.0 110.271 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.426 HD22 ' HB2' ' A' ' 132' ' ' ALA . 73.3 mt -62.17 -31.99 72.55 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.261 0.624 . . . . 0.0 111.413 -175.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.552 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 49.7 mt-30 -62.1 -50.38 72.15 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.496 0.718 . . . . 0.0 111.131 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.25 -20.11 35.13 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -175.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -87.38 -62.31 1.53 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.8 0.44 . . . . 0.0 111.285 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.449 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -111.05 -51.95 2.82 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.315 0.646 . . . . 0.0 111.679 -162.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.552 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 57.5 t-105 -61.38 -79.62 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.37 1.468 . . . . 0.0 110.675 -173.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 50.71 -125.68 23.43 Favored Glycine 0 C--N 1.35 1.353 0 C-N-CA 123.834 0.73 . . . . 0.0 114.847 171.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 30.4 t -74.53 -39.68 62.2 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.645 0.778 . . . . 0.0 110.126 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 27.5 p -86.21 75.43 9.87 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.527 0.731 . . . . 0.0 110.405 -177.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -110.52 135.45 51.16 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.055 -176.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.638 ' HB2' ' HA3' ' A' ' 179' ' ' GLY . 8.6 mm-40 -79.21 143.09 35.69 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.422 0.689 . . . . 0.0 109.639 175.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -145.92 148.89 33.29 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.055 0.542 . . . . 0.0 109.828 -176.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 132.83 145.82 5.49 Favored Glycine 0 C--N 1.344 1.002 0 O-C-N 123.281 0.363 . . . . 0.0 112.626 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.472 ' HB3' ' HB3' ' A' ' 186' ' ' GLU . 0.1 OUTLIER -147.53 101.85 3.74 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.817 0.847 . . . . 0.0 109.56 177.66 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -62.29 113.9 2.11 Favored 'Trans proline' 0 CA--C 1.555 1.535 0 C-N-CA 122.173 1.915 . . . . 0.0 110.552 165.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -61.05 133.02 44.75 Favored 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 122.308 2.005 . . . . 0.0 111.715 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.4 102.22 0.52 Allowed 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 18.9 p -74.45 155.5 37.96 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.34 1.056 . . . . 0.0 111.851 -174.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.5 pp -109.37 166.1 11.13 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.497 0.719 . . . . 0.0 110.163 177.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 . . . . . 0 C--O 1.251 1.163 0 C-N-CA 123.592 0.757 . . . . 0.0 109.302 -179.461 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.5 166.24 27.71 Favored 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.37 2.047 . . . . 0.0 111.537 176.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.13 115.27 7.42 Favored 'General case' 0 C--O 1.239 0.533 0 O-C-N 123.833 0.708 . . . . 0.0 109.949 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.9 p -60.73 106.74 0.6 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.262 1.025 . . . . 0.0 110.188 178.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.405 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 41.3 ttm180 -100.97 145.28 28.87 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -175.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -119.36 109.95 16.39 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.781 0.833 . . . . 0.0 108.928 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.8 mm -87.09 131.69 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 123.457 0.703 . . . . 0.0 109.413 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.461 ' HA ' HD21 ' A' ' 133' ' ' ASN . 50.9 p -118.48 81.06 1.62 Allowed 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 172.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -74.56 -27.45 60.51 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.606 -174.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.472 ' HB2' ' HG3' ' A' ' 97' ' ' GLU . 23.4 ptt? -102.89 134.14 46.81 Favored 'General case' 0 C--O 1.245 0.86 0 C-N-CA 123.361 0.664 . . . . 0.0 109.553 174.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.419 ' O ' ' HB2' ' A' ' 98' ' ' LEU . 9.8 t -81.84 171.72 14.17 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.337 0.655 . . . . 0.0 110.908 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -55.7 -43.02 71.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 126.024 1.73 . . . . 0.0 111.384 -176.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 100' ' ' ARG . 27.0 mm-40 -52.38 -40.64 62.3 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.126 0.97 . . . . 0.0 113.454 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.472 ' HG3' ' HB2' ' A' ' 93' ' ' MET . 12.7 pt-20 -97.73 -22.1 16.61 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.22 0.608 . . . . 0.0 111.291 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 94' ' ' THR . 2.2 tt -73.91 -59.93 2.49 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.634 0.773 . . . . 0.0 109.077 -176.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 39.7 m -80.67 -7.5 59.33 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.378 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.431 ' HB2' ' O ' ' A' ' 96' ' ' GLU . 9.2 tpm_? -58.81 122.33 13.31 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 123.416 0.687 . . . . 0.0 110.501 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -92.9 145.9 24.04 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 173.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 30.7 p-90 -154.16 178.65 9.75 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.828 0.851 . . . . 0.0 109.921 -166.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -136.84 151.17 48.82 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.093 0.957 . . . . 0.0 109.618 -177.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 65.6 mtp -93.17 95.16 9.23 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 172.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -57.14 -37.95 72.78 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.54 0.525 . . . . 0.0 111.312 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.589 ' HB3' ' HB2' ' A' ' 121' ' ' GLN . 8.7 mmt -124.77 97.06 39.41 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 168.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -82.82 127.06 4.71 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.965 2.444 . . . . 0.0 114.202 -170.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.53 ' HB3' ' HB ' ' A' ' 119' ' ' ILE . 87.5 tttt -123.19 116.29 23.17 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 162.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.489 ' NE2' ' SG ' ' A' ' 116' ' ' CYS . 50.8 tp60 -106.91 111.59 24.16 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -176.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.43 ' HG2' HG13 ' A' ' 180' ' ' VAL . 50.5 tptt -117.12 135.83 53.46 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 124.858 1.263 . . . . 0.0 108.58 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.1 t -112.06 118.67 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 170.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -110.15 88.52 2.78 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.79 -115.96 7.77 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.343 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -85.49 -1.43 9.07 Favored 'Trans proline' 0 C--N 1.367 1.52 0 C-N-CA 122.898 2.398 . . . . 0.0 113.694 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.467 HD13 ' HB3' ' A' ' 177' ' ' ALA . 45.0 mt -116.23 152.07 34.5 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.187 0.595 . . . . 0.0 110.743 -171.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.489 ' SG ' ' NE2' ' A' ' 109' ' ' GLN . 37.9 t -106.55 110.79 23.09 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.234 1.014 . . . . 0.0 109.824 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.8 mm -95.92 142.5 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.803 0.841 . . . . 0.0 109.317 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -128.52 121.76 29.57 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.53 ' HB ' ' HB3' ' A' ' 108' ' ' LYS . 37.3 mm -116.8 127.18 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.43 1.092 . . . . 0.0 109.762 -176.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -79.55 141.02 37.02 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 170.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.589 ' HB2' ' HB3' ' A' ' 106' ' ' MET . 58.8 mt-30 -103.4 3.19 34.82 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.919 172.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -108.14 -46.41 3.75 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -170.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.424 HG13 HG13 ' A' ' 157' ' ' VAL . 30.1 mm -81.98 106.63 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 121.295 0.569 . . . . 0.0 109.99 -163.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 63.0 mtt -127.82 161.45 28.98 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.527 1.131 . . . . 0.0 109.76 -172.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 66.43 6.39 4.31 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 124.311 1.045 . . . . 0.0 112.822 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -103.91 153.61 20.59 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.594 0.757 . . . . 0.0 110.393 -171.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -88.14 107.62 18.86 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 172.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.624 HD12 HG21 ' A' ' 157' ' ' VAL . 47.5 mt -105.62 117.9 52.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.625 0.726 . . . . 0.0 109.251 -175.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 13.4 tpt -102.47 133.86 46.73 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.423 -173.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 15.2 mt -108.36 104.04 13.32 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -176.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.404 ' HA ' ' OG ' ' A' ' 195' ' ' SER . 68.2 mttm -116.7 149.78 39.27 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.329 0.652 . . . . 0.0 110.501 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -141.08 161.94 36.66 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 122.146 0.974 . . . . 0.0 113.02 -174.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.461 HD21 ' HA ' ' A' ' 91' ' ' THR . 8.8 m120 -108.47 133.24 52.9 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 160.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -160.53 160.85 32.4 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.254 0.55 . . . . 0.0 111.6 -177.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.0 m -87.82 154.72 20.32 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.428 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.405 ' HB ' ' HB3' ' A' ' 88' ' ' ARG . 79.4 t -128.7 131.35 68.63 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 C-N-CA 123.938 0.895 . . . . 0.0 109.427 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 6.7 tp -142.99 141.51 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 171.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 58.2 37.92 26.23 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.832 0.853 . . . . 0.0 112.115 176.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 63.18 16.62 9.54 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 125.036 1.335 . . . . 0.0 112.446 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 16.1 ptt-85 -132.6 167.22 20.42 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.15 0.58 . . . . 0.0 110.856 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.6 tt -67.81 115.85 7.82 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -78.21 -61.9 1.85 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 122.789 0.436 . . . . 0.0 110.468 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 97.3 m -147.2 125.89 12.58 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.569 0.748 . . . . 0.0 110.12 -171.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.441 HD11 ' HB2' ' A' ' 147' ' ' LEU . 47.9 tp -73.51 129.53 38.18 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.191 0.596 . . . . 0.0 109.784 176.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 85.3 mt -88.27 -51.05 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.699 0.8 . . . . 0.0 109.283 174.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 54.3 tp -162.23 148.06 13.02 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 175.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.604 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 7.7 tt -137.28 149.45 47.11 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 175.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.493 ' HD3' HD13 ' A' ' 156' ' ' ILE . 46.8 mtt-85 -133.87 145.52 49.74 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.491 0.717 . . . . 0.0 110.729 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.541 ' HB2' HD21 ' A' ' 181' ' ' LEU . . . -109.76 123.52 49.68 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 168.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.497 ' HB3' ' HA ' ' A' ' 156' ' ' ILE . 18.8 p90 -150.22 168.51 23.79 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.64 0.776 . . . . 0.0 110.186 -176.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 79.1 p -85.69 165.87 16.61 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 173.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.05 -9.46 39.5 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 120.691 0.282 . . . . 0.0 111.675 174.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -79.83 -23.7 41.85 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.018 1.327 . . . . 0.0 110.973 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 106.18 -1.48 37.84 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-N 115.637 -0.711 . . . . 0.0 113.003 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.24 106.9 6.1 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.216 0.606 . . . . 0.0 109.911 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.497 ' HA ' ' HB3' ' A' ' 150' ' ' PHE . 25.6 mt -77.46 118.51 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -177.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.624 HG21 HD12 ' A' ' 128' ' ' ILE . 18.9 m -106.89 -15.31 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 124.595 1.158 . . . . 0.0 111.994 -170.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -165.25 177.23 40.72 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 111.826 -0.51 . . . . 0.0 111.826 -172.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -166.17 153.94 10.28 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.739 0.416 . . . . 0.0 111.046 -173.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.604 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 67.9 mt -127.61 116.49 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 166.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 33.4 t -128.03 118.74 20.84 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.108 0.563 . . . . 0.0 109.898 -174.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -62.14 121.45 9.49 Favored 'Trans proline' 0 C--N 1.382 2.328 0 C-N-CA 122.798 2.332 . . . . 0.0 111.91 176.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.4 mt -72.19 128.29 89.22 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 122.862 0.465 . . . . 0.0 110.217 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -60.78 -15.92 40.82 Favored 'Trans proline' 0 C--N 1.382 2.297 0 C-N-CA 124.098 3.199 . . . . 0.0 114.513 -177.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 19.5 m -64.13 -17.09 63.13 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.245 0.618 . . . . 0.0 111.559 172.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -123.9 90.71 50.41 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -68.26 -32.07 27.44 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 122.62 2.213 . . . . 0.0 112.556 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -119.41 97.64 0.69 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -177.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -113.16 157.32 21.81 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.159 0.584 . . . . 0.0 109.684 172.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.0 m -107.27 161.86 14.41 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.269 1.027 . . . . 0.0 110.82 -169.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.594 HD12 ' HA ' ' A' ' 202' ' ' ALA . 14.8 tt -56.05 -29.99 28.06 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.308 0 C-N-CA 124.235 1.014 . . . . 0.0 112.307 172.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -56.21 -52.65 63.65 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.059 0.944 . . . . 0.0 111.835 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -73.63 -25.2 60.19 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.978 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 178' ' ' ILE . 63.4 t -65.78 -40.92 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 122.643 0.377 . . . . 0.0 110.185 172.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -72.1 -30.7 65.36 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.477 0.311 . . . . 0.0 111.005 178.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.433 ' O ' HG21 ' A' ' 180' ' ' VAL . 94.8 m-20 -62.79 -46.16 89.27 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 169.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.467 ' HB3' HD13 ' A' ' 115' ' ' LEU . . . -61.87 -48.21 81.53 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.766 1.226 . . . . 0.0 112.339 -174.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 174' ' ' VAL . 45.6 mt -68.32 -32.36 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -65.31 -38.74 95.39 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-N 116.086 -0.506 . . . . 0.0 113.364 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.433 HG21 ' O ' ' A' ' 176' ' ' ASN . 95.8 t -72.45 -42.81 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.066 0.546 . . . . 0.0 109.847 177.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.541 HD21 ' HB2' ' A' ' 149' ' ' ALA . 35.4 tp -54.15 -55.97 22.69 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.027 0.931 . . . . 0.0 110.536 176.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.493 ' O ' ' HG2' ' A' ' 186' ' ' GLU . 24.7 mt -55.0 -45.27 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 124.152 0.907 . . . . 0.0 110.74 172.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -55.24 -41.86 80.45 Favored Glycine 0 CA--C 1.533 1.189 0 O-C-N 123.793 0.683 . . . . 0.0 114.268 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.35 -33.26 64.53 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-O 121.302 0.39 . . . . 0.0 112.134 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.422 ' HB3' ' OD1' ' A' ' 190' ' ' ASN . 88.9 mt -72.2 -28.82 63.44 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 124.618 1.167 . . . . 0.0 111.403 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 18.2 mm-40 -60.55 -38.45 84.56 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.703 0.801 . . . . 0.0 110.044 175.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 67.4 mtp85 -69.42 -30.83 68.86 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.24 -1.345 . . . . 0.0 110.821 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -83.09 4.81 24.76 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.516 0.727 . . . . 0.0 112.652 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 36.9 t70 59.33 26.96 15.92 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.986 0.898 . . . . 0.0 111.124 173.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.422 ' OD1' ' HB3' ' A' ' 185' ' ' LEU . 28.8 p30 -105.09 161.48 14.2 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -177.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 35.4 m -91.27 113.79 26.15 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.28 0.632 . . . . 0.0 109.827 -172.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.48 HG21 HG22 ' A' ' 182' ' ' ILE . 35.2 m -89.83 134.43 28.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-O 121.324 0.583 . . . . 0.0 109.986 -177.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -140.76 129.78 23.33 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.755 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 4.7 t -105.34 152.62 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.404 ' OG ' ' HA ' ' A' ' 131' ' ' LYS . 63.5 m -59.06 145.84 40.64 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 118.222 0.464 . . . . 0.0 111.037 176.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 200' ' ' ARG . 0.2 OUTLIER -69.26 -28.08 66.0 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.294 0.371 . . . . 0.0 110.222 -178.216 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 62.6 p -67.34 -50.15 61.12 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 171.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 33.6 mt -58.58 -30.61 67.32 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.464 0.705 . . . . 0.0 111.26 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.639 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 45.6 mt-30 -70.58 -55.18 9.43 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.161 0.585 . . . . 0.0 110.897 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 196' ' ' LYS . 0.0 OUTLIER -81.61 -11.78 58.99 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -173.213 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -97.37 -39.51 9.17 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.038 0.535 . . . . 0.0 111.13 175.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.594 ' HA ' HD12 ' A' ' 171' ' ' ILE . . . -121.67 -61.55 1.5 Allowed 'General case' 0 N--CA 1.479 0.993 0 O-C-N 122.15 -0.344 . . . . 0.0 111.287 -172.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.639 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 51.2 t-105 -74.29 79.15 1.83 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.584 1.153 . . . . 0.0 110.445 -165.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 177.7 -136.39 3.04 Favored Glycine 0 C--O 1.239 0.466 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 74.4 p -87.72 12.84 11.78 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.391 0.676 . . . . 0.0 112.117 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 23.4 m -74.36 89.25 2.09 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 123.455 0.702 . . . . 0.0 111.056 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -116.21 140.05 49.71 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.427 0.691 . . . . 0.0 110.397 178.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -96.39 129.18 43.8 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.044 0.938 . . . . 0.0 110.172 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -98.57 79.37 2.46 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.384 0.673 . . . . 0.0 109.189 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -94.8 122.24 7.1 Favored Glycine 0 C--N 1.34 0.792 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 42.6 ptt85 -86.62 145.8 40.12 Favored Pre-proline 0 CA--C 1.55 0.959 0 CA-C-N 117.256 0.528 . . . . 0.0 110.088 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.42 137.35 69.41 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.751 2.301 . . . . 0.0 111.872 173.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -69.94 110.16 2.52 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.309 2.006 . . . . 0.0 110.447 176.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 71.1 mt -92.36 51.22 1.73 Allowed 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 47.0 p -82.23 144.28 30.78 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.563 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.01 158.82 35.93 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.38 1.072 . . . . 0.0 109.375 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 C--O 1.251 1.135 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -177.601 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.83 114.38 2.39 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.832 2.355 . . . . 0.0 111.638 174.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.33 134.39 33.83 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.705 0.802 . . . . 0.0 109.524 176.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 30.2 p -63.8 105.46 0.83 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.111 0.964 . . . . 0.0 110.009 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -110.71 135.1 51.82 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.329 0.652 . . . . 0.0 110.625 -170.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -99.1 98.73 9.71 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.954 0.901 . . . . 0.0 109.197 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.8 mm -77.22 137.44 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.994 0.918 . . . . 0.0 109.018 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.2 p -127.35 85.92 2.43 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.107 0.563 . . . . 0.0 109.534 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -72.55 -25.52 61.39 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 122.824 0.45 . . . . 0.0 111.319 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.54 ' HB2' ' HG3' ' A' ' 97' ' ' GLU . 9.1 ptp -106.04 131.7 53.01 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 172.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 77.1 p -70.05 169.24 13.81 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.415 0.686 . . . . 0.0 109.946 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 45.0 mm -62.16 -35.66 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 122.593 0.357 . . . . 0.0 110.582 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 100' ' ' ARG . 43.2 mt-10 -53.72 -44.13 69.61 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.803 0.841 . . . . 0.0 112.294 176.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.54 ' HG3' ' HB2' ' A' ' 93' ' ' MET . 13.7 pt-20 -96.7 -13.23 22.89 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.076 0.55 . . . . 0.0 110.996 -177.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.563 HD11 HD23 ' A' ' 146' ' ' LEU . 53.2 tp -68.9 -50.21 51.5 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.919 0.888 . . . . 0.0 110.768 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.1 p -103.42 14.33 31.63 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.659 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 96' ' ' GLU . 59.5 ttt85 -72.15 141.38 49.11 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.237 0.615 . . . . 0.0 111.279 -174.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -84.28 152.28 24.26 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.344 0.592 . . . . 0.0 109.812 173.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.468 ' HE1' HH12 ' A' ' 148' ' ' ARG . 7.9 p-90 -149.6 167.51 26.14 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.389 1.076 . . . . 0.0 109.396 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -129.19 145.08 51.4 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.685 0.794 . . . . 0.0 109.605 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.549 ' SD ' ' HD2' ' A' ' 118' ' ' ARG . 69.7 mtp -116.9 150.92 37.68 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.662 0.785 . . . . 0.0 109.886 178.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -126.93 -23.73 3.6 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.672 0.789 . . . . 0.0 110.552 -177.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 25.6 mmt -130.12 72.72 81.83 Favored Pre-proline 0 N--CA 1.49 1.563 0 C-N-CA 123.119 0.568 . . . . 0.0 109.627 167.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.93 135.66 35.85 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.867 2.378 . . . . 0.0 113.61 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -129.88 118.9 22.44 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.032 0.933 . . . . 0.0 109.133 173.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.413 ' NE2' ' SG ' ' A' ' 116' ' ' CYS . 0.0 OUTLIER -108.33 103.8 13.04 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.715 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.7 tptt -120.79 126.36 49.91 Favored 'General case' 0 C--O 1.206 -1.207 0 C-N-CA 124.957 1.303 . . . . 0.0 107.911 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 81.3 t -96.4 133.85 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 173.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -126.12 92.65 3.62 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 175.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.61 -133.25 25.3 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.909 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -75.65 3.78 5.64 Favored 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 123.716 2.944 . . . . 0.0 113.697 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 5.3 mp -125.23 156.67 38.14 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.267 0.627 . . . . 0.0 109.71 -177.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.413 ' SG ' ' NE2' ' A' ' 109' ' ' GLN . 42.6 t -116.87 132.75 56.62 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.002 0.921 . . . . 0.0 108.825 -177.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.41 HD11 ' HB2' ' A' ' 177' ' ' ALA . 12.6 mm -106.03 143.71 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.472 1.109 . . . . 0.0 109.184 -176.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.613 ' HB3' ' HB3' ' A' ' 159' ' ' GLU . 71.3 ttp85 -129.3 120.64 25.99 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 176.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.552 HD13 ' HA3' ' A' ' 184' ' ' GLY . 44.2 mt -128.68 139.17 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -176.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -107.86 121.92 45.73 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 171.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.445 ' HA ' ' ND2' ' A' ' 188' ' ' ASN . 70.2 mt-30 -82.96 -9.29 59.36 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -173.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.27 -32.18 26.53 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.798 0.439 . . . . 0.0 111.5 178.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.419 HG12 ' CG1' ' A' ' 157' ' ' VAL . 1.8 mp -71.02 108.57 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.758 0.789 . . . . 0.0 109.117 -178.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.413 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 58.4 mtt -132.08 163.19 29.01 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 113.684 -1.598 . . . . 0.0 108.988 -175.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 71.35 5.33 5.39 Favored 'General case' 0 N--CA 1.502 2.126 0 C-N-CA 124.543 1.137 . . . . 0.0 112.998 171.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -97.08 151.13 20.06 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.653 0.781 . . . . 0.0 112.143 -170.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -91.98 108.33 19.85 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 164.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.531 HG12 HG23 ' A' ' 151' ' ' THR . 34.0 mt -110.92 147.91 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 123.598 0.759 . . . . 0.0 110.397 -172.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 15.4 tpt -130.67 120.76 24.39 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.544 1.138 . . . . 0.0 109.768 -169.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -88.21 103.63 15.95 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -117.25 138.14 51.92 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.487 0.715 . . . . 0.0 109.26 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -134.8 147.03 49.86 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.512 0.931 . . . . 0.0 113.512 -171.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.449 ' OD1' ' HG2' ' A' ' 93' ' ' MET . 5.2 m-20 -102.07 122.92 45.03 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 165.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -159.73 158.7 31.78 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 122.901 0.48 . . . . 0.0 111.645 -171.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.9 t -88.02 155.11 19.99 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.008 0.923 . . . . 0.0 109.914 173.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 87' ' ' SER . 45.9 t -130.5 145.6 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 124.901 1.281 . . . . 0.0 109.297 -177.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.499 HG21 ' HB2' ' A' ' 142' ' ' GLU . 11.0 tp -157.95 144.01 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 171.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 55.5 27.59 10.49 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 123.64 0.776 . . . . 0.0 112.858 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 66.18 23.19 10.95 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.97 1.308 . . . . 0.0 112.661 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 137' ' ' ILE . 28.8 ptt180 -117.66 160.96 20.44 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.945 0.498 . . . . 0.0 109.78 175.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.8 tt -71.2 112.99 7.78 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 166.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.499 ' HB2' HG21 ' A' ' 137' ' ' ILE . 11.9 tp10 -81.43 -58.46 3.02 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.67 0.388 . . . . 0.0 110.186 177.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 96.4 m -141.78 120.94 12.97 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.249 0.22 . . . . 0.0 110.808 -174.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 43.6 tp -77.2 119.3 20.69 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.057 0.543 . . . . 0.0 109.577 172.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 72.0 mt -80.56 -53.68 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 174.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.563 HD23 HD11 ' A' ' 98' ' ' LEU . 65.0 tp -156.61 146.09 20.66 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.888 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.551 HD12 HD13 ' A' ' 160' ' ' ILE . 8.2 tt -133.2 145.59 50.72 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 171.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.653 HH11 HG21 ' A' ' 156' ' ' ILE . 84.4 mtt-85 -140.52 143.69 35.54 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.227 1.011 . . . . 0.0 108.845 178.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -101.61 112.43 24.99 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 176.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -106.58 125.31 50.84 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.382 1.073 . . . . 0.0 109.74 -175.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.531 HG23 HG12 ' A' ' 128' ' ' ILE . 43.7 p -71.64 -174.07 1.06 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.034 0.534 . . . . 0.0 111.583 175.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -19.2 65.5 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.462 0.705 . . . . 0.0 112.833 175.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -98.3 -1.2 42.37 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.728 0.811 . . . . 0.0 111.358 172.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 76.38 26.3 63.91 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 116.396 -0.365 . . . . 0.0 113.343 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -77.7 131.63 37.79 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.653 HG21 HH11 ' A' ' 148' ' ' ARG . 22.9 mt -83.02 86.86 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 121.649 0.738 . . . . 0.0 109.181 -177.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.419 ' CG1' HG12 ' A' ' 123' ' ' ILE . 19.3 m -100.09 -12.89 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.519 1.128 . . . . 0.0 111.185 -169.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.406 ' HA3' HD11 ' A' ' 181' ' ' LEU . . . -142.84 164.76 27.05 Favored Glycine 0 C--O 1.245 0.836 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.613 ' HB3' ' HB3' ' A' ' 118' ' ' ARG . 32.8 tt0 -167.89 150.05 5.56 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 117.437 0.618 . . . . 0.0 110.428 -173.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.551 HD13 HD12 ' A' ' 147' ' ' LEU . 57.6 mt -136.0 125.67 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 170.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 14.4 m -138.46 122.88 11.7 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.574 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 88.1 Cg_exo -48.51 142.44 17.78 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 123.257 2.638 . . . . 0.0 113.175 173.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 90.4 mt -61.06 135.7 93.43 Favored Pre-proline 0 CA--C 1.559 1.307 0 C-N-CA 123.623 0.769 . . . . 0.0 111.09 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.87 72.2 3.94 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 123.21 2.607 . . . . 0.0 111.916 176.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 32.6 t 173.28 -18.59 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 126.411 1.884 . . . . 0.0 108.883 -175.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -115.39 84.14 11.46 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 124.944 1.298 . . . . 0.0 109.492 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.58 -24.94 5.85 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 122.647 2.231 . . . . 0.0 113.461 -177.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -122.45 87.6 0.4 Allowed Glycine 0 C--N 1.349 1.278 0 N-CA-C 111.681 -0.568 . . . . 0.0 111.681 -172.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -98.26 177.58 5.33 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.769 0.827 . . . . 0.0 110.26 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.8 m -122.51 154.96 37.15 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.447 HD11 ' HA ' ' A' ' 202' ' ' ALA . 10.7 tt -51.88 -34.96 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 C-N-CA 124.726 1.21 . . . . 0.0 113.001 177.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -61.97 -44.15 97.35 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.221 1.008 . . . . 0.0 112.784 -177.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -82.75 -25.62 32.67 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.647 0.379 . . . . 0.0 111.276 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 178' ' ' ILE . 91.4 t -64.49 -48.64 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 122.809 0.444 . . . . 0.0 110.858 172.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -65.96 -28.22 68.74 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.61 0.364 . . . . 0.0 110.905 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.417 ' O ' HG22 ' A' ' 180' ' ' VAL . 13.7 m120 -68.53 -43.56 76.48 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 123.144 0.578 . . . . 0.0 109.495 171.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.41 ' HB2' HD11 ' A' ' 117' ' ' ILE . . . -61.3 -40.52 94.46 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.842 0.857 . . . . 0.0 111.36 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 174' ' ' VAL . 57.6 mt -65.0 -39.91 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.19 -36.98 94.16 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.476 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 176' ' ' ASN . 80.9 t -66.2 -47.59 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.218 0.607 . . . . 0.0 110.613 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.406 HD11 ' HA3' ' A' ' 158' ' ' GLY . 32.7 tp -59.46 -46.76 87.85 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.879 0.737 . . . . 0.0 110.344 178.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.787 HG23 HG22 ' A' ' 192' ' ' VAL . 47.8 mt -57.12 -46.19 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.37 1.068 . . . . 0.0 111.447 176.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -63.41 -34.58 90.34 Favored Glycine 0 C--N 1.341 0.841 0 O-C-N 123.675 0.609 . . . . 0.0 113.104 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.552 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -71.12 -27.61 71.67 Favored Glycine 0 C--N 1.35 1.343 0 O-C-N 123.751 0.324 . . . . 0.0 113.0 177.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.406 HD21 ' CD1' ' A' ' 128' ' ' ILE . 64.2 mt -77.28 -47.35 20.29 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.832 0.853 . . . . 0.0 110.076 175.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -67.14 -34.11 76.89 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.316 0.646 . . . . 0.0 112.417 -174.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -66.89 -29.05 68.85 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 122.432 0.293 . . . . 0.0 111.365 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.445 ' ND2' ' HA ' ' A' ' 121' ' ' GLN . 49.5 m-20 -80.38 8.19 8.11 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.207 0.603 . . . . 0.0 110.86 174.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 34.4 t70 65.49 64.2 0.6 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.776 1.23 . . . . 0.0 110.207 177.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -124.46 172.96 8.76 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.153 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 70.2 m -122.93 102.55 8.08 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.787 HG22 HG23 ' A' ' 182' ' ' ILE . 31.8 m -89.99 150.97 3.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 CA-C-O 121.898 0.856 . . . . 0.0 111.574 -174.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -141.22 131.23 24.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 113.8 -1.545 . . . . 0.0 107.701 173.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 5.8 t -89.75 152.7 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 38.6 t -62.95 141.6 58.66 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 118.179 0.445 . . . . 0.0 109.929 176.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -57.94 -33.73 69.13 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.258 0.623 . . . . 0.0 111.888 -177.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 15.0 p -66.79 -49.6 65.34 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.433 0.458 . . . . 0.0 110.242 174.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 72.5 mt -58.63 -34.65 71.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 122.697 0.399 . . . . 0.0 110.775 178.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.553 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 75.5 mt-30 -61.35 -41.53 97.21 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.092 0.957 . . . . 0.0 112.666 -175.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.26 -21.09 14.41 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -178.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -79.49 -48.69 13.47 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 118.745 0.702 . . . . 0.0 111.107 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.447 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -114.82 -50.89 2.76 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.498 0.666 . . . . 0.0 111.221 -174.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.553 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 35.4 t-105 -79.18 4.58 14.44 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 124.97 1.308 . . . . 0.0 111.391 -171.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -58.79 -20.27 46.99 Favored Glycine 0 C--N 1.362 2.003 0 C-N-CA 123.08 0.371 . . . . 0.0 113.731 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 19.6 m -68.14 100.18 0.98 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.767 0.827 . . . . 0.0 110.072 170.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 49.5 m -87.55 75.78 9.05 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.868 0.842 . . . . 0.0 109.296 176.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -108.4 2.11 22.2 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.725 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -152.46 143.12 22.82 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.968 0.907 . . . . 0.0 109.317 -176.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -100.25 121.23 41.13 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 172.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -77.06 -97.38 0.18 Allowed Glycine 0 C--N 1.346 1.124 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 175.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.416 ' HA ' ' HD3' ' A' ' 212' ' ' PRO . 5.8 ptm180 -176.42 137.54 0.46 Allowed Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 124.151 0.98 . . . . 0.0 110.091 171.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 211' ' ' ARG . 1.6 Cg_endo -81.7 120.49 3.51 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.926 2.418 . . . . 0.0 110.229 174.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -58.26 103.0 0.14 Allowed 'Trans proline' 0 C--N 1.383 2.342 0 C-N-CA 123.069 2.513 . . . . 0.0 111.207 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 89.9 mt -71.89 91.0 1.15 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.971 -173.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 41.9 p -83.07 141.28 32.13 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.833 175.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.8 pp -71.68 161.65 30.66 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.418 0.687 . . . . 0.0 111.696 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 C--O 1.252 1.237 0 CA-C-O 118.75 -0.643 . . . . 0.0 109.581 -173.09 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.432 ' SD ' ' N ' ' A' ' 84' ' ' MET . 0.5 OUTLIER . . . . . 0 CA--C 1.553 1.069 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.437 ' HB3' ' HA ' ' A' ' 138' ' ' PHE . 53.1 Cg_endo -67.4 121.06 8.14 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.939 2.426 . . . . 0.0 112.038 178.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.1 126.21 41.17 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.729 0.811 . . . . 0.0 109.679 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.5 p -76.44 83.09 3.16 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 170.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -114.77 153.6 30.06 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.606 -173.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -116.4 113.54 23.02 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.888 0.875 . . . . 0.0 109.345 174.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 32.5 mm -78.38 132.85 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 36.1 p -128.25 87.93 2.67 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.923 0.889 . . . . 0.0 109.305 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -71.33 -22.9 61.86 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 173.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.426 ' SD ' ' HB2' ' A' ' 148' ' ' ARG . 56.9 mtm -119.63 139.89 51.47 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 125.15 1.38 . . . . 0.0 109.027 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 72.2 p -88.88 165.67 14.48 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 172.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.504 ' HA ' HD12 ' A' ' 98' ' ' LEU . 2.2 mp -53.93 -30.73 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 124.609 1.164 . . . . 0.0 111.736 -171.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -53.33 -62.69 1.49 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.355 1.062 . . . . 0.0 111.984 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.714 ' HA ' ' HB2' ' A' ' 100' ' ' ARG . 14.9 pm0 -77.21 -22.56 52.14 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.834 0.453 . . . . 0.0 111.74 -177.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.61 HD13 ' ND2' ' A' ' 133' ' ' ASN . 32.7 mt -58.53 -39.17 79.4 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.089 0.556 . . . . 0.0 110.491 169.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.3 m -108.32 20.96 17.98 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.278 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.714 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 6.5 tpt180 -71.29 143.05 50.46 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.75 0.42 . . . . 0.0 110.861 -174.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -96.12 104.99 16.98 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.113 0.965 . . . . 0.0 109.563 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.401 ' HE1' ' NH1' ' A' ' 148' ' ' ARG . 46.0 p-90 -137.04 172.66 12.67 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.216 1.006 . . . . 0.0 110.496 -177.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -138.38 166.22 24.8 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.611 0.764 . . . . 0.0 110.657 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.415 ' HG2' ' HB2' ' A' ' 120' ' ' ASP . 55.9 mtm -122.16 129.19 52.08 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.286 1.034 . . . . 0.0 109.105 172.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 56.3 tp -71.38 -40.62 70.45 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.023 0.929 . . . . 0.0 110.034 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 24.1 mmt -125.0 77.97 66.48 Favored Pre-proline 0 N--CA 1.483 1.194 0 C-N-CA 124.404 1.082 . . . . 0.0 109.451 174.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.43 111.93 3.43 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.627 2.218 . . . . 0.0 112.352 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -87.04 111.2 20.65 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 172.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -89.21 116.8 27.72 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.547 0.339 . . . . 0.0 110.271 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.406 ' HG2' HG13 ' A' ' 180' ' ' VAL . 14.4 tppt? -127.47 140.23 52.29 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.983 1.313 . . . . 0.0 109.332 174.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.56 HG12 HD12 ' A' ' 163' ' ' LEU . 79.5 t -123.24 99.5 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 166.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.496 ' HG2' HG21 ' A' ' 180' ' ' VAL . 9.1 tp10 -104.3 95.56 6.04 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -175.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.16 -125.91 19.19 Favored Glycine 0 CA--C 1.536 1.362 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.39 -176.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -85.75 6.38 5.59 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 123.246 2.63 . . . . 0.0 112.875 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.42 HD11 ' HB3' ' A' ' 177' ' ' ALA . 73.6 mt -123.51 144.32 49.62 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.345 0.658 . . . . 0.0 109.666 -171.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 46.4 t -107.66 115.58 30.4 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.322 0.649 . . . . 0.0 109.458 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.0 mm -99.72 133.71 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.2 mtm180 -134.42 120.98 20.47 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.66 0.784 . . . . 0.0 108.946 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.546 HG12 HD12 ' A' ' 181' ' ' LEU . 49.6 mt -126.06 132.47 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.391 1.077 . . . . 0.0 108.988 -173.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.421 ' OD2' HG12 ' A' ' 123' ' ' ILE . 16.7 t70 -89.29 120.09 30.34 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 118.064 0.393 . . . . 0.0 109.958 176.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.466 ' HA ' ' ND2' ' A' ' 188' ' ' ASN . 82.2 mt-30 -91.35 2.21 56.56 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.74 0.816 . . . . 0.0 113.118 -175.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.11 -27.82 16.04 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 174.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.421 HG12 ' OD2' ' A' ' 120' ' ' ASP . 22.5 mm -78.49 95.03 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.685 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.488 ' HE1' ' HA ' ' A' ' 188' ' ' ASN . 37.4 mtt -122.74 149.33 44.24 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.045 -178.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.0 t70 65.55 52.1 1.41 Allowed 'General case' 0 N--CA 1.484 1.23 0 O-C-N 124.529 1.143 . . . . 0.0 110.928 175.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -130.03 156.1 45.05 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.068 0.947 . . . . 0.0 110.691 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -95.64 108.27 20.54 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 170.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.528 ' HB ' HG12 ' A' ' 192' ' ' VAL . 58.7 mt -113.66 143.56 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.761 0.824 . . . . 0.0 111.186 -171.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.548 ' HE2' ' HA ' ' A' ' 195' ' ' SER . 12.4 tpt -118.41 122.85 43.79 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.324 1.05 . . . . 0.0 108.912 -177.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.412 HD12 HG22 ' A' ' 194' ' ' VAL . 12.1 mt -94.79 103.87 15.77 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -175.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -118.37 140.74 49.37 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.948 0.899 . . . . 0.0 109.974 -170.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -135.6 154.12 51.44 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 122.581 1.181 . . . . 0.0 114.141 -171.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.61 ' ND2' HD13 ' A' ' 98' ' ' LEU . 3.3 m-20 -108.06 127.63 53.96 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 162.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -156.21 159.6 39.09 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.682 0.614 . . . . 0.0 110.556 -176.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.2 t -86.3 162.85 18.04 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 173.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.8 t -135.02 133.87 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.625 1.17 . . . . 0.0 109.132 -174.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.6 tp -148.88 145.81 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 172.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.437 ' HA ' ' HB3' ' A' ' 85' ' ' PRO . 38.7 m-85 59.21 30.47 20.24 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.741 0.816 . . . . 0.0 111.3 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 64.06 17.74 10.81 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.057 1.343 . . . . 0.0 112.096 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -127.36 175.39 8.23 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.899 0.88 . . . . 0.0 110.0 176.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.484 HD23 ' HA ' ' A' ' 171' ' ' ILE . 9.1 tt -67.33 123.46 20.42 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.545 0.738 . . . . 0.0 109.119 175.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -82.99 -70.19 0.57 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.137 0.575 . . . . 0.0 109.886 174.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 61.4 m -147.92 129.34 14.85 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.88 0.872 . . . . 0.0 109.656 -174.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 59.3 tp -72.3 134.55 45.59 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.768 0.827 . . . . 0.0 110.46 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 66.1 mt -96.16 -43.48 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.924 0.89 . . . . 0.0 110.102 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.428 HD21 ' NH2' ' A' ' 148' ' ' ARG . 40.9 tp -169.5 149.12 3.9 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.922 0.889 . . . . 0.0 109.253 174.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.667 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 7.5 tt -136.0 144.93 45.59 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.691 ' HD3' HD12 ' A' ' 156' ' ' ILE . 71.7 mtt-85 -142.54 146.75 34.98 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.224 1.01 . . . . 0.0 109.939 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.73 118.72 37.47 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.239 1.016 . . . . 0.0 108.844 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -110.25 128.94 55.77 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.277 1.031 . . . . 0.0 110.397 -174.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 31.4 p -76.8 179.27 6.21 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.022 0.529 . . . . 0.0 111.022 172.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -61.97 -21.02 64.48 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.884 0.874 . . . . 0.0 112.02 174.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -83.04 -1.54 52.98 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.801 1.24 . . . . 0.0 111.569 176.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 69.0 18.23 72.51 Favored Glycine 0 C--N 1.357 1.709 0 CA-C-N 116.456 -0.338 . . . . 0.0 112.847 -173.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -92.57 129.47 38.49 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.383 0.673 . . . . 0.0 109.419 -174.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.691 HD12 ' HD3' ' A' ' 148' ' ' ARG . 24.4 mt -79.97 109.26 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.1 m -117.08 -0.55 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.974 0.91 . . . . 0.0 111.397 -173.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -150.22 164.47 29.71 Favored Glycine 0 C--N 1.34 0.76 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -165.57 144.39 6.23 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 117.149 0.475 . . . . 0.0 110.595 -174.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.667 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 73.8 mt -127.05 102.84 10.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.1 t -106.79 112.62 63.39 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 123.366 0.666 . . . . 0.0 109.579 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -58.96 128.26 27.26 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.749 2.299 . . . . 0.0 111.983 174.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.56 HD12 HG12 ' A' ' 111' ' ' VAL . 88.8 mt -65.83 128.0 93.5 Favored Pre-proline 0 CA--C 1.548 0.873 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.202 -177.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.44 -9.02 25.14 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 123.185 2.59 . . . . 0.0 113.013 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 25.3 p -71.89 -13.18 61.59 Favored 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 123.738 0.815 . . . . 0.0 111.255 169.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -121.88 113.13 31.7 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 125.01 1.324 . . . . 0.0 107.698 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.63 -34.51 90.52 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.39 2.727 . . . . 0.0 113.792 -177.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -163.41 -179.29 37.75 Favored Glycine 0 N--CA 1.467 0.73 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 42.3 p-80 -153.05 -175.7 5.45 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.477 0.711 . . . . 0.0 110.551 175.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 19.2 m -106.56 158.16 17.14 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.269 1.027 . . . . 0.0 110.064 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.484 ' HA ' HD23 ' A' ' 141' ' ' LEU . 2.8 tt -48.22 -39.78 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 125.563 1.545 . . . . 0.0 113.024 174.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -63.54 -34.17 77.21 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.55 0.74 . . . . 0.0 111.687 -174.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -65.98 -37.05 84.96 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.861 0.864 . . . . 0.0 110.546 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 25.5 t -68.63 -34.95 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 123.865 0.728 . . . . 0.0 110.611 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -64.24 -38.27 90.47 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 120.486 0.184 . . . . 0.0 110.707 176.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -63.16 -47.21 83.64 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 123.992 0.808 . . . . 0.0 109.568 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.42 ' HB3' HD11 ' A' ' 115' ' ' LEU . . . -60.41 -48.78 80.27 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 114.29 -1.323 . . . . 0.0 112.2 -175.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 68.5 mt -67.42 -38.73 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 123.779 0.674 . . . . 0.0 109.418 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.26 -30.07 76.42 Favored Glycine 0 CA--C 1.536 1.372 0 O-C-N 123.328 0.392 . . . . 0.0 113.677 176.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.496 HG21 ' HG2' ' A' ' 112' ' ' GLU . 43.2 t -76.45 -43.73 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.663 0.785 . . . . 0.0 110.32 175.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.546 HD12 HG12 ' A' ' 119' ' ' ILE . 36.6 tp -56.53 -49.04 75.92 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.727 0.811 . . . . 0.0 110.509 175.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.459 ' O ' ' HG2' ' A' ' 186' ' ' GLU . 77.3 mt -61.54 -52.18 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.14 0.976 . . . . 0.0 110.272 174.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -54.99 -36.26 60.41 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 124.153 0.908 . . . . 0.0 114.141 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.13 -41.34 47.69 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 112.235 -0.346 . . . . 0.0 112.235 174.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.456 HD13 HG13 ' A' ' 192' ' ' VAL . 35.5 mt -69.79 -16.49 63.3 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.304 1.042 . . . . 0.0 111.944 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 20.5 mm-40 -70.81 -39.27 73.18 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 171.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -77.83 -34.48 51.89 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.451 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.488 ' HA ' ' HE1' ' A' ' 124' ' ' MET . 7.9 m-20 -72.59 -13.63 61.43 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.692 170.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 38.6 t70 57.57 67.63 0.95 Allowed 'General case' 0 C--N 1.355 0.842 0 C-N-CA 125.556 1.542 . . . . 0.0 111.367 176.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -124.92 139.2 54.05 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.484 -1.235 . . . . 0.0 107.843 175.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 86.7 m -79.54 102.44 8.84 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.528 HG12 ' HB ' ' A' ' 128' ' ' ILE . 34.0 m -107.57 147.58 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 121.505 0.669 . . . . 0.0 110.983 -173.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -135.79 139.93 43.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 113.957 -1.474 . . . . 0.0 107.779 175.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.412 HG22 HD12 ' A' ' 130' ' ' LEU . 16.5 t -89.42 155.96 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.548 ' HA ' ' HE2' ' A' ' 129' ' ' MET . 28.8 t -56.1 151.75 11.68 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.186 0.595 . . . . 0.0 112.172 -178.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.78 -44.73 82.15 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 124.04 0.838 . . . . 0.0 109.861 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 63.7 p -65.83 -49.3 68.69 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 113.93 -1.486 . . . . 0.0 110.516 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 54.9 mt -62.56 -35.06 78.28 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.321 0.649 . . . . 0.0 110.868 -177.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.537 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 42.0 mt-30 -62.39 -34.06 75.98 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.775 0.83 . . . . 0.0 111.775 -176.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.16 -30.54 10.14 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -76.48 -33.42 58.67 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.218 0.607 . . . . 0.0 111.562 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.418 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -121.13 -58.18 1.81 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.174 0.59 . . . . 0.0 110.643 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.537 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 27.7 t-105 -77.06 -6.74 53.91 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 125.026 1.33 . . . . 0.0 111.225 -166.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -143.9 41.44 1.12 Allowed Glycine 0 C--N 1.347 1.17 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 177.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 33.4 t -128.51 -27.69 2.6 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.693 0.797 . . . . 0.0 111.995 -172.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 27.9 p -146.94 -55.23 0.24 Allowed 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -174.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 62.08 20.78 11.9 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 124.961 1.305 . . . . 0.0 112.775 169.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -123.02 -176.5 3.43 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 123.407 0.683 . . . . 0.0 110.978 -175.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -60.39 -30.82 69.83 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.906 0.882 . . . . 0.0 111.645 174.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 113.67 20.48 6.11 Favored Glycine 0 CA--C 1.502 -0.748 0 CA-C-O 119.416 -0.658 . . . . 0.0 113.72 173.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 64.93 107.55 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.647 1.179 . . . . 0.0 111.514 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -62.39 111.66 1.36 Allowed 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.105 1.87 . . . . 0.0 108.929 169.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -57.25 98.37 0.08 OUTLIER 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 123.073 2.515 . . . . 0.0 112.72 -171.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 84.4 mt -73.56 88.33 1.65 Allowed 'General case' 0 C--O 1.24 0.585 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 65.6 p -89.49 125.75 35.31 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.603 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.8 pp -73.24 -172.87 1.2 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.24 0.616 . . . . 0.0 111.487 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 . . . . . 0 CA--C 1.554 1.096 0 C-N-CA 123.361 0.665 . . . . 0.0 109.569 -178.973 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.44 148.3 23.4 Favored 'Trans proline' 0 C--N 1.365 1.434 0 C-N-CA 122.215 1.944 . . . . 0.0 110.663 165.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.24 116.05 17.54 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 27.2 p -56.85 109.02 0.57 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.464 0.706 . . . . 0.0 111.222 -177.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -101.1 138.62 37.9 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.519 0.728 . . . . 0.0 109.635 -171.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -100.82 100.98 11.71 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.536 0.734 . . . . 0.0 109.658 -175.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 50.8 mm -78.41 120.5 29.45 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.088 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 174.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 62.2 p -114.49 97.38 6.27 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -88.84 -25.56 22.12 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.513 0.325 . . . . 0.0 110.301 -178.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.507 ' HB3' ' HG3' ' A' ' 97' ' ' GLU . 2.7 mpp? -101.44 144.24 30.47 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.897 0.879 . . . . 0.0 108.945 172.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.3 m -72.94 161.05 31.17 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.328 0.651 . . . . 0.0 109.533 171.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.0 mp -55.69 -39.26 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.612 0.765 . . . . 0.0 111.373 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -65.37 -52.37 54.09 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.446 0.699 . . . . 0.0 111.699 -175.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.507 ' HG3' ' HB3' ' A' ' 93' ' ' MET . 11.3 pt-20 -70.25 -26.73 63.97 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 122.903 0.481 . . . . 0.0 111.532 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.1 tt -66.56 -44.29 82.73 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.732 0.813 . . . . 0.0 109.787 174.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 39.1 t -99.66 20.63 13.68 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.95 0.9 . . . . 0.0 110.734 -177.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.435 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 20.4 tpt180 -80.09 136.46 36.55 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.532 0.733 . . . . 0.0 111.657 -176.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -84.94 136.15 33.74 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 170.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 16.6 p-90 -144.14 137.74 27.68 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.229 1.012 . . . . 0.0 109.52 -175.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -94.73 138.19 32.86 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.505 ' HE1' ' HA ' ' A' ' 107' ' ' PRO . 18.1 ptm -123.97 124.11 41.86 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 173.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.431 ' H ' HD22 ' A' ' 105' ' ' LEU . 1.6 pt? -82.55 -25.21 33.55 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.114 0.566 . . . . 0.0 111.571 -171.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 23.4 mmt -123.23 80.87 52.3 Favored Pre-proline 0 N--CA 1.475 0.816 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 175.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.505 ' HA ' ' HE1' ' A' ' 104' ' ' MET . 3.8 Cg_exo -76.04 110.66 3.12 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.493 2.129 . . . . 0.0 112.12 -177.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -95.96 112.28 24.05 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 165.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.499 ' NE2' ' SG ' ' A' ' 116' ' ' CYS . 0.0 OUTLIER -91.95 98.82 11.81 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 179.068 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.52 ' HG2' HG13 ' A' ' 180' ' ' VAL . 51.2 tptt -107.65 147.2 31.0 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.243 1.017 . . . . 0.0 108.906 177.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 51.5 t -130.68 129.18 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 172.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -135.88 104.83 5.87 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.43 -148.62 42.49 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 119.507 -0.607 . . . . 0.0 111.958 -175.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -73.89 13.11 0.84 Allowed 'Trans proline' 0 CA--C 1.555 1.552 0 C-N-CA 123.37 2.713 . . . . 0.0 114.097 173.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.2 mp -125.35 152.28 44.96 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.754 0.822 . . . . 0.0 108.802 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.499 ' SG ' ' NE2' ' A' ' 109' ' ' GLN . 23.5 t -109.07 140.45 42.6 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.328 0.651 . . . . 0.0 110.029 175.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.7 mm -111.34 147.57 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.625 0.77 . . . . 0.0 109.518 178.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -124.86 119.98 30.38 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.405 HD13 ' HA ' ' A' ' 181' ' ' LEU . 27.6 mm -116.05 123.9 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 175.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -90.96 116.68 28.95 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 168.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -75.18 -16.63 60.49 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.552 0.741 . . . . 0.0 112.484 -173.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.44 -35.58 19.6 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.428 0.691 . . . . 0.0 112.128 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.85 109.95 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-O 121.994 0.902 . . . . 0.0 109.304 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.435 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 51.2 mtt -135.17 156.22 49.37 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 113.908 -1.496 . . . . 0.0 109.602 -177.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.3 t70 61.61 24.08 14.26 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 124.713 1.205 . . . . 0.0 112.228 174.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 54.3 mmtt -104.55 146.13 29.33 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 121.657 -0.652 . . . . 0.0 111.466 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.548 ' HA ' ' HB ' ' A' ' 191' ' ' THR . 0.8 OUTLIER -83.96 102.41 12.42 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 174.586 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.485 HD12 HD21 ' A' ' 185' ' ' LEU . 59.4 mt -114.95 141.07 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 123.681 0.793 . . . . 0.0 110.496 -172.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 14.0 tpt -117.59 131.42 56.68 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.304 1.042 . . . . 0.0 109.326 -174.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 2.9 mm? -91.4 104.4 16.92 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -118.45 136.1 53.98 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.365 1.066 . . . . 0.0 109.613 -171.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.448 ' HB1' ' HG ' ' A' ' 147' ' ' LEU . . . -142.22 152.52 43.16 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 -177.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -110.79 131.11 55.32 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 114.138 -1.392 . . . . 0.0 107.267 167.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.473 ' HA ' HG13 ' A' ' 145' ' ' ILE . 44.1 p90 -161.93 164.69 28.34 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.13 0.572 . . . . 0.0 111.4 -171.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.6 p -92.91 161.27 14.54 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.852 0.861 . . . . 0.0 109.667 173.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 87' ' ' SER . 54.8 t -128.27 133.36 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 124.288 1.035 . . . . 0.0 109.854 -176.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 8.7 tp -143.83 144.98 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 60.34 32.77 20.78 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.003 0.921 . . . . 0.0 112.447 174.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.7 t70 76.41 -0.07 3.13 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 124.555 1.142 . . . . 0.0 111.982 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -126.73 179.94 5.11 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.377 1.071 . . . . 0.0 110.136 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.521 ' HB3' HG13 ' A' ' 171' ' ' ILE . 9.9 tt -70.09 136.3 50.09 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.853 0.461 . . . . 0.0 109.877 177.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -91.48 -66.72 0.9 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.736 0.814 . . . . 0.0 110.517 174.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 75.9 m -145.96 130.0 17.41 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.513 0.725 . . . . 0.0 109.713 -174.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.445 HD22 ' HB2' ' A' ' 147' ' ' LEU . 40.6 tp -72.34 129.83 39.3 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 173.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.473 HG13 ' HA ' ' A' ' 134' ' ' PHE . 66.1 mt -87.14 -51.1 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 174.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 59.0 tp -163.77 147.42 10.11 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.225 1.01 . . . . 0.0 109.227 175.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.651 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 7.0 tt -131.8 148.15 52.54 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 173.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.498 HH11 HG21 ' A' ' 156' ' ' ILE . 55.2 mtt-85 -142.92 148.23 36.58 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.18 0.992 . . . . 0.0 109.857 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.438 ' HB2' HD22 ' A' ' 181' ' ' LEU . . . -105.63 112.39 25.45 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.354 1.062 . . . . 0.0 108.499 175.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -106.2 130.16 54.12 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.403 0.681 . . . . 0.0 110.347 -177.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 28.3 p -71.29 174.01 7.03 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.069 0.548 . . . . 0.0 110.991 170.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.42 -18.26 64.4 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.433 0.693 . . . . 0.0 111.349 171.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -64.08 -29.7 70.82 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.952 0.901 . . . . 0.0 110.76 168.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 91.91 20.6 36.1 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.747 -173.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -103.31 134.48 46.62 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.815 0.846 . . . . 0.0 110.668 -175.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.498 HG21 HH11 ' A' ' 148' ' ' ARG . 16.2 mt -73.87 116.03 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.43 -1.06 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.685 0.794 . . . . 0.0 110.787 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -157.13 161.86 31.42 Favored Glycine 0 C--N 1.334 0.417 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -162.0 150.46 15.11 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 117.482 0.641 . . . . 0.0 109.968 -172.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.651 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 67.5 mt -129.34 103.71 9.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 167.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.5 t -107.34 106.45 58.4 Favored Pre-proline 0 C--O 1.243 0.757 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.45 117.59 4.31 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.997 2.465 . . . . 0.0 112.258 175.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.7 mt -72.68 123.42 89.53 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 123.738 0.815 . . . . 0.0 111.985 -173.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.9 -7.46 20.79 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.999 2.466 . . . . 0.0 112.342 173.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 16.5 m -60.48 -25.25 65.92 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.321 1.048 . . . . 0.0 111.759 173.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -118.79 129.31 25.46 Favored Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -176.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -44.19 -52.66 5.47 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 124.419 3.413 . . . . 0.0 114.533 -170.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -162.3 -174.45 32.21 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.181 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -147.19 163.07 37.51 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-O 121.377 0.608 . . . . 0.0 110.754 176.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 27.9 m -99.58 164.46 12.06 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.279 1.031 . . . . 0.0 109.385 174.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.521 HG13 ' HB3' ' A' ' 141' ' ' LEU . 7.7 tt -49.83 -36.41 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 124.613 1.165 . . . . 0.0 112.051 174.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -60.59 -39.63 88.81 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.348 1.059 . . . . 0.0 111.308 -177.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -66.31 -36.6 83.36 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.461 0.705 . . . . 0.0 110.969 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.505 ' O ' HG13 ' A' ' 178' ' ' ILE . 46.3 t -65.19 -39.68 86.27 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.687 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.245 175.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.435 ' HE2' ' O ' ' A' ' 202' ' ' ALA . 88.1 mttt -58.79 -45.54 89.63 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.117 0.567 . . . . 0.0 110.775 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.475 ' O ' HG22 ' A' ' 180' ' ' VAL . 53.6 m-80 -64.15 -43.29 95.66 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.182 177.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.2 -50.27 74.11 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.209 0.943 . . . . 0.0 111.568 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 174' ' ' VAL . 39.9 mt -62.84 -40.27 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -58.69 -32.99 70.66 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 115.474 -0.785 . . . . 0.0 113.88 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.52 HG13 ' HG2' ' A' ' 110' ' ' LYS . 41.0 t -73.09 -46.38 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 117.041 0.421 . . . . 0.0 110.039 177.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.471 HD21 HG13 ' A' ' 160' ' ' ILE . 21.7 tp -61.77 -46.37 89.87 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 123.79 0.682 . . . . 0.0 110.825 -177.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 75.4 mt -61.41 -50.39 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.547 0.739 . . . . 0.0 110.078 175.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 187' ' ' ARG . . . -53.99 -47.85 64.87 Favored Glycine 0 C--N 1.346 1.13 0 O-C-N 124.201 0.938 . . . . 0.0 113.629 -177.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.19 -40.86 99.16 Favored Glycine 0 C--N 1.344 0.974 0 C-N-CA 123.164 0.411 . . . . 0.0 112.23 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.485 HD21 HD12 ' A' ' 128' ' ' ILE . 96.7 mt -63.7 -39.58 94.66 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.421 0.688 . . . . 0.0 111.084 176.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -67.75 -35.29 78.46 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.487 0.715 . . . . 0.0 110.984 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' ' 183' ' ' GLY . 12.6 mmp_? -75.04 -27.48 60.05 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.81 0.444 . . . . 0.0 110.63 177.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.435 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 6.1 m-20 -81.02 -7.12 59.49 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.304 0.641 . . . . 0.0 110.898 170.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 38.7 t70 63.33 67.18 0.67 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.051 1.341 . . . . 0.0 111.328 -176.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -119.0 145.95 45.42 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.847 0.859 . . . . 0.0 109.074 175.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.548 ' HB ' ' HA ' ' A' ' 127' ' ' ASN . 28.2 m -76.99 107.51 9.39 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -178.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 18.0 m -101.85 134.85 41.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 121.265 0.555 . . . . 0.0 110.865 -172.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -143.9 133.87 24.06 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.321 1.048 . . . . 0.0 108.273 169.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.501 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 5.2 t -90.87 151.51 3.49 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 48.0 t -59.06 139.14 57.16 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 175.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -62.44 -25.29 67.89 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.985 0.514 . . . . 0.0 111.19 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 67.0 p -76.33 -44.59 36.02 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.213 0.605 . . . . 0.0 109.378 175.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.401 HD22 ' HB3' ' A' ' 132' ' ' ALA . 28.4 mt -58.65 -33.37 70.01 Favored 'General case' 0 C--O 1.2 -1.524 0 C-N-CA 122.713 0.405 . . . . 0.0 111.493 172.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.492 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 50.6 mt-30 -76.92 -41.2 44.44 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.999 0.52 . . . . 0.0 110.412 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 41.6 tpt85 -62.73 -43.23 99.35 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.282 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -100.72 -49.07 4.29 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.446 -169.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.435 ' O ' ' HE2' ' A' ' 175' ' ' LYS . . . -97.19 -57.4 2.27 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -167.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.492 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 49.4 t-105 -68.78 -13.03 62.14 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.621 1.168 . . . . 0.0 112.271 -164.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -57.11 115.28 6.33 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 169.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 21.2 m -55.71 138.8 46.8 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.608 1.163 . . . . 0.0 113.214 -169.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 18.9 m -64.85 -26.59 68.4 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.893 0.877 . . . . 0.0 112.044 -177.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -66.6 93.52 0.25 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.009 0.924 . . . . 0.0 110.36 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -140.01 90.25 2.37 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -80.95 77.69 7.82 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.56 0.744 . . . . 0.0 110.789 -172.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 50.0 47.55 40.22 Favored Glycine 0 C--N 1.349 1.294 0 O-C-N 123.965 0.791 . . . . 0.0 113.398 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -69.28 115.77 35.65 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 122.613 0.365 . . . . 0.0 110.692 -172.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -75.74 160.88 37.29 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.605 2.203 . . . . 0.0 111.459 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.16 129.02 25.64 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.049 1.833 . . . . 0.0 110.581 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 94.9 mt -68.59 90.15 0.38 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.293 0.568 . . . . 0.0 110.399 -176.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 33.3 p -80.68 151.03 29.15 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-N 114.799 -1.092 . . . . 0.0 110.735 -176.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.2 pp -140.39 163.13 33.63 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.792 0.837 . . . . 0.0 109.485 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 . . . . . 0 CA--C 1.555 1.144 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -177.72 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 23.0 mmt . . . . . 0 N--CA 1.48 1.045 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.43 -33.29 97.78 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.579 2.186 . . . . 0.0 113.314 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -164.83 86.19 0.43 Allowed 'General case' 0 C--N 1.353 0.745 0 C-N-CA 123.255 0.622 . . . . 0.0 110.528 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 22.5 p -94.41 115.21 27.37 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.982 0.513 . . . . 0.0 110.095 177.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -104.82 139.42 39.61 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 176.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -104.71 101.71 11.32 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 177.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 133' ' ' ASN . 38.5 mm -75.93 129.59 36.93 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 68.6 p -122.14 80.7 1.74 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.844 0.858 . . . . 0.0 108.783 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.454 ' HB2' ' HB3' ' A' ' 131' ' ' LYS . 37.8 m-20 -69.84 -31.25 69.0 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 121.855 0.836 . . . . 0.0 109.55 172.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.581 ' HG3' ' HG3' ' A' ' 97' ' ' GLU . 25.1 ttp -102.69 121.81 43.17 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.142 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.4 m -72.97 155.65 39.63 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.832 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.8 mp -53.59 -34.3 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 C-N-CA 123.958 0.903 . . . . 0.0 111.084 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -50.9 -68.39 0.17 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.878 1.271 . . . . 0.0 112.108 173.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.581 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 9.9 pt-20 -71.13 -22.64 62.05 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.329 1.052 . . . . 0.0 112.063 -178.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.543 ' HG ' HD22 ' A' ' 146' ' ' LEU . 9.8 tt -66.72 -45.37 78.92 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.221 1.008 . . . . 0.0 110.347 174.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.9 t -98.94 1.63 45.76 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.39 0.676 . . . . 0.0 111.323 -175.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -61.01 140.88 57.72 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.554 0.742 . . . . 0.0 111.121 175.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -86.24 142.27 28.69 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.125 0.57 . . . . 0.0 109.751 171.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 28.7 p-90 -152.85 156.83 39.75 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.34 -170.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -111.26 155.24 23.3 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.265 1.026 . . . . 0.0 110.579 -175.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.517 ' HE3' ' HA ' ' A' ' 107' ' ' PRO . 93.8 mtp -128.43 109.23 11.22 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.113 0.965 . . . . 0.0 108.464 166.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.4 tp -67.92 -49.5 61.51 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.637 0.775 . . . . 0.0 110.261 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.46 ' HG2' ' HB2' ' A' ' 122' ' ' ALA . 97.7 mmm -119.95 82.19 28.19 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 124.151 0.98 . . . . 0.0 109.54 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.517 ' HA ' ' HE3' ' A' ' 104' ' ' MET . 69.1 Cg_endo -71.9 125.72 11.26 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.506 2.138 . . . . 0.0 112.675 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -95.76 110.18 22.37 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 166.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 20.4 tm0? -80.43 106.08 12.17 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 176.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.454 ' HG2' HG11 ' A' ' 180' ' ' VAL . 22.7 tptm -130.01 143.99 51.09 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.817 0.847 . . . . 0.0 108.745 170.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.446 HG11 HD11 ' A' ' 163' ' ' LEU . 63.1 t -131.72 122.16 49.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 168.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -109.18 97.56 7.15 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.29 -126.14 8.07 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 119.083 -0.843 . . . . 0.0 111.724 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.589 ' HG2' ' HB3' ' A' ' 169' ' ' HIS . 42.3 Cg_endo -98.26 31.88 0.13 Allowed 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 123.408 2.739 . . . . 0.0 111.74 172.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 162' ' ' PRO . 90.4 mt -131.17 123.97 29.67 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.177 0.991 . . . . 0.0 109.448 -178.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 16.6 p -83.78 122.69 29.01 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.445 0.698 . . . . 0.0 109.92 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.4 mm -103.11 106.65 20.48 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 C-N-CA 123.69 0.796 . . . . 0.0 109.3 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.606 ' HD2' ' HB3' ' A' ' 159' ' ' GLU . 77.2 mtt85 -95.93 119.92 35.29 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.76 0.824 . . . . 0.0 108.834 176.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.5 HD12 ' HA3' ' A' ' 184' ' ' GLY . 82.3 mt -129.76 123.79 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 124.401 1.08 . . . . 0.0 108.307 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -92.65 128.37 38.48 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.322 0.582 . . . . 0.0 110.029 177.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.484 ' HA ' ' ND2' ' A' ' 188' ' ' ASN . 75.1 mt-30 -91.13 -11.45 38.49 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.233 -174.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.46 ' HB2' ' HG2' ' A' ' 106' ' ' MET . . . -79.41 -49.43 12.35 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 120.997 0.427 . . . . 0.0 110.589 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.543 HG12 HG12 ' A' ' 157' ' ' VAL . 1.7 mp -71.34 109.73 3.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.288 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 50.3 mtt -131.61 159.2 38.97 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 113.693 -1.594 . . . . 0.0 109.554 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.4 t70 67.97 18.36 9.53 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 125.288 1.435 . . . . 0.0 112.295 174.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -103.61 151.99 22.28 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.585 0.754 . . . . 0.0 111.162 -176.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -84.31 102.2 12.51 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 168.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.5 HD13 HD22 ' A' ' 185' ' ' LEU . 44.3 mt -103.28 124.12 57.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -176.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.5 ' HG3' ' HG3' ' A' ' 131' ' ' LYS . 14.0 tpt -98.61 126.65 44.27 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.435 1.094 . . . . 0.0 109.069 -175.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.432 HD13 HG21 ' A' ' 194' ' ' VAL . 12.4 mt -105.79 103.43 12.93 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -174.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.5 ' HG3' ' HG3' ' A' ' 129' ' ' MET . 45.1 mtmt -126.5 150.95 48.44 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.037 0.535 . . . . 0.0 109.981 -176.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -136.91 153.68 50.67 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.907 0.86 . . . . 0.0 112.304 -174.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 4.6 m-20 -107.5 120.77 43.11 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 162.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -156.4 160.18 39.4 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.264 0.626 . . . . 0.0 111.02 -170.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 53.5 p -86.28 151.22 23.78 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.749 0.819 . . . . 0.0 109.226 174.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 87' ' ' SER . 60.0 t -130.55 132.75 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.381 1.073 . . . . 0.0 108.477 -177.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.3 tp -140.78 140.68 33.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 174.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 58.19 31.04 20.29 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.933 0.893 . . . . 0.0 111.946 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 63.31 30.88 15.59 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 124.97 1.308 . . . . 0.0 112.338 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 7.8 ppt_? -143.65 165.68 26.95 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.226 0.61 . . . . 0.0 109.687 173.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.462 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 10.5 tt -66.48 121.56 15.59 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.313 0.645 . . . . 0.0 109.742 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -82.31 -67.14 0.81 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.257 0.623 . . . . 0.0 110.281 173.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 62.2 m -141.96 127.4 18.87 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.885 0.474 . . . . 0.0 109.843 -173.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.639 HD12 ' HB2' ' A' ' 147' ' ' LEU . 51.9 tp -77.37 114.56 16.33 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.716 0.807 . . . . 0.0 109.545 178.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 57.1 mt -77.82 -52.65 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 175.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.543 HD22 ' HG ' ' A' ' 98' ' ' LEU . 50.2 tp -158.82 145.12 16.92 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.452 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.639 ' HB2' HD12 ' A' ' 144' ' ' LEU . 8.2 tt -139.26 152.25 47.13 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 176.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.715 HH11 HG22 ' A' ' 156' ' ' ILE . 6.8 ptp180 -150.73 157.44 42.96 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 122.046 0.927 . . . . 0.0 112.503 174.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.658 ' HB2' HD22 ' A' ' 181' ' ' LEU . . . -117.55 117.78 30.36 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 113.346 -1.752 . . . . 0.0 107.317 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -145.64 145.1 30.8 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.049 0.452 . . . . 0.0 111.709 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 80.5 p -65.13 163.28 15.29 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.457 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -64.82 -19.6 65.94 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -84.59 -1.46 55.98 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.164 0.586 . . . . 0.0 111.4 176.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 97.45 -5.25 62.5 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-O 119.931 -0.372 . . . . 0.0 114.005 172.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.99 105.97 6.26 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.991 0.395 . . . . 0.0 110.085 -175.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.715 HG22 HH11 ' A' ' 148' ' ' ARG . 13.8 mt -79.51 126.65 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.543 HG12 HG12 ' A' ' 123' ' ' ILE . 24.2 m -134.63 5.41 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 123.902 0.881 . . . . 0.0 110.964 -174.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -153.27 156.06 26.52 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.606 ' HB3' ' HD2' ' A' ' 118' ' ' ARG . 40.5 tt0 -164.83 141.64 6.01 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.802 0.441 . . . . 0.0 110.368 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.5 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 72.2 mt -120.62 121.64 65.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 172.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 15.5 m -137.52 148.13 60.32 Favored Pre-proline 0 N--CA 1.469 0.509 0 C-N-CA 123.272 0.629 . . . . 0.0 109.898 -177.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.449 ' HA ' HD23 ' A' ' 115' ' ' LEU . 18.1 Cg_endo -61.01 134.46 53.19 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 121.864 1.709 . . . . 0.0 110.302 165.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 166' ' ' PHE . 66.2 mt -62.22 145.37 93.87 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.266 0.626 . . . . 0.0 110.886 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -59.01 127.22 23.49 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.53 2.154 . . . . 0.0 110.879 172.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 30.1 m 73.92 10.15 4.65 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.649 1.579 . . . . 0.0 112.519 -175.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.571 ' HB2' ' HB2' ' A' ' 163' ' ' LEU . 90.9 m-85 -132.51 73.41 76.83 Favored Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 123.702 0.801 . . . . 0.0 110.255 175.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -97.68 43.7 0.1 OUTLIER 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 123.612 2.875 . . . . 0.0 111.22 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -129.48 69.22 0.53 Allowed Glycine 0 C--N 1.345 1.04 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.792 -174.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.589 ' HB3' ' HG2' ' A' ' 114' ' ' PRO . 25.4 p-80 -122.66 150.08 43.17 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.474 0.71 . . . . 0.0 110.663 172.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 65.2 p -98.43 -178.62 4.08 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.471 169.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.462 ' HB ' ' O ' ' A' ' 141' ' ' LEU . 5.8 tt -54.6 -41.85 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.152 171.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.546 ' HA ' ' HD3' ' A' ' 175' ' ' LYS . 14.7 mm-40 -56.91 -41.35 77.99 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.366 1.066 . . . . 0.0 111.613 -176.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -64.05 -40.17 95.7 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.372 0.669 . . . . 0.0 111.018 178.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 46.2 t -68.1 -32.65 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.175 0.59 . . . . 0.0 110.604 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.546 ' HD3' ' HA ' ' A' ' 172' ' ' GLU . 27.3 mtpp -62.08 -42.92 99.7 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.564 0.745 . . . . 0.0 110.684 176.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.485 ' O ' HG22 ' A' ' 180' ' ' VAL . 60.7 m-80 -68.58 -41.27 79.9 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.143 175.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.99 -53.28 60.01 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 124.416 1.073 . . . . 0.0 112.008 -175.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 49.9 mt -63.19 -35.43 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 O-C-N 123.604 0.565 . . . . 0.0 109.756 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.19 -32.09 81.15 Favored Glycine 0 C--N 1.347 1.155 0 CA-C-N 116.159 -0.473 . . . . 0.0 114.082 177.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 176' ' ' ASN . 98.0 t -73.0 -44.66 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.658 HD22 ' HB2' ' A' ' 149' ' ' ALA . 48.9 tp -54.44 -49.76 69.27 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.261 1.025 . . . . 0.0 110.674 176.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.457 HD11 ' CH2' ' A' ' 203' ' ' TRP . 17.8 mt -63.88 -45.66 96.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.929 0.891 . . . . 0.0 110.979 176.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -55.1 -36.87 62.15 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 123.893 0.746 . . . . 0.0 113.811 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.5 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -70.07 -48.75 38.0 Favored Glycine 0 C--N 1.347 1.142 0 N-CA-C 111.793 -0.523 . . . . 0.0 111.793 174.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.5 HD22 HD13 ' A' ' 128' ' ' ILE . 97.7 mt -64.19 -31.97 73.37 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.985 0.914 . . . . 0.0 112.419 -176.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -66.24 -41.99 89.23 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.419 0.688 . . . . 0.0 111.121 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -74.84 -34.65 62.34 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.216 0.607 . . . . 0.0 110.417 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.484 ' ND2' ' HA ' ' A' ' 121' ' ' GLN . 6.0 m-20 -67.28 -15.14 63.52 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.344 0.657 . . . . 0.0 110.297 169.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 21.9 t70 64.49 65.99 0.62 Allowed 'General case' 0 C--N 1.349 0.577 0 C-N-CA 125.799 1.64 . . . . 0.0 110.223 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -121.95 139.69 53.36 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 175.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 74.0 m -78.46 104.81 9.3 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 23.9 m -80.77 130.23 36.24 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.591 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.4 ' HG2' ' SD ' ' A' ' 129' ' ' MET . 38.5 ttp180 -133.36 123.07 24.74 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 173.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.432 HG21 HD13 ' A' ' 130' ' ' LEU . 4.3 t -101.82 150.05 6.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 -175.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 34.0 t -58.68 143.48 46.54 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.867 0.467 . . . . 0.0 111.146 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -57.01 -32.96 66.67 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.939 0.896 . . . . 0.0 111.25 -178.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 67.8 p -72.02 -48.49 44.24 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.582 175.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 58.3 mt -62.67 -36.45 82.92 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.107 0.563 . . . . 0.0 110.389 -177.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.531 ' HB3' ' HB3' ' A' ' 206' ' ' SER . 42.2 mt-30 -55.51 -33.79 64.05 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.596 1.159 . . . . 0.0 112.426 -177.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -101.25 -39.53 7.58 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -73.97 -38.03 64.3 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -168.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.428 ' O ' ' HG2' ' A' ' 175' ' ' LYS . . . -120.64 -57.7 1.88 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.896 0.478 . . . . 0.0 110.074 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.472 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 69.5 t-105 -58.36 -21.54 50.26 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 125.272 1.429 . . . . 0.0 114.057 -168.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 132.59 -127.38 4.81 Favored Glycine 0 N--CA 1.471 1.014 0 CA-C-O 119.75 -0.472 . . . . 0.0 112.184 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 31.2 t -109.59 112.59 24.77 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 123.554 0.742 . . . . 0.0 109.395 -177.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.531 ' HB3' ' HB3' ' A' ' 199' ' ' GLN . 32.1 t -155.28 101.67 2.23 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -76.17 87.15 3.02 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.514 0.725 . . . . 0.0 109.162 178.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.85 160.83 31.89 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.503 178.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -142.88 88.7 2.07 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.169 0.588 . . . . 0.0 110.102 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -69.87 115.9 6.49 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 171.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -60.83 148.74 82.35 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 123.387 0.675 . . . . 0.0 111.391 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -53.13 134.5 56.45 Favored 'Trans proline' 0 C--N 1.383 2.358 0 C-N-CA 123.109 2.54 . . . . 0.0 112.162 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -64.85 85.19 0.17 Allowed 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.916 2.411 . . . . 0.0 112.07 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 72.6 mt -139.41 149.44 44.08 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.139 1.375 . . . . 0.0 108.096 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.435 HG22 ' HG ' ' A' ' 216' ' ' LEU . 33.0 m -133.94 -78.97 0.47 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.435 ' HG ' HG22 ' A' ' 215' ' ' THR . 71.3 mt -140.95 163.66 32.36 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.522 1.129 . . . . 0.0 109.067 -176.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 . . . . . 0 CA--C 1.555 1.166 0 CA-C-O 118.5 -0.762 . . . . 0.0 109.195 176.145 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 N--CA 1.482 1.145 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.531 ' HB2' HD11 ' A' ' 137' ' ' ILE . 45.5 Cg_endo -64.71 115.54 3.29 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.607 2.204 . . . . 0.0 112.376 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -89.15 141.4 28.55 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.566 0.746 . . . . 0.0 110.597 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 50.4 m -99.63 128.29 45.74 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.396 0.678 . . . . 0.0 110.276 178.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 29.8 ttp-105 -115.59 140.87 48.78 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.617 0.767 . . . . 0.0 109.956 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -99.65 109.52 22.0 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.834 0.853 . . . . 0.0 109.945 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.7 mm -78.85 121.68 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 123.783 0.833 . . . . 0.0 109.352 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.1 p -108.38 66.19 0.64 Allowed 'General case' 0 C--O 1.244 0.781 0 CA-C-O 122.672 1.225 . . . . 0.0 108.112 173.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.536 ' HB3' ' O ' ' A' ' 132' ' ' ALA . 19.1 t70 -68.95 -35.54 76.88 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 112.91 -1.95 . . . . 0.0 110.963 -177.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.569 ' HB3' ' HB3' ' A' ' 131' ' ' LYS . 26.2 ptt? -110.93 146.24 36.92 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 171.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.1 m -91.85 158.02 16.55 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.308 0.643 . . . . 0.0 111.069 -167.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.2 mp -58.53 -34.97 52.54 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 C-N-CA 124.122 0.969 . . . . 0.0 110.385 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -48.91 -43.02 38.94 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.358 1.063 . . . . 0.0 113.094 176.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.52 -24.45 15.56 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 122.847 0.459 . . . . 0.0 111.102 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.441 ' HA ' HH21 ' A' ' 148' ' ' ARG . 9.0 tt -67.46 -45.81 74.89 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.616 0.766 . . . . 0.0 110.128 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 26.4 t -96.32 10.93 36.46 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.561 1.144 . . . . 0.0 110.316 -175.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -74.23 136.02 42.72 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.049 0.54 . . . . 0.0 110.517 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -77.42 133.56 38.62 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 174.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 17.9 p-90 -150.76 171.35 17.33 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.661 0.784 . . . . 0.0 110.406 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -148.2 165.33 31.24 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.728 1.211 . . . . 0.0 108.665 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 62.3 mtp -110.37 127.77 55.24 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 36.2 tp -73.39 -40.84 64.01 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.411 0.684 . . . . 0.0 109.642 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.497 ' HG2' ' HB3' ' A' ' 122' ' ' ALA . 23.8 mmt -124.77 88.96 53.11 Favored Pre-proline 0 N--CA 1.482 1.134 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 169.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.18 112.38 2.74 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 122.995 2.464 . . . . 0.0 112.236 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.434 ' HB2' ' NE2' ' A' ' 121' ' ' GLN . 58.7 tptt -115.61 118.39 32.99 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 169.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -100.96 115.37 30.29 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.47 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 16.7 tppt? -120.9 159.84 24.7 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.429 1.092 . . . . 0.0 108.377 175.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.5 t -137.68 140.8 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -122.84 84.7 2.3 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 171.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.5 -116.71 7.2 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.883 175.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -85.25 8.84 4.39 Favored 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 123.227 2.618 . . . . 0.0 112.739 -177.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.8 mt -131.87 121.95 24.89 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.977 0.911 . . . . 0.0 109.021 -171.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.574 ' SG ' HD22 ' A' ' 163' ' ' LEU . 90.0 m -90.51 120.61 31.75 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.964 0.506 . . . . 0.0 111.252 -178.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.47 ' HB ' ' HB3' ' A' ' 110' ' ' LYS . 17.2 mm -86.64 155.3 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.358 0 C-N-CA 124.298 1.039 . . . . 0.0 110.034 -176.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -134.66 121.27 20.61 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.42 HD11 ' HA3' ' A' ' 184' ' ' GLY . 50.5 mm -123.7 122.85 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 123.416 0.686 . . . . 0.0 109.686 -177.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -98.64 115.45 28.7 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 172.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.434 ' NE2' ' HB2' ' A' ' 108' ' ' LYS . 44.4 mt-30 -84.08 -6.91 59.49 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.02 0.928 . . . . 0.0 113.327 -174.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.497 ' HB3' ' HG2' ' A' ' 106' ' ' MET . . . -87.7 -45.45 10.35 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.963 0.505 . . . . 0.0 110.301 177.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.448 HG12 HG11 ' A' ' 157' ' ' VAL . 1.8 mp -70.67 110.7 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-O 122.038 0.923 . . . . 0.0 110.006 -177.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.572 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 51.3 mtt -131.72 158.43 41.19 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.224 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.5 t70 67.82 13.47 9.2 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.757 1.223 . . . . 0.0 112.739 174.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -97.55 146.82 24.9 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.43 -0.793 . . . . 0.0 110.611 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.548 ' HB2' ' HB3' ' A' ' 152' ' ' GLU . 39.4 m-80 -82.73 97.74 8.72 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 174.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.45 HD12 HD22 ' A' ' 185' ' ' LEU . 53.4 mt -105.82 130.12 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.462 0.705 . . . . 0.0 110.111 -171.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 12.2 tpt -105.12 134.11 48.77 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.163 0.985 . . . . 0.0 110.026 -175.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 2.2 mm? -100.2 109.15 21.4 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.569 ' HB3' ' HB3' ' A' ' 93' ' ' MET . 40.9 mttm -127.56 152.0 48.18 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.049 0.939 . . . . 0.0 110.682 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.573 ' HB3' HD23 ' A' ' 198' ' ' LEU . . . -146.63 149.42 33.47 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -105.5 132.69 51.36 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 165.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.487 ' HA ' HG13 ' A' ' 145' ' ' ILE . 39.6 p90 -158.79 159.27 34.95 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.761 0.824 . . . . 0.0 109.979 -171.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.8 p -86.57 160.69 18.86 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.391 0.676 . . . . 0.0 109.695 173.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 87' ' ' SER . 77.7 t -128.0 135.79 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.36 1.064 . . . . 0.0 109.135 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.531 HD11 ' HB2' ' A' ' 85' ' ' PRO . 8.2 tp -142.08 139.46 30.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 170.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 57.25 33.8 23.84 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.776 0.83 . . . . 0.0 111.72 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 36.0 t70 67.35 8.82 6.54 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.892 1.277 . . . . 0.0 112.636 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 44.5 ptt85 -116.57 165.25 13.46 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.647 0.779 . . . . 0.0 110.033 176.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.418 ' HB3' HG13 ' A' ' 171' ' ' ILE . 8.5 tt -64.26 108.63 1.64 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.507 0.723 . . . . 0.0 109.204 175.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -68.18 -68.73 0.37 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.341 0.656 . . . . 0.0 110.334 177.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.6 m -143.68 130.56 20.44 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.418 -175.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.7 tp -73.16 124.88 26.46 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 175.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.487 HG13 ' HA ' ' A' ' 134' ' ' PHE . 70.1 mt -84.54 -49.86 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 176.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 48.2 tp -164.8 147.53 8.48 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.75 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.765 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 6.7 tt -134.06 153.52 51.75 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 176.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.486 ' N ' HD22 ' A' ' 147' ' ' LEU . 45.1 ttm-85 -143.23 147.25 34.54 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.546 0.738 . . . . 0.0 111.284 -173.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.593 ' HB1' HD23 ' A' ' 181' ' ' LEU . . . -120.69 111.3 17.44 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.791 1.237 . . . . 0.0 107.856 169.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 40.5 p90 -127.67 157.27 40.74 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.166 0.986 . . . . 0.0 108.756 -178.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.45 ' HG1' ' HB3' ' A' ' 155' ' ' ALA . 63.0 p -86.02 176.65 7.91 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.39 0.614 . . . . 0.0 111.122 -174.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.548 ' HB3' ' HB2' ' A' ' 127' ' ' ASN . 11.0 pt-20 -54.38 -35.78 63.19 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.912 1.285 . . . . 0.0 112.144 174.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -88.32 -9.22 53.52 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.115 0.966 . . . . 0.0 111.618 -177.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 100.63 -3.36 56.17 Favored Glycine 0 C--N 1.352 1.43 0 CA-C-O 120.016 -0.324 . . . . 0.0 113.471 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.45 ' HB3' ' HG1' ' A' ' 151' ' ' THR . . . -69.82 104.9 2.59 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.433 HD11 ' HD3' ' A' ' 148' ' ' ARG . 26.3 mt -69.87 124.28 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.178 0.591 . . . . 0.0 109.53 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.448 HG11 HG12 ' A' ' 123' ' ' ILE . 35.0 m -126.41 -3.68 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.737 0.815 . . . . 0.0 111.382 -174.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -155.31 164.96 32.19 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.651 -175.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -167.43 153.86 8.05 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.245 0.618 . . . . 0.0 109.528 -176.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.765 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 78.6 mt -125.75 102.99 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 165.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 84.0 p -99.0 110.42 57.66 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 123.61 0.764 . . . . 0.0 110.014 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.06 123.95 14.59 Favored 'Trans proline' 0 C--N 1.367 1.513 0 C-N-CA 122.921 2.414 . . . . 0.0 112.921 174.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.574 HD22 ' SG ' ' A' ' 116' ' ' CYS . 89.5 mt -62.13 129.18 91.88 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 123.789 0.836 . . . . 0.0 110.714 177.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 163' ' ' LEU . 15.3 Cg_exo -68.71 -21.1 39.37 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 123.267 2.645 . . . . 0.0 111.951 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 48.0 p -69.99 -18.09 63.31 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.804 0.842 . . . . 0.0 111.414 173.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -128.67 75.74 79.44 Favored Pre-proline 0 N--CA 1.479 0.98 0 C-N-CA 123.642 0.777 . . . . 0.0 110.109 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.25 -31.42 7.57 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.283 1.989 . . . . 0.0 112.087 175.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -92.79 68.73 1.74 Allowed Glycine 0 C--N 1.345 1.082 0 N-CA-C 111.781 -0.527 . . . . 0.0 111.781 -176.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -108.75 151.94 25.53 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.36 0.664 . . . . 0.0 110.097 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 44.5 p -84.57 160.58 20.43 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.493 0.663 . . . . 0.0 112.081 -174.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.418 HG13 ' HB3' ' A' ' 141' ' ' LEU . 11.4 tt -57.58 -32.1 41.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.648 170.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -72.85 -30.54 64.09 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.539 0.736 . . . . 0.0 111.353 -177.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -60.76 -39.72 89.82 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 122.843 0.457 . . . . 0.0 110.499 173.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 178' ' ' ILE . 38.5 t -64.88 -39.13 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 O-C-N 124.471 1.107 . . . . 0.0 110.2 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -59.26 -48.76 80.43 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.525 0.73 . . . . 0.0 111.459 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.447 ' O ' HG23 ' A' ' 180' ' ' VAL . 65.0 m-80 -65.71 -38.86 90.37 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.935 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.4 -43.4 97.65 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 124.137 0.898 . . . . 0.0 111.451 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 174' ' ' VAL . 60.5 mt -67.52 -34.1 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.9 -33.38 87.09 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 116.625 -0.262 . . . . 0.0 113.596 176.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 176' ' ' ASN . 97.8 t -78.71 -43.25 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.48 0.712 . . . . 0.0 110.353 177.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.593 HD23 ' HB1' ' A' ' 149' ' ' ALA . 38.6 tp -57.34 -54.79 42.81 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.819 0.848 . . . . 0.0 111.035 176.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.602 HG21 HG23 ' A' ' 192' ' ' VAL . 61.8 mt -58.06 -40.12 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 123.821 0.848 . . . . 0.0 110.225 170.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.4 -21.82 54.88 Favored Glycine 0 N--CA 1.475 1.28 0 N-CA-C 115.151 0.82 . . . . 0.0 115.151 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.42 ' HA3' HD11 ' A' ' 119' ' ' ILE . . . -95.74 -16.11 40.45 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 117.004 0.402 . . . . 0.0 112.751 173.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.45 HD22 HD12 ' A' ' 128' ' ' ILE . 81.9 mt -91.76 -32.66 15.31 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.408 1.083 . . . . 0.0 111.825 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.506 ' O ' ' HD3' ' A' ' 212' ' ' PRO . 0.4 OUTLIER -77.84 -31.8 51.76 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.136 0.574 . . . . 0.0 111.132 -173.439 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 8.7 ptm85 -70.23 -24.77 63.15 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.669 0.787 . . . . 0.0 110.942 173.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.572 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 4.2 m-20 -81.48 -10.88 59.39 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.79 0.836 . . . . 0.0 110.293 172.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 19.5 t70 57.63 65.79 1.26 Allowed 'General case' 0 C--N 1.358 0.975 0 C-N-CA 125.414 1.486 . . . . 0.0 110.2 -171.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -107.57 145.71 32.85 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.635 169.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.1 m -83.47 100.31 10.66 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.602 HG23 HG21 ' A' ' 182' ' ' ILE . 18.7 m -99.27 134.63 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 123.645 0.778 . . . . 0.0 110.571 -171.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -135.66 129.82 33.35 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.411 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 2.9 t -90.01 143.03 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 23.2 t -69.11 156.58 38.44 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -172.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -50.23 -49.5 52.73 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.312 1.045 . . . . 0.0 111.812 -176.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 38.1 p -61.18 -50.84 71.52 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 123.967 0.792 . . . . 0.0 110.19 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.573 HD23 ' HB3' ' A' ' 132' ' ' ALA . 62.9 mt -60.07 -36.47 77.43 Favored 'General case' 0 C--O 1.215 -0.735 0 O-C-N 123.882 0.739 . . . . 0.0 111.752 -176.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.506 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 48.3 mt-30 -66.0 -51.7 55.99 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.472 0.709 . . . . 0.0 110.776 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.26 -24.79 51.08 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -175.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.415 ' O ' HD13 ' A' ' 171' ' ' ILE . 25.3 m-85 -82.04 -57.37 3.43 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.819 0.448 . . . . 0.0 110.698 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -116.82 -57.77 2.14 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.24 0.616 . . . . 0.0 110.408 -166.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.506 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 51.4 t-105 -79.65 73.98 6.33 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.857 1.263 . . . . 0.0 111.103 -168.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -102.2 20.7 44.18 Favored Glycine 0 N--CA 1.469 0.853 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 172.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 37.0 p -146.69 93.85 2.35 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.276 1.03 . . . . 0.0 109.128 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 15.4 p -81.07 95.7 6.92 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.507 0.723 . . . . 0.0 109.21 174.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -118.17 6.97 12.03 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.307 0.643 . . . . 0.0 112.542 -168.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.423 ' HG3' ' HG2' ' A' ' 186' ' ' GLU . 8.7 tp10 -138.54 101.67 4.41 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.285 0.564 . . . . 0.0 111.807 -176.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -149.66 30.42 0.74 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 125.813 1.645 . . . . 0.0 108.661 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -63.29 -41.91 99.39 Favored Glycine 0 C--N 1.351 1.378 0 CA-C-N 115.84 -0.618 . . . . 0.0 113.898 -170.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 66.15 156.39 0.13 Allowed Pre-proline 0 N--CA 1.493 1.69 0 C-N-CA 125.438 1.495 . . . . 0.0 112.623 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 186' ' ' GLU . 85.2 Cg_endo -77.02 130.52 11.34 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 122.174 1.916 . . . . 0.0 110.649 178.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -47.74 123.28 8.11 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 123.769 2.979 . . . . 0.0 112.223 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 73.2 mt -72.42 83.22 1.08 Allowed 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.271 0.558 . . . . 0.0 109.888 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 71.6 p -73.09 142.59 47.56 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.823 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.4 pp -66.53 146.77 54.16 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 123.237 0.336 . . . . 0.0 110.662 -175.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 . . . . . 0 CA--C 1.55 0.977 0 C-N-CA 123.801 0.84 . . . . 0.0 109.317 179.257 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.405 ' SD ' ' N ' ' A' ' 84' ' ' MET . 1.4 pmm? . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.17 -13.92 40.66 Favored 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 123.124 2.549 . . . . 0.0 112.923 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 69.09 39.26 1.78 Allowed 'General case' 0 C--N 1.353 0.743 0 C-N-CA 124.689 1.195 . . . . 0.0 110.846 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.4 t -96.31 130.16 43.47 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.529 177.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -156.86 147.39 21.44 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.146 0.578 . . . . 0.0 110.823 -174.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -97.54 111.74 23.89 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 168.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.6 mm -77.42 140.43 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.749 0.82 . . . . 0.0 109.76 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.6 p -141.34 61.12 1.49 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.183 0.993 . . . . 0.0 109.326 -173.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.9 -15.01 60.27 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.493 172.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 69.2 mtm -110.66 133.71 53.09 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 165.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 74.8 p -71.6 159.65 34.05 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 167.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.72 -34.76 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 123.195 0.598 . . . . 0.0 110.249 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -56.6 -61.51 2.37 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.375 1.07 . . . . 0.0 112.053 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -73.51 -26.5 60.91 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -176.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.8 tt -63.18 -51.98 64.2 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.62 0.768 . . . . 0.0 109.785 176.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.9 t -91.94 2.28 56.64 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.583 -174.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -69.71 132.46 46.16 Favored 'General case' 0 C--N 1.356 0.858 0 C-N-CA 122.717 0.407 . . . . 0.0 111.262 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -89.15 148.77 23.48 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.665 0.786 . . . . 0.0 109.729 176.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.438 ' HE1' ' NH1' ' A' ' 148' ' ' ARG . 12.2 p-90 -151.93 164.45 37.12 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 124.337 1.055 . . . . 0.0 110.373 -171.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -115.19 158.17 22.63 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.526 1.13 . . . . 0.0 110.135 -176.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.477 ' SD ' ' HD2' ' A' ' 118' ' ' ARG . 70.2 mtp -122.02 145.53 48.05 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.386 0.674 . . . . 0.0 110.454 178.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.7 tp -91.97 -42.49 9.97 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.856 0.862 . . . . 0.0 109.926 177.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 24.9 mmt -126.49 85.69 59.79 Favored Pre-proline 0 N--CA 1.482 1.159 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 173.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -70.47 113.27 3.44 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 123.125 2.55 . . . . 0.0 111.676 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.483 ' HD3' ' NE2' ' A' ' 121' ' ' GLN . 55.9 tptt -98.23 118.49 34.99 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 172.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -82.76 105.68 13.98 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 170.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -125.98 145.49 50.27 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.907 0.883 . . . . 0.0 108.91 174.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.0 t -136.77 139.53 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 173.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -126.82 86.08 2.46 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 174.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.38 -121.52 8.22 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.48 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -89.54 15.96 1.86 Allowed 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 123.339 2.693 . . . . 0.0 113.225 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.638 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 5.4 mp -129.11 137.4 51.2 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.658 0.783 . . . . 0.0 108.976 176.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 53.5 t -92.03 130.46 37.77 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 173.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.1 mm -100.76 155.9 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.962 0.905 . . . . 0.0 108.802 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.477 ' HD2' ' SD ' ' A' ' 104' ' ' MET . 20.2 tpp180 -138.61 120.54 15.48 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.443 HD11 ' HA ' ' A' ' 181' ' ' LEU . 38.8 mm -123.56 134.84 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.555 1.142 . . . . 0.0 108.703 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -101.65 115.19 29.97 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 169.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.483 ' NE2' ' HD3' ' A' ' 108' ' ' LYS . 85.5 mt-30 -78.73 -2.07 37.61 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.557 0.743 . . . . 0.0 112.912 -172.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.59 -32.75 10.94 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.359 0.664 . . . . 0.0 110.395 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 31.2 mm -71.23 110.88 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 121.468 0.651 . . . . 0.0 110.739 -176.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.469 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 57.9 mtt -136.34 161.91 34.48 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.218 -173.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 62.62 19.66 11.47 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.739 1.215 . . . . 0.0 113.351 171.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -102.3 149.94 23.83 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.336 0.654 . . . . 0.0 110.016 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -87.23 102.87 14.9 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 167.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 57.3 mt -104.2 142.31 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 123.607 0.763 . . . . 0.0 109.038 -172.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.47 ' HE2' ' HA ' ' A' ' 195' ' ' SER . 11.4 tpt -126.65 125.13 41.36 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.274 1.029 . . . . 0.0 108.636 -173.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 14.6 mt -90.46 102.73 15.47 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -176.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.475 ' HD3' ' CD1' ' A' ' 150' ' ' PHE . 25.0 mtpp -113.71 129.84 56.51 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.528 1.131 . . . . 0.0 108.771 -171.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.478 ' HB3' ' HG ' ' A' ' 147' ' ' LEU . . . -134.67 154.98 51.29 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.797 0.808 . . . . 0.0 113.017 -172.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -116.48 134.9 54.32 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 114.061 -1.427 . . . . 0.0 107.774 165.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.515 ' HA ' HG13 ' A' ' 145' ' ' ILE . 37.6 p90 -162.96 165.05 25.46 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.508 0.505 . . . . 0.0 111.581 -176.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 44.7 p -85.98 148.76 25.6 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.462 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 90.1 t -126.44 151.81 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.252 1.021 . . . . 0.0 109.148 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.3 tp -158.4 144.87 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 170.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 57.41 26.52 12.64 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 176.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 67.83 15.03 9.57 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 124.758 1.223 . . . . 0.0 112.701 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -120.82 160.7 22.87 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.715 0.806 . . . . 0.0 109.457 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.491 HD12 ' HB1' ' A' ' 202' ' ' ALA . 9.8 tt -66.6 123.27 19.62 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 174.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -78.93 -69.38 0.57 Allowed 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 176.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 99.0 m -145.8 129.5 17.13 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.368 0.667 . . . . 0.0 109.418 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.546 HD22 HG12 ' A' ' 174' ' ' VAL . 53.3 tp -71.52 115.83 11.15 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 123.894 0.746 . . . . 0.0 109.966 176.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.515 HG13 ' HA ' ' A' ' 134' ' ' PHE . 73.5 mt -74.29 -53.83 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 57.7 tp -160.18 149.74 17.81 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.134 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.632 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 7.1 tt -134.51 148.78 50.6 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 174.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.447 ' N ' HD23 ' A' ' 147' ' ' LEU . 43.5 mtt-85 -141.95 159.48 42.14 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.994 0.918 . . . . 0.0 110.329 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -115.77 112.15 21.59 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.121 0.968 . . . . 0.0 109.166 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.475 ' CD1' ' HD3' ' A' ' 131' ' ' LYS . 56.9 m-85 -107.99 136.01 48.4 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.232 1.013 . . . . 0.0 109.93 -177.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 66.9 p -81.43 -172.93 4.08 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.955 0.502 . . . . 0.0 110.648 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -53.76 -37.56 63.53 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.446 0.698 . . . . 0.0 111.882 170.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -80.5 -5.5 56.76 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.121 0.968 . . . . 0.0 111.91 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 75.46 23.05 74.39 Favored Glycine 0 C--N 1.347 1.19 0 N-CA-C 112.102 -0.399 . . . . 0.0 112.102 -174.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -82.69 121.25 26.61 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 12.2 mt -75.6 110.3 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.6 m -120.41 1.86 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.337 1.055 . . . . 0.0 111.047 -175.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -157.23 166.59 33.69 Favored Glycine 0 C--O 1.242 0.634 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -165.26 150.17 9.09 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -174.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.632 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 63.9 mt -128.43 102.69 8.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 164.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 48.1 t -112.06 113.35 52.07 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.638 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 19.0 Cg_endo -57.79 136.21 73.95 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.291 1.994 . . . . 0.0 111.787 178.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 83.2 mt -57.54 136.89 82.19 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 123.968 0.907 . . . . 0.0 112.402 -171.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.23 -31.65 84.83 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 123.521 2.814 . . . . 0.0 113.109 175.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 25.1 m -77.43 -6.64 54.16 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.99 0.916 . . . . 0.0 112.509 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -133.43 89.87 30.86 Favored Pre-proline 0 N--CA 1.479 0.982 0 C-N-CA 123.92 0.888 . . . . 0.0 109.143 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -76.32 3.04 6.62 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.333 2.689 . . . . 0.0 113.792 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -146.94 146.16 15.73 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 177.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -148.48 163.52 36.92 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 123.823 0.849 . . . . 0.0 109.553 175.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 34.5 p -83.94 156.26 22.43 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.467 HG13 ' HB3' ' A' ' 141' ' ' LEU . 7.2 tt -58.37 -31.89 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 124.178 0.991 . . . . 0.0 110.593 171.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -67.15 -38.08 84.9 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.474 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -62.71 -33.93 76.12 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.834 0.454 . . . . 0.0 110.833 176.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.546 HG12 HD22 ' A' ' 144' ' ' LEU . 60.9 t -66.56 -52.53 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 124.009 0.818 . . . . 0.0 111.618 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -63.04 -33.98 76.6 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 122.225 0.21 . . . . 0.0 111.456 -176.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -69.82 -40.36 75.95 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.161 0.584 . . . . 0.0 110.185 174.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -59.91 -40.44 88.82 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 124.084 0.865 . . . . 0.0 110.805 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 174' ' ' VAL . 67.5 mt -68.2 -38.86 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.352 0.661 . . . . 0.0 109.671 177.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.36 -35.29 91.44 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 116.003 -0.544 . . . . 0.0 113.612 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.2 t -76.09 -38.67 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.112 0.565 . . . . 0.0 110.194 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.443 ' HA ' HD11 ' A' ' 119' ' ' ILE . 30.1 tp -57.01 -48.09 79.31 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.354 0.661 . . . . 0.0 110.276 173.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.412 ' O ' ' HG2' ' A' ' 186' ' ' GLU . 47.6 mt -60.82 -48.9 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.82 0.848 . . . . 0.0 110.492 176.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -55.93 -44.61 87.64 Favored Glycine 0 C--N 1.347 1.154 0 O-C-N 123.796 0.685 . . . . 0.0 113.438 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -66.79 -28.57 73.83 Favored Glycine 0 C--N 1.35 1.343 0 O-C-N 123.959 0.446 . . . . 0.0 113.676 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 33.9 mt -83.21 -33.27 26.16 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.296 1.038 . . . . 0.0 111.711 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 52.3 mm-40 -68.62 -39.3 80.88 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.541 0.737 . . . . 0.0 110.873 -177.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -73.8 -16.47 61.15 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.894 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.469 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 8.1 m-20 -77.09 -15.44 59.57 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.386 0.674 . . . . 0.0 111.743 169.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 66.72 64.31 0.48 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.408 1.083 . . . . 0.0 110.138 -172.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -137.06 154.6 50.3 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.755 167.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 20.7 m -98.95 105.98 18.18 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.744 0.818 . . . . 0.0 109.483 -169.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 13.7 m -97.93 150.3 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-O 121.714 0.769 . . . . 0.0 112.095 -178.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 19.6 tpp85 -133.37 139.1 46.61 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.9 t -98.69 146.77 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -178.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.47 ' HA ' ' HE2' ' A' ' 129' ' ' MET . 27.9 t -55.08 145.54 20.53 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.286 0.634 . . . . 0.0 111.943 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -51.86 -37.8 53.52 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.005 0.922 . . . . 0.0 111.284 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 53.3 p -73.2 -51.86 16.22 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.726 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 62.2 mt -57.02 -39.02 73.98 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.09 0.556 . . . . 0.0 111.241 -177.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.436 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 46.7 mt-30 -58.81 -39.4 81.06 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.958 0.903 . . . . 0.0 112.246 -176.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.01 -32.54 10.9 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -176.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.456 ' O ' HD13 ' A' ' 171' ' ' ILE . 35.0 m-85 -74.97 -52.29 11.52 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 117.951 0.341 . . . . 0.0 111.25 -175.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.491 ' HB1' HD12 ' A' ' 141' ' ' LEU . . . -109.63 -50.62 2.96 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.056 0.542 . . . . 0.0 111.346 -172.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.436 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 70.7 t-105 -66.61 -44.33 82.37 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.369 1.068 . . . . 0.0 111.156 -170.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.36 -15.84 77.46 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 115.622 -0.717 . . . . 0.0 113.466 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 23.0 t -62.84 116.75 5.54 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.658 0.783 . . . . 0.0 109.1 178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 46.8 m -145.07 176.01 9.82 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.915 0.886 . . . . 0.0 110.381 -173.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 63.3 33.94 13.62 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.065 0.946 . . . . 0.0 111.495 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -97.7 -145.55 0.31 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.752 1.221 . . . . 0.0 110.368 -176.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -155.69 -58.75 0.1 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.884 0.474 . . . . 0.0 110.662 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 126.98 -27.07 4.93 Favored Glycine 0 N--CA 1.471 1.031 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 -173.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 17.1 mtm180 50.46 85.16 0.19 Allowed Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 125.216 1.406 . . . . 0.0 110.689 -175.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -76.15 157.52 37.92 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 123.023 2.482 . . . . 0.0 111.901 -170.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -51.41 117.84 3.82 Favored 'Trans proline' 0 C--N 1.384 2.421 0 C-N-CA 122.898 2.399 . . . . 0.0 111.243 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 84.9 mt -65.04 107.09 1.41 Allowed 'General case' 0 C--O 1.241 0.621 0 O-C-N 123.379 0.424 . . . . 0.0 110.287 -174.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 16.3 p -67.42 141.75 56.92 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.387 -177.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.1 pp -137.9 -173.34 3.48 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 124.225 1.01 . . . . 0.0 110.512 -172.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.556 1.21 0 C-N-CA 124.262 1.025 . . . . 0.0 108.623 -175.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 12.6 tpt . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -86.42 176.72 4.75 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.779 2.32 . . . . 0.0 111.197 168.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.87 101.77 0.53 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.992 0.517 . . . . 0.0 110.67 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.8 t -131.42 142.35 50.0 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.633 0.773 . . . . 0.0 109.929 -174.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -158.48 148.82 20.01 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.145 0.578 . . . . 0.0 109.997 -173.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -98.78 110.49 23.09 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 168.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.8 mm -77.47 118.7 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.608 0.763 . . . . 0.0 109.025 173.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 38.5 p -102.47 68.02 1.04 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.537 ' HB3' ' O ' ' A' ' 132' ' ' ALA . 32.4 t70 -72.77 -25.17 61.08 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 114.439 -1.255 . . . . 0.0 111.059 -175.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 60.7 mtm -92.92 136.98 32.77 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 162.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 77.0 p -67.37 163.82 19.92 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 167.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 29.8 mm -57.04 -36.06 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 173.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -58.94 -42.07 88.9 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.313 175.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -77.43 -35.94 53.58 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 122.873 0.469 . . . . 0.0 111.549 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.418 HD11 ' ND2' ' A' ' 133' ' ' ASN . 6.7 tt -64.03 -40.23 95.85 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.974 1.31 . . . . 0.0 109.826 -177.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.0 t -113.34 22.05 14.61 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.348 1.059 . . . . 0.0 109.91 -176.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -66.33 137.5 56.96 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.481 0.712 . . . . 0.0 111.14 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -79.03 136.14 37.1 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 175.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.426 ' CG ' ' HB ' ' A' ' 156' ' ' ILE . 38.3 p-90 -156.06 164.86 37.9 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.932 0.893 . . . . 0.0 110.33 176.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -136.93 149.58 47.67 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.763 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.533 ' HE3' ' HA ' ' A' ' 107' ' ' PRO . 13.2 ptm -129.78 129.66 44.37 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 173.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.448 HD21 ' H ' ' A' ' 105' ' ' LEU . 0.9 OUTLIER -94.75 -19.41 20.39 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.297 0.639 . . . . 0.0 110.857 -173.169 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 94.1 mmm -127.37 72.44 77.33 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.187 0.995 . . . . 0.0 109.375 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.533 ' HA ' ' HE3' ' A' ' 104' ' ' MET . 12.3 Cg_exo -71.03 110.39 2.8 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 122.63 2.22 . . . . 0.0 111.741 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.485 ' HB3' ' HB ' ' A' ' 119' ' ' ILE . 57.7 tptt -82.83 117.07 22.44 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 173.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 20.6 tm0? -77.3 102.24 6.65 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.459 ' HA ' ' HE3' ' A' ' 110' ' ' LYS . 0.1 OUTLIER -137.09 130.63 31.55 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.383 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 91.0 t -134.43 138.01 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 173.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -123.61 102.96 8.14 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.154 0.582 . . . . 0.0 109.44 175.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.17 -125.18 26.71 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.007 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -86.31 13.79 2.63 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 123.397 2.732 . . . . 0.0 113.289 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.504 HD21 ' HA ' ' A' ' 162' ' ' PRO . 86.7 mt -130.97 130.85 43.93 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.567 0.747 . . . . 0.0 110.381 -175.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 53.3 t -83.83 137.27 33.78 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.502 0.721 . . . . 0.0 110.266 173.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.3 mm -106.08 151.93 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 C-N-CA 123.924 0.89 . . . . 0.0 108.763 175.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -130.79 124.29 31.04 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 173.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.547 HD13 ' HA3' ' A' ' 184' ' ' GLY . 55.3 mt -132.3 122.69 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.506 ' HB3' ' HB ' ' A' ' 157' ' ' VAL . 23.7 t70 -93.85 121.42 35.28 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.453 ' HA ' ' ND2' ' A' ' 188' ' ' ASN . 81.9 mt-30 -84.29 -7.83 59.21 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -174.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.83 -47.45 11.09 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 118.287 0.494 . . . . 0.0 110.4 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.503 HG22 ' HG3' ' A' ' 126' ' ' LYS . 1.7 mp -71.74 102.47 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-O 122.32 1.057 . . . . 0.0 109.499 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 38.6 mtt -124.55 170.14 11.2 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-N 113.613 -1.63 . . . . 0.0 109.773 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 70.47 11.67 7.38 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 124.762 1.225 . . . . 0.0 112.573 173.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.503 ' HG3' HG22 ' A' ' 123' ' ' ILE . 74.7 mmtt -100.64 156.67 17.18 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.708 0.803 . . . . 0.0 112.227 -171.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.417 ' HB2' ' HG2' ' A' ' 152' ' ' GLU . 90.4 m-20 -89.77 108.91 19.97 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 166.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.543 ' HB ' HG11 ' A' ' 192' ' ' VAL . 64.4 mt -112.55 137.33 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.261 0.624 . . . . 0.0 110.355 -176.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.488 ' HG3' ' HG2' ' A' ' 131' ' ' LYS . 37.2 tpp -113.84 132.81 55.75 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.912 1.285 . . . . 0.0 109.774 -175.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.502 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 2.4 mm? -93.18 102.49 14.79 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.56 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 9.1 mmpt? -105.53 143.2 34.03 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 175.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.537 ' O ' ' HB3' ' A' ' 92' ' ' ASP . . . -145.58 136.58 24.65 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.418 ' ND2' HD11 ' A' ' 98' ' ' LEU . 4.9 m-20 -89.62 118.68 29.42 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 163.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -148.58 157.5 43.5 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.094 0.558 . . . . 0.0 110.728 -174.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.5 t -86.43 160.19 19.11 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.756 174.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.6 t -134.41 143.92 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.371 1.068 . . . . 0.0 109.071 -176.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.4 tp -150.26 140.9 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 168.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 58.02 31.75 21.07 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 175.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 64.34 24.02 13.16 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.448 1.099 . . . . 0.0 112.589 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.475 ' HB2' HD11 ' A' ' 171' ' ' ILE . 2.9 ptp180 -133.09 165.53 24.55 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 173.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.577 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 10.3 tt -65.84 126.23 27.83 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 176.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -81.7 -74.05 0.35 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.3 m -139.17 125.68 20.49 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -175.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 60.0 tp -70.49 132.98 46.37 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.411 0.685 . . . . 0.0 110.167 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.5 mp -89.15 -52.38 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 173.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 40.4 tp -164.6 142.42 6.62 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.655 0.782 . . . . 0.0 109.142 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.587 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 9.3 tt -130.72 139.58 50.3 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 176.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 61.3 mtp85 -141.69 132.8 26.22 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.382 1.073 . . . . 0.0 109.117 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -116.71 126.69 53.54 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.881 1.272 . . . . 0.0 108.829 -173.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.56 ' CZ ' ' HG3' ' A' ' 131' ' ' LYS . 3.7 p90 -143.75 166.81 23.85 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.28 0.562 . . . . 0.0 111.852 -173.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 68.0 p -82.29 175.35 10.34 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.373 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.417 ' HG2' ' HB2' ' A' ' 127' ' ' ASN . 35.9 mm-40 -57.42 -29.51 64.2 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 121.198 0.523 . . . . 0.0 111.125 171.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -74.04 -16.86 61.03 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.155 0.982 . . . . 0.0 111.052 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 92.01 5.41 66.08 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 116.327 -0.397 . . . . 0.0 112.521 -177.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.63 102.72 6.26 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -178.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.512 HG12 ' HB3' ' A' ' 150' ' ' PHE . 16.8 mt -72.19 122.54 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -177.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.506 ' HB ' ' HB3' ' A' ' 120' ' ' ASP . 27.4 m -130.08 6.09 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.228 1.011 . . . . 0.0 110.592 -175.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -150.81 156.95 26.95 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -165.75 145.55 6.48 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.854 0.462 . . . . 0.0 110.078 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.587 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 63.7 mt -124.92 106.32 16.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 168.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 88.0 p -115.59 134.97 22.57 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.504 ' HA ' HD21 ' A' ' 115' ' ' LEU . 52.3 Cg_exo -53.85 140.99 67.45 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 122.743 2.295 . . . . 0.0 111.873 172.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 166' ' ' PHE . 80.0 mt -63.6 143.81 97.88 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -59.7 -26.21 81.45 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 122.569 2.179 . . . . 0.0 112.778 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 79.0 p -93.64 -6.04 47.3 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.372 0.669 . . . . 0.0 111.747 177.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.421 ' HB2' ' HB2' ' A' ' 163' ' ' LEU . 96.6 m-85 -132.84 77.11 69.48 Favored Pre-proline 0 N--CA 1.485 1.293 0 C-N-CA 123.586 0.754 . . . . 0.0 110.408 176.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.75 -32.06 7.84 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.182 1.922 . . . . 0.0 111.896 173.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -96.82 125.59 8.52 Favored Glycine 0 C--N 1.347 1.183 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 -152.09 164.13 37.9 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.97 0.908 . . . . 0.0 110.291 178.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 22.7 m -96.66 158.34 15.48 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 123.898 0.879 . . . . 0.0 109.395 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.577 ' HB ' ' O ' ' A' ' 141' ' ' LEU . 4.7 tt -48.52 -38.61 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 125.378 1.471 . . . . 0.0 112.836 174.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.433 ' HG3' ' HB3' ' A' ' 208' ' ' GLU . 55.3 mm-40 -62.21 -40.36 95.86 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.846 0.858 . . . . 0.0 111.517 -175.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -62.85 -41.1 99.23 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.984 0.914 . . . . 0.0 110.005 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.473 ' O ' HG13 ' A' ' 178' ' ' ILE . 44.3 t -63.24 -54.46 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 O-C-N 124.398 1.061 . . . . 0.0 111.603 -177.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -61.3 -35.09 76.38 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 124.05 0.844 . . . . 0.0 110.991 -175.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.43 ' O ' HG21 ' A' ' 180' ' ' VAL . 76.9 m-20 -69.69 -41.88 74.83 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.9 -36.28 82.8 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.163 0.914 . . . . 0.0 111.036 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 174' ' ' VAL . 66.6 mt -65.68 -39.18 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 175.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -71.06 -24.64 76.89 Favored Glycine 0 C--N 1.341 0.852 0 O-C-N 123.668 0.605 . . . . 0.0 113.551 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.43 HG21 ' O ' ' A' ' 176' ' ' ASN . 71.1 t -76.04 -43.15 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.441 0.697 . . . . 0.0 109.711 175.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 19.9 tp -60.92 -46.59 90.07 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.43 0.692 . . . . 0.0 110.473 173.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.456 ' O ' ' HG2' ' A' ' 186' ' ' GLU . 57.5 mt -60.56 -50.07 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 123.967 0.907 . . . . 0.0 110.254 175.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -60.9 -33.15 82.39 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 123.447 0.467 . . . . 0.0 113.639 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.547 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -67.79 -43.81 82.56 Favored Glycine 0 C--N 1.347 1.19 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 171.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.444 HD23 HD11 ' A' ' 128' ' ' ILE . 53.4 mt -68.7 -23.9 64.43 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.521 1.129 . . . . 0.0 111.705 177.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 52.4 mm-40 -74.73 -41.9 59.28 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.947 0.499 . . . . 0.0 109.947 178.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -64.23 -41.72 96.88 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.128 171.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.453 ' ND2' ' HA ' ' A' ' 121' ' ' GLN . 6.2 m-20 -68.05 -10.66 55.51 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.552 0.741 . . . . 0.0 111.39 173.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 16.6 t70 63.52 64.49 0.8 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.475 1.11 . . . . 0.0 110.031 174.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -126.22 134.17 51.3 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.8 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 127' ' ' ASN . 59.2 m -80.92 99.25 8.27 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.543 HG11 ' HB ' ' A' ' 128' ' ' ILE . 24.5 m -104.87 148.38 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.668 0.747 . . . . 0.0 111.553 -172.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 44.0 ttt180 -137.76 135.48 36.39 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 114.25 -1.341 . . . . 0.0 107.937 173.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.502 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 4.1 t -87.33 155.27 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -178.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.516 ' HB3' ' HE2' ' A' ' 131' ' ' LYS . 88.6 p -62.45 149.15 43.46 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.446 0.566 . . . . 0.0 111.083 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -55.35 -34.68 64.47 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.188 0.995 . . . . 0.0 110.448 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 52.1 p -64.08 -58.65 6.03 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.436 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.419 ' HB2' HG12 ' A' ' 194' ' ' VAL . 69.7 mt -62.72 -37.45 86.58 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.148 0.579 . . . . 0.0 110.912 -174.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -55.79 -37.54 68.75 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.712 0.805 . . . . 0.0 112.085 -176.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -102.22 -25.33 13.73 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -82.73 -54.32 5.22 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 118.403 0.547 . . . . 0.0 111.519 -176.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -102.56 -56.72 2.19 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.811 0.844 . . . . 0.0 110.694 -171.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 44.3 t-105 -61.67 -42.21 98.61 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.383 1.473 . . . . 0.0 109.601 -177.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.24 174.73 19.22 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.365 169.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 23.2 m 60.83 24.44 14.39 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.779 1.231 . . . . 0.0 112.335 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 17.9 p -114.5 138.22 50.88 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.205 1.002 . . . . 0.0 109.93 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -140.85 80.63 1.76 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.443 0.697 . . . . 0.0 110.85 -174.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.433 ' HB3' ' HG3' ' A' ' 172' ' ' GLU . 7.2 pt-20 -79.74 112.21 16.8 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 167.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -83.46 86.57 7.06 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -177.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -76.1 85.04 0.91 Allowed Glycine 0 C--N 1.347 1.172 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.089 -175.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -86.25 143.93 37.63 Favored Pre-proline 0 C--O 1.241 0.629 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 172.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.99 123.87 14.18 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.375 2.05 . . . . 0.0 111.12 167.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -56.88 124.42 16.2 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 122.685 2.256 . . . . 0.0 111.304 -176.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 94.2 mt -66.1 95.52 0.28 Allowed 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.809 0.844 . . . . 0.0 110.732 -173.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 72.0 p -72.52 138.45 46.95 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.935 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.28 161.52 13.75 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.714 1.206 . . . . 0.0 108.575 175.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 . . . . . 0 CA--C 1.557 1.223 0 CA-C-O 118.83 -0.605 . . . . 0.0 109.684 178.299 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 62.6 ttp . . . . . 0 N--CA 1.476 0.852 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -68.55 136.78 37.39 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 122.289 1.992 . . . . 0.0 110.951 168.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.74 102.76 0.49 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.962 0.505 . . . . 0.0 111.257 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.5 t -80.56 144.87 32.1 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 170.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.535 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 8.1 ttm180 -151.65 152.87 33.41 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -167.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -121.74 101.42 7.57 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 172.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.9 mm -81.76 132.89 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 123.617 0.767 . . . . 0.0 109.787 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 34.2 p -121.96 83.55 2.11 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 171.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -70.19 -31.37 68.8 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.174 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.461 ' HE2' HD13 ' A' ' 98' ' ' LEU . 25.0 ptt? -111.07 141.92 43.92 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 174.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 81.6 p -65.4 152.97 42.6 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.091 0.472 . . . . 0.0 110.569 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.52 -29.34 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.951 173.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -65.97 -49.61 67.25 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.644 1.177 . . . . 0.0 111.946 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.511 ' HA ' ' HB2' ' A' ' 100' ' ' ARG . 12.5 pt-20 -75.58 -22.32 57.07 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 120.801 0.334 . . . . 0.0 110.334 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.53 ' HG ' HD21 ' A' ' 146' ' ' LEU . 9.2 tt -69.15 -33.73 73.9 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.885 0.874 . . . . 0.0 109.542 170.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.3 t -103.12 13.75 33.4 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.7 0.8 . . . . 0.0 110.983 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.511 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 71.2 ttt180 -65.39 150.16 48.79 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.661 0.784 . . . . 0.0 111.723 -174.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -80.45 125.41 29.9 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 170.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -154.14 173.21 16.38 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.66 0.784 . . . . 0.0 110.488 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -138.78 146.74 41.73 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.158 0.583 . . . . 0.0 110.714 175.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.541 ' SD ' ' HB3' ' A' ' 107' ' ' PRO . 14.3 ptp -99.76 108.43 20.75 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 167.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 48.0 tp -71.58 -38.16 70.94 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.032 0.533 . . . . 0.0 110.552 -175.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 24.9 mmt -121.12 84.81 40.42 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 123.779 0.832 . . . . 0.0 109.088 173.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.541 ' HB3' ' SD ' ' A' ' 104' ' ' MET . 56.5 Cg_endo -67.81 117.86 5.19 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.144 2.563 . . . . 0.0 113.088 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.417 ' HD2' HE21 ' A' ' 121' ' ' GLN . 61.6 tttp -118.66 131.98 56.17 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 167.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -122.84 120.84 34.71 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 176.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.79 106.6 9.8 Favored 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 124.676 1.19 . . . . 0.0 107.997 176.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.421 HG11 HD11 ' A' ' 163' ' ' LEU . 79.3 t -75.35 128.54 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -122.57 85.24 2.38 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 124.864 1.266 . . . . 0.0 108.363 -176.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 68.01 -113.13 5.2 Favored Glycine 0 CA--C 1.539 1.531 0 CA-C-N 114.966 -1.016 . . . . 0.0 113.239 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -89.97 9.21 3.39 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 123.624 2.883 . . . . 0.0 113.227 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 162' ' ' PRO . 60.1 mt -129.95 158.27 40.02 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -175.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.423 ' HB3' HD22 ' A' ' 163' ' ' LEU . 23.7 p -125.51 119.04 27.11 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 176.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.0 mm -86.72 140.94 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.378 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -122.36 129.97 52.65 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 170.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.568 HD12 ' HA3' ' A' ' 184' ' ' GLY . 60.4 mt -128.08 122.86 59.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -178.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -94.28 114.72 26.85 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 174.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.417 HE21 ' HD2' ' A' ' 108' ' ' LYS . 76.2 mt-30 -82.72 -10.49 58.88 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.097 0.959 . . . . 0.0 111.51 -175.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.71 -41.57 53.25 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.019 0.527 . . . . 0.0 111.881 -174.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.85 113.14 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.866 0.841 . . . . 0.0 109.834 -176.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 44.8 mtt -131.2 166.16 21.75 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.321 -1.309 . . . . 0.0 109.501 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.5 t70 57.69 32.72 22.29 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.828 0.851 . . . . 0.0 111.313 177.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -120.71 153.94 36.27 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.878 0.871 . . . . 0.0 110.507 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -90.78 106.97 18.88 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 173.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.54 HG12 HG23 ' A' ' 151' ' ' THR . 48.2 mt -108.14 130.77 60.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 123.478 0.711 . . . . 0.0 110.315 -173.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.606 ' HE1' ' HD2' ' A' ' 193' ' ' ARG . 52.1 tpp -110.0 126.47 53.98 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.28 1.032 . . . . 0.0 108.752 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 25.1 mt -87.77 103.0 15.22 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -110.55 132.39 54.23 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.313 1.045 . . . . 0.0 109.988 -172.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.547 ' HB2' ' HG ' ' A' ' 147' ' ' LEU . . . -136.99 154.93 50.29 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -175.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -112.84 128.44 56.45 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 167.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.41 ' HB3' HD12 ' A' ' 144' ' ' LEU . 33.0 p90 -157.37 163.57 38.46 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.351 0.596 . . . . 0.0 112.393 -170.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 46.6 t -85.14 156.99 20.79 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.425 -1.261 . . . . 0.0 109.417 173.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.535 ' HB ' ' HB3' ' A' ' 88' ' ' ARG . 79.1 t -140.27 142.96 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.378 1.071 . . . . 0.0 109.935 -174.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.414 ' O ' ' HG2' ' A' ' 140' ' ' ARG . 11.3 tp -150.3 145.6 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 168.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 60.62 22.8 12.61 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 123.632 0.773 . . . . 0.0 112.119 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 58.77 39.61 23.98 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.316 1.046 . . . . 0.0 111.658 -172.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 137' ' ' ILE . 5.8 ptp180 -144.85 163.35 34.35 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.509 0.724 . . . . 0.0 109.694 172.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.471 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 10.5 tt -63.85 117.25 6.68 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.952 0.501 . . . . 0.0 110.08 -176.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -79.8 -60.63 2.27 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.839 0.856 . . . . 0.0 109.121 175.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 80.5 m -147.75 132.13 17.59 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.632 0.773 . . . . 0.0 109.366 177.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.41 HD12 ' HB3' ' A' ' 134' ' ' PHE . 51.3 tp -76.7 131.59 38.87 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.557 0.743 . . . . 0.0 110.156 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.9 mp -87.15 -46.88 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 173.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.53 HD21 ' HG ' ' A' ' 98' ' ' LEU . 57.7 tp -167.94 149.08 5.22 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.573 0.749 . . . . 0.0 109.585 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.651 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 6.6 tt -134.19 140.08 46.27 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 177.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 58.7 mtp85 -145.48 147.63 32.38 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.32 1.048 . . . . 0.0 108.991 -175.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.01 109.2 21.1 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.009 0.923 . . . . 0.0 109.269 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -106.29 124.15 49.15 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.424 0.69 . . . . 0.0 110.187 -175.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.54 HG23 HG12 ' A' ' 128' ' ' ILE . 33.7 p -73.0 -174.45 1.51 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.372 0.669 . . . . 0.0 110.955 169.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.95 -25.51 63.68 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 122.257 -0.277 . . . . 0.0 111.243 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -83.85 -8.1 59.29 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.748 0.819 . . . . 0.0 110.381 173.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 78.99 23.02 64.63 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 116.331 -0.395 . . . . 0.0 113.391 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.26 127.62 32.57 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.7 mp -81.8 101.39 6.58 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.9 m -111.16 24.33 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.305 1.042 . . . . 0.0 109.991 -172.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 176.05 151.28 8.66 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 114.119 -1.401 . . . . 0.0 110.28 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -158.39 130.55 6.89 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.069 0.935 . . . . 0.0 111.047 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.651 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 67.3 mt -107.43 102.99 14.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 173.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 27.7 t -104.17 120.73 49.97 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 123.427 0.691 . . . . 0.0 109.37 -177.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.419 ' HA ' HD23 ' A' ' 115' ' ' LEU . 74.8 Cg_exo -54.22 123.79 14.43 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.666 2.244 . . . . 0.0 112.492 172.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.423 HD22 ' HB3' ' A' ' 116' ' ' CYS . 67.2 mt -67.18 127.3 93.45 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 123.268 0.627 . . . . 0.0 111.261 -177.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.72 -16.1 52.75 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 123.578 2.852 . . . . 0.0 113.775 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.4 m -87.76 1.31 54.18 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.921 0.488 . . . . 0.0 111.804 175.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -131.32 83.1 60.51 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.7 89.57 0.98 Allowed 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.738 2.292 . . . . 0.0 112.138 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 104.41 131.19 7.07 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.228 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 34.9 p-80 -140.0 165.55 27.03 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.187 0.995 . . . . 0.0 109.762 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 27.3 m -93.03 159.01 15.49 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.363 0.665 . . . . 0.0 109.866 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 141' ' ' LEU . 7.6 tt -50.99 -37.77 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.728 1.211 . . . . 0.0 111.997 173.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -64.24 -35.41 80.72 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.417 1.087 . . . . 0.0 111.445 -175.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -64.38 -38.83 92.4 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.89 0.876 . . . . 0.0 110.488 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.451 ' O ' HG13 ' A' ' 178' ' ' ILE . 43.7 t -67.79 -37.11 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.297 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -62.14 -40.28 95.42 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.034 0.534 . . . . 0.0 110.747 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.414 ' O ' HG22 ' A' ' 180' ' ' VAL . 79.6 m-20 -61.0 -48.04 83.64 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 123.906 0.754 . . . . 0.0 109.568 174.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.55 -48.64 78.62 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 114.066 -1.424 . . . . 0.0 112.681 -173.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 174' ' ' VAL . 69.8 mt -59.66 -41.8 86.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -61.18 -34.37 87.79 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 115.301 -0.863 . . . . 0.0 114.005 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 176' ' ' ASN . 93.1 t -70.77 -44.08 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 122.956 0.502 . . . . 0.0 110.307 177.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 32.3 tp -59.91 -43.81 94.65 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.822 176.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.513 HG21 HG23 ' A' ' 192' ' ' VAL . 86.6 mt -59.83 -51.58 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.575 0.75 . . . . 0.0 110.267 175.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.22 -42.38 97.21 Favored Glycine 0 C--N 1.344 1.006 0 O-C-N 123.804 0.69 . . . . 0.0 113.779 -176.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.568 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -68.9 -24.81 75.62 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 115.502 -0.349 . . . . 0.0 113.116 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.431 HD21 HD13 ' A' ' 128' ' ' ILE . 32.6 mt -86.54 -25.69 24.92 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.878 0.871 . . . . 0.0 111.564 176.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 182' ' ' ILE . 50.2 mt-10 -70.78 -31.26 67.97 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 122.084 -0.385 . . . . 0.0 110.789 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -81.09 -20.66 41.04 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.161 0.585 . . . . 0.0 111.092 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -65.53 -20.82 66.49 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.011 0.525 . . . . 0.0 110.466 165.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 33.6 t70 63.4 67.47 0.65 Allowed 'General case' 0 C--N 1.355 0.833 0 C-N-CA 124.418 1.087 . . . . 0.0 110.195 -178.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -138.01 178.65 6.96 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.125 175.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 85.3 m -102.51 103.52 13.88 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -174.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.513 HG23 HG21 ' A' ' 182' ' ' ILE . 35.5 m -101.47 146.54 9.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 C-N-CA 123.388 0.675 . . . . 0.0 110.897 -178.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.606 ' HD2' ' HE1' ' A' ' 129' ' ' MET . 30.2 ttm180 -143.84 145.37 32.28 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.522 171.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 4.6 t -89.9 137.6 21.11 Favored 'Isoleucine or valine' 0 C--O 1.245 0.818 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 173.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 78.9 p -56.96 148.29 21.62 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 118.819 0.736 . . . . 0.0 111.045 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -57.06 -27.03 61.34 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.545 0.738 . . . . 0.0 111.808 -177.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 65.1 p -70.49 -54.25 13.02 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 123.387 0.675 . . . . 0.0 109.847 174.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 33.5 mt -63.45 -26.98 68.98 Favored 'General case' 0 C--O 1.208 -1.079 0 CA-C-O 119.004 -0.522 . . . . 0.0 111.577 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -67.76 -49.71 61.03 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.886 0.474 . . . . 0.0 110.856 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -77.27 -36.54 54.23 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.341 0.401 . . . . 0.0 111.62 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -85.41 -54.94 4.26 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 122.257 -0.277 . . . . 0.0 111.152 -171.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -95.08 -60.37 1.7 Allowed 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.185 0.517 . . . . 0.0 111.447 -170.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 43.5 t-105 -63.92 -33.32 75.45 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.026 1.73 . . . . 0.0 111.039 -169.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -134.56 -153.29 6.84 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 170.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 65.2 m -132.22 124.93 29.95 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 29.0 t -62.74 98.0 0.11 Allowed 'General case' 0 C--N 1.351 0.669 0 O-C-N 123.745 0.653 . . . . 0.0 109.512 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -96.4 26.84 4.09 Favored 'General case' 0 CA--C 1.558 1.279 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -88.87 65.69 7.69 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 125.226 1.41 . . . . 0.0 108.143 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -90.96 -176.43 4.64 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.638 -168.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 177.2 -123.25 0.88 Allowed Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -165.62 145.84 5.63 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 123.829 0.852 . . . . 0.0 109.156 176.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -46.77 120.13 3.82 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.774 2.316 . . . . 0.0 112.232 168.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -52.8 118.25 4.55 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 123.101 2.534 . . . . 0.0 112.175 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 58.2 mt -69.57 93.39 0.69 Allowed 'General case' 0 CA--C 1.537 0.443 0 O-C-N 123.941 0.776 . . . . 0.0 109.63 -175.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 75.8 p -60.87 144.17 53.36 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.419 -175.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 55.9 mt -74.4 142.64 45.01 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.417 0.687 . . . . 0.0 110.685 -173.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 . . . . . 0 CA--C 1.558 1.283 0 C-N-CA 123.437 0.695 . . . . 0.0 109.378 176.662 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.428 ' HB2' HD11 ' A' ' 137' ' ' ILE . 32.4 Cg_endo -60.97 132.69 43.35 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 123.371 2.714 . . . . 0.0 112.809 -178.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.31 119.96 27.14 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.398 0.679 . . . . 0.0 110.275 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.1 p -108.08 140.19 41.62 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.08 0.952 . . . . 0.0 109.347 174.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -155.63 152.45 28.72 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.93 0.492 . . . . 0.0 110.014 -173.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -115.38 111.11 20.34 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 171.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.4 mm -81.83 130.42 35.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 123.597 0.759 . . . . 0.0 109.382 175.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.7 p -117.51 81.91 1.73 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -76.89 -13.46 59.99 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.582 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.529 ' HB3' ' HG3' ' A' ' 97' ' ' GLU . 63.2 mtm -114.97 143.94 44.37 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.139 1.376 . . . . 0.0 107.321 161.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 69.3 p -72.29 152.21 42.29 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 167.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 57.0 mt -57.41 -27.68 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 122.606 0.362 . . . . 0.0 111.13 178.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -54.67 -62.36 1.71 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.07 0.948 . . . . 0.0 111.801 170.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.529 ' HG3' ' HB3' ' A' ' 93' ' ' MET . 11.0 pt-20 -73.54 -22.07 60.2 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 122.924 0.49 . . . . 0.0 112.152 -177.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.567 ' HG ' HD21 ' A' ' 146' ' ' LEU . 10.0 tt -63.19 -36.44 83.65 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.007 0.923 . . . . 0.0 109.32 171.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.3 m -109.47 16.91 21.94 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.659 0.784 . . . . 0.0 111.601 -177.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.425 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 62.0 ttt180 -75.03 140.01 43.27 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.671 0.788 . . . . 0.0 110.828 -177.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -75.22 136.52 40.97 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.564 0.745 . . . . 0.0 111.248 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 28.0 p-90 -161.14 171.54 18.34 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.654 1.182 . . . . 0.0 109.666 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -141.0 165.08 28.54 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.244 0.618 . . . . 0.0 111.171 -175.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.461 ' HE3' ' HA ' ' A' ' 107' ' ' PRO . 63.6 mtp -118.11 131.08 56.46 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.046 0.939 . . . . 0.0 108.466 172.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.416 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.5 pt? -109.29 -29.21 8.59 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.289 0.636 . . . . 0.0 110.829 -175.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.479 ' HA ' ' HE3' ' A' ' 106' ' ' MET . 7.7 mmt -123.24 70.31 42.51 Favored Pre-proline 0 N--CA 1.486 1.375 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 166.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.461 ' HA ' ' HE3' ' A' ' 104' ' ' MET . 91.5 Cg_endo -73.9 145.09 35.54 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 122.243 1.962 . . . . 0.0 113.014 -170.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.455 ' HB3' ' HB ' ' A' ' 119' ' ' ILE . 25.0 ttmm -134.94 120.31 19.06 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 168.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -96.81 100.04 11.59 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -178.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.549 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 17.7 tppt? -96.66 148.78 22.52 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 174.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 68.6 t -128.03 133.62 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 175.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -137.3 95.32 3.06 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 68.37 -131.25 27.0 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.289 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -82.19 18.21 1.45 Allowed 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 123.356 2.704 . . . . 0.0 113.421 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -134.42 170.66 15.41 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.8 0.84 . . . . 0.0 109.655 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 17.9 p -136.33 143.61 44.22 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.033 0.933 . . . . 0.0 109.341 177.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.549 ' HB ' ' HB3' ' A' ' 110' ' ' LYS . 9.3 mm -111.09 147.35 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 124.371 1.069 . . . . 0.0 109.681 -173.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.521 ' HG3' ' HB3' ' A' ' 159' ' ' GLU . 36.3 mmt180 -109.87 118.52 36.7 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 173.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.492 HD13 ' HA3' ' A' ' 184' ' ' GLY . 46.1 mm -119.81 122.29 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 175.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -115.05 118.98 34.93 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -80.23 -9.18 59.72 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.695 0.798 . . . . 0.0 112.789 -170.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -79.66 -36.01 38.39 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 120.654 0.264 . . . . 0.0 110.787 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.6 mp -80.12 99.62 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 45.3 mtt -131.66 156.7 45.39 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-N 114.132 -1.395 . . . . 0.0 109.249 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.3 t70 72.03 2.17 4.2 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 124.384 1.074 . . . . 0.0 112.718 175.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -85.95 148.65 25.67 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 121.635 -0.665 . . . . 0.0 112.087 -173.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -91.16 105.38 17.77 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 172.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.606 ' HB ' HG13 ' A' ' 192' ' ' VAL . 56.8 mt -115.39 146.37 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 123.71 0.804 . . . . 0.0 110.257 -172.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.448 ' SD ' ' HB3' ' A' ' 193' ' ' ARG . 15.7 tpt -129.23 128.63 43.67 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 125.481 1.512 . . . . 0.0 107.781 177.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 35.7 mt -81.39 145.6 30.73 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -142.55 133.96 26.36 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 173.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.518 ' HB1' ' HG ' ' A' ' 147' ' ' LEU . . . -141.45 142.94 33.63 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -170.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -101.9 133.6 46.42 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 171.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.496 ' HA ' HD12 ' A' ' 145' ' ' ILE . 37.3 p90 -161.1 161.62 31.27 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 123.79 0.681 . . . . 0.0 111.057 -175.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.1 p -86.35 161.32 18.77 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.099 0.96 . . . . 0.0 109.41 172.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 53.9 t -139.25 139.39 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.258 1.423 . . . . 0.0 108.467 -175.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.428 HD11 ' HB2' ' A' ' 85' ' ' PRO . 9.8 tp -130.87 132.85 63.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 169.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 62.4 -84.59 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.914 1.286 . . . . 0.0 110.459 -173.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -158.98 23.42 0.21 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.13 0.972 . . . . 0.0 109.897 -176.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.504 ' HB2' HD11 ' A' ' 171' ' ' ILE . 11.1 ptp180 -127.47 163.06 24.92 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.584 0.754 . . . . 0.0 109.797 176.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.48 HD23 ' HA ' ' A' ' 171' ' ' ILE . 9.0 tt -67.7 125.41 26.13 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 171.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -81.35 -59.7 2.54 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 123.876 0.87 . . . . 0.0 108.811 174.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 95.6 m -149.71 136.68 19.58 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.98 0.912 . . . . 0.0 109.293 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.473 HD22 HG12 ' A' ' 174' ' ' VAL . 50.1 tp -77.73 121.47 24.08 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 134' ' ' PHE . 1.6 mp -77.14 -52.14 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.516 0.727 . . . . 0.0 109.161 176.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.567 HD21 ' HG ' ' A' ' 98' ' ' LEU . 39.3 tp -165.69 150.2 8.47 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.735 0.814 . . . . 0.0 109.358 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.664 HD13 HD13 ' A' ' 160' ' ' ILE . 7.4 tt -133.16 145.85 51.02 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.474 ' HD3' HD12 ' A' ' 156' ' ' ILE . 45.5 mtt-85 -141.28 148.3 39.59 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.906 0.882 . . . . 0.0 110.189 176.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.1 110.35 22.25 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.468 1.107 . . . . 0.0 108.441 176.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -104.45 127.95 52.24 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.555 0.742 . . . . 0.0 109.347 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.452 HG21 HG12 ' A' ' 128' ' ' ILE . 41.6 p -70.97 -175.81 1.22 Allowed 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.267 0.556 . . . . 0.0 111.191 176.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -27.13 68.71 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.55 0.74 . . . . 0.0 111.971 173.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -83.26 -4.08 58.08 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.451 0.7 . . . . 0.0 111.243 171.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 77.45 27.07 60.07 Favored Glycine 0 C--N 1.348 1.241 0 CA-C-N 116.441 -0.345 . . . . 0.0 112.944 178.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -92.66 129.45 38.59 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.013 0.525 . . . . 0.0 110.221 -176.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.474 HD12 ' HD3' ' A' ' 148' ' ' ARG . 17.0 mt -72.59 102.93 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.463 0.705 . . . . 0.0 109.141 177.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.9 m -113.83 -2.14 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.287 1.035 . . . . 0.0 111.514 -176.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -157.18 167.43 33.88 Favored Glycine 0 C--N 1.338 0.648 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.521 ' HB3' ' HG3' ' A' ' 118' ' ' ARG . 27.2 tt0 -166.61 149.03 6.6 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.256 0.622 . . . . 0.0 109.627 -174.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.664 HD13 HD13 ' A' ' 147' ' ' LEU . 71.6 mt -130.06 117.69 41.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 169.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.0 t -128.0 138.04 32.09 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.77 139.96 83.21 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 122.951 2.434 . . . . 0.0 111.644 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 88.1 mt -60.77 138.07 93.34 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 123.0 0.52 . . . . 0.0 110.781 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -67.14 -22.2 47.55 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.83 2.353 . . . . 0.0 112.574 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 18.0 m -78.23 -14.47 59.43 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.937 0.895 . . . . 0.0 111.514 175.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -121.1 92.58 48.59 Favored Pre-proline 0 N--CA 1.477 0.912 0 C-N-CA 124.418 1.087 . . . . 0.0 109.366 -175.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -90.48 31.62 0.35 Allowed 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 123.316 2.677 . . . . 0.0 112.237 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -169.44 119.17 0.81 Allowed Glycine 0 C--N 1.342 0.915 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.007 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 31.2 p-80 -147.59 154.0 40.12 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.836 0.855 . . . . 0.0 109.683 171.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.625 HG21 HG21 ' A' ' 171' ' ' ILE . 4.9 m -99.35 171.73 7.79 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.915 0.886 . . . . 0.0 109.789 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.625 HG21 HG21 ' A' ' 170' ' ' THR . 11.2 tt -48.6 -41.84 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 125.84 1.656 . . . . 0.0 113.754 176.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -56.7 -35.83 68.94 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.187 1.395 . . . . 0.0 111.961 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -73.0 -38.02 66.75 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.26 0.624 . . . . 0.0 111.581 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.473 HG12 HD22 ' A' ' 144' ' ' LEU . 58.1 t -65.19 -51.4 65.86 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.88 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.931 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.485 ' HB2' ' HZ1' ' A' ' 175' ' ' LYS . 0.1 OUTLIER -63.27 -24.43 67.86 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 123.826 0.704 . . . . 0.0 112.026 -175.707 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.401 ' O ' HG23 ' A' ' 180' ' ' VAL . 15.4 m120 -70.77 -50.67 33.43 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.992 0.517 . . . . 0.0 109.624 169.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.21 -40.29 81.25 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.236 1.014 . . . . 0.0 111.817 -177.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 174' ' ' VAL . 61.5 mt -60.5 -46.33 95.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.716 0.806 . . . . 0.0 109.478 178.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.05 -25.67 72.18 Favored Glycine 0 C--N 1.343 0.934 0 CA-C-N 115.293 -0.867 . . . . 0.0 113.427 -177.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 176' ' ' ASN . 91.8 t -74.67 -43.53 47.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.04 0.536 . . . . 0.0 110.135 176.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 57.0 tp -59.35 -47.13 86.59 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.861 0.464 . . . . 0.0 110.453 175.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.456 ' O ' ' HG3' ' A' ' 186' ' ' GLU . 93.3 mt -59.01 -48.5 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.817 0.847 . . . . 0.0 110.167 177.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -62.24 -30.55 76.25 Favored Glycine 0 C--N 1.348 1.248 0 O-C-N 123.578 0.549 . . . . 0.0 113.385 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.492 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -75.76 -27.36 63.03 Favored Glycine 0 C--N 1.348 1.22 0 N-CA-C 112.345 -0.302 . . . . 0.0 112.345 175.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.473 ' HB3' HG11 ' A' ' 192' ' ' VAL . 61.0 mt -80.97 -31.54 34.76 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.239 1.015 . . . . 0.0 110.842 176.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 182' ' ' ILE . 49.2 mt-10 -72.05 -40.58 68.25 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.866 0.866 . . . . 0.0 110.765 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -70.07 -32.49 70.6 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.836 0.454 . . . . 0.0 110.46 176.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -76.35 -1.77 28.47 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.231 0.613 . . . . 0.0 111.394 170.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 23.4 t70 64.11 49.38 2.71 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.436 1.094 . . . . 0.0 111.011 170.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -109.95 140.36 44.03 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.622 1.169 . . . . 0.0 109.145 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 29.4 m -84.46 100.85 11.6 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.606 HG13 ' HB ' ' A' ' 128' ' ' ILE . 33.2 m -116.83 152.4 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-O 121.703 0.763 . . . . 0.0 112.822 -168.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.448 ' HB3' ' SD ' ' A' ' 129' ' ' MET . 63.4 ttt180 -134.99 142.96 46.58 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 114.043 -1.435 . . . . 0.0 108.307 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.454 HG22 HD11 ' A' ' 182' ' ' ILE . 13.2 t -82.37 154.38 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 5.4 m -50.53 132.48 25.38 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.423 0.689 . . . . 0.0 111.537 178.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -53.43 -30.74 42.03 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 124.218 1.007 . . . . 0.0 111.704 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 68.7 p -79.47 -47.06 16.28 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.983 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 90.6 mt -68.21 -33.68 74.87 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.948 0.499 . . . . 0.0 110.759 -177.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -51.06 -30.46 15.79 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.456 1.102 . . . . 0.0 112.624 -176.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -102.49 -47.92 4.31 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 171.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -67.89 -44.42 77.03 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -166.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -113.72 -54.26 2.62 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.33 0.652 . . . . 0.0 111.173 -175.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -68.77 -55.88 9.82 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.114 1.366 . . . . 0.0 111.511 -172.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -70.32 -26.24 74.49 Favored Glycine 0 N--CA 1.472 1.089 0 CA-C-N 116.168 -0.469 . . . . 0.0 113.203 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 20.6 t -69.27 110.15 4.47 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.657 0.783 . . . . 0.0 109.875 177.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 34.0 m -69.53 103.09 1.97 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.035 0.934 . . . . 0.0 110.523 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -126.22 128.34 47.07 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.697 0.799 . . . . 0.0 109.493 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -118.43 141.3 48.69 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.144 0.978 . . . . 0.0 110.357 -175.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 41.1 p30 -151.6 -157.13 0.78 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.626 1.171 . . . . 0.0 108.502 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 142.09 -115.36 0.96 Allowed Glycine 0 C--N 1.345 1.039 0 CA-C-O 119.411 -0.661 . . . . 0.0 111.791 170.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -61.18 113.04 6.84 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.18 0.992 . . . . 0.0 110.559 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -63.74 150.65 87.95 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.649 2.233 . . . . 0.0 111.596 173.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.52 115.14 2.47 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.67 2.247 . . . . 0.0 110.482 174.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 85.5 mt -65.67 130.97 45.18 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 123.738 0.649 . . . . 0.0 110.557 -176.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 74.3 p -71.58 177.36 4.11 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.617 0.767 . . . . 0.0 112.176 -175.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 94.5 mt -67.05 173.52 3.66 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.542 0.737 . . . . 0.0 111.557 177.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 . . . . . 0 C--O 1.251 1.173 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.164 -177.982 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.482 1.135 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -69.54 129.76 18.4 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 123.181 2.587 . . . . 0.0 113.061 -172.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -139.12 127.14 22.35 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.806 0.842 . . . . 0.0 109.587 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.9 t -66.6 100.03 0.64 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.696 0.798 . . . . 0.0 110.144 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 66.9 ttt180 -109.73 130.42 55.52 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.307 0.643 . . . . 0.0 110.391 -177.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -92.36 97.73 11.05 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.699 0.8 . . . . 0.0 109.401 -178.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.9 mm -81.84 122.66 37.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.968 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.9 p -117.18 97.38 5.89 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.93 0.892 . . . . 0.0 110.292 -174.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -79.34 -27.74 42.03 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.828 0.851 . . . . 0.0 111.002 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.453 ' HB2' ' HG3' ' A' ' 97' ' ' GLU . 24.4 ptt? -119.02 141.43 48.7 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.776 0.83 . . . . 0.0 109.188 -177.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.8 m -68.69 160.23 30.64 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.067 0.947 . . . . 0.0 110.599 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 61.1 mt -62.43 -31.84 53.14 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 C-N-CA 122.809 0.443 . . . . 0.0 111.47 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.23 -54.14 49.29 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.511 0.324 . . . . 0.0 111.328 175.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.647 ' HA ' ' HB2' ' A' ' 100' ' ' ARG . 14.8 pt-20 -77.19 -18.31 57.85 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.029 0.531 . . . . 0.0 111.874 -177.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.497 HD12 ' ND2' ' A' ' 133' ' ' ASN . 6.0 tt -59.92 -43.75 94.73 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.37 1.068 . . . . 0.0 108.89 167.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.1 t -105.76 21.11 17.81 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.745 -176.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.647 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 30.8 tpt180 -67.45 133.1 48.91 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.802 0.441 . . . . 0.0 110.639 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -72.1 136.99 46.75 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 123.692 0.62 . . . . 0.0 109.8 174.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 20.4 p-90 -157.59 166.3 33.25 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.837 0.855 . . . . 0.0 109.485 176.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -142.62 144.02 32.63 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 123.547 0.739 . . . . 0.0 109.033 -176.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.543 ' SD ' ' HD2' ' A' ' 118' ' ' ARG . 67.4 mtp -85.48 105.51 16.15 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.2 tp -62.51 -36.36 82.3 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.192 0.997 . . . . 0.0 110.331 177.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.455 ' HG2' ' HB2' ' A' ' 122' ' ' ALA . 20.7 mmt -134.38 92.48 20.62 Favored Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 123.736 0.814 . . . . 0.0 109.153 168.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.49 ' HA ' ' HE2' ' A' ' 104' ' ' MET . 55.7 Cg_endo -67.24 112.95 2.69 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 123.165 2.577 . . . . 0.0 114.394 -176.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -109.54 117.96 35.35 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 161.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -107.72 113.44 26.71 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -125.88 103.31 7.71 Favored 'General case' 0 C--O 1.214 -0.767 0 C-N-CA 123.485 0.714 . . . . 0.0 109.516 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . 84.8 t -75.6 137.89 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 174.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -133.25 93.13 3.11 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-O 120.993 0.425 . . . . 0.0 109.963 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.15 -128.71 37.01 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.743 176.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -72.05 1.36 6.01 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 123.37 2.713 . . . . 0.0 114.126 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 4.3 mp -127.04 175.49 8.06 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.795 0.838 . . . . 0.0 109.411 -178.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.487 ' SG ' ' NH1' ' A' ' 118' ' ' ARG . 49.6 t -136.53 146.47 46.24 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 174.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.8 mm -116.22 147.32 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.309 1.044 . . . . 0.0 109.394 -174.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.543 ' HD2' ' SD ' ' A' ' 104' ' ' MET . 68.7 mmt-85 -119.54 127.31 52.88 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.049 0.939 . . . . 0.0 108.688 172.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.453 HD11 ' HA ' ' A' ' 181' ' ' LEU . 41.6 mm -122.84 125.59 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 173.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -93.45 116.86 29.4 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.402 ' HA ' HD22 ' A' ' 188' ' ' ASN . 80.3 mt-30 -78.51 -13.45 59.82 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.383 0.673 . . . . 0.0 112.257 -174.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.455 ' HB2' ' HG2' ' A' ' 106' ' ' MET . . . -82.86 -49.4 9.71 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.099 0.56 . . . . 0.0 110.791 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.405 HG12 HG11 ' A' ' 157' ' ' VAL . 1.8 mp -69.91 108.81 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-O 122.01 0.91 . . . . 0.0 109.731 -174.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.421 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 50.0 mtt -132.23 156.8 45.84 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 113.192 -1.822 . . . . 0.0 109.624 -177.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.0 t70 63.19 29.07 16.06 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.463 1.105 . . . . 0.0 111.801 173.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -115.0 149.56 37.21 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.569 0.748 . . . . 0.0 111.408 -179.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 152' ' ' GLU . 43.9 m-80 -83.52 107.29 15.9 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.506 HD12 HD22 ' A' ' 185' ' ' LEU . 50.2 mt -112.44 123.84 68.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-O 121.943 0.878 . . . . 0.0 111.105 -174.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 5.6 tpt -102.61 119.24 38.49 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 126.926 2.09 . . . . 0.0 108.905 -176.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 20.4 mt -95.25 104.9 16.8 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -115.43 144.8 43.27 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.192 0.597 . . . . 0.0 109.834 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -138.76 156.55 47.28 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.6 0.714 . . . . 0.0 112.479 -175.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.497 ' ND2' HD12 ' A' ' 98' ' ' LEU . 70.7 m-20 -113.6 119.38 37.28 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 165.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -153.1 157.96 41.18 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.416 0.686 . . . . 0.0 110.403 -167.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.0 p -89.66 156.8 18.32 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.345 0.658 . . . . 0.0 109.425 175.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.9 t -131.44 129.0 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.569 1.148 . . . . 0.0 109.325 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.5 tp -133.69 140.27 46.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 175.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 63.23 25.83 14.94 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.077 0.951 . . . . 0.0 111.604 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 66.13 15.73 10.19 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 124.986 1.314 . . . . 0.0 112.398 -176.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -127.27 171.19 11.69 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.471 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 7.0 tt -68.83 128.79 37.92 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -175.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -85.58 -69.61 0.65 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.757 0.823 . . . . 0.0 110.481 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 63.6 m -147.91 136.68 21.85 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.761 0.824 . . . . 0.0 109.05 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.434 HD21 HG11 ' A' ' 174' ' ' VAL . 47.6 tp -82.63 114.99 21.39 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.269 0.627 . . . . 0.0 109.58 177.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.0 mp -74.57 -50.8 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 175.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 49.4 tp -161.03 144.46 13.07 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.252 0.621 . . . . 0.0 109.464 178.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.605 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 7.6 tt -135.17 142.44 46.11 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 173.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.415 ' HB2' ' CE1' ' A' ' 150' ' ' PHE . 44.3 mtp85 -138.74 139.46 38.34 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -177.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.45 ' HB2' HD23 ' A' ' 181' ' ' LEU . . . -97.18 100.61 12.08 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -177.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.415 ' CE1' ' HB2' ' A' ' 148' ' ' ARG . 87.6 m-85 -96.56 124.55 40.58 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -177.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.508 ' HG1' ' HB3' ' A' ' 155' ' ' ALA . 58.6 p -67.5 178.84 1.47 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.266 0.555 . . . . 0.0 110.752 173.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.469 ' HB3' ' HB2' ' A' ' 127' ' ' ASN . 10.3 pt-20 -60.84 -22.21 63.99 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.371 1.068 . . . . 0.0 112.076 174.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -91.23 -1.35 57.71 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.075 0.95 . . . . 0.0 111.327 176.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 79.79 9.69 86.51 Favored Glycine 0 C--N 1.348 1.222 0 O-C-N 123.375 0.422 . . . . 0.0 113.148 -177.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.508 ' HB3' ' HG1' ' A' ' 151' ' ' THR . . . -87.25 120.8 28.91 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.69 0.796 . . . . 0.0 109.51 -174.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 16.1 mt -77.95 121.89 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -175.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.405 HG11 HG12 ' A' ' 123' ' ' ILE . 33.7 m -123.56 5.9 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.979 0.912 . . . . 0.0 110.948 -177.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -164.12 163.12 35.79 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -178.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -160.36 144.76 14.32 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.605 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 53.9 mt -123.71 115.54 45.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 172.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 18.4 p -138.84 132.34 16.1 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 122.902 0.481 . . . . 0.0 110.434 -175.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 31.1 Cg_endo -62.12 133.75 45.63 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.577 2.184 . . . . 0.0 111.875 176.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.2 mt -59.22 147.71 74.38 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 123.699 0.8 . . . . 0.0 111.256 177.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -64.04 -22.25 68.0 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.882 2.388 . . . . 0.0 112.439 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 39.8 m -78.52 -5.53 52.92 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.8 0.84 . . . . 0.0 111.936 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -131.93 94.91 23.45 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 124.146 0.978 . . . . 0.0 109.029 178.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -57.07 -32.98 94.85 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 123.56 2.84 . . . . 0.0 112.815 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.44 168.92 29.08 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.19 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -152.77 175.8 12.47 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.298 1.039 . . . . 0.0 109.867 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 6.3 m -96.15 162.33 13.58 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.533 0.733 . . . . 0.0 109.218 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 141' ' ' LEU . 9.2 tt -50.15 -33.74 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 124.606 1.162 . . . . 0.0 112.13 171.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -52.73 -48.25 66.81 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.48 1.112 . . . . 0.0 111.458 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -69.16 -36.33 77.26 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.741 -176.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.434 HG11 HD21 ' A' ' 144' ' ' LEU . 46.0 t -64.12 -48.88 83.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 O-C-N 123.948 0.78 . . . . 0.0 111.002 178.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -59.81 -40.72 89.34 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.638 0.775 . . . . 0.0 110.982 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.458 ' O ' HG22 ' A' ' 180' ' ' VAL . 89.4 m-20 -64.04 -46.26 85.21 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.871 176.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -61.76 -40.8 96.42 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.717 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 174' ' ' VAL . 66.6 mt -68.05 -37.5 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -65.72 -26.61 72.12 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 116.046 -0.524 . . . . 0.0 113.447 177.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.458 HG22 ' O ' ' A' ' 176' ' ' ASN . 98.3 t -75.59 -45.96 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.209 0.604 . . . . 0.0 109.916 175.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.453 ' HA ' HD11 ' A' ' 119' ' ' ILE . 42.6 tp -55.93 -52.5 63.92 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.342 0.657 . . . . 0.0 110.816 176.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.4 HG21 HG23 ' A' ' 192' ' ' VAL . 79.8 mt -60.13 -46.65 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.79 0.836 . . . . 0.0 110.595 176.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -52.65 -45.71 59.86 Favored Glycine 0 C--N 1.345 1.045 0 O-C-N 124.097 0.873 . . . . 0.0 114.156 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -68.14 -38.11 87.74 Favored Glycine 0 C--N 1.347 1.14 0 O-C-N 123.917 0.422 . . . . 0.0 112.538 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.506 HD22 HD12 ' A' ' 128' ' ' ILE . 97.5 mt -67.29 -34.12 76.73 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.484 0.713 . . . . 0.0 111.226 178.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -69.12 -38.81 79.07 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.59 0.756 . . . . 0.0 110.407 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -61.56 -41.35 97.24 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.191 174.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.421 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 6.7 m-20 -80.19 -2.86 46.64 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.965 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 61.68 57.03 2.33 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.054 0.941 . . . . 0.0 111.298 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -111.81 143.37 42.86 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.756 0.822 . . . . 0.0 109.146 174.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 96.0 m -78.64 102.84 8.2 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.4 HG23 HG21 ' A' ' 182' ' ' ILE . 26.7 m -86.7 143.0 12.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.418 -173.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -147.7 129.72 15.4 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 171.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 3.7 t -96.99 146.35 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 31.2 t -57.53 139.15 54.15 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 118.913 -0.565 . . . . 0.0 110.072 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -54.89 -37.89 66.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 123.497 0.498 . . . . 0.0 110.609 -177.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 41.1 p -62.02 -52.55 63.53 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.596 0.758 . . . . 0.0 109.541 176.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 68.9 mt -58.71 -28.09 65.49 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.61 0.764 . . . . 0.0 111.489 177.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.532 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 46.5 mt-30 -73.46 -42.74 61.56 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 119.021 -0.514 . . . . 0.0 112.191 -176.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.33 -20.78 20.05 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 119.541 1.064 . . . . 0.0 111.574 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -80.51 -41.78 23.65 Favored 'General case' 0 C--N 1.35 0.602 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.47 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -114.4 -60.59 1.87 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.059 0.543 . . . . 0.0 111.617 -176.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.532 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 46.1 t-105 -71.65 -15.77 62.24 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -161.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 153.49 -112.7 0.54 Allowed Glycine 0 C--N 1.339 0.723 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -178.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 58.2 m -149.73 96.5 2.48 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.43 0.692 . . . . 0.0 109.786 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 55.6 p -89.42 79.21 7.02 Favored 'General case' 0 C--N 1.351 0.657 0 CA-C-O 121.738 0.78 . . . . 0.0 108.933 171.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -139.11 91.31 2.5 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 174.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -67.66 83.13 0.18 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.852 0.861 . . . . 0.0 109.988 -173.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -79.04 116.0 19.07 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.383 -174.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -145.93 -118.42 1.14 Allowed Glycine 0 C--O 1.239 0.41 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 176.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 34.2 mtm-85 -120.16 139.44 28.45 Favored Pre-proline 0 C--O 1.243 0.732 0 C-N-CA 123.662 0.785 . . . . 0.0 109.416 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -61.0 127.56 22.66 Favored 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.542 2.162 . . . . 0.0 110.768 172.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -62.4 147.15 95.37 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.364 2.043 . . . . 0.0 111.525 173.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 78.8 mt -62.85 137.6 58.31 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 45.6 p -57.1 149.21 19.88 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.548 0.739 . . . . 0.0 112.11 -175.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 84.4 mt -67.25 95.44 0.42 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.573 0.749 . . . . 0.0 110.793 -175.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 . . . . . 0 C--O 1.251 1.17 0 CA-C-N 114.871 -1.058 . . . . 0.0 111.017 178.834 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 23.7 ptp . . . . . 0 N--CA 1.482 1.15 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.93 133.62 59.14 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 122.023 1.816 . . . . 0.0 110.987 166.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.72 98.0 0.09 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.817 0.847 . . . . 0.0 109.877 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 40.7 p -68.03 127.44 32.87 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.689 0.796 . . . . 0.0 110.482 -175.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -116.07 136.72 52.77 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.148 0.579 . . . . 0.0 110.523 -174.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -85.58 105.58 16.26 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 169.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.0 mm -77.6 120.45 28.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 175.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.4 p -100.85 66.54 1.18 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 132' ' ' ALA . 22.6 t70 -67.84 -29.15 68.22 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.755 176.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.711 ' HG3' ' HG3' ' A' ' 97' ' ' GLU . 32.7 ttp -104.84 129.42 53.16 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.724 1.61 . . . . 0.0 107.141 170.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 48.0 p -67.1 156.16 36.85 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 121.309 -0.87 . . . . 0.0 109.94 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -59.64 -35.3 58.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -57.87 -58.29 9.02 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.01 0.924 . . . . 0.0 112.175 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.711 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 12.5 pt-20 -71.15 -27.09 63.3 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 122.703 0.401 . . . . 0.0 111.05 -178.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.545 ' HG ' HD23 ' A' ' 146' ' ' LEU . 9.5 tt -60.71 -39.91 90.31 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.207 1.003 . . . . 0.0 110.201 171.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 81.1 p -107.07 19.96 19.69 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.277 0.631 . . . . 0.0 111.219 -177.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.533 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 2.5 tpm_? -69.78 140.15 53.34 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.879 0.871 . . . . 0.0 111.203 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -78.89 128.26 33.1 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 173.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 40.2 p-90 -150.65 168.13 25.25 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.064 0.946 . . . . 0.0 110.088 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -126.85 136.51 52.44 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.39 0.676 . . . . 0.0 109.795 178.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.531 ' HG2' ' HA ' ' A' ' 107' ' ' PRO . 43.7 ttp -94.31 93.06 7.51 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 167.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.2 tp -55.62 -53.73 52.93 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.718 1.207 . . . . 0.0 111.367 -168.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.488 ' HA ' ' HE3' ' A' ' 106' ' ' MET . 27.5 mmt -101.95 93.75 3.97 Favored Pre-proline 0 C--O 1.244 0.779 0 C-N-CA 124.145 0.978 . . . . 0.0 108.581 171.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.531 ' HA ' ' HG2' ' A' ' 104' ' ' MET . 7.0 Cg_exo -73.02 111.73 3.35 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 122.573 2.182 . . . . 0.0 112.345 -172.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -114.63 112.32 22.71 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 171.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -94.92 101.5 13.29 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -177.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.439 ' HE2' HG12 ' A' ' 180' ' ' VAL . 55.2 tptt -101.93 146.23 28.15 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 170.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 93.2 t -131.01 129.29 63.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 167.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -123.78 95.11 4.44 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.35 -137.12 21.42 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.549 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -82.08 20.4 1.1 Allowed 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 123.705 2.937 . . . . 0.0 113.075 173.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.465 HD11 HG22 ' A' ' 174' ' ' VAL . 87.5 mt -127.86 122.69 33.24 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.358 0.663 . . . . 0.0 109.618 -175.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 49.4 t -85.44 115.41 23.15 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.038 0.935 . . . . 0.0 110.099 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.6 mm -100.47 121.88 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.588 0.755 . . . . 0.0 109.363 -175.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 51.3 mtt-85 -103.09 119.84 39.58 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 34.9 mm -114.56 122.04 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.522 ' HB2' ' HG3' ' A' ' 104' ' ' MET . 18.8 t70 -97.04 113.09 24.61 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 170.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -77.25 -11.56 59.84 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.716 0.806 . . . . 0.0 112.127 -175.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.66 -62.51 1.56 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.321 0.649 . . . . 0.0 111.765 -174.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.7 mp -71.23 115.0 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-O 122.014 0.911 . . . . 0.0 110.883 -174.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 59.1 mtt -133.11 167.25 20.67 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 113.83 -1.532 . . . . 0.0 109.879 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.9 t70 55.17 42.15 30.88 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.636 1.174 . . . . 0.0 111.374 177.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 190' ' ' ASN . 45.5 mmtm -124.75 153.39 42.49 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.209 1.004 . . . . 0.0 110.145 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -88.3 106.36 18.17 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 172.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.471 HG12 HG21 ' A' ' 151' ' ' THR . 56.0 mt -107.88 136.08 44.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 124.702 1.201 . . . . 0.0 110.031 -174.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 11.8 tpt -115.41 138.16 51.29 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.422 1.089 . . . . 0.0 110.057 -175.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.524 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 3.4 mm? -92.64 117.71 30.26 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.975 0.91 . . . . 0.0 108.92 177.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.458 ' HB3' ' HB2' ' A' ' 93' ' ' MET . 73.5 mmtt -123.6 125.47 44.9 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.668 1.187 . . . . 0.0 109.211 176.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.509 ' HB1' ' HG ' ' A' ' 147' ' ' LEU . . . -137.49 144.43 42.22 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -175.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -106.29 130.77 54.08 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 169.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.403 ' HA ' HD12 ' A' ' 145' ' ' ILE . 4.9 p90 -162.87 157.46 21.32 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 124.15 0.906 . . . . 0.0 109.38 -172.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 22.2 p -85.65 152.1 23.36 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 172.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 87.6 t -121.84 138.51 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.847 0.859 . . . . 0.0 109.738 -177.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.0 tp -145.05 142.43 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 170.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 60.39 17.87 7.58 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.714 0.806 . . . . 0.0 112.757 177.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 73.87 21.08 2.75 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 126.566 1.947 . . . . 0.0 112.155 -177.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.413 ' HB2' HD11 ' A' ' 171' ' ' ILE . 10.8 ptp180 -125.39 172.19 9.82 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.938 0.895 . . . . 0.0 109.863 175.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.2 tt -69.32 119.56 13.78 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.365 0.666 . . . . 0.0 109.669 174.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -83.41 -65.93 0.95 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.319 1.047 . . . . 0.0 108.947 176.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 69.4 m -141.55 130.94 23.7 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.608 0.763 . . . . 0.0 109.028 175.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 52.9 tp -77.6 121.31 23.76 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.993 0.917 . . . . 0.0 109.812 174.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 134' ' ' PHE . 1.7 mp -81.94 -44.49 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.579 0.752 . . . . 0.0 109.458 176.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.545 HD23 ' HG ' ' A' ' 98' ' ' LEU . 34.0 tp -167.72 148.89 5.37 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.943 0.897 . . . . 0.0 108.714 173.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.7 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 8.3 tt -129.17 150.13 50.68 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 174.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.718 HH11 HG23 ' A' ' 156' ' ' ILE . 44.0 ttm-85 -143.1 143.57 31.89 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.379 0.672 . . . . 0.0 110.8 -173.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -124.22 118.8 27.65 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.437 1.095 . . . . 0.0 108.308 174.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -145.92 144.66 30.31 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.198 0.523 . . . . 0.0 111.018 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.471 HG21 HG12 ' A' ' 128' ' ' ILE . 55.3 p -65.41 171.51 3.9 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.616 -1.174 . . . . 0.0 112.197 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -65.3 -23.22 66.96 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.003 0.521 . . . . 0.0 110.821 172.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -66.12 -30.04 70.46 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.226 1.01 . . . . 0.0 110.234 174.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 107.3 -5.36 35.74 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.039 -174.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -70.26 105.14 2.87 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.434 0.694 . . . . 0.0 110.681 -175.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.718 HG23 HH11 ' A' ' 148' ' ' ARG . 33.3 mt -73.92 118.9 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.45 ' HB ' ' HB3' ' A' ' 120' ' ' ASP . 35.6 m -130.98 15.3 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.833 0.853 . . . . 0.0 110.648 -175.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -164.39 151.78 21.14 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -163.54 141.58 7.68 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.7 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 69.1 mt -113.13 102.74 14.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 170.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 20.7 t -98.93 108.49 49.4 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.135 0.974 . . . . 0.0 108.85 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.19 134.55 62.53 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.514 2.143 . . . . 0.0 111.318 175.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.9 mt -69.88 122.92 87.53 Favored Pre-proline 0 CA--C 1.551 1.001 0 O-C-N 123.531 0.52 . . . . 0.0 109.859 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -61.14 -17.84 54.69 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 123.785 2.99 . . . . 0.0 113.676 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 25.5 p -72.29 -14.22 61.7 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 124.076 0.95 . . . . 0.0 112.277 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -120.69 100.8 46.38 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 124.568 1.147 . . . . 0.0 108.271 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.42 -49.03 17.47 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.229 2.619 . . . . 0.0 113.145 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -125.25 155.35 18.72 Favored Glycine 0 C--N 1.35 1.321 0 CA-C-N 116.45 -0.341 . . . . 0.0 112.684 -175.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -150.63 154.79 38.15 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.496 1.118 . . . . 0.0 109.558 176.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.403 ' O ' HG21 ' A' ' 174' ' ' VAL . 80.7 p -87.69 151.4 22.96 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.064 0.546 . . . . 0.0 110.385 -174.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.434 ' O ' ' HG3' ' A' ' 175' ' ' LYS . 8.3 tt -58.52 -38.76 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 O-C-N 123.99 0.806 . . . . 0.0 111.129 175.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 47.2 mp0 -55.54 -41.57 73.4 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.086 0.955 . . . . 0.0 110.461 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -67.38 -47.19 71.08 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.556 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.48 ' O ' HG13 ' A' ' 178' ' ' ILE . 57.4 t -61.53 -34.28 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 122.974 0.509 . . . . 0.0 110.959 -176.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 171' ' ' ILE . 39.2 mtpt -61.05 -34.7 75.3 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.247 0.619 . . . . 0.0 111.781 177.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -68.0 -47.65 67.94 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.35 -45.11 84.68 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 124.374 1.046 . . . . 0.0 112.249 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.509 ' HB ' ' HZ3' ' A' ' 203' ' ' TRP . 23.2 mt -72.06 -37.57 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -64.8 -27.47 72.12 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 116.126 -0.488 . . . . 0.0 113.003 177.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.439 HG12 ' HE2' ' A' ' 110' ' ' LYS . 54.1 t -83.15 -39.91 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.746 0.818 . . . . 0.0 110.203 177.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.471 HD22 HG13 ' A' ' 160' ' ' ILE . 58.7 tp -58.52 -53.03 62.95 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.084 0.554 . . . . 0.0 110.406 174.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.618 HG22 HG21 ' A' ' 192' ' ' VAL . 70.4 mt -59.28 -43.48 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.44 1.096 . . . . 0.0 110.278 173.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -58.53 -35.0 78.16 Favored Glycine 0 CA--C 1.533 1.203 0 O-C-N 123.886 0.741 . . . . 0.0 113.83 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -72.39 -35.49 59.91 Favored Glycine 0 C--N 1.349 1.292 0 N-CA-C 111.847 -0.501 . . . . 0.0 111.847 175.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.411 HD21 HD13 ' A' ' 128' ' ' ILE . 75.3 mt -71.06 -25.25 62.56 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 124.297 1.039 . . . . 0.0 111.252 175.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 26.9 mm-40 -70.85 -37.78 73.13 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.713 0.805 . . . . 0.0 110.06 174.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -73.83 -31.68 63.33 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.293 177.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -72.6 -14.72 61.68 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.088 169.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 15.6 t70 57.3 64.85 1.5 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.629 1.172 . . . . 0.0 110.313 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 10.5 p30 -131.84 165.73 23.18 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.671 174.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 42.3 m -87.78 106.39 18.04 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.507 -172.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.618 HG21 HG22 ' A' ' 182' ' ' ILE . 34.3 m -94.81 141.98 14.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.763 0 C-N-CA 122.918 0.487 . . . . 0.0 110.689 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -144.76 131.3 19.87 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.233 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.524 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 5.2 t -95.69 149.51 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.401 ' HB2' ' HG ' ' A' ' 198' ' ' LEU . 69.9 m -67.44 144.59 55.66 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 118.95 0.795 . . . . 0.0 110.947 177.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -60.22 -26.29 66.28 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.079 0.952 . . . . 0.0 111.797 -177.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.0 p -67.68 -53.18 29.74 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 172.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.489 ' HB2' HG13 ' A' ' 194' ' ' VAL . 68.1 mt -62.91 -25.61 68.41 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.881 0.873 . . . . 0.0 111.506 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.586 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 78.3 mt-30 -69.24 -44.12 72.65 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.224 0.61 . . . . 0.0 110.824 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.08 -30.0 20.22 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.662 -175.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -83.3 -57.89 3.07 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.548 0.339 . . . . 0.0 110.803 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -98.73 -37.37 9.51 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.16 0.584 . . . . 0.0 111.703 -165.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.586 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 43.4 t-105 -101.24 19.09 18.3 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.275 1.03 . . . . 0.0 109.415 -170.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -70.33 163.44 52.87 Favored Glycine 0 C--N 1.356 1.668 0 CA-C-N 115.96 -0.564 . . . . 0.0 113.336 -176.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 24.2 t -58.66 113.32 1.97 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.838 0.855 . . . . 0.0 111.26 -175.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 37.3 t -143.78 -178.43 5.91 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.266 1.026 . . . . 0.0 109.439 -173.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -72.7 103.0 3.48 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 165.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -69.79 86.84 0.51 Allowed 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.94 0.896 . . . . 0.0 109.189 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -61.74 122.84 16.35 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.907 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -161.57 122.69 1.13 Allowed Glycine 0 C--N 1.334 0.425 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -177.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.9 155.7 80.01 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 123.874 0.87 . . . . 0.0 109.686 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.42 134.7 42.82 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.437 2.092 . . . . 0.0 111.466 -178.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -61.48 151.62 78.6 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.772 2.315 . . . . 0.0 112.385 179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 65.0 mt -69.48 96.38 0.9 Allowed 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.855 0.862 . . . . 0.0 109.709 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 51.0 p -70.83 148.85 47.43 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.091 0.557 . . . . 0.0 111.049 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 34.3 mt -86.14 143.05 28.22 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.448 0.699 . . . . 0.0 109.665 -175.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 . . . . . 0 CA--C 1.556 1.194 0 C-N-CA 123.688 0.795 . . . . 0.0 108.869 -179.245 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 49.8 tpp . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -68.64 130.62 21.12 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 122.665 2.244 . . . . 0.0 111.394 175.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.93 93.61 0.09 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.012 0.925 . . . . 0.0 111.414 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 34.3 t -79.42 72.3 6.03 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 171.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -128.27 133.67 48.81 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.465 -168.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -86.47 105.03 16.49 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 175.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 49.9 mm -78.73 125.89 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 62.4 p -114.26 91.42 3.62 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.641 -176.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -75.51 -17.84 59.99 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.182 0.593 . . . . 0.0 110.703 177.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.506 ' SD ' ' HB3' ' A' ' 148' ' ' ARG . 61.1 mtm -117.22 128.72 55.38 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.456 1.103 . . . . 0.0 108.943 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.4 m -77.82 162.15 27.11 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 171.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -48.55 -35.41 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 124.402 1.081 . . . . 0.0 111.763 -177.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -51.58 -71.14 0.07 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.211 1.404 . . . . 0.0 112.207 177.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -69.11 -29.84 67.99 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.528 0.731 . . . . 0.0 111.744 -176.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.8 tt -62.5 -43.1 99.63 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.235 1.014 . . . . 0.0 109.263 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.2 m -105.23 15.18 27.85 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.738 0.815 . . . . 0.0 111.815 -175.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -80.88 135.47 35.92 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.159 0.583 . . . . 0.0 110.222 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -88.22 144.87 26.19 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.776 0.83 . . . . 0.0 109.306 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 18.5 p-90 -152.42 154.29 35.26 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.192 0.997 . . . . 0.0 110.465 -173.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -96.42 160.47 14.39 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.538 0.735 . . . . 0.0 110.791 -177.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 65.9 mtp -128.74 116.88 20.21 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 170.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.3 tt -70.71 -54.78 10.51 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.466 ' HE2' ' HA ' ' A' ' 106' ' ' MET . 21.5 mmt -119.22 86.56 33.03 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 124.126 0.97 . . . . 0.0 109.378 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -76.67 113.61 3.69 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 122.837 2.358 . . . . 0.0 112.493 -175.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.533 ' HE3' ' HB2' ' A' ' 110' ' ' LYS . 51.4 tptt -90.59 106.69 18.68 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 169.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 51.2 tp60 -90.92 107.27 19.09 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.146 -0.933 . . . . 0.0 108.698 176.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.533 ' HB2' ' HE3' ' A' ' 108' ' ' LYS . 58.7 tttm -140.12 143.44 36.23 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.992 172.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 68.0 t -105.67 147.24 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 169.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -134.66 90.75 2.69 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 174.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.3 -136.37 21.21 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 114.823 -1.08 . . . . 0.0 112.687 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -81.43 17.9 1.42 Allowed 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 123.687 2.925 . . . . 0.0 113.148 176.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.3 mp -134.87 136.42 42.39 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.745 0.818 . . . . 0.0 108.91 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 26.4 p -100.82 138.83 37.35 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.105 0.562 . . . . 0.0 110.085 177.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.2 mm -106.72 133.94 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.326 1.05 . . . . 0.0 110.637 -171.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -108.84 118.18 36.12 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 173.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.496 ' HB ' ' HB3' ' A' ' 108' ' ' LYS . 87.0 mt -126.97 125.63 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -97.03 117.73 31.85 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 118.78 0.718 . . . . 0.0 109.331 173.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -78.5 -8.31 58.41 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.303 1.041 . . . . 0.0 112.506 -172.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.41 -26.33 23.36 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.676 0.39 . . . . 0.0 110.292 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 41.2 mm -81.89 102.15 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 121.997 0.904 . . . . 0.0 110.995 -173.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.511 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 52.1 mtt -134.09 160.47 37.67 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 114.253 -1.34 . . . . 0.0 108.763 -178.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.8 t70 65.34 24.56 12.1 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.719 0.771 . . . . 0.0 111.64 174.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 190' ' ' ASN . 74.9 mmtt -117.45 148.61 41.65 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.236 1.014 . . . . 0.0 110.66 -179.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.8 106.48 17.73 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 171.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.503 HD11 HD23 ' A' ' 185' ' ' LEU . 50.1 mt -102.28 128.63 54.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.893 0.877 . . . . 0.0 111.25 -174.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.544 ' HG3' ' HG3' ' A' ' 131' ' ' LYS . 4.0 tpt -98.99 116.38 31.1 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.064 1.746 . . . . 0.0 109.636 -176.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -98.57 104.7 16.76 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.544 ' HG3' ' HG3' ' A' ' 129' ' ' MET . 47.3 mtmt -127.17 149.58 49.91 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.166 0.586 . . . . 0.0 110.975 -177.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.468 ' HB2' HD21 ' A' ' 198' ' ' LEU . . . -141.4 149.93 41.7 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -173.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -100.25 118.88 37.46 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 163.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -151.91 159.18 43.89 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.157 0.583 . . . . 0.0 110.964 -171.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.8 m -86.36 150.52 24.27 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.787 1.235 . . . . 0.0 109.703 177.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 98.2 t -122.4 145.62 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 175.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.43 HG21 ' HB2' ' A' ' 142' ' ' GLU . 9.7 tp -162.67 145.48 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 167.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 56.29 25.68 9.61 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 124.043 0.937 . . . . 0.0 112.606 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 69.72 25.52 5.12 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 125.781 1.632 . . . . 0.0 112.487 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.521 ' HB2' HD11 ' A' ' 171' ' ' ILE . 1.2 ptp85 -132.56 171.65 13.54 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.325 0.65 . . . . 0.0 110.902 175.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.7 tt -74.44 114.07 12.41 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 114.904 -1.043 . . . . 0.0 108.662 172.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.43 ' HB2' HG21 ' A' ' 137' ' ' ILE . 9.4 tp10 -73.45 -61.84 1.69 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.902 0.881 . . . . 0.0 110.247 175.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 65.4 m -146.32 127.53 14.76 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.99 0.916 . . . . 0.0 109.438 -175.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.465 HD12 ' HB1' ' A' ' 132' ' ' ALA . 36.7 tp -74.06 125.23 27.84 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 172.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.9 mp -83.35 -48.51 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 172.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.54 HD22 ' NH2' ' A' ' 148' ' ' ARG . 46.5 tp -165.26 147.42 7.8 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.687 0.795 . . . . 0.0 109.626 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.632 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 8.9 tt -129.62 156.75 43.7 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 171.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.748 ' HD3' HD13 ' A' ' 156' ' ' ILE . 48.4 ttm-85 -154.07 141.16 19.39 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.082 0.553 . . . . 0.0 110.733 -175.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.98 121.14 44.51 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.627 1.171 . . . . 0.0 109.411 -177.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -110.99 155.94 21.98 Favored 'General case' 0 C--O 1.208 -1.087 0 C-N-CA 124.74 1.216 . . . . 0.0 108.541 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 24.9 p -100.18 168.3 9.9 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 118.852 0.751 . . . . 0.0 109.833 168.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.8 -21.17 62.51 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 172.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -61.7 -30.27 70.64 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.103 0.961 . . . . 0.0 111.422 169.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 99.21 14.31 36.36 Favored Glycine 0 C--N 1.346 1.116 0 O-C-N 123.714 0.634 . . . . 0.0 112.84 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -101.1 135.11 43.09 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.41 0.684 . . . . 0.0 109.957 176.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.748 HD13 ' HD3' ' A' ' 148' ' ' ARG . 47.1 mt -78.93 127.13 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 174.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.6 m -127.01 1.41 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.636 0.774 . . . . 0.0 112.435 -171.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -164.81 170.03 39.73 Favored Glycine 0 C--N 1.344 0.973 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 34.6 tt0 -167.67 153.75 7.63 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.04 0.936 . . . . 0.0 109.139 -177.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.632 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 70.6 mt -129.4 104.23 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 167.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 5.4 p -109.95 121.84 40.71 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 123.85 0.86 . . . . 0.0 109.627 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -62.53 140.11 79.81 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.752 2.301 . . . . 0.0 111.824 175.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 96.6 mt -72.72 123.25 89.33 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 123.744 0.818 . . . . 0.0 110.543 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.54 -10.48 29.16 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 123.361 2.707 . . . . 0.0 112.75 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 27.4 p -81.39 -1.87 47.23 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 124.06 0.944 . . . . 0.0 111.557 173.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -129.54 99.04 21.4 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 124.75 1.22 . . . . 0.0 108.567 177.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -71.71 79.16 1.61 Allowed 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 123.155 2.57 . . . . 0.0 112.688 177.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 108.16 156.47 18.88 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 115.959 -0.564 . . . . 0.0 113.925 173.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -151.4 172.13 16.42 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.069 1.348 . . . . 0.0 109.781 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 59.1 p -98.23 166.08 11.57 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 123.31 0.644 . . . . 0.0 110.268 174.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.571 HD12 ' HA ' ' A' ' 202' ' ' ALA . 12.7 tt -52.78 -35.84 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 124.189 0.996 . . . . 0.0 110.882 170.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -59.72 -44.71 93.61 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.55 1.14 . . . . 0.0 111.469 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -63.34 -43.69 97.01 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 124.105 0.878 . . . . 0.0 111.093 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.477 ' O ' HG13 ' A' ' 178' ' ' ILE . 67.3 t -64.07 -42.91 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.944 -178.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -62.14 -36.84 83.03 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.028 0.531 . . . . 0.0 111.634 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -66.29 -43.99 84.77 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 175.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -59.33 -44.69 92.58 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.232 1.013 . . . . 0.0 111.719 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 174' ' ' VAL . 51.3 mt -70.38 -35.99 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.27 0.628 . . . . 0.0 109.661 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.96 -27.17 73.31 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 116.22 -0.445 . . . . 0.0 113.723 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 45.5 t -75.2 -47.03 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.499 0.72 . . . . 0.0 110.614 175.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 30.0 tp -60.89 -52.76 63.66 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 123.748 0.655 . . . . 0.0 110.573 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.411 HG22 HG13 ' A' ' 192' ' ' VAL . 65.3 mt -65.85 -46.8 87.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.77 0.828 . . . . 0.0 111.149 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -58.13 -34.48 73.35 Favored Glycine 0 C--N 1.345 1.075 0 O-C-N 123.599 0.562 . . . . 0.0 113.396 177.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.5 -47.04 92.35 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 172.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.503 HD23 HD11 ' A' ' 128' ' ' ILE . 93.8 mt -64.54 -29.25 70.28 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.787 1.235 . . . . 0.0 111.92 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -69.68 -41.55 75.29 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.519 0.728 . . . . 0.0 110.493 177.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 20.6 mtm180 -74.53 -26.88 60.26 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.891 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.511 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 16.0 m120 -71.99 -20.07 61.78 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.237 0.615 . . . . 0.0 111.152 172.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 65.66 66.3 0.52 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.528 1.131 . . . . 0.0 110.831 -173.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 11.6 p30 -136.57 158.26 44.86 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.156 168.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 86.2 m -83.65 105.93 14.96 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.616 0.766 . . . . 0.0 110.588 -170.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.411 HG13 HG22 ' A' ' 182' ' ' ILE . 33.0 m -83.18 145.41 8.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 C-N-CA 123.153 0.581 . . . . 0.0 110.308 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -146.16 125.13 12.76 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 170.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 3.0 t -93.46 149.16 4.37 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -177.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 43.0 t -59.7 141.45 55.1 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.736 0.414 . . . . 0.0 110.235 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -52.61 -38.66 60.59 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.06 0.944 . . . . 0.0 111.443 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 68.6 p -67.54 -49.73 61.92 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.331 1.052 . . . . 0.0 110.647 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.468 HD21 ' HB2' ' A' ' 132' ' ' ALA . 71.5 mt -59.67 -34.81 73.33 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.714 0.805 . . . . 0.0 110.922 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.57 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 50.5 mt-30 -63.65 -54.53 34.26 Favored 'General case' 0 C--N 1.348 0.543 0 O-C-N 123.88 0.737 . . . . 0.0 110.974 178.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.39 -12.81 53.77 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -172.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -96.0 -40.43 9.27 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 118.058 0.39 . . . . 0.0 111.764 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.571 ' HA ' HD12 ' A' ' 171' ' ' ILE . . . -121.82 -61.49 1.5 Allowed 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -172.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.57 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 60.3 t-105 -64.3 -32.63 74.31 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.378 1.071 . . . . 0.0 112.323 -164.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -110.84 -53.44 0.55 Allowed Glycine 0 C--N 1.341 0.825 0 C-N-CA 123.709 0.671 . . . . 0.0 111.629 -173.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 47.8 m -94.93 112.74 24.42 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 69.5 m -150.9 82.96 1.33 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.98 1.312 . . . . 0.0 108.288 169.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -133.31 103.6 6.05 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.434 ' HB3' ' NH2' ' A' ' 140' ' ' ARG . 0.1 OUTLIER -147.3 136.5 22.47 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.264 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -165.07 85.25 0.4 Allowed 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -175.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -79.92 -53.24 4.31 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.942 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 52.7 mtm180 64.86 118.28 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.398 0 C-N-CA 125.554 1.542 . . . . 0.0 112.096 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -69.05 152.38 72.99 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.585 2.19 . . . . 0.0 111.274 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.31 113.84 1.67 Allowed 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.693 2.262 . . . . 0.0 111.567 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 66.3 mt -63.82 101.65 0.39 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.641 0.777 . . . . 0.0 109.996 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 71.6 p -74.64 144.0 44.05 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.19 0.519 . . . . 0.0 111.356 -174.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 30.6 mt -108.98 -179.5 3.87 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.039 0.935 . . . . 0.0 109.944 -175.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 . . . . . 0 C--O 1.249 1.037 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.965 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 61.7 mtt . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -63.71 162.75 27.05 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 123.507 2.805 . . . . 0.0 112.949 179.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.47 111.71 6.22 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 175.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.2 p -68.54 124.04 22.49 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.347 0.659 . . . . 0.0 110.07 177.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 45.0 ttm180 -118.66 140.1 50.47 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.076 0.55 . . . . 0.0 111.134 -173.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -96.85 111.05 23.41 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 170.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 133' ' ' ASN . 48.2 mm -83.05 117.69 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 170.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 37.7 p -113.5 88.49 2.85 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.017 0.927 . . . . 0.0 109.06 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -68.81 -31.06 69.78 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.456 177.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.443 ' HE3' ' HG ' ' A' ' 98' ' ' LEU . 24.5 ptt? -121.31 142.88 49.53 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.816 0.847 . . . . 0.0 108.934 178.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 68.5 p -78.96 163.07 25.53 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.767 0.318 . . . . 0.0 110.297 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.46 -31.42 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.291 0 C-N-CA 124.863 1.265 . . . . 0.0 111.995 -176.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -54.34 -69.58 0.12 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.269 1.027 . . . . 0.0 112.363 178.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.9 pm0 -69.02 -25.19 64.37 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.007 0.523 . . . . 0.0 111.758 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.443 ' HG ' ' HE3' ' A' ' 93' ' ' MET . 6.4 tt -59.67 -48.79 80.27 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.479 0.712 . . . . 0.0 109.386 176.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.8 t -106.77 19.24 20.76 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.203 0.601 . . . . 0.0 111.202 -175.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -77.58 140.59 39.71 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.689 0.796 . . . . 0.0 110.242 174.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -91.67 145.72 24.36 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.545 0.738 . . . . 0.0 110.459 174.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.548 ' HH2' ' HG2' ' A' ' 118' ' ' ARG . 42.3 p-90 -158.41 179.77 8.83 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.929 1.292 . . . . 0.0 109.78 -172.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -139.72 158.36 44.23 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.333 0.653 . . . . 0.0 110.513 177.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.513 ' HE1' ' HA ' ' A' ' 107' ' ' PRO . 71.0 mtm -105.99 145.62 31.12 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.741 0.816 . . . . 0.0 109.334 171.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.9 tp -82.2 -40.15 22.11 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.189 0.596 . . . . 0.0 110.177 -175.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 19.7 mmt -122.68 88.74 49.95 Favored Pre-proline 0 N--CA 1.484 1.236 0 C-N-CA 124.562 1.145 . . . . 0.0 108.666 169.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.513 ' HA ' ' HE1' ' A' ' 104' ' ' MET . 17.4 Cg_exo -68.27 131.96 24.69 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.622 2.215 . . . . 0.0 113.307 -178.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.452 ' HD2' HE21 ' A' ' 121' ' ' GLN . 86.9 tttt -135.57 135.91 40.69 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.404 1.082 . . . . 0.0 108.372 171.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -112.82 124.15 51.93 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.11 0.564 . . . . 0.0 110.144 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -125.53 150.06 47.76 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 168.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 12.9 t -126.81 142.51 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 172.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -138.68 98.12 3.5 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 68.69 -127.25 22.56 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 119.351 -0.694 . . . . 0.0 112.162 -177.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -89.45 14.75 2.12 Favored 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 123.483 2.789 . . . . 0.0 112.803 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.518 HD22 ' HA ' ' A' ' 162' ' ' PRO . 93.9 mt -128.03 122.44 32.21 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.931 0.492 . . . . 0.0 110.096 -172.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 40.2 t -83.05 116.9 22.5 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.345 1.058 . . . . 0.0 109.702 177.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 10.4 mm -90.81 115.96 31.09 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 C-N-CA 123.777 0.831 . . . . 0.0 109.287 -177.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.548 ' HG2' ' HH2' ' A' ' 102' ' ' TRP . 7.9 tpt180 -94.7 118.53 31.88 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 43.9 mm -123.3 134.39 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.531 0.732 . . . . 0.0 109.509 -176.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -117.97 120.87 39.13 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.445 0.698 . . . . 0.0 109.153 174.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.452 HE21 ' HD2' ' A' ' 108' ' ' LYS . 82.4 mt-30 -82.98 -1.24 52.0 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.949 0.9 . . . . 0.0 112.893 -177.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.13 -56.92 3.12 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 117.934 0.334 . . . . 0.0 111.455 -173.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.458 HG22 ' HG3' ' A' ' 126' ' ' LYS . 2.0 mp -70.14 104.07 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-O 121.938 0.875 . . . . 0.0 110.314 -175.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.41 ' HE3' ' O ' ' A' ' 121' ' ' GLN . 51.9 mtt -126.56 159.42 33.53 Favored 'General case' 0 C--N 1.348 0.508 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.964 178.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.71 33.84 21.94 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.608 0.763 . . . . 0.0 112.294 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.458 ' HG3' HG22 ' A' ' 123' ' ' ILE . 74.1 mmtt -114.49 155.23 26.79 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.461 0.705 . . . . 0.0 110.594 176.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.436 ' HB2' ' HB3' ' A' ' 152' ' ' GLU . 0.8 OUTLIER -89.73 101.63 14.32 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 170.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.486 ' HB ' HG13 ' A' ' 192' ' ' VAL . 66.5 mt -101.77 139.73 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.535 0.734 . . . . 0.0 109.431 -172.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 14.2 tpt -123.0 127.03 48.24 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.822 0.849 . . . . 0.0 109.649 -175.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 22.8 mt -99.15 104.59 16.58 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -176.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.431 ' HB2' ' HE1' ' A' ' 150' ' ' PHE . 2.8 mtpm? -117.23 130.72 56.76 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -175.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -133.52 152.69 51.94 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 122.016 0.912 . . . . 0.0 112.782 -170.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.428 ' ND2' HD13 ' A' ' 98' ' ' LEU . 5.2 m-20 -108.22 125.35 51.55 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 168.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -155.48 159.09 39.51 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.297 0.639 . . . . 0.0 111.083 -172.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.485 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . 37.9 m -90.12 161.69 15.66 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.985 0.914 . . . . 0.0 110.94 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 70.9 t -139.88 130.81 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 124.263 1.025 . . . . 0.0 110.075 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.559 HG21 ' HG2' ' A' ' 142' ' ' GLU . 9.1 tp -146.89 144.7 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 170.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 57.55 24.69 10.66 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.622 0.769 . . . . 0.0 111.628 -178.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 63.4 30.36 15.46 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.824 1.25 . . . . 0.0 112.28 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -131.9 165.45 23.86 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.615 0.766 . . . . 0.0 109.458 171.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.471 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 9.8 tt -70.9 129.39 38.91 Favored 'General case' 0 CA--C 1.554 1.096 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.559 ' HG2' HG21 ' A' ' 137' ' ' ILE . 31.8 mt-10 -83.88 -67.52 0.79 Allowed 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.698 0.761 . . . . 0.0 109.736 173.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 27.6 m -144.85 138.75 27.24 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.9 -170.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.423 HD23 HG13 ' A' ' 174' ' ' VAL . 56.5 tp -84.2 112.36 20.2 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.077 0.551 . . . . 0.0 109.577 175.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.13 -51.42 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 174.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.413 HD23 ' NH2' ' A' ' 148' ' ' ARG . 35.2 tp -170.6 149.13 3.15 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.321 177.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.522 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 10.0 tt -124.0 150.97 44.24 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 172.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.476 ' HD3' HD13 ' A' ' 156' ' ' ILE . 32.5 ttm-85 -143.31 135.09 26.61 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 122.671 0.388 . . . . 0.0 110.265 -178.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.06 113.73 27.44 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.431 ' HE1' ' HB2' ' A' ' 131' ' ' LYS . 17.4 m-85 -103.62 166.0 10.69 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 57.6 p -93.98 -179.44 4.97 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 120.949 0.404 . . . . 0.0 110.125 166.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.436 ' HB3' ' HB2' ' A' ' 127' ' ' ASN . 13.3 pt-20 -61.94 -26.64 68.31 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.343 1.057 . . . . 0.0 110.913 172.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -77.57 -29.42 52.08 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.854 1.262 . . . . 0.0 110.815 174.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 103.96 11.03 33.29 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.908 -178.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.32 124.35 27.38 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.143 0.577 . . . . 0.0 109.503 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.476 HD13 ' HD3' ' A' ' 148' ' ' ARG . 54.9 mt -75.47 107.18 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -178.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.6 m -117.21 4.01 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.303 1.041 . . . . 0.0 111.869 -173.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -168.45 172.34 42.94 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-N 116.509 -0.314 . . . . 0.0 112.453 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -166.78 153.58 8.84 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.738 0.815 . . . . 0.0 109.394 -175.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.568 HD13 ' HB2' ' A' ' 181' ' ' LEU . 40.3 mm -124.95 103.58 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 164.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 55.9 p -102.68 126.95 31.35 Favored Pre-proline 0 N--CA 1.474 0.733 0 C-N-CA 123.146 0.578 . . . . 0.0 110.545 -177.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.518 ' HA ' HD22 ' A' ' 115' ' ' LEU . 56.4 Cg_endo -67.3 150.01 81.21 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 122.163 1.908 . . . . 0.0 112.015 175.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 77.0 mt -76.22 145.4 76.56 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.12 -27.54 78.98 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.906 2.404 . . . . 0.0 112.487 -176.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 24.2 m -74.32 -24.67 59.24 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.547 0.739 . . . . 0.0 111.567 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -131.8 71.47 80.58 Favored Pre-proline 0 N--CA 1.488 1.445 0 C-N-CA 123.23 0.612 . . . . 0.0 111.171 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -84.47 -6.09 10.01 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.657 2.238 . . . . 0.0 111.823 174.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -125.45 66.18 0.54 Allowed Glycine 0 C--N 1.347 1.151 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.437 ' CE1' HD21 ' A' ' 115' ' ' LEU . 27.2 p-80 -90.62 -175.68 4.5 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.857 0.863 . . . . 0.0 109.763 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 42.6 m -110.99 161.83 15.47 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.596 0.758 . . . . 0.0 110.315 -174.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 141' ' ' LEU . 6.8 tt -45.94 -39.14 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.996 1.318 . . . . 0.0 112.498 173.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.583 ' HA ' ' NZ ' ' A' ' 175' ' ' LYS . 22.9 mm-40 -53.41 -48.87 68.32 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.262 1.025 . . . . 0.0 112.085 -176.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -61.11 -40.24 93.01 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 124.653 1.221 . . . . 0.0 110.813 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.423 HG13 HD23 ' A' ' 144' ' ' LEU . 41.1 t -66.8 -40.13 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.242 -175.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.583 ' NZ ' ' HA ' ' A' ' 172' ' ' GLU . 25.9 mtmm -60.39 -42.02 95.01 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 120.984 0.421 . . . . 0.0 110.009 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.488 ' O ' HG21 ' A' ' 180' ' ' VAL . 13.4 m120 -62.92 -48.51 78.64 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.653 175.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -59.68 -48.01 83.36 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.997 0.811 . . . . 0.0 112.616 -173.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.8 mt -63.57 -37.8 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.283 175.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.44 -30.82 77.22 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 115.578 -0.737 . . . . 0.0 114.432 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.488 HG21 ' O ' ' A' ' 176' ' ' ASN . 44.9 t -76.03 -43.15 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 117.79 0.795 . . . . 0.0 108.994 176.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.568 ' HB2' HD13 ' A' ' 160' ' ' ILE . 37.8 tp -53.38 -53.19 54.75 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.339 176.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.415 HD13 ' CH2' ' A' ' 203' ' ' TRP . 43.1 mt -64.1 -39.76 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.898 0.879 . . . . 0.0 110.716 174.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -53.12 -35.56 49.62 Favored Glycine 0 CA--C 1.533 1.214 0 O-C-N 123.466 0.478 . . . . 0.0 114.088 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -83.43 -39.45 9.8 Favored Glycine 0 C--N 1.348 1.235 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 175.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 46.1 mt -66.21 -31.67 72.65 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.168 0.987 . . . . 0.0 112.437 -176.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -69.57 -33.58 72.94 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.743 0.417 . . . . 0.0 110.329 176.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -71.32 -32.83 69.07 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.181 176.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -63.31 -16.99 62.04 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.141 0.576 . . . . 0.0 111.767 171.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 63.5 65.78 0.73 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.976 0.91 . . . . 0.0 110.136 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -141.0 175.9 9.24 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.069 176.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 90.9 m -109.91 101.91 10.71 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.106 0.563 . . . . 0.0 109.582 -173.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.486 HG13 ' HB ' ' A' ' 128' ' ' ILE . 12.7 m -99.82 153.87 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 121.535 0.683 . . . . 0.0 111.357 -177.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -136.56 143.91 43.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.174 -1.375 . . . . 0.0 108.305 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 3.3 t -111.06 145.88 16.79 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 47.4 m -57.93 140.66 51.62 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 118.014 0.37 . . . . 0.0 111.043 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -57.94 -29.91 65.53 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.291 0.636 . . . . 0.0 110.802 177.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 41.3 p -67.98 -52.64 33.52 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.784 0.834 . . . . 0.0 109.561 176.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 32.5 mt -54.58 -38.29 66.52 Favored 'General case' 0 C--O 1.208 -1.106 0 C-N-CA 123.871 0.868 . . . . 0.0 111.057 176.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.636 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 49.4 mt-30 -71.14 -39.74 71.8 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.258 0.623 . . . . 0.0 111.962 -176.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.29 -12.03 44.74 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -177.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -101.59 -42.53 6.19 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 178.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.439 ' HB2' HD11 ' A' ' 141' ' ' LEU . . . -123.42 -61.58 1.39 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.159 0.584 . . . . 0.0 112.243 -172.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.636 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 52.6 t-105 -70.49 79.39 0.57 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.841 1.257 . . . . 0.0 111.084 -171.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -112.09 -50.76 0.57 Allowed Glycine 0 C--O 1.242 0.652 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 170.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 31.5 m -141.86 87.52 2.05 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.604 0.762 . . . . 0.0 108.967 173.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.525 ' HA ' ' HB3' ' A' ' 175' ' ' LYS . 68.9 p -59.01 -46.28 88.57 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.678 0.791 . . . . 0.0 110.262 177.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 16.6 m120 61.75 19.36 10.48 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.412 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -96.46 84.07 3.64 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -87.17 86.36 7.28 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.578 -175.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -72.11 76.33 0.74 Allowed Glycine 0 C--N 1.348 1.231 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 171.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -79.98 156.69 74.47 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.095 0.958 . . . . 0.0 111.763 -166.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -81.76 125.07 4.75 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.022 1.814 . . . . 0.0 110.853 167.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -69.33 172.03 12.95 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 122.474 2.116 . . . . 0.0 111.587 171.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 91.1 mt -71.35 84.71 0.8 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 169.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 35.9 p -79.51 134.87 36.52 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.864 -173.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.5 pp -65.0 155.39 34.78 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.95 0.9 . . . . 0.0 112.446 -175.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 . . . . . 0 C--O 1.252 1.225 0 C-N-CA 123.952 0.901 . . . . 0.0 109.619 -179.314 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.477 ' HG3' ' HB2' ' A' ' 87' ' ' SER . 1.5 pmm? . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.15 -35.23 33.95 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.116 1.877 . . . . 0.0 111.197 172.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -167.28 144.55 4.58 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.866 1.266 . . . . 0.0 108.525 174.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.477 ' HB2' ' HG3' ' A' ' 84' ' ' MET . 40.4 t -139.85 147.44 40.68 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.245 1.018 . . . . 0.0 108.432 176.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.466 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 22.4 ttm-85 -102.2 118.22 36.42 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -174.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -92.76 101.97 14.36 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.942 0.897 . . . . 0.0 108.68 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.7 mm -78.96 114.33 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.491 0.716 . . . . 0.0 109.979 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.7 p -100.2 67.4 1.37 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 122.424 1.107 . . . . 0.0 108.752 174.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.45 ' HB3' ' O ' ' A' ' 132' ' ' ALA . 11.4 t70 -83.37 -33.31 25.84 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.76 -176.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 34.4 ttp -99.46 131.36 45.52 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 170.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.8 m -70.63 153.15 43.14 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 120.81 0.338 . . . . 0.0 110.4 177.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.43 -34.8 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.561 1.144 . . . . 0.0 110.406 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -54.44 -41.4 69.37 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.882 0.873 . . . . 0.0 111.627 174.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -80.69 -41.95 22.83 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.646 0.778 . . . . 0.0 110.451 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.541 ' HG ' HD22 ' A' ' 146' ' ' LEU . 10.4 tt -58.58 -46.65 86.48 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.565 1.146 . . . . 0.0 110.556 -176.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.5 t -100.22 19.28 16.8 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.764 0.826 . . . . 0.0 110.986 -175.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -84.74 128.11 34.44 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.033 0.533 . . . . 0.0 110.186 176.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -91.84 149.03 21.79 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.842 0.857 . . . . 0.0 108.949 174.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 24.2 p-90 -159.58 162.49 35.33 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.91 0.884 . . . . 0.0 110.463 -169.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -113.38 152.38 30.08 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.268 0.627 . . . . 0.0 109.974 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 66.2 mtp -104.79 123.2 47.25 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 175.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 42.7 tp -76.03 -40.28 53.8 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.502 0.721 . . . . 0.0 110.082 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 21.8 mmt -129.7 81.08 70.33 Favored Pre-proline 0 N--CA 1.482 1.173 0 C-N-CA 123.871 0.869 . . . . 0.0 108.926 171.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.81 113.39 3.19 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.7 2.266 . . . . 0.0 112.716 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.541 ' HB3' ' HB ' ' A' ' 119' ' ' ILE . 60.5 tttm -100.4 103.56 14.94 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 163.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.0 104.06 15.26 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -171.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.446 ' HG2' HG12 ' A' ' 180' ' ' VAL . 22.7 tptm -114.24 142.06 46.76 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.638 0.775 . . . . 0.0 109.451 177.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 97.6 t -125.82 126.4 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 170.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -115.06 83.96 2.0 Allowed 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 62.11 -114.95 7.3 Favored Glycine 0 CA--C 1.539 1.558 0 CA-C-N 114.875 -1.057 . . . . 0.0 113.468 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -84.93 5.93 5.99 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 123.702 2.935 . . . . 0.0 113.546 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.484 HD23 ' HA ' ' A' ' 162' ' ' PRO . 35.2 mt -133.93 111.91 10.82 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -173.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 44.5 t -84.19 127.96 34.26 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.201 0.6 . . . . 0.0 110.063 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.5 mm -102.91 137.22 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.353 0.661 . . . . 0.0 110.126 -174.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.497 ' HG3' ' HB3' ' A' ' 159' ' ' GLU . 29.1 mmt180 -107.56 116.83 32.65 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 173.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.541 ' HB ' ' HB3' ' A' ' 108' ' ' LYS . 43.3 mm -113.87 120.01 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 172.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -103.01 116.29 32.24 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 174.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -75.75 -22.15 56.77 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.066 0.947 . . . . 0.0 111.848 -174.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.27 -46.99 37.88 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.062 0.545 . . . . 0.0 111.477 -175.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.48 HG23 HG11 ' A' ' 157' ' ' VAL . 1.9 mp -71.25 108.52 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-O 121.928 0.87 . . . . 0.0 110.08 -177.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.472 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 45.9 mtt -130.56 160.67 33.47 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.415 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.4 t70 63.73 38.6 9.16 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 124.338 1.055 . . . . 0.0 112.126 172.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -123.61 151.38 43.05 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.266 0.626 . . . . 0.0 110.774 177.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -85.03 103.05 13.71 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 169.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.529 HD12 HG22 ' A' ' 157' ' ' VAL . 48.0 mt -107.64 129.97 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.65 0.738 . . . . 0.0 110.515 -172.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.49 ' HG3' ' HG3' ' A' ' 131' ' ' LYS . 2.4 tpt -97.51 123.29 41.32 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 125.47 1.508 . . . . 0.0 109.644 -174.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.513 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 3.5 mm? -94.73 103.75 15.66 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.49 ' HG3' ' HG3' ' A' ' 129' ' ' MET . 62.5 mttm -124.44 153.32 42.12 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.054 0.542 . . . . 0.0 111.242 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.521 ' HB3' ' HG ' ' A' ' 147' ' ' LEU . . . -147.07 160.67 42.12 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.549 -176.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -112.13 131.63 55.34 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 163.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -160.25 154.7 23.7 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.752 0.658 . . . . 0.0 110.931 -172.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.7 t -86.11 153.67 21.92 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.375 1.07 . . . . 0.0 108.325 175.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.466 ' HB ' ' HB3' ' A' ' 88' ' ' ARG . 79.6 t -134.88 139.73 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.516 0.726 . . . . 0.0 110.432 -175.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.9 tp -143.89 139.28 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 172.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 61.48 27.61 17.12 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 124.394 1.078 . . . . 0.0 112.354 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 61.14 29.96 19.11 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.669 1.187 . . . . 0.0 111.866 -177.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 7.5 ppt_? -135.3 158.22 44.91 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 173.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.6 tt -61.55 113.97 2.99 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.244 0.618 . . . . 0.0 110.288 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -75.28 -61.74 1.8 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.447 0.699 . . . . 0.0 110.462 176.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 40.5 m -147.09 129.03 15.41 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.516 0.726 . . . . 0.0 109.304 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 57.3 tp -78.11 120.6 23.15 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.894 0.878 . . . . 0.0 109.51 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.8 mp -77.91 -47.54 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 175.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.541 HD22 ' HG ' ' A' ' 98' ' ' LEU . 55.2 tp -167.22 147.41 5.43 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.007 0.923 . . . . 0.0 109.079 175.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.739 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 6.6 tt -127.09 154.02 45.25 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 175.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.503 HH11 HG21 ' A' ' 156' ' ' ILE . 39.2 ttm-85 -150.58 143.82 24.89 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.094 0.558 . . . . 0.0 111.316 -171.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.43 ' HB1' HD23 ' A' ' 181' ' ' LEU . . . -117.27 111.84 19.94 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.765 1.226 . . . . 0.0 107.878 173.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.468 ' HZ ' ' HD2' ' A' ' 131' ' ' LYS . 46.5 p90 -131.55 142.58 49.95 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 72.3 p -62.95 169.4 3.31 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.524 0.729 . . . . 0.0 112.133 -177.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -51.9 -28.63 16.91 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.965 1.306 . . . . 0.0 112.317 174.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -84.18 -29.49 26.59 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.009 0.924 . . . . 0.0 111.313 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 114.03 8.37 17.77 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 116.482 -0.327 . . . . 0.0 113.593 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -79.92 114.29 18.73 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.503 HG21 HH11 ' A' ' 148' ' ' ARG . 23.9 mt -71.29 124.14 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 122.626 0.37 . . . . 0.0 110.188 -177.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.529 HG22 HD12 ' A' ' 128' ' ' ILE . 26.6 m -124.8 -5.67 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.243 1.017 . . . . 0.0 111.236 -176.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -158.97 164.96 34.0 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -178.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.497 ' HB3' ' HG3' ' A' ' 118' ' ' ARG . 26.2 tt0 -168.28 150.52 5.29 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.257 0.623 . . . . 0.0 109.346 -176.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.739 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 83.7 mt -121.75 104.13 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 168.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 35.3 t -96.08 107.96 38.1 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 123.933 0.893 . . . . 0.0 110.233 -177.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.484 ' HA ' HD23 ' A' ' 115' ' ' LEU . 51.5 Cg_exo -58.47 113.65 1.64 Allowed 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.526 2.151 . . . . 0.0 111.681 172.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.25 122.9 87.76 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 124.11 0.964 . . . . 0.0 111.377 -174.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -67.49 -12.69 36.6 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.975 2.45 . . . . 0.0 112.688 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 28.0 m -65.09 -24.74 67.53 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.063 0.945 . . . . 0.0 111.172 173.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -110.55 116.29 52.77 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 124.66 1.184 . . . . 0.0 108.618 -176.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -83.18 36.0 0.59 Allowed 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 123.067 2.511 . . . . 0.0 113.507 -176.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 160.52 157.86 8.93 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 116.696 -0.229 . . . . 0.0 113.058 174.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 -152.13 140.44 20.47 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.927 1.291 . . . . 0.0 108.556 173.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 14.7 m -88.31 152.4 21.96 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 6.7 tt -59.12 -35.91 59.9 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 124.933 1.293 . . . . 0.0 112.029 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.22 -31.91 73.3 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.753 0.821 . . . . 0.0 110.413 177.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.433 ' HA ' ' ND2' ' A' ' 176' ' ' ASN . 18.4 t70 -83.6 -30.01 27.3 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.712 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.508 ' O ' HG13 ' A' ' 178' ' ' ILE . 79.5 t -62.14 -38.82 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 171.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -52.0 -43.23 63.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 124.079 0.862 . . . . 0.0 110.85 173.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.439 ' O ' HG21 ' A' ' 180' ' ' VAL . 53.5 m-20 -66.18 -45.29 81.37 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.989 0.805 . . . . 0.0 109.996 -177.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.5 -46.38 88.71 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.751 0.82 . . . . 0.0 111.908 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 174' ' ' VAL . 40.8 mt -63.37 -36.33 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 177.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.49 -35.52 91.86 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 115.433 -0.803 . . . . 0.0 113.403 176.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.446 HG12 ' HG2' ' A' ' 110' ' ' LYS . 60.2 t -68.39 -48.88 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.572 HD22 HG13 ' A' ' 160' ' ' ILE . 24.4 tp -59.77 -50.37 74.08 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.256 -178.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 70.4 mt -62.11 -47.47 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.48 0.712 . . . . 0.0 110.757 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -58.51 -35.15 78.72 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 123.938 0.774 . . . . 0.0 114.128 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.461 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -69.37 -38.21 80.48 Favored Glycine 0 C--N 1.347 1.156 0 C-N-CA 122.947 0.308 . . . . 0.0 112.488 176.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.427 HD12 ' O ' ' A' ' 181' ' ' LEU . 8.9 mp -71.37 -32.58 68.66 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.679 0.792 . . . . 0.0 111.702 178.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -69.83 -38.24 76.46 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.1 0.56 . . . . 0.0 111.896 -177.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -79.02 -16.6 56.64 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.71 0.404 . . . . 0.0 111.406 177.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.472 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 7.0 m-20 -76.32 -11.49 59.91 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.062 0.545 . . . . 0.0 110.876 165.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 25.5 t70 65.43 59.87 0.77 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.483 1.113 . . . . 0.0 109.424 -176.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -110.57 151.29 27.79 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.349 169.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 49.9 m -83.43 102.67 12.22 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 171.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 35.4 m -88.3 140.79 15.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 123.701 0.8 . . . . 0.0 109.351 -175.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 24.7 ttm-85 -145.09 127.32 15.75 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.51 175.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.513 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 2.6 t -87.85 143.02 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 26.5 t -63.76 147.8 50.82 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 118.519 0.599 . . . . 0.0 111.035 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -54.19 -35.59 62.51 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.031 0.932 . . . . 0.0 111.591 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 60.9 p -65.38 -53.15 47.58 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.945 0.898 . . . . 0.0 110.029 176.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.422 HD21 ' HB2' ' A' ' 132' ' ' ALA . 73.9 mt -62.93 -26.41 68.8 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.261 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.542 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 49.2 mt-30 -75.48 -46.68 30.93 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.29 0.636 . . . . 0.0 110.702 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.21 -12.29 47.25 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -175.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -106.5 -45.3 4.29 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 122.932 0.493 . . . . 0.0 112.283 178.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -114.87 -36.24 4.54 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -164.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.542 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 72.5 t-105 -98.37 -37.86 9.46 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.826 0.851 . . . . 0.0 110.551 -167.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.19 171.35 55.17 Favored Glycine 0 C--N 1.341 0.835 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.253 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 23.3 m 57.7 29.07 16.74 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.058 0.943 . . . . 0.0 110.35 -171.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 47.0 t -66.03 -41.21 91.21 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.244 1.017 . . . . 0.0 110.37 -175.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -73.72 158.05 35.37 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.064 173.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.57 135.31 54.92 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -153.15 165.46 35.58 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.145 0.578 . . . . 0.0 110.303 -172.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -75.18 159.97 52.12 Favored Glycine 0 C--N 1.341 0.85 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.076 175.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -151.48 157.71 34.68 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 123.889 0.876 . . . . 0.0 109.472 -177.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -59.72 158.61 27.69 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 123.024 2.482 . . . . 0.0 112.798 176.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.11 114.42 1.8 Allowed 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 122.902 2.401 . . . . 0.0 111.3 173.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 82.5 mt -73.29 120.76 19.35 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.114 0.565 . . . . 0.0 111.272 -170.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 10.3 m -76.43 108.35 9.34 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.924 0.889 . . . . 0.0 108.851 174.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 63.5 mt -130.41 144.88 51.67 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.899 0.48 . . . . 0.0 111.096 -170.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 C--O 1.252 1.188 0 C-N-CA 124.255 1.022 . . . . 0.0 110.232 178.948 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 19.7 ptp . . . . . 0 CA--C 1.55 0.976 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.32 175.44 11.09 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.948 2.432 . . . . 0.0 112.341 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.94 109.53 3.48 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.696 0.798 . . . . 0.0 110.696 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.1 m -125.02 132.32 53.25 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 124.374 1.07 . . . . 0.0 109.031 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -156.49 158.0 36.44 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.107 0.563 . . . . 0.0 109.967 -174.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -123.91 105.83 9.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.597 0.759 . . . . 0.0 109.656 174.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 50.6 mm -79.91 139.86 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 174.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.8 p -137.64 93.05 2.75 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.555 0.742 . . . . 0.0 109.546 176.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -80.93 -21.06 40.77 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.157 0.583 . . . . 0.0 111.106 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.47 ' HE1' ' HG3' ' A' ' 148' ' ' ARG . 4.3 mpp? -100.67 126.82 47.22 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 175.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.61 177.28 8.78 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.88 0.872 . . . . 0.0 109.295 173.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -63.43 -43.16 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 123.88 0.872 . . . . 0.0 112.116 -167.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -62.46 -49.17 76.46 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.997 0.519 . . . . 0.0 111.931 -178.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.642 ' HA ' ' HB2' ' A' ' 100' ' ' ARG . 14.7 pt-20 -74.85 -19.82 60.01 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 123.475 0.485 . . . . 0.0 111.469 -178.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.8 tp -68.2 -32.3 72.43 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.29 1.036 . . . . 0.0 110.212 172.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.2 t -117.07 18.25 14.66 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.417 1.087 . . . . 0.0 110.849 -178.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.642 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 26.5 tpt180 -66.79 142.88 57.21 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.749 0.419 . . . . 0.0 112.107 -174.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -77.62 121.16 23.57 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.741 174.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.401 ' HH2' ' HG3' ' A' ' 118' ' ' ARG . 6.3 p-90 -140.12 149.25 42.82 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.402 1.081 . . . . 0.0 109.933 178.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -134.16 135.51 43.15 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.922 0.889 . . . . 0.0 109.179 178.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.52 ' HE2' ' HA ' ' A' ' 107' ' ' PRO . 92.1 mtp -101.69 112.45 25.03 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.63 0.772 . . . . 0.0 109.324 -178.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 45.4 tp -65.93 -39.12 90.22 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.675 0.79 . . . . 0.0 110.206 -178.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.478 ' HE2' ' HA ' ' A' ' 106' ' ' MET . 11.3 mmt -124.25 86.41 54.53 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 124.322 1.049 . . . . 0.0 108.407 173.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.52 ' HA ' ' HE2' ' A' ' 104' ' ' MET . 56.1 Cg_endo -67.37 131.36 24.64 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.253 1.969 . . . . 0.0 111.663 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.506 ' HB3' ' HB ' ' A' ' 119' ' ' ILE . 60.4 tptt -131.75 119.96 22.04 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 173.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.42 ' NE2' ' HB2' ' A' ' 116' ' ' CYS . 58.9 tp60 -108.63 106.06 15.95 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -176.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.51 97.96 5.9 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 123.677 0.791 . . . . 0.0 109.006 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . 55.9 t -78.75 124.79 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -122.45 94.33 4.26 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.8 -127.11 30.48 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.259 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -86.07 21.32 1.09 Allowed 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 123.054 2.503 . . . . 0.0 112.615 175.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 4.3 mp -129.63 167.57 17.77 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.973 0.909 . . . . 0.0 109.002 174.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 20.3 p -140.23 130.74 25.49 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 176.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 17.6 mm -105.83 132.63 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.285 1.034 . . . . 0.0 109.87 -170.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.401 ' HG3' ' HH2' ' A' ' 102' ' ' TRP . 15.9 mmt85 -99.99 122.93 43.65 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.76 1.224 . . . . 0.0 108.917 172.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.506 ' HB ' ' HB3' ' A' ' 108' ' ' LYS . 42.5 mm -122.69 121.59 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 172.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -95.5 111.83 23.66 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 168.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -78.86 -3.43 44.59 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.254 -174.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.3 -27.81 20.29 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.138 0.575 . . . . 0.0 110.505 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 39.5 mm -79.49 101.69 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-O 121.667 0.746 . . . . 0.0 111.145 -172.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.453 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 36.4 mtt -129.48 147.11 51.26 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.898 -174.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.0 t70 62.23 42.11 9.79 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.128 0.971 . . . . 0.0 111.765 175.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -119.76 147.91 44.06 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.195 0.998 . . . . 0.0 110.371 176.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.423 ' HA ' ' HB ' ' A' ' 191' ' ' THR . 44.2 m-80 -83.56 110.0 17.87 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 171.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 61.6 mt -117.54 134.13 62.12 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 123.382 0.673 . . . . 0.0 111.23 -171.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 37.7 tpp -111.59 125.61 54.12 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.513 1.925 . . . . 0.0 108.763 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.468 ' HB3' HD21 ' A' ' 147' ' ' LEU . 18.5 mt -97.23 102.59 14.39 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -98.5 149.18 22.99 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.667 0.787 . . . . 0.0 109.365 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -142.56 144.44 32.9 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 122.239 1.018 . . . . 0.0 113.723 175.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -99.52 122.51 42.69 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 163.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.513 ' HB3' HD12 ' A' ' 144' ' ' LEU . 49.7 p90 -153.15 159.78 42.77 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.268 0.556 . . . . 0.0 111.763 -175.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.7 t -90.94 156.36 18.04 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.982 177.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 72.0 t -130.72 136.03 59.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.906 1.282 . . . . 0.0 108.575 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.3 tp -145.19 144.09 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 170.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 62.39 24.18 14.38 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.661 0.785 . . . . 0.0 111.348 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.5 t70 71.03 5.46 5.49 Favored 'General case' 0 CA--C 1.564 1.511 0 C-N-CA 124.931 1.292 . . . . 0.0 111.954 -176.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -114.58 172.2 7.17 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.343 -0.848 . . . . 0.0 109.78 176.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.591 ' HB2' ' HB3' ' A' ' 201' ' ' PHE . 6.8 tt -69.39 125.49 26.84 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -83.7 -66.61 0.87 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.299 0.64 . . . . 0.0 110.247 177.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 65.9 m -149.88 131.12 14.56 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.808 1.243 . . . . 0.0 108.49 -173.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.513 HD12 ' HB3' ' A' ' 134' ' ' PHE . 44.7 tp -71.96 131.91 43.58 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 175.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.38 -50.06 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 172.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 54.4 tp -164.95 151.25 10.29 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.016 0.926 . . . . 0.0 109.358 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.696 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 7.2 tt -136.62 145.82 45.32 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 172.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.47 ' HG3' ' HE1' ' A' ' 93' ' ' MET . 17.5 mtp180 -141.32 144.23 34.48 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.697 0.799 . . . . 0.0 109.599 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.11 111.86 24.77 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.399 1.08 . . . . 0.0 108.927 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.405 ' CE1' ' HB2' ' A' ' 148' ' ' ARG . 65.0 m-85 -106.6 137.2 45.04 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.191 0.996 . . . . 0.0 109.207 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 47.2 p -76.01 -179.9 5.2 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-O 121.286 0.565 . . . . 0.0 110.142 172.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -61.71 -20.44 63.49 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.515 0.726 . . . . 0.0 111.048 169.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -88.51 -1.75 58.22 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.962 1.305 . . . . 0.0 111.604 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 74.33 15.08 80.34 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-N 116.448 -0.342 . . . . 0.0 112.971 -178.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -86.01 125.0 33.08 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.426 0.69 . . . . 0.0 109.852 -176.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.449 HD11 ' HB3' ' A' ' 100' ' ' ARG . 22.6 mt -78.84 100.99 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -177.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.2 m -105.36 -0.16 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.138 0.975 . . . . 0.0 111.433 -173.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -162.96 167.07 37.19 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.329 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -163.47 153.36 15.28 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.696 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 63.1 mt -128.88 102.92 8.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 170.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 3.1 p -112.83 110.05 52.28 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 123.901 0.881 . . . . 0.0 109.605 -177.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.539 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 20.7 Cg_endo -60.04 127.85 24.62 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.641 2.227 . . . . 0.0 111.515 171.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.1 mt -64.12 120.43 64.23 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.812 0.845 . . . . 0.0 110.366 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -65.98 162.03 37.09 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.874 2.383 . . . . 0.0 111.733 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 13.6 t 71.24 20.11 5.17 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 125.206 1.402 . . . . 0.0 111.359 -175.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -126.95 90.27 49.95 Favored Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 123.979 0.912 . . . . 0.0 109.212 177.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.13 -23.23 39.87 Favored 'Trans proline' 0 C--N 1.381 2.288 0 C-N-CA 122.976 2.45 . . . . 0.0 112.419 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -71.39 90.21 0.44 Allowed Glycine 0 C--N 1.351 1.408 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 176.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -152.08 125.55 8.84 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 35.8 p -126.91 171.08 11.59 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.022 0.929 . . . . 0.0 110.36 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.46 ' O ' ' HG3' ' A' ' 175' ' ' LYS . 15.1 tt -50.69 -37.14 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.406 170.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -52.32 -51.29 59.53 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.338 1.455 . . . . 0.0 111.019 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -59.33 -41.1 88.34 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.949 0.9 . . . . 0.0 111.851 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 178' ' ' ILE . 25.9 t -64.07 -40.72 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 O-C-N 124.117 0.885 . . . . 0.0 110.52 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 171' ' ' ILE . 56.5 mtpt -61.66 -42.52 99.02 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.746 0.818 . . . . 0.0 111.165 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.465 ' O ' HG22 ' A' ' 180' ' ' VAL . 24.4 m120 -66.68 -43.24 84.97 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 123.591 0.557 . . . . 0.0 109.645 176.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -60.9 -45.08 96.03 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 124.584 1.177 . . . . 0.0 112.279 -175.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 174' ' ' VAL . 25.8 mt -69.27 -32.83 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.96 -30.64 78.31 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.433 174.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 176' ' ' ASN . 61.3 t -74.84 -51.08 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 122.813 0.445 . . . . 0.0 109.819 175.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.467 ' HA ' HD12 ' A' ' 119' ' ' ILE . 47.9 tp -54.18 -51.13 65.33 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 123.933 0.77 . . . . 0.0 111.26 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.498 ' O ' ' HG3' ' A' ' 186' ' ' GLU . 10.4 tt -62.27 -37.2 78.0 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.934 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.613 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -62.19 -42.53 99.72 Favored Glycine 0 C--N 1.351 1.366 0 O-C-N 123.287 0.367 . . . . 0.0 113.903 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -65.98 -35.85 91.23 Favored Glycine 0 C--N 1.348 1.208 0 O-C-N 123.843 0.378 . . . . 0.0 112.294 175.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 86.4 mt -68.33 -42.25 79.58 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.17 0.988 . . . . 0.0 111.49 177.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 182' ' ' ILE . 49.3 mt-10 -67.72 -38.41 83.53 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.494 0.718 . . . . 0.0 110.269 -176.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.11 -24.32 59.44 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.351 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.453 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 97.6 m-20 -68.93 -18.87 64.16 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 122.667 0.387 . . . . 0.0 111.059 170.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 35.9 t70 65.9 65.69 0.52 Allowed 'General case' 0 C--N 1.354 0.784 0 C-N-CA 124.116 0.967 . . . . 0.0 109.662 -174.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -131.14 169.09 16.38 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.694 173.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.423 ' HB ' ' HA ' ' A' ' 127' ' ' ASN . 89.5 m -84.17 114.72 22.0 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 30.0 m -97.52 136.37 28.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -145.04 128.09 16.56 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 176.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 4.8 t -103.07 150.58 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -175.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 45.8 t -60.91 141.07 57.51 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.86 -28.02 63.76 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.825 0.85 . . . . 0.0 112.249 -177.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 37.6 p -70.95 -45.25 64.48 Favored 'General case' 0 C--N 1.348 0.516 0 C-N-CA 123.544 0.738 . . . . 0.0 109.903 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 78.7 mt -65.1 -39.97 93.89 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.174 0.59 . . . . 0.0 110.52 176.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.614 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 49.5 mt-30 -60.06 -31.33 69.89 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.807 0.843 . . . . 0.0 111.101 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -83.87 -61.04 1.92 Allowed 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 123.887 0.875 . . . . 0.0 110.717 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.591 ' HB3' ' HB2' ' A' ' 141' ' ' LEU . 61.5 m-85 -71.44 -47.1 57.93 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.178 0.991 . . . . 0.0 112.84 -167.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.487 ' HB2' HD12 ' A' ' 141' ' ' LEU . . . -109.25 -58.15 2.07 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 122.944 0.497 . . . . 0.0 110.771 -170.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.614 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 40.4 t-105 -62.76 -25.81 68.39 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.751 1.221 . . . . 0.0 111.532 -175.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -72.96 -116.47 0.06 OUTLIER Glycine 0 CA--C 1.531 1.05 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 165.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 33.1 t 52.13 37.36 21.46 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.181 0.993 . . . . 0.0 112.758 172.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 14.1 m -74.87 83.16 2.17 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -143.47 149.17 37.17 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.066 -177.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -115.43 163.26 15.98 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.77 0.828 . . . . 0.0 109.179 170.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -83.53 114.87 21.81 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.509 0.724 . . . . 0.0 109.826 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -70.06 114.89 5.79 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 165.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 72.73 156.59 0.16 Allowed Pre-proline 0 N--CA 1.493 1.725 0 C-N-CA 124.696 1.198 . . . . 0.0 111.2 -171.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -58.76 149.62 76.17 Favored 'Trans proline' 0 C--N 1.388 2.627 0 C-N-CA 122.988 2.459 . . . . 0.0 113.136 -178.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -59.32 104.73 0.22 Allowed 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 122.898 2.398 . . . . 0.0 111.212 175.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 86.9 mt -71.58 90.62 1.03 Allowed 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 35.2 p -91.78 170.58 9.78 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.869 0.868 . . . . 0.0 110.664 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.404 ' H ' HD11 ' A' ' 216' ' ' LEU . 4.1 mp -69.33 111.03 4.96 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.598 0.759 . . . . 0.0 110.406 -168.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 . . . . . 0 C--O 1.249 1.039 0 C-N-CA 123.435 0.694 . . . . 0.0 110.236 -178.306 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.409 ' HB3' ' HB3' ' A' ' 87' ' ' SER . 61.0 mtt . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.79 116.45 4.01 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 123.071 2.514 . . . . 0.0 111.814 -176.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 64.01 9.97 5.02 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.323 1.049 . . . . 0.0 112.528 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 17.0 t -93.62 106.98 18.9 Favored 'General case' 0 C--N 1.345 0.392 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -127.57 148.56 50.35 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.848 0.859 . . . . 0.0 110.159 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -90.2 108.99 20.09 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 174.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.0 mm -77.25 117.72 22.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 176.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.2 p -98.0 75.31 2.34 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -73.51 -32.02 64.03 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 113.726 -1.579 . . . . 0.0 109.966 -178.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.435 ' HB3' ' HB3' ' A' ' 131' ' ' LYS . 21.2 ptt? -109.74 138.67 45.77 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 165.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 66.7 p -65.3 157.32 29.39 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.726 0.41 . . . . 0.0 110.128 177.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.9 mp -58.07 -35.85 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -56.56 -60.3 3.73 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.092 1.357 . . . . 0.0 112.481 176.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.401 ' HG3' ' HB2' ' A' ' 93' ' ' MET . 11.9 pt-20 -70.71 -24.99 62.75 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 122.631 0.372 . . . . 0.0 111.18 -176.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.482 ' HA ' ' HE ' ' A' ' 148' ' ' ARG . 7.8 tt -65.36 -48.26 73.58 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.818 0.847 . . . . 0.0 109.622 172.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 90.5 p -84.3 -3.08 58.01 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.192 0.597 . . . . 0.0 112.389 -173.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.1 tpt85 -61.51 126.89 28.96 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.584 0.754 . . . . 0.0 110.915 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -82.42 155.07 24.86 Favored 'General case' 0 C--O 1.239 0.535 0 O-C-N 123.976 0.797 . . . . 0.0 109.801 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -161.3 169.05 22.85 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.65 0.78 . . . . 0.0 110.84 -173.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -125.89 151.82 46.38 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.201 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.518 ' HE2' ' HA ' ' A' ' 107' ' ' PRO . 72.9 mtp -109.86 105.05 14.1 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 171.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.9 tt -62.64 -44.1 97.12 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 80.4 mmm -119.58 88.37 38.8 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 123.904 0.882 . . . . 0.0 109.416 171.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.518 ' HA ' ' HE2' ' A' ' 104' ' ' MET . 79.1 Cg_endo -73.71 124.54 9.34 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.69 2.26 . . . . 0.0 112.355 -178.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.456 ' HD2' ' NE2' ' A' ' 121' ' ' GLN . 59.5 tttp -123.15 124.76 43.78 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.39 101.31 7.1 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -102.82 129.11 49.38 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.103 0.961 . . . . 0.0 108.815 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 72.7 t -86.76 133.8 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 173.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -128.36 85.3 2.32 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 62.31 -121.43 25.37 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.666 176.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.473 ' HB2' ' HB3' ' A' ' 169' ' ' HIS . 3.7 Cg_exo -78.92 8.48 3.75 Favored 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 123.728 2.952 . . . . 0.0 114.199 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.5 mp -133.62 163.5 29.28 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.375 0.67 . . . . 0.0 109.506 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.474 ' SG ' ' HB2' ' A' ' 161' ' ' SER . 31.5 p -126.86 136.02 51.78 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 10.2 mm -110.43 124.91 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.304 1.042 . . . . 0.0 109.542 -169.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -108.65 121.99 46.18 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.428 1.091 . . . . 0.0 108.347 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.528 HD12 ' HA3' ' A' ' 184' ' ' GLY . 53.0 mt -131.29 121.92 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.432 ' HB3' ' HB ' ' A' ' 157' ' ' VAL . 23.8 t70 -94.49 115.28 27.42 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 175.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.456 ' NE2' ' HD2' ' A' ' 108' ' ' LYS . 83.6 mt-30 -81.22 -10.64 59.57 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.715 0.806 . . . . 0.0 112.016 -174.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.2 -41.68 63.53 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.266 0.626 . . . . 0.0 110.963 -176.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.6 mp -76.91 115.83 19.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.882 177.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 48.6 mtt -132.89 154.97 49.88 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.567 1.147 . . . . 0.0 110.102 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.7 t70 62.34 23.95 14.23 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.354 1.062 . . . . 0.0 112.105 176.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 190' ' ' ASN . 73.9 mmtt -105.76 149.95 25.98 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.202 0.601 . . . . 0.0 110.079 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.535 ' HB2' ' HG2' ' A' ' 152' ' ' GLU . 75.8 m-20 -83.06 106.56 14.97 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 173.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 80.5 mt -106.29 121.86 59.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 123.39 0.676 . . . . 0.0 110.147 -174.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 36.7 tpp -96.33 130.44 43.44 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.879 1.272 . . . . 0.0 109.322 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 19.2 mt -100.07 104.27 15.83 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 93' ' ' MET . 32.7 mmtp -98.8 155.4 17.38 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.998 0.919 . . . . 0.0 109.507 173.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.496 ' HB2' HD13 ' A' ' 144' ' ' LEU . . . -155.49 145.69 21.73 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 168.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -108.18 134.35 51.15 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 172.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.444 ' HA ' HD12 ' A' ' 145' ' ' ILE . 37.9 p90 -160.01 160.62 33.5 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.735 0.814 . . . . 0.0 110.589 -169.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 43.7 p -85.47 155.24 21.32 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.866 0.866 . . . . 0.0 108.81 171.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 87' ' ' SER . 91.0 t -116.5 154.05 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.959 0.904 . . . . 0.0 110.308 -177.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.466 ' O ' ' HG3' ' A' ' 140' ' ' ARG . 11.0 tp -156.09 134.44 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 164.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 58.14 24.76 11.66 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.961 0.904 . . . . 0.0 113.024 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.535 ' HB3' HH22 ' A' ' 200' ' ' ARG . 1.6 m-20 65.5 35.03 7.52 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.869 1.268 . . . . 0.0 111.832 -176.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 137' ' ' ILE . 7.6 ppt_? -136.24 162.93 31.61 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.679 0.792 . . . . 0.0 109.048 169.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.465 ' HB3' HG13 ' A' ' 171' ' ' ILE . 9.7 tt -68.14 110.05 3.81 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.658 0.783 . . . . 0.0 109.765 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -70.78 -64.87 0.82 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.893 0.877 . . . . 0.0 109.558 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 53.1 m -142.54 131.31 22.78 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.515 HD21 ' HB2' ' A' ' 147' ' ' LEU . 53.6 tp -73.07 129.22 37.6 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.391 0.676 . . . . 0.0 109.455 173.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.444 HD12 ' HA ' ' A' ' 134' ' ' PHE . 1.6 mp -84.9 -52.86 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 174.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 39.9 tp -162.04 148.6 13.63 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.028 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.683 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 8.9 tt -125.76 149.13 48.81 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 174.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.602 HH11 HG22 ' A' ' 156' ' ' ILE . 21.7 ttm-85 -141.93 139.75 32.61 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.025 0.93 . . . . 0.0 110.583 -176.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.505 ' HB1' ' HA3' ' A' ' 158' ' ' GLY . . . -123.87 122.46 38.05 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.487 1.115 . . . . 0.0 108.023 176.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -142.05 166.36 24.92 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.241 0.616 . . . . 0.0 110.861 -177.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.415 ' HG1' ' HB3' ' A' ' 155' ' ' ALA . 82.4 p -85.67 179.0 7.17 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.735 0.814 . . . . 0.0 110.301 -177.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.535 ' HG2' ' HB2' ' A' ' 127' ' ' ASN . 24.3 mm-40 -63.44 -21.84 66.54 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 122.16 -0.338 . . . . 0.0 111.889 172.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -78.78 -13.7 59.67 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.014 0.525 . . . . 0.0 111.059 176.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 88.84 -2.72 84.51 Favored Glycine 0 C--N 1.349 1.254 0 N-CA-C 112.044 -0.422 . . . . 0.0 112.044 -173.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.415 ' HB3' ' HG1' ' A' ' 151' ' ' THR . . . -67.92 108.18 2.93 Favored 'General case' 0 C--N 1.353 0.721 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -178.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.602 HG22 HH11 ' A' ' 148' ' ' ARG . 23.6 mt -77.91 128.43 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 O-C-N 123.56 0.538 . . . . 0.0 110.415 -170.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' A' ' 120' ' ' ASP . 34.6 m -130.62 8.06 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 123.883 0.873 . . . . 0.0 111.228 -174.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.505 ' HA3' ' HB1' ' A' ' 149' ' ' ALA . . . -161.23 157.53 29.13 Favored Glycine 0 C--N 1.339 0.703 0 N-CA-C 111.856 -0.498 . . . . 0.0 111.856 -177.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -168.35 140.96 2.96 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.562 0.745 . . . . 0.0 109.765 -178.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.683 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 70.9 mt -123.7 112.66 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 175.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.474 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 20.3 m -112.53 118.32 45.51 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.094 0.958 . . . . 0.0 109.919 -177.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -63.94 124.55 13.74 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 122.855 2.37 . . . . 0.0 112.59 176.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 96.5 mt -64.43 129.75 94.33 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 124.343 1.057 . . . . 0.0 112.207 -177.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -67.33 -9.26 24.63 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.955 2.437 . . . . 0.0 112.803 169.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.9 m -65.26 -24.29 67.28 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.85 0.86 . . . . 0.0 111.29 169.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -132.53 90.67 32.68 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 124.134 0.974 . . . . 0.0 108.841 -178.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.78 90.68 1.25 Allowed 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.768 2.312 . . . . 0.0 112.567 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 114.22 96.83 2.18 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.845 174.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 114' ' ' PRO . 20.2 p-80 -102.44 162.71 12.7 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.873 0.869 . . . . 0.0 109.785 178.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 76.5 p -84.27 160.44 20.75 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 173.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.498 HD13 ' HA ' ' A' ' 202' ' ' ALA . 9.4 tt -54.64 -32.96 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 123.215 0.606 . . . . 0.0 110.712 168.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.669 ' HA ' ' HE2' ' A' ' 175' ' ' LYS . 35.6 mt-10 -64.71 -33.47 76.03 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.108 -178.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -70.62 -33.16 70.71 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.408 0.683 . . . . 0.0 111.55 175.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 56.4 t -69.76 -36.04 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 122.493 0.317 . . . . 0.0 110.33 174.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.669 ' HE2' ' HA ' ' A' ' 172' ' ' GLU . 48.6 mtmt -62.3 -38.04 87.89 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 120.77 0.319 . . . . 0.0 110.389 175.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -64.02 -44.23 93.2 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.221 174.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.87 -51.09 68.34 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.742 -175.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 49.5 mt -64.46 -33.37 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.15 0.58 . . . . 0.0 109.821 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -59.4 -39.72 95.16 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-N 115.653 -0.703 . . . . 0.0 113.649 175.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 97.2 t -72.42 -44.02 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 122.767 0.427 . . . . 0.0 110.395 176.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.447 HD11 HG12 ' A' ' 119' ' ' ILE . 59.5 tp -52.59 -57.3 10.43 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.802 0.841 . . . . 0.0 111.309 177.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.581 HG22 HG21 ' A' ' 192' ' ' VAL . 50.6 mt -58.88 -45.27 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 O-C-N 124.013 0.821 . . . . 0.0 110.598 174.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -53.54 -38.13 57.6 Favored Glycine 0 C--N 1.346 1.122 0 O-C-N 123.949 0.78 . . . . 0.0 114.066 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.528 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -81.0 -28.81 44.12 Favored Glycine 0 C--N 1.348 1.195 0 N-CA-C 112.577 -0.209 . . . . 0.0 112.577 176.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.462 ' HB3' HD22 ' A' ' 190' ' ' ASN . 68.6 mt -71.83 -21.45 61.68 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.237 0.615 . . . . 0.0 110.715 174.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 19.5 mm-40 -68.76 -36.56 78.5 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.354 0.662 . . . . 0.0 110.853 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -76.97 -24.77 52.27 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 122.939 0.149 . . . . 0.0 110.824 176.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -63.95 -22.55 66.97 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.57 0.348 . . . . 0.0 110.437 167.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 13.4 t70 53.19 67.33 1.01 Allowed 'General case' 0 C--N 1.356 0.85 0 C-N-CA 124.893 1.277 . . . . 0.0 111.252 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 8.5 p30 -124.5 -161.31 1.0 Allowed 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.825 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 31.9 m -120.07 101.49 7.88 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.581 HG21 HG22 ' A' ' 182' ' ' ILE . 26.7 m -93.28 147.28 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 121.145 0.497 . . . . 0.0 110.386 -177.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 40.1 ttt180 -142.22 132.96 25.54 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.13 172.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.452 HG21 HD11 ' A' ' 182' ' ' ILE . 3.2 t -90.41 134.26 29.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 N-CA-C 104.802 -2.295 . . . . 0.0 104.802 175.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 27.9 t -60.35 151.74 27.04 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.142 0.428 . . . . 0.0 111.654 -173.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -51.44 -40.15 58.8 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.755 1.222 . . . . 0.0 112.241 -175.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 75.8 p -68.82 -49.29 59.7 Favored 'General case' 0 C--N 1.345 0.393 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.467 HD21 ' HB3' ' A' ' 132' ' ' ALA . 41.1 mt -61.22 -29.96 70.14 Favored 'General case' 0 C--O 1.21 -0.976 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.151 -177.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.599 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 48.9 mt-30 -68.17 -57.03 6.69 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.487 0.715 . . . . 0.0 110.956 178.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.535 HH22 ' HB3' ' A' ' 139' ' ' ASP . 0.0 OUTLIER -72.75 -21.55 61.0 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -176.196 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -83.99 -59.79 2.3 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.13 0.572 . . . . 0.0 111.034 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.498 ' HA ' HD13 ' A' ' 171' ' ' ILE . . . -114.39 -60.66 1.86 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.255 0.622 . . . . 0.0 111.546 -165.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.599 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 67.8 t-105 -66.89 -10.82 52.61 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.479 1.112 . . . . 0.0 112.685 -168.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -70.63 72.02 0.66 Allowed Glycine 0 C--N 1.346 1.091 0 N-CA-C 111.929 -0.468 . . . . 0.0 111.929 175.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 47.2 t -161.87 99.48 1.11 Allowed 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.547 1.139 . . . . 0.0 108.757 -173.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 51.1 p -69.47 -33.22 72.58 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.412 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 8.2 t30 61.22 22.73 13.03 Favored 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 124.377 1.071 . . . . 0.0 109.798 -176.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -63.77 -51.9 62.78 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 124.836 1.254 . . . . 0.0 110.766 -169.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -87.67 53.14 2.68 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-O 121.969 0.89 . . . . 0.0 109.393 173.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -155.77 48.89 0.48 Allowed Glycine 0 C--N 1.343 0.966 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.301 -177.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -96.16 148.93 35.27 Favored Pre-proline 0 N--CA 1.482 1.132 0 C-N-CA 123.553 0.741 . . . . 0.0 109.921 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.74 125.69 13.59 Favored 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.469 2.112 . . . . 0.0 110.943 173.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.92 143.62 85.94 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.452 2.101 . . . . 0.0 111.949 175.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 86.5 mt -68.53 93.85 0.53 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.131 0.573 . . . . 0.0 110.504 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 32.4 p -81.23 143.92 31.96 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.881 0.873 . . . . 0.0 111.046 -176.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.1 pp -105.1 156.81 17.73 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.905 0.882 . . . . 0.0 111.859 -175.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 . . . . . 0 C--O 1.254 1.338 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 171.678 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 21.2 ptp . . . . . 0 CA--C 1.56 1.346 0 N-CA-C 110.527 -0.175 . . . . 0.0 110.527 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -70.93 -164.8 0.16 Allowed 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 123.491 2.794 . . . . 0.0 112.917 175.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.88 79.97 0.46 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.633 0.773 . . . . 0.0 110.738 177.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.4 p -93.22 89.66 6.51 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.897 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -118.9 145.71 45.51 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.628 0.371 . . . . 0.0 110.738 -175.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 19.3 m-85 -96.3 108.95 21.52 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.641 0.776 . . . . 0.0 109.166 175.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 50.0 mm -78.31 116.43 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 174.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 36.8 p -98.35 72.96 2.12 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.521 ' HB3' ' O ' ' A' ' 132' ' ' ALA . 31.0 t70 -72.8 -30.76 64.33 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.056 -174.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.567 ' SD ' ' HB3' ' A' ' 148' ' ' ARG . 59.5 mtm -98.12 151.15 20.69 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 166.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 64.6 p -69.93 158.84 34.84 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 173.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 69.1 mt -59.23 -31.39 46.01 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 173.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -57.87 -55.98 27.87 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.434 171.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -61.41 -38.67 87.94 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.012 0.525 . . . . 0.0 111.311 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.9 tt -63.89 -38.91 92.85 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.128 0.971 . . . . 0.0 109.378 -177.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.8 t -108.9 20.38 18.52 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 123.875 0.87 . . . . 0.0 111.066 -176.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.506 ' HD3' HD12 ' A' ' 156' ' ' ILE . 76.8 ttt180 -78.3 142.57 37.68 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.762 0.825 . . . . 0.0 111.696 -174.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -82.73 138.02 34.21 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.939 0.895 . . . . 0.0 110.524 176.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.512 ' CZ3' ' SD ' ' A' ' 104' ' ' MET . 11.3 p-90 -157.33 160.28 38.36 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.842 1.257 . . . . 0.0 109.825 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -110.89 159.65 17.5 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.431 0.692 . . . . 0.0 111.693 -173.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.512 ' SD ' ' CZ3' ' A' ' 102' ' ' TRP . 99.2 mmm -120.65 93.06 3.91 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.237 1.015 . . . . 0.0 108.758 172.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.422 HD23 ' HB2' ' A' ' 122' ' ' ALA . 50.4 tp -71.8 -43.34 65.81 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.3 mmt -129.17 81.41 70.6 Favored Pre-proline 0 N--CA 1.479 1.002 0 C-N-CA 123.94 0.896 . . . . 0.0 109.353 175.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.75 145.56 46.46 Favored 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 122.104 1.869 . . . . 0.0 111.652 177.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -124.93 120.89 32.91 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 172.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.36 104.64 11.04 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.459 0.704 . . . . 0.0 109.624 -174.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -132.73 135.83 46.0 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.992 0.917 . . . . 0.0 109.467 172.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.2 t -125.4 142.79 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 166.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -123.34 91.6 3.51 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 176.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.37 -112.76 5.26 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.999 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -91.75 8.36 3.07 Favored 'Trans proline' 0 C--N 1.368 1.593 0 C-N-CA 123.27 2.647 . . . . 0.0 113.273 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.504 HD22 ' HA ' ' A' ' 162' ' ' PRO . 61.4 mt -130.44 116.45 18.25 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.516 0.727 . . . . 0.0 109.656 -170.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 41.9 t -83.34 127.23 33.49 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.231 0.612 . . . . 0.0 110.256 -177.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.8 mm -106.94 110.03 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.232 0 C-N-CA 124.034 0.933 . . . . 0.0 110.58 -173.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -92.81 125.89 37.63 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.487 0.715 . . . . 0.0 109.858 173.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.553 HD12 ' HA3' ' A' ' 184' ' ' GLY . 73.2 mt -131.89 123.73 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.237 1.015 . . . . 0.0 108.561 176.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -99.49 120.76 40.14 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.44 0.696 . . . . 0.0 109.498 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -84.99 -14.96 45.82 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.619 1.168 . . . . 0.0 111.734 -174.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.422 ' HB2' HD23 ' A' ' 105' ' ' LEU . . . -68.57 -38.4 80.68 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.01 0.524 . . . . 0.0 111.106 -176.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.454 HG23 ' HG3' ' A' ' 126' ' ' LYS . 1.8 mp -87.07 112.79 23.63 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 CA-C-O 121.969 0.89 . . . . 0.0 109.7 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 48.0 mtt -129.23 159.5 35.9 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.859 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.8 t70 76.21 12.14 2.78 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 124.667 1.187 . . . . 0.0 112.365 172.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.454 ' HG3' HG23 ' A' ' 123' ' ' ILE . 75.1 mmtt -99.79 151.99 20.63 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.48 0.712 . . . . 0.0 111.976 -173.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -90.38 112.19 23.7 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 168.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.433 HD13 HD21 ' A' ' 185' ' ' LEU . 65.3 mt -114.01 135.23 54.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.965 0.888 . . . . 0.0 111.325 -171.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.529 ' HG3' ' HG3' ' A' ' 131' ' ' LYS . 8.0 tpt -102.81 121.65 42.92 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.203 1.801 . . . . 0.0 109.643 -172.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 3.7 mm? -96.25 104.75 16.73 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.529 ' HG3' ' HG3' ' A' ' 129' ' ' MET . 90.8 mttt -125.58 149.4 48.4 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.455 0.702 . . . . 0.0 110.497 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.578 ' HB1' HD22 ' A' ' 198' ' ' LEU . . . -149.37 152.99 36.72 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -174.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -102.77 128.44 49.5 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 169.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -154.97 155.44 34.22 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.544 0.738 . . . . 0.0 109.871 -170.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 58.1 p -87.48 169.58 12.09 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.246 0.618 . . . . 0.0 109.775 172.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 79.5 t -132.15 136.3 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 123.564 0.746 . . . . 0.0 110.595 -173.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 7.5 tp -146.18 139.6 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 169.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 60.94 33.11 19.93 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 124.195 0.998 . . . . 0.0 111.936 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.3 t70 65.75 18.66 11.22 Favored 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 125.341 1.456 . . . . 0.0 111.644 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -132.54 172.9 11.9 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.815 -0.553 . . . . 0.0 109.643 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.455 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 10.3 tt -64.63 126.77 28.94 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -88.99 -77.8 0.37 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.991 0.516 . . . . 0.0 109.951 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.1 m -125.64 137.62 53.88 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.773 0.829 . . . . 0.0 109.321 -173.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 50.3 tp -82.96 126.64 32.74 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 174.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.43 -51.7 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 172.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 50.9 tp -164.19 146.73 9.13 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.833 0.853 . . . . 0.0 109.121 177.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.712 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 8.0 tt -125.5 154.75 41.63 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.676 HH11 HG23 ' A' ' 156' ' ' ILE . 47.3 ttm-85 -150.18 138.75 20.66 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 123.131 0.573 . . . . 0.0 110.971 -173.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -115.57 115.58 26.68 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 175.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.417 ' HD1' ' HG2' ' A' ' 148' ' ' ARG . 31.6 p90 -136.08 145.98 46.53 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.543 0.737 . . . . 0.0 109.59 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 54.5 p -69.32 175.84 3.71 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.79 0.836 . . . . 0.0 111.01 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -54.69 -32.38 59.36 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.687 0.795 . . . . 0.0 111.617 172.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -70.98 -29.24 65.16 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.944 1.298 . . . . 0.0 110.801 179.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 100.05 8.57 50.55 Favored Glycine 0 C--N 1.345 1.064 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.565 -173.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -73.16 104.56 4.26 Favored 'General case' 0 C--N 1.352 0.713 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 177.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.676 HG23 HH11 ' A' ' 148' ' ' ARG . 24.1 mt -75.93 122.72 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -175.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.4 m -130.74 9.53 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.636 0.774 . . . . 0.0 111.065 -175.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -159.89 159.26 30.51 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.428 -178.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -165.67 150.99 8.92 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.353 0.661 . . . . 0.0 109.457 -177.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.712 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 71.0 mt -131.4 106.85 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 170.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 78.9 p -109.18 119.05 49.7 Favored Pre-proline 0 C--O 1.24 0.556 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.504 ' HA ' HD22 ' A' ' 115' ' ' LEU . 11.1 Cg_endo -55.48 134.78 65.88 Favored 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 122.254 1.969 . . . . 0.0 111.384 168.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 90.0 mt -73.59 127.62 88.38 Favored Pre-proline 0 CA--C 1.546 0.803 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 175.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 163' ' ' LEU . 32.5 Cg_exo -60.08 -28.14 86.4 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 123.562 2.842 . . . . 0.0 113.57 -177.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.1 m -71.36 -10.76 60.28 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.679 0.791 . . . . 0.0 111.89 175.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -123.12 77.11 51.65 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 123.856 0.862 . . . . 0.0 109.089 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -80.13 1.47 9.22 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 123.125 2.55 . . . . 0.0 112.982 -177.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -122.5 83.02 0.35 Allowed Glycine 0 C--N 1.345 1.066 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -120.23 132.74 55.47 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 169.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 57.9 p -82.48 173.15 12.26 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.64 0.376 . . . . 0.0 110.902 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.474 HD11 ' HA ' ' A' ' 202' ' ' ALA . 7.7 tt -51.67 -40.84 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.088 171.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -65.12 -36.57 84.68 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.842 0.857 . . . . 0.0 111.216 -173.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -62.74 -42.08 99.5 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 123.694 0.621 . . . . 0.0 110.604 174.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.516 ' O ' HG13 ' A' ' 178' ' ' ILE . 40.6 t -63.17 -41.9 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 123.829 0.706 . . . . 0.0 109.921 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 171' ' ' ILE . 57.7 mtpt -57.55 -42.69 83.47 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.815 0.846 . . . . 0.0 111.206 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.444 ' O ' HG21 ' A' ' 180' ' ' VAL . 63.0 m-80 -66.15 -47.44 74.05 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.993 0.517 . . . . 0.0 110.123 176.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.42 -42.28 86.9 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.462 1.101 . . . . 0.0 112.053 -175.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 174' ' ' VAL . 53.1 mt -60.75 -41.45 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 177.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -68.05 -26.68 73.94 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.66 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.444 HG21 ' O ' ' A' ' 176' ' ' ASN . 69.5 t -72.56 -50.06 37.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 123.414 0.686 . . . . 0.0 109.926 176.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 15.7 tp -59.41 -46.08 89.7 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.708 177.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.509 HD12 HG23 ' A' ' 194' ' ' VAL . 32.2 mt -56.76 -49.17 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.588 1.155 . . . . 0.0 111.299 174.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.43 ' O ' ' HG3' ' A' ' 187' ' ' ARG . . . -55.28 -42.14 81.63 Favored Glycine 0 C--N 1.343 0.923 0 O-C-N 124.149 0.905 . . . . 0.0 113.618 -178.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.553 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -71.29 -34.84 63.89 Favored Glycine 0 C--N 1.347 1.189 0 O-C-N 123.787 0.345 . . . . 0.0 113.084 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.433 HD21 HD13 ' A' ' 128' ' ' ILE . 95.0 mt -64.02 -40.74 97.0 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.372 0.669 . . . . 0.0 110.556 175.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -63.37 -35.34 80.08 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.607 0.763 . . . . 0.0 111.012 178.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 183' ' ' GLY . 83.0 mtp180 -64.99 -39.0 92.82 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.302 0.641 . . . . 0.0 110.451 175.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -70.92 -3.92 21.79 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.987 0.915 . . . . 0.0 112.082 175.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.9 t70 65.95 46.39 2.24 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 122.646 1.212 . . . . 0.0 109.089 -176.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -111.08 138.37 47.59 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.088 177.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 26.6 m -79.79 114.02 18.39 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -177.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 27.3 m -92.65 139.01 18.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.612 -174.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -149.18 146.38 27.61 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.948 171.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.509 HG23 HD12 ' A' ' 182' ' ' ILE . 2.8 t -109.06 147.27 13.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 -175.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 27.2 t -61.0 152.3 28.24 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 118.158 0.435 . . . . 0.0 111.292 -174.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.37 -41.05 62.76 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 124.297 0.998 . . . . 0.0 110.988 179.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 57.9 p -70.49 -52.2 23.64 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.083 0.953 . . . . 0.0 110.01 178.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.578 HD22 ' HB1' ' A' ' 132' ' ' ALA . 34.9 mt -58.9 -29.68 67.22 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.751 0.82 . . . . 0.0 112.128 -176.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.555 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 47.5 mt-30 -72.09 -54.65 9.14 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.26 0.624 . . . . 0.0 110.554 177.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.81 -9.22 59.38 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -174.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -100.82 -50.46 3.84 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.008 0.523 . . . . 0.0 111.556 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.474 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -113.6 -62.47 1.59 Allowed 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -168.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.555 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 65.9 t-105 -59.29 -57.37 13.32 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.891 1.276 . . . . 0.0 111.246 -165.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -82.25 134.85 13.43 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 165.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 21.2 m -78.48 80.12 4.88 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.301 0.64 . . . . 0.0 111.306 -174.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 42.5 t -81.68 68.33 8.0 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 123.59 0.756 . . . . 0.0 109.32 172.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 7.2 p30 175.34 145.4 0.07 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.383 1.473 . . . . 0.0 108.065 -175.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -155.23 149.39 25.86 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.114 0.483 . . . . 0.0 110.681 175.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -117.97 75.85 1.03 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 168.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -61.53 -47.88 88.0 Favored Glycine 0 C--N 1.355 1.596 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 172.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 58.9 mtm-85 -113.24 133.55 22.06 Favored Pre-proline 0 C--O 1.244 0.81 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 165.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.14 146.76 94.42 Favored 'Trans proline' 0 C--N 1.366 1.496 0 C-N-CA 121.657 1.571 . . . . 0.0 110.898 170.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.17 164.66 19.11 Favored 'Trans proline' 0 C--N 1.368 1.585 0 C-N-CA 121.815 1.676 . . . . 0.0 110.909 167.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 84.7 mt -57.22 103.72 0.13 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 61.1 p -60.43 146.07 45.88 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.204 -173.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 79.4 mt -66.96 88.31 0.15 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.647 0.779 . . . . 0.0 111.759 -169.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.353 0 C-N-CA 124.308 1.043 . . . . 0.0 111.462 178.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.448 ' SD ' ' N ' ' A' ' 84' ' ' MET . 0.7 OUTLIER . . . . . 0 CA--C 1.557 1.237 0 CA-C-O 118.351 -0.833 . . . . 0.0 111.101 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.423 ' HD3' ' HB2' ' A' ' 84' ' ' MET . 14.0 Cg_exo -71.69 148.3 52.63 Favored 'Trans proline' 0 C--N 1.392 2.861 0 C-N-CA 121.706 1.604 . . . . 0.0 111.247 168.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.4 104.97 2.43 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 122.818 0.447 . . . . 0.0 110.124 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 37.9 p -56.41 109.94 0.69 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.628 0.771 . . . . 0.0 110.866 -178.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.9 ttp180 -102.4 159.59 15.29 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.622 1.169 . . . . 0.0 109.616 -170.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -123.21 109.12 13.58 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.122 0.969 . . . . 0.0 109.322 173.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 36.1 mm -82.35 133.95 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 171.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 37.8 p -126.96 93.43 3.76 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.104 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -77.9 -25.88 48.76 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.73 177.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.664 ' SD ' ' HG2' ' A' ' 148' ' ' ARG . 40.1 mtm -104.83 129.16 53.18 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 124.199 0.999 . . . . 0.0 108.495 178.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 69.9 p -87.61 175.16 8.03 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 170.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 83.5 mt -56.43 -32.36 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 123.709 0.804 . . . . 0.0 111.116 -177.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -48.76 -55.5 11.32 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.152 1.381 . . . . 0.0 113.547 177.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -95.66 -25.73 16.01 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 118.039 0.382 . . . . 0.0 111.009 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.5 tt -66.72 -49.49 65.85 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -176.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.7 m -95.63 16.25 17.76 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.824 0.849 . . . . 0.0 110.86 -177.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -82.28 126.84 32.59 Favored 'General case' 0 C--N 1.35 0.604 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -80.43 128.17 33.26 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 169.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -137.18 164.82 27.57 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.261 0.624 . . . . 0.0 110.293 -174.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -134.84 149.99 50.42 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.286 0.634 . . . . 0.0 109.676 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 10.8 ptm -126.0 128.57 47.66 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.4 tp -69.88 -41.22 75.06 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.719 0.807 . . . . 0.0 111.316 -170.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.519 ' HE1' ' HA ' ' A' ' 106' ' ' MET . 4.0 mmt -116.67 88.1 23.66 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 123.792 0.837 . . . . 0.0 109.864 173.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -74.8 137.58 22.4 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.678 2.252 . . . . 0.0 113.201 -177.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -130.67 135.43 47.83 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.058 0.943 . . . . 0.0 108.469 166.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -121.82 123.75 42.51 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 173.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -144.24 121.53 11.59 Favored 'General case' 0 C--O 1.217 -0.623 0 C-N-CA 123.374 0.669 . . . . 0.0 109.241 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 97.1 t -79.23 137.67 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.029 0.531 . . . . 0.0 110.501 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -125.12 85.42 2.41 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 171.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.89 -119.42 6.41 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.279 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -89.74 16.73 1.69 Allowed 'Trans proline' 0 CA--C 1.552 1.411 0 C-N-CA 123.531 2.821 . . . . 0.0 113.044 177.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.537 HD21 ' HA ' ' A' ' 162' ' ' PRO . 96.1 mt -128.85 151.91 49.09 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.844 0.858 . . . . 0.0 109.965 -176.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 36.1 t -115.28 131.2 57.0 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.177 0.991 . . . . 0.0 108.897 177.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.4 mm -106.34 139.6 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.562 0.745 . . . . 0.0 109.219 -177.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -119.29 119.73 34.9 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 175.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.415 HD13 ' HA3' ' A' ' 184' ' ' GLY . 69.9 mt -126.05 124.08 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -178.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 106' ' ' MET . 24.4 t70 -97.59 123.27 41.42 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.837 0.455 . . . . 0.0 110.24 174.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -88.35 -11.2 46.94 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.21 -50.32 14.81 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.156 0.503 . . . . 0.0 111.454 -174.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.8 mp -72.34 112.67 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.706 1.202 . . . . 0.0 109.523 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.2 mtt -130.3 162.71 28.4 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.481 1.112 . . . . 0.0 109.974 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 73.78 18.96 3.28 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 125.037 1.335 . . . . 0.0 112.915 176.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -111.43 149.58 31.05 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.449 0.7 . . . . 0.0 111.716 -173.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -87.99 102.78 15.07 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 171.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.477 HG12 HG23 ' A' ' 151' ' ' THR . 54.8 mt -106.56 131.14 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.003 0.521 . . . . 0.0 109.92 -173.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 14.7 tpt -106.08 127.1 52.95 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.209 1.004 . . . . 0.0 109.688 -172.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.45 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 25.7 mt -99.16 105.08 17.11 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -177.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -130.42 145.56 51.84 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.42 0.688 . . . . 0.0 111.13 -175.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.49 155.43 46.66 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -170.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -109.02 122.19 46.72 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 166.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -155.84 161.07 40.67 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.692 0.797 . . . . 0.0 110.546 -170.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.7 p -86.56 163.77 17.28 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.688 173.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 90.0 t -139.04 137.26 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.667 1.187 . . . . 0.0 109.109 -174.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.2 tp -152.04 144.17 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 172.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 57.99 26.5 13.54 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 124.248 1.019 . . . . 0.0 111.767 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 57.63 44.32 20.98 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.655 1.182 . . . . 0.0 111.345 -174.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -146.74 166.79 25.55 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.162 169.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.507 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 9.6 tt -64.21 123.55 19.38 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -79.38 -70.28 0.52 Allowed 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 175.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 99.8 m -143.71 135.4 26.27 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.064 0.946 . . . . 0.0 109.185 177.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.47 ' HB3' ' NE2' ' A' ' 169' ' ' HIS . 62.7 tp -77.98 126.67 31.18 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.828 0.851 . . . . 0.0 109.716 178.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.58 -49.96 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 174.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.436 HD23 ' NH2' ' A' ' 148' ' ' ARG . 51.0 tp -162.66 147.59 12.03 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.408 0.683 . . . . 0.0 109.664 -178.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.623 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 8.8 tt -138.88 154.67 48.41 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.664 ' HG2' ' SD ' ' A' ' 93' ' ' MET . 10.8 ptp180 -153.7 158.33 40.87 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.78 0.8 . . . . 0.0 111.738 173.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.519 ' HB2' HD23 ' A' ' 181' ' ' LEU . . . -111.29 116.1 30.43 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.294 1.438 . . . . 0.0 107.748 176.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.476 ' HD1' ' HG3' ' A' ' 148' ' ' ARG . 44.6 p90 -134.69 136.78 43.0 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.067 0.547 . . . . 0.0 110.333 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.477 HG23 HG12 ' A' ' 128' ' ' ILE . 52.7 p -63.96 177.49 0.77 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.484 1.114 . . . . 0.0 112.364 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -64.99 -17.55 64.52 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.479 0.712 . . . . 0.0 112.384 173.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -81.7 -24.04 36.44 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 122.819 0.448 . . . . 0.0 109.826 172.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 101.23 3.56 54.01 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.576 -175.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -68.7 103.38 1.72 Allowed 'General case' 0 C--N 1.352 0.717 0 C-N-CA 123.489 0.716 . . . . 0.0 109.776 -178.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.565 HD13 HH11 ' A' ' 148' ' ' ARG . 14.5 mt -73.14 116.72 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -178.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' A' ' 120' ' ' ASP . 35.3 m -123.08 3.48 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.167 0.987 . . . . 0.0 111.17 -176.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -154.84 161.69 30.42 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.602 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 38.8 tt0 -166.0 144.65 5.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 122.687 0.395 . . . . 0.0 110.267 -177.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.623 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 68.8 mt -126.77 116.38 44.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 173.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 19.3 m -126.4 141.52 40.23 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 123.465 0.706 . . . . 0.0 109.954 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.537 ' HA ' HD21 ' A' ' 115' ' ' LEU . 32.0 Cg_exo -58.87 147.22 90.21 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.672 2.248 . . . . 0.0 112.171 173.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 76.3 mt -67.99 145.86 97.96 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 122.777 0.431 . . . . 0.0 110.454 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.2 -33.45 64.73 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 123.212 2.608 . . . . 0.0 113.23 170.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 40.9 m -82.22 -26.62 33.13 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.321 0.648 . . . . 0.0 111.602 177.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -134.42 74.07 67.21 Favored Pre-proline 0 N--CA 1.488 1.426 0 C-N-CA 123.079 0.552 . . . . 0.0 111.306 -175.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -72.1 -33.37 9.61 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.587 2.192 . . . . 0.0 112.028 174.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -94.47 119.2 6.0 Favored Glycine 0 C--N 1.345 1.048 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -175.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.47 ' NE2' ' HB3' ' A' ' 144' ' ' LEU . 51.6 p-80 -149.75 174.5 12.54 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.454 0.702 . . . . 0.0 110.484 -175.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 14.8 m -107.95 162.92 13.58 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.284 1.033 . . . . 0.0 109.692 -177.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.575 HD13 ' HA ' ' A' ' 202' ' ' ALA . 14.9 tt -54.63 -35.08 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 125.743 1.617 . . . . 0.0 113.465 178.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -63.12 -29.43 70.79 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.377 0.671 . . . . 0.0 111.331 -176.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -71.6 -38.86 70.8 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.159 0.584 . . . . 0.0 110.295 175.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 44.7 t -67.4 -41.72 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 124.067 0.854 . . . . 0.0 111.373 -175.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -65.32 -33.58 76.31 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 122.949 0.155 . . . . 0.0 110.854 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -70.23 -39.91 74.79 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.911 0.484 . . . . 0.0 109.719 175.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.58 -47.59 80.87 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.338 1.055 . . . . 0.0 111.353 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 73.2 mt -63.44 -35.05 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.532 0.733 . . . . 0.0 109.477 176.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -60.77 -36.3 91.58 Favored Glycine 0 C--N 1.349 1.278 0 O-C-N 123.586 0.554 . . . . 0.0 113.986 176.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 98.8 t -72.04 -45.99 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.135 0.574 . . . . 0.0 110.015 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.519 HD23 ' HB2' ' A' ' 149' ' ' ALA . 41.0 tp -58.23 -45.2 88.14 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.725 0.81 . . . . 0.0 111.168 178.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.477 ' O ' ' HG2' ' A' ' 186' ' ' GLU . 49.0 mt -62.05 -50.86 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.996 0.918 . . . . 0.0 110.169 175.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.408 ' O ' ' HG2' ' A' ' 187' ' ' ARG . . . -53.69 -37.81 57.66 Favored Glycine 0 C--N 1.346 1.089 0 O-C-N 124.067 0.854 . . . . 0.0 113.964 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.415 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -71.64 -38.43 61.38 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 123.676 0.28 . . . . 0.0 112.937 175.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.464 HD21 HD13 ' A' ' 128' ' ' ILE . 95.0 mt -72.36 -21.75 61.26 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.427 0.691 . . . . 0.0 111.469 176.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 11.6 mm-40 -74.76 -32.48 62.08 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.291 0.636 . . . . 0.0 109.64 176.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 183' ' ' GLY . 17.8 mmt180 -63.55 -39.12 93.59 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.375 172.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -75.47 -5.6 45.9 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.582 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 26.9 t70 63.6 21.86 12.9 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 123.977 0.911 . . . . 0.0 110.748 -177.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -80.95 138.15 36.11 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.129 0.972 . . . . 0.0 110.412 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 41.1 m -79.78 103.04 9.41 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.427 HG21 HG22 ' A' ' 182' ' ' ILE . 25.5 m -85.17 143.81 10.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.023 -177.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -143.87 127.32 16.88 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 168.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.45 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 7.8 t -88.27 146.53 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 27.7 t -57.32 144.32 36.33 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 118.429 0.558 . . . . 0.0 111.02 -176.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -55.76 -31.52 62.63 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.209 0.603 . . . . 0.0 111.11 -178.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 37.7 p -67.65 -57.53 6.24 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.808 172.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 56.3 mt -59.47 -25.32 64.31 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.07 0.948 . . . . 0.0 112.02 -174.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.582 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 49.9 mt-30 -74.63 -55.22 6.13 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.093 0.557 . . . . 0.0 110.242 178.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.82 -24.34 60.89 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 116.81 -0.177 . . . . 0.0 111.379 -174.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -84.56 -52.19 6.31 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.322 0.649 . . . . 0.0 110.764 177.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.575 ' HA ' HD13 ' A' ' 171' ' ' ILE . . . -114.64 -42.8 3.22 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -165.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.582 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 27.9 t-105 -94.62 9.35 39.07 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.908 0.483 . . . . 0.0 111.972 -168.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -63.21 -64.17 3.98 Favored Glycine 0 N--CA 1.479 1.527 0 N-CA-C 112.331 -0.307 . . . . 0.0 112.331 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 25.4 m -85.2 84.08 7.8 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 169.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 31.8 t -131.27 154.85 48.06 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.73 0.812 . . . . 0.0 109.501 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -150.2 157.54 43.2 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.813 0.845 . . . . 0.0 109.039 -176.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -149.99 124.99 9.95 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.839 0.855 . . . . 0.0 109.096 177.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -96.81 106.39 18.69 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 174.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -77.39 79.73 1.34 Allowed Glycine 0 C--N 1.345 1.044 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 171.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -63.09 127.84 91.45 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 123.087 0.555 . . . . 0.0 111.261 -174.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.61 134.21 46.43 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.611 2.207 . . . . 0.0 111.472 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -56.05 123.13 13.09 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 123.071 2.514 . . . . 0.0 111.753 -176.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 88.6 mt -58.98 133.28 55.95 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.235 0.614 . . . . 0.0 112.21 -174.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 49.0 p -62.65 130.58 45.65 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.221 1.009 . . . . 0.0 111.107 -176.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.2 pp -73.38 -176.22 2.18 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.396 0.679 . . . . 0.0 111.656 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.558 1.263 0 CA-C-O 118.831 -0.604 . . . . 0.0 111.343 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.574 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 74.7 ttt180 . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -121.96 121.17 36.47 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 175.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.429 HG22 ' HB2' ' A' ' 92' ' ' ASP . 49.0 mm -91.25 112.9 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.5 p -98.75 65.54 1.56 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 170.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 132' ' ' ALA . 27.5 t70 -67.61 -41.07 84.6 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 113.489 -1.687 . . . . 0.0 110.361 -177.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -109.84 151.02 27.55 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 173.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.5 m -86.82 154.23 21.05 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.593 0.357 . . . . 0.0 111.126 -170.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 49.8 mm -63.13 -35.91 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 123.157 0.583 . . . . 0.0 110.424 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -47.66 -46.64 29.27 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.859 1.264 . . . . 0.0 112.743 174.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.38 -20.11 20.02 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.204 -175.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.489 ' HG ' HD23 ' A' ' 146' ' ' LEU . 8.7 tt -69.03 -35.77 76.98 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.739 0.815 . . . . 0.0 109.812 174.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.8 m -97.84 12.01 35.38 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.84 0.856 . . . . 0.0 110.753 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -79.41 131.58 36.13 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.533 0.733 . . . . 0.0 109.868 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -81.47 140.64 34.48 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 38.4 p-90 -158.7 176.22 12.64 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.086 0.954 . . . . 0.0 109.044 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -151.88 166.68 30.69 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.636 0.775 . . . . 0.0 109.259 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 74.4 mtm -102.07 127.8 48.81 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.066 0.546 . . . . 0.0 109.788 170.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.518 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.2 pt? -78.31 -33.3 49.43 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.11 0.564 . . . . 0.0 110.638 178.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 23.5 mmt -120.0 80.7 26.65 Favored Pre-proline 0 N--CA 1.485 1.287 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 168.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -73.23 129.23 13.75 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.669 2.246 . . . . 0.0 112.579 -173.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -134.81 121.84 21.23 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 174.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -109.65 110.24 21.23 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -174.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.461 ' HG2' HG11 ' A' ' 180' ' ' VAL . 22.1 tptm -100.79 133.6 45.02 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 169.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.8 t -103.61 126.92 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 171.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -131.46 88.65 2.61 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.29 -124.16 13.1 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.315 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -91.07 13.55 2.11 Favored 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 123.113 2.542 . . . . 0.0 112.476 176.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.1 mt -128.83 114.84 17.04 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.695 0.798 . . . . 0.0 108.916 -171.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.638 ' SG ' ' HB2' ' A' ' 161' ' ' SER . 25.6 p -89.8 114.14 25.82 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.062 0.458 . . . . 0.0 110.364 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.416 ' HB ' ' HB3' ' A' ' 110' ' ' LYS . 12.0 mm -86.07 121.0 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 124.812 1.245 . . . . 0.0 110.607 -175.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -94.18 118.44 31.57 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 33.1 mm -118.26 121.84 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -102.41 114.33 28.43 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 169.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -71.01 -16.8 62.64 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -176.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.13 -26.04 25.43 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 118.169 0.441 . . . . 0.0 111.954 -174.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.555 HG13 ' HB ' ' A' ' 157' ' ' VAL . 29.2 mm -70.55 104.08 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 122.493 0.317 . . . . 0.0 110.46 -176.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 48.1 mtt -134.41 152.38 51.76 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.376 1.07 . . . . 0.0 109.702 -176.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.3 t70 71.89 7.84 5.92 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.608 1.163 . . . . 0.0 112.129 174.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -93.03 151.27 19.98 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.778 0.831 . . . . 0.0 110.532 -175.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -95.22 108.64 20.78 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 171.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.613 ' HB ' HG12 ' A' ' 192' ' ' VAL . 66.5 mt -115.52 149.15 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.405 0.682 . . . . 0.0 110.167 -170.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 55.8 tpp -125.31 134.36 52.28 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.149 0.979 . . . . 0.0 109.504 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -94.3 103.38 15.39 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.477 ' HG3' ' CE1' ' A' ' 150' ' ' PHE . 25.1 mmmt -114.52 149.94 35.66 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.62 1.168 . . . . 0.0 109.229 -173.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.536 ' HB2' ' HG ' ' A' ' 147' ' ' LEU . . . -153.49 144.12 22.57 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -104.92 133.68 49.31 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 167.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.481 ' HA ' HG13 ' A' ' 145' ' ' ILE . 28.4 p90 -162.16 164.19 28.02 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.182 0.515 . . . . 0.0 111.569 -172.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.1 t -88.53 157.4 18.63 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.614 172.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' A' ' 88' ' ' ARG . 74.1 t -136.31 140.01 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.303 1.041 . . . . 0.0 109.028 -174.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 7.9 tp -145.95 140.55 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 172.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 58.82 26.96 15.44 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.753 0.821 . . . . 0.0 112.34 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.0 t70 72.29 14.41 5.48 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.338 1.455 . . . . 0.0 111.895 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -123.54 160.71 26.42 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.12 0.568 . . . . 0.0 109.764 175.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.434 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 8.7 tt -62.87 119.04 8.61 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 177.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -82.67 -69.38 0.63 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.158 0.983 . . . . 0.0 109.135 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 93.8 m -137.17 129.71 30.01 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.647 0.779 . . . . 0.0 109.271 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.492 HD21 ' HB2' ' A' ' 147' ' ' LEU . 52.2 tp -73.13 123.51 23.74 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.641 0.776 . . . . 0.0 109.449 176.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.481 HG13 ' HA ' ' A' ' 134' ' ' PHE . 69.0 mt -83.79 -48.56 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.489 HD23 ' HG ' ' A' ' 98' ' ' LEU . 49.2 tp -161.98 149.57 14.42 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.899 0.88 . . . . 0.0 109.503 172.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.715 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 7.7 tt -126.52 142.74 51.44 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 172.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.559 HH11 HG21 ' A' ' 156' ' ' ILE . 46.6 ttm-85 -135.0 137.57 43.15 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.772 1.229 . . . . 0.0 110.53 -177.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.567 ' HB2' HD21 ' A' ' 181' ' ' LEU . . . -111.67 118.6 36.1 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 171.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.477 ' CE1' ' HG3' ' A' ' 131' ' ' LYS . 29.2 p90 -143.39 160.41 40.6 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 40.8 p -80.83 170.82 15.79 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.003 -174.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.27 -11.39 60.87 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 120.735 0.302 . . . . 0.0 111.11 171.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -71.03 -30.19 66.32 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.852 0.861 . . . . 0.0 110.066 168.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 106.6 -4.93 37.24 Favored Glycine 0 C--N 1.352 1.447 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.443 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -77.66 122.34 25.19 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.388 0.675 . . . . 0.0 110.493 -174.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.559 HG21 HH11 ' A' ' 148' ' ' ARG . 39.3 mt -76.53 103.99 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.212 0.605 . . . . 0.0 110.651 -175.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.555 ' HB ' HG13 ' A' ' 123' ' ' ILE . 27.2 m -99.27 -9.49 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 123.74 0.816 . . . . 0.0 112.061 -172.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -167.79 173.03 42.75 Favored Glycine 0 C--N 1.34 0.785 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 147' ' ' LEU . 37.5 tt0 -164.08 157.79 18.64 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.715 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 93.6 mt -123.53 103.87 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 167.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.638 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 2.7 m -93.7 109.47 41.41 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.563 -177.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -64.34 119.11 6.06 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.624 2.216 . . . . 0.0 111.307 172.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 CA--C 1.545 0.751 0 O-C-N 124.051 0.844 . . . . 0.0 110.411 178.858 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 16.0 p-80 . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 5.0 m -102.17 162.25 13.06 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.618 0.767 . . . . 0.0 110.199 -173.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.437 HD11 ' HA ' ' A' ' 202' ' ' ALA . 17.8 tt -56.78 -28.98 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 C-N-CA 124.95 1.3 . . . . 0.0 111.819 173.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -54.86 -42.79 72.44 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.721 1.208 . . . . 0.0 111.607 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.01 -44.0 90.64 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.809 0.844 . . . . 0.0 110.482 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.484 ' O ' HG13 ' A' ' 178' ' ' ILE . 50.9 t -65.58 -48.66 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.633 -172.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -58.15 -36.08 72.47 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.595 0.758 . . . . 0.0 111.757 -175.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.429 ' O ' HG23 ' A' ' 180' ' ' VAL . 16.2 m120 -74.02 -43.09 59.14 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.618 0.767 . . . . 0.0 110.142 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -59.56 -42.15 91.77 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.185 0.928 . . . . 0.0 111.562 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 174' ' ' VAL . 62.0 mt -57.71 -42.8 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 123.734 0.813 . . . . 0.0 109.171 177.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -76.9 -22.43 71.79 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-N 114.662 -1.154 . . . . 0.0 114.431 -175.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.461 HG11 ' HG2' ' A' ' 110' ' ' LYS . 97.6 t -73.5 -43.43 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 172.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.641 HD22 HG13 ' A' ' 160' ' ' ILE . 33.0 tp -58.97 -48.85 80.06 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.656 173.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.51 ' O ' ' HG2' ' A' ' 186' ' ' GLU . 70.0 mt -60.46 -44.66 96.81 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.997 0 C-N-CA 123.856 0.862 . . . . 0.0 110.61 176.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.449 ' O ' ' HG3' ' A' ' 187' ' ' ARG . . . -56.67 -39.31 85.89 Favored Glycine 0 C--N 1.342 0.869 0 O-C-N 123.512 0.508 . . . . 0.0 113.268 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -67.01 -41.21 93.3 Favored Glycine 0 C--N 1.353 1.489 0 N-CA-C 112.058 -0.417 . . . . 0.0 112.058 174.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 182' ' ' ILE . 76.9 mt -62.96 -34.32 77.26 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.012 0.925 . . . . 0.0 111.043 176.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 31.1 mm-40 -68.41 -42.63 78.71 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 123.922 0.889 . . . . 0.0 109.827 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 183' ' ' GLY . 74.0 mtp180 -60.35 -38.38 83.62 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.299 0.64 . . . . 0.0 110.65 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -72.72 -14.21 61.51 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.951 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 36.6 t70 64.12 67.22 0.6 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.977 0.911 . . . . 0.0 110.819 -177.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -104.63 -162.82 0.91 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 170.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.1 m -135.0 101.0 4.74 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 169.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.613 HG12 ' HB ' ' A' ' 128' ' ' ILE . 8.2 m -111.02 153.26 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 121.784 0.802 . . . . 0.0 111.02 -172.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 52.2 ttm-85 -139.58 142.23 37.14 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.032 -1.44 . . . . 0.0 107.895 174.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.41 HG22 HD11 ' A' ' 182' ' ' ILE . 3.4 t -88.14 145.65 7.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 34.3 t -57.68 144.32 38.3 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.581 0.352 . . . . 0.0 111.272 178.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -45.8 -37.78 6.45 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 124.429 1.081 . . . . 0.0 112.062 174.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 70.5 p -69.29 -55.54 10.18 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 123.525 0.73 . . . . 0.0 110.271 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.44 HD21 ' HB3' ' A' ' 132' ' ' ALA . 73.3 mt -62.17 -31.99 72.55 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.261 0.624 . . . . 0.0 111.413 -175.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.569 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 49.7 mt-30 -62.1 -50.38 72.15 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.496 0.718 . . . . 0.0 111.131 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.25 -20.11 35.13 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -175.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -87.38 -62.31 1.53 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.8 0.44 . . . . 0.0 111.285 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.437 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -111.05 -51.95 2.82 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.315 0.646 . . . . 0.0 111.679 -162.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.569 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 57.5 t-105 . . . . . 0 CA--C 1.554 1.116 0 C-N-CA 125.37 1.468 . . . . 0.0 110.675 -173.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.405 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 41.3 ttm180 . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -119.36 109.95 16.39 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.781 0.833 . . . . 0.0 108.928 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.8 mm -87.09 131.69 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 123.457 0.703 . . . . 0.0 109.413 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.492 ' HA ' HD22 ' A' ' 133' ' ' ASN . 50.9 p -118.48 81.06 1.62 Allowed 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 172.045 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -74.56 -27.45 60.51 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.606 -174.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.489 ' HB2' ' HG3' ' A' ' 97' ' ' GLU . 23.4 ptt? -102.89 134.14 46.81 Favored 'General case' 0 C--O 1.245 0.86 0 C-N-CA 123.361 0.664 . . . . 0.0 109.553 174.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.434 ' O ' ' HB2' ' A' ' 98' ' ' LEU . 9.8 t -81.84 171.72 14.17 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.337 0.655 . . . . 0.0 110.908 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -55.7 -43.02 71.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 126.024 1.73 . . . . 0.0 111.384 -176.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.44 ' O ' ' HB2' ' A' ' 100' ' ' ARG . 27.0 mm-40 -52.38 -40.64 62.3 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.126 0.97 . . . . 0.0 113.454 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.489 ' HG3' ' HB2' ' A' ' 93' ' ' MET . 12.7 pt-20 -97.73 -22.1 16.61 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.22 0.608 . . . . 0.0 111.291 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 94' ' ' THR . 2.2 tt -73.91 -59.93 2.49 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.634 0.773 . . . . 0.0 109.077 -176.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 39.7 m -80.67 -7.5 59.33 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.378 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 96' ' ' GLU . 9.2 tpm_? -58.81 122.33 13.31 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 123.416 0.687 . . . . 0.0 110.501 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -92.9 145.9 24.04 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 173.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' TRP . . . . . 0.416 ' HE1' ' NH1' ' A' ' 148' ' ' ARG . 30.7 p-90 -154.16 178.65 9.75 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.828 0.851 . . . . 0.0 109.921 -166.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -136.84 151.17 48.82 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.093 0.957 . . . . 0.0 109.618 -177.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 65.6 mtp -93.17 95.16 9.23 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 172.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -57.14 -37.95 72.78 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.54 0.525 . . . . 0.0 111.312 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.604 ' HB3' ' HB2' ' A' ' 121' ' ' GLN . 8.7 mmt -124.77 97.06 39.41 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 168.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -82.82 127.06 4.71 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.965 2.444 . . . . 0.0 114.202 -170.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.534 ' HB3' ' HB ' ' A' ' 119' ' ' ILE . 87.5 tttt -123.19 116.29 23.17 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 162.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -106.91 111.59 24.16 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -176.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.445 ' HG2' HG11 ' A' ' 180' ' ' VAL . 50.5 tptt -117.12 135.83 53.46 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 124.858 1.263 . . . . 0.0 108.58 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.1 t -112.06 118.67 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 170.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -110.15 88.52 2.78 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.79 -115.96 7.77 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.343 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -85.49 -1.43 9.07 Favored 'Trans proline' 0 C--N 1.367 1.52 0 C-N-CA 122.898 2.398 . . . . 0.0 113.694 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.475 HD12 ' HB2' ' A' ' 177' ' ' ALA . 45.0 mt -116.23 152.07 34.5 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.187 0.595 . . . . 0.0 110.743 -171.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 37.9 t -106.55 110.79 23.09 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.234 1.014 . . . . 0.0 109.824 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.8 mm -95.92 142.5 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.803 0.841 . . . . 0.0 109.317 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -128.52 121.76 29.57 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.534 ' HB ' ' HB3' ' A' ' 108' ' ' LYS . 37.3 mm -116.8 127.18 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.43 1.092 . . . . 0.0 109.762 -176.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -79.55 141.02 37.02 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 170.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.604 ' HB2' ' HB3' ' A' ' 106' ' ' MET . 14.9 mt-30 -103.4 3.19 34.82 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.919 172.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -108.14 -46.41 3.75 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -170.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.439 HG13 HG12 ' A' ' 157' ' ' VAL . 30.1 mm -81.98 106.63 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 121.295 0.569 . . . . 0.0 109.99 -163.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 63.0 mtt -127.82 161.45 28.98 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.527 1.131 . . . . 0.0 109.76 -172.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 66.43 6.39 4.31 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 124.311 1.045 . . . . 0.0 112.822 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -103.91 153.61 20.59 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.594 0.757 . . . . 0.0 110.393 -171.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -88.14 107.62 18.86 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 172.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.621 HD13 HG21 ' A' ' 157' ' ' VAL . 47.5 mt -105.62 117.9 52.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.625 0.726 . . . . 0.0 109.251 -175.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 13.4 tpt -102.47 133.86 46.73 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.423 -173.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 15.2 mt -108.36 104.04 13.32 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -176.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.414 ' HA ' ' OG ' ' A' ' 195' ' ' SER . 68.2 mttm -116.7 149.78 39.27 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.329 0.652 . . . . 0.0 110.501 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -141.08 161.94 36.66 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 122.146 0.974 . . . . 0.0 113.02 -174.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.492 HD22 ' HA ' ' A' ' 91' ' ' THR . 8.8 m120 -108.47 133.24 52.9 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 160.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -160.53 160.85 32.4 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.254 0.55 . . . . 0.0 111.6 -177.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.0 m -87.82 154.72 20.32 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.428 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.405 ' HB ' ' HB3' ' A' ' 88' ' ' ARG . 79.4 t -128.7 131.35 68.63 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 C-N-CA 123.938 0.895 . . . . 0.0 109.427 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 6.7 tp -142.99 141.51 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 171.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 58.2 37.92 26.23 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.832 0.853 . . . . 0.0 112.115 176.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 63.18 16.62 9.54 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 125.036 1.335 . . . . 0.0 112.446 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 16.1 ptt-85 -132.6 167.22 20.42 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.15 0.58 . . . . 0.0 110.856 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.6 tt -67.81 115.85 7.82 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -78.21 -61.9 1.85 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 122.789 0.436 . . . . 0.0 110.468 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 97.3 m -147.2 125.89 12.58 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.569 0.748 . . . . 0.0 110.12 -171.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.444 HD11 ' HB2' ' A' ' 147' ' ' LEU . 47.9 tp -73.51 129.53 38.18 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.191 0.596 . . . . 0.0 109.784 176.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 85.3 mt -88.27 -51.05 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.699 0.8 . . . . 0.0 109.283 174.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 54.3 tp -162.23 148.06 13.02 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 175.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.609 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 7.7 tt -137.28 149.45 47.11 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 175.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.486 ' HD3' HD13 ' A' ' 156' ' ' ILE . 46.8 mtt-85 -133.87 145.52 49.74 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.491 0.717 . . . . 0.0 110.729 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.556 ' HB2' HD21 ' A' ' 181' ' ' LEU . . . -109.76 123.52 49.68 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 168.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.528 ' HB3' ' HA ' ' A' ' 156' ' ' ILE . 18.8 p90 -150.22 168.51 23.79 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.64 0.776 . . . . 0.0 110.186 -176.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 79.1 p -85.69 165.87 16.61 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 173.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.05 -9.46 39.5 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 120.691 0.282 . . . . 0.0 111.675 174.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -79.83 -23.7 41.85 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.018 1.327 . . . . 0.0 110.973 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 106.18 -1.48 37.84 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-N 115.637 -0.711 . . . . 0.0 113.003 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.24 106.9 6.1 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.216 0.606 . . . . 0.0 109.911 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.528 ' HA ' ' HB3' ' A' ' 150' ' ' PHE . 25.6 mt -77.46 118.51 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -177.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.621 HG21 HD13 ' A' ' 128' ' ' ILE . 18.9 m -106.89 -15.31 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 124.595 1.158 . . . . 0.0 111.994 -170.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -165.25 177.23 40.72 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 111.826 -0.51 . . . . 0.0 111.826 -172.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -166.17 153.94 10.28 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.739 0.416 . . . . 0.0 111.046 -173.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.609 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 67.9 mt -127.61 116.49 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 166.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 33.4 t -128.03 118.74 20.84 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.108 0.563 . . . . 0.0 109.898 -174.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -62.14 121.45 9.49 Favored 'Trans proline' 0 C--N 1.382 2.328 0 C-N-CA 122.798 2.332 . . . . 0.0 111.91 176.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.4 mt . . . . . 0 CA--C 1.548 0.903 0 C-N-CA 122.862 0.465 . . . . 0.0 110.217 -178.92 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 10.1 p80 . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.0 m -107.27 161.86 14.41 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.269 1.027 . . . . 0.0 110.82 -169.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.603 HD11 ' HA ' ' A' ' 202' ' ' ALA . 14.8 tt -56.05 -29.99 28.06 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.308 0 C-N-CA 124.235 1.014 . . . . 0.0 112.307 172.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -56.21 -52.65 63.65 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.059 0.944 . . . . 0.0 111.835 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -73.63 -25.2 60.19 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.978 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 178' ' ' ILE . 63.4 t -65.78 -40.92 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 122.643 0.377 . . . . 0.0 110.185 172.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -72.1 -30.7 65.36 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.477 0.311 . . . . 0.0 111.005 178.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.441 ' O ' HG23 ' A' ' 180' ' ' VAL . 94.8 m-20 -62.79 -46.16 89.27 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 169.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.475 ' HB2' HD12 ' A' ' 115' ' ' LEU . . . -61.87 -48.21 81.53 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.766 1.226 . . . . 0.0 112.339 -174.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 174' ' ' VAL . 45.6 mt -68.32 -32.36 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -65.31 -38.74 95.39 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-N 116.086 -0.506 . . . . 0.0 113.364 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.445 HG11 ' HG2' ' A' ' 110' ' ' LYS . 95.8 t -72.45 -42.81 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.066 0.546 . . . . 0.0 109.847 177.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.556 HD21 ' HB2' ' A' ' 149' ' ' ALA . 35.4 tp -54.15 -55.97 22.69 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.027 0.931 . . . . 0.0 110.536 176.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.496 ' O ' ' HG2' ' A' ' 186' ' ' GLU . 24.7 mt -55.0 -45.27 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 124.152 0.907 . . . . 0.0 110.74 172.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -55.24 -41.86 80.45 Favored Glycine 0 CA--C 1.533 1.189 0 O-C-N 123.793 0.683 . . . . 0.0 114.268 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.35 -33.26 64.53 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-O 121.302 0.39 . . . . 0.0 112.134 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.428 ' HB3' ' OD1' ' A' ' 190' ' ' ASN . 88.9 mt -72.2 -28.82 63.44 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 124.618 1.167 . . . . 0.0 111.403 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 18.2 mm-40 -60.55 -38.45 84.56 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.703 0.801 . . . . 0.0 110.044 175.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 67.4 mtp85 -69.42 -30.83 68.86 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.24 -1.345 . . . . 0.0 110.821 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -83.09 4.81 24.76 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.516 0.727 . . . . 0.0 112.652 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 36.9 t70 59.33 26.96 15.92 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.986 0.898 . . . . 0.0 111.124 173.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.428 ' OD1' ' HB3' ' A' ' 185' ' ' LEU . 28.8 p30 -105.09 161.48 14.2 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -177.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 35.4 m -91.27 113.79 26.15 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.28 0.632 . . . . 0.0 109.827 -172.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.493 HG21 HG23 ' A' ' 182' ' ' ILE . 35.2 m -89.83 134.43 28.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-O 121.324 0.583 . . . . 0.0 109.986 -177.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -140.76 129.78 23.33 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.755 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 4.7 t -105.34 152.62 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.414 ' OG ' ' HA ' ' A' ' 131' ' ' LYS . 63.5 m -59.06 145.84 40.64 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 118.222 0.464 . . . . 0.0 111.037 176.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' LYS . . . . . 0.411 ' O ' ' HG3' ' A' ' 200' ' ' ARG . 0.2 OUTLIER -69.26 -28.08 66.0 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.294 0.371 . . . . 0.0 110.222 -178.216 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 62.6 p -67.34 -50.15 61.12 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 171.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 33.6 mt -58.58 -30.61 67.32 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.464 0.705 . . . . 0.0 111.26 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.673 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 49.4 mt-30 -70.58 -55.18 9.43 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.161 0.585 . . . . 0.0 110.897 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 196' ' ' LYS . 0.0 OUTLIER -81.61 -11.78 58.99 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -173.213 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -97.37 -39.51 9.17 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.038 0.535 . . . . 0.0 111.13 175.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.603 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -121.67 -61.55 1.5 Allowed 'General case' 0 N--CA 1.479 0.993 0 O-C-N 122.15 -0.344 . . . . 0.0 111.287 -172.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.673 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 51.2 t-105 . . . . . 0 CA--C 1.545 0.757 0 C-N-CA 124.584 1.153 . . . . 0.0 110.445 -165.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 120.5 0.19 . . . . 0.0 110.625 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -99.1 98.73 9.71 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.954 0.901 . . . . 0.0 109.197 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.8 mm -77.22 137.44 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.994 0.918 . . . . 0.0 109.018 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.2 p -127.35 85.92 2.43 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.107 0.563 . . . . 0.0 109.534 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -72.55 -25.52 61.39 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 122.824 0.45 . . . . 0.0 111.319 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.534 ' HB2' ' HG3' ' A' ' 97' ' ' GLU . 9.1 ptp -106.04 131.7 53.01 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 172.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 77.1 p -70.05 169.24 13.81 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.415 0.686 . . . . 0.0 109.946 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 45.0 mm -62.16 -35.66 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 122.593 0.357 . . . . 0.0 110.582 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 100' ' ' ARG . 43.2 mt-10 -53.72 -44.13 69.61 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.803 0.841 . . . . 0.0 112.294 176.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.534 ' HG3' ' HB2' ' A' ' 93' ' ' MET . 13.7 pt-20 -96.7 -13.23 22.89 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.076 0.55 . . . . 0.0 110.996 -177.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.565 HD12 HD23 ' A' ' 146' ' ' LEU . 53.2 tp -68.9 -50.21 51.5 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.919 0.888 . . . . 0.0 110.768 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.1 p -103.42 14.33 31.63 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.659 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 96' ' ' GLU . 59.5 ttt85 -72.15 141.38 49.11 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.237 0.615 . . . . 0.0 111.279 -174.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -84.28 152.28 24.26 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.344 0.592 . . . . 0.0 109.812 173.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' TRP . . . . . 0.55 ' HE1' HH12 ' A' ' 148' ' ' ARG . 7.9 p-90 -149.6 167.51 26.14 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.389 1.076 . . . . 0.0 109.396 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -129.19 145.08 51.4 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.685 0.794 . . . . 0.0 109.605 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.548 ' SD ' ' HD2' ' A' ' 118' ' ' ARG . 69.7 mtp -116.9 150.92 37.68 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.662 0.785 . . . . 0.0 109.886 178.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.446 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.9 pt? -126.93 -23.73 3.6 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.672 0.789 . . . . 0.0 110.552 -177.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 25.6 mmt -130.12 72.72 81.83 Favored Pre-proline 0 N--CA 1.49 1.563 0 C-N-CA 123.119 0.568 . . . . 0.0 109.627 167.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.93 135.66 35.85 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.867 2.378 . . . . 0.0 113.61 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -129.88 118.9 22.44 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.032 0.933 . . . . 0.0 109.133 173.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -108.33 103.8 13.04 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.7 tptt -120.79 126.36 49.91 Favored 'General case' 0 C--O 1.206 -1.207 0 C-N-CA 124.957 1.303 . . . . 0.0 107.911 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 81.3 t -96.4 133.85 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 173.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -126.12 92.65 3.62 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 175.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.61 -133.25 25.3 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.909 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -75.65 3.78 5.64 Favored 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 123.716 2.944 . . . . 0.0 113.697 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.639 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 5.3 mp -125.23 156.67 38.14 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.267 0.627 . . . . 0.0 109.71 -177.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 42.6 t -116.87 132.75 56.62 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.002 0.921 . . . . 0.0 108.825 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.419 HD11 ' HB1' ' A' ' 177' ' ' ALA . 12.6 mm -106.03 143.71 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.472 1.109 . . . . 0.0 109.184 -176.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.618 ' HB3' ' HB3' ' A' ' 159' ' ' GLU . 71.3 ttp85 -129.3 120.64 25.99 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 176.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.595 HD13 ' HA3' ' A' ' 184' ' ' GLY . 44.2 mt -128.68 139.17 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -176.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -107.86 121.92 45.73 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 171.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -82.96 -9.29 59.36 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -173.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.27 -32.18 26.53 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.798 0.439 . . . . 0.0 111.5 178.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.442 HG12 ' CG1' ' A' ' 157' ' ' VAL . 1.8 mp -71.02 108.57 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.758 0.789 . . . . 0.0 109.117 -178.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.439 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 58.4 mtt -132.08 163.19 29.01 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 113.684 -1.598 . . . . 0.0 108.988 -175.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 71.35 5.33 5.39 Favored 'General case' 0 N--CA 1.502 2.126 0 C-N-CA 124.543 1.137 . . . . 0.0 112.998 171.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -97.08 151.13 20.06 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.653 0.781 . . . . 0.0 112.143 -170.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -91.98 108.33 19.85 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 164.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.548 HG12 HG22 ' A' ' 151' ' ' THR . 34.0 mt -110.92 147.91 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 123.598 0.759 . . . . 0.0 110.397 -172.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 15.4 tpt -130.67 120.76 24.39 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.544 1.138 . . . . 0.0 109.768 -169.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -88.21 103.63 15.95 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -117.25 138.14 51.92 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.487 0.715 . . . . 0.0 109.26 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -134.8 147.03 49.86 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.512 0.931 . . . . 0.0 113.512 -171.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.458 ' OD1' ' HG2' ' A' ' 93' ' ' MET . 5.2 m-20 -102.07 122.92 45.03 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 165.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -159.73 158.7 31.78 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 122.901 0.48 . . . . 0.0 111.645 -171.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.9 t -88.02 155.11 19.99 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.008 0.923 . . . . 0.0 109.914 173.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.9 t -130.5 145.6 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 124.901 1.281 . . . . 0.0 109.297 -177.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.544 HG22 ' HB2' ' A' ' 142' ' ' GLU . 11.0 tp -157.95 144.01 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 171.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 55.5 27.59 10.49 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 123.64 0.776 . . . . 0.0 112.858 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 66.18 23.19 10.95 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.97 1.308 . . . . 0.0 112.661 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.452 ' HG2' ' O ' ' A' ' 137' ' ' ILE . 28.8 ptt180 -117.66 160.96 20.44 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.945 0.498 . . . . 0.0 109.78 175.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.8 tt -71.2 112.99 7.78 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 166.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.544 ' HB2' HG22 ' A' ' 137' ' ' ILE . 11.9 tp10 -81.43 -58.46 3.02 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.67 0.388 . . . . 0.0 110.186 177.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 96.4 m -141.78 120.94 12.97 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.249 0.22 . . . . 0.0 110.808 -174.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 43.6 tp -77.2 119.3 20.69 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.057 0.543 . . . . 0.0 109.577 172.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 72.0 mt -80.56 -53.68 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 174.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.565 HD23 HD12 ' A' ' 98' ' ' LEU . 65.0 tp -156.61 146.09 20.66 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.888 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.564 HD13 HD12 ' A' ' 160' ' ' ILE . 8.2 tt -133.2 145.59 50.72 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 171.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.681 HH11 HG21 ' A' ' 156' ' ' ILE . 84.4 mtt-85 -140.52 143.69 35.54 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.227 1.011 . . . . 0.0 108.845 178.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -101.61 112.43 24.99 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 176.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -106.58 125.31 50.84 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.382 1.073 . . . . 0.0 109.74 -175.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.548 HG22 HG12 ' A' ' 128' ' ' ILE . 43.7 p -71.64 -174.07 1.06 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.034 0.534 . . . . 0.0 111.583 175.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -19.2 65.5 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.462 0.705 . . . . 0.0 112.833 175.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -98.3 -1.2 42.37 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.728 0.811 . . . . 0.0 111.358 172.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 76.38 26.3 63.91 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 116.396 -0.365 . . . . 0.0 113.343 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -77.7 131.63 37.79 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.681 HG21 HH11 ' A' ' 148' ' ' ARG . 22.9 mt -83.02 86.86 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 121.649 0.738 . . . . 0.0 109.181 -177.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.442 ' CG1' HG12 ' A' ' 123' ' ' ILE . 19.3 m -100.09 -12.89 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.519 1.128 . . . . 0.0 111.185 -169.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.44 ' HA3' HD11 ' A' ' 181' ' ' LEU . . . -142.84 164.76 27.05 Favored Glycine 0 C--O 1.245 0.836 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.618 ' HB3' ' HB3' ' A' ' 118' ' ' ARG . 32.8 tt0 -167.89 150.05 5.56 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 117.437 0.618 . . . . 0.0 110.428 -173.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.564 HD12 HD13 ' A' ' 147' ' ' LEU . 57.6 mt -136.0 125.67 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 170.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 14.4 m -138.46 122.88 11.7 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.639 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 88.1 Cg_exo -48.51 142.44 17.78 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 123.257 2.638 . . . . 0.0 113.175 173.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 90.4 mt . . . . . 0 CA--C 1.559 1.307 0 C-N-CA 123.623 0.769 . . . . 0.0 111.09 178.873 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.8 m -122.51 154.96 37.15 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.465 HD11 ' HA ' ' A' ' 202' ' ' ALA . 10.7 tt -51.88 -34.96 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 C-N-CA 124.726 1.21 . . . . 0.0 113.001 177.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -61.97 -44.15 97.35 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.221 1.008 . . . . 0.0 112.784 -177.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -82.75 -25.62 32.67 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.647 0.379 . . . . 0.0 111.276 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.453 ' O ' HG13 ' A' ' 178' ' ' ILE . 91.4 t -64.49 -48.64 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 122.809 0.444 . . . . 0.0 110.858 172.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -65.96 -28.22 68.74 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.61 0.364 . . . . 0.0 110.905 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.426 ' O ' HG23 ' A' ' 180' ' ' VAL . 13.7 m120 -68.53 -43.56 76.48 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 123.144 0.578 . . . . 0.0 109.495 171.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.419 ' HB1' HD11 ' A' ' 117' ' ' ILE . . . -61.3 -40.52 94.46 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.842 0.857 . . . . 0.0 111.36 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 174' ' ' VAL . 57.6 mt -65.0 -39.91 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.19 -36.98 94.16 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.476 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 176' ' ' ASN . 80.9 t -66.2 -47.59 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.218 0.607 . . . . 0.0 110.613 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.44 HD11 ' HA3' ' A' ' 158' ' ' GLY . 32.7 tp -59.46 -46.76 87.85 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.879 0.737 . . . . 0.0 110.344 178.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.8 HG23 HG21 ' A' ' 192' ' ' VAL . 47.8 mt -57.12 -46.19 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.37 1.068 . . . . 0.0 111.447 176.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -63.41 -34.58 90.34 Favored Glycine 0 C--N 1.341 0.841 0 O-C-N 123.675 0.609 . . . . 0.0 113.104 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.595 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -71.12 -27.61 71.67 Favored Glycine 0 C--N 1.35 1.343 0 O-C-N 123.751 0.324 . . . . 0.0 113.0 177.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.411 HD22 ' CD1' ' A' ' 128' ' ' ILE . 64.2 mt -77.28 -47.35 20.29 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.832 0.853 . . . . 0.0 110.076 175.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -67.14 -34.11 76.89 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.316 0.646 . . . . 0.0 112.417 -174.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -66.89 -29.05 68.85 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 122.432 0.293 . . . . 0.0 111.365 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.439 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 8.4 m120 -80.38 8.19 8.11 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.207 0.603 . . . . 0.0 110.86 174.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 34.4 t70 65.49 64.2 0.6 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.776 1.23 . . . . 0.0 110.207 177.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.408 HD21 ' HA ' ' A' ' 124' ' ' MET . 35.7 m-80 -124.46 172.96 8.76 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.153 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 70.2 m -122.93 102.55 8.08 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.8 HG21 HG23 ' A' ' 182' ' ' ILE . 31.8 m -89.99 150.97 3.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 CA-C-O 121.898 0.856 . . . . 0.0 111.574 -174.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -141.22 131.23 24.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 113.8 -1.545 . . . . 0.0 107.701 173.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 5.8 t -89.75 152.7 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 38.6 t -62.95 141.6 58.66 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 118.179 0.445 . . . . 0.0 109.929 176.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -57.94 -33.73 69.13 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.258 0.623 . . . . 0.0 111.888 -177.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 15.0 p -66.79 -49.6 65.34 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.433 0.458 . . . . 0.0 110.242 174.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 72.5 mt -58.63 -34.65 71.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 122.697 0.399 . . . . 0.0 110.775 178.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.58 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 75.5 mt-30 -61.35 -41.53 97.21 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.092 0.957 . . . . 0.0 112.666 -175.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.26 -21.09 14.41 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -178.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -79.49 -48.69 13.47 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 118.745 0.702 . . . . 0.0 111.107 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.465 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -114.82 -50.89 2.76 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.498 0.666 . . . . 0.0 111.221 -174.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.58 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 35.4 t-105 . . . . . 0 CA--C 1.555 1.136 0 C-N-CA 124.97 1.308 . . . . 0.0 111.391 -171.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -116.4 113.54 23.02 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.888 0.875 . . . . 0.0 109.345 174.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 32.5 mm -78.38 132.85 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 36.1 p -128.25 87.93 2.67 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.923 0.889 . . . . 0.0 109.305 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -71.33 -22.9 61.86 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 173.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.419 ' SD ' ' HB2' ' A' ' 148' ' ' ARG . 56.9 mtm -119.63 139.89 51.47 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 125.15 1.38 . . . . 0.0 109.027 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 72.2 p -88.88 165.67 14.48 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 172.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.482 ' HA ' HD12 ' A' ' 98' ' ' LEU . 2.2 mp -53.93 -30.73 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 124.609 1.164 . . . . 0.0 111.736 -171.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -53.33 -62.69 1.49 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.355 1.062 . . . . 0.0 111.984 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.719 ' HA ' ' HB2' ' A' ' 100' ' ' ARG . 14.9 pm0 -77.21 -22.56 52.14 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.834 0.453 . . . . 0.0 111.74 -177.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.633 HD11 ' ND2' ' A' ' 133' ' ' ASN . 32.7 mt -58.53 -39.17 79.4 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.089 0.556 . . . . 0.0 110.491 169.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.3 m -108.32 20.96 17.98 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.278 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.719 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 6.5 tpt180 -71.29 143.05 50.46 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.75 0.42 . . . . 0.0 110.861 -174.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -96.12 104.99 16.98 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.113 0.965 . . . . 0.0 109.563 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' TRP . . . . . 0.431 ' HE1' ' NH1' ' A' ' 148' ' ' ARG . 46.0 p-90 -137.04 172.66 12.67 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.216 1.006 . . . . 0.0 110.496 -177.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -138.38 166.22 24.8 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.611 0.764 . . . . 0.0 110.657 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.413 ' HG2' ' HB2' ' A' ' 120' ' ' ASP . 55.9 mtm -122.16 129.19 52.08 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.286 1.034 . . . . 0.0 109.105 172.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 56.3 tp -71.38 -40.62 70.45 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.023 0.929 . . . . 0.0 110.034 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.425 ' HG2' ' HB2' ' A' ' 122' ' ' ALA . 24.1 mmt -125.0 77.97 66.48 Favored Pre-proline 0 N--CA 1.483 1.194 0 C-N-CA 124.404 1.082 . . . . 0.0 109.451 174.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.43 111.93 3.43 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.627 2.218 . . . . 0.0 112.352 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -87.04 111.2 20.65 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 172.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -89.21 116.8 27.72 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.547 0.339 . . . . 0.0 110.271 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.422 ' HG2' HG11 ' A' ' 180' ' ' VAL . 14.4 tppt? -127.47 140.23 52.29 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.983 1.313 . . . . 0.0 109.332 174.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.559 HG13 HD11 ' A' ' 163' ' ' LEU . 79.5 t -123.24 99.5 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 166.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.48 ' HG2' HG21 ' A' ' 180' ' ' VAL . 9.1 tp10 -104.3 95.56 6.04 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -175.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.16 -125.91 19.19 Favored Glycine 0 CA--C 1.536 1.362 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.39 -176.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -85.75 6.38 5.59 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 123.246 2.63 . . . . 0.0 112.875 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.407 HD12 ' HB2' ' A' ' 177' ' ' ALA . 73.6 mt -123.51 144.32 49.62 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.345 0.658 . . . . 0.0 109.666 -171.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 46.4 t -107.66 115.58 30.4 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.322 0.649 . . . . 0.0 109.458 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.0 mm -99.72 133.71 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.2 mtm180 -134.42 120.98 20.47 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.66 0.784 . . . . 0.0 108.946 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.551 HG12 HD12 ' A' ' 181' ' ' LEU . 49.6 mt -126.06 132.47 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.391 1.077 . . . . 0.0 108.988 -173.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.426 ' OD2' HG12 ' A' ' 123' ' ' ILE . 16.7 t70 -89.29 120.09 30.34 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 118.064 0.393 . . . . 0.0 109.958 176.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.457 ' HA ' ' ND2' ' A' ' 188' ' ' ASN . 22.3 mt-30 -91.35 2.21 56.56 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.74 0.816 . . . . 0.0 113.118 -175.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.425 ' HB2' ' HG2' ' A' ' 106' ' ' MET . . . -94.11 -27.82 16.04 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 174.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.426 HG12 ' OD2' ' A' ' 120' ' ' ASP . 22.5 mm -78.49 95.03 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.685 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 37.4 mtt -122.74 149.33 44.24 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.045 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.0 t70 65.55 52.1 1.41 Allowed 'General case' 0 N--CA 1.484 1.23 0 O-C-N 124.529 1.143 . . . . 0.0 110.928 175.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -130.03 156.1 45.05 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.068 0.947 . . . . 0.0 110.691 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -95.64 108.27 20.54 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 170.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.545 ' HB ' HG12 ' A' ' 192' ' ' VAL . 58.7 mt -113.66 143.56 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.761 0.824 . . . . 0.0 111.186 -171.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 12.4 tpt -118.41 122.85 43.79 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.324 1.05 . . . . 0.0 108.912 -177.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.434 HD12 HG22 ' A' ' 194' ' ' VAL . 12.1 mt -94.79 103.87 15.77 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -175.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.406 ' HA ' ' HB2' ' A' ' 195' ' ' SER . 53.4 mtpt -118.37 140.74 49.37 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.948 0.899 . . . . 0.0 109.974 -170.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -135.6 154.12 51.44 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 122.581 1.181 . . . . 0.0 114.141 -171.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.633 ' ND2' HD11 ' A' ' 98' ' ' LEU . 3.3 m-20 -108.06 127.63 53.96 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 162.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -156.21 159.6 39.09 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.682 0.614 . . . . 0.0 110.556 -176.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.2 t -86.3 162.85 18.04 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 173.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.8 t -135.02 133.87 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.625 1.17 . . . . 0.0 109.132 -174.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.6 tp -148.88 145.81 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 172.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 59.21 30.47 20.24 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.741 0.816 . . . . 0.0 111.3 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 64.06 17.74 10.81 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.057 1.343 . . . . 0.0 112.096 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -127.36 175.39 8.23 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.899 0.88 . . . . 0.0 110.0 176.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.467 HD22 ' HA ' ' A' ' 171' ' ' ILE . 9.1 tt -67.33 123.46 20.42 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.545 0.738 . . . . 0.0 109.119 175.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -82.99 -70.19 0.57 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.137 0.575 . . . . 0.0 109.886 174.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 61.4 m -147.92 129.34 14.85 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.88 0.872 . . . . 0.0 109.656 -174.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 59.3 tp -72.3 134.55 45.59 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.768 0.827 . . . . 0.0 110.46 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 66.1 mt -96.16 -43.48 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.924 0.89 . . . . 0.0 110.102 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.439 HD21 ' NH2' ' A' ' 148' ' ' ARG . 40.9 tp -169.5 149.12 3.9 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.922 0.889 . . . . 0.0 109.253 174.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.666 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 7.5 tt -136.0 144.93 45.59 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.717 ' HD3' HD13 ' A' ' 156' ' ' ILE . 71.7 mtt-85 -142.54 146.75 34.98 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.224 1.01 . . . . 0.0 109.939 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.73 118.72 37.47 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.239 1.016 . . . . 0.0 108.844 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -110.25 128.94 55.77 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.277 1.031 . . . . 0.0 110.397 -174.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 31.4 p -76.8 179.27 6.21 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.022 0.529 . . . . 0.0 111.022 172.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -61.97 -21.02 64.48 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.884 0.874 . . . . 0.0 112.02 174.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -83.04 -1.54 52.98 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.801 1.24 . . . . 0.0 111.569 176.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 69.0 18.23 72.51 Favored Glycine 0 C--N 1.357 1.709 0 CA-C-N 116.456 -0.338 . . . . 0.0 112.847 -173.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -92.57 129.47 38.49 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.383 0.673 . . . . 0.0 109.419 -174.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.717 HD13 ' HD3' ' A' ' 148' ' ' ARG . 24.4 mt -79.97 109.26 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.1 m -117.08 -0.55 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.974 0.91 . . . . 0.0 111.397 -173.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -150.22 164.47 29.71 Favored Glycine 0 C--N 1.34 0.76 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -165.57 144.39 6.23 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 117.149 0.475 . . . . 0.0 110.595 -174.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.666 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 73.8 mt -127.05 102.84 10.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.1 t -106.79 112.62 63.39 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 123.366 0.666 . . . . 0.0 109.579 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -58.96 128.26 27.26 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.749 2.299 . . . . 0.0 111.983 174.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.559 HD11 HG13 ' A' ' 111' ' ' VAL . 88.8 mt . . . . . 0 CA--C 1.548 0.873 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.202 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.401 ' CE1' HD21 ' A' ' 115' ' ' LEU . 42.3 p-80 . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 120.993 0.425 . . . . 0.0 110.551 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 19.2 m -106.56 158.16 17.14 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.269 1.027 . . . . 0.0 110.064 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.467 ' HA ' HD22 ' A' ' 141' ' ' LEU . 2.8 tt -48.22 -39.78 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 125.563 1.545 . . . . 0.0 113.024 174.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -63.54 -34.17 77.21 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.55 0.74 . . . . 0.0 111.687 -174.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -65.98 -37.05 84.96 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.861 0.864 . . . . 0.0 110.546 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 25.5 t -68.63 -34.95 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 123.865 0.728 . . . . 0.0 110.611 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -64.24 -38.27 90.47 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 120.486 0.184 . . . . 0.0 110.707 176.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -63.16 -47.21 83.64 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 123.992 0.808 . . . . 0.0 109.568 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.407 ' HB2' HD12 ' A' ' 115' ' ' LEU . . . -60.41 -48.78 80.27 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 114.29 -1.323 . . . . 0.0 112.2 -175.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 68.5 mt -67.42 -38.73 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 123.779 0.674 . . . . 0.0 109.418 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.26 -30.07 76.42 Favored Glycine 0 CA--C 1.536 1.372 0 O-C-N 123.328 0.392 . . . . 0.0 113.677 176.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.48 HG21 ' HG2' ' A' ' 112' ' ' GLU . 43.2 t -76.45 -43.73 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.663 0.785 . . . . 0.0 110.32 175.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.551 HD12 HG12 ' A' ' 119' ' ' ILE . 36.6 tp -56.53 -49.04 75.92 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.727 0.811 . . . . 0.0 110.509 175.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.461 ' O ' ' HG2' ' A' ' 186' ' ' GLU . 77.3 mt -61.54 -52.18 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.14 0.976 . . . . 0.0 110.272 174.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -54.99 -36.26 60.41 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 124.153 0.908 . . . . 0.0 114.141 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.13 -41.34 47.69 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 112.235 -0.346 . . . . 0.0 112.235 174.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.492 HD13 HG11 ' A' ' 192' ' ' VAL . 35.5 mt -69.79 -16.49 63.3 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.304 1.042 . . . . 0.0 111.944 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 20.5 mm-40 -70.81 -39.27 73.18 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 171.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -77.83 -34.48 51.89 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.451 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.457 ' ND2' ' HA ' ' A' ' 121' ' ' GLN . 7.9 m-20 -72.59 -13.63 61.43 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.692 170.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 38.6 t70 57.57 67.63 0.95 Allowed 'General case' 0 C--N 1.355 0.842 0 C-N-CA 125.556 1.542 . . . . 0.0 111.367 176.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -124.92 139.2 54.05 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.484 -1.235 . . . . 0.0 107.843 175.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 86.7 m -79.54 102.44 8.84 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.545 HG12 ' HB ' ' A' ' 128' ' ' ILE . 34.0 m -107.57 147.58 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 121.505 0.669 . . . . 0.0 110.983 -173.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -135.79 139.93 43.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 113.957 -1.474 . . . . 0.0 107.779 175.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.434 HG22 HD12 ' A' ' 130' ' ' LEU . 16.5 t -89.42 155.96 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.406 ' HB2' ' HA ' ' A' ' 131' ' ' LYS . 28.8 t -56.1 151.75 11.68 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.186 0.595 . . . . 0.0 112.172 -178.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' LYS . . . . . 0.4 ' H ' ' HD2' ' A' ' 196' ' ' LYS . 0.2 OUTLIER -56.78 -44.73 82.15 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 124.04 0.838 . . . . 0.0 109.861 179.757 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 63.7 p -65.83 -49.3 68.69 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 113.93 -1.486 . . . . 0.0 110.516 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 54.9 mt -62.56 -35.06 78.28 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.321 0.649 . . . . 0.0 110.868 -177.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.548 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 42.0 mt-30 -62.39 -34.06 75.98 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.775 0.83 . . . . 0.0 111.775 -176.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.417 ' HE ' ' HB2' ' A' ' 200' ' ' ARG . 0.0 OUTLIER -104.16 -30.54 10.14 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -76.48 -33.42 58.67 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.218 0.607 . . . . 0.0 111.562 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.42 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -121.13 -58.18 1.81 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.174 0.59 . . . . 0.0 110.643 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.548 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 27.7 t-105 . . . . . 0 CA--C 1.555 1.167 0 C-N-CA 125.026 1.33 . . . . 0.0 111.225 -166.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -100.82 100.98 11.71 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.536 0.734 . . . . 0.0 109.658 -175.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 50.8 mm -78.41 120.5 29.45 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.088 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 174.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 62.2 p -114.49 97.38 6.27 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -88.84 -25.56 22.12 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.513 0.325 . . . . 0.0 110.301 -178.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.513 ' HB3' ' HG3' ' A' ' 97' ' ' GLU . 2.7 mpp? -101.44 144.24 30.47 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.897 0.879 . . . . 0.0 108.945 172.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.3 m -72.94 161.05 31.17 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.328 0.651 . . . . 0.0 109.533 171.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.41 ' H ' HD12 ' A' ' 95' ' ' ILE . 3.0 mp -55.69 -39.26 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.612 0.765 . . . . 0.0 111.373 -177.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -65.37 -52.37 54.09 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.446 0.699 . . . . 0.0 111.699 -175.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.513 ' HG3' ' HB3' ' A' ' 93' ' ' MET . 11.3 pt-20 -70.25 -26.73 63.97 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 122.903 0.481 . . . . 0.0 111.532 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.406 ' HG ' HD23 ' A' ' 146' ' ' LEU . 9.1 tt -66.56 -44.29 82.73 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.732 0.813 . . . . 0.0 109.787 174.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 39.1 t -99.66 20.63 13.68 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.95 0.9 . . . . 0.0 110.734 -177.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.447 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 20.4 tpt180 -80.09 136.46 36.55 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.532 0.733 . . . . 0.0 111.657 -176.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -84.94 136.15 33.74 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 170.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 16.6 p-90 -144.14 137.74 27.68 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.229 1.012 . . . . 0.0 109.52 -175.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -94.73 138.19 32.86 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 18.1 ptm -123.97 124.11 41.86 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 173.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.53 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.6 pt? -82.55 -25.21 33.55 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.114 0.566 . . . . 0.0 111.571 -171.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 23.4 mmt -123.23 80.87 52.3 Favored Pre-proline 0 N--CA 1.475 0.816 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 175.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -76.04 110.66 3.12 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.493 2.129 . . . . 0.0 112.12 -177.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -95.96 112.28 24.05 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 165.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -91.95 98.82 11.81 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 179.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.543 ' HG2' HG11 ' A' ' 180' ' ' VAL . 51.2 tptt -107.65 147.2 31.0 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.243 1.017 . . . . 0.0 108.906 177.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 51.5 t -130.68 129.18 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 172.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -135.88 104.83 5.87 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.43 -148.62 42.49 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 119.507 -0.607 . . . . 0.0 111.958 -175.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -73.89 13.11 0.84 Allowed 'Trans proline' 0 CA--C 1.555 1.552 0 C-N-CA 123.37 2.713 . . . . 0.0 114.097 173.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 4.2 mp -125.35 152.28 44.96 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.754 0.822 . . . . 0.0 108.802 -176.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 23.5 t -109.07 140.45 42.6 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.328 0.651 . . . . 0.0 110.029 175.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.7 mm -111.34 147.57 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.625 0.77 . . . . 0.0 109.518 178.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -124.86 119.98 30.38 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 27.6 mm -116.05 123.9 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -90.96 116.68 28.95 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 168.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.445 ' HA ' HD21 ' A' ' 188' ' ' ASN . 75.5 mt-30 -75.18 -16.63 60.49 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.552 0.741 . . . . 0.0 112.484 -173.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.44 -35.58 19.6 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.428 0.691 . . . . 0.0 112.128 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.85 109.95 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-O 121.994 0.902 . . . . 0.0 109.304 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.45 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 51.2 mtt -135.17 156.22 49.37 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 113.908 -1.496 . . . . 0.0 109.602 -177.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.3 t70 61.61 24.08 14.26 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 124.713 1.205 . . . . 0.0 112.228 174.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 54.3 mmtt -104.55 146.13 29.33 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 121.657 -0.652 . . . . 0.0 111.466 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.554 ' HA ' ' HB ' ' A' ' 191' ' ' THR . 3.0 m-20 -83.96 102.41 12.42 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 174.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.495 HD12 HD22 ' A' ' 185' ' ' LEU . 59.4 mt -114.95 141.07 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 123.681 0.793 . . . . 0.0 110.496 -172.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 14.0 tpt -117.59 131.42 56.68 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.304 1.042 . . . . 0.0 109.326 -174.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.517 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 2.9 mm? -91.4 104.4 16.92 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -118.45 136.1 53.98 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.365 1.066 . . . . 0.0 109.613 -171.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.464 ' HB2' ' HG ' ' A' ' 147' ' ' LEU . . . -142.22 152.52 43.16 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 -177.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -110.79 131.11 55.32 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 114.138 -1.392 . . . . 0.0 107.267 167.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.467 ' HA ' HG13 ' A' ' 145' ' ' ILE . 44.1 p90 -161.93 164.69 28.34 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.13 0.572 . . . . 0.0 111.4 -171.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.6 p -92.91 161.27 14.54 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.852 0.861 . . . . 0.0 109.667 173.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 54.8 t -128.27 133.36 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 124.288 1.035 . . . . 0.0 109.854 -176.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 8.7 tp -143.83 144.98 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 60.34 32.77 20.78 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.003 0.921 . . . . 0.0 112.447 174.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.7 t70 76.41 -0.07 3.13 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 124.555 1.142 . . . . 0.0 111.982 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -126.73 179.94 5.11 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.377 1.071 . . . . 0.0 110.136 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.515 ' HB3' HG13 ' A' ' 171' ' ' ILE . 9.9 tt -70.09 136.3 50.09 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.853 0.461 . . . . 0.0 109.877 177.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -91.48 -66.72 0.9 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.736 0.814 . . . . 0.0 110.517 174.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 75.9 m -145.96 130.0 17.41 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.513 0.725 . . . . 0.0 109.713 -174.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.487 HD21 ' HB2' ' A' ' 147' ' ' LEU . 40.6 tp -72.34 129.83 39.3 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 173.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.467 HG13 ' HA ' ' A' ' 134' ' ' PHE . 66.1 mt -87.14 -51.1 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 174.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.406 HD23 ' HG ' ' A' ' 98' ' ' LEU . 59.0 tp -163.77 147.42 10.11 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.225 1.01 . . . . 0.0 109.227 175.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.659 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 7.0 tt -131.8 148.15 52.54 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 173.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.509 HH11 HG21 ' A' ' 156' ' ' ILE . 55.2 mtt-85 -142.92 148.23 36.58 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.18 0.992 . . . . 0.0 109.857 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.436 ' HB2' HD21 ' A' ' 181' ' ' LEU . . . -105.63 112.39 25.45 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.354 1.062 . . . . 0.0 108.499 175.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -106.2 130.16 54.12 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.403 0.681 . . . . 0.0 110.347 -177.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 28.3 p -71.29 174.01 7.03 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.069 0.548 . . . . 0.0 110.991 170.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.42 -18.26 64.4 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.433 0.693 . . . . 0.0 111.349 171.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -64.08 -29.7 70.82 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.952 0.901 . . . . 0.0 110.76 168.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 91.91 20.6 36.1 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.747 -173.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -103.31 134.48 46.62 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.815 0.846 . . . . 0.0 110.668 -175.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.509 HG21 HH11 ' A' ' 148' ' ' ARG . 16.2 mt -73.87 116.03 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.43 -1.06 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.685 0.794 . . . . 0.0 110.787 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -157.13 161.86 31.42 Favored Glycine 0 C--N 1.334 0.417 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -162.0 150.46 15.11 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 117.482 0.641 . . . . 0.0 109.968 -172.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.659 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 67.5 mt -129.34 103.71 9.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 167.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.5 t -107.34 106.45 58.4 Favored Pre-proline 0 C--O 1.243 0.757 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 51.1 Cg_exo -57.45 117.59 4.31 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.997 2.465 . . . . 0.0 112.258 175.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.7 mt . . . . . 0 CA--C 1.548 0.879 0 C-N-CA 123.738 0.815 . . . . 0.0 111.985 -173.029 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 . . . . . 0 C--O 1.243 0.747 0 CA-C-O 121.377 0.608 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 27.9 m -99.58 164.46 12.06 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.279 1.031 . . . . 0.0 109.385 174.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.515 HG13 ' HB3' ' A' ' 141' ' ' LEU . 7.7 tt -49.83 -36.41 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 124.613 1.165 . . . . 0.0 112.051 174.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -60.59 -39.63 88.81 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.348 1.059 . . . . 0.0 111.308 -177.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -66.31 -36.6 83.36 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.461 0.705 . . . . 0.0 110.969 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 178' ' ' ILE . 46.3 t -65.19 -39.68 86.27 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.687 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.245 175.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.441 ' HE2' ' O ' ' A' ' 202' ' ' ALA . 88.1 mttt -58.79 -45.54 89.63 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.117 0.567 . . . . 0.0 110.775 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.486 ' O ' HG23 ' A' ' 180' ' ' VAL . 53.6 m-80 -64.15 -43.29 95.66 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.182 177.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.2 -50.27 74.11 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.209 0.943 . . . . 0.0 111.568 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 174' ' ' VAL . 39.9 mt -62.84 -40.27 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -58.69 -32.99 70.66 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 115.474 -0.785 . . . . 0.0 113.88 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.543 HG11 ' HG2' ' A' ' 110' ' ' LYS . 41.0 t -73.09 -46.38 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 117.041 0.421 . . . . 0.0 110.039 177.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.473 HD22 HG13 ' A' ' 160' ' ' ILE . 21.7 tp -61.77 -46.37 89.87 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 123.79 0.682 . . . . 0.0 110.825 -177.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 75.4 mt -61.41 -50.39 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.547 0.739 . . . . 0.0 110.078 175.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.45 ' O ' ' HG2' ' A' ' 187' ' ' ARG . . . -53.99 -47.85 64.87 Favored Glycine 0 C--N 1.346 1.13 0 O-C-N 124.201 0.938 . . . . 0.0 113.629 -177.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.19 -40.86 99.16 Favored Glycine 0 C--N 1.344 0.974 0 C-N-CA 123.164 0.411 . . . . 0.0 112.23 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.495 HD22 HD12 ' A' ' 128' ' ' ILE . 96.7 mt -63.7 -39.58 94.66 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.421 0.688 . . . . 0.0 111.084 176.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -67.75 -35.29 78.46 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.487 0.715 . . . . 0.0 110.984 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 183' ' ' GLY . 12.6 mmp_? -75.04 -27.48 60.05 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.81 0.444 . . . . 0.0 110.63 177.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.45 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 6.1 m-20 -81.02 -7.12 59.49 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.304 0.641 . . . . 0.0 110.898 170.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 38.7 t70 63.33 67.18 0.67 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.051 1.341 . . . . 0.0 111.328 -176.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -119.0 145.95 45.42 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.847 0.859 . . . . 0.0 109.074 175.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.554 ' HB ' ' HA ' ' A' ' 127' ' ' ASN . 28.2 m -76.99 107.51 9.39 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -178.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 18.0 m -101.85 134.85 41.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 121.265 0.555 . . . . 0.0 110.865 -172.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -143.9 133.87 24.06 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.321 1.048 . . . . 0.0 108.273 169.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.517 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 5.2 t -90.87 151.51 3.49 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 48.0 t -59.06 139.14 57.16 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 175.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -62.44 -25.29 67.89 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.985 0.514 . . . . 0.0 111.19 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 67.0 p -76.33 -44.59 36.02 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.213 0.605 . . . . 0.0 109.378 175.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.422 HD21 ' HB3' ' A' ' 132' ' ' ALA . 28.4 mt -58.65 -33.37 70.01 Favored 'General case' 0 C--O 1.2 -1.524 0 C-N-CA 122.713 0.405 . . . . 0.0 111.493 172.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.502 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 50.6 mt-30 -76.92 -41.2 44.44 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.999 0.52 . . . . 0.0 110.412 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 41.6 tpt85 -62.73 -43.23 99.35 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.282 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -100.72 -49.07 4.29 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.446 -169.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.461 ' HB2' HD13 ' A' ' 141' ' ' LEU . . . -97.19 -57.4 2.27 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -167.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.502 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 49.4 t-105 . . . . . 0 N--CA 1.48 1.042 0 C-N-CA 124.621 1.168 . . . . 0.0 112.271 -164.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 . . . . . 0 N--CA 1.473 0.692 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -104.71 101.71 11.32 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 177.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 133' ' ' ASN . 38.5 mm -75.93 129.59 36.93 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 68.6 p -122.14 80.7 1.74 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.844 0.858 . . . . 0.0 108.783 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.456 ' HB2' ' HB3' ' A' ' 131' ' ' LYS . 37.8 m-20 -69.84 -31.25 69.0 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 121.855 0.836 . . . . 0.0 109.55 172.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.609 ' HG3' ' HG3' ' A' ' 97' ' ' GLU . 25.1 ttp -102.69 121.81 43.17 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.142 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.4 m -72.97 155.65 39.63 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.832 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.8 mp -53.59 -34.3 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 C-N-CA 123.958 0.903 . . . . 0.0 111.084 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -50.9 -68.39 0.17 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.878 1.271 . . . . 0.0 112.108 173.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.609 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 9.9 pt-20 -71.13 -22.64 62.05 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.329 1.052 . . . . 0.0 112.063 -178.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.539 ' HG ' HD23 ' A' ' 146' ' ' LEU . 9.8 tt -66.72 -45.37 78.92 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.221 1.008 . . . . 0.0 110.347 174.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.9 t -98.94 1.63 45.76 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.39 0.676 . . . . 0.0 111.323 -175.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -61.01 140.88 57.72 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.554 0.742 . . . . 0.0 111.121 175.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -86.24 142.27 28.69 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.125 0.57 . . . . 0.0 109.751 171.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 28.7 p-90 -152.85 156.83 39.75 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.34 -170.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -111.26 155.24 23.3 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.265 1.026 . . . . 0.0 110.579 -175.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 93.8 mtp -128.43 109.23 11.22 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.113 0.965 . . . . 0.0 108.464 166.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.4 tp -67.92 -49.5 61.51 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.637 0.775 . . . . 0.0 110.261 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.502 ' HG2' ' HB2' ' A' ' 122' ' ' ALA . 97.7 mmm -119.95 82.19 28.19 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 124.151 0.98 . . . . 0.0 109.54 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -71.9 125.72 11.26 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.506 2.138 . . . . 0.0 112.675 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -95.76 110.18 22.37 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 166.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 20.4 tm0? -80.43 106.08 12.17 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 176.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.471 ' HG2' HG11 ' A' ' 180' ' ' VAL . 22.7 tptm -130.01 143.99 51.09 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.817 0.847 . . . . 0.0 108.745 170.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.451 HG11 HD11 ' A' ' 163' ' ' LEU . 63.1 t -131.72 122.16 49.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 168.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -109.18 97.56 7.15 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.29 -126.14 8.07 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 119.083 -0.843 . . . . 0.0 111.724 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.619 ' HG2' ' HB3' ' A' ' 169' ' ' HIS . 42.3 Cg_endo -98.26 31.88 0.13 Allowed 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 123.408 2.739 . . . . 0.0 111.74 172.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 162' ' ' PRO . 90.4 mt -131.17 123.97 29.67 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.177 0.991 . . . . 0.0 109.448 -178.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 16.6 p -83.78 122.69 29.01 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.445 0.698 . . . . 0.0 109.92 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.4 mm -103.11 106.65 20.48 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 C-N-CA 123.69 0.796 . . . . 0.0 109.3 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.618 ' HD2' ' HB3' ' A' ' 159' ' ' GLU . 77.2 mtt85 -95.93 119.92 35.29 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.76 0.824 . . . . 0.0 108.834 176.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.517 HD13 ' HA3' ' A' ' 184' ' ' GLY . 82.3 mt -129.76 123.79 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 124.401 1.08 . . . . 0.0 108.307 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -92.65 128.37 38.48 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.322 0.582 . . . . 0.0 110.029 177.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.482 ' HA ' ' ND2' ' A' ' 188' ' ' ASN . 75.1 mt-30 -91.13 -11.45 38.49 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.233 -174.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.502 ' HB2' ' HG2' ' A' ' 106' ' ' MET . . . -79.41 -49.43 12.35 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 120.997 0.427 . . . . 0.0 110.589 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.544 HG12 HG11 ' A' ' 157' ' ' VAL . 1.7 mp -71.34 109.73 3.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.288 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 50.3 mtt -131.61 159.2 38.97 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 113.693 -1.594 . . . . 0.0 109.554 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.4 t70 67.97 18.36 9.53 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 125.288 1.435 . . . . 0.0 112.295 174.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -103.61 151.99 22.28 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.585 0.754 . . . . 0.0 111.162 -176.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -84.31 102.2 12.51 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 168.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.507 HD12 HD22 ' A' ' 185' ' ' LEU . 44.3 mt -103.28 124.12 57.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -176.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.528 ' HG3' ' HG3' ' A' ' 131' ' ' LYS . 14.0 tpt -98.61 126.65 44.27 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.435 1.094 . . . . 0.0 109.069 -175.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.455 HD12 HG22 ' A' ' 194' ' ' VAL . 12.4 mt -105.79 103.43 12.93 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -174.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.528 ' HG3' ' HG3' ' A' ' 129' ' ' MET . 45.1 mtmt -126.5 150.95 48.44 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.037 0.535 . . . . 0.0 109.981 -176.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -136.91 153.68 50.67 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.907 0.86 . . . . 0.0 112.304 -174.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.52 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 4.6 m-20 -107.5 120.77 43.11 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 162.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -156.4 160.18 39.4 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.264 0.626 . . . . 0.0 111.02 -170.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 53.5 p -86.28 151.22 23.78 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.749 0.819 . . . . 0.0 109.226 174.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.0 t -130.55 132.75 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.381 1.073 . . . . 0.0 108.477 -177.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.3 tp -140.78 140.68 33.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 174.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 58.19 31.04 20.29 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.933 0.893 . . . . 0.0 111.946 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 63.31 30.88 15.59 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 124.97 1.308 . . . . 0.0 112.338 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 7.8 ppt_? -143.65 165.68 26.95 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.226 0.61 . . . . 0.0 109.687 173.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.472 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 10.5 tt -66.48 121.56 15.59 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.313 0.645 . . . . 0.0 109.742 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -82.31 -67.14 0.81 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.257 0.623 . . . . 0.0 110.281 173.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 62.2 m -141.96 127.4 18.87 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.885 0.474 . . . . 0.0 109.843 -173.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.647 HD11 ' HB2' ' A' ' 147' ' ' LEU . 51.9 tp -77.37 114.56 16.33 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.716 0.807 . . . . 0.0 109.545 178.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 57.1 mt -77.82 -52.65 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 175.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.539 HD23 ' HG ' ' A' ' 98' ' ' LEU . 50.2 tp -158.82 145.12 16.92 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.452 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.647 ' HB2' HD11 ' A' ' 144' ' ' LEU . 8.2 tt -139.26 152.25 47.13 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 176.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.738 HH11 HG21 ' A' ' 156' ' ' ILE . 6.8 ptp180 -150.73 157.44 42.96 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 122.046 0.927 . . . . 0.0 112.503 174.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.684 ' HB2' HD21 ' A' ' 181' ' ' LEU . . . -117.55 117.78 30.36 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 113.346 -1.752 . . . . 0.0 107.317 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -145.64 145.1 30.8 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.049 0.452 . . . . 0.0 111.709 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 80.5 p -65.13 163.28 15.29 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.457 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -64.82 -19.6 65.94 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -84.59 -1.46 55.98 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.164 0.586 . . . . 0.0 111.4 176.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 97.45 -5.25 62.5 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-O 119.931 -0.372 . . . . 0.0 114.005 172.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.99 105.97 6.26 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.991 0.395 . . . . 0.0 110.085 -175.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.738 HG21 HH11 ' A' ' 148' ' ' ARG . 13.8 mt -79.51 126.65 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.544 HG11 HG12 ' A' ' 123' ' ' ILE . 24.2 m -134.63 5.41 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 123.902 0.881 . . . . 0.0 110.964 -174.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -153.27 156.06 26.52 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.618 ' HB3' ' HD2' ' A' ' 118' ' ' ARG . 40.5 tt0 -164.83 141.64 6.01 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.802 0.441 . . . . 0.0 110.368 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.498 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 72.2 mt -120.62 121.64 65.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 172.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 15.5 m -137.52 148.13 60.32 Favored Pre-proline 0 N--CA 1.469 0.509 0 C-N-CA 123.272 0.629 . . . . 0.0 109.898 -177.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.403 ' HA ' HD23 ' A' ' 115' ' ' LEU . 18.1 Cg_endo -61.01 134.46 53.19 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 121.864 1.709 . . . . 0.0 110.302 165.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.451 HD11 HG11 ' A' ' 111' ' ' VAL . 66.2 mt . . . . . 0 CA--C 1.548 0.901 0 C-N-CA 123.266 0.626 . . . . 0.0 110.886 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.619 ' HB3' ' HG2' ' A' ' 114' ' ' PRO . 25.4 p-80 . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 121.181 0.515 . . . . 0.0 110.663 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 65.2 p -98.43 -178.62 4.08 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.471 169.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.472 ' HB ' ' O ' ' A' ' 141' ' ' LEU . 5.8 tt -54.6 -41.85 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.152 171.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.546 ' HA ' ' HD3' ' A' ' 175' ' ' LYS . 14.7 mm-40 -56.91 -41.35 77.99 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.366 1.066 . . . . 0.0 111.613 -176.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -64.05 -40.17 95.7 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.372 0.669 . . . . 0.0 111.018 178.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 46.2 t -68.1 -32.65 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.175 0.59 . . . . 0.0 110.604 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.546 ' HD3' ' HA ' ' A' ' 172' ' ' GLU . 27.3 mtpp -62.08 -42.92 99.7 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.564 0.745 . . . . 0.0 110.684 176.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.497 ' O ' HG23 ' A' ' 180' ' ' VAL . 60.7 m-80 -68.58 -41.27 79.9 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.143 175.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.99 -53.28 60.01 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 124.416 1.073 . . . . 0.0 112.008 -175.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 49.9 mt -63.19 -35.43 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 O-C-N 123.604 0.565 . . . . 0.0 109.756 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.19 -32.09 81.15 Favored Glycine 0 C--N 1.347 1.155 0 CA-C-N 116.159 -0.473 . . . . 0.0 114.082 177.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 176' ' ' ASN . 98.0 t -73.0 -44.66 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.684 HD21 ' HB2' ' A' ' 149' ' ' ALA . 48.9 tp -54.44 -49.76 69.27 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.261 1.025 . . . . 0.0 110.674 176.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.468 HD12 ' CH2' ' A' ' 203' ' ' TRP . 17.8 mt -63.88 -45.66 96.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.929 0.891 . . . . 0.0 110.979 176.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -55.1 -36.87 62.15 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 123.893 0.746 . . . . 0.0 113.811 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.517 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -70.07 -48.75 38.0 Favored Glycine 0 C--N 1.347 1.142 0 N-CA-C 111.793 -0.523 . . . . 0.0 111.793 174.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.507 HD22 HD12 ' A' ' 128' ' ' ILE . 97.7 mt -64.19 -31.97 73.37 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.985 0.914 . . . . 0.0 112.419 -176.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -66.24 -41.99 89.23 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.419 0.688 . . . . 0.0 111.121 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -74.84 -34.65 62.34 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.216 0.607 . . . . 0.0 110.417 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.482 ' ND2' ' HA ' ' A' ' 121' ' ' GLN . 6.0 m-20 -67.28 -15.14 63.52 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.344 0.657 . . . . 0.0 110.297 169.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 21.9 t70 64.49 65.99 0.62 Allowed 'General case' 0 C--N 1.349 0.577 0 C-N-CA 125.799 1.64 . . . . 0.0 110.223 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -121.95 139.69 53.36 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 175.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 74.0 m -78.46 104.81 9.3 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 23.9 m -80.77 130.23 36.24 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.591 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -133.36 123.07 24.74 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 173.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.455 HG22 HD12 ' A' ' 130' ' ' LEU . 4.3 t -101.82 150.05 6.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 -175.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 34.0 t -58.68 143.48 46.54 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.867 0.467 . . . . 0.0 111.146 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -57.01 -32.96 66.67 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.939 0.896 . . . . 0.0 111.25 -178.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 67.8 p -72.02 -48.49 44.24 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.582 175.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 58.3 mt -62.67 -36.45 82.92 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.107 0.563 . . . . 0.0 110.389 -177.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.499 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 43.7 mt-30 -55.51 -33.79 64.05 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.596 1.159 . . . . 0.0 112.426 -177.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -101.25 -39.53 7.58 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -73.97 -38.03 64.3 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -168.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.435 ' O ' ' HG2' ' A' ' 175' ' ' LYS . . . -120.64 -57.7 1.88 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.896 0.478 . . . . 0.0 110.074 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.499 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 69.5 t-105 . . . . . 0 CA--C 1.556 1.188 0 C-N-CA 125.272 1.429 . . . . 0.0 114.057 -168.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 29.8 ttp-105 . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -99.65 109.52 22.0 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.834 0.853 . . . . 0.0 109.945 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.7 mm -78.85 121.68 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 123.783 0.833 . . . . 0.0 109.352 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.1 p -108.38 66.19 0.64 Allowed 'General case' 0 C--O 1.244 0.781 0 CA-C-O 122.672 1.225 . . . . 0.0 108.112 173.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.543 ' HB3' ' O ' ' A' ' 132' ' ' ALA . 19.1 t70 -68.95 -35.54 76.88 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 112.91 -1.95 . . . . 0.0 110.963 -177.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.582 ' HB3' ' HB3' ' A' ' 131' ' ' LYS . 26.2 ptt? -110.93 146.24 36.92 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 171.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.1 m -91.85 158.02 16.55 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.308 0.643 . . . . 0.0 111.069 -167.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.2 mp -58.53 -34.97 52.54 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 C-N-CA 124.122 0.969 . . . . 0.0 110.385 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -48.91 -43.02 38.94 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.358 1.063 . . . . 0.0 113.094 176.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.52 -24.45 15.56 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 122.847 0.459 . . . . 0.0 111.102 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.476 ' HA ' HH21 ' A' ' 148' ' ' ARG . 9.0 tt -67.46 -45.81 74.89 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.616 0.766 . . . . 0.0 110.128 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 26.4 t -96.32 10.93 36.46 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.561 1.144 . . . . 0.0 110.316 -175.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -74.23 136.02 42.72 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.049 0.54 . . . . 0.0 110.517 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -77.42 133.56 38.62 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 174.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 17.9 p-90 -150.76 171.35 17.33 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.661 0.784 . . . . 0.0 110.406 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -148.2 165.33 31.24 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.728 1.211 . . . . 0.0 108.665 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 62.3 mtp -110.37 127.77 55.24 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 36.2 tp -73.39 -40.84 64.01 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.411 0.684 . . . . 0.0 109.642 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.521 ' HG2' ' HB2' ' A' ' 122' ' ' ALA . 23.8 mmt -124.77 88.96 53.11 Favored Pre-proline 0 N--CA 1.482 1.134 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 169.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.18 112.38 2.74 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 122.995 2.464 . . . . 0.0 112.236 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 119' ' ' ILE . 58.7 tptt -115.61 118.39 32.99 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 169.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -100.96 115.37 30.29 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.46 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 16.7 tppt? -120.9 159.84 24.7 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.429 1.092 . . . . 0.0 108.377 175.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.5 t -137.68 140.8 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -122.84 84.7 2.3 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 171.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.5 -116.71 7.2 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.883 175.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -85.25 8.84 4.39 Favored 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 123.227 2.618 . . . . 0.0 112.739 -177.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.8 mt -131.87 121.95 24.89 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.977 0.911 . . . . 0.0 109.021 -171.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.573 ' SG ' HD21 ' A' ' 163' ' ' LEU . 90.0 m -90.51 120.61 31.75 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.964 0.506 . . . . 0.0 111.252 -178.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.46 ' HB ' ' HB3' ' A' ' 110' ' ' LYS . 17.2 mm -86.64 155.3 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.358 0 C-N-CA 124.298 1.039 . . . . 0.0 110.034 -176.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -134.66 121.27 20.61 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.438 HD12 ' HA3' ' A' ' 184' ' ' GLY . 50.5 mm -123.7 122.85 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 123.416 0.686 . . . . 0.0 109.686 -177.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -98.64 115.45 28.7 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 172.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.477 ' HA ' HD21 ' A' ' 188' ' ' ASN . 45.6 mt-30 -84.08 -6.91 59.49 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.02 0.928 . . . . 0.0 113.327 -174.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.521 ' HB2' ' HG2' ' A' ' 106' ' ' MET . . . -87.7 -45.45 10.35 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.963 0.505 . . . . 0.0 110.301 177.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.467 HG12 HG11 ' A' ' 157' ' ' VAL . 1.8 mp -70.67 110.7 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-O 122.038 0.923 . . . . 0.0 110.006 -177.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.585 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 51.3 mtt -131.72 158.43 41.19 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.224 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.5 t70 67.82 13.47 9.2 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.757 1.223 . . . . 0.0 112.739 174.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -97.55 146.82 24.9 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.43 -0.793 . . . . 0.0 110.611 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.563 ' HB2' ' HB3' ' A' ' 152' ' ' GLU . 39.4 m-80 -82.73 97.74 8.72 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 174.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.444 HD12 HD22 ' A' ' 185' ' ' LEU . 53.4 mt -105.82 130.12 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.462 0.705 . . . . 0.0 110.111 -171.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 12.2 tpt -105.12 134.11 48.77 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.163 0.985 . . . . 0.0 110.026 -175.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.425 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 2.2 mm? -100.2 109.15 21.4 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.582 ' HB3' ' HB3' ' A' ' 93' ' ' MET . 40.9 mttm -127.56 152.0 48.18 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.049 0.939 . . . . 0.0 110.682 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.698 ' HB3' HD21 ' A' ' 198' ' ' LEU . . . -146.63 149.42 33.47 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -105.5 132.69 51.36 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 165.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.471 ' HA ' HG13 ' A' ' 145' ' ' ILE . 39.6 p90 -158.79 159.27 34.95 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.761 0.824 . . . . 0.0 109.979 -171.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.8 p -86.57 160.69 18.86 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.391 0.676 . . . . 0.0 109.695 173.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 77.7 t -128.0 135.79 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.36 1.064 . . . . 0.0 109.135 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' A' ' 137' ' ' ILE . 8.2 tp -142.08 139.46 30.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 170.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 57.25 33.8 23.84 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.776 0.83 . . . . 0.0 111.72 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 36.0 t70 67.35 8.82 6.54 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.892 1.277 . . . . 0.0 112.636 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 44.5 ptt85 -116.57 165.25 13.46 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.647 0.779 . . . . 0.0 110.033 176.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.404 ' HB3' HG13 ' A' ' 171' ' ' ILE . 8.5 tt -64.26 108.63 1.64 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.507 0.723 . . . . 0.0 109.204 175.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -68.18 -68.73 0.37 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.341 0.656 . . . . 0.0 110.334 177.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.6 m -143.68 130.56 20.44 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.418 -175.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.7 tp -73.16 124.88 26.46 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 175.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.471 HG13 ' HA ' ' A' ' 134' ' ' PHE . 70.1 mt -84.54 -49.86 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 176.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 48.2 tp -164.8 147.53 8.48 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.75 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.774 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 6.7 tt -134.06 153.52 51.75 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 176.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.494 ' N ' HD23 ' A' ' 147' ' ' LEU . 45.1 ttm-85 -143.23 147.25 34.54 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.546 0.738 . . . . 0.0 111.284 -173.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.595 ' HB2' HD21 ' A' ' 181' ' ' LEU . . . -120.69 111.3 17.44 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.791 1.237 . . . . 0.0 107.856 169.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 40.5 p90 -127.67 157.27 40.74 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.166 0.986 . . . . 0.0 108.756 -178.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 63.0 p -86.02 176.65 7.91 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.39 0.614 . . . . 0.0 111.122 -174.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 127' ' ' ASN . 11.0 pt-20 -54.38 -35.78 63.19 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.912 1.285 . . . . 0.0 112.144 174.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.418 ' HG2' ' H ' ' A' ' 153' ' ' GLU . 8.5 pt-20 -88.32 -9.22 53.52 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.115 0.966 . . . . 0.0 111.618 -177.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 100.63 -3.36 56.17 Favored Glycine 0 C--N 1.352 1.43 0 CA-C-O 120.016 -0.324 . . . . 0.0 113.471 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.82 104.9 2.59 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.437 HD13 ' HD3' ' A' ' 148' ' ' ARG . 26.3 mt -69.87 124.28 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.178 0.591 . . . . 0.0 109.53 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.467 HG11 HG12 ' A' ' 123' ' ' ILE . 35.0 m -126.41 -3.68 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.737 0.815 . . . . 0.0 111.382 -174.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -155.31 164.96 32.19 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.651 -175.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -167.43 153.86 8.05 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.245 0.618 . . . . 0.0 109.528 -176.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.774 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 78.6 mt -125.75 102.99 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 165.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 84.0 p -99.0 110.42 57.66 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 123.61 0.764 . . . . 0.0 110.014 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.06 123.95 14.59 Favored 'Trans proline' 0 C--N 1.367 1.513 0 C-N-CA 122.921 2.414 . . . . 0.0 112.921 174.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.573 HD21 ' SG ' ' A' ' 116' ' ' CYS . 89.5 mt . . . . . 0 CA--C 1.544 0.723 0 C-N-CA 123.789 0.836 . . . . 0.0 110.714 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 44.5 p -84.57 160.58 20.43 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.493 0.663 . . . . 0.0 112.081 -174.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.428 HD11 ' O ' ' A' ' 201' ' ' PHE . 11.4 tt -57.58 -32.1 41.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.648 170.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -72.85 -30.54 64.09 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.539 0.736 . . . . 0.0 111.353 -177.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -60.76 -39.72 89.82 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 122.843 0.457 . . . . 0.0 110.499 173.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 178' ' ' ILE . 38.5 t -64.88 -39.13 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 O-C-N 124.471 1.107 . . . . 0.0 110.2 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -59.26 -48.76 80.43 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.525 0.73 . . . . 0.0 111.459 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.465 ' O ' HG23 ' A' ' 180' ' ' VAL . 65.0 m-80 -65.71 -38.86 90.37 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.935 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.4 -43.4 97.65 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 124.137 0.898 . . . . 0.0 111.451 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 174' ' ' VAL . 60.5 mt -67.52 -34.1 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.9 -33.38 87.09 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 116.625 -0.262 . . . . 0.0 113.596 176.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 176' ' ' ASN . 97.8 t -78.71 -43.25 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.48 0.712 . . . . 0.0 110.353 177.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.595 HD21 ' HB2' ' A' ' 149' ' ' ALA . 38.6 tp -57.34 -54.79 42.81 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.819 0.848 . . . . 0.0 111.035 176.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.614 HG23 HG21 ' A' ' 192' ' ' VAL . 61.8 mt -58.06 -40.12 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 123.821 0.848 . . . . 0.0 110.225 170.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.4 -21.82 54.88 Favored Glycine 0 N--CA 1.475 1.28 0 N-CA-C 115.151 0.82 . . . . 0.0 115.151 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.438 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -95.74 -16.11 40.45 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 117.004 0.402 . . . . 0.0 112.751 173.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.444 HD22 HD12 ' A' ' 128' ' ' ILE . 81.9 mt -91.76 -32.66 15.31 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.408 1.083 . . . . 0.0 111.825 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 182' ' ' ILE . 0.4 OUTLIER -77.84 -31.8 51.76 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.136 0.574 . . . . 0.0 111.132 -173.439 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 8.7 ptm85 -70.23 -24.77 63.15 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.669 0.787 . . . . 0.0 110.942 173.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.585 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 4.2 m-20 -81.48 -10.88 59.39 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.79 0.836 . . . . 0.0 110.293 172.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 19.5 t70 57.63 65.79 1.26 Allowed 'General case' 0 C--N 1.358 0.975 0 C-N-CA 125.414 1.486 . . . . 0.0 110.2 -171.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -107.57 145.71 32.85 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.635 169.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.1 m -83.47 100.31 10.66 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.614 HG21 HG23 ' A' ' 182' ' ' ILE . 18.7 m -99.27 134.63 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 123.645 0.778 . . . . 0.0 110.571 -171.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -135.66 129.82 33.35 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.425 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 2.9 t -90.01 143.03 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 23.2 t -69.11 156.58 38.44 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -172.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -50.23 -49.5 52.73 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.312 1.045 . . . . 0.0 111.812 -176.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 38.1 p -61.18 -50.84 71.52 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 123.967 0.792 . . . . 0.0 110.19 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.698 HD21 ' HB3' ' A' ' 132' ' ' ALA . 62.9 mt -60.07 -36.47 77.43 Favored 'General case' 0 C--O 1.215 -0.735 0 O-C-N 123.882 0.739 . . . . 0.0 111.752 -176.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.495 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 56.0 mt-30 -66.0 -51.7 55.99 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.472 0.709 . . . . 0.0 110.776 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.26 -24.79 51.08 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -175.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.428 ' O ' HD11 ' A' ' 171' ' ' ILE . 25.3 m-85 -82.04 -57.37 3.43 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.819 0.448 . . . . 0.0 110.698 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -116.82 -57.77 2.14 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.24 0.616 . . . . 0.0 110.408 -166.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.495 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 51.4 t-105 . . . . . 0 CA--C 1.546 0.826 0 C-N-CA 124.857 1.263 . . . . 0.0 111.103 -168.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 . . . . . 0 N--CA 1.476 0.832 0 CA-C-O 120.897 0.379 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -97.54 111.74 23.89 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 168.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.6 mm -77.42 140.43 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.749 0.82 . . . . 0.0 109.76 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.6 p -141.34 61.12 1.49 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.183 0.993 . . . . 0.0 109.326 -173.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.9 -15.01 60.27 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.493 172.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 69.2 mtm -110.66 133.71 53.09 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 165.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 74.8 p -71.6 159.65 34.05 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 167.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.72 -34.76 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 123.195 0.598 . . . . 0.0 110.249 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -56.6 -61.51 2.37 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.375 1.07 . . . . 0.0 112.053 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -73.51 -26.5 60.91 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -176.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.402 ' HG ' HD23 ' A' ' 146' ' ' LEU . 7.8 tt -63.18 -51.98 64.2 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.62 0.768 . . . . 0.0 109.785 176.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.9 t -91.94 2.28 56.64 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.583 -174.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -69.71 132.46 46.16 Favored 'General case' 0 C--N 1.356 0.858 0 C-N-CA 122.717 0.407 . . . . 0.0 111.262 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -89.15 148.77 23.48 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.665 0.786 . . . . 0.0 109.729 176.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' TRP . . . . . 0.464 ' HE1' ' NH1' ' A' ' 148' ' ' ARG . 12.2 p-90 -151.93 164.45 37.12 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 124.337 1.055 . . . . 0.0 110.373 -171.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -115.19 158.17 22.63 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.526 1.13 . . . . 0.0 110.135 -176.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.484 ' SD ' ' HD2' ' A' ' 118' ' ' ARG . 70.2 mtp -122.02 145.53 48.05 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.386 0.674 . . . . 0.0 110.454 178.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.7 tp -91.97 -42.49 9.97 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.856 0.862 . . . . 0.0 109.926 177.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 24.9 mmt -126.49 85.69 59.79 Favored Pre-proline 0 N--CA 1.482 1.159 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 173.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -70.47 113.27 3.44 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 123.125 2.55 . . . . 0.0 111.676 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.487 ' HD3' ' NE2' ' A' ' 121' ' ' GLN . 55.9 tptt -98.23 118.49 34.99 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 172.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -82.76 105.68 13.98 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 170.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -125.98 145.49 50.27 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.907 0.883 . . . . 0.0 108.91 174.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.0 t -136.77 139.53 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 173.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -126.82 86.08 2.46 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 174.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.38 -121.52 8.22 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.48 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -89.54 15.96 1.86 Allowed 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 123.339 2.693 . . . . 0.0 113.225 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.667 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 5.4 mp -129.11 137.4 51.2 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.658 0.783 . . . . 0.0 108.976 176.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 53.5 t -92.03 130.46 37.77 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 173.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.1 mm -100.76 155.9 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.962 0.905 . . . . 0.0 108.802 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.484 ' HD2' ' SD ' ' A' ' 104' ' ' MET . 20.2 tpp180 -138.61 120.54 15.48 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.463 HD11 ' HA ' ' A' ' 181' ' ' LEU . 38.8 mm -123.56 134.84 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.555 1.142 . . . . 0.0 108.703 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -101.65 115.19 29.97 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 169.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.487 ' NE2' ' HD3' ' A' ' 108' ' ' LYS . 85.5 mt-30 -78.73 -2.07 37.61 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.557 0.743 . . . . 0.0 112.912 -172.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.59 -32.75 10.94 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.359 0.664 . . . . 0.0 110.395 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 31.2 mm -71.23 110.88 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 121.468 0.651 . . . . 0.0 110.739 -176.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.486 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 57.9 mtt -136.34 161.91 34.48 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.218 -173.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 62.62 19.66 11.47 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.739 1.215 . . . . 0.0 113.351 171.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -102.3 149.94 23.83 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.336 0.654 . . . . 0.0 110.016 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -87.23 102.87 14.9 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 167.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 57.3 mt -104.2 142.31 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 123.607 0.763 . . . . 0.0 109.038 -172.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 11.4 tpt -126.65 125.13 41.36 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.274 1.029 . . . . 0.0 108.636 -173.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 14.6 mt -90.46 102.73 15.47 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -176.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.481 ' HD3' ' CD1' ' A' ' 150' ' ' PHE . 25.0 mtpp -113.71 129.84 56.51 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.528 1.131 . . . . 0.0 108.771 -171.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.491 ' HB2' ' HG ' ' A' ' 147' ' ' LEU . . . -134.67 154.98 51.29 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.797 0.808 . . . . 0.0 113.017 -172.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -116.48 134.9 54.32 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 114.061 -1.427 . . . . 0.0 107.774 165.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.507 ' HA ' HG13 ' A' ' 145' ' ' ILE . 37.6 p90 -162.96 165.05 25.46 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.508 0.505 . . . . 0.0 111.581 -176.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 44.7 p -85.98 148.76 25.6 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.462 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 90.1 t -126.44 151.81 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.252 1.021 . . . . 0.0 109.148 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.3 tp -158.4 144.87 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 170.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 57.41 26.52 12.64 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 176.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 67.83 15.03 9.57 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 124.758 1.223 . . . . 0.0 112.701 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -120.82 160.7 22.87 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.715 0.806 . . . . 0.0 109.457 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.519 HD13 ' HB2' ' A' ' 202' ' ' ALA . 9.8 tt -66.6 123.27 19.62 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 174.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -78.93 -69.38 0.57 Allowed 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 176.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 99.0 m -145.8 129.5 17.13 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.368 0.667 . . . . 0.0 109.418 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.567 HD22 HG13 ' A' ' 174' ' ' VAL . 53.3 tp -71.52 115.83 11.15 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 123.894 0.746 . . . . 0.0 109.966 176.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.507 HG13 ' HA ' ' A' ' 134' ' ' PHE . 73.5 mt -74.29 -53.83 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.402 HD23 ' HG ' ' A' ' 98' ' ' LEU . 57.7 tp -160.18 149.74 17.81 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.134 177.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.633 HD13 HD12 ' A' ' 160' ' ' ILE . 7.1 tt -134.51 148.78 50.6 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 174.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.464 ' NH1' ' HE1' ' A' ' 102' ' ' TRP . 43.5 mtt-85 -141.95 159.48 42.14 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.994 0.918 . . . . 0.0 110.329 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -115.77 112.15 21.59 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.121 0.968 . . . . 0.0 109.166 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.481 ' CD1' ' HD3' ' A' ' 131' ' ' LYS . 56.9 m-85 -107.99 136.01 48.4 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.232 1.013 . . . . 0.0 109.93 -177.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 66.9 p -81.43 -172.93 4.08 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.955 0.502 . . . . 0.0 110.648 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -53.76 -37.56 63.53 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.446 0.698 . . . . 0.0 111.882 170.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -80.5 -5.5 56.76 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.121 0.968 . . . . 0.0 111.91 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 75.46 23.05 74.39 Favored Glycine 0 C--N 1.347 1.19 0 N-CA-C 112.102 -0.399 . . . . 0.0 112.102 -174.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -82.69 121.25 26.61 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.417 HD13 ' HD3' ' A' ' 148' ' ' ARG . 12.2 mt -75.6 110.3 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.6 m -120.41 1.86 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.337 1.055 . . . . 0.0 111.047 -175.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -157.23 166.59 33.69 Favored Glycine 0 C--O 1.242 0.634 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -165.26 150.17 9.09 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -174.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.633 HD12 HD13 ' A' ' 147' ' ' LEU . 63.9 mt -128.43 102.69 8.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 164.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 48.1 t -112.06 113.35 52.07 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.667 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 19.0 Cg_endo -57.79 136.21 73.95 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.291 1.994 . . . . 0.0 111.787 178.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 83.2 mt . . . . . 0 CA--C 1.552 1.036 0 C-N-CA 123.968 0.907 . . . . 0.0 112.402 -171.741 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 . . . . . 0 C--O 1.245 0.839 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 34.5 p -83.94 156.26 22.43 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.479 HD11 ' O ' ' A' ' 201' ' ' PHE . 7.2 tt -58.37 -31.89 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 124.178 0.991 . . . . 0.0 110.593 171.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -67.15 -38.08 84.9 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.474 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -62.71 -33.93 76.12 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.834 0.454 . . . . 0.0 110.833 176.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.567 HG13 HD22 ' A' ' 144' ' ' LEU . 60.9 t -66.56 -52.53 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 124.009 0.818 . . . . 0.0 111.618 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -63.04 -33.98 76.6 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 122.225 0.21 . . . . 0.0 111.456 -176.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.401 ' O ' HG23 ' A' ' 180' ' ' VAL . 51.5 m-80 -69.82 -40.36 75.95 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.161 0.584 . . . . 0.0 110.185 174.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -59.91 -40.44 88.82 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 124.084 0.865 . . . . 0.0 110.805 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 174' ' ' VAL . 67.5 mt -68.2 -38.86 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.352 0.661 . . . . 0.0 109.671 177.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.36 -35.29 91.44 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 116.003 -0.544 . . . . 0.0 113.612 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 176' ' ' ASN . 76.2 t -76.09 -38.67 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.112 0.565 . . . . 0.0 110.194 177.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.463 ' HA ' HD11 ' A' ' 119' ' ' ILE . 30.1 tp -57.01 -48.09 79.31 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.354 0.661 . . . . 0.0 110.276 173.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.414 ' O ' ' HG2' ' A' ' 186' ' ' GLU . 47.6 mt -60.82 -48.9 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.82 0.848 . . . . 0.0 110.492 176.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -55.93 -44.61 87.64 Favored Glycine 0 C--N 1.347 1.154 0 O-C-N 123.796 0.685 . . . . 0.0 113.438 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -66.79 -28.57 73.83 Favored Glycine 0 C--N 1.35 1.343 0 O-C-N 123.959 0.446 . . . . 0.0 113.676 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 33.9 mt -83.21 -33.27 26.16 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.296 1.038 . . . . 0.0 111.711 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 52.3 mm-40 -68.62 -39.3 80.88 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.541 0.737 . . . . 0.0 110.873 -177.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -73.8 -16.47 61.15 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.894 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.486 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 8.1 m-20 -77.09 -15.44 59.57 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.386 0.674 . . . . 0.0 111.743 169.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 66.72 64.31 0.48 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.408 1.083 . . . . 0.0 110.138 -172.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -137.06 154.6 50.3 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.755 167.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 20.7 m -98.95 105.98 18.18 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.744 0.818 . . . . 0.0 109.483 -169.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 13.7 m -97.93 150.3 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-O 121.714 0.769 . . . . 0.0 112.095 -178.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 19.6 tpp85 -133.37 139.1 46.61 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.9 t -98.69 146.77 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -178.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 27.9 t -55.08 145.54 20.53 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.286 0.634 . . . . 0.0 111.943 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -51.86 -37.8 53.52 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.005 0.922 . . . . 0.0 111.284 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 53.3 p -73.2 -51.86 16.22 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.726 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 62.2 mt -57.02 -39.02 73.98 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.09 0.556 . . . . 0.0 111.241 -177.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.452 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 46.7 mt-30 -58.81 -39.4 81.06 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.958 0.903 . . . . 0.0 112.246 -176.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.01 -32.54 10.9 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -176.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.479 ' O ' HD11 ' A' ' 171' ' ' ILE . 35.0 m-85 -74.97 -52.29 11.52 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 117.951 0.341 . . . . 0.0 111.25 -175.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.519 ' HB2' HD13 ' A' ' 141' ' ' LEU . . . -109.63 -50.62 2.96 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.056 0.542 . . . . 0.0 111.346 -172.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.452 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 70.7 t-105 . . . . . 0 N--CA 1.477 0.924 0 C-N-CA 124.369 1.068 . . . . 0.0 111.156 -170.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -98.78 110.49 23.09 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 168.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.8 mm -77.47 118.7 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.608 0.763 . . . . 0.0 109.025 173.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 38.5 p -102.47 68.02 1.04 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.538 ' HB3' ' O ' ' A' ' 132' ' ' ALA . 32.4 t70 -72.77 -25.17 61.08 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 114.439 -1.255 . . . . 0.0 111.059 -175.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 60.7 mtm -92.92 136.98 32.77 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 162.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 77.0 p -67.37 163.82 19.92 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 167.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 29.8 mm -57.04 -36.06 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 173.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -58.94 -42.07 88.9 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.313 175.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -77.43 -35.94 53.58 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 122.873 0.469 . . . . 0.0 111.549 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.429 HD12 ' ND2' ' A' ' 133' ' ' ASN . 6.7 tt -64.03 -40.23 95.85 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.974 1.31 . . . . 0.0 109.826 -177.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.0 t -113.34 22.05 14.61 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.348 1.059 . . . . 0.0 109.91 -176.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -66.33 137.5 56.96 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.481 0.712 . . . . 0.0 111.14 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -79.03 136.14 37.1 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 175.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' TRP . . . . . 0.433 ' CG ' ' HB ' ' A' ' 156' ' ' ILE . 38.3 p-90 -156.06 164.86 37.9 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.932 0.893 . . . . 0.0 110.33 176.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -136.93 149.58 47.67 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.763 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.43 ' HG3' ' HG3' ' A' ' 107' ' ' PRO . 13.2 ptm -129.78 129.66 44.37 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 173.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.546 ' H ' HD23 ' A' ' 105' ' ' LEU . 0.9 OUTLIER -94.75 -19.41 20.39 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.297 0.639 . . . . 0.0 110.857 -173.169 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 94.1 mmm -127.37 72.44 77.33 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.187 0.995 . . . . 0.0 109.375 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.43 ' HG3' ' HG3' ' A' ' 104' ' ' MET . 12.3 Cg_exo -71.03 110.39 2.8 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 122.63 2.22 . . . . 0.0 111.741 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.491 ' HB3' ' HB ' ' A' ' 119' ' ' ILE . 57.7 tptt -82.83 117.07 22.44 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 173.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 20.6 tm0? -77.3 102.24 6.65 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.486 ' HA ' ' HE3' ' A' ' 110' ' ' LYS . 0.1 OUTLIER -137.09 130.63 31.55 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.383 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 91.0 t -134.43 138.01 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 173.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -123.61 102.96 8.14 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.154 0.582 . . . . 0.0 109.44 175.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.17 -125.18 26.71 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.007 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -86.31 13.79 2.63 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 123.397 2.732 . . . . 0.0 113.289 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.493 HD23 ' HA ' ' A' ' 162' ' ' PRO . 86.7 mt -130.97 130.85 43.93 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.567 0.747 . . . . 0.0 110.381 -175.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 53.3 t -83.83 137.27 33.78 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.502 0.721 . . . . 0.0 110.266 173.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.3 mm -106.08 151.93 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 C-N-CA 123.924 0.89 . . . . 0.0 108.763 175.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -130.79 124.29 31.04 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 173.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.616 HD13 ' HA3' ' A' ' 184' ' ' GLY . 55.3 mt -132.3 122.69 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.513 ' HB3' ' HB ' ' A' ' 157' ' ' VAL . 23.7 t70 -93.85 121.42 35.28 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.454 ' HA ' ' ND2' ' A' ' 188' ' ' ASN . 22.3 mt-30 -84.29 -7.83 59.21 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -174.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.83 -47.45 11.09 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 118.287 0.494 . . . . 0.0 110.4 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.523 HG23 ' HG3' ' A' ' 126' ' ' LYS . 1.7 mp -71.74 102.47 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-O 122.32 1.057 . . . . 0.0 109.499 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 38.6 mtt -124.55 170.14 11.2 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-N 113.613 -1.63 . . . . 0.0 109.773 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 70.47 11.67 7.38 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 124.762 1.225 . . . . 0.0 112.573 173.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.523 ' HG3' HG23 ' A' ' 123' ' ' ILE . 74.7 mmtt -100.64 156.67 17.18 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.708 0.803 . . . . 0.0 112.227 -171.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.437 ' HB2' ' HG2' ' A' ' 152' ' ' GLU . 90.4 m-20 -89.77 108.91 19.97 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 166.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.562 ' HB ' HG12 ' A' ' 192' ' ' VAL . 64.4 mt -112.55 137.33 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.261 0.624 . . . . 0.0 110.355 -176.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.508 ' HG3' ' HG2' ' A' ' 131' ' ' LYS . 37.2 tpp -113.84 132.81 55.75 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.912 1.285 . . . . 0.0 109.774 -175.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.524 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 2.4 mm? -93.18 102.49 14.79 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.583 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 9.1 mmpt? -105.53 143.2 34.03 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 175.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.538 ' O ' ' HB3' ' A' ' 92' ' ' ASP . . . -145.58 136.58 24.65 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.429 ' ND2' HD12 ' A' ' 98' ' ' LEU . 4.9 m-20 -89.62 118.68 29.42 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 163.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -148.58 157.5 43.5 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.094 0.558 . . . . 0.0 110.728 -174.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.5 t -86.43 160.19 19.11 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.756 174.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.6 t -134.41 143.92 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.371 1.068 . . . . 0.0 109.071 -176.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.4 tp -150.26 140.9 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 168.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 58.02 31.75 21.07 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 175.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 64.34 24.02 13.16 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.448 1.099 . . . . 0.0 112.589 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.482 ' HB2' HD12 ' A' ' 171' ' ' ILE . 2.9 ptp180 -133.09 165.53 24.55 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 173.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.59 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 10.3 tt -65.84 126.23 27.83 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 176.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -81.7 -74.05 0.35 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.3 m -139.17 125.68 20.49 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -175.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.4 HD22 HG13 ' A' ' 174' ' ' VAL . 60.0 tp -70.49 132.98 46.37 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.411 0.685 . . . . 0.0 110.167 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.5 mp -89.15 -52.38 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 173.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 40.4 tp -164.6 142.42 6.62 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.655 0.782 . . . . 0.0 109.142 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.591 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 9.3 tt -130.72 139.58 50.3 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 176.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 61.3 mtp85 -141.69 132.8 26.22 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.382 1.073 . . . . 0.0 109.117 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -116.71 126.69 53.54 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.881 1.272 . . . . 0.0 108.829 -173.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.583 ' CZ ' ' HG3' ' A' ' 131' ' ' LYS . 3.7 p90 -143.75 166.81 23.85 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.28 0.562 . . . . 0.0 111.852 -173.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 68.0 p -82.29 175.35 10.34 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.373 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.437 ' HG2' ' HB2' ' A' ' 127' ' ' ASN . 35.9 mm-40 -57.42 -29.51 64.2 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 121.198 0.523 . . . . 0.0 111.125 171.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -74.04 -16.86 61.03 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.155 0.982 . . . . 0.0 111.052 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 92.01 5.41 66.08 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 116.327 -0.397 . . . . 0.0 112.521 -177.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.63 102.72 6.26 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -178.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.542 HG12 ' HB3' ' A' ' 150' ' ' PHE . 16.8 mt -72.19 122.54 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -177.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.513 ' HB ' ' HB3' ' A' ' 120' ' ' ASP . 27.4 m -130.08 6.09 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.228 1.011 . . . . 0.0 110.592 -175.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -150.81 156.95 26.95 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -165.75 145.55 6.48 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.854 0.462 . . . . 0.0 110.078 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 63.7 mt -124.92 106.32 16.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 168.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 88.0 p -115.59 134.97 22.57 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.493 ' HA ' HD23 ' A' ' 115' ' ' LEU . 52.3 Cg_exo -53.85 140.99 67.45 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 122.743 2.295 . . . . 0.0 111.873 172.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 80.0 mt . . . . . 0 CA--C 1.547 0.859 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.765 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 . . . . . 0 N--CA 1.476 0.83 0 CA-C-O 120.747 0.308 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 22.7 m -96.66 158.34 15.48 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 123.898 0.879 . . . . 0.0 109.395 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.59 ' HB ' ' O ' ' A' ' 141' ' ' LEU . 4.7 tt -48.52 -38.61 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 125.378 1.471 . . . . 0.0 112.836 174.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -62.21 -40.36 95.86 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.846 0.858 . . . . 0.0 111.517 -175.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -62.85 -41.1 99.23 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.984 0.914 . . . . 0.0 110.005 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 178' ' ' ILE . 44.3 t -63.24 -54.46 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 O-C-N 124.398 1.061 . . . . 0.0 111.603 -177.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -61.3 -35.09 76.38 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 124.05 0.844 . . . . 0.0 110.991 -175.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.44 ' O ' HG23 ' A' ' 180' ' ' VAL . 76.9 m-20 -69.69 -41.88 74.83 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.9 -36.28 82.8 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.163 0.914 . . . . 0.0 111.036 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 174' ' ' VAL . 66.6 mt -65.68 -39.18 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 175.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -71.06 -24.64 76.89 Favored Glycine 0 C--N 1.341 0.852 0 O-C-N 123.668 0.605 . . . . 0.0 113.551 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 176' ' ' ASN . 71.1 t -76.04 -43.15 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.441 0.697 . . . . 0.0 109.711 175.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 19.9 tp -60.92 -46.59 90.07 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.43 0.692 . . . . 0.0 110.473 173.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.457 ' O ' ' HG2' ' A' ' 186' ' ' GLU . 57.5 mt -60.56 -50.07 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 123.967 0.907 . . . . 0.0 110.254 175.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -60.9 -33.15 82.39 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 123.447 0.467 . . . . 0.0 113.639 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.616 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -67.79 -43.81 82.56 Favored Glycine 0 C--N 1.347 1.19 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 171.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.439 HD22 HD12 ' A' ' 128' ' ' ILE . 53.4 mt -68.7 -23.9 64.43 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.521 1.129 . . . . 0.0 111.705 177.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 52.4 mm-40 -74.73 -41.9 59.28 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.947 0.499 . . . . 0.0 109.947 178.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -64.23 -41.72 96.88 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.128 171.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.454 ' ND2' ' HA ' ' A' ' 121' ' ' GLN . 6.2 m-20 -68.05 -10.66 55.51 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.552 0.741 . . . . 0.0 111.39 173.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 16.6 t70 63.52 64.49 0.8 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.475 1.11 . . . . 0.0 110.031 174.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -126.22 134.17 51.3 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.8 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 127' ' ' ASN . 59.2 m -80.92 99.25 8.27 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.562 HG12 ' HB ' ' A' ' 128' ' ' ILE . 24.5 m -104.87 148.38 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.668 0.747 . . . . 0.0 111.553 -172.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 44.0 ttt180 -137.76 135.48 36.39 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 114.25 -1.341 . . . . 0.0 107.937 173.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.524 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 4.1 t -87.33 155.27 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -178.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.543 ' HB3' ' HE2' ' A' ' 131' ' ' LYS . 88.6 p -62.45 149.15 43.46 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.446 0.566 . . . . 0.0 111.083 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -55.35 -34.68 64.47 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.188 0.995 . . . . 0.0 110.448 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 52.1 p -64.08 -58.65 6.03 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.436 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.434 ' HB2' HG12 ' A' ' 194' ' ' VAL . 69.7 mt -62.72 -37.45 86.58 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.148 0.579 . . . . 0.0 110.912 -174.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -55.79 -37.54 68.75 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.712 0.805 . . . . 0.0 112.085 -176.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -102.22 -25.33 13.73 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -82.73 -54.32 5.22 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 118.403 0.547 . . . . 0.0 111.519 -176.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.433 ' HB2' HD13 ' A' ' 141' ' ' LEU . . . -102.56 -56.72 2.19 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.811 0.844 . . . . 0.0 110.694 -171.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 44.3 t-105 . . . . . 0 N--CA 1.476 0.842 0 C-N-CA 125.383 1.473 . . . . 0.0 109.601 -177.303 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.519 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 8.1 ttm180 . . . . . 0 N--CA 1.473 0.698 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -121.74 101.42 7.57 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 172.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.9 mm -81.76 132.89 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 123.617 0.767 . . . . 0.0 109.787 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 34.2 p -121.96 83.55 2.11 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 171.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -70.19 -31.37 68.8 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.174 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -111.07 141.92 43.92 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 174.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 81.6 p -65.4 152.97 42.6 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.091 0.472 . . . . 0.0 110.569 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.52 -29.34 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.951 173.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -65.97 -49.61 67.25 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.644 1.177 . . . . 0.0 111.946 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.517 ' HA ' ' HB2' ' A' ' 100' ' ' ARG . 12.5 pt-20 -75.58 -22.32 57.07 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 120.801 0.334 . . . . 0.0 110.334 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.502 ' HG ' HD23 ' A' ' 146' ' ' LEU . 9.2 tt -69.15 -33.73 73.9 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.885 0.874 . . . . 0.0 109.542 170.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.3 t -103.12 13.75 33.4 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.7 0.8 . . . . 0.0 110.983 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.517 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 71.2 ttt180 -65.39 150.16 48.79 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.661 0.784 . . . . 0.0 111.723 -174.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -80.45 125.41 29.9 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 170.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -154.14 173.21 16.38 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.66 0.784 . . . . 0.0 110.488 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -138.78 146.74 41.73 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.158 0.583 . . . . 0.0 110.714 175.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.538 ' SD ' ' HB3' ' A' ' 107' ' ' PRO . 14.3 ptp -99.76 108.43 20.75 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 167.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 48.0 tp -71.58 -38.16 70.94 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.032 0.533 . . . . 0.0 110.552 -175.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 24.9 mmt -121.12 84.81 40.42 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 123.779 0.832 . . . . 0.0 109.088 173.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.538 ' HB3' ' SD ' ' A' ' 104' ' ' MET . 56.5 Cg_endo -67.81 117.86 5.19 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.144 2.563 . . . . 0.0 113.088 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -118.66 131.98 56.17 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 167.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -122.84 120.84 34.71 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 176.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.79 106.6 9.8 Favored 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 124.676 1.19 . . . . 0.0 107.997 176.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.443 HG13 HD11 ' A' ' 163' ' ' LEU . 79.3 t -75.35 128.54 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -122.57 85.24 2.38 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 124.864 1.266 . . . . 0.0 108.363 -176.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 68.01 -113.13 5.2 Favored Glycine 0 CA--C 1.539 1.531 0 CA-C-N 114.966 -1.016 . . . . 0.0 113.239 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -89.97 9.21 3.39 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 123.624 2.883 . . . . 0.0 113.227 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.1 mt -129.95 158.27 40.02 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -175.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 23.7 p -125.51 119.04 27.11 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 176.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.0 mm -86.72 140.94 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.378 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -122.36 129.97 52.65 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 170.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.605 HD13 ' HA3' ' A' ' 184' ' ' GLY . 60.4 mt -128.08 122.86 59.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -178.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -94.28 114.72 26.85 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 174.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -82.72 -10.49 58.88 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.097 0.959 . . . . 0.0 111.51 -175.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.71 -41.57 53.25 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.019 0.527 . . . . 0.0 111.881 -174.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.85 113.14 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.866 0.841 . . . . 0.0 109.834 -176.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 44.8 mtt -131.2 166.16 21.75 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.321 -1.309 . . . . 0.0 109.501 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.5 t70 57.69 32.72 22.29 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.828 0.851 . . . . 0.0 111.313 177.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -120.71 153.94 36.27 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.878 0.871 . . . . 0.0 110.507 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -90.78 106.97 18.88 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 173.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.617 HG12 HG22 ' A' ' 151' ' ' THR . 48.2 mt -108.14 130.77 60.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 123.478 0.711 . . . . 0.0 110.315 -173.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 52.1 tpp -110.0 126.47 53.98 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.28 1.032 . . . . 0.0 108.752 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 25.1 mt -87.77 103.0 15.22 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -110.55 132.39 54.23 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.313 1.045 . . . . 0.0 109.988 -172.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.563 ' HB2' ' HG ' ' A' ' 147' ' ' LEU . . . -136.99 154.93 50.29 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -175.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -112.84 128.44 56.45 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 167.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.456 ' HA ' HD13 ' A' ' 145' ' ' ILE . 33.0 p90 -157.37 163.57 38.46 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.351 0.596 . . . . 0.0 112.393 -170.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 46.6 t -85.14 156.99 20.79 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.425 -1.261 . . . . 0.0 109.417 173.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.519 ' HB ' ' HB3' ' A' ' 88' ' ' ARG . 79.1 t -140.27 142.96 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.378 1.071 . . . . 0.0 109.935 -174.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.428 ' O ' ' HG2' ' A' ' 140' ' ' ARG . 11.3 tp -150.3 145.6 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 168.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 60.62 22.8 12.61 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 123.632 0.773 . . . . 0.0 112.119 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 58.77 39.61 23.98 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.316 1.046 . . . . 0.0 111.658 -172.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 137' ' ' ILE . 5.8 ptp180 -144.85 163.35 34.35 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.509 0.724 . . . . 0.0 109.694 172.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.477 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 10.5 tt -63.85 117.25 6.68 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.952 0.501 . . . . 0.0 110.08 -176.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -79.8 -60.63 2.27 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.839 0.856 . . . . 0.0 109.121 175.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 80.5 m -147.75 132.13 17.59 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.632 0.773 . . . . 0.0 109.366 177.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.434 HD21 ' HB2' ' A' ' 147' ' ' LEU . 51.3 tp -76.7 131.59 38.87 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.557 0.743 . . . . 0.0 110.156 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.456 HD13 ' HA ' ' A' ' 134' ' ' PHE . 1.9 mp -87.15 -46.88 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 173.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.502 HD23 ' HG ' ' A' ' 98' ' ' LEU . 57.7 tp -167.94 149.08 5.22 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.573 0.749 . . . . 0.0 109.585 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.652 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 6.6 tt -134.19 140.08 46.27 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 177.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 58.7 mtp85 -145.48 147.63 32.38 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.32 1.048 . . . . 0.0 108.991 -175.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.01 109.2 21.1 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.009 0.923 . . . . 0.0 109.269 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -106.29 124.15 49.15 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.424 0.69 . . . . 0.0 110.187 -175.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.617 HG22 HG12 ' A' ' 128' ' ' ILE . 33.7 p -73.0 -174.45 1.51 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.372 0.669 . . . . 0.0 110.955 169.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.95 -25.51 63.68 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 122.257 -0.277 . . . . 0.0 111.243 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -83.85 -8.1 59.29 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.748 0.819 . . . . 0.0 110.381 173.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 78.99 23.02 64.63 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 116.331 -0.395 . . . . 0.0 113.391 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.26 127.62 32.57 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.7 mp -81.8 101.39 6.58 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.9 m -111.16 24.33 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.305 1.042 . . . . 0.0 109.991 -172.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 176.05 151.28 8.66 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 114.119 -1.401 . . . . 0.0 110.28 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -158.39 130.55 6.89 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.069 0.935 . . . . 0.0 111.047 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.652 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 67.3 mt -107.43 102.99 14.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 173.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 27.7 t -104.17 120.73 49.97 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 123.427 0.691 . . . . 0.0 109.37 -177.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -54.22 123.79 14.43 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.666 2.244 . . . . 0.0 112.492 172.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.443 HD11 HG13 ' A' ' 111' ' ' VAL . 67.2 mt . . . . . 0 CA--C 1.55 0.961 0 C-N-CA 123.268 0.627 . . . . 0.0 111.261 -177.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 34.9 p-80 . . . . . 0 N--CA 1.476 0.871 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 27.3 m -93.03 159.01 15.49 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.363 0.665 . . . . 0.0 109.866 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 141' ' ' LEU . 7.6 tt -50.99 -37.77 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.728 1.211 . . . . 0.0 111.997 173.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -64.24 -35.41 80.72 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.417 1.087 . . . . 0.0 111.445 -175.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -64.38 -38.83 92.4 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.89 0.876 . . . . 0.0 110.488 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.45 ' O ' HG13 ' A' ' 178' ' ' ILE . 43.7 t -67.79 -37.11 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.297 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -62.14 -40.28 95.42 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.034 0.534 . . . . 0.0 110.747 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.424 ' O ' HG23 ' A' ' 180' ' ' VAL . 79.6 m-20 -61.0 -48.04 83.64 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 123.906 0.754 . . . . 0.0 109.568 174.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.55 -48.64 78.62 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 114.066 -1.424 . . . . 0.0 112.681 -173.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 174' ' ' VAL . 69.8 mt -59.66 -41.8 86.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -61.18 -34.37 87.79 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 115.301 -0.863 . . . . 0.0 114.005 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 176' ' ' ASN . 93.1 t -70.77 -44.08 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 122.956 0.502 . . . . 0.0 110.307 177.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 32.3 tp -59.91 -43.81 94.65 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.822 176.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.536 HG23 HG21 ' A' ' 192' ' ' VAL . 86.6 mt -59.83 -51.58 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.575 0.75 . . . . 0.0 110.267 175.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.22 -42.38 97.21 Favored Glycine 0 C--N 1.344 1.006 0 O-C-N 123.804 0.69 . . . . 0.0 113.779 -176.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.605 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -68.9 -24.81 75.62 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 115.502 -0.349 . . . . 0.0 113.116 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.444 HD22 HD12 ' A' ' 128' ' ' ILE . 32.6 mt -86.54 -25.69 24.92 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.878 0.871 . . . . 0.0 111.564 176.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 182' ' ' ILE . 50.2 mt-10 -70.78 -31.26 67.97 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 122.084 -0.385 . . . . 0.0 110.789 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -81.09 -20.66 41.04 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.161 0.585 . . . . 0.0 111.092 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -65.53 -20.82 66.49 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.011 0.525 . . . . 0.0 110.466 165.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 33.6 t70 63.4 67.47 0.65 Allowed 'General case' 0 C--N 1.355 0.833 0 C-N-CA 124.418 1.087 . . . . 0.0 110.195 -178.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -138.01 178.65 6.96 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.125 175.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 85.3 m -102.51 103.52 13.88 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -174.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.536 HG21 HG23 ' A' ' 182' ' ' ILE . 35.5 m -101.47 146.54 9.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 C-N-CA 123.388 0.675 . . . . 0.0 110.897 -178.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -143.84 145.37 32.28 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.522 171.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 4.6 t -89.9 137.6 21.11 Favored 'Isoleucine or valine' 0 C--O 1.245 0.818 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 173.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 78.9 p -56.96 148.29 21.62 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 118.819 0.736 . . . . 0.0 111.045 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -57.06 -27.03 61.34 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.545 0.738 . . . . 0.0 111.808 -177.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 65.1 p -70.49 -54.25 13.02 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 123.387 0.675 . . . . 0.0 109.847 174.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 33.5 mt -63.45 -26.98 68.98 Favored 'General case' 0 C--O 1.208 -1.079 0 CA-C-O 119.004 -0.522 . . . . 0.0 111.577 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -67.76 -49.71 61.03 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.886 0.474 . . . . 0.0 110.856 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -77.27 -36.54 54.23 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.341 0.401 . . . . 0.0 111.62 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -85.41 -54.94 4.26 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 122.257 -0.277 . . . . 0.0 111.152 -171.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -95.08 -60.37 1.7 Allowed 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.185 0.517 . . . . 0.0 111.447 -170.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 43.5 t-105 . . . . . 0 N--CA 1.475 0.814 0 C-N-CA 126.026 1.73 . . . . 0.0 111.039 -169.967 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -115.38 111.11 20.34 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 171.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.4 mm -81.83 130.42 35.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 123.597 0.759 . . . . 0.0 109.382 175.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.7 p -117.51 81.91 1.73 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -76.89 -13.46 59.99 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.582 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.533 ' HB3' ' HG3' ' A' ' 97' ' ' GLU . 63.2 mtm -114.97 143.94 44.37 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.139 1.376 . . . . 0.0 107.321 161.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 69.3 p -72.29 152.21 42.29 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 167.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 57.0 mt -57.41 -27.68 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 122.606 0.362 . . . . 0.0 111.13 178.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -54.67 -62.36 1.71 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.07 0.948 . . . . 0.0 111.801 170.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.533 ' HG3' ' HB3' ' A' ' 93' ' ' MET . 11.0 pt-20 -73.54 -22.07 60.2 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 122.924 0.49 . . . . 0.0 112.152 -177.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.586 ' HG ' HD23 ' A' ' 146' ' ' LEU . 10.0 tt -63.19 -36.44 83.65 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.007 0.923 . . . . 0.0 109.32 171.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.3 m -109.47 16.91 21.94 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.659 0.784 . . . . 0.0 111.601 -177.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.443 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 62.0 ttt180 -75.03 140.01 43.27 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.671 0.788 . . . . 0.0 110.828 -177.152 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -75.22 136.52 40.97 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.564 0.745 . . . . 0.0 111.248 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 28.0 p-90 -161.14 171.54 18.34 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.654 1.182 . . . . 0.0 109.666 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -141.0 165.08 28.54 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.244 0.618 . . . . 0.0 111.171 -175.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.408 ' SD ' ' HD2' ' A' ' 118' ' ' ARG . 63.6 mtp -118.11 131.08 56.46 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.046 0.939 . . . . 0.0 108.466 172.045 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.519 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.5 pt? -109.29 -29.21 8.59 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.289 0.636 . . . . 0.0 110.829 -175.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 7.7 mmt -123.24 70.31 42.51 Favored Pre-proline 0 N--CA 1.486 1.375 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 166.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.9 145.09 35.54 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 122.243 1.962 . . . . 0.0 113.014 -170.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.45 ' HB3' ' HB ' ' A' ' 119' ' ' ILE . 25.0 ttmm -134.94 120.31 19.06 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 168.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -96.81 100.04 11.59 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -178.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.552 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 17.7 tppt? -96.66 148.78 22.52 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 174.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 68.6 t -128.03 133.62 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 175.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -137.3 95.32 3.06 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 68.37 -131.25 27.0 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.289 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.402 ' HB2' ' HB3' ' A' ' 169' ' ' HIS . 6.2 Cg_exo -82.19 18.21 1.45 Allowed 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 123.356 2.704 . . . . 0.0 113.421 177.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -134.42 170.66 15.41 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.8 0.84 . . . . 0.0 109.655 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.411 ' HB3' HD21 ' A' ' 163' ' ' LEU . 17.9 p -136.33 143.61 44.22 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.033 0.933 . . . . 0.0 109.341 177.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.552 ' HB ' ' HB3' ' A' ' 110' ' ' LYS . 9.3 mm -111.09 147.35 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 124.371 1.069 . . . . 0.0 109.681 -173.056 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.542 ' HG3' ' HB3' ' A' ' 159' ' ' GLU . 36.3 mmt180 -109.87 118.52 36.7 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 173.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.554 HD12 ' HA3' ' A' ' 184' ' ' GLY . 46.1 mm -119.81 122.29 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 175.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -115.05 118.98 34.93 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -80.23 -9.18 59.72 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.695 0.798 . . . . 0.0 112.789 -170.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -79.66 -36.01 38.39 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 120.654 0.264 . . . . 0.0 110.787 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.6 mp -80.12 99.62 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 45.3 mtt -131.66 156.7 45.39 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-N 114.132 -1.395 . . . . 0.0 109.249 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.3 t70 72.03 2.17 4.2 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 124.384 1.074 . . . . 0.0 112.718 175.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -85.95 148.65 25.67 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 121.635 -0.665 . . . . 0.0 112.087 -173.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -91.16 105.38 17.77 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 172.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.667 ' HB ' HG12 ' A' ' 192' ' ' VAL . 56.8 mt -115.39 146.37 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 123.71 0.804 . . . . 0.0 110.257 -172.124 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.449 ' SD ' ' HB3' ' A' ' 193' ' ' ARG . 15.7 tpt -129.23 128.63 43.67 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 125.481 1.512 . . . . 0.0 107.781 177.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 35.7 mt -81.39 145.6 30.73 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -142.55 133.96 26.36 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 173.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.551 ' HB2' ' HG ' ' A' ' 147' ' ' LEU . . . -141.45 142.94 33.63 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -170.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -101.9 133.6 46.42 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 171.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.518 ' HA ' HD13 ' A' ' 145' ' ' ILE . 37.3 p90 -161.1 161.62 31.27 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 123.79 0.681 . . . . 0.0 111.057 -175.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.1 p -86.35 161.32 18.77 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.099 0.96 . . . . 0.0 109.41 172.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 53.9 t -139.25 139.39 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.258 1.423 . . . . 0.0 108.467 -175.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 9.8 tp -130.87 132.85 63.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 169.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 62.4 -84.59 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.914 1.286 . . . . 0.0 110.459 -173.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -158.98 23.42 0.21 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.13 0.972 . . . . 0.0 109.897 -176.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.506 ' HB2' HD12 ' A' ' 171' ' ' ILE . 11.1 ptp180 -127.47 163.06 24.92 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.584 0.754 . . . . 0.0 109.797 176.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.474 HD22 ' HA ' ' A' ' 171' ' ' ILE . 9.0 tt -67.7 125.41 26.13 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 171.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -81.35 -59.7 2.54 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 123.876 0.87 . . . . 0.0 108.811 174.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 95.6 m -149.71 136.68 19.58 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.98 0.912 . . . . 0.0 109.293 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.512 HD21 ' HB2' ' A' ' 147' ' ' LEU . 50.1 tp -77.73 121.47 24.08 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.518 HD13 ' HA ' ' A' ' 134' ' ' PHE . 1.6 mp -77.14 -52.14 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.516 0.727 . . . . 0.0 109.161 176.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.586 HD23 ' HG ' ' A' ' 98' ' ' LEU . 39.3 tp -165.69 150.2 8.47 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.735 0.814 . . . . 0.0 109.358 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.681 HD13 HD12 ' A' ' 160' ' ' ILE . 7.4 tt -133.16 145.85 51.02 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.479 ' HD3' HD13 ' A' ' 156' ' ' ILE . 45.5 mtt-85 -141.28 148.3 39.59 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.906 0.882 . . . . 0.0 110.189 176.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.1 110.35 22.25 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.468 1.107 . . . . 0.0 108.441 176.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -104.45 127.95 52.24 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.555 0.742 . . . . 0.0 109.347 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.462 HG22 HG12 ' A' ' 128' ' ' ILE . 41.6 p -70.97 -175.81 1.22 Allowed 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.267 0.556 . . . . 0.0 111.191 176.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -27.13 68.71 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.55 0.74 . . . . 0.0 111.971 173.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -83.26 -4.08 58.08 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.451 0.7 . . . . 0.0 111.243 171.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 77.45 27.07 60.07 Favored Glycine 0 C--N 1.348 1.241 0 CA-C-N 116.441 -0.345 . . . . 0.0 112.944 178.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -92.66 129.45 38.59 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.013 0.525 . . . . 0.0 110.221 -176.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.479 HD13 ' HD3' ' A' ' 148' ' ' ARG . 17.0 mt -72.59 102.93 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.463 0.705 . . . . 0.0 109.141 177.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.9 m -113.83 -2.14 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.287 1.035 . . . . 0.0 111.514 -176.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -157.18 167.43 33.88 Favored Glycine 0 C--N 1.338 0.648 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.542 ' HB3' ' HG3' ' A' ' 118' ' ' ARG . 27.2 tt0 -166.61 149.03 6.6 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.256 0.622 . . . . 0.0 109.627 -174.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.681 HD12 HD13 ' A' ' 147' ' ' LEU . 71.6 mt -130.06 117.69 41.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 169.389 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.0 t -128.0 138.04 32.09 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.77 139.96 83.21 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 122.951 2.434 . . . . 0.0 111.644 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.411 HD21 ' HB3' ' A' ' 116' ' ' CYS . 88.1 mt . . . . . 0 CA--C 1.548 0.899 0 C-N-CA 123.0 0.52 . . . . 0.0 110.781 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.402 ' HB3' ' HB2' ' A' ' 114' ' ' PRO . 31.2 p-80 . . . . . 0 N--CA 1.473 0.692 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.624 HG22 HG22 ' A' ' 171' ' ' ILE . 4.9 m -99.35 171.73 7.79 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.915 0.886 . . . . 0.0 109.789 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.624 HG22 HG22 ' A' ' 170' ' ' THR . 11.2 tt -48.6 -41.84 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 125.84 1.656 . . . . 0.0 113.754 176.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -56.7 -35.83 68.94 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.187 1.395 . . . . 0.0 111.961 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -73.0 -38.02 66.75 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.26 0.624 . . . . 0.0 111.581 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.498 HG13 HD22 ' A' ' 144' ' ' LEU . 58.1 t -65.19 -51.4 65.86 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.88 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.931 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.27 -24.43 67.86 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 123.826 0.704 . . . . 0.0 112.026 -175.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.41 ' O ' HG23 ' A' ' 180' ' ' VAL . 91.1 m-20 -70.77 -50.67 33.43 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.992 0.517 . . . . 0.0 109.624 169.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.21 -40.29 81.25 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.236 1.014 . . . . 0.0 111.817 -177.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 174' ' ' VAL . 61.5 mt -60.5 -46.33 95.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.716 0.806 . . . . 0.0 109.478 178.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.05 -25.67 72.18 Favored Glycine 0 C--N 1.343 0.934 0 CA-C-N 115.293 -0.867 . . . . 0.0 113.427 -177.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 176' ' ' ASN . 91.8 t -74.67 -43.53 47.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.04 0.536 . . . . 0.0 110.135 176.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.411 ' HB2' HD11 ' A' ' 160' ' ' ILE . 57.0 tp -59.35 -47.13 86.59 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.861 0.464 . . . . 0.0 110.453 175.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.477 HD11 HG22 ' A' ' 194' ' ' VAL . 93.3 mt -59.01 -48.5 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.817 0.847 . . . . 0.0 110.167 177.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -62.24 -30.55 76.25 Favored Glycine 0 C--N 1.348 1.248 0 O-C-N 123.578 0.549 . . . . 0.0 113.385 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.554 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -75.76 -27.36 63.03 Favored Glycine 0 C--N 1.348 1.22 0 N-CA-C 112.345 -0.302 . . . . 0.0 112.345 175.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.559 ' HB3' HG11 ' A' ' 192' ' ' VAL . 61.0 mt -80.97 -31.54 34.76 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.239 1.015 . . . . 0.0 110.842 176.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 182' ' ' ILE . 49.2 mt-10 -72.05 -40.58 68.25 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.866 0.866 . . . . 0.0 110.765 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -70.07 -32.49 70.6 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.836 0.454 . . . . 0.0 110.46 176.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -76.35 -1.77 28.47 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.231 0.613 . . . . 0.0 111.394 170.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 23.4 t70 64.11 49.38 2.71 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.436 1.094 . . . . 0.0 111.011 170.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -109.95 140.36 44.03 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.622 1.169 . . . . 0.0 109.145 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 29.4 m -84.46 100.85 11.6 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.667 HG12 ' HB ' ' A' ' 128' ' ' ILE . 33.2 m -116.83 152.4 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-O 121.703 0.763 . . . . 0.0 112.822 -168.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.449 ' HB3' ' SD ' ' A' ' 129' ' ' MET . 63.4 ttt180 -134.99 142.96 46.58 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 114.043 -1.435 . . . . 0.0 108.307 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.477 HG22 HD11 ' A' ' 182' ' ' ILE . 13.2 t -82.37 154.38 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 5.4 m -50.53 132.48 25.38 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.423 0.689 . . . . 0.0 111.537 178.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -53.43 -30.74 42.03 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 124.218 1.007 . . . . 0.0 111.704 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 68.7 p -79.47 -47.06 16.28 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.983 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 90.6 mt -68.21 -33.68 74.87 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.948 0.499 . . . . 0.0 110.759 -177.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -51.06 -30.46 15.79 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.456 1.102 . . . . 0.0 112.624 -176.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -102.49 -47.92 4.31 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 171.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -67.89 -44.42 77.03 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -166.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -113.72 -54.26 2.62 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.33 0.652 . . . . 0.0 111.173 -175.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 . . . . . 0 CA--C 1.544 0.732 0 C-N-CA 125.114 1.366 . . . . 0.0 111.511 -172.637 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 66.9 ttt180 . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -92.36 97.73 11.05 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.699 0.8 . . . . 0.0 109.401 -178.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.9 mm -81.84 122.66 37.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.968 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.9 p -117.18 97.38 5.89 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.93 0.892 . . . . 0.0 110.292 -174.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -79.34 -27.74 42.03 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.828 0.851 . . . . 0.0 111.002 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.456 ' HB2' ' HG3' ' A' ' 97' ' ' GLU . 24.4 ptt? -119.02 141.43 48.7 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.776 0.83 . . . . 0.0 109.188 -177.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.8 m -68.69 160.23 30.64 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.067 0.947 . . . . 0.0 110.599 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 61.1 mt -62.43 -31.84 53.14 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 C-N-CA 122.809 0.443 . . . . 0.0 111.47 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.23 -54.14 49.29 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.511 0.324 . . . . 0.0 111.328 175.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.667 ' HA ' ' HB2' ' A' ' 100' ' ' ARG . 14.8 pt-20 -77.19 -18.31 57.85 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.029 0.531 . . . . 0.0 111.874 -177.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.521 HD12 HD22 ' A' ' 133' ' ' ASN . 6.0 tt -59.92 -43.75 94.73 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.37 1.068 . . . . 0.0 108.89 167.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.1 t -105.76 21.11 17.81 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.745 -176.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.667 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 30.8 tpt180 -67.45 133.1 48.91 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.802 0.441 . . . . 0.0 110.639 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -72.1 136.99 46.75 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 123.692 0.62 . . . . 0.0 109.8 174.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 20.4 p-90 -157.59 166.3 33.25 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.837 0.855 . . . . 0.0 109.485 176.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -142.62 144.02 32.63 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 123.547 0.739 . . . . 0.0 109.033 -176.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.534 ' SD ' ' HD2' ' A' ' 118' ' ' ARG . 67.4 mtp -85.48 105.51 16.15 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.2 tp -62.51 -36.36 82.3 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.192 0.997 . . . . 0.0 110.331 177.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.478 ' HG2' ' HB2' ' A' ' 122' ' ' ALA . 20.7 mmt -134.38 92.48 20.62 Favored Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 123.736 0.814 . . . . 0.0 109.153 168.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.24 112.95 2.69 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 123.165 2.577 . . . . 0.0 114.394 -176.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 119' ' ' ILE . 55.5 tptt -109.54 117.96 35.35 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 161.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -107.72 113.44 26.71 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -125.88 103.31 7.71 Favored 'General case' 0 C--O 1.214 -0.767 0 C-N-CA 123.485 0.714 . . . . 0.0 109.516 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . 84.8 t -75.6 137.89 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 174.009 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -133.25 93.13 3.11 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-O 120.993 0.425 . . . . 0.0 109.963 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.15 -128.71 37.01 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.743 176.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -72.05 1.36 6.01 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 123.37 2.713 . . . . 0.0 114.126 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 4.3 mp -127.04 175.49 8.06 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.795 0.838 . . . . 0.0 109.411 -178.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.487 ' SG ' ' NH1' ' A' ' 118' ' ' ARG . 49.6 t -136.53 146.47 46.24 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 174.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.8 mm -116.22 147.32 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.309 1.044 . . . . 0.0 109.394 -174.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.534 ' HD2' ' SD ' ' A' ' 104' ' ' MET . 68.7 mmt-85 -119.54 127.31 52.88 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.049 0.939 . . . . 0.0 108.688 172.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.469 HD11 ' HA ' ' A' ' 181' ' ' LEU . 41.6 mm -122.84 125.59 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 173.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -93.45 116.86 29.4 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.411 ' HA ' HD21 ' A' ' 188' ' ' ASN . 80.3 mt-30 -78.51 -13.45 59.82 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.383 0.673 . . . . 0.0 112.257 -174.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.478 ' HB2' ' HG2' ' A' ' 106' ' ' MET . . . -82.86 -49.4 9.71 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.099 0.56 . . . . 0.0 110.791 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.424 HG12 HG11 ' A' ' 157' ' ' VAL . 1.8 mp -69.91 108.81 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-O 122.01 0.91 . . . . 0.0 109.731 -174.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.434 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 50.0 mtt -132.23 156.8 45.84 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 113.192 -1.822 . . . . 0.0 109.624 -177.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.0 t70 63.19 29.07 16.06 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.463 1.105 . . . . 0.0 111.801 173.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -115.0 149.56 37.21 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.569 0.748 . . . . 0.0 111.408 -179.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 152' ' ' GLU . 43.9 m-80 -83.52 107.29 15.9 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.542 HD12 HD22 ' A' ' 185' ' ' LEU . 50.2 mt -112.44 123.84 68.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-O 121.943 0.878 . . . . 0.0 111.105 -174.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 5.6 tpt -102.61 119.24 38.49 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 126.926 2.09 . . . . 0.0 108.905 -176.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 20.4 mt -95.25 104.9 16.8 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -115.43 144.8 43.27 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.192 0.597 . . . . 0.0 109.834 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -138.76 156.55 47.28 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.6 0.714 . . . . 0.0 112.479 -175.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.521 HD22 HD12 ' A' ' 98' ' ' LEU . 70.7 m-20 -113.6 119.38 37.28 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 165.204 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -153.1 157.96 41.18 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.416 0.686 . . . . 0.0 110.403 -167.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.0 p -89.66 156.8 18.32 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.345 0.658 . . . . 0.0 109.425 175.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.9 t -131.44 129.0 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.569 1.148 . . . . 0.0 109.325 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.5 tp -133.69 140.27 46.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 175.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 63.23 25.83 14.94 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.077 0.951 . . . . 0.0 111.604 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 66.13 15.73 10.19 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 124.986 1.314 . . . . 0.0 112.398 -176.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.424 HH21 HD13 ' A' ' 171' ' ' ILE . 9.7 ptm180 -127.27 171.19 11.69 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.481 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 7.0 tt -68.83 128.79 37.92 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -175.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -85.58 -69.61 0.65 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.757 0.823 . . . . 0.0 110.481 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 63.6 m -147.91 136.68 21.85 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.761 0.824 . . . . 0.0 109.05 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.459 HD22 HG13 ' A' ' 174' ' ' VAL . 47.6 tp -82.63 114.99 21.39 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.269 0.627 . . . . 0.0 109.58 177.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.0 mp -74.57 -50.8 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 175.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 49.4 tp -161.03 144.46 13.07 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.252 0.621 . . . . 0.0 109.464 178.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.61 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 7.6 tt -135.17 142.44 46.11 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 173.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.428 ' HB2' ' CE1' ' A' ' 150' ' ' PHE . 44.3 mtp85 -138.74 139.46 38.34 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -177.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.472 ' HB2' HD21 ' A' ' 181' ' ' LEU . . . -97.18 100.61 12.08 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -177.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.428 ' CE1' ' HB2' ' A' ' 148' ' ' ARG . 87.6 m-85 -96.56 124.55 40.58 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -177.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.485 HG22 HG12 ' A' ' 128' ' ' ILE . 58.6 p -67.5 178.84 1.47 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.266 0.555 . . . . 0.0 110.752 173.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 127' ' ' ASN . 10.3 pt-20 -60.84 -22.21 63.99 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.371 1.068 . . . . 0.0 112.076 174.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -91.23 -1.35 57.71 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.075 0.95 . . . . 0.0 111.327 176.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 79.79 9.69 86.51 Favored Glycine 0 C--N 1.348 1.222 0 O-C-N 123.375 0.422 . . . . 0.0 113.148 -177.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -87.25 120.8 28.91 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.69 0.796 . . . . 0.0 109.51 -174.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 16.1 mt -77.95 121.89 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -175.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.424 HG11 HG12 ' A' ' 123' ' ' ILE . 33.7 m -123.56 5.9 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.979 0.912 . . . . 0.0 110.948 -177.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -164.12 163.12 35.79 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -178.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -160.36 144.76 14.32 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.61 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 53.9 mt -123.71 115.54 45.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 172.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 18.4 p -138.84 132.34 16.1 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 122.902 0.481 . . . . 0.0 110.434 -175.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 31.1 Cg_endo -62.12 133.75 45.63 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.577 2.184 . . . . 0.0 111.875 176.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.2 mt . . . . . 0 CA--C 1.549 0.925 0 C-N-CA 123.699 0.8 . . . . 0.0 111.256 177.553 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 6.3 m -96.15 162.33 13.58 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.533 0.733 . . . . 0.0 109.218 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 141' ' ' LEU . 9.2 tt -50.15 -33.74 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 124.606 1.162 . . . . 0.0 112.13 171.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -52.73 -48.25 66.81 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.48 1.112 . . . . 0.0 111.458 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -69.16 -36.33 77.26 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.741 -176.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.459 HG13 HD22 ' A' ' 144' ' ' LEU . 46.0 t -64.12 -48.88 83.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 O-C-N 123.948 0.78 . . . . 0.0 111.002 178.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -59.81 -40.72 89.34 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.638 0.775 . . . . 0.0 110.982 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.469 ' O ' HG23 ' A' ' 180' ' ' VAL . 89.4 m-20 -64.04 -46.26 85.21 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.871 176.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -61.76 -40.8 96.42 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.717 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 174' ' ' VAL . 66.6 mt -68.05 -37.5 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -65.72 -26.61 72.12 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 116.046 -0.524 . . . . 0.0 113.447 177.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 176' ' ' ASN . 98.3 t -75.59 -45.96 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.209 0.604 . . . . 0.0 109.916 175.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.472 HD21 ' HB2' ' A' ' 149' ' ' ALA . 42.6 tp -55.93 -52.5 63.92 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.342 0.657 . . . . 0.0 110.816 176.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.409 HG23 HG21 ' A' ' 192' ' ' VAL . 79.8 mt -60.13 -46.65 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.79 0.836 . . . . 0.0 110.595 176.084 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -52.65 -45.71 59.86 Favored Glycine 0 C--N 1.345 1.045 0 O-C-N 124.097 0.873 . . . . 0.0 114.156 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -68.14 -38.11 87.74 Favored Glycine 0 C--N 1.347 1.14 0 O-C-N 123.917 0.422 . . . . 0.0 112.538 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.542 HD22 HD12 ' A' ' 128' ' ' ILE . 97.5 mt -67.29 -34.12 76.73 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.484 0.713 . . . . 0.0 111.226 178.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -69.12 -38.81 79.07 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.59 0.756 . . . . 0.0 110.407 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -61.56 -41.35 97.24 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.191 174.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.434 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 6.7 m-20 -80.19 -2.86 46.64 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.965 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 61.68 57.03 2.33 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.054 0.941 . . . . 0.0 111.298 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -111.81 143.37 42.86 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.756 0.822 . . . . 0.0 109.146 174.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 96.0 m -78.64 102.84 8.2 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.409 HG21 HG23 ' A' ' 182' ' ' ILE . 26.7 m -86.7 143.0 12.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.418 -173.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -147.7 129.72 15.4 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 171.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 3.7 t -96.99 146.35 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 31.2 t -57.53 139.15 54.15 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 118.913 -0.565 . . . . 0.0 110.072 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -54.89 -37.89 66.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 123.497 0.498 . . . . 0.0 110.609 -177.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 41.1 p -62.02 -52.55 63.53 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.596 0.758 . . . . 0.0 109.541 176.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 68.9 mt -58.71 -28.09 65.49 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.61 0.764 . . . . 0.0 111.489 177.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.55 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 49.3 mt-30 -73.46 -42.74 61.56 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 119.021 -0.514 . . . . 0.0 112.191 -176.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.33 -20.78 20.05 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 119.541 1.064 . . . . 0.0 111.574 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -80.51 -41.78 23.65 Favored 'General case' 0 C--N 1.35 0.602 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.475 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -114.4 -60.59 1.87 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.059 0.543 . . . . 0.0 111.617 -176.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.55 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 46.1 t-105 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -161.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 110.523 -0.177 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -85.58 105.58 16.26 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 169.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.0 mm -77.6 120.45 28.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 175.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.4 p -100.85 66.54 1.18 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.416 ' HB3' ' O ' ' A' ' 132' ' ' ALA . 22.6 t70 -67.84 -29.15 68.22 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.755 176.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.743 ' HG3' ' HG3' ' A' ' 97' ' ' GLU . 32.7 ttp -104.84 129.42 53.16 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.724 1.61 . . . . 0.0 107.141 170.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 48.0 p -67.1 156.16 36.85 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 121.309 -0.87 . . . . 0.0 109.94 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -59.64 -35.3 58.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -57.87 -58.29 9.02 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.01 0.924 . . . . 0.0 112.175 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.743 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 12.5 pt-20 -71.15 -27.09 63.3 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 122.703 0.401 . . . . 0.0 111.05 -178.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.567 ' HG ' HD23 ' A' ' 146' ' ' LEU . 9.5 tt -60.71 -39.91 90.31 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.207 1.003 . . . . 0.0 110.201 171.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 81.1 p -107.07 19.96 19.69 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.277 0.631 . . . . 0.0 111.219 -177.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.545 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 2.5 tpm_? -69.78 140.15 53.34 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.879 0.871 . . . . 0.0 111.203 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -78.89 128.26 33.1 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 173.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 40.2 p-90 -150.65 168.13 25.25 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.064 0.946 . . . . 0.0 110.088 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -126.85 136.51 52.44 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.39 0.676 . . . . 0.0 109.795 178.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.508 ' HG3' ' HB2' ' A' ' 120' ' ' ASP . 43.7 ttp -94.31 93.06 7.51 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 167.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.2 tp -55.62 -53.73 52.93 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.718 1.207 . . . . 0.0 111.367 -168.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 27.5 mmt -101.95 93.75 3.97 Favored Pre-proline 0 C--O 1.244 0.779 0 C-N-CA 124.145 0.978 . . . . 0.0 108.581 171.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.501 ' HA ' ' HG2' ' A' ' 104' ' ' MET . 7.0 Cg_exo -73.02 111.73 3.35 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 122.573 2.182 . . . . 0.0 112.345 -172.076 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -114.63 112.32 22.71 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 171.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -94.92 101.5 13.29 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -177.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.471 ' HE2' HG11 ' A' ' 180' ' ' VAL . 55.2 tptt -101.93 146.23 28.15 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 170.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 93.2 t -131.01 129.29 63.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 167.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -123.78 95.11 4.44 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.35 -137.12 21.42 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.549 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -82.08 20.4 1.1 Allowed 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 123.705 2.937 . . . . 0.0 113.075 173.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.496 HD11 HG22 ' A' ' 174' ' ' VAL . 87.5 mt -127.86 122.69 33.24 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.358 0.663 . . . . 0.0 109.618 -175.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 49.4 t -85.44 115.41 23.15 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.038 0.935 . . . . 0.0 110.099 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.6 mm -100.47 121.88 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.588 0.755 . . . . 0.0 109.363 -175.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 51.3 mtt-85 -103.09 119.84 39.58 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 34.9 mm -114.56 122.04 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.508 ' HB2' ' HG3' ' A' ' 104' ' ' MET . 18.8 t70 -97.04 113.09 24.61 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 170.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -77.25 -11.56 59.84 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.716 0.806 . . . . 0.0 112.127 -175.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.66 -62.51 1.56 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.321 0.649 . . . . 0.0 111.765 -174.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.7 mp -71.23 115.0 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-O 122.014 0.911 . . . . 0.0 110.883 -174.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 59.1 mtt -133.11 167.25 20.67 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 113.83 -1.532 . . . . 0.0 109.879 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.9 t70 55.17 42.15 30.88 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.636 1.174 . . . . 0.0 111.374 177.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 190' ' ' ASN . 45.5 mmtm -124.75 153.39 42.49 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.209 1.004 . . . . 0.0 110.145 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -88.3 106.36 18.17 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 172.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.493 HG12 HG22 ' A' ' 151' ' ' THR . 56.0 mt -107.88 136.08 44.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 124.702 1.201 . . . . 0.0 110.031 -174.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 11.8 tpt -115.41 138.16 51.29 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.422 1.089 . . . . 0.0 110.057 -175.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.556 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 3.4 mm? -92.64 117.71 30.26 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.975 0.91 . . . . 0.0 108.92 177.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 93' ' ' MET . 73.5 mmtt -123.6 125.47 44.9 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.668 1.187 . . . . 0.0 109.211 176.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.548 ' HB2' ' HG ' ' A' ' 147' ' ' LEU . . . -137.49 144.43 42.22 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -175.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -106.29 130.77 54.08 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 169.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.425 ' HA ' HD13 ' A' ' 145' ' ' ILE . 4.9 p90 -162.87 157.46 21.32 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 124.15 0.906 . . . . 0.0 109.38 -172.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 22.2 p -85.65 152.1 23.36 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 172.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 87.6 t -121.84 138.51 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.847 0.859 . . . . 0.0 109.738 -177.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.0 tp -145.05 142.43 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 170.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 60.39 17.87 7.58 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.714 0.806 . . . . 0.0 112.757 177.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 73.87 21.08 2.75 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 126.566 1.947 . . . . 0.0 112.155 -177.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.419 ' HB2' HD12 ' A' ' 171' ' ' ILE . 10.8 ptp180 -125.39 172.19 9.82 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.938 0.895 . . . . 0.0 109.863 175.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.2 tt -69.32 119.56 13.78 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.365 0.666 . . . . 0.0 109.669 174.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -83.41 -65.93 0.95 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.319 1.047 . . . . 0.0 108.947 176.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 69.4 m -141.55 130.94 23.7 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.608 0.763 . . . . 0.0 109.028 175.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.431 HD21 ' HB2' ' A' ' 147' ' ' LEU . 52.9 tp -77.6 121.31 23.76 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.993 0.917 . . . . 0.0 109.812 174.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 134' ' ' PHE . 1.7 mp -81.94 -44.49 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.579 0.752 . . . . 0.0 109.458 176.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.567 HD23 ' HG ' ' A' ' 98' ' ' LEU . 34.0 tp -167.72 148.89 5.37 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.943 0.897 . . . . 0.0 108.714 173.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.71 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 8.3 tt -129.17 150.13 50.68 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 174.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.745 HH11 HG21 ' A' ' 156' ' ' ILE . 44.0 ttm-85 -143.1 143.57 31.89 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.379 0.672 . . . . 0.0 110.8 -173.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -124.22 118.8 27.65 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.437 1.095 . . . . 0.0 108.308 174.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -145.92 144.66 30.31 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.198 0.523 . . . . 0.0 111.018 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.493 HG22 HG12 ' A' ' 128' ' ' ILE . 55.3 p -65.41 171.51 3.9 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.616 -1.174 . . . . 0.0 112.197 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -65.3 -23.22 66.96 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.003 0.521 . . . . 0.0 110.821 172.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -66.12 -30.04 70.46 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.226 1.01 . . . . 0.0 110.234 174.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 107.3 -5.36 35.74 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.039 -174.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -70.26 105.14 2.87 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.434 0.694 . . . . 0.0 110.681 -175.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.745 HG21 HH11 ' A' ' 148' ' ' ARG . 33.3 mt -73.92 118.9 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.45 ' HB ' ' HB3' ' A' ' 120' ' ' ASP . 35.6 m -130.98 15.3 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.833 0.853 . . . . 0.0 110.648 -175.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -164.39 151.78 21.14 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -163.54 141.58 7.68 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.71 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 69.1 mt -113.13 102.74 14.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 170.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 20.7 t -98.93 108.49 49.4 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.135 0.974 . . . . 0.0 108.85 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.19 134.55 62.53 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.514 2.143 . . . . 0.0 111.318 175.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 CA--C 1.551 1.001 0 O-C-N 123.531 0.52 . . . . 0.0 109.859 -179.614 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.413 ' O ' HG23 ' A' ' 174' ' ' VAL . 80.7 p -87.69 151.4 22.96 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.064 0.546 . . . . 0.0 110.385 -174.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.443 ' O ' ' HG3' ' A' ' 175' ' ' LYS . 8.3 tt -58.52 -38.76 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 O-C-N 123.99 0.806 . . . . 0.0 111.129 175.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 47.2 mp0 -55.54 -41.57 73.4 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.086 0.955 . . . . 0.0 110.461 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -67.38 -47.19 71.08 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.556 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.496 HG22 HD11 ' A' ' 115' ' ' LEU . 57.4 t -61.53 -34.28 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 122.974 0.509 . . . . 0.0 110.959 -176.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 171' ' ' ILE . 39.2 mtpt -61.05 -34.7 75.3 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.247 0.619 . . . . 0.0 111.781 177.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -68.0 -47.65 67.94 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.35 -45.11 84.68 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 124.374 1.046 . . . . 0.0 112.249 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.5 ' HB ' ' HZ3' ' A' ' 203' ' ' TRP . 23.2 mt -72.06 -37.57 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -64.8 -27.47 72.12 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 116.126 -0.488 . . . . 0.0 113.003 177.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.471 HG11 ' HE2' ' A' ' 110' ' ' LYS . 54.1 t -83.15 -39.91 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.746 0.818 . . . . 0.0 110.203 177.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.483 HD22 HG13 ' A' ' 160' ' ' ILE . 58.7 tp -58.52 -53.03 62.95 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.084 0.554 . . . . 0.0 110.406 174.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.634 HG23 HG21 ' A' ' 192' ' ' VAL . 70.4 mt -59.28 -43.48 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.44 1.096 . . . . 0.0 110.278 173.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -58.53 -35.0 78.16 Favored Glycine 0 CA--C 1.533 1.203 0 O-C-N 123.886 0.741 . . . . 0.0 113.83 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -72.39 -35.49 59.91 Favored Glycine 0 C--N 1.349 1.292 0 N-CA-C 111.847 -0.501 . . . . 0.0 111.847 175.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.412 HD22 HD12 ' A' ' 128' ' ' ILE . 75.3 mt -71.06 -25.25 62.56 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 124.297 1.039 . . . . 0.0 111.252 175.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 26.9 mm-40 -70.85 -37.78 73.13 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.713 0.805 . . . . 0.0 110.06 174.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -73.83 -31.68 63.33 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.293 177.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -72.6 -14.72 61.68 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.088 169.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 15.6 t70 57.3 64.85 1.5 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.629 1.172 . . . . 0.0 110.313 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 10.5 p30 -131.84 165.73 23.18 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.671 174.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 42.3 m -87.78 106.39 18.04 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.507 -172.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.634 HG21 HG23 ' A' ' 182' ' ' ILE . 34.3 m -94.81 141.98 14.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.763 0 C-N-CA 122.918 0.487 . . . . 0.0 110.689 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -144.76 131.3 19.87 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.233 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.556 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 5.2 t -95.69 149.51 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.413 ' HB2' ' HG ' ' A' ' 198' ' ' LEU . 69.9 m -67.44 144.59 55.66 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 118.95 0.795 . . . . 0.0 110.947 177.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -60.22 -26.29 66.28 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.079 0.952 . . . . 0.0 111.797 -177.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.0 p -67.68 -53.18 29.74 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 172.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.51 ' HB2' HG12 ' A' ' 194' ' ' VAL . 68.1 mt -62.91 -25.61 68.41 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.881 0.873 . . . . 0.0 111.506 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.595 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 78.3 mt-30 -69.24 -44.12 72.65 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.224 0.61 . . . . 0.0 110.824 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.08 -30.0 20.22 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.662 -175.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -83.3 -57.89 3.07 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.548 0.339 . . . . 0.0 110.803 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -98.73 -37.37 9.51 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.16 0.584 . . . . 0.0 111.703 -165.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.595 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 43.4 t-105 . . . . . 0 N--CA 1.481 1.103 0 C-N-CA 124.275 1.03 . . . . 0.0 109.415 -170.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 . . . . . 0 N--CA 1.47 0.526 0 CA-C-O 120.76 0.314 . . . . 0.0 111.465 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -86.47 105.03 16.49 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 175.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 49.9 mm -78.73 125.89 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 62.4 p -114.26 91.42 3.62 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.641 -176.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -75.51 -17.84 59.99 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.182 0.593 . . . . 0.0 110.703 177.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.508 ' SD ' ' HB3' ' A' ' 148' ' ' ARG . 61.1 mtm -117.22 128.72 55.38 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.456 1.103 . . . . 0.0 108.943 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.4 m -77.82 162.15 27.11 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 171.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -48.55 -35.41 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 124.402 1.081 . . . . 0.0 111.763 -177.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -51.58 -71.14 0.07 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.211 1.404 . . . . 0.0 112.207 177.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -69.11 -29.84 67.99 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.528 0.731 . . . . 0.0 111.744 -176.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.8 tt -62.5 -43.1 99.63 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.235 1.014 . . . . 0.0 109.263 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.2 m -105.23 15.18 27.85 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.738 0.815 . . . . 0.0 111.815 -175.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -80.88 135.47 35.92 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.159 0.583 . . . . 0.0 110.222 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -88.22 144.87 26.19 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.776 0.83 . . . . 0.0 109.306 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 18.5 p-90 -152.42 154.29 35.26 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.192 0.997 . . . . 0.0 110.465 -173.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -96.42 160.47 14.39 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.538 0.735 . . . . 0.0 110.791 -177.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 65.9 mtp -128.74 116.88 20.21 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 170.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.3 tt -70.71 -54.78 10.51 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 21.5 mmt -119.22 86.56 33.03 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 124.126 0.97 . . . . 0.0 109.378 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -76.67 113.61 3.69 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 122.837 2.358 . . . . 0.0 112.493 -175.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.55 ' HE3' ' HB2' ' A' ' 110' ' ' LYS . 51.4 tptt -90.59 106.69 18.68 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 169.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 51.2 tp60 -90.92 107.27 19.09 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.146 -0.933 . . . . 0.0 108.698 176.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.55 ' HB2' ' HE3' ' A' ' 108' ' ' LYS . 58.7 tttm -140.12 143.44 36.23 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.992 172.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 68.0 t -105.67 147.24 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 169.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -134.66 90.75 2.69 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 174.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.3 -136.37 21.21 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 114.823 -1.08 . . . . 0.0 112.687 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -81.43 17.9 1.42 Allowed 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 123.687 2.925 . . . . 0.0 113.148 176.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 4.3 mp -134.87 136.42 42.39 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.745 0.818 . . . . 0.0 108.91 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 26.4 p -100.82 138.83 37.35 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.105 0.562 . . . . 0.0 110.085 177.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.2 mm -106.72 133.94 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.326 1.05 . . . . 0.0 110.637 -171.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -108.84 118.18 36.12 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 173.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.496 ' HB ' ' HB3' ' A' ' 108' ' ' LYS . 87.0 mt -126.97 125.63 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -97.03 117.73 31.85 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 118.78 0.718 . . . . 0.0 109.331 173.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -78.5 -8.31 58.41 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.303 1.041 . . . . 0.0 112.506 -172.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.41 -26.33 23.36 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.676 0.39 . . . . 0.0 110.292 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 41.2 mm -81.89 102.15 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 121.997 0.904 . . . . 0.0 110.995 -173.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.527 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 52.1 mtt -134.09 160.47 37.67 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 114.253 -1.34 . . . . 0.0 108.763 -178.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.8 t70 65.34 24.56 12.1 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.719 0.771 . . . . 0.0 111.64 174.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 190' ' ' ASN . 74.9 mmtt -117.45 148.61 41.65 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.236 1.014 . . . . 0.0 110.66 -179.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -86.8 106.48 17.73 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 171.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.533 HD12 HD22 ' A' ' 185' ' ' LEU . 50.1 mt -102.28 128.63 54.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.893 0.877 . . . . 0.0 111.25 -174.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.558 ' HG3' ' HG3' ' A' ' 131' ' ' LYS . 4.0 tpt -98.99 116.38 31.1 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.064 1.746 . . . . 0.0 109.636 -176.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -98.57 104.7 16.76 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.558 ' HG3' ' HG3' ' A' ' 129' ' ' MET . 47.3 mtmt -127.17 149.58 49.91 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.166 0.586 . . . . 0.0 110.975 -177.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.485 ' HB3' HD21 ' A' ' 198' ' ' LEU . . . -141.4 149.93 41.7 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -173.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -100.25 118.88 37.46 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 163.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -151.91 159.18 43.89 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.157 0.583 . . . . 0.0 110.964 -171.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.8 m -86.36 150.52 24.27 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.787 1.235 . . . . 0.0 109.703 177.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 98.2 t -122.4 145.62 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 175.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.465 HG22 ' HB2' ' A' ' 142' ' ' GLU . 9.7 tp -162.67 145.48 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 167.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 56.29 25.68 9.61 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 124.043 0.937 . . . . 0.0 112.606 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 69.72 25.52 5.12 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 125.781 1.632 . . . . 0.0 112.487 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.575 ' HB2' HD12 ' A' ' 171' ' ' ILE . 1.2 ptp85 -132.56 171.65 13.54 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.325 0.65 . . . . 0.0 110.902 175.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.7 tt -74.44 114.07 12.41 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 114.904 -1.043 . . . . 0.0 108.662 172.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.465 ' HB2' HG22 ' A' ' 137' ' ' ILE . 9.4 tp10 -73.45 -61.84 1.69 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.902 0.881 . . . . 0.0 110.247 175.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 65.4 m -146.32 127.53 14.76 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.99 0.916 . . . . 0.0 109.438 -175.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.452 HD11 ' HB1' ' A' ' 132' ' ' ALA . 36.7 tp -74.06 125.23 27.84 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 172.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.9 mp -83.35 -48.51 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 172.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.548 HD21 ' NH2' ' A' ' 148' ' ' ARG . 46.5 tp -165.26 147.42 7.8 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.687 0.795 . . . . 0.0 109.626 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.638 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 8.9 tt -129.62 156.75 43.7 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 171.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.793 ' HD3' HD13 ' A' ' 156' ' ' ILE . 48.4 ttm-85 -154.07 141.16 19.39 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.082 0.553 . . . . 0.0 110.733 -175.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.98 121.14 44.51 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.627 1.171 . . . . 0.0 109.411 -177.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -110.99 155.94 21.98 Favored 'General case' 0 C--O 1.208 -1.087 0 C-N-CA 124.74 1.216 . . . . 0.0 108.541 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 24.9 p -100.18 168.3 9.9 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 118.852 0.751 . . . . 0.0 109.833 168.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.8 -21.17 62.51 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 172.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -61.7 -30.27 70.64 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.103 0.961 . . . . 0.0 111.422 169.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 99.21 14.31 36.36 Favored Glycine 0 C--N 1.346 1.116 0 O-C-N 123.714 0.634 . . . . 0.0 112.84 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -101.1 135.11 43.09 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.41 0.684 . . . . 0.0 109.957 176.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.793 HD13 ' HD3' ' A' ' 148' ' ' ARG . 47.1 mt -78.93 127.13 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 174.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.6 m -127.01 1.41 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.636 0.774 . . . . 0.0 112.435 -171.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -164.81 170.03 39.73 Favored Glycine 0 C--N 1.344 0.973 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 34.6 tt0 -167.67 153.75 7.63 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.04 0.936 . . . . 0.0 109.139 -177.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.638 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 70.6 mt -129.4 104.23 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 167.328 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 5.4 p -109.95 121.84 40.71 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 123.85 0.86 . . . . 0.0 109.627 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 37.1 Cg_exo -62.53 140.11 79.81 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.752 2.301 . . . . 0.0 111.824 175.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 CA--C 1.548 0.874 0 C-N-CA 123.744 0.818 . . . . 0.0 110.543 179.297 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 59.1 p -98.23 166.08 11.57 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 123.31 0.644 . . . . 0.0 110.268 174.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.626 HD11 ' HA ' ' A' ' 202' ' ' ALA . 12.7 tt -52.78 -35.84 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 124.189 0.996 . . . . 0.0 110.882 170.038 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -59.72 -44.71 93.61 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.55 1.14 . . . . 0.0 111.469 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -63.34 -43.69 97.01 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 124.105 0.878 . . . . 0.0 111.093 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.478 ' O ' HG13 ' A' ' 178' ' ' ILE . 67.3 t -64.07 -42.91 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.944 -178.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -62.14 -36.84 83.03 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.028 0.531 . . . . 0.0 111.634 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -66.29 -43.99 84.77 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 175.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -59.33 -44.69 92.58 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.232 1.013 . . . . 0.0 111.719 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 174' ' ' VAL . 51.3 mt -70.38 -35.99 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.27 0.628 . . . . 0.0 109.661 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.96 -27.17 73.31 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 116.22 -0.445 . . . . 0.0 113.723 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 45.5 t -75.2 -47.03 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.499 0.72 . . . . 0.0 110.614 175.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 30.0 tp -60.89 -52.76 63.66 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 123.748 0.655 . . . . 0.0 110.573 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.43 HG23 HG11 ' A' ' 192' ' ' VAL . 65.3 mt -65.85 -46.8 87.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.77 0.828 . . . . 0.0 111.149 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -58.13 -34.48 73.35 Favored Glycine 0 C--N 1.345 1.075 0 O-C-N 123.599 0.562 . . . . 0.0 113.396 177.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.5 -47.04 92.35 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 172.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.533 HD22 HD12 ' A' ' 128' ' ' ILE . 93.8 mt -64.54 -29.25 70.28 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.787 1.235 . . . . 0.0 111.92 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -69.68 -41.55 75.29 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.519 0.728 . . . . 0.0 110.493 177.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 20.6 mtm180 -74.53 -26.88 60.26 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.891 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.527 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 16.0 m120 -71.99 -20.07 61.78 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.237 0.615 . . . . 0.0 111.152 172.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 65.66 66.3 0.52 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.528 1.131 . . . . 0.0 110.831 -173.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 11.6 p30 -136.57 158.26 44.86 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.156 168.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 86.2 m -83.65 105.93 14.96 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.616 0.766 . . . . 0.0 110.588 -170.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.43 HG11 HG23 ' A' ' 182' ' ' ILE . 33.0 m -83.18 145.41 8.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 C-N-CA 123.153 0.581 . . . . 0.0 110.308 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -146.16 125.13 12.76 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 170.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 3.0 t -93.46 149.16 4.37 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -177.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 43.0 t -59.7 141.45 55.1 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.736 0.414 . . . . 0.0 110.235 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -52.61 -38.66 60.59 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.06 0.944 . . . . 0.0 111.443 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 68.6 p -67.54 -49.73 61.92 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.331 1.052 . . . . 0.0 110.647 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.485 HD21 ' HB3' ' A' ' 132' ' ' ALA . 71.5 mt -59.67 -34.81 73.33 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.714 0.805 . . . . 0.0 110.922 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.592 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 53.3 mt-30 -63.65 -54.53 34.26 Favored 'General case' 0 C--N 1.348 0.543 0 O-C-N 123.88 0.737 . . . . 0.0 110.974 178.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.39 -12.81 53.77 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -172.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -96.0 -40.43 9.27 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 118.058 0.39 . . . . 0.0 111.764 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.626 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -121.82 -61.49 1.5 Allowed 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -172.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.592 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 60.3 t-105 . . . . . 0 N--CA 1.484 1.226 0 C-N-CA 124.378 1.071 . . . . 0.0 112.323 -164.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 45.0 ttm180 . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 120.97 0.414 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -96.85 111.05 23.41 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 170.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 133' ' ' ASN . 48.2 mm -83.05 117.69 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 170.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 37.7 p -113.5 88.49 2.85 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.017 0.927 . . . . 0.0 109.06 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -68.81 -31.06 69.78 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.456 177.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -121.31 142.88 49.53 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.816 0.847 . . . . 0.0 108.934 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 68.5 p -78.96 163.07 25.53 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.767 0.318 . . . . 0.0 110.297 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.46 -31.42 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.291 0 C-N-CA 124.863 1.265 . . . . 0.0 111.995 -176.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -54.34 -69.58 0.12 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.269 1.027 . . . . 0.0 112.363 178.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.9 pm0 -69.02 -25.19 64.37 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.007 0.523 . . . . 0.0 111.758 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.442 HD12 ' ND2' ' A' ' 133' ' ' ASN . 6.4 tt -59.67 -48.79 80.27 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.479 0.712 . . . . 0.0 109.386 176.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.8 t -106.77 19.24 20.76 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.203 0.601 . . . . 0.0 111.202 -175.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -77.58 140.59 39.71 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.689 0.796 . . . . 0.0 110.242 174.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -91.67 145.72 24.36 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.545 0.738 . . . . 0.0 110.459 174.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' TRP . . . . . 0.552 ' HH2' ' HG2' ' A' ' 118' ' ' ARG . 42.3 p-90 -158.41 179.77 8.83 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.929 1.292 . . . . 0.0 109.78 -172.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -139.72 158.36 44.23 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.333 0.653 . . . . 0.0 110.513 177.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.541 ' HE3' ' HA ' ' A' ' 107' ' ' PRO . 71.0 mtm -105.99 145.62 31.12 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.741 0.816 . . . . 0.0 109.334 171.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.9 tp -82.2 -40.15 22.11 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.189 0.596 . . . . 0.0 110.177 -175.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 19.7 mmt -122.68 88.74 49.95 Favored Pre-proline 0 N--CA 1.484 1.236 0 C-N-CA 124.562 1.145 . . . . 0.0 108.666 169.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.541 ' HA ' ' HE3' ' A' ' 104' ' ' MET . 17.4 Cg_exo -68.27 131.96 24.69 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.622 2.215 . . . . 0.0 113.307 -178.113 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -135.57 135.91 40.69 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.404 1.082 . . . . 0.0 108.372 171.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -112.82 124.15 51.93 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.11 0.564 . . . . 0.0 110.144 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -125.53 150.06 47.76 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 168.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 12.9 t -126.81 142.51 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 172.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -138.68 98.12 3.5 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 68.69 -127.25 22.56 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 119.351 -0.694 . . . . 0.0 112.162 -177.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -89.45 14.75 2.12 Favored 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 123.483 2.789 . . . . 0.0 112.803 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.494 HD23 ' HA ' ' A' ' 162' ' ' PRO . 93.9 mt -128.03 122.44 32.21 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.931 0.492 . . . . 0.0 110.096 -172.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 40.2 t -83.05 116.9 22.5 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.345 1.058 . . . . 0.0 109.702 177.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 10.4 mm -90.81 115.96 31.09 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 C-N-CA 123.777 0.831 . . . . 0.0 109.287 -177.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.552 ' HG2' ' HH2' ' A' ' 102' ' ' TRP . 7.9 tpt180 -94.7 118.53 31.88 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 43.9 mm -123.3 134.39 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.531 0.732 . . . . 0.0 109.509 -176.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -117.97 120.87 39.13 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.445 0.698 . . . . 0.0 109.153 174.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -82.98 -1.24 52.0 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.949 0.9 . . . . 0.0 112.893 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.13 -56.92 3.12 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 117.934 0.334 . . . . 0.0 111.455 -173.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.474 HG23 ' HG3' ' A' ' 126' ' ' LYS . 2.0 mp -70.14 104.07 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-O 121.938 0.875 . . . . 0.0 110.314 -175.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.9 mtt -126.56 159.42 33.53 Favored 'General case' 0 C--N 1.348 0.508 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.964 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.71 33.84 21.94 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.608 0.763 . . . . 0.0 112.294 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.474 ' HG3' HG23 ' A' ' 123' ' ' ILE . 74.1 mmtt -114.49 155.23 26.79 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.461 0.705 . . . . 0.0 110.594 176.113 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.455 ' HB2' ' HB3' ' A' ' 152' ' ' GLU . 2.7 m-20 -89.73 101.63 14.32 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 170.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.506 ' HB ' HG12 ' A' ' 192' ' ' VAL . 66.5 mt -101.77 139.73 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.535 0.734 . . . . 0.0 109.431 -172.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 14.2 tpt -123.0 127.03 48.24 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.822 0.849 . . . . 0.0 109.649 -175.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 22.8 mt -99.15 104.59 16.58 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -176.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.419 ' HB2' ' HE1' ' A' ' 150' ' ' PHE . 2.8 mtpm? -117.23 130.72 56.76 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -175.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -133.52 152.69 51.94 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 122.016 0.912 . . . . 0.0 112.782 -170.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.442 ' ND2' HD12 ' A' ' 98' ' ' LEU . 5.2 m-20 -108.22 125.35 51.55 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 168.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -155.48 159.09 39.51 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.297 0.639 . . . . 0.0 111.083 -172.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.508 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . 37.9 m -90.12 161.69 15.66 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.985 0.914 . . . . 0.0 110.94 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 70.9 t -139.88 130.81 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 124.263 1.025 . . . . 0.0 110.075 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.618 HG22 ' HG2' ' A' ' 142' ' ' GLU . 9.1 tp -146.89 144.7 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 170.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 57.55 24.69 10.66 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.622 0.769 . . . . 0.0 111.628 -178.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 63.4 30.36 15.46 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.824 1.25 . . . . 0.0 112.28 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -131.9 165.45 23.86 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.615 0.766 . . . . 0.0 109.458 171.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.482 HD13 ' HB2' ' A' ' 202' ' ' ALA . 9.8 tt -70.9 129.39 38.91 Favored 'General case' 0 CA--C 1.554 1.096 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.618 ' HG2' HG22 ' A' ' 137' ' ' ILE . 31.8 mt-10 -83.88 -67.52 0.79 Allowed 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.698 0.761 . . . . 0.0 109.736 173.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 27.6 m -144.85 138.75 27.24 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.9 -170.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.449 HD22 HG13 ' A' ' 174' ' ' VAL . 56.5 tp -84.2 112.36 20.2 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.077 0.551 . . . . 0.0 109.577 175.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.13 -51.42 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 174.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.406 HD21 ' NH2' ' A' ' 148' ' ' ARG . 35.2 tp -170.6 149.13 3.15 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.321 177.02 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.538 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 10.0 tt -124.0 150.97 44.24 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 172.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.489 ' HD3' HD13 ' A' ' 156' ' ' ILE . 32.5 ttm-85 -143.31 135.09 26.61 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 122.671 0.388 . . . . 0.0 110.265 -178.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.06 113.73 27.44 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.419 ' HE1' ' HB2' ' A' ' 131' ' ' LYS . 17.4 m-85 -103.62 166.0 10.69 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 57.6 p -93.98 -179.44 4.97 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 120.949 0.404 . . . . 0.0 110.125 166.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 127' ' ' ASN . 13.3 pt-20 -61.94 -26.64 68.31 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.343 1.057 . . . . 0.0 110.913 172.11 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -77.57 -29.42 52.08 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.854 1.262 . . . . 0.0 110.815 174.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 103.96 11.03 33.29 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.908 -178.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.32 124.35 27.38 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.143 0.577 . . . . 0.0 109.503 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.489 HD13 ' HD3' ' A' ' 148' ' ' ARG . 54.9 mt -75.47 107.18 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -178.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.6 m -117.21 4.01 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.303 1.041 . . . . 0.0 111.869 -173.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -168.45 172.34 42.94 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-N 116.509 -0.314 . . . . 0.0 112.453 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -166.78 153.58 8.84 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.738 0.815 . . . . 0.0 109.394 -175.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.584 HD11 ' HB2' ' A' ' 181' ' ' LEU . 40.3 mm -124.95 103.58 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 164.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 55.9 p -102.68 126.95 31.35 Favored Pre-proline 0 N--CA 1.474 0.733 0 C-N-CA 123.146 0.578 . . . . 0.0 110.545 -177.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.494 ' HA ' HD23 ' A' ' 115' ' ' LEU . 56.4 Cg_endo -67.3 150.01 81.21 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 122.163 1.908 . . . . 0.0 112.015 175.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 77.0 mt . . . . . 0 CA--C 1.543 0.686 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.547 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.445 ' CE1' HD21 ' A' ' 115' ' ' LEU . 27.2 p-80 . . . . . 0 N--CA 1.477 0.908 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 42.6 m -110.99 161.83 15.47 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.596 0.758 . . . . 0.0 110.315 -174.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' A' ' 141' ' ' LEU . 6.8 tt -45.94 -39.14 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.996 1.318 . . . . 0.0 112.498 173.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.594 ' HA ' ' NZ ' ' A' ' 175' ' ' LYS . 22.9 mm-40 -53.41 -48.87 68.32 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.262 1.025 . . . . 0.0 112.085 -176.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -61.11 -40.24 93.01 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 124.653 1.221 . . . . 0.0 110.813 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.449 HG13 HD22 ' A' ' 144' ' ' LEU . 41.1 t -66.8 -40.13 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.242 -175.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.594 ' NZ ' ' HA ' ' A' ' 172' ' ' GLU . 25.9 mtmm -60.39 -42.02 95.01 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 120.984 0.421 . . . . 0.0 110.009 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.498 ' O ' HG23 ' A' ' 180' ' ' VAL . 23.3 m-80 -62.92 -48.51 78.64 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.653 175.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -59.68 -48.01 83.36 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.997 0.811 . . . . 0.0 112.616 -173.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.8 mt -63.57 -37.8 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.283 175.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.44 -30.82 77.22 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 115.578 -0.737 . . . . 0.0 114.432 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 176' ' ' ASN . 44.9 t -76.03 -43.15 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 117.79 0.795 . . . . 0.0 108.994 176.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.584 ' HB2' HD11 ' A' ' 160' ' ' ILE . 37.8 tp -53.38 -53.19 54.75 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.339 176.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.423 HD12 ' CH2' ' A' ' 203' ' ' TRP . 43.1 mt -64.1 -39.76 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.898 0.879 . . . . 0.0 110.716 174.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -53.12 -35.56 49.62 Favored Glycine 0 CA--C 1.533 1.214 0 O-C-N 123.466 0.478 . . . . 0.0 114.088 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -83.43 -39.45 9.8 Favored Glycine 0 C--N 1.348 1.235 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 175.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 46.1 mt -66.21 -31.67 72.65 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.168 0.987 . . . . 0.0 112.437 -176.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -69.57 -33.58 72.94 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.743 0.417 . . . . 0.0 110.329 176.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -71.32 -32.83 69.07 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.181 176.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -63.31 -16.99 62.04 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.141 0.576 . . . . 0.0 111.767 171.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 63.5 65.78 0.73 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.976 0.91 . . . . 0.0 110.136 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.411 ' HB2' ' H ' ' A' ' 126' ' ' LYS . 4.0 p30 -141.0 175.9 9.24 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.069 176.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 90.9 m -109.91 101.91 10.71 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.106 0.563 . . . . 0.0 109.582 -173.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.506 HG12 ' HB ' ' A' ' 128' ' ' ILE . 12.7 m -99.82 153.87 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 121.535 0.683 . . . . 0.0 111.357 -177.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -136.56 143.91 43.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.174 -1.375 . . . . 0.0 108.305 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 3.3 t -111.06 145.88 16.79 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 47.4 m -57.93 140.66 51.62 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 118.014 0.37 . . . . 0.0 111.043 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -57.94 -29.91 65.53 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.291 0.636 . . . . 0.0 110.802 177.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 41.3 p -67.98 -52.64 33.52 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.784 0.834 . . . . 0.0 109.561 176.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 32.5 mt -54.58 -38.29 66.52 Favored 'General case' 0 C--O 1.208 -1.106 0 C-N-CA 123.871 0.868 . . . . 0.0 111.057 176.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.652 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 56.2 mt-30 -71.14 -39.74 71.8 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.258 0.623 . . . . 0.0 111.962 -176.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.29 -12.03 44.74 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -177.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -101.59 -42.53 6.19 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 178.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.482 ' HB2' HD13 ' A' ' 141' ' ' LEU . . . -123.42 -61.58 1.39 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.159 0.584 . . . . 0.0 112.243 -172.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.652 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 52.6 t-105 . . . . . 0 N--CA 1.475 0.804 0 C-N-CA 124.841 1.257 . . . . 0.0 111.084 -171.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.475 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 22.4 ttm-85 . . . . . 0 N--CA 1.471 0.6 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -92.76 101.97 14.36 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.942 0.897 . . . . 0.0 108.68 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.7 mm -78.96 114.33 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.491 0.716 . . . . 0.0 109.979 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.7 p -100.2 67.4 1.37 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 122.424 1.107 . . . . 0.0 108.752 174.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.455 ' HB3' ' O ' ' A' ' 132' ' ' ALA . 11.4 t70 -83.37 -33.31 25.84 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.76 -176.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 34.4 ttp -99.46 131.36 45.52 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 170.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.8 m -70.63 153.15 43.14 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 120.81 0.338 . . . . 0.0 110.4 177.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.43 -34.8 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.561 1.144 . . . . 0.0 110.406 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -54.44 -41.4 69.37 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.882 0.873 . . . . 0.0 111.627 174.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -80.69 -41.95 22.83 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.646 0.778 . . . . 0.0 110.451 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.572 ' HG ' HD23 ' A' ' 146' ' ' LEU . 10.4 tt -58.58 -46.65 86.48 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.565 1.146 . . . . 0.0 110.556 -176.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.5 t -100.22 19.28 16.8 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.764 0.826 . . . . 0.0 110.986 -175.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -84.74 128.11 34.44 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.033 0.533 . . . . 0.0 110.186 176.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -91.84 149.03 21.79 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.842 0.857 . . . . 0.0 108.949 174.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 24.2 p-90 -159.58 162.49 35.33 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.91 0.884 . . . . 0.0 110.463 -169.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -113.38 152.38 30.08 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.268 0.627 . . . . 0.0 109.974 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 66.2 mtp -104.79 123.2 47.25 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 175.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 42.7 tp -76.03 -40.28 53.8 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.502 0.721 . . . . 0.0 110.082 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 21.8 mmt -129.7 81.08 70.33 Favored Pre-proline 0 N--CA 1.482 1.173 0 C-N-CA 123.871 0.869 . . . . 0.0 108.926 171.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.81 113.39 3.19 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.7 2.266 . . . . 0.0 112.716 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.539 ' HB3' ' HB ' ' A' ' 119' ' ' ILE . 60.5 tttm -100.4 103.56 14.94 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 163.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.0 104.06 15.26 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -171.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.467 ' HG2' HG11 ' A' ' 180' ' ' VAL . 22.7 tptm -114.24 142.06 46.76 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.638 0.775 . . . . 0.0 109.451 177.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 97.6 t -125.82 126.4 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 170.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -115.06 83.96 2.0 Allowed 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 62.11 -114.95 7.3 Favored Glycine 0 CA--C 1.539 1.558 0 CA-C-N 114.875 -1.057 . . . . 0.0 113.468 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -84.93 5.93 5.99 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 123.702 2.935 . . . . 0.0 113.546 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 162' ' ' PRO . 35.2 mt -133.93 111.91 10.82 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -173.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 44.5 t -84.19 127.96 34.26 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.201 0.6 . . . . 0.0 110.063 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.5 mm -102.91 137.22 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.353 0.661 . . . . 0.0 110.126 -174.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.508 ' HG3' ' HB3' ' A' ' 159' ' ' GLU . 29.1 mmt180 -107.56 116.83 32.65 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 173.022 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.539 ' HB ' ' HB3' ' A' ' 108' ' ' LYS . 43.3 mm -113.87 120.01 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 172.119 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -103.01 116.29 32.24 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 174.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -75.75 -22.15 56.77 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.066 0.947 . . . . 0.0 111.848 -174.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.27 -46.99 37.88 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.062 0.545 . . . . 0.0 111.477 -175.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.499 HG21 HG11 ' A' ' 157' ' ' VAL . 1.9 mp -71.25 108.52 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-O 121.928 0.87 . . . . 0.0 110.08 -177.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.475 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 45.9 mtt -130.56 160.67 33.47 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.415 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.4 t70 63.73 38.6 9.16 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 124.338 1.055 . . . . 0.0 112.126 172.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -123.61 151.38 43.05 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.266 0.626 . . . . 0.0 110.774 177.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -85.03 103.05 13.71 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 169.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.527 HD13 HG21 ' A' ' 157' ' ' VAL . 48.0 mt -107.64 129.97 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.65 0.738 . . . . 0.0 110.515 -172.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.492 ' HG3' ' HG3' ' A' ' 131' ' ' LYS . 2.4 tpt -97.51 123.29 41.32 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 125.47 1.508 . . . . 0.0 109.644 -174.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.503 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 3.5 mm? -94.73 103.75 15.66 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.492 ' HG3' ' HG3' ' A' ' 129' ' ' MET . 62.5 mttm -124.44 153.32 42.12 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.054 0.542 . . . . 0.0 111.242 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.541 ' HB2' ' HG ' ' A' ' 147' ' ' LEU . . . -147.07 160.67 42.12 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.549 -176.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -112.13 131.63 55.34 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 163.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.4 ' HA ' HD13 ' A' ' 145' ' ' ILE . 28.0 p90 -160.25 154.7 23.7 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.752 0.658 . . . . 0.0 110.931 -172.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.7 t -86.11 153.67 21.92 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.375 1.07 . . . . 0.0 108.325 175.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 88' ' ' ARG . 79.6 t -134.88 139.73 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.516 0.726 . . . . 0.0 110.432 -175.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.9 tp -143.89 139.28 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 172.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 61.48 27.61 17.12 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 124.394 1.078 . . . . 0.0 112.354 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 61.14 29.96 19.11 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.669 1.187 . . . . 0.0 111.866 -177.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 7.5 ppt_? -135.3 158.22 44.91 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 173.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.6 tt -61.55 113.97 2.99 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.244 0.618 . . . . 0.0 110.288 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -75.28 -61.74 1.8 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.447 0.699 . . . . 0.0 110.462 176.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 40.5 m -147.09 129.03 15.41 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.516 0.726 . . . . 0.0 109.304 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.443 HD21 ' HB2' ' A' ' 147' ' ' LEU . 57.3 tp -78.11 120.6 23.15 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.894 0.878 . . . . 0.0 109.51 176.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 134' ' ' PHE . 1.8 mp -77.91 -47.54 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 175.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.572 HD23 ' HG ' ' A' ' 98' ' ' LEU . 55.2 tp -167.22 147.41 5.43 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.007 0.923 . . . . 0.0 109.079 175.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.738 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 6.6 tt -127.09 154.02 45.25 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 175.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.524 HH11 HG21 ' A' ' 156' ' ' ILE . 39.2 ttm-85 -150.58 143.82 24.89 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.094 0.558 . . . . 0.0 111.316 -171.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.403 ' HB2' HD21 ' A' ' 181' ' ' LEU . . . -117.27 111.84 19.94 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.765 1.226 . . . . 0.0 107.878 173.273 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.465 ' HZ ' ' HD2' ' A' ' 131' ' ' LYS . 46.5 p90 -131.55 142.58 49.95 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 72.3 p -62.95 169.4 3.31 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.524 0.729 . . . . 0.0 112.133 -177.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -51.9 -28.63 16.91 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.965 1.306 . . . . 0.0 112.317 174.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -84.18 -29.49 26.59 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.009 0.924 . . . . 0.0 111.313 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 114.03 8.37 17.77 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 116.482 -0.327 . . . . 0.0 113.593 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -79.92 114.29 18.73 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.524 HG21 HH11 ' A' ' 148' ' ' ARG . 23.9 mt -71.29 124.14 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 122.626 0.37 . . . . 0.0 110.188 -177.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.527 HG21 HD13 ' A' ' 128' ' ' ILE . 26.6 m -124.8 -5.67 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.243 1.017 . . . . 0.0 111.236 -176.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -158.97 164.96 34.0 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -178.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.508 ' HB3' ' HG3' ' A' ' 118' ' ' ARG . 26.2 tt0 -168.28 150.52 5.29 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.257 0.623 . . . . 0.0 109.346 -176.344 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.738 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 83.7 mt -121.75 104.13 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 168.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 35.3 t -96.08 107.96 38.1 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 123.933 0.893 . . . . 0.0 110.233 -177.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.426 ' HA ' HD23 ' A' ' 115' ' ' LEU . 51.5 Cg_exo -58.47 113.65 1.64 Allowed 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.526 2.151 . . . . 0.0 111.681 172.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 CA--C 1.542 0.65 0 C-N-CA 124.11 0.964 . . . . 0.0 111.377 -174.114 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 . . . . . 0 C--O 1.242 0.69 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 14.7 m -88.31 152.4 21.96 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 6.7 tt -59.12 -35.91 59.9 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 124.933 1.293 . . . . 0.0 112.029 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.22 -31.91 73.3 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.753 0.821 . . . . 0.0 110.413 177.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -83.6 -30.01 27.3 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.712 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.507 ' O ' HG13 ' A' ' 178' ' ' ILE . 79.5 t -62.14 -38.82 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 171.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -52.0 -43.23 63.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 124.079 0.862 . . . . 0.0 110.85 173.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.444 ' O ' HG23 ' A' ' 180' ' ' VAL . 9.1 m120 -66.18 -45.29 81.37 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.989 0.805 . . . . 0.0 109.996 -177.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.5 -46.38 88.71 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.751 0.82 . . . . 0.0 111.908 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 174' ' ' VAL . 40.8 mt -63.37 -36.33 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 177.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.49 -35.52 91.86 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 115.433 -0.803 . . . . 0.0 113.403 176.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.467 HG11 ' HG2' ' A' ' 110' ' ' LYS . 60.2 t -68.39 -48.88 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.59 HD22 HG13 ' A' ' 160' ' ' ILE . 24.4 tp -59.77 -50.37 74.08 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.256 -178.137 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 70.4 mt -62.11 -47.47 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.48 0.712 . . . . 0.0 110.757 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -58.51 -35.15 78.72 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 123.938 0.774 . . . . 0.0 114.128 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.477 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -69.37 -38.21 80.48 Favored Glycine 0 C--N 1.347 1.156 0 C-N-CA 122.947 0.308 . . . . 0.0 112.488 176.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.442 HD13 ' O ' ' A' ' 181' ' ' LEU . 8.9 mp -71.37 -32.58 68.66 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.679 0.792 . . . . 0.0 111.702 178.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -69.83 -38.24 76.46 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.1 0.56 . . . . 0.0 111.896 -177.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -79.02 -16.6 56.64 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.71 0.404 . . . . 0.0 111.406 177.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.475 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 7.0 m-20 -76.32 -11.49 59.91 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.062 0.545 . . . . 0.0 110.876 165.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 25.5 t70 65.43 59.87 0.77 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.483 1.113 . . . . 0.0 109.424 -176.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -110.57 151.29 27.79 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.349 169.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 49.9 m -83.43 102.67 12.22 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 171.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 35.4 m -88.3 140.79 15.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 123.701 0.8 . . . . 0.0 109.351 -175.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 24.7 ttm-85 -145.09 127.32 15.75 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.51 175.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.503 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 2.6 t -87.85 143.02 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 26.5 t -63.76 147.8 50.82 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 118.519 0.599 . . . . 0.0 111.035 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -54.19 -35.59 62.51 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.031 0.932 . . . . 0.0 111.591 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 60.9 p -65.38 -53.15 47.58 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.945 0.898 . . . . 0.0 110.029 176.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.445 HD21 ' HB3' ' A' ' 132' ' ' ALA . 73.9 mt -62.93 -26.41 68.8 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.261 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.556 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 49.2 mt-30 -75.48 -46.68 30.93 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.29 0.636 . . . . 0.0 110.702 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.21 -12.29 47.25 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -175.463 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -106.5 -45.3 4.29 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 122.932 0.493 . . . . 0.0 112.283 178.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -114.87 -36.24 4.54 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -164.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.556 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 72.5 t-105 . . . . . 0 N--CA 1.486 1.33 0 C-N-CA 123.826 0.851 . . . . 0.0 110.551 -167.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -123.91 105.83 9.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.597 0.759 . . . . 0.0 109.656 174.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 50.6 mm -79.91 139.86 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 174.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.8 p -137.64 93.05 2.75 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.555 0.742 . . . . 0.0 109.546 176.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -80.93 -21.06 40.77 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.157 0.583 . . . . 0.0 111.106 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -100.67 126.82 47.22 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 175.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.61 177.28 8.78 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.88 0.872 . . . . 0.0 109.295 173.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -63.43 -43.16 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 123.88 0.872 . . . . 0.0 112.116 -167.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -62.46 -49.17 76.46 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.997 0.519 . . . . 0.0 111.931 -178.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.656 ' HA ' ' HB2' ' A' ' 100' ' ' ARG . 14.7 pt-20 -74.85 -19.82 60.01 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 123.475 0.485 . . . . 0.0 111.469 -178.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.8 tp -68.2 -32.3 72.43 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.29 1.036 . . . . 0.0 110.212 172.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.2 t -117.07 18.25 14.66 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.417 1.087 . . . . 0.0 110.849 -178.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.656 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 26.5 tpt180 -66.79 142.88 57.21 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.749 0.419 . . . . 0.0 112.107 -174.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -77.62 121.16 23.57 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.741 174.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 6.3 p-90 -140.12 149.25 42.82 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.402 1.081 . . . . 0.0 109.933 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -134.16 135.51 43.15 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.922 0.889 . . . . 0.0 109.179 178.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 92.1 mtp -101.69 112.45 25.03 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.63 0.772 . . . . 0.0 109.324 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 45.4 tp -65.93 -39.12 90.22 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.675 0.79 . . . . 0.0 110.206 -178.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 11.3 mmt -124.25 86.41 54.53 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 124.322 1.049 . . . . 0.0 108.407 173.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.37 131.36 24.64 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.253 1.969 . . . . 0.0 111.663 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.502 ' HB3' ' HB ' ' A' ' 119' ' ' ILE . 60.4 tptt -131.75 119.96 22.04 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 173.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.423 ' NE2' ' HB2' ' A' ' 116' ' ' CYS . 58.9 tp60 -108.63 106.06 15.95 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -176.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.51 97.96 5.9 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 123.677 0.791 . . . . 0.0 109.006 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.495 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . 55.9 t -78.75 124.79 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -122.45 94.33 4.26 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.8 -127.11 30.48 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.259 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -86.07 21.32 1.09 Allowed 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 123.054 2.503 . . . . 0.0 112.615 175.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.591 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 4.3 mp -129.63 167.57 17.77 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.973 0.909 . . . . 0.0 109.002 174.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 20.3 p -140.23 130.74 25.49 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 176.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 17.6 mm -105.83 132.63 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.285 1.034 . . . . 0.0 109.87 -170.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 15.9 mmt85 -99.99 122.93 43.65 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.76 1.224 . . . . 0.0 108.917 172.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.502 ' HB ' ' HB3' ' A' ' 108' ' ' LYS . 42.5 mm -122.69 121.59 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 172.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -95.5 111.83 23.66 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 168.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -78.86 -3.43 44.59 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.254 -174.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.3 -27.81 20.29 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.138 0.575 . . . . 0.0 110.505 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.408 HG21 HG11 ' A' ' 157' ' ' VAL . 39.5 mm -79.49 101.69 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-O 121.667 0.746 . . . . 0.0 111.145 -172.293 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.471 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 36.4 mtt -129.48 147.11 51.26 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.898 -174.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.0 t70 62.23 42.11 9.79 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.128 0.971 . . . . 0.0 111.765 175.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -119.76 147.91 44.06 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.195 0.998 . . . . 0.0 110.371 176.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.439 ' HA ' ' HB ' ' A' ' 191' ' ' THR . 44.2 m-80 -83.56 110.0 17.87 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 171.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 61.6 mt -117.54 134.13 62.12 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 123.382 0.673 . . . . 0.0 111.23 -171.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 37.7 tpp -111.59 125.61 54.12 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.513 1.925 . . . . 0.0 108.763 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.472 ' HB3' HD21 ' A' ' 147' ' ' LEU . 18.5 mt -97.23 102.59 14.39 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -98.5 149.18 22.99 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.667 0.787 . . . . 0.0 109.365 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -142.56 144.44 32.9 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 122.239 1.018 . . . . 0.0 113.723 175.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -99.52 122.51 42.69 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 163.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.537 ' HB3' HD12 ' A' ' 144' ' ' LEU . 49.7 p90 -153.15 159.78 42.77 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.268 0.556 . . . . 0.0 111.763 -175.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.7 t -90.94 156.36 18.04 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.982 177.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 72.0 t -130.72 136.03 59.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.906 1.282 . . . . 0.0 108.575 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.3 tp -145.19 144.09 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 170.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 62.39 24.18 14.38 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.661 0.785 . . . . 0.0 111.348 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.5 t70 71.03 5.46 5.49 Favored 'General case' 0 CA--C 1.564 1.511 0 C-N-CA 124.931 1.292 . . . . 0.0 111.954 -176.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -114.58 172.2 7.17 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.343 -0.848 . . . . 0.0 109.78 176.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.599 ' HB2' ' HB3' ' A' ' 201' ' ' PHE . 6.8 tt -69.39 125.49 26.84 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -83.7 -66.61 0.87 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.299 0.64 . . . . 0.0 110.247 177.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 65.9 m -149.88 131.12 14.56 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.808 1.243 . . . . 0.0 108.49 -173.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.537 HD12 ' HB3' ' A' ' 134' ' ' PHE . 44.7 tp -71.96 131.91 43.58 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 175.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.38 -50.06 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 172.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 54.4 tp -164.95 151.25 10.29 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.016 0.926 . . . . 0.0 109.358 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.709 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 7.2 tt -136.62 145.82 45.32 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 172.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.504 ' HE ' HD13 ' A' ' 156' ' ' ILE . 17.5 mtp180 -141.32 144.23 34.48 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.697 0.799 . . . . 0.0 109.599 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.11 111.86 24.77 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.399 1.08 . . . . 0.0 108.927 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.413 ' CE1' ' HB2' ' A' ' 148' ' ' ARG . 65.0 m-85 -106.6 137.2 45.04 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.191 0.996 . . . . 0.0 109.207 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 47.2 p -76.01 -179.9 5.2 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-O 121.286 0.565 . . . . 0.0 110.142 172.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -61.71 -20.44 63.49 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.515 0.726 . . . . 0.0 111.048 169.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -88.51 -1.75 58.22 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.962 1.305 . . . . 0.0 111.604 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 74.33 15.08 80.34 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-N 116.448 -0.342 . . . . 0.0 112.971 -178.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -86.01 125.0 33.08 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.426 0.69 . . . . 0.0 109.852 -176.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.504 HD13 ' HE ' ' A' ' 148' ' ' ARG . 22.6 mt -78.84 100.99 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -177.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.408 HG11 HG21 ' A' ' 123' ' ' ILE . 33.2 m -105.36 -0.16 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.138 0.975 . . . . 0.0 111.433 -173.096 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -162.96 167.07 37.19 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.329 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -163.47 153.36 15.28 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.709 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 63.1 mt -128.88 102.92 8.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 170.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.405 ' HA ' ' HD2' ' A' ' 162' ' ' PRO . 3.1 p -112.83 110.05 52.28 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 123.901 0.881 . . . . 0.0 109.605 -177.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.591 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 20.7 Cg_endo -60.04 127.85 24.62 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.641 2.227 . . . . 0.0 111.515 171.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.1 mt . . . . . 0 CA--C 1.55 0.943 0 C-N-CA 123.812 0.845 . . . . 0.0 110.366 177.195 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 . . . . . 0 CA--C 1.541 0.631 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 35.8 p -126.91 171.08 11.59 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.022 0.929 . . . . 0.0 110.36 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.46 ' O ' ' HG3' ' A' ' 175' ' ' LYS . 15.1 tt -50.69 -37.14 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.406 170.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -52.32 -51.29 59.53 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.338 1.455 . . . . 0.0 111.019 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -59.33 -41.1 88.34 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.949 0.9 . . . . 0.0 111.851 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.468 ' O ' HG13 ' A' ' 178' ' ' ILE . 25.9 t -64.07 -40.72 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 O-C-N 124.117 0.885 . . . . 0.0 110.52 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 171' ' ' ILE . 56.5 mtpt -61.66 -42.52 99.02 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.746 0.818 . . . . 0.0 111.165 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.47 ' O ' HG23 ' A' ' 180' ' ' VAL . 24.4 m120 -66.68 -43.24 84.97 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 123.591 0.557 . . . . 0.0 109.645 176.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -60.9 -45.08 96.03 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 124.584 1.177 . . . . 0.0 112.279 -175.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 174' ' ' VAL . 25.8 mt -69.27 -32.83 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.96 -30.64 78.31 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.433 174.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 176' ' ' ASN . 61.3 t -74.84 -51.08 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 122.813 0.445 . . . . 0.0 109.819 175.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.499 ' HA ' HD11 ' A' ' 119' ' ' ILE . 47.9 tp -54.18 -51.13 65.33 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 123.933 0.77 . . . . 0.0 111.26 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.491 ' O ' ' HG3' ' A' ' 186' ' ' GLU . 10.4 tt -62.27 -37.2 78.0 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.934 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.613 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -62.19 -42.53 99.72 Favored Glycine 0 C--N 1.351 1.366 0 O-C-N 123.287 0.367 . . . . 0.0 113.903 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -65.98 -35.85 91.23 Favored Glycine 0 C--N 1.348 1.208 0 O-C-N 123.843 0.378 . . . . 0.0 112.294 175.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 86.4 mt -68.33 -42.25 79.58 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.17 0.988 . . . . 0.0 111.49 177.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 182' ' ' ILE . 49.3 mt-10 -67.72 -38.41 83.53 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.494 0.718 . . . . 0.0 110.269 -176.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.11 -24.32 59.44 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.351 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.471 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 97.6 m-20 -68.93 -18.87 64.16 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 122.667 0.387 . . . . 0.0 111.059 170.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 35.9 t70 65.9 65.69 0.52 Allowed 'General case' 0 C--N 1.354 0.784 0 C-N-CA 124.116 0.967 . . . . 0.0 109.662 -174.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -131.14 169.09 16.38 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.694 173.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.439 ' HB ' ' HA ' ' A' ' 127' ' ' ASN . 89.5 m -84.17 114.72 22.0 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 30.0 m -97.52 136.37 28.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -145.04 128.09 16.56 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 176.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 4.8 t -103.07 150.58 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -175.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 45.8 t -60.91 141.07 57.51 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.86 -28.02 63.76 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.825 0.85 . . . . 0.0 112.249 -177.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 37.6 p -70.95 -45.25 64.48 Favored 'General case' 0 C--N 1.348 0.516 0 C-N-CA 123.544 0.738 . . . . 0.0 109.903 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 78.7 mt -65.1 -39.97 93.89 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.174 0.59 . . . . 0.0 110.52 176.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.647 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 52.5 mt-30 -60.06 -31.33 69.89 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.807 0.843 . . . . 0.0 111.101 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -83.87 -61.04 1.92 Allowed 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 123.887 0.875 . . . . 0.0 110.717 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.599 ' HB3' ' HB2' ' A' ' 141' ' ' LEU . 61.5 m-85 -71.44 -47.1 57.93 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.178 0.991 . . . . 0.0 112.84 -167.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.533 ' HB2' HD13 ' A' ' 141' ' ' LEU . . . -109.25 -58.15 2.07 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 122.944 0.497 . . . . 0.0 110.771 -170.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.647 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 40.4 t-105 . . . . . 0 N--CA 1.479 1.025 0 C-N-CA 124.751 1.221 . . . . 0.0 111.532 -175.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -90.2 108.99 20.09 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 174.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.0 mm -77.25 117.72 22.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 176.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.2 p -98.0 75.31 2.34 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -73.51 -32.02 64.03 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 113.726 -1.579 . . . . 0.0 109.966 -178.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.43 ' HB3' ' HB3' ' A' ' 131' ' ' LYS . 21.2 ptt? -109.74 138.67 45.77 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 165.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 66.7 p -65.3 157.32 29.39 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.726 0.41 . . . . 0.0 110.128 177.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.9 mp -58.07 -35.85 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -56.56 -60.3 3.73 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.092 1.357 . . . . 0.0 112.481 176.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.415 ' HG3' ' HB2' ' A' ' 93' ' ' MET . 11.9 pt-20 -70.71 -24.99 62.75 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 122.631 0.372 . . . . 0.0 111.18 -176.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.525 ' HA ' ' HE ' ' A' ' 148' ' ' ARG . 7.8 tt -65.36 -48.26 73.58 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.818 0.847 . . . . 0.0 109.622 172.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 90.5 p -84.3 -3.08 58.01 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.192 0.597 . . . . 0.0 112.389 -173.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.1 tpt85 -61.51 126.89 28.96 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.584 0.754 . . . . 0.0 110.915 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -82.42 155.07 24.86 Favored 'General case' 0 C--O 1.239 0.535 0 O-C-N 123.976 0.797 . . . . 0.0 109.801 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -161.3 169.05 22.85 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.65 0.78 . . . . 0.0 110.84 -173.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -125.89 151.82 46.38 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.201 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 72.9 mtp -109.86 105.05 14.1 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 171.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.9 tt -62.64 -44.1 97.12 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 80.4 mmm -119.58 88.37 38.8 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 123.904 0.882 . . . . 0.0 109.416 171.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.71 124.54 9.34 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.69 2.26 . . . . 0.0 112.355 -178.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -123.15 124.76 43.78 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.39 101.31 7.1 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -102.82 129.11 49.38 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.103 0.961 . . . . 0.0 108.815 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 72.7 t -86.76 133.8 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 173.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -128.36 85.3 2.32 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 62.31 -121.43 25.37 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.666 176.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.496 ' HB2' ' HB3' ' A' ' 169' ' ' HIS . 3.7 Cg_exo -78.92 8.48 3.75 Favored 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 123.728 2.952 . . . . 0.0 114.199 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 4.5 mp -133.62 163.5 29.28 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.375 0.67 . . . . 0.0 109.506 -178.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.486 ' SG ' ' HB2' ' A' ' 161' ' ' SER . 31.5 p -126.86 136.02 51.78 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 10.2 mm -110.43 124.91 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.304 1.042 . . . . 0.0 109.542 -169.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -108.65 121.99 46.18 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.428 1.091 . . . . 0.0 108.347 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.579 HD13 ' HA3' ' A' ' 184' ' ' GLY . 53.0 mt -131.29 121.92 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.437 ' HB3' ' HB ' ' A' ' 157' ' ' VAL . 23.8 t70 -94.49 115.28 27.42 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 175.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -81.22 -10.64 59.57 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.715 0.806 . . . . 0.0 112.016 -174.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.2 -41.68 63.53 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.266 0.626 . . . . 0.0 110.963 -176.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.6 mp -76.91 115.83 19.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.882 177.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 48.6 mtt -132.89 154.97 49.88 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.567 1.147 . . . . 0.0 110.102 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.7 t70 62.34 23.95 14.23 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.354 1.062 . . . . 0.0 112.105 176.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 190' ' ' ASN . 73.9 mmtt -105.76 149.95 25.98 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.202 0.601 . . . . 0.0 110.079 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.559 ' HB2' ' HG2' ' A' ' 152' ' ' GLU . 75.8 m-20 -83.06 106.56 14.97 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 173.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 80.5 mt -106.29 121.86 59.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 123.39 0.676 . . . . 0.0 110.147 -174.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 36.7 tpp -96.33 130.44 43.44 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.879 1.272 . . . . 0.0 109.322 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 19.2 mt -100.07 104.27 15.83 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 93' ' ' MET . 32.7 mmtp -98.8 155.4 17.38 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.998 0.919 . . . . 0.0 109.507 173.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.566 ' HB3' HD21 ' A' ' 198' ' ' LEU . . . -155.49 145.69 21.73 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 168.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -108.18 134.35 51.15 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 172.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.461 ' HA ' HD13 ' A' ' 145' ' ' ILE . 37.9 p90 -160.01 160.62 33.5 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.735 0.814 . . . . 0.0 110.589 -169.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 43.7 p -85.47 155.24 21.32 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.866 0.866 . . . . 0.0 108.81 171.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 91.0 t -116.5 154.05 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.959 0.904 . . . . 0.0 110.308 -177.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.474 ' O ' ' HG3' ' A' ' 140' ' ' ARG . 11.0 tp -156.09 134.44 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 164.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 58.14 24.76 11.66 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.961 0.904 . . . . 0.0 113.024 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.549 ' HB3' HH22 ' A' ' 200' ' ' ARG . 1.6 m-20 65.5 35.03 7.52 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.869 1.268 . . . . 0.0 111.832 -176.389 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 137' ' ' ILE . 7.6 ppt_? -136.24 162.93 31.61 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.679 0.792 . . . . 0.0 109.048 169.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.458 ' HB3' HG13 ' A' ' 171' ' ' ILE . 9.7 tt -68.14 110.05 3.81 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.658 0.783 . . . . 0.0 109.765 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -70.78 -64.87 0.82 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.893 0.877 . . . . 0.0 109.558 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 53.1 m -142.54 131.31 22.78 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.549 HD21 ' HB2' ' A' ' 147' ' ' LEU . 53.6 tp -73.07 129.22 37.6 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.391 0.676 . . . . 0.0 109.455 173.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.461 HD13 ' HA ' ' A' ' 134' ' ' PHE . 1.6 mp -84.9 -52.86 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 174.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 39.9 tp -162.04 148.6 13.63 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.028 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.688 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 8.9 tt -125.76 149.13 48.81 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 174.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.617 HH11 HG21 ' A' ' 156' ' ' ILE . 21.7 ttm-85 -141.93 139.75 32.61 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.025 0.93 . . . . 0.0 110.583 -176.032 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.492 ' HB3' ' HA3' ' A' ' 158' ' ' GLY . . . -123.87 122.46 38.05 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.487 1.115 . . . . 0.0 108.023 176.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -142.05 166.36 24.92 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.241 0.616 . . . . 0.0 110.861 -177.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 82.4 p -85.67 179.0 7.17 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.735 0.814 . . . . 0.0 110.301 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.559 ' HG2' ' HB2' ' A' ' 127' ' ' ASN . 24.3 mm-40 -63.44 -21.84 66.54 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 122.16 -0.338 . . . . 0.0 111.889 172.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -78.78 -13.7 59.67 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.014 0.525 . . . . 0.0 111.059 176.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 88.84 -2.72 84.51 Favored Glycine 0 C--N 1.349 1.254 0 N-CA-C 112.044 -0.422 . . . . 0.0 112.044 -173.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.92 108.18 2.93 Favored 'General case' 0 C--N 1.353 0.721 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -178.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.617 HG21 HH11 ' A' ' 148' ' ' ARG . 23.6 mt -77.91 128.43 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 O-C-N 123.56 0.538 . . . . 0.0 110.415 -170.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 120' ' ' ASP . 34.6 m -130.62 8.06 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 123.883 0.873 . . . . 0.0 111.228 -174.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.492 ' HA3' ' HB3' ' A' ' 149' ' ' ALA . . . -161.23 157.53 29.13 Favored Glycine 0 C--N 1.339 0.703 0 N-CA-C 111.856 -0.498 . . . . 0.0 111.856 -177.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -168.35 140.96 2.96 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.562 0.745 . . . . 0.0 109.765 -178.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.688 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 70.9 mt -123.7 112.66 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 175.198 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.486 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 20.3 m -112.53 118.32 45.51 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.094 0.958 . . . . 0.0 109.919 -177.016 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 38.8 Cg_exo -63.94 124.55 13.74 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 122.855 2.37 . . . . 0.0 112.59 176.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 CA--C 1.549 0.936 0 C-N-CA 124.343 1.057 . . . . 0.0 112.207 -177.121 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 114' ' ' PRO . 20.2 p-80 . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 76.5 p -84.27 160.44 20.75 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 173.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.505 HD11 ' HA ' ' A' ' 202' ' ' ALA . 9.4 tt -54.64 -32.96 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 123.215 0.606 . . . . 0.0 110.712 168.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.676 ' HA ' ' HE2' ' A' ' 175' ' ' LYS . 35.6 mt-10 -64.71 -33.47 76.03 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.108 -178.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -70.62 -33.16 70.71 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.408 0.683 . . . . 0.0 111.55 175.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 56.4 t -69.76 -36.04 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 122.493 0.317 . . . . 0.0 110.33 174.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.676 ' HE2' ' HA ' ' A' ' 172' ' ' GLU . 48.6 mtmt -62.3 -38.04 87.89 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 120.77 0.319 . . . . 0.0 110.389 175.104 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -64.02 -44.23 93.2 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.221 174.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.87 -51.09 68.34 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.742 -175.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 49.5 mt -64.46 -33.37 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.15 0.58 . . . . 0.0 109.821 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -59.4 -39.72 95.16 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-N 115.653 -0.703 . . . . 0.0 113.649 175.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 97.2 t -72.42 -44.02 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 122.767 0.427 . . . . 0.0 110.395 176.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.464 HD12 HG12 ' A' ' 119' ' ' ILE . 59.5 tp -52.59 -57.3 10.43 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.802 0.841 . . . . 0.0 111.309 177.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.592 HG23 HG21 ' A' ' 192' ' ' VAL . 50.6 mt -58.88 -45.27 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 O-C-N 124.013 0.821 . . . . 0.0 110.598 174.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -53.54 -38.13 57.6 Favored Glycine 0 C--N 1.346 1.122 0 O-C-N 123.949 0.78 . . . . 0.0 114.066 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.579 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -81.0 -28.81 44.12 Favored Glycine 0 C--N 1.348 1.195 0 N-CA-C 112.577 -0.209 . . . . 0.0 112.577 176.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 68.6 mt -71.83 -21.45 61.68 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.237 0.615 . . . . 0.0 110.715 174.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 19.5 mm-40 -68.76 -36.56 78.5 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.354 0.662 . . . . 0.0 110.853 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -76.97 -24.77 52.27 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 122.939 0.149 . . . . 0.0 110.824 176.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -63.95 -22.55 66.97 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.57 0.348 . . . . 0.0 110.437 167.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 13.4 t70 53.19 67.33 1.01 Allowed 'General case' 0 C--N 1.356 0.85 0 C-N-CA 124.893 1.277 . . . . 0.0 111.252 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 3.0 p-10 -124.5 -161.31 1.0 Allowed 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.825 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 31.9 m -120.07 101.49 7.88 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.592 HG21 HG23 ' A' ' 182' ' ' ILE . 26.7 m -93.28 147.28 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 121.145 0.497 . . . . 0.0 110.386 -177.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 40.1 ttt180 -142.22 132.96 25.54 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.13 172.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.463 HG22 HD11 ' A' ' 182' ' ' ILE . 3.2 t -90.41 134.26 29.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 N-CA-C 104.802 -2.295 . . . . 0.0 104.802 175.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 27.9 t -60.35 151.74 27.04 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.142 0.428 . . . . 0.0 111.654 -173.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -51.44 -40.15 58.8 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.755 1.222 . . . . 0.0 112.241 -175.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 75.8 p -68.82 -49.29 59.7 Favored 'General case' 0 C--N 1.345 0.393 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.566 HD21 ' HB3' ' A' ' 132' ' ' ALA . 41.1 mt -61.22 -29.96 70.14 Favored 'General case' 0 C--O 1.21 -0.976 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.151 -177.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.617 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 53.3 mt-30 -68.17 -57.03 6.69 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.487 0.715 . . . . 0.0 110.956 178.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.549 HH22 ' HB3' ' A' ' 139' ' ' ASP . 0.0 OUTLIER -72.75 -21.55 61.0 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -176.196 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -83.99 -59.79 2.3 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.13 0.572 . . . . 0.0 111.034 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.505 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -114.39 -60.66 1.86 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.255 0.622 . . . . 0.0 111.546 -165.041 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.617 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 67.8 t-105 . . . . . 0 N--CA 1.483 1.217 0 C-N-CA 124.479 1.112 . . . . 0.0 112.685 -168.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 . . . . . 0 N--CA 1.477 0.885 0 CA-C-O 120.517 0.198 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 19.3 m-85 -96.3 108.95 21.52 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.641 0.776 . . . . 0.0 109.166 175.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 50.0 mm -78.31 116.43 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 174.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 36.8 p -98.35 72.96 2.12 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.53 ' HB3' ' O ' ' A' ' 132' ' ' ALA . 31.0 t70 -72.8 -30.76 64.33 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.056 -174.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.565 ' SD ' ' HB3' ' A' ' 148' ' ' ARG . 59.5 mtm -98.12 151.15 20.69 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 166.017 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 64.6 p -69.93 158.84 34.84 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 173.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 69.1 mt -59.23 -31.39 46.01 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 173.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -57.87 -55.98 27.87 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.434 171.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -61.41 -38.67 87.94 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.012 0.525 . . . . 0.0 111.311 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.9 tt -63.89 -38.91 92.85 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.128 0.971 . . . . 0.0 109.378 -177.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.8 t -108.9 20.38 18.52 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 123.875 0.87 . . . . 0.0 111.066 -176.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.544 ' HD3' HD11 ' A' ' 156' ' ' ILE . 76.8 ttt180 -78.3 142.57 37.68 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.762 0.825 . . . . 0.0 111.696 -174.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -82.73 138.02 34.21 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.939 0.895 . . . . 0.0 110.524 176.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' TRP . . . . . 0.512 ' CZ3' ' SD ' ' A' ' 104' ' ' MET . 11.3 p-90 -157.33 160.28 38.36 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.842 1.257 . . . . 0.0 109.825 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -110.89 159.65 17.5 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.431 0.692 . . . . 0.0 111.693 -173.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.512 ' SD ' ' CZ3' ' A' ' 102' ' ' TRP . 99.2 mmm -120.65 93.06 3.91 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.237 1.015 . . . . 0.0 108.758 172.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.439 HD23 ' HB1' ' A' ' 122' ' ' ALA . 50.4 tp -71.8 -43.34 65.81 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.3 mmt -129.17 81.41 70.6 Favored Pre-proline 0 N--CA 1.479 1.002 0 C-N-CA 123.94 0.896 . . . . 0.0 109.353 175.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.75 145.56 46.46 Favored 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 122.104 1.869 . . . . 0.0 111.652 177.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -124.93 120.89 32.91 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 172.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -80.36 104.64 11.04 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.459 0.704 . . . . 0.0 109.624 -174.189 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -132.73 135.83 46.0 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.992 0.917 . . . . 0.0 109.467 172.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.2 t -125.4 142.79 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 166.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -123.34 91.6 3.51 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 176.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.37 -112.76 5.26 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.999 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -91.75 8.36 3.07 Favored 'Trans proline' 0 C--N 1.368 1.593 0 C-N-CA 123.27 2.647 . . . . 0.0 113.273 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 162' ' ' PRO . 61.4 mt -130.44 116.45 18.25 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.516 0.727 . . . . 0.0 109.656 -170.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 41.9 t -83.34 127.23 33.49 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.231 0.612 . . . . 0.0 110.256 -177.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.8 mm -106.94 110.03 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.232 0 C-N-CA 124.034 0.933 . . . . 0.0 110.58 -173.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -92.81 125.89 37.63 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.487 0.715 . . . . 0.0 109.858 173.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.574 HD13 ' HA3' ' A' ' 184' ' ' GLY . 73.2 mt -131.89 123.73 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.237 1.015 . . . . 0.0 108.561 176.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -99.49 120.76 40.14 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.44 0.696 . . . . 0.0 109.498 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.404 ' HA ' ' ND2' ' A' ' 188' ' ' ASN . 17.2 mt-30 -84.99 -14.96 45.82 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.619 1.168 . . . . 0.0 111.734 -174.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.439 ' HB1' HD23 ' A' ' 105' ' ' LEU . . . -68.57 -38.4 80.68 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.01 0.524 . . . . 0.0 111.106 -176.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.485 HG23 ' HG3' ' A' ' 126' ' ' LYS . 1.8 mp -87.07 112.79 23.63 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 CA-C-O 121.969 0.89 . . . . 0.0 109.7 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 48.0 mtt -129.23 159.5 35.9 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.859 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.8 t70 76.21 12.14 2.78 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 124.667 1.187 . . . . 0.0 112.365 172.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.485 ' HG3' HG23 ' A' ' 123' ' ' ILE . 75.1 mmtt -99.79 151.99 20.63 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.48 0.712 . . . . 0.0 111.976 -173.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -90.38 112.19 23.7 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 168.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.464 HD12 HD22 ' A' ' 185' ' ' LEU . 65.3 mt -114.01 135.23 54.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.965 0.888 . . . . 0.0 111.325 -171.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.536 ' HG3' ' HG3' ' A' ' 131' ' ' LYS . 8.0 tpt -102.81 121.65 42.92 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.203 1.801 . . . . 0.0 109.643 -172.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.46 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 3.7 mm? -96.25 104.75 16.73 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.536 ' HG3' ' HG3' ' A' ' 129' ' ' MET . 90.8 mttt -125.58 149.4 48.4 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.455 0.702 . . . . 0.0 110.497 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.616 ' HB3' HD21 ' A' ' 198' ' ' LEU . . . -149.37 152.99 36.72 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -174.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -102.77 128.44 49.5 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 169.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -154.97 155.44 34.22 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.544 0.738 . . . . 0.0 109.871 -170.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 58.1 p -87.48 169.58 12.09 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.246 0.618 . . . . 0.0 109.775 172.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 79.5 t -132.15 136.3 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 123.564 0.746 . . . . 0.0 110.595 -173.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 7.5 tp -146.18 139.6 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 169.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 60.94 33.11 19.93 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 124.195 0.998 . . . . 0.0 111.936 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.3 t70 65.75 18.66 11.22 Favored 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 125.341 1.456 . . . . 0.0 111.644 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -132.54 172.9 11.9 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.815 -0.553 . . . . 0.0 109.643 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.468 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 10.3 tt -64.63 126.77 28.94 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.198 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -88.99 -77.8 0.37 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.991 0.516 . . . . 0.0 109.951 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.1 m -125.64 137.62 53.88 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.773 0.829 . . . . 0.0 109.321 -173.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 50.3 tp -82.96 126.64 32.74 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 174.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.43 -51.7 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 172.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 50.9 tp -164.19 146.73 9.13 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.833 0.853 . . . . 0.0 109.121 177.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.723 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 8.0 tt -125.5 154.75 41.63 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.702 HH11 HG21 ' A' ' 156' ' ' ILE . 47.3 ttm-85 -150.18 138.75 20.66 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 123.131 0.573 . . . . 0.0 110.971 -173.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -115.57 115.58 26.68 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 175.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.408 ' HD1' ' HG2' ' A' ' 148' ' ' ARG . 31.6 p90 -136.08 145.98 46.53 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.543 0.737 . . . . 0.0 109.59 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 54.5 p -69.32 175.84 3.71 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.79 0.836 . . . . 0.0 111.01 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -54.69 -32.38 59.36 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.687 0.795 . . . . 0.0 111.617 172.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -70.98 -29.24 65.16 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.944 1.298 . . . . 0.0 110.801 179.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 100.05 8.57 50.55 Favored Glycine 0 C--N 1.345 1.064 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.565 -173.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -73.16 104.56 4.26 Favored 'General case' 0 C--N 1.352 0.713 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 177.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.702 HG21 HH11 ' A' ' 148' ' ' ARG . 24.1 mt -75.93 122.72 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -175.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.404 HG11 HG21 ' A' ' 123' ' ' ILE . 30.4 m -130.74 9.53 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.636 0.774 . . . . 0.0 111.065 -175.052 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -159.89 159.26 30.51 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.428 -178.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -165.67 150.99 8.92 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.353 0.661 . . . . 0.0 109.457 -177.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.723 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 71.0 mt -131.4 106.85 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 170.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 78.9 p -109.18 119.05 49.7 Favored Pre-proline 0 C--O 1.24 0.556 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.46 ' HA ' HD23 ' A' ' 115' ' ' LEU . 11.1 Cg_endo -55.48 134.78 65.88 Favored 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 122.254 1.969 . . . . 0.0 111.384 168.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 90.0 mt . . . . . 0 CA--C 1.546 0.803 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 175.303 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 57.9 p -82.48 173.15 12.26 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.64 0.376 . . . . 0.0 110.902 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.477 HD11 ' HA ' ' A' ' 202' ' ' ALA . 7.7 tt -51.67 -40.84 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.088 171.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -65.12 -36.57 84.68 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.842 0.857 . . . . 0.0 111.216 -173.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -62.74 -42.08 99.5 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 123.694 0.621 . . . . 0.0 110.604 174.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.526 ' O ' HG13 ' A' ' 178' ' ' ILE . 40.6 t -63.17 -41.9 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 123.829 0.706 . . . . 0.0 109.921 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 171' ' ' ILE . 57.7 mtpt -57.55 -42.69 83.47 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.815 0.846 . . . . 0.0 111.206 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.452 ' O ' HG23 ' A' ' 180' ' ' VAL . 63.0 m-80 -66.15 -47.44 74.05 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.993 0.517 . . . . 0.0 110.123 176.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.42 -42.28 86.9 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.462 1.101 . . . . 0.0 112.053 -175.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.526 HG13 ' O ' ' A' ' 174' ' ' VAL . 53.1 mt -60.75 -41.45 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 177.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -68.05 -26.68 73.94 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.66 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 176' ' ' ASN . 69.5 t -72.56 -50.06 37.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 123.414 0.686 . . . . 0.0 109.926 176.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 15.7 tp -59.41 -46.08 89.7 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.708 177.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.531 HD11 HG22 ' A' ' 194' ' ' VAL . 32.2 mt -56.76 -49.17 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.588 1.155 . . . . 0.0 111.299 174.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.43 ' O ' ' HG3' ' A' ' 187' ' ' ARG . . . -55.28 -42.14 81.63 Favored Glycine 0 C--N 1.343 0.923 0 O-C-N 124.149 0.905 . . . . 0.0 113.618 -178.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.574 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -71.29 -34.84 63.89 Favored Glycine 0 C--N 1.347 1.189 0 O-C-N 123.787 0.345 . . . . 0.0 113.084 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.464 HD22 HD12 ' A' ' 128' ' ' ILE . 95.0 mt -64.02 -40.74 97.0 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.372 0.669 . . . . 0.0 110.556 175.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -63.37 -35.34 80.08 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.607 0.763 . . . . 0.0 111.012 178.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 183' ' ' GLY . 83.0 mtp180 -64.99 -39.0 92.82 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.302 0.641 . . . . 0.0 110.451 175.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.404 ' ND2' ' HA ' ' A' ' 121' ' ' GLN . 5.7 m-20 -70.92 -3.92 21.79 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.987 0.915 . . . . 0.0 112.082 175.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.9 t70 65.95 46.39 2.24 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 122.646 1.212 . . . . 0.0 109.089 -176.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -111.08 138.37 47.59 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.088 177.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 26.6 m -79.79 114.02 18.39 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -177.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.412 HG21 HG23 ' A' ' 182' ' ' ILE . 27.3 m -92.65 139.01 18.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.612 -174.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -149.18 146.38 27.61 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.948 171.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.531 HG22 HD11 ' A' ' 182' ' ' ILE . 2.8 t -109.06 147.27 13.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 -175.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 27.2 t -61.0 152.3 28.24 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 118.158 0.435 . . . . 0.0 111.292 -174.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.37 -41.05 62.76 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 124.297 0.998 . . . . 0.0 110.988 179.083 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 57.9 p -70.49 -52.2 23.64 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.083 0.953 . . . . 0.0 110.01 178.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.616 HD21 ' HB3' ' A' ' 132' ' ' ALA . 34.9 mt -58.9 -29.68 67.22 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.751 0.82 . . . . 0.0 112.128 -176.042 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.572 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 47.5 mt-30 -72.09 -54.65 9.14 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.26 0.624 . . . . 0.0 110.554 177.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.81 -9.22 59.38 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -174.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -100.82 -50.46 3.84 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.008 0.523 . . . . 0.0 111.556 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.477 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -113.6 -62.47 1.59 Allowed 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -168.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.572 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 65.9 t-105 . . . . . 0 N--CA 1.481 1.08 0 C-N-CA 124.891 1.276 . . . . 0.0 111.246 -165.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.9 ttp180 . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -123.21 109.12 13.58 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.122 0.969 . . . . 0.0 109.322 173.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 36.1 mm -82.35 133.95 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 171.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 37.8 p -126.96 93.43 3.76 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.104 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -77.9 -25.88 48.76 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.73 177.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.659 ' SD ' ' HG2' ' A' ' 148' ' ' ARG . 40.1 mtm -104.83 129.16 53.18 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 124.199 0.999 . . . . 0.0 108.495 178.272 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 69.9 p -87.61 175.16 8.03 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 170.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 83.5 mt -56.43 -32.36 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 123.709 0.804 . . . . 0.0 111.116 -177.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 100' ' ' ARG . 39.4 mt-10 -48.76 -55.5 11.32 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.152 1.381 . . . . 0.0 113.547 177.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -95.66 -25.73 16.01 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 118.039 0.382 . . . . 0.0 111.009 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.5 tt -66.72 -49.49 65.85 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -176.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.7 m -95.63 16.25 17.76 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.824 0.849 . . . . 0.0 110.86 -177.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 96' ' ' GLU . 73.9 ttt180 -82.28 126.84 32.59 Favored 'General case' 0 C--N 1.35 0.604 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -80.43 128.17 33.26 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 169.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -137.18 164.82 27.57 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.261 0.624 . . . . 0.0 110.293 -174.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -134.84 149.99 50.42 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.286 0.634 . . . . 0.0 109.676 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 10.8 ptm -126.0 128.57 47.66 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.4 tp -69.88 -41.22 75.06 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.719 0.807 . . . . 0.0 111.316 -170.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.413 ' O ' ' HA ' ' A' ' 120' ' ' ASP . 4.0 mmt -116.67 88.1 23.66 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 123.792 0.837 . . . . 0.0 109.864 173.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -74.8 137.58 22.4 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.678 2.252 . . . . 0.0 113.201 -177.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -130.67 135.43 47.83 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.058 0.943 . . . . 0.0 108.469 166.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -121.82 123.75 42.51 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 173.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -144.24 121.53 11.59 Favored 'General case' 0 C--O 1.217 -0.623 0 C-N-CA 123.374 0.669 . . . . 0.0 109.241 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 97.1 t -79.23 137.67 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.029 0.531 . . . . 0.0 110.501 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -125.12 85.42 2.41 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 171.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.89 -119.42 6.41 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.279 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -89.74 16.73 1.69 Allowed 'Trans proline' 0 CA--C 1.552 1.411 0 C-N-CA 123.531 2.821 . . . . 0.0 113.044 177.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.52 HD23 ' HA ' ' A' ' 162' ' ' PRO . 96.1 mt -128.85 151.91 49.09 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.844 0.858 . . . . 0.0 109.965 -176.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 36.1 t -115.28 131.2 57.0 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.177 0.991 . . . . 0.0 108.897 177.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.4 mm -106.34 139.6 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.562 0.745 . . . . 0.0 109.219 -177.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -119.29 119.73 34.9 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 175.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.436 HD13 ' HA3' ' A' ' 184' ' ' GLY . 69.9 mt -126.05 124.08 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -178.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' A' ' 106' ' ' MET . 24.4 t70 -97.59 123.27 41.42 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.837 0.455 . . . . 0.0 110.24 174.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.46 ' HA ' HD21 ' A' ' 188' ' ' ASN . 77.6 mt-30 -88.35 -11.2 46.94 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.21 -50.32 14.81 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.156 0.503 . . . . 0.0 111.454 -174.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.8 mp -72.34 112.67 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.706 1.202 . . . . 0.0 109.523 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.2 mtt -130.3 162.71 28.4 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.481 1.112 . . . . 0.0 109.974 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 73.78 18.96 3.28 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 125.037 1.335 . . . . 0.0 112.915 176.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -111.43 149.58 31.05 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.449 0.7 . . . . 0.0 111.716 -173.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -87.99 102.78 15.07 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 171.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.489 HG12 HG22 ' A' ' 151' ' ' THR . 54.8 mt -106.56 131.14 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.003 0.521 . . . . 0.0 109.92 -173.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 14.7 tpt -106.08 127.1 52.95 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.209 1.004 . . . . 0.0 109.688 -172.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.453 HD12 HG22 ' A' ' 194' ' ' VAL . 25.7 mt -99.16 105.08 17.11 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -177.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -130.42 145.56 51.84 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.42 0.688 . . . . 0.0 111.13 -175.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.49 155.43 46.66 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -170.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -109.02 122.19 46.72 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 166.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -155.84 161.07 40.67 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.692 0.797 . . . . 0.0 110.546 -170.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.7 p -86.56 163.77 17.28 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.688 173.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 90.0 t -139.04 137.26 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.667 1.187 . . . . 0.0 109.109 -174.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.2 tp -152.04 144.17 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 172.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 57.99 26.5 13.54 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 124.248 1.019 . . . . 0.0 111.767 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 57.63 44.32 20.98 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.655 1.182 . . . . 0.0 111.345 -174.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -146.74 166.79 25.55 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.162 169.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.507 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 9.6 tt -64.21 123.55 19.38 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.042 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -79.38 -70.28 0.52 Allowed 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 175.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 99.8 m -143.71 135.4 26.27 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.064 0.946 . . . . 0.0 109.185 177.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.475 ' HB3' ' NE2' ' A' ' 169' ' ' HIS . 62.7 tp -77.98 126.67 31.18 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.828 0.851 . . . . 0.0 109.716 178.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.58 -49.96 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 174.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.425 HD21 ' NH2' ' A' ' 148' ' ' ARG . 51.0 tp -162.66 147.59 12.03 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.408 0.683 . . . . 0.0 109.664 -178.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.62 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 8.8 tt -138.88 154.67 48.41 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.659 ' HG2' ' SD ' ' A' ' 93' ' ' MET . 10.8 ptp180 -153.7 158.33 40.87 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.78 0.8 . . . . 0.0 111.738 173.037 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.528 ' HB2' HD21 ' A' ' 181' ' ' LEU . . . -111.29 116.1 30.43 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.294 1.438 . . . . 0.0 107.748 176.114 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.476 ' HD1' ' HG3' ' A' ' 148' ' ' ARG . 44.6 p90 -134.69 136.78 43.0 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.067 0.547 . . . . 0.0 110.333 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.489 HG22 HG12 ' A' ' 128' ' ' ILE . 52.7 p -63.96 177.49 0.77 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.484 1.114 . . . . 0.0 112.364 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -64.99 -17.55 64.52 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.479 0.712 . . . . 0.0 112.384 173.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -81.7 -24.04 36.44 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 122.819 0.448 . . . . 0.0 109.826 172.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 101.23 3.56 54.01 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.576 -175.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -68.7 103.38 1.72 Allowed 'General case' 0 C--N 1.352 0.717 0 C-N-CA 123.489 0.716 . . . . 0.0 109.776 -178.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.588 HD13 HH11 ' A' ' 148' ' ' ARG . 14.5 mt -73.14 116.72 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -178.213 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.3 m -123.08 3.48 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.167 0.987 . . . . 0.0 111.17 -176.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -154.84 161.69 30.42 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.609 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 38.8 tt0 -166.0 144.65 5.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 122.687 0.395 . . . . 0.0 110.267 -177.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.62 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 68.8 mt -126.77 116.38 44.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 173.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 19.3 m -126.4 141.52 40.23 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 123.465 0.706 . . . . 0.0 109.954 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.52 ' HA ' HD23 ' A' ' 115' ' ' LEU . 32.0 Cg_exo -58.87 147.22 90.21 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.672 2.248 . . . . 0.0 112.171 173.468 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 76.3 mt . . . . . 0 CA--C 1.546 0.804 0 C-N-CA 122.777 0.431 . . . . 0.0 110.454 179.559 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.475 ' NE2' ' HB3' ' A' ' 144' ' ' LEU . 51.6 p-80 . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 121.073 0.463 . . . . 0.0 110.484 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 14.8 m -107.95 162.92 13.58 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.284 1.033 . . . . 0.0 109.692 -177.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.589 HD11 ' HA ' ' A' ' 202' ' ' ALA . 14.9 tt -54.63 -35.08 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 125.743 1.617 . . . . 0.0 113.465 178.213 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -63.12 -29.43 70.79 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.377 0.671 . . . . 0.0 111.331 -176.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -71.6 -38.86 70.8 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.159 0.584 . . . . 0.0 110.295 175.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 44.7 t -67.4 -41.72 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 124.067 0.854 . . . . 0.0 111.373 -175.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -65.32 -33.58 76.31 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 122.949 0.155 . . . . 0.0 110.854 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -70.23 -39.91 74.79 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.911 0.484 . . . . 0.0 109.719 175.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.58 -47.59 80.87 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.338 1.055 . . . . 0.0 111.353 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 73.2 mt -63.44 -35.05 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.532 0.733 . . . . 0.0 109.477 176.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -60.77 -36.3 91.58 Favored Glycine 0 C--N 1.349 1.278 0 O-C-N 123.586 0.554 . . . . 0.0 113.986 176.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 98.8 t -72.04 -45.99 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.135 0.574 . . . . 0.0 110.015 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.528 HD21 ' HB2' ' A' ' 149' ' ' ALA . 41.0 tp -58.23 -45.2 88.14 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.725 0.81 . . . . 0.0 111.168 178.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.485 ' O ' ' HG2' ' A' ' 186' ' ' GLU . 49.0 mt -62.05 -50.86 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.996 0.918 . . . . 0.0 110.169 175.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.413 ' O ' ' HG2' ' A' ' 187' ' ' ARG . . . -53.69 -37.81 57.66 Favored Glycine 0 C--N 1.346 1.089 0 O-C-N 124.067 0.854 . . . . 0.0 113.964 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.436 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -71.64 -38.43 61.38 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 123.676 0.28 . . . . 0.0 112.937 175.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.473 HD22 HD12 ' A' ' 128' ' ' ILE . 95.0 mt -72.36 -21.75 61.26 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.427 0.691 . . . . 0.0 111.469 176.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 11.6 mm-40 -74.76 -32.48 62.08 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.291 0.636 . . . . 0.0 109.64 176.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 183' ' ' GLY . 17.8 mmt180 -63.55 -39.12 93.59 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.375 172.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.46 HD21 ' HA ' ' A' ' 121' ' ' GLN . 4.6 m-20 -75.47 -5.6 45.9 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.582 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 26.9 t70 63.6 21.86 12.9 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 123.977 0.911 . . . . 0.0 110.748 -177.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -80.95 138.15 36.11 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.129 0.972 . . . . 0.0 110.412 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 41.1 m -79.78 103.04 9.41 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.462 HG21 HG23 ' A' ' 182' ' ' ILE . 25.5 m -85.17 143.81 10.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.023 -177.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -143.87 127.32 16.88 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 168.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.453 HG22 HD12 ' A' ' 130' ' ' LEU . 7.8 t -88.27 146.53 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 27.7 t -57.32 144.32 36.33 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 118.429 0.558 . . . . 0.0 111.02 -176.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -55.76 -31.52 62.63 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.209 0.603 . . . . 0.0 111.11 -178.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 37.7 p -67.65 -57.53 6.24 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.808 172.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 56.3 mt -59.47 -25.32 64.31 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.07 0.948 . . . . 0.0 112.02 -174.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.615 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 57.1 mt-30 -74.63 -55.22 6.13 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.093 0.557 . . . . 0.0 110.242 178.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.82 -24.34 60.89 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 116.81 -0.177 . . . . 0.0 111.379 -174.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -84.56 -52.19 6.31 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.322 0.649 . . . . 0.0 110.764 177.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.589 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -114.64 -42.8 3.22 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -165.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.615 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 27.9 t-105 . . . . . 0 N--CA 1.488 1.437 0 C-N-CA 122.908 0.483 . . . . 0.0 111.972 -168.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 26.3 ttt . . . . . 0 N--CA 1.477 0.878 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.506 ' HG2' HD11 ' A' ' 137' ' ' ILE . 34.0 Cg_endo -63.96 151.47 85.09 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.287 1.991 . . . . 0.0 111.077 168.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.89 124.22 20.18 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.587 0.755 . . . . 0.0 111.239 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 55.8 p -88.31 126.63 35.28 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.451 0.7 . . . . 0.0 109.413 175.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.574 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 74.7 ttt180 -95.93 153.33 17.82 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.544 0.737 . . . . 0.0 109.21 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -121.96 121.17 36.47 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 175.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.429 HG22 ' HB2' ' A' ' 92' ' ' ASP . 49.0 mm -91.25 112.9 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.5 p -98.75 65.54 1.56 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 170.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 132' ' ' ALA . 27.5 t70 -67.61 -41.07 84.6 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 113.489 -1.687 . . . . 0.0 110.361 -177.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -109.84 151.02 27.55 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 173.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.5 m -86.82 154.23 21.05 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.593 0.357 . . . . 0.0 111.126 -170.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 49.8 mm -63.13 -35.91 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 123.157 0.583 . . . . 0.0 110.424 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -47.66 -46.64 29.27 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.859 1.264 . . . . 0.0 112.743 174.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.38 -20.11 20.02 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.204 -175.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.489 ' HG ' HD23 ' A' ' 146' ' ' LEU . 8.7 tt -69.03 -35.77 76.98 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.739 0.815 . . . . 0.0 109.812 174.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.8 m -97.84 12.01 35.38 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.84 0.856 . . . . 0.0 110.753 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -79.41 131.58 36.13 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.533 0.733 . . . . 0.0 109.868 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -81.47 140.64 34.48 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 38.4 p-90 -158.7 176.22 12.64 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.086 0.954 . . . . 0.0 109.044 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -151.88 166.68 30.69 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.636 0.775 . . . . 0.0 109.259 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 74.4 mtm -102.07 127.8 48.81 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.066 0.546 . . . . 0.0 109.788 170.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.518 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.2 pt? -78.31 -33.3 49.43 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.11 0.564 . . . . 0.0 110.638 178.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 23.5 mmt -120.0 80.7 26.65 Favored Pre-proline 0 N--CA 1.485 1.287 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 168.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -73.23 129.23 13.75 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.669 2.246 . . . . 0.0 112.579 -173.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -134.81 121.84 21.23 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 174.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -109.65 110.24 21.23 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -174.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.461 ' HG2' HG11 ' A' ' 180' ' ' VAL . 22.1 tptm -100.79 133.6 45.02 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 169.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.8 t -103.61 126.92 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 171.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -131.46 88.65 2.61 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.29 -124.16 13.1 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.315 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -91.07 13.55 2.11 Favored 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 123.113 2.542 . . . . 0.0 112.476 176.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.1 mt -128.83 114.84 17.04 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.695 0.798 . . . . 0.0 108.916 -171.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.638 ' SG ' ' HB2' ' A' ' 161' ' ' SER . 25.6 p -89.8 114.14 25.82 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.062 0.458 . . . . 0.0 110.364 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.416 ' HB ' ' HB3' ' A' ' 110' ' ' LYS . 12.0 mm -86.07 121.0 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 124.812 1.245 . . . . 0.0 110.607 -175.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -94.18 118.44 31.57 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 33.1 mm -118.26 121.84 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -102.41 114.33 28.43 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 169.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -71.01 -16.8 62.64 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -176.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.13 -26.04 25.43 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 118.169 0.441 . . . . 0.0 111.954 -174.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.555 HG13 ' HB ' ' A' ' 157' ' ' VAL . 29.2 mm -70.55 104.08 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 122.493 0.317 . . . . 0.0 110.46 -176.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 48.1 mtt -134.41 152.38 51.76 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.376 1.07 . . . . 0.0 109.702 -176.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.3 t70 71.89 7.84 5.92 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.608 1.163 . . . . 0.0 112.129 174.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -93.03 151.27 19.98 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.778 0.831 . . . . 0.0 110.532 -175.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -95.22 108.64 20.78 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 171.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.613 ' HB ' HG12 ' A' ' 192' ' ' VAL . 66.5 mt -115.52 149.15 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.405 0.682 . . . . 0.0 110.167 -170.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 55.8 tpp -125.31 134.36 52.28 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.149 0.979 . . . . 0.0 109.504 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -94.3 103.38 15.39 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.477 ' HG3' ' CE1' ' A' ' 150' ' ' PHE . 25.1 mmmt -114.52 149.94 35.66 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.62 1.168 . . . . 0.0 109.229 -173.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.536 ' HB2' ' HG ' ' A' ' 147' ' ' LEU . . . -153.49 144.12 22.57 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -104.92 133.68 49.31 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 167.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.481 ' HA ' HG13 ' A' ' 145' ' ' ILE . 28.4 p90 -162.16 164.19 28.02 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.182 0.515 . . . . 0.0 111.569 -172.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.1 t -88.53 157.4 18.63 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.614 172.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' A' ' 88' ' ' ARG . 74.1 t -136.31 140.01 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.303 1.041 . . . . 0.0 109.028 -174.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.506 HD11 ' HG2' ' A' ' 85' ' ' PRO . 7.9 tp -145.95 140.55 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 172.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 58.82 26.96 15.44 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.753 0.821 . . . . 0.0 112.34 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.0 t70 72.29 14.41 5.48 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.338 1.455 . . . . 0.0 111.895 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -123.54 160.71 26.42 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.12 0.568 . . . . 0.0 109.764 175.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.434 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 8.7 tt -62.87 119.04 8.61 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 177.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -82.67 -69.38 0.63 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.158 0.983 . . . . 0.0 109.135 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 93.8 m -137.17 129.71 30.01 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.647 0.779 . . . . 0.0 109.271 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.492 HD21 ' HB2' ' A' ' 147' ' ' LEU . 52.2 tp -73.13 123.51 23.74 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.641 0.776 . . . . 0.0 109.449 176.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.481 HG13 ' HA ' ' A' ' 134' ' ' PHE . 69.0 mt -83.79 -48.56 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.489 HD23 ' HG ' ' A' ' 98' ' ' LEU . 49.2 tp -161.98 149.57 14.42 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.899 0.88 . . . . 0.0 109.503 172.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.715 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 7.7 tt -126.52 142.74 51.44 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 172.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.559 HH11 HG21 ' A' ' 156' ' ' ILE . 46.6 ttm-85 -135.0 137.57 43.15 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.772 1.229 . . . . 0.0 110.53 -177.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.567 ' HB2' HD21 ' A' ' 181' ' ' LEU . . . -111.67 118.6 36.1 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 171.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.477 ' CE1' ' HG3' ' A' ' 131' ' ' LYS . 29.2 p90 -143.39 160.41 40.6 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 40.8 p -80.83 170.82 15.79 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.003 -174.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.27 -11.39 60.87 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 120.735 0.302 . . . . 0.0 111.11 171.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -71.03 -30.19 66.32 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.852 0.861 . . . . 0.0 110.066 168.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 106.6 -4.93 37.24 Favored Glycine 0 C--N 1.352 1.447 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.443 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -77.66 122.34 25.19 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.388 0.675 . . . . 0.0 110.493 -174.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.559 HG21 HH11 ' A' ' 148' ' ' ARG . 39.3 mt -76.53 103.99 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.212 0.605 . . . . 0.0 110.651 -175.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.555 ' HB ' HG13 ' A' ' 123' ' ' ILE . 27.2 m -99.27 -9.49 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 123.74 0.816 . . . . 0.0 112.061 -172.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -167.79 173.03 42.75 Favored Glycine 0 C--N 1.34 0.785 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 147' ' ' LEU . 37.5 tt0 -164.08 157.79 18.64 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.715 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 93.6 mt -123.53 103.87 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 167.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.638 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 2.7 m -93.7 109.47 41.41 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.563 -177.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -64.34 119.11 6.06 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.624 2.216 . . . . 0.0 111.307 172.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.472 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 94.7 mt -58.36 124.51 71.57 Favored Pre-proline 0 CA--C 1.545 0.751 0 O-C-N 124.051 0.844 . . . . 0.0 110.411 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 163' ' ' LEU . 16.8 Cg_exo -66.31 -24.18 50.81 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 123.397 2.732 . . . . 0.0 112.045 -172.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 77.7 p -74.05 -4.21 34.05 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.981 0.913 . . . . 0.0 111.809 177.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -123.96 81.39 56.51 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 124.251 1.02 . . . . 0.0 109.332 176.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -85.92 -6.05 8.65 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.329 2.019 . . . . 0.0 112.716 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -121.63 63.71 0.51 Allowed Glycine 0 C--N 1.344 0.984 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -175.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 16.0 p-80 -108.0 157.62 18.08 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 175.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 5.0 m -102.17 162.25 13.06 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.618 0.767 . . . . 0.0 110.199 -173.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.437 HD11 ' HA ' ' A' ' 202' ' ' ALA . 17.8 tt -56.78 -28.98 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 C-N-CA 124.95 1.3 . . . . 0.0 111.819 173.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -54.86 -42.79 72.44 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.721 1.208 . . . . 0.0 111.607 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.01 -44.0 90.64 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.809 0.844 . . . . 0.0 110.482 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.484 ' O ' HG13 ' A' ' 178' ' ' ILE . 50.9 t -65.58 -48.66 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.633 -172.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -58.15 -36.08 72.47 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.595 0.758 . . . . 0.0 111.757 -175.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.429 ' O ' HG23 ' A' ' 180' ' ' VAL . 16.2 m120 -74.02 -43.09 59.14 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.618 0.767 . . . . 0.0 110.142 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -59.56 -42.15 91.77 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.185 0.928 . . . . 0.0 111.562 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 174' ' ' VAL . 62.0 mt -57.71 -42.8 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 123.734 0.813 . . . . 0.0 109.171 177.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.66 ' HA3' ' HB2' ' A' ' 208' ' ' GLU . . . -76.9 -22.43 71.79 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-N 114.662 -1.154 . . . . 0.0 114.431 -175.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.461 HG11 ' HG2' ' A' ' 110' ' ' LYS . 97.6 t -73.5 -43.43 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 172.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.641 HD22 HG13 ' A' ' 160' ' ' ILE . 33.0 tp -58.97 -48.85 80.06 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.656 173.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.51 ' O ' ' HG2' ' A' ' 186' ' ' GLU . 70.0 mt -60.46 -44.66 96.81 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.997 0 C-N-CA 123.856 0.862 . . . . 0.0 110.61 176.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.449 ' O ' ' HG3' ' A' ' 187' ' ' ARG . . . -56.67 -39.31 85.89 Favored Glycine 0 C--N 1.342 0.869 0 O-C-N 123.512 0.508 . . . . 0.0 113.268 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -67.01 -41.21 93.3 Favored Glycine 0 C--N 1.353 1.489 0 N-CA-C 112.058 -0.417 . . . . 0.0 112.058 174.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 182' ' ' ILE . 76.9 mt -62.96 -34.32 77.26 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.012 0.925 . . . . 0.0 111.043 176.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 31.1 mm-40 -68.41 -42.63 78.71 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 123.922 0.889 . . . . 0.0 109.827 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 183' ' ' GLY . 74.0 mtp180 -60.35 -38.38 83.62 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.299 0.64 . . . . 0.0 110.65 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -72.72 -14.21 61.51 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.951 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 36.6 t70 64.12 67.22 0.6 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.977 0.911 . . . . 0.0 110.819 -177.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -104.63 -162.82 0.91 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 170.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.1 m -135.0 101.0 4.74 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 169.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.613 HG12 ' HB ' ' A' ' 128' ' ' ILE . 8.2 m -111.02 153.26 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 121.784 0.802 . . . . 0.0 111.02 -172.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 52.2 ttm-85 -139.58 142.23 37.14 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.032 -1.44 . . . . 0.0 107.895 174.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.41 HG22 HD11 ' A' ' 182' ' ' ILE . 3.4 t -88.14 145.65 7.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 34.3 t -57.68 144.32 38.3 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.581 0.352 . . . . 0.0 111.272 178.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -45.8 -37.78 6.45 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 124.429 1.081 . . . . 0.0 112.062 174.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 70.5 p -69.29 -55.54 10.18 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 123.525 0.73 . . . . 0.0 110.271 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.44 HD21 ' HB3' ' A' ' 132' ' ' ALA . 73.3 mt -62.17 -31.99 72.55 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.261 0.624 . . . . 0.0 111.413 -175.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.569 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 49.7 mt-30 -62.1 -50.38 72.15 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.496 0.718 . . . . 0.0 111.131 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.25 -20.11 35.13 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -175.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -87.38 -62.31 1.53 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.8 0.44 . . . . 0.0 111.285 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.437 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -111.05 -51.95 2.82 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.315 0.646 . . . . 0.0 111.679 -162.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.569 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 57.5 t-105 -61.38 -79.62 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.37 1.468 . . . . 0.0 110.675 -173.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 50.71 -125.68 23.43 Favored Glycine 0 C--N 1.35 1.353 0 C-N-CA 123.834 0.73 . . . . 0.0 114.847 171.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 30.4 t -74.53 -39.68 62.2 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.645 0.778 . . . . 0.0 110.126 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 27.5 p -86.21 75.43 9.87 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.527 0.731 . . . . 0.0 110.405 -177.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -110.52 135.45 51.16 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.055 -176.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.66 ' HB2' ' HA3' ' A' ' 179' ' ' GLY . 8.6 mm-40 -79.21 143.09 35.69 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.422 0.689 . . . . 0.0 109.639 175.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -145.92 148.89 33.29 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.055 0.542 . . . . 0.0 109.828 -176.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 132.83 145.82 5.49 Favored Glycine 0 C--N 1.344 1.002 0 O-C-N 123.281 0.363 . . . . 0.0 112.626 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.492 ' HB3' ' HB3' ' A' ' 186' ' ' GLU . 0.1 OUTLIER -147.53 101.85 3.74 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.817 0.847 . . . . 0.0 109.56 177.66 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -62.29 113.9 2.11 Favored 'Trans proline' 0 CA--C 1.555 1.535 0 C-N-CA 122.173 1.915 . . . . 0.0 110.552 165.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -61.05 133.02 44.75 Favored 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 122.308 2.005 . . . . 0.0 111.715 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.4 102.22 0.52 Allowed 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 18.9 p -74.45 155.5 37.96 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.34 1.056 . . . . 0.0 111.851 -174.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.5 pp -109.37 166.1 11.13 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.497 0.719 . . . . 0.0 110.163 177.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 . . . . . 0 C--O 1.251 1.163 0 C-N-CA 123.592 0.757 . . . . 0.0 109.302 -179.461 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.5 166.24 27.71 Favored 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.37 2.047 . . . . 0.0 111.537 176.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.13 115.27 7.42 Favored 'General case' 0 C--O 1.239 0.533 0 O-C-N 123.833 0.708 . . . . 0.0 109.949 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.9 p -60.73 106.74 0.6 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.262 1.025 . . . . 0.0 110.188 178.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.405 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 41.3 ttm180 -100.97 145.28 28.87 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -175.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -119.36 109.95 16.39 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.781 0.833 . . . . 0.0 108.928 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.8 mm -87.09 131.69 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 123.457 0.703 . . . . 0.0 109.413 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.492 ' HA ' HD22 ' A' ' 133' ' ' ASN . 50.9 p -118.48 81.06 1.62 Allowed 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 172.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -74.56 -27.45 60.51 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.606 -174.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.489 ' HB2' ' HG3' ' A' ' 97' ' ' GLU . 23.4 ptt? -102.89 134.14 46.81 Favored 'General case' 0 C--O 1.245 0.86 0 C-N-CA 123.361 0.664 . . . . 0.0 109.553 174.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.434 ' O ' ' HB2' ' A' ' 98' ' ' LEU . 9.8 t -81.84 171.72 14.17 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.337 0.655 . . . . 0.0 110.908 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -55.7 -43.02 71.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 126.024 1.73 . . . . 0.0 111.384 -176.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.44 ' O ' ' HB2' ' A' ' 100' ' ' ARG . 27.0 mm-40 -52.38 -40.64 62.3 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.126 0.97 . . . . 0.0 113.454 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.489 ' HG3' ' HB2' ' A' ' 93' ' ' MET . 12.7 pt-20 -97.73 -22.1 16.61 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.22 0.608 . . . . 0.0 111.291 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 94' ' ' THR . 2.2 tt -73.91 -59.93 2.49 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.634 0.773 . . . . 0.0 109.077 -176.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 39.7 m -80.67 -7.5 59.33 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.378 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 96' ' ' GLU . 9.2 tpm_? -58.81 122.33 13.31 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 123.416 0.687 . . . . 0.0 110.501 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -92.9 145.9 24.04 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 173.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.416 ' HE1' ' NH1' ' A' ' 148' ' ' ARG . 30.7 p-90 -154.16 178.65 9.75 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.828 0.851 . . . . 0.0 109.921 -166.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -136.84 151.17 48.82 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.093 0.957 . . . . 0.0 109.618 -177.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 65.6 mtp -93.17 95.16 9.23 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 172.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -57.14 -37.95 72.78 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.54 0.525 . . . . 0.0 111.312 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.604 ' HB3' ' HB2' ' A' ' 121' ' ' GLN . 8.7 mmt -124.77 97.06 39.41 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 168.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -82.82 127.06 4.71 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.965 2.444 . . . . 0.0 114.202 -170.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.534 ' HB3' ' HB ' ' A' ' 119' ' ' ILE . 87.5 tttt -123.19 116.29 23.17 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 162.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -106.91 111.59 24.16 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -176.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.445 ' HG2' HG11 ' A' ' 180' ' ' VAL . 50.5 tptt -117.12 135.83 53.46 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 124.858 1.263 . . . . 0.0 108.58 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.1 t -112.06 118.67 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 170.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -110.15 88.52 2.78 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.79 -115.96 7.77 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.343 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -85.49 -1.43 9.07 Favored 'Trans proline' 0 C--N 1.367 1.52 0 C-N-CA 122.898 2.398 . . . . 0.0 113.694 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.475 HD12 ' HB2' ' A' ' 177' ' ' ALA . 45.0 mt -116.23 152.07 34.5 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.187 0.595 . . . . 0.0 110.743 -171.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 37.9 t -106.55 110.79 23.09 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.234 1.014 . . . . 0.0 109.824 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.8 mm -95.92 142.5 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.803 0.841 . . . . 0.0 109.317 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -128.52 121.76 29.57 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.534 ' HB ' ' HB3' ' A' ' 108' ' ' LYS . 37.3 mm -116.8 127.18 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.43 1.092 . . . . 0.0 109.762 -176.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -79.55 141.02 37.02 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 170.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.604 ' HB2' ' HB3' ' A' ' 106' ' ' MET . 14.9 mt-30 -103.4 3.19 34.82 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.919 172.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -108.14 -46.41 3.75 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -170.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.439 HG13 HG12 ' A' ' 157' ' ' VAL . 30.1 mm -81.98 106.63 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 121.295 0.569 . . . . 0.0 109.99 -163.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 63.0 mtt -127.82 161.45 28.98 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.527 1.131 . . . . 0.0 109.76 -172.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 66.43 6.39 4.31 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 124.311 1.045 . . . . 0.0 112.822 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -103.91 153.61 20.59 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.594 0.757 . . . . 0.0 110.393 -171.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -88.14 107.62 18.86 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 172.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.621 HD13 HG21 ' A' ' 157' ' ' VAL . 47.5 mt -105.62 117.9 52.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.625 0.726 . . . . 0.0 109.251 -175.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 13.4 tpt -102.47 133.86 46.73 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.423 -173.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 15.2 mt -108.36 104.04 13.32 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -176.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.414 ' HA ' ' OG ' ' A' ' 195' ' ' SER . 68.2 mttm -116.7 149.78 39.27 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.329 0.652 . . . . 0.0 110.501 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -141.08 161.94 36.66 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 122.146 0.974 . . . . 0.0 113.02 -174.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.492 HD22 ' HA ' ' A' ' 91' ' ' THR . 8.8 m120 -108.47 133.24 52.9 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 160.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -160.53 160.85 32.4 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.254 0.55 . . . . 0.0 111.6 -177.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.0 m -87.82 154.72 20.32 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.428 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.405 ' HB ' ' HB3' ' A' ' 88' ' ' ARG . 79.4 t -128.7 131.35 68.63 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 C-N-CA 123.938 0.895 . . . . 0.0 109.427 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 6.7 tp -142.99 141.51 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 171.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 58.2 37.92 26.23 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.832 0.853 . . . . 0.0 112.115 176.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 63.18 16.62 9.54 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 125.036 1.335 . . . . 0.0 112.446 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 16.1 ptt-85 -132.6 167.22 20.42 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.15 0.58 . . . . 0.0 110.856 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.6 tt -67.81 115.85 7.82 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -78.21 -61.9 1.85 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 122.789 0.436 . . . . 0.0 110.468 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 97.3 m -147.2 125.89 12.58 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.569 0.748 . . . . 0.0 110.12 -171.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.444 HD11 ' HB2' ' A' ' 147' ' ' LEU . 47.9 tp -73.51 129.53 38.18 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.191 0.596 . . . . 0.0 109.784 176.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 85.3 mt -88.27 -51.05 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.699 0.8 . . . . 0.0 109.283 174.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 54.3 tp -162.23 148.06 13.02 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 175.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.609 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 7.7 tt -137.28 149.45 47.11 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 175.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.486 ' HD3' HD13 ' A' ' 156' ' ' ILE . 46.8 mtt-85 -133.87 145.52 49.74 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.491 0.717 . . . . 0.0 110.729 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.556 ' HB2' HD21 ' A' ' 181' ' ' LEU . . . -109.76 123.52 49.68 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 168.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.528 ' HB3' ' HA ' ' A' ' 156' ' ' ILE . 18.8 p90 -150.22 168.51 23.79 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.64 0.776 . . . . 0.0 110.186 -176.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 79.1 p -85.69 165.87 16.61 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 173.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.05 -9.46 39.5 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 120.691 0.282 . . . . 0.0 111.675 174.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -79.83 -23.7 41.85 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.018 1.327 . . . . 0.0 110.973 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 106.18 -1.48 37.84 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-N 115.637 -0.711 . . . . 0.0 113.003 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.24 106.9 6.1 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.216 0.606 . . . . 0.0 109.911 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.528 ' HA ' ' HB3' ' A' ' 150' ' ' PHE . 25.6 mt -77.46 118.51 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -177.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.621 HG21 HD13 ' A' ' 128' ' ' ILE . 18.9 m -106.89 -15.31 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 124.595 1.158 . . . . 0.0 111.994 -170.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -165.25 177.23 40.72 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 111.826 -0.51 . . . . 0.0 111.826 -172.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -166.17 153.94 10.28 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.739 0.416 . . . . 0.0 111.046 -173.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.609 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 67.9 mt -127.61 116.49 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 166.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 33.4 t -128.03 118.74 20.84 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.108 0.563 . . . . 0.0 109.898 -174.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -62.14 121.45 9.49 Favored 'Trans proline' 0 C--N 1.382 2.328 0 C-N-CA 122.798 2.332 . . . . 0.0 111.91 176.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.4 mt -72.19 128.29 89.22 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 122.862 0.465 . . . . 0.0 110.217 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -60.78 -15.92 40.82 Favored 'Trans proline' 0 C--N 1.382 2.297 0 C-N-CA 124.098 3.199 . . . . 0.0 114.513 -177.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 19.5 m -64.13 -17.09 63.13 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.245 0.618 . . . . 0.0 111.559 172.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -123.9 90.71 50.41 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -68.26 -32.07 27.44 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 122.62 2.213 . . . . 0.0 112.556 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -119.41 97.64 0.69 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -177.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -113.16 157.32 21.81 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.159 0.584 . . . . 0.0 109.684 172.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.0 m -107.27 161.86 14.41 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.269 1.027 . . . . 0.0 110.82 -169.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.603 HD11 ' HA ' ' A' ' 202' ' ' ALA . 14.8 tt -56.05 -29.99 28.06 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.308 0 C-N-CA 124.235 1.014 . . . . 0.0 112.307 172.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -56.21 -52.65 63.65 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.059 0.944 . . . . 0.0 111.835 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -73.63 -25.2 60.19 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.978 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 178' ' ' ILE . 63.4 t -65.78 -40.92 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 122.643 0.377 . . . . 0.0 110.185 172.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -72.1 -30.7 65.36 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.477 0.311 . . . . 0.0 111.005 178.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.441 ' O ' HG23 ' A' ' 180' ' ' VAL . 94.8 m-20 -62.79 -46.16 89.27 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 169.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.475 ' HB2' HD12 ' A' ' 115' ' ' LEU . . . -61.87 -48.21 81.53 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.766 1.226 . . . . 0.0 112.339 -174.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 174' ' ' VAL . 45.6 mt -68.32 -32.36 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -65.31 -38.74 95.39 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-N 116.086 -0.506 . . . . 0.0 113.364 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.445 HG11 ' HG2' ' A' ' 110' ' ' LYS . 95.8 t -72.45 -42.81 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.066 0.546 . . . . 0.0 109.847 177.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.556 HD21 ' HB2' ' A' ' 149' ' ' ALA . 35.4 tp -54.15 -55.97 22.69 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.027 0.931 . . . . 0.0 110.536 176.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.496 ' O ' ' HG2' ' A' ' 186' ' ' GLU . 24.7 mt -55.0 -45.27 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 124.152 0.907 . . . . 0.0 110.74 172.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -55.24 -41.86 80.45 Favored Glycine 0 CA--C 1.533 1.189 0 O-C-N 123.793 0.683 . . . . 0.0 114.268 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.35 -33.26 64.53 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-O 121.302 0.39 . . . . 0.0 112.134 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.428 ' HB3' ' OD1' ' A' ' 190' ' ' ASN . 88.9 mt -72.2 -28.82 63.44 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 124.618 1.167 . . . . 0.0 111.403 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 18.2 mm-40 -60.55 -38.45 84.56 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.703 0.801 . . . . 0.0 110.044 175.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 67.4 mtp85 -69.42 -30.83 68.86 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.24 -1.345 . . . . 0.0 110.821 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -83.09 4.81 24.76 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.516 0.727 . . . . 0.0 112.652 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 36.9 t70 59.33 26.96 15.92 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.986 0.898 . . . . 0.0 111.124 173.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.428 ' OD1' ' HB3' ' A' ' 185' ' ' LEU . 28.8 p30 -105.09 161.48 14.2 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -177.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 35.4 m -91.27 113.79 26.15 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.28 0.632 . . . . 0.0 109.827 -172.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.493 HG21 HG23 ' A' ' 182' ' ' ILE . 35.2 m -89.83 134.43 28.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-O 121.324 0.583 . . . . 0.0 109.986 -177.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -140.76 129.78 23.33 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.755 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 4.7 t -105.34 152.62 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.414 ' OG ' ' HA ' ' A' ' 131' ' ' LYS . 63.5 m -59.06 145.84 40.64 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 118.222 0.464 . . . . 0.0 111.037 176.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.411 ' O ' ' HG3' ' A' ' 200' ' ' ARG . 0.2 OUTLIER -69.26 -28.08 66.0 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.294 0.371 . . . . 0.0 110.222 -178.216 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 62.6 p -67.34 -50.15 61.12 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 171.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 33.6 mt -58.58 -30.61 67.32 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.464 0.705 . . . . 0.0 111.26 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.673 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 49.4 mt-30 -70.58 -55.18 9.43 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.161 0.585 . . . . 0.0 110.897 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 196' ' ' LYS . 0.0 OUTLIER -81.61 -11.78 58.99 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -173.213 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -97.37 -39.51 9.17 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.038 0.535 . . . . 0.0 111.13 175.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.603 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -121.67 -61.55 1.5 Allowed 'General case' 0 N--CA 1.479 0.993 0 O-C-N 122.15 -0.344 . . . . 0.0 111.287 -172.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.673 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 51.2 t-105 -74.29 79.15 1.83 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.584 1.153 . . . . 0.0 110.445 -165.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 177.7 -136.39 3.04 Favored Glycine 0 C--O 1.239 0.466 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 74.4 p -87.72 12.84 11.78 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.391 0.676 . . . . 0.0 112.117 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 23.4 m -74.36 89.25 2.09 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 123.455 0.702 . . . . 0.0 111.056 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -116.21 140.05 49.71 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.427 0.691 . . . . 0.0 110.397 178.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -96.39 129.18 43.8 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.044 0.938 . . . . 0.0 110.172 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -98.57 79.37 2.46 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.384 0.673 . . . . 0.0 109.189 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -94.8 122.24 7.1 Favored Glycine 0 C--N 1.34 0.792 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 42.6 ptt85 -86.62 145.8 40.12 Favored Pre-proline 0 CA--C 1.55 0.959 0 CA-C-N 117.256 0.528 . . . . 0.0 110.088 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 213' ' ' PRO . 31.7 Cg_exo -61.42 137.35 69.41 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.751 2.301 . . . . 0.0 111.872 173.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 212' ' ' PRO . 8.9 Cg_exo -69.94 110.16 2.52 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.309 2.006 . . . . 0.0 110.447 176.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 71.1 mt -92.36 51.22 1.73 Allowed 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 47.0 p -82.23 144.28 30.78 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.563 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.01 158.82 35.93 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.38 1.072 . . . . 0.0 109.375 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 C--O 1.251 1.135 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -177.601 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.83 114.38 2.39 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.832 2.355 . . . . 0.0 111.638 174.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.33 134.39 33.83 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.705 0.802 . . . . 0.0 109.524 176.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 30.2 p -63.8 105.46 0.83 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.111 0.964 . . . . 0.0 110.009 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -110.71 135.1 51.82 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.329 0.652 . . . . 0.0 110.625 -170.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -99.1 98.73 9.71 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.954 0.901 . . . . 0.0 109.197 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.8 mm -77.22 137.44 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.994 0.918 . . . . 0.0 109.018 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.2 p -127.35 85.92 2.43 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.107 0.563 . . . . 0.0 109.534 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -72.55 -25.52 61.39 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 122.824 0.45 . . . . 0.0 111.319 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.534 ' HB2' ' HG3' ' A' ' 97' ' ' GLU . 9.1 ptp -106.04 131.7 53.01 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 172.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 77.1 p -70.05 169.24 13.81 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.415 0.686 . . . . 0.0 109.946 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 45.0 mm -62.16 -35.66 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 122.593 0.357 . . . . 0.0 110.582 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 100' ' ' ARG . 43.2 mt-10 -53.72 -44.13 69.61 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.803 0.841 . . . . 0.0 112.294 176.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.534 ' HG3' ' HB2' ' A' ' 93' ' ' MET . 13.7 pt-20 -96.7 -13.23 22.89 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.076 0.55 . . . . 0.0 110.996 -177.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.565 HD12 HD23 ' A' ' 146' ' ' LEU . 53.2 tp -68.9 -50.21 51.5 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.919 0.888 . . . . 0.0 110.768 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.1 p -103.42 14.33 31.63 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.659 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 96' ' ' GLU . 59.5 ttt85 -72.15 141.38 49.11 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.237 0.615 . . . . 0.0 111.279 -174.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -84.28 152.28 24.26 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.344 0.592 . . . . 0.0 109.812 173.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.55 ' HE1' HH12 ' A' ' 148' ' ' ARG . 7.9 p-90 -149.6 167.51 26.14 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.389 1.076 . . . . 0.0 109.396 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -129.19 145.08 51.4 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.685 0.794 . . . . 0.0 109.605 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.548 ' SD ' ' HD2' ' A' ' 118' ' ' ARG . 69.7 mtp -116.9 150.92 37.68 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.662 0.785 . . . . 0.0 109.886 178.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.446 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.9 pt? -126.93 -23.73 3.6 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.672 0.789 . . . . 0.0 110.552 -177.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 25.6 mmt -130.12 72.72 81.83 Favored Pre-proline 0 N--CA 1.49 1.563 0 C-N-CA 123.119 0.568 . . . . 0.0 109.627 167.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.93 135.66 35.85 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.867 2.378 . . . . 0.0 113.61 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -129.88 118.9 22.44 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.032 0.933 . . . . 0.0 109.133 173.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -108.33 103.8 13.04 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.7 tptt -120.79 126.36 49.91 Favored 'General case' 0 C--O 1.206 -1.207 0 C-N-CA 124.957 1.303 . . . . 0.0 107.911 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 81.3 t -96.4 133.85 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 173.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -126.12 92.65 3.62 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 175.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.61 -133.25 25.3 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.909 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -75.65 3.78 5.64 Favored 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 123.716 2.944 . . . . 0.0 113.697 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.639 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 5.3 mp -125.23 156.67 38.14 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.267 0.627 . . . . 0.0 109.71 -177.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 42.6 t -116.87 132.75 56.62 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.002 0.921 . . . . 0.0 108.825 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.419 HD11 ' HB1' ' A' ' 177' ' ' ALA . 12.6 mm -106.03 143.71 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.472 1.109 . . . . 0.0 109.184 -176.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.618 ' HB3' ' HB3' ' A' ' 159' ' ' GLU . 71.3 ttp85 -129.3 120.64 25.99 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 176.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.595 HD13 ' HA3' ' A' ' 184' ' ' GLY . 44.2 mt -128.68 139.17 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -176.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -107.86 121.92 45.73 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 171.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -82.96 -9.29 59.36 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -173.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.27 -32.18 26.53 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.798 0.439 . . . . 0.0 111.5 178.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.442 HG12 ' CG1' ' A' ' 157' ' ' VAL . 1.8 mp -71.02 108.57 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.758 0.789 . . . . 0.0 109.117 -178.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.439 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 58.4 mtt -132.08 163.19 29.01 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 113.684 -1.598 . . . . 0.0 108.988 -175.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 71.35 5.33 5.39 Favored 'General case' 0 N--CA 1.502 2.126 0 C-N-CA 124.543 1.137 . . . . 0.0 112.998 171.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -97.08 151.13 20.06 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.653 0.781 . . . . 0.0 112.143 -170.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -91.98 108.33 19.85 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 164.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.548 HG12 HG22 ' A' ' 151' ' ' THR . 34.0 mt -110.92 147.91 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 123.598 0.759 . . . . 0.0 110.397 -172.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 15.4 tpt -130.67 120.76 24.39 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.544 1.138 . . . . 0.0 109.768 -169.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -88.21 103.63 15.95 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -117.25 138.14 51.92 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.487 0.715 . . . . 0.0 109.26 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -134.8 147.03 49.86 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.512 0.931 . . . . 0.0 113.512 -171.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.458 ' OD1' ' HG2' ' A' ' 93' ' ' MET . 5.2 m-20 -102.07 122.92 45.03 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 165.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -159.73 158.7 31.78 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 122.901 0.48 . . . . 0.0 111.645 -171.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.9 t -88.02 155.11 19.99 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.008 0.923 . . . . 0.0 109.914 173.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 87' ' ' SER . 45.9 t -130.5 145.6 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 124.901 1.281 . . . . 0.0 109.297 -177.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.544 HG22 ' HB2' ' A' ' 142' ' ' GLU . 11.0 tp -157.95 144.01 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 171.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 55.5 27.59 10.49 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 123.64 0.776 . . . . 0.0 112.858 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 66.18 23.19 10.95 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.97 1.308 . . . . 0.0 112.661 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.452 ' HG2' ' O ' ' A' ' 137' ' ' ILE . 28.8 ptt180 -117.66 160.96 20.44 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.945 0.498 . . . . 0.0 109.78 175.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.8 tt -71.2 112.99 7.78 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 166.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.544 ' HB2' HG22 ' A' ' 137' ' ' ILE . 11.9 tp10 -81.43 -58.46 3.02 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.67 0.388 . . . . 0.0 110.186 177.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 96.4 m -141.78 120.94 12.97 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.249 0.22 . . . . 0.0 110.808 -174.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 43.6 tp -77.2 119.3 20.69 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.057 0.543 . . . . 0.0 109.577 172.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 72.0 mt -80.56 -53.68 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 174.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.565 HD23 HD12 ' A' ' 98' ' ' LEU . 65.0 tp -156.61 146.09 20.66 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.888 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.564 HD13 HD12 ' A' ' 160' ' ' ILE . 8.2 tt -133.2 145.59 50.72 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 171.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.681 HH11 HG21 ' A' ' 156' ' ' ILE . 84.4 mtt-85 -140.52 143.69 35.54 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.227 1.011 . . . . 0.0 108.845 178.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -101.61 112.43 24.99 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 176.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -106.58 125.31 50.84 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.382 1.073 . . . . 0.0 109.74 -175.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.548 HG22 HG12 ' A' ' 128' ' ' ILE . 43.7 p -71.64 -174.07 1.06 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.034 0.534 . . . . 0.0 111.583 175.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -19.2 65.5 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.462 0.705 . . . . 0.0 112.833 175.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -98.3 -1.2 42.37 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.728 0.811 . . . . 0.0 111.358 172.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 76.38 26.3 63.91 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 116.396 -0.365 . . . . 0.0 113.343 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -77.7 131.63 37.79 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.681 HG21 HH11 ' A' ' 148' ' ' ARG . 22.9 mt -83.02 86.86 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 121.649 0.738 . . . . 0.0 109.181 -177.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.442 ' CG1' HG12 ' A' ' 123' ' ' ILE . 19.3 m -100.09 -12.89 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.519 1.128 . . . . 0.0 111.185 -169.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.44 ' HA3' HD11 ' A' ' 181' ' ' LEU . . . -142.84 164.76 27.05 Favored Glycine 0 C--O 1.245 0.836 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.618 ' HB3' ' HB3' ' A' ' 118' ' ' ARG . 32.8 tt0 -167.89 150.05 5.56 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 117.437 0.618 . . . . 0.0 110.428 -173.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.564 HD12 HD13 ' A' ' 147' ' ' LEU . 57.6 mt -136.0 125.67 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 170.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 14.4 m -138.46 122.88 11.7 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.639 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 88.1 Cg_exo -48.51 142.44 17.78 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 123.257 2.638 . . . . 0.0 113.175 173.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 90.4 mt -61.06 135.7 93.43 Favored Pre-proline 0 CA--C 1.559 1.307 0 C-N-CA 123.623 0.769 . . . . 0.0 111.09 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.87 72.2 3.94 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 123.21 2.607 . . . . 0.0 111.916 176.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 32.6 t 173.28 -18.59 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 126.411 1.884 . . . . 0.0 108.883 -175.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -115.39 84.14 11.46 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 124.944 1.298 . . . . 0.0 109.492 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.58 -24.94 5.85 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 122.647 2.231 . . . . 0.0 113.461 -177.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -122.45 87.6 0.4 Allowed Glycine 0 C--N 1.349 1.278 0 N-CA-C 111.681 -0.568 . . . . 0.0 111.681 -172.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -98.26 177.58 5.33 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.769 0.827 . . . . 0.0 110.26 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.8 m -122.51 154.96 37.15 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.465 HD11 ' HA ' ' A' ' 202' ' ' ALA . 10.7 tt -51.88 -34.96 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 C-N-CA 124.726 1.21 . . . . 0.0 113.001 177.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -61.97 -44.15 97.35 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.221 1.008 . . . . 0.0 112.784 -177.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -82.75 -25.62 32.67 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.647 0.379 . . . . 0.0 111.276 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.453 ' O ' HG13 ' A' ' 178' ' ' ILE . 91.4 t -64.49 -48.64 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 122.809 0.444 . . . . 0.0 110.858 172.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -65.96 -28.22 68.74 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.61 0.364 . . . . 0.0 110.905 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.426 ' O ' HG23 ' A' ' 180' ' ' VAL . 13.7 m120 -68.53 -43.56 76.48 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 123.144 0.578 . . . . 0.0 109.495 171.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.419 ' HB1' HD11 ' A' ' 117' ' ' ILE . . . -61.3 -40.52 94.46 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.842 0.857 . . . . 0.0 111.36 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 174' ' ' VAL . 57.6 mt -65.0 -39.91 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.19 -36.98 94.16 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.476 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 176' ' ' ASN . 80.9 t -66.2 -47.59 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.218 0.607 . . . . 0.0 110.613 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.44 HD11 ' HA3' ' A' ' 158' ' ' GLY . 32.7 tp -59.46 -46.76 87.85 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.879 0.737 . . . . 0.0 110.344 178.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.8 HG23 HG21 ' A' ' 192' ' ' VAL . 47.8 mt -57.12 -46.19 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.37 1.068 . . . . 0.0 111.447 176.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -63.41 -34.58 90.34 Favored Glycine 0 C--N 1.341 0.841 0 O-C-N 123.675 0.609 . . . . 0.0 113.104 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.595 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -71.12 -27.61 71.67 Favored Glycine 0 C--N 1.35 1.343 0 O-C-N 123.751 0.324 . . . . 0.0 113.0 177.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.411 HD22 ' CD1' ' A' ' 128' ' ' ILE . 64.2 mt -77.28 -47.35 20.29 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.832 0.853 . . . . 0.0 110.076 175.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -67.14 -34.11 76.89 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.316 0.646 . . . . 0.0 112.417 -174.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -66.89 -29.05 68.85 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 122.432 0.293 . . . . 0.0 111.365 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.439 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 8.4 m120 -80.38 8.19 8.11 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.207 0.603 . . . . 0.0 110.86 174.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 34.4 t70 65.49 64.2 0.6 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.776 1.23 . . . . 0.0 110.207 177.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.408 HD21 ' HA ' ' A' ' 124' ' ' MET . 35.7 m-80 -124.46 172.96 8.76 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.153 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 70.2 m -122.93 102.55 8.08 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.8 HG21 HG23 ' A' ' 182' ' ' ILE . 31.8 m -89.99 150.97 3.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 CA-C-O 121.898 0.856 . . . . 0.0 111.574 -174.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -141.22 131.23 24.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 113.8 -1.545 . . . . 0.0 107.701 173.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 5.8 t -89.75 152.7 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 38.6 t -62.95 141.6 58.66 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 118.179 0.445 . . . . 0.0 109.929 176.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -57.94 -33.73 69.13 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.258 0.623 . . . . 0.0 111.888 -177.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 15.0 p -66.79 -49.6 65.34 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.433 0.458 . . . . 0.0 110.242 174.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 72.5 mt -58.63 -34.65 71.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 122.697 0.399 . . . . 0.0 110.775 178.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.58 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 75.5 mt-30 -61.35 -41.53 97.21 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.092 0.957 . . . . 0.0 112.666 -175.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.26 -21.09 14.41 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -178.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -79.49 -48.69 13.47 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 118.745 0.702 . . . . 0.0 111.107 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.465 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -114.82 -50.89 2.76 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.498 0.666 . . . . 0.0 111.221 -174.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.58 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 35.4 t-105 -79.18 4.58 14.44 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 124.97 1.308 . . . . 0.0 111.391 -171.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -58.79 -20.27 46.99 Favored Glycine 0 C--N 1.362 2.003 0 C-N-CA 123.08 0.371 . . . . 0.0 113.731 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 19.6 m -68.14 100.18 0.98 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.767 0.827 . . . . 0.0 110.072 170.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 49.5 m -87.55 75.78 9.05 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.868 0.842 . . . . 0.0 109.296 176.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -108.4 2.11 22.2 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.725 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -152.46 143.12 22.82 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.968 0.907 . . . . 0.0 109.317 -176.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -100.25 121.23 41.13 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 172.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -77.06 -97.38 0.18 Allowed Glycine 0 C--N 1.346 1.124 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 175.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.423 ' HA ' ' HD3' ' A' ' 212' ' ' PRO . 5.8 ptm180 -176.42 137.54 0.46 Allowed Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 124.151 0.98 . . . . 0.0 110.091 171.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 211' ' ' ARG . 1.6 Cg_endo -81.7 120.49 3.51 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.926 2.418 . . . . 0.0 110.229 174.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -58.26 103.0 0.14 Allowed 'Trans proline' 0 C--N 1.383 2.342 0 C-N-CA 123.069 2.513 . . . . 0.0 111.207 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 89.9 mt -71.89 91.0 1.15 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.971 -173.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 41.9 p -83.07 141.28 32.13 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.833 175.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.8 pp -71.68 161.65 30.66 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.418 0.687 . . . . 0.0 111.696 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 C--O 1.252 1.237 0 CA-C-O 118.75 -0.643 . . . . 0.0 109.581 -173.09 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.432 ' SD ' ' N ' ' A' ' 84' ' ' MET . 0.5 OUTLIER . . . . . 0 CA--C 1.553 1.069 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.43 ' HB3' ' HA ' ' A' ' 138' ' ' PHE . 53.1 Cg_endo -67.4 121.06 8.14 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.939 2.426 . . . . 0.0 112.038 178.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.1 126.21 41.17 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.729 0.811 . . . . 0.0 109.679 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.5 p -76.44 83.09 3.16 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 170.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -114.77 153.6 30.06 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.606 -173.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -116.4 113.54 23.02 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.888 0.875 . . . . 0.0 109.345 174.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 32.5 mm -78.38 132.85 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 36.1 p -128.25 87.93 2.67 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.923 0.889 . . . . 0.0 109.305 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -71.33 -22.9 61.86 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 173.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.419 ' SD ' ' HB2' ' A' ' 148' ' ' ARG . 56.9 mtm -119.63 139.89 51.47 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 125.15 1.38 . . . . 0.0 109.027 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 72.2 p -88.88 165.67 14.48 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 172.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.482 ' HA ' HD12 ' A' ' 98' ' ' LEU . 2.2 mp -53.93 -30.73 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 124.609 1.164 . . . . 0.0 111.736 -171.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -53.33 -62.69 1.49 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.355 1.062 . . . . 0.0 111.984 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.719 ' HA ' ' HB2' ' A' ' 100' ' ' ARG . 14.9 pm0 -77.21 -22.56 52.14 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.834 0.453 . . . . 0.0 111.74 -177.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.633 HD11 ' ND2' ' A' ' 133' ' ' ASN . 32.7 mt -58.53 -39.17 79.4 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.089 0.556 . . . . 0.0 110.491 169.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.3 m -108.32 20.96 17.98 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.278 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.719 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 6.5 tpt180 -71.29 143.05 50.46 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.75 0.42 . . . . 0.0 110.861 -174.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -96.12 104.99 16.98 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.113 0.965 . . . . 0.0 109.563 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.431 ' HE1' ' NH1' ' A' ' 148' ' ' ARG . 46.0 p-90 -137.04 172.66 12.67 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.216 1.006 . . . . 0.0 110.496 -177.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -138.38 166.22 24.8 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.611 0.764 . . . . 0.0 110.657 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.413 ' HG2' ' HB2' ' A' ' 120' ' ' ASP . 55.9 mtm -122.16 129.19 52.08 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.286 1.034 . . . . 0.0 109.105 172.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 56.3 tp -71.38 -40.62 70.45 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.023 0.929 . . . . 0.0 110.034 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.425 ' HG2' ' HB2' ' A' ' 122' ' ' ALA . 24.1 mmt -125.0 77.97 66.48 Favored Pre-proline 0 N--CA 1.483 1.194 0 C-N-CA 124.404 1.082 . . . . 0.0 109.451 174.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.43 111.93 3.43 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.627 2.218 . . . . 0.0 112.352 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -87.04 111.2 20.65 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 172.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -89.21 116.8 27.72 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.547 0.339 . . . . 0.0 110.271 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.422 ' HG2' HG11 ' A' ' 180' ' ' VAL . 14.4 tppt? -127.47 140.23 52.29 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.983 1.313 . . . . 0.0 109.332 174.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.559 HG13 HD11 ' A' ' 163' ' ' LEU . 79.5 t -123.24 99.5 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 166.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.48 ' HG2' HG21 ' A' ' 180' ' ' VAL . 9.1 tp10 -104.3 95.56 6.04 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -175.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.16 -125.91 19.19 Favored Glycine 0 CA--C 1.536 1.362 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.39 -176.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -85.75 6.38 5.59 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 123.246 2.63 . . . . 0.0 112.875 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.407 HD12 ' HB2' ' A' ' 177' ' ' ALA . 73.6 mt -123.51 144.32 49.62 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.345 0.658 . . . . 0.0 109.666 -171.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 46.4 t -107.66 115.58 30.4 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.322 0.649 . . . . 0.0 109.458 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.0 mm -99.72 133.71 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.2 mtm180 -134.42 120.98 20.47 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.66 0.784 . . . . 0.0 108.946 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.551 HG12 HD12 ' A' ' 181' ' ' LEU . 49.6 mt -126.06 132.47 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.391 1.077 . . . . 0.0 108.988 -173.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.426 ' OD2' HG12 ' A' ' 123' ' ' ILE . 16.7 t70 -89.29 120.09 30.34 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 118.064 0.393 . . . . 0.0 109.958 176.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.457 ' HA ' ' ND2' ' A' ' 188' ' ' ASN . 22.3 mt-30 -91.35 2.21 56.56 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.74 0.816 . . . . 0.0 113.118 -175.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.425 ' HB2' ' HG2' ' A' ' 106' ' ' MET . . . -94.11 -27.82 16.04 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 174.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.426 HG12 ' OD2' ' A' ' 120' ' ' ASP . 22.5 mm -78.49 95.03 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.685 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 37.4 mtt -122.74 149.33 44.24 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.045 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.0 t70 65.55 52.1 1.41 Allowed 'General case' 0 N--CA 1.484 1.23 0 O-C-N 124.529 1.143 . . . . 0.0 110.928 175.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -130.03 156.1 45.05 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.068 0.947 . . . . 0.0 110.691 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -95.64 108.27 20.54 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 170.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.545 ' HB ' HG12 ' A' ' 192' ' ' VAL . 58.7 mt -113.66 143.56 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.761 0.824 . . . . 0.0 111.186 -171.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 12.4 tpt -118.41 122.85 43.79 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.324 1.05 . . . . 0.0 108.912 -177.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.434 HD12 HG22 ' A' ' 194' ' ' VAL . 12.1 mt -94.79 103.87 15.77 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -175.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.406 ' HA ' ' HB2' ' A' ' 195' ' ' SER . 53.4 mtpt -118.37 140.74 49.37 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.948 0.899 . . . . 0.0 109.974 -170.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -135.6 154.12 51.44 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 122.581 1.181 . . . . 0.0 114.141 -171.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.633 ' ND2' HD11 ' A' ' 98' ' ' LEU . 3.3 m-20 -108.06 127.63 53.96 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 162.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -156.21 159.6 39.09 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.682 0.614 . . . . 0.0 110.556 -176.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.2 t -86.3 162.85 18.04 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 173.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.8 t -135.02 133.87 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.625 1.17 . . . . 0.0 109.132 -174.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.6 tp -148.88 145.81 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 172.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.43 ' HA ' ' HB3' ' A' ' 85' ' ' PRO . 38.7 m-85 59.21 30.47 20.24 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.741 0.816 . . . . 0.0 111.3 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 64.06 17.74 10.81 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.057 1.343 . . . . 0.0 112.096 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -127.36 175.39 8.23 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.899 0.88 . . . . 0.0 110.0 176.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.467 HD22 ' HA ' ' A' ' 171' ' ' ILE . 9.1 tt -67.33 123.46 20.42 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.545 0.738 . . . . 0.0 109.119 175.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -82.99 -70.19 0.57 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.137 0.575 . . . . 0.0 109.886 174.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 61.4 m -147.92 129.34 14.85 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.88 0.872 . . . . 0.0 109.656 -174.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 59.3 tp -72.3 134.55 45.59 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.768 0.827 . . . . 0.0 110.46 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 66.1 mt -96.16 -43.48 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.924 0.89 . . . . 0.0 110.102 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.439 HD21 ' NH2' ' A' ' 148' ' ' ARG . 40.9 tp -169.5 149.12 3.9 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.922 0.889 . . . . 0.0 109.253 174.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.666 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 7.5 tt -136.0 144.93 45.59 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.717 ' HD3' HD13 ' A' ' 156' ' ' ILE . 71.7 mtt-85 -142.54 146.75 34.98 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.224 1.01 . . . . 0.0 109.939 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.73 118.72 37.47 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.239 1.016 . . . . 0.0 108.844 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -110.25 128.94 55.77 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.277 1.031 . . . . 0.0 110.397 -174.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 31.4 p -76.8 179.27 6.21 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.022 0.529 . . . . 0.0 111.022 172.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -61.97 -21.02 64.48 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.884 0.874 . . . . 0.0 112.02 174.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -83.04 -1.54 52.98 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.801 1.24 . . . . 0.0 111.569 176.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 69.0 18.23 72.51 Favored Glycine 0 C--N 1.357 1.709 0 CA-C-N 116.456 -0.338 . . . . 0.0 112.847 -173.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -92.57 129.47 38.49 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.383 0.673 . . . . 0.0 109.419 -174.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.717 HD13 ' HD3' ' A' ' 148' ' ' ARG . 24.4 mt -79.97 109.26 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.1 m -117.08 -0.55 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.974 0.91 . . . . 0.0 111.397 -173.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -150.22 164.47 29.71 Favored Glycine 0 C--N 1.34 0.76 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -165.57 144.39 6.23 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 117.149 0.475 . . . . 0.0 110.595 -174.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.666 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 73.8 mt -127.05 102.84 10.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.1 t -106.79 112.62 63.39 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 123.366 0.666 . . . . 0.0 109.579 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -58.96 128.26 27.26 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.749 2.299 . . . . 0.0 111.983 174.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.559 HD11 HG13 ' A' ' 111' ' ' VAL . 88.8 mt -65.83 128.0 93.5 Favored Pre-proline 0 CA--C 1.548 0.873 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.202 -177.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.44 -9.02 25.14 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 123.185 2.59 . . . . 0.0 113.013 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 25.3 p -71.89 -13.18 61.59 Favored 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 123.738 0.815 . . . . 0.0 111.255 169.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -121.88 113.13 31.7 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 125.01 1.324 . . . . 0.0 107.698 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.63 -34.51 90.52 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.39 2.727 . . . . 0.0 113.792 -177.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -163.41 -179.29 37.75 Favored Glycine 0 N--CA 1.467 0.73 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.401 ' CE1' HD21 ' A' ' 115' ' ' LEU . 42.3 p-80 -153.05 -175.7 5.45 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.477 0.711 . . . . 0.0 110.551 175.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 19.2 m -106.56 158.16 17.14 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.269 1.027 . . . . 0.0 110.064 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.467 ' HA ' HD22 ' A' ' 141' ' ' LEU . 2.8 tt -48.22 -39.78 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 125.563 1.545 . . . . 0.0 113.024 174.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -63.54 -34.17 77.21 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.55 0.74 . . . . 0.0 111.687 -174.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -65.98 -37.05 84.96 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.861 0.864 . . . . 0.0 110.546 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 25.5 t -68.63 -34.95 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 123.865 0.728 . . . . 0.0 110.611 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -64.24 -38.27 90.47 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 120.486 0.184 . . . . 0.0 110.707 176.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -63.16 -47.21 83.64 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 123.992 0.808 . . . . 0.0 109.568 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.407 ' HB2' HD12 ' A' ' 115' ' ' LEU . . . -60.41 -48.78 80.27 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 114.29 -1.323 . . . . 0.0 112.2 -175.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 68.5 mt -67.42 -38.73 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 123.779 0.674 . . . . 0.0 109.418 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.26 -30.07 76.42 Favored Glycine 0 CA--C 1.536 1.372 0 O-C-N 123.328 0.392 . . . . 0.0 113.677 176.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.48 HG21 ' HG2' ' A' ' 112' ' ' GLU . 43.2 t -76.45 -43.73 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.663 0.785 . . . . 0.0 110.32 175.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.551 HD12 HG12 ' A' ' 119' ' ' ILE . 36.6 tp -56.53 -49.04 75.92 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.727 0.811 . . . . 0.0 110.509 175.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.461 ' O ' ' HG2' ' A' ' 186' ' ' GLU . 77.3 mt -61.54 -52.18 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.14 0.976 . . . . 0.0 110.272 174.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -54.99 -36.26 60.41 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 124.153 0.908 . . . . 0.0 114.141 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.13 -41.34 47.69 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 112.235 -0.346 . . . . 0.0 112.235 174.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.492 HD13 HG11 ' A' ' 192' ' ' VAL . 35.5 mt -69.79 -16.49 63.3 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.304 1.042 . . . . 0.0 111.944 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 20.5 mm-40 -70.81 -39.27 73.18 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 171.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -77.83 -34.48 51.89 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.451 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.457 ' ND2' ' HA ' ' A' ' 121' ' ' GLN . 7.9 m-20 -72.59 -13.63 61.43 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.692 170.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 38.6 t70 57.57 67.63 0.95 Allowed 'General case' 0 C--N 1.355 0.842 0 C-N-CA 125.556 1.542 . . . . 0.0 111.367 176.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -124.92 139.2 54.05 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.484 -1.235 . . . . 0.0 107.843 175.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 86.7 m -79.54 102.44 8.84 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.545 HG12 ' HB ' ' A' ' 128' ' ' ILE . 34.0 m -107.57 147.58 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 121.505 0.669 . . . . 0.0 110.983 -173.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -135.79 139.93 43.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 113.957 -1.474 . . . . 0.0 107.779 175.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.434 HG22 HD12 ' A' ' 130' ' ' LEU . 16.5 t -89.42 155.96 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.406 ' HB2' ' HA ' ' A' ' 131' ' ' LYS . 28.8 t -56.1 151.75 11.68 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.186 0.595 . . . . 0.0 112.172 -178.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.4 ' H ' ' HD2' ' A' ' 196' ' ' LYS . 0.2 OUTLIER -56.78 -44.73 82.15 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 124.04 0.838 . . . . 0.0 109.861 179.757 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 63.7 p -65.83 -49.3 68.69 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 113.93 -1.486 . . . . 0.0 110.516 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 54.9 mt -62.56 -35.06 78.28 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.321 0.649 . . . . 0.0 110.868 -177.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.548 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 42.0 mt-30 -62.39 -34.06 75.98 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.775 0.83 . . . . 0.0 111.775 -176.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.417 ' HE ' ' HB2' ' A' ' 200' ' ' ARG . 0.0 OUTLIER -104.16 -30.54 10.14 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -76.48 -33.42 58.67 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.218 0.607 . . . . 0.0 111.562 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.42 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -121.13 -58.18 1.81 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.174 0.59 . . . . 0.0 110.643 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.548 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 27.7 t-105 -77.06 -6.74 53.91 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 125.026 1.33 . . . . 0.0 111.225 -166.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -143.9 41.44 1.12 Allowed Glycine 0 C--N 1.347 1.17 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 177.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 33.4 t -128.51 -27.69 2.6 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.693 0.797 . . . . 0.0 111.995 -172.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 27.9 p -146.94 -55.23 0.24 Allowed 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -174.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 62.08 20.78 11.9 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 124.961 1.305 . . . . 0.0 112.775 169.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -123.02 -176.5 3.43 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 123.407 0.683 . . . . 0.0 110.978 -175.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -60.39 -30.82 69.83 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.906 0.882 . . . . 0.0 111.645 174.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 113.67 20.48 6.11 Favored Glycine 0 CA--C 1.502 -0.748 0 CA-C-O 119.416 -0.658 . . . . 0.0 113.72 173.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 64.93 107.55 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.647 1.179 . . . . 0.0 111.514 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -62.39 111.66 1.36 Allowed 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.105 1.87 . . . . 0.0 108.929 169.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -57.25 98.37 0.08 OUTLIER 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 123.073 2.515 . . . . 0.0 112.72 -171.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 84.4 mt -73.56 88.33 1.65 Allowed 'General case' 0 C--O 1.24 0.585 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 65.6 p -89.49 125.75 35.31 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.603 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.8 pp -73.24 -172.87 1.2 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.24 0.616 . . . . 0.0 111.487 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 . . . . . 0 CA--C 1.554 1.096 0 C-N-CA 123.361 0.665 . . . . 0.0 109.569 -178.973 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.44 148.3 23.4 Favored 'Trans proline' 0 C--N 1.365 1.434 0 C-N-CA 122.215 1.944 . . . . 0.0 110.663 165.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.24 116.05 17.54 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 27.2 p -56.85 109.02 0.57 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.464 0.706 . . . . 0.0 111.222 -177.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -101.1 138.62 37.9 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.519 0.728 . . . . 0.0 109.635 -171.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -100.82 100.98 11.71 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.536 0.734 . . . . 0.0 109.658 -175.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 50.8 mm -78.41 120.5 29.45 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.088 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 174.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 62.2 p -114.49 97.38 6.27 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -88.84 -25.56 22.12 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.513 0.325 . . . . 0.0 110.301 -178.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.513 ' HB3' ' HG3' ' A' ' 97' ' ' GLU . 2.7 mpp? -101.44 144.24 30.47 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.897 0.879 . . . . 0.0 108.945 172.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.3 m -72.94 161.05 31.17 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.328 0.651 . . . . 0.0 109.533 171.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.41 ' H ' HD12 ' A' ' 95' ' ' ILE . 3.0 mp -55.69 -39.26 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.612 0.765 . . . . 0.0 111.373 -177.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -65.37 -52.37 54.09 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.446 0.699 . . . . 0.0 111.699 -175.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.513 ' HG3' ' HB3' ' A' ' 93' ' ' MET . 11.3 pt-20 -70.25 -26.73 63.97 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 122.903 0.481 . . . . 0.0 111.532 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.406 ' HG ' HD23 ' A' ' 146' ' ' LEU . 9.1 tt -66.56 -44.29 82.73 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.732 0.813 . . . . 0.0 109.787 174.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 39.1 t -99.66 20.63 13.68 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.95 0.9 . . . . 0.0 110.734 -177.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.447 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 20.4 tpt180 -80.09 136.46 36.55 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.532 0.733 . . . . 0.0 111.657 -176.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -84.94 136.15 33.74 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 170.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 16.6 p-90 -144.14 137.74 27.68 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.229 1.012 . . . . 0.0 109.52 -175.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -94.73 138.19 32.86 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 18.1 ptm -123.97 124.11 41.86 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 173.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.53 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.6 pt? -82.55 -25.21 33.55 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.114 0.566 . . . . 0.0 111.571 -171.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 23.4 mmt -123.23 80.87 52.3 Favored Pre-proline 0 N--CA 1.475 0.816 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 175.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -76.04 110.66 3.12 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.493 2.129 . . . . 0.0 112.12 -177.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -95.96 112.28 24.05 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 165.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -91.95 98.82 11.81 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 179.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.543 ' HG2' HG11 ' A' ' 180' ' ' VAL . 51.2 tptt -107.65 147.2 31.0 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.243 1.017 . . . . 0.0 108.906 177.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 51.5 t -130.68 129.18 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 172.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -135.88 104.83 5.87 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.43 -148.62 42.49 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 119.507 -0.607 . . . . 0.0 111.958 -175.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -73.89 13.11 0.84 Allowed 'Trans proline' 0 CA--C 1.555 1.552 0 C-N-CA 123.37 2.713 . . . . 0.0 114.097 173.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 4.2 mp -125.35 152.28 44.96 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.754 0.822 . . . . 0.0 108.802 -176.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 160' ' ' ILE . 23.5 t -109.07 140.45 42.6 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.328 0.651 . . . . 0.0 110.029 175.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.7 mm -111.34 147.57 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.625 0.77 . . . . 0.0 109.518 178.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -124.86 119.98 30.38 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 27.6 mm -116.05 123.9 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -90.96 116.68 28.95 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 168.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.445 ' HA ' HD21 ' A' ' 188' ' ' ASN . 75.5 mt-30 -75.18 -16.63 60.49 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.552 0.741 . . . . 0.0 112.484 -173.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.44 -35.58 19.6 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.428 0.691 . . . . 0.0 112.128 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.85 109.95 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-O 121.994 0.902 . . . . 0.0 109.304 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.45 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 51.2 mtt -135.17 156.22 49.37 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 113.908 -1.496 . . . . 0.0 109.602 -177.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.3 t70 61.61 24.08 14.26 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 124.713 1.205 . . . . 0.0 112.228 174.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 54.3 mmtt -104.55 146.13 29.33 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 121.657 -0.652 . . . . 0.0 111.466 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.554 ' HA ' ' HB ' ' A' ' 191' ' ' THR . 3.0 m-20 -83.96 102.41 12.42 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 174.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.495 HD12 HD22 ' A' ' 185' ' ' LEU . 59.4 mt -114.95 141.07 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 123.681 0.793 . . . . 0.0 110.496 -172.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 14.0 tpt -117.59 131.42 56.68 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.304 1.042 . . . . 0.0 109.326 -174.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.517 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 2.9 mm? -91.4 104.4 16.92 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -118.45 136.1 53.98 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.365 1.066 . . . . 0.0 109.613 -171.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.464 ' HB2' ' HG ' ' A' ' 147' ' ' LEU . . . -142.22 152.52 43.16 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 -177.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -110.79 131.11 55.32 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 114.138 -1.392 . . . . 0.0 107.267 167.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.467 ' HA ' HG13 ' A' ' 145' ' ' ILE . 44.1 p90 -161.93 164.69 28.34 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.13 0.572 . . . . 0.0 111.4 -171.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.6 p -92.91 161.27 14.54 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.852 0.861 . . . . 0.0 109.667 173.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 87' ' ' SER . 54.8 t -128.27 133.36 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 124.288 1.035 . . . . 0.0 109.854 -176.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 8.7 tp -143.83 144.98 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 60.34 32.77 20.78 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.003 0.921 . . . . 0.0 112.447 174.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.7 t70 76.41 -0.07 3.13 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 124.555 1.142 . . . . 0.0 111.982 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -126.73 179.94 5.11 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.377 1.071 . . . . 0.0 110.136 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.515 ' HB3' HG13 ' A' ' 171' ' ' ILE . 9.9 tt -70.09 136.3 50.09 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.853 0.461 . . . . 0.0 109.877 177.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -91.48 -66.72 0.9 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.736 0.814 . . . . 0.0 110.517 174.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 75.9 m -145.96 130.0 17.41 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.513 0.725 . . . . 0.0 109.713 -174.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.487 HD21 ' HB2' ' A' ' 147' ' ' LEU . 40.6 tp -72.34 129.83 39.3 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 173.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.467 HG13 ' HA ' ' A' ' 134' ' ' PHE . 66.1 mt -87.14 -51.1 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 174.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.406 HD23 ' HG ' ' A' ' 98' ' ' LEU . 59.0 tp -163.77 147.42 10.11 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.225 1.01 . . . . 0.0 109.227 175.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.659 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 7.0 tt -131.8 148.15 52.54 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 173.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.509 HH11 HG21 ' A' ' 156' ' ' ILE . 55.2 mtt-85 -142.92 148.23 36.58 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.18 0.992 . . . . 0.0 109.857 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.436 ' HB2' HD21 ' A' ' 181' ' ' LEU . . . -105.63 112.39 25.45 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.354 1.062 . . . . 0.0 108.499 175.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -106.2 130.16 54.12 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.403 0.681 . . . . 0.0 110.347 -177.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 28.3 p -71.29 174.01 7.03 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.069 0.548 . . . . 0.0 110.991 170.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.42 -18.26 64.4 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.433 0.693 . . . . 0.0 111.349 171.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -64.08 -29.7 70.82 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.952 0.901 . . . . 0.0 110.76 168.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 91.91 20.6 36.1 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.747 -173.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -103.31 134.48 46.62 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.815 0.846 . . . . 0.0 110.668 -175.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.509 HG21 HH11 ' A' ' 148' ' ' ARG . 16.2 mt -73.87 116.03 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.43 -1.06 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.685 0.794 . . . . 0.0 110.787 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -157.13 161.86 31.42 Favored Glycine 0 C--N 1.334 0.417 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -162.0 150.46 15.11 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 117.482 0.641 . . . . 0.0 109.968 -172.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.659 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 67.5 mt -129.34 103.71 9.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 167.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.5 t -107.34 106.45 58.4 Favored Pre-proline 0 C--O 1.243 0.757 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 51.1 Cg_exo -57.45 117.59 4.31 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.997 2.465 . . . . 0.0 112.258 175.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.7 mt -72.68 123.42 89.53 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 123.738 0.815 . . . . 0.0 111.985 -173.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.9 -7.46 20.79 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.999 2.466 . . . . 0.0 112.342 173.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 16.5 m -60.48 -25.25 65.92 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.321 1.048 . . . . 0.0 111.759 173.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -118.79 129.31 25.46 Favored Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -176.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -44.19 -52.66 5.47 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 124.419 3.413 . . . . 0.0 114.533 -170.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -162.3 -174.45 32.21 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.181 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -147.19 163.07 37.51 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-O 121.377 0.608 . . . . 0.0 110.754 176.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 27.9 m -99.58 164.46 12.06 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.279 1.031 . . . . 0.0 109.385 174.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.515 HG13 ' HB3' ' A' ' 141' ' ' LEU . 7.7 tt -49.83 -36.41 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 124.613 1.165 . . . . 0.0 112.051 174.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -60.59 -39.63 88.81 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.348 1.059 . . . . 0.0 111.308 -177.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -66.31 -36.6 83.36 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.461 0.705 . . . . 0.0 110.969 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 178' ' ' ILE . 46.3 t -65.19 -39.68 86.27 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.687 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.245 175.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.441 ' HE2' ' O ' ' A' ' 202' ' ' ALA . 88.1 mttt -58.79 -45.54 89.63 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.117 0.567 . . . . 0.0 110.775 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.486 ' O ' HG23 ' A' ' 180' ' ' VAL . 53.6 m-80 -64.15 -43.29 95.66 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.182 177.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.2 -50.27 74.11 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.209 0.943 . . . . 0.0 111.568 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 174' ' ' VAL . 39.9 mt -62.84 -40.27 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -58.69 -32.99 70.66 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 115.474 -0.785 . . . . 0.0 113.88 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.543 HG11 ' HG2' ' A' ' 110' ' ' LYS . 41.0 t -73.09 -46.38 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 117.041 0.421 . . . . 0.0 110.039 177.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.473 HD22 HG13 ' A' ' 160' ' ' ILE . 21.7 tp -61.77 -46.37 89.87 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 123.79 0.682 . . . . 0.0 110.825 -177.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 75.4 mt -61.41 -50.39 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.547 0.739 . . . . 0.0 110.078 175.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.45 ' O ' ' HG2' ' A' ' 187' ' ' ARG . . . -53.99 -47.85 64.87 Favored Glycine 0 C--N 1.346 1.13 0 O-C-N 124.201 0.938 . . . . 0.0 113.629 -177.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.19 -40.86 99.16 Favored Glycine 0 C--N 1.344 0.974 0 C-N-CA 123.164 0.411 . . . . 0.0 112.23 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.495 HD22 HD12 ' A' ' 128' ' ' ILE . 96.7 mt -63.7 -39.58 94.66 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.421 0.688 . . . . 0.0 111.084 176.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -67.75 -35.29 78.46 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.487 0.715 . . . . 0.0 110.984 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 183' ' ' GLY . 12.6 mmp_? -75.04 -27.48 60.05 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.81 0.444 . . . . 0.0 110.63 177.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.45 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 6.1 m-20 -81.02 -7.12 59.49 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.304 0.641 . . . . 0.0 110.898 170.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 38.7 t70 63.33 67.18 0.67 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.051 1.341 . . . . 0.0 111.328 -176.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -119.0 145.95 45.42 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.847 0.859 . . . . 0.0 109.074 175.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.554 ' HB ' ' HA ' ' A' ' 127' ' ' ASN . 28.2 m -76.99 107.51 9.39 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -178.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 18.0 m -101.85 134.85 41.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 121.265 0.555 . . . . 0.0 110.865 -172.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -143.9 133.87 24.06 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.321 1.048 . . . . 0.0 108.273 169.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.517 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 5.2 t -90.87 151.51 3.49 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 48.0 t -59.06 139.14 57.16 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 175.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -62.44 -25.29 67.89 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.985 0.514 . . . . 0.0 111.19 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 67.0 p -76.33 -44.59 36.02 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.213 0.605 . . . . 0.0 109.378 175.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.422 HD21 ' HB3' ' A' ' 132' ' ' ALA . 28.4 mt -58.65 -33.37 70.01 Favored 'General case' 0 C--O 1.2 -1.524 0 C-N-CA 122.713 0.405 . . . . 0.0 111.493 172.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.502 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 50.6 mt-30 -76.92 -41.2 44.44 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.999 0.52 . . . . 0.0 110.412 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 41.6 tpt85 -62.73 -43.23 99.35 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.282 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -100.72 -49.07 4.29 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.446 -169.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.461 ' HB2' HD13 ' A' ' 141' ' ' LEU . . . -97.19 -57.4 2.27 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -167.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.502 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 49.4 t-105 -68.78 -13.03 62.14 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.621 1.168 . . . . 0.0 112.271 -164.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -57.11 115.28 6.33 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 169.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 21.2 m -55.71 138.8 46.8 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.608 1.163 . . . . 0.0 113.214 -169.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 18.9 m -64.85 -26.59 68.4 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.893 0.877 . . . . 0.0 112.044 -177.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -66.6 93.52 0.25 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.009 0.924 . . . . 0.0 110.36 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -140.01 90.25 2.37 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -80.95 77.69 7.82 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.56 0.744 . . . . 0.0 110.789 -172.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 50.0 47.55 40.22 Favored Glycine 0 C--N 1.349 1.294 0 O-C-N 123.965 0.791 . . . . 0.0 113.398 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -69.28 115.77 35.65 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 122.613 0.365 . . . . 0.0 110.692 -172.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -75.74 160.88 37.29 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.605 2.203 . . . . 0.0 111.459 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.16 129.02 25.64 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.049 1.833 . . . . 0.0 110.581 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 94.9 mt -68.59 90.15 0.38 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.293 0.568 . . . . 0.0 110.399 -176.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 33.3 p -80.68 151.03 29.15 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-N 114.799 -1.092 . . . . 0.0 110.735 -176.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.2 pp -140.39 163.13 33.63 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.792 0.837 . . . . 0.0 109.485 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 . . . . . 0 CA--C 1.555 1.144 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -177.72 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 23.0 mmt . . . . . 0 N--CA 1.48 1.045 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.43 -33.29 97.78 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.579 2.186 . . . . 0.0 113.314 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -164.83 86.19 0.43 Allowed 'General case' 0 C--N 1.353 0.745 0 C-N-CA 123.255 0.622 . . . . 0.0 110.528 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 22.5 p -94.41 115.21 27.37 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.982 0.513 . . . . 0.0 110.095 177.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -104.82 139.42 39.61 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 176.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -104.71 101.71 11.32 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 177.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 133' ' ' ASN . 38.5 mm -75.93 129.59 36.93 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 68.6 p -122.14 80.7 1.74 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.844 0.858 . . . . 0.0 108.783 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.456 ' HB2' ' HB3' ' A' ' 131' ' ' LYS . 37.8 m-20 -69.84 -31.25 69.0 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 121.855 0.836 . . . . 0.0 109.55 172.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.609 ' HG3' ' HG3' ' A' ' 97' ' ' GLU . 25.1 ttp -102.69 121.81 43.17 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.142 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.4 m -72.97 155.65 39.63 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.832 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.8 mp -53.59 -34.3 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 C-N-CA 123.958 0.903 . . . . 0.0 111.084 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -50.9 -68.39 0.17 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.878 1.271 . . . . 0.0 112.108 173.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.609 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 9.9 pt-20 -71.13 -22.64 62.05 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.329 1.052 . . . . 0.0 112.063 -178.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.539 ' HG ' HD23 ' A' ' 146' ' ' LEU . 9.8 tt -66.72 -45.37 78.92 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.221 1.008 . . . . 0.0 110.347 174.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.9 t -98.94 1.63 45.76 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.39 0.676 . . . . 0.0 111.323 -175.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -61.01 140.88 57.72 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.554 0.742 . . . . 0.0 111.121 175.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -86.24 142.27 28.69 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.125 0.57 . . . . 0.0 109.751 171.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 28.7 p-90 -152.85 156.83 39.75 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.34 -170.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -111.26 155.24 23.3 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.265 1.026 . . . . 0.0 110.579 -175.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 93.8 mtp -128.43 109.23 11.22 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.113 0.965 . . . . 0.0 108.464 166.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.4 tp -67.92 -49.5 61.51 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.637 0.775 . . . . 0.0 110.261 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.502 ' HG2' ' HB2' ' A' ' 122' ' ' ALA . 97.7 mmm -119.95 82.19 28.19 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 124.151 0.98 . . . . 0.0 109.54 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -71.9 125.72 11.26 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.506 2.138 . . . . 0.0 112.675 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -95.76 110.18 22.37 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 166.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 20.4 tm0? -80.43 106.08 12.17 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 176.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.471 ' HG2' HG11 ' A' ' 180' ' ' VAL . 22.7 tptm -130.01 143.99 51.09 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.817 0.847 . . . . 0.0 108.745 170.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.451 HG11 HD11 ' A' ' 163' ' ' LEU . 63.1 t -131.72 122.16 49.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 168.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -109.18 97.56 7.15 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.29 -126.14 8.07 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 119.083 -0.843 . . . . 0.0 111.724 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.619 ' HG2' ' HB3' ' A' ' 169' ' ' HIS . 42.3 Cg_endo -98.26 31.88 0.13 Allowed 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 123.408 2.739 . . . . 0.0 111.74 172.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 162' ' ' PRO . 90.4 mt -131.17 123.97 29.67 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.177 0.991 . . . . 0.0 109.448 -178.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 16.6 p -83.78 122.69 29.01 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.445 0.698 . . . . 0.0 109.92 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.4 mm -103.11 106.65 20.48 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 C-N-CA 123.69 0.796 . . . . 0.0 109.3 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.618 ' HD2' ' HB3' ' A' ' 159' ' ' GLU . 77.2 mtt85 -95.93 119.92 35.29 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.76 0.824 . . . . 0.0 108.834 176.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.517 HD13 ' HA3' ' A' ' 184' ' ' GLY . 82.3 mt -129.76 123.79 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 124.401 1.08 . . . . 0.0 108.307 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -92.65 128.37 38.48 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.322 0.582 . . . . 0.0 110.029 177.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.482 ' HA ' ' ND2' ' A' ' 188' ' ' ASN . 75.1 mt-30 -91.13 -11.45 38.49 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.233 -174.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.502 ' HB2' ' HG2' ' A' ' 106' ' ' MET . . . -79.41 -49.43 12.35 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 120.997 0.427 . . . . 0.0 110.589 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.544 HG12 HG11 ' A' ' 157' ' ' VAL . 1.7 mp -71.34 109.73 3.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.288 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 50.3 mtt -131.61 159.2 38.97 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 113.693 -1.594 . . . . 0.0 109.554 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.4 t70 67.97 18.36 9.53 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 125.288 1.435 . . . . 0.0 112.295 174.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -103.61 151.99 22.28 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.585 0.754 . . . . 0.0 111.162 -176.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -84.31 102.2 12.51 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 168.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.507 HD12 HD22 ' A' ' 185' ' ' LEU . 44.3 mt -103.28 124.12 57.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -176.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.528 ' HG3' ' HG3' ' A' ' 131' ' ' LYS . 14.0 tpt -98.61 126.65 44.27 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.435 1.094 . . . . 0.0 109.069 -175.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.455 HD12 HG22 ' A' ' 194' ' ' VAL . 12.4 mt -105.79 103.43 12.93 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -174.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.528 ' HG3' ' HG3' ' A' ' 129' ' ' MET . 45.1 mtmt -126.5 150.95 48.44 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.037 0.535 . . . . 0.0 109.981 -176.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -136.91 153.68 50.67 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.907 0.86 . . . . 0.0 112.304 -174.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.52 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 4.6 m-20 -107.5 120.77 43.11 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 162.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -156.4 160.18 39.4 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.264 0.626 . . . . 0.0 111.02 -170.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 53.5 p -86.28 151.22 23.78 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.749 0.819 . . . . 0.0 109.226 174.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 87' ' ' SER . 60.0 t -130.55 132.75 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.381 1.073 . . . . 0.0 108.477 -177.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.3 tp -140.78 140.68 33.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 174.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 58.19 31.04 20.29 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.933 0.893 . . . . 0.0 111.946 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 63.31 30.88 15.59 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 124.97 1.308 . . . . 0.0 112.338 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 7.8 ppt_? -143.65 165.68 26.95 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.226 0.61 . . . . 0.0 109.687 173.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.472 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 10.5 tt -66.48 121.56 15.59 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.313 0.645 . . . . 0.0 109.742 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -82.31 -67.14 0.81 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.257 0.623 . . . . 0.0 110.281 173.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 62.2 m -141.96 127.4 18.87 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.885 0.474 . . . . 0.0 109.843 -173.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.647 HD11 ' HB2' ' A' ' 147' ' ' LEU . 51.9 tp -77.37 114.56 16.33 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.716 0.807 . . . . 0.0 109.545 178.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 57.1 mt -77.82 -52.65 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 175.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.539 HD23 ' HG ' ' A' ' 98' ' ' LEU . 50.2 tp -158.82 145.12 16.92 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.452 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.647 ' HB2' HD11 ' A' ' 144' ' ' LEU . 8.2 tt -139.26 152.25 47.13 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 176.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.738 HH11 HG21 ' A' ' 156' ' ' ILE . 6.8 ptp180 -150.73 157.44 42.96 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 122.046 0.927 . . . . 0.0 112.503 174.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.684 ' HB2' HD21 ' A' ' 181' ' ' LEU . . . -117.55 117.78 30.36 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 113.346 -1.752 . . . . 0.0 107.317 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -145.64 145.1 30.8 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.049 0.452 . . . . 0.0 111.709 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 80.5 p -65.13 163.28 15.29 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.457 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -64.82 -19.6 65.94 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -84.59 -1.46 55.98 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.164 0.586 . . . . 0.0 111.4 176.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 97.45 -5.25 62.5 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-O 119.931 -0.372 . . . . 0.0 114.005 172.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.99 105.97 6.26 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.991 0.395 . . . . 0.0 110.085 -175.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.738 HG21 HH11 ' A' ' 148' ' ' ARG . 13.8 mt -79.51 126.65 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.544 HG11 HG12 ' A' ' 123' ' ' ILE . 24.2 m -134.63 5.41 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 123.902 0.881 . . . . 0.0 110.964 -174.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -153.27 156.06 26.52 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.618 ' HB3' ' HD2' ' A' ' 118' ' ' ARG . 40.5 tt0 -164.83 141.64 6.01 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.802 0.441 . . . . 0.0 110.368 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.498 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 72.2 mt -120.62 121.64 65.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 172.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 15.5 m -137.52 148.13 60.32 Favored Pre-proline 0 N--CA 1.469 0.509 0 C-N-CA 123.272 0.629 . . . . 0.0 109.898 -177.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.403 ' HA ' HD23 ' A' ' 115' ' ' LEU . 18.1 Cg_endo -61.01 134.46 53.19 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 121.864 1.709 . . . . 0.0 110.302 165.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.586 ' HB2' ' HB2' ' A' ' 166' ' ' PHE . 66.2 mt -62.22 145.37 93.87 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.266 0.626 . . . . 0.0 110.886 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -59.01 127.22 23.49 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.53 2.154 . . . . 0.0 110.879 172.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 30.1 m 73.92 10.15 4.65 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.649 1.579 . . . . 0.0 112.519 -175.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.586 ' HB2' ' HB2' ' A' ' 163' ' ' LEU . 90.9 m-85 -132.51 73.41 76.83 Favored Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 123.702 0.801 . . . . 0.0 110.255 175.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -97.68 43.7 0.1 OUTLIER 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 123.612 2.875 . . . . 0.0 111.22 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -129.48 69.22 0.53 Allowed Glycine 0 C--N 1.345 1.04 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.792 -174.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.619 ' HB3' ' HG2' ' A' ' 114' ' ' PRO . 25.4 p-80 -122.66 150.08 43.17 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.474 0.71 . . . . 0.0 110.663 172.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 65.2 p -98.43 -178.62 4.08 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.471 169.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.472 ' HB ' ' O ' ' A' ' 141' ' ' LEU . 5.8 tt -54.6 -41.85 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.152 171.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.546 ' HA ' ' HD3' ' A' ' 175' ' ' LYS . 14.7 mm-40 -56.91 -41.35 77.99 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.366 1.066 . . . . 0.0 111.613 -176.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -64.05 -40.17 95.7 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.372 0.669 . . . . 0.0 111.018 178.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 46.2 t -68.1 -32.65 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.175 0.59 . . . . 0.0 110.604 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.546 ' HD3' ' HA ' ' A' ' 172' ' ' GLU . 27.3 mtpp -62.08 -42.92 99.7 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.564 0.745 . . . . 0.0 110.684 176.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.497 ' O ' HG23 ' A' ' 180' ' ' VAL . 60.7 m-80 -68.58 -41.27 79.9 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.143 175.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.99 -53.28 60.01 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 124.416 1.073 . . . . 0.0 112.008 -175.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 49.9 mt -63.19 -35.43 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 O-C-N 123.604 0.565 . . . . 0.0 109.756 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.19 -32.09 81.15 Favored Glycine 0 C--N 1.347 1.155 0 CA-C-N 116.159 -0.473 . . . . 0.0 114.082 177.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 176' ' ' ASN . 98.0 t -73.0 -44.66 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.684 HD21 ' HB2' ' A' ' 149' ' ' ALA . 48.9 tp -54.44 -49.76 69.27 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.261 1.025 . . . . 0.0 110.674 176.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.468 HD12 ' CH2' ' A' ' 203' ' ' TRP . 17.8 mt -63.88 -45.66 96.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.929 0.891 . . . . 0.0 110.979 176.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -55.1 -36.87 62.15 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 123.893 0.746 . . . . 0.0 113.811 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.517 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -70.07 -48.75 38.0 Favored Glycine 0 C--N 1.347 1.142 0 N-CA-C 111.793 -0.523 . . . . 0.0 111.793 174.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.507 HD22 HD12 ' A' ' 128' ' ' ILE . 97.7 mt -64.19 -31.97 73.37 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.985 0.914 . . . . 0.0 112.419 -176.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -66.24 -41.99 89.23 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.419 0.688 . . . . 0.0 111.121 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -74.84 -34.65 62.34 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.216 0.607 . . . . 0.0 110.417 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.482 ' ND2' ' HA ' ' A' ' 121' ' ' GLN . 6.0 m-20 -67.28 -15.14 63.52 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.344 0.657 . . . . 0.0 110.297 169.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 21.9 t70 64.49 65.99 0.62 Allowed 'General case' 0 C--N 1.349 0.577 0 C-N-CA 125.799 1.64 . . . . 0.0 110.223 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -121.95 139.69 53.36 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 175.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 74.0 m -78.46 104.81 9.3 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 23.9 m -80.77 130.23 36.24 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.591 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -133.36 123.07 24.74 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 173.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.455 HG22 HD12 ' A' ' 130' ' ' LEU . 4.3 t -101.82 150.05 6.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 -175.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 34.0 t -58.68 143.48 46.54 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.867 0.467 . . . . 0.0 111.146 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -57.01 -32.96 66.67 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.939 0.896 . . . . 0.0 111.25 -178.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 67.8 p -72.02 -48.49 44.24 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.582 175.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 58.3 mt -62.67 -36.45 82.92 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.107 0.563 . . . . 0.0 110.389 -177.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.541 ' HB3' ' HB3' ' A' ' 206' ' ' SER . 43.7 mt-30 -55.51 -33.79 64.05 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.596 1.159 . . . . 0.0 112.426 -177.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -101.25 -39.53 7.58 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -73.97 -38.03 64.3 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -168.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.435 ' O ' ' HG2' ' A' ' 175' ' ' LYS . . . -120.64 -57.7 1.88 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.896 0.478 . . . . 0.0 110.074 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.499 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 69.5 t-105 -58.36 -21.54 50.26 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 125.272 1.429 . . . . 0.0 114.057 -168.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 132.59 -127.38 4.81 Favored Glycine 0 N--CA 1.471 1.014 0 CA-C-O 119.75 -0.472 . . . . 0.0 112.184 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 31.2 t -109.59 112.59 24.77 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 123.554 0.742 . . . . 0.0 109.395 -177.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.541 ' HB3' ' HB3' ' A' ' 199' ' ' GLN . 32.1 t -155.28 101.67 2.23 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -76.17 87.15 3.02 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.514 0.725 . . . . 0.0 109.162 178.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.85 160.83 31.89 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.503 178.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -142.88 88.7 2.07 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.169 0.588 . . . . 0.0 110.102 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -69.87 115.9 6.49 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 171.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -60.83 148.74 82.35 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 123.387 0.675 . . . . 0.0 111.391 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -53.13 134.5 56.45 Favored 'Trans proline' 0 C--N 1.383 2.358 0 C-N-CA 123.109 2.54 . . . . 0.0 112.162 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -64.85 85.19 0.17 Allowed 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.916 2.411 . . . . 0.0 112.07 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 72.6 mt -139.41 149.44 44.08 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.139 1.375 . . . . 0.0 108.096 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.451 HG22 ' HG ' ' A' ' 216' ' ' LEU . 33.0 m -133.94 -78.97 0.47 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.451 ' HG ' HG22 ' A' ' 215' ' ' THR . 71.3 mt -140.95 163.66 32.36 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.522 1.129 . . . . 0.0 109.067 -176.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 . . . . . 0 CA--C 1.555 1.166 0 CA-C-O 118.5 -0.762 . . . . 0.0 109.195 176.145 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 N--CA 1.482 1.145 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.559 ' HB2' HD11 ' A' ' 137' ' ' ILE . 45.5 Cg_endo -64.71 115.54 3.29 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.607 2.204 . . . . 0.0 112.376 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -89.15 141.4 28.55 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.566 0.746 . . . . 0.0 110.597 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 50.4 m -99.63 128.29 45.74 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.396 0.678 . . . . 0.0 110.276 178.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 29.8 ttp-105 -115.59 140.87 48.78 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.617 0.767 . . . . 0.0 109.956 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -99.65 109.52 22.0 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.834 0.853 . . . . 0.0 109.945 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.7 mm -78.85 121.68 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 123.783 0.833 . . . . 0.0 109.352 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.1 p -108.38 66.19 0.64 Allowed 'General case' 0 C--O 1.244 0.781 0 CA-C-O 122.672 1.225 . . . . 0.0 108.112 173.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.543 ' HB3' ' O ' ' A' ' 132' ' ' ALA . 19.1 t70 -68.95 -35.54 76.88 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 112.91 -1.95 . . . . 0.0 110.963 -177.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.582 ' HB3' ' HB3' ' A' ' 131' ' ' LYS . 26.2 ptt? -110.93 146.24 36.92 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 171.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.1 m -91.85 158.02 16.55 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.308 0.643 . . . . 0.0 111.069 -167.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.2 mp -58.53 -34.97 52.54 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 C-N-CA 124.122 0.969 . . . . 0.0 110.385 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -48.91 -43.02 38.94 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.358 1.063 . . . . 0.0 113.094 176.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.52 -24.45 15.56 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 122.847 0.459 . . . . 0.0 111.102 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.476 ' HA ' HH21 ' A' ' 148' ' ' ARG . 9.0 tt -67.46 -45.81 74.89 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.616 0.766 . . . . 0.0 110.128 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 26.4 t -96.32 10.93 36.46 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.561 1.144 . . . . 0.0 110.316 -175.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -74.23 136.02 42.72 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.049 0.54 . . . . 0.0 110.517 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -77.42 133.56 38.62 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 174.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 17.9 p-90 -150.76 171.35 17.33 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.661 0.784 . . . . 0.0 110.406 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -148.2 165.33 31.24 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.728 1.211 . . . . 0.0 108.665 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 62.3 mtp -110.37 127.77 55.24 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 36.2 tp -73.39 -40.84 64.01 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.411 0.684 . . . . 0.0 109.642 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.521 ' HG2' ' HB2' ' A' ' 122' ' ' ALA . 23.8 mmt -124.77 88.96 53.11 Favored Pre-proline 0 N--CA 1.482 1.134 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 169.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.18 112.38 2.74 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 122.995 2.464 . . . . 0.0 112.236 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 119' ' ' ILE . 58.7 tptt -115.61 118.39 32.99 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 169.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -100.96 115.37 30.29 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.46 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 16.7 tppt? -120.9 159.84 24.7 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.429 1.092 . . . . 0.0 108.377 175.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.5 t -137.68 140.8 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -122.84 84.7 2.3 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 171.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.5 -116.71 7.2 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.883 175.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -85.25 8.84 4.39 Favored 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 123.227 2.618 . . . . 0.0 112.739 -177.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.8 mt -131.87 121.95 24.89 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.977 0.911 . . . . 0.0 109.021 -171.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.573 ' SG ' HD21 ' A' ' 163' ' ' LEU . 90.0 m -90.51 120.61 31.75 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.964 0.506 . . . . 0.0 111.252 -178.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.46 ' HB ' ' HB3' ' A' ' 110' ' ' LYS . 17.2 mm -86.64 155.3 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.358 0 C-N-CA 124.298 1.039 . . . . 0.0 110.034 -176.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -134.66 121.27 20.61 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.438 HD12 ' HA3' ' A' ' 184' ' ' GLY . 50.5 mm -123.7 122.85 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 123.416 0.686 . . . . 0.0 109.686 -177.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -98.64 115.45 28.7 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 172.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.477 ' HA ' HD21 ' A' ' 188' ' ' ASN . 45.6 mt-30 -84.08 -6.91 59.49 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.02 0.928 . . . . 0.0 113.327 -174.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.521 ' HB2' ' HG2' ' A' ' 106' ' ' MET . . . -87.7 -45.45 10.35 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.963 0.505 . . . . 0.0 110.301 177.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.467 HG12 HG11 ' A' ' 157' ' ' VAL . 1.8 mp -70.67 110.7 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-O 122.038 0.923 . . . . 0.0 110.006 -177.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.585 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 51.3 mtt -131.72 158.43 41.19 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.224 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.5 t70 67.82 13.47 9.2 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.757 1.223 . . . . 0.0 112.739 174.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -97.55 146.82 24.9 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.43 -0.793 . . . . 0.0 110.611 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.563 ' HB2' ' HB3' ' A' ' 152' ' ' GLU . 39.4 m-80 -82.73 97.74 8.72 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 174.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.444 HD12 HD22 ' A' ' 185' ' ' LEU . 53.4 mt -105.82 130.12 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.462 0.705 . . . . 0.0 110.111 -171.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 12.2 tpt -105.12 134.11 48.77 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.163 0.985 . . . . 0.0 110.026 -175.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.425 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 2.2 mm? -100.2 109.15 21.4 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.582 ' HB3' ' HB3' ' A' ' 93' ' ' MET . 40.9 mttm -127.56 152.0 48.18 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.049 0.939 . . . . 0.0 110.682 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.698 ' HB3' HD21 ' A' ' 198' ' ' LEU . . . -146.63 149.42 33.47 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -105.5 132.69 51.36 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 165.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.471 ' HA ' HG13 ' A' ' 145' ' ' ILE . 39.6 p90 -158.79 159.27 34.95 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.761 0.824 . . . . 0.0 109.979 -171.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.8 p -86.57 160.69 18.86 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.391 0.676 . . . . 0.0 109.695 173.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 87' ' ' SER . 77.7 t -128.0 135.79 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.36 1.064 . . . . 0.0 109.135 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.559 HD11 ' HB2' ' A' ' 85' ' ' PRO . 8.2 tp -142.08 139.46 30.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 170.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 57.25 33.8 23.84 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.776 0.83 . . . . 0.0 111.72 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 36.0 t70 67.35 8.82 6.54 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.892 1.277 . . . . 0.0 112.636 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 44.5 ptt85 -116.57 165.25 13.46 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.647 0.779 . . . . 0.0 110.033 176.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.404 ' HB3' HG13 ' A' ' 171' ' ' ILE . 8.5 tt -64.26 108.63 1.64 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.507 0.723 . . . . 0.0 109.204 175.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -68.18 -68.73 0.37 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.341 0.656 . . . . 0.0 110.334 177.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.6 m -143.68 130.56 20.44 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.418 -175.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.7 tp -73.16 124.88 26.46 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 175.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.471 HG13 ' HA ' ' A' ' 134' ' ' PHE . 70.1 mt -84.54 -49.86 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 176.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 48.2 tp -164.8 147.53 8.48 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.75 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.774 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 6.7 tt -134.06 153.52 51.75 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 176.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.494 ' N ' HD23 ' A' ' 147' ' ' LEU . 45.1 ttm-85 -143.23 147.25 34.54 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.546 0.738 . . . . 0.0 111.284 -173.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.595 ' HB2' HD21 ' A' ' 181' ' ' LEU . . . -120.69 111.3 17.44 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.791 1.237 . . . . 0.0 107.856 169.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 40.5 p90 -127.67 157.27 40.74 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.166 0.986 . . . . 0.0 108.756 -178.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 63.0 p -86.02 176.65 7.91 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.39 0.614 . . . . 0.0 111.122 -174.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 127' ' ' ASN . 11.0 pt-20 -54.38 -35.78 63.19 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.912 1.285 . . . . 0.0 112.144 174.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.418 ' HG2' ' H ' ' A' ' 153' ' ' GLU . 8.5 pt-20 -88.32 -9.22 53.52 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.115 0.966 . . . . 0.0 111.618 -177.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 100.63 -3.36 56.17 Favored Glycine 0 C--N 1.352 1.43 0 CA-C-O 120.016 -0.324 . . . . 0.0 113.471 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.82 104.9 2.59 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.437 HD13 ' HD3' ' A' ' 148' ' ' ARG . 26.3 mt -69.87 124.28 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.178 0.591 . . . . 0.0 109.53 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.467 HG11 HG12 ' A' ' 123' ' ' ILE . 35.0 m -126.41 -3.68 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.737 0.815 . . . . 0.0 111.382 -174.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -155.31 164.96 32.19 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.651 -175.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -167.43 153.86 8.05 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.245 0.618 . . . . 0.0 109.528 -176.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.774 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 78.6 mt -125.75 102.99 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 165.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 84.0 p -99.0 110.42 57.66 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 123.61 0.764 . . . . 0.0 110.014 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.06 123.95 14.59 Favored 'Trans proline' 0 C--N 1.367 1.513 0 C-N-CA 122.921 2.414 . . . . 0.0 112.921 174.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.573 HD21 ' SG ' ' A' ' 116' ' ' CYS . 89.5 mt -62.13 129.18 91.88 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 123.789 0.836 . . . . 0.0 110.714 177.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 163' ' ' LEU . 15.3 Cg_exo -68.71 -21.1 39.37 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 123.267 2.645 . . . . 0.0 111.951 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 48.0 p -69.99 -18.09 63.31 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.804 0.842 . . . . 0.0 111.414 173.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -128.67 75.74 79.44 Favored Pre-proline 0 N--CA 1.479 0.98 0 C-N-CA 123.642 0.777 . . . . 0.0 110.109 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.25 -31.42 7.57 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.283 1.989 . . . . 0.0 112.087 175.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -92.79 68.73 1.74 Allowed Glycine 0 C--N 1.345 1.082 0 N-CA-C 111.781 -0.527 . . . . 0.0 111.781 -176.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -108.75 151.94 25.53 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.36 0.664 . . . . 0.0 110.097 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 44.5 p -84.57 160.58 20.43 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.493 0.663 . . . . 0.0 112.081 -174.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.428 HD11 ' O ' ' A' ' 201' ' ' PHE . 11.4 tt -57.58 -32.1 41.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.648 170.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -72.85 -30.54 64.09 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.539 0.736 . . . . 0.0 111.353 -177.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -60.76 -39.72 89.82 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 122.843 0.457 . . . . 0.0 110.499 173.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 178' ' ' ILE . 38.5 t -64.88 -39.13 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 O-C-N 124.471 1.107 . . . . 0.0 110.2 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -59.26 -48.76 80.43 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.525 0.73 . . . . 0.0 111.459 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.465 ' O ' HG23 ' A' ' 180' ' ' VAL . 65.0 m-80 -65.71 -38.86 90.37 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.935 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.4 -43.4 97.65 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 124.137 0.898 . . . . 0.0 111.451 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 174' ' ' VAL . 60.5 mt -67.52 -34.1 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.9 -33.38 87.09 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 116.625 -0.262 . . . . 0.0 113.596 176.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 176' ' ' ASN . 97.8 t -78.71 -43.25 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.48 0.712 . . . . 0.0 110.353 177.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.595 HD21 ' HB2' ' A' ' 149' ' ' ALA . 38.6 tp -57.34 -54.79 42.81 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.819 0.848 . . . . 0.0 111.035 176.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.614 HG23 HG21 ' A' ' 192' ' ' VAL . 61.8 mt -58.06 -40.12 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 123.821 0.848 . . . . 0.0 110.225 170.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.4 -21.82 54.88 Favored Glycine 0 N--CA 1.475 1.28 0 N-CA-C 115.151 0.82 . . . . 0.0 115.151 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.438 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -95.74 -16.11 40.45 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 117.004 0.402 . . . . 0.0 112.751 173.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.444 HD22 HD12 ' A' ' 128' ' ' ILE . 81.9 mt -91.76 -32.66 15.31 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.408 1.083 . . . . 0.0 111.825 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.517 ' O ' ' HD3' ' A' ' 212' ' ' PRO . 0.4 OUTLIER -77.84 -31.8 51.76 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.136 0.574 . . . . 0.0 111.132 -173.439 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 8.7 ptm85 -70.23 -24.77 63.15 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.669 0.787 . . . . 0.0 110.942 173.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.585 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 4.2 m-20 -81.48 -10.88 59.39 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.79 0.836 . . . . 0.0 110.293 172.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 19.5 t70 57.63 65.79 1.26 Allowed 'General case' 0 C--N 1.358 0.975 0 C-N-CA 125.414 1.486 . . . . 0.0 110.2 -171.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -107.57 145.71 32.85 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.635 169.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.1 m -83.47 100.31 10.66 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.614 HG21 HG23 ' A' ' 182' ' ' ILE . 18.7 m -99.27 134.63 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 123.645 0.778 . . . . 0.0 110.571 -171.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -135.66 129.82 33.35 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.425 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 2.9 t -90.01 143.03 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 23.2 t -69.11 156.58 38.44 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -172.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -50.23 -49.5 52.73 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.312 1.045 . . . . 0.0 111.812 -176.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 38.1 p -61.18 -50.84 71.52 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 123.967 0.792 . . . . 0.0 110.19 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.698 HD21 ' HB3' ' A' ' 132' ' ' ALA . 62.9 mt -60.07 -36.47 77.43 Favored 'General case' 0 C--O 1.215 -0.735 0 O-C-N 123.882 0.739 . . . . 0.0 111.752 -176.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.495 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 56.0 mt-30 -66.0 -51.7 55.99 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.472 0.709 . . . . 0.0 110.776 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.26 -24.79 51.08 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -175.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.428 ' O ' HD11 ' A' ' 171' ' ' ILE . 25.3 m-85 -82.04 -57.37 3.43 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.819 0.448 . . . . 0.0 110.698 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -116.82 -57.77 2.14 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.24 0.616 . . . . 0.0 110.408 -166.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.495 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 51.4 t-105 -79.65 73.98 6.33 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.857 1.263 . . . . 0.0 111.103 -168.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -102.2 20.7 44.18 Favored Glycine 0 N--CA 1.469 0.853 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 172.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 37.0 p -146.69 93.85 2.35 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.276 1.03 . . . . 0.0 109.128 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 15.4 p -81.07 95.7 6.92 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.507 0.723 . . . . 0.0 109.21 174.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -118.17 6.97 12.03 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.307 0.643 . . . . 0.0 112.542 -168.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.439 ' HG3' ' HG2' ' A' ' 186' ' ' GLU . 8.7 tp10 -138.54 101.67 4.41 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.285 0.564 . . . . 0.0 111.807 -176.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -149.66 30.42 0.74 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 125.813 1.645 . . . . 0.0 108.661 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -63.29 -41.91 99.39 Favored Glycine 0 C--N 1.351 1.378 0 CA-C-N 115.84 -0.618 . . . . 0.0 113.898 -170.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 66.15 156.39 0.13 Allowed Pre-proline 0 N--CA 1.493 1.69 0 C-N-CA 125.438 1.495 . . . . 0.0 112.623 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.517 ' HD3' ' O ' ' A' ' 186' ' ' GLU . 85.2 Cg_endo -77.02 130.52 11.34 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 122.174 1.916 . . . . 0.0 110.649 178.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -47.74 123.28 8.11 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 123.769 2.979 . . . . 0.0 112.223 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 73.2 mt -72.42 83.22 1.08 Allowed 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.271 0.558 . . . . 0.0 109.888 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 71.6 p -73.09 142.59 47.56 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.823 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.4 pp -66.53 146.77 54.16 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 123.237 0.336 . . . . 0.0 110.662 -175.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 . . . . . 0 CA--C 1.55 0.977 0 C-N-CA 123.801 0.84 . . . . 0.0 109.317 179.257 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.405 ' SD ' ' N ' ' A' ' 84' ' ' MET . 1.4 pmm? . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.17 -13.92 40.66 Favored 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 123.124 2.549 . . . . 0.0 112.923 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 69.09 39.26 1.78 Allowed 'General case' 0 C--N 1.353 0.743 0 C-N-CA 124.689 1.195 . . . . 0.0 110.846 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.4 t -96.31 130.16 43.47 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.529 177.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -156.86 147.39 21.44 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.146 0.578 . . . . 0.0 110.823 -174.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -97.54 111.74 23.89 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 168.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.6 mm -77.42 140.43 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.749 0.82 . . . . 0.0 109.76 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.6 p -141.34 61.12 1.49 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.183 0.993 . . . . 0.0 109.326 -173.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.9 -15.01 60.27 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.493 172.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 69.2 mtm -110.66 133.71 53.09 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 165.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 74.8 p -71.6 159.65 34.05 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 167.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.72 -34.76 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 123.195 0.598 . . . . 0.0 110.249 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -56.6 -61.51 2.37 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.375 1.07 . . . . 0.0 112.053 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -73.51 -26.5 60.91 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -176.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.402 ' HG ' HD23 ' A' ' 146' ' ' LEU . 7.8 tt -63.18 -51.98 64.2 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.62 0.768 . . . . 0.0 109.785 176.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.9 t -91.94 2.28 56.64 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.583 -174.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -69.71 132.46 46.16 Favored 'General case' 0 C--N 1.356 0.858 0 C-N-CA 122.717 0.407 . . . . 0.0 111.262 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -89.15 148.77 23.48 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.665 0.786 . . . . 0.0 109.729 176.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.464 ' HE1' ' NH1' ' A' ' 148' ' ' ARG . 12.2 p-90 -151.93 164.45 37.12 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 124.337 1.055 . . . . 0.0 110.373 -171.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -115.19 158.17 22.63 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.526 1.13 . . . . 0.0 110.135 -176.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.484 ' SD ' ' HD2' ' A' ' 118' ' ' ARG . 70.2 mtp -122.02 145.53 48.05 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.386 0.674 . . . . 0.0 110.454 178.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.7 tp -91.97 -42.49 9.97 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.856 0.862 . . . . 0.0 109.926 177.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 24.9 mmt -126.49 85.69 59.79 Favored Pre-proline 0 N--CA 1.482 1.159 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 173.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -70.47 113.27 3.44 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 123.125 2.55 . . . . 0.0 111.676 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.487 ' HD3' ' NE2' ' A' ' 121' ' ' GLN . 55.9 tptt -98.23 118.49 34.99 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 172.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -82.76 105.68 13.98 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 170.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -125.98 145.49 50.27 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.907 0.883 . . . . 0.0 108.91 174.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.0 t -136.77 139.53 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 173.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -126.82 86.08 2.46 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 174.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.38 -121.52 8.22 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.48 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -89.54 15.96 1.86 Allowed 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 123.339 2.693 . . . . 0.0 113.225 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.667 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 5.4 mp -129.11 137.4 51.2 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.658 0.783 . . . . 0.0 108.976 176.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 53.5 t -92.03 130.46 37.77 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 173.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.1 mm -100.76 155.9 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.962 0.905 . . . . 0.0 108.802 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.484 ' HD2' ' SD ' ' A' ' 104' ' ' MET . 20.2 tpp180 -138.61 120.54 15.48 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.463 HD11 ' HA ' ' A' ' 181' ' ' LEU . 38.8 mm -123.56 134.84 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.555 1.142 . . . . 0.0 108.703 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -101.65 115.19 29.97 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 169.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.487 ' NE2' ' HD3' ' A' ' 108' ' ' LYS . 85.5 mt-30 -78.73 -2.07 37.61 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.557 0.743 . . . . 0.0 112.912 -172.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.59 -32.75 10.94 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.359 0.664 . . . . 0.0 110.395 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 31.2 mm -71.23 110.88 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 121.468 0.651 . . . . 0.0 110.739 -176.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.486 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 57.9 mtt -136.34 161.91 34.48 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.218 -173.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 62.62 19.66 11.47 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.739 1.215 . . . . 0.0 113.351 171.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -102.3 149.94 23.83 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.336 0.654 . . . . 0.0 110.016 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -87.23 102.87 14.9 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 167.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 57.3 mt -104.2 142.31 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 123.607 0.763 . . . . 0.0 109.038 -172.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 11.4 tpt -126.65 125.13 41.36 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.274 1.029 . . . . 0.0 108.636 -173.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 14.6 mt -90.46 102.73 15.47 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -176.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.481 ' HD3' ' CD1' ' A' ' 150' ' ' PHE . 25.0 mtpp -113.71 129.84 56.51 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.528 1.131 . . . . 0.0 108.771 -171.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.491 ' HB2' ' HG ' ' A' ' 147' ' ' LEU . . . -134.67 154.98 51.29 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.797 0.808 . . . . 0.0 113.017 -172.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -116.48 134.9 54.32 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 114.061 -1.427 . . . . 0.0 107.774 165.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.507 ' HA ' HG13 ' A' ' 145' ' ' ILE . 37.6 p90 -162.96 165.05 25.46 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.508 0.505 . . . . 0.0 111.581 -176.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 44.7 p -85.98 148.76 25.6 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.462 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 90.1 t -126.44 151.81 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.252 1.021 . . . . 0.0 109.148 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.3 tp -158.4 144.87 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 170.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 57.41 26.52 12.64 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 176.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 67.83 15.03 9.57 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 124.758 1.223 . . . . 0.0 112.701 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -120.82 160.7 22.87 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.715 0.806 . . . . 0.0 109.457 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.519 HD13 ' HB2' ' A' ' 202' ' ' ALA . 9.8 tt -66.6 123.27 19.62 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 174.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -78.93 -69.38 0.57 Allowed 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 176.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 99.0 m -145.8 129.5 17.13 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.368 0.667 . . . . 0.0 109.418 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.567 HD22 HG13 ' A' ' 174' ' ' VAL . 53.3 tp -71.52 115.83 11.15 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 123.894 0.746 . . . . 0.0 109.966 176.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.507 HG13 ' HA ' ' A' ' 134' ' ' PHE . 73.5 mt -74.29 -53.83 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.402 HD23 ' HG ' ' A' ' 98' ' ' LEU . 57.7 tp -160.18 149.74 17.81 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.134 177.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.633 HD13 HD12 ' A' ' 160' ' ' ILE . 7.1 tt -134.51 148.78 50.6 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 174.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.464 ' NH1' ' HE1' ' A' ' 102' ' ' TRP . 43.5 mtt-85 -141.95 159.48 42.14 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.994 0.918 . . . . 0.0 110.329 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -115.77 112.15 21.59 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.121 0.968 . . . . 0.0 109.166 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.481 ' CD1' ' HD3' ' A' ' 131' ' ' LYS . 56.9 m-85 -107.99 136.01 48.4 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.232 1.013 . . . . 0.0 109.93 -177.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 66.9 p -81.43 -172.93 4.08 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.955 0.502 . . . . 0.0 110.648 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -53.76 -37.56 63.53 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.446 0.698 . . . . 0.0 111.882 170.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -80.5 -5.5 56.76 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.121 0.968 . . . . 0.0 111.91 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 75.46 23.05 74.39 Favored Glycine 0 C--N 1.347 1.19 0 N-CA-C 112.102 -0.399 . . . . 0.0 112.102 -174.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -82.69 121.25 26.61 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.417 HD13 ' HD3' ' A' ' 148' ' ' ARG . 12.2 mt -75.6 110.3 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.6 m -120.41 1.86 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.337 1.055 . . . . 0.0 111.047 -175.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -157.23 166.59 33.69 Favored Glycine 0 C--O 1.242 0.634 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -165.26 150.17 9.09 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -174.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.633 HD12 HD13 ' A' ' 147' ' ' LEU . 63.9 mt -128.43 102.69 8.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 164.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 48.1 t -112.06 113.35 52.07 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.667 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 19.0 Cg_endo -57.79 136.21 73.95 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.291 1.994 . . . . 0.0 111.787 178.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 83.2 mt -57.54 136.89 82.19 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 123.968 0.907 . . . . 0.0 112.402 -171.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.23 -31.65 84.83 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 123.521 2.814 . . . . 0.0 113.109 175.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 25.1 m -77.43 -6.64 54.16 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.99 0.916 . . . . 0.0 112.509 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -133.43 89.87 30.86 Favored Pre-proline 0 N--CA 1.479 0.982 0 C-N-CA 123.92 0.888 . . . . 0.0 109.143 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -76.32 3.04 6.62 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.333 2.689 . . . . 0.0 113.792 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -146.94 146.16 15.73 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 177.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -148.48 163.52 36.92 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 123.823 0.849 . . . . 0.0 109.553 175.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 34.5 p -83.94 156.26 22.43 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.479 HD11 ' O ' ' A' ' 201' ' ' PHE . 7.2 tt -58.37 -31.89 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 124.178 0.991 . . . . 0.0 110.593 171.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -67.15 -38.08 84.9 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.474 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -62.71 -33.93 76.12 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.834 0.454 . . . . 0.0 110.833 176.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.567 HG13 HD22 ' A' ' 144' ' ' LEU . 60.9 t -66.56 -52.53 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 124.009 0.818 . . . . 0.0 111.618 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -63.04 -33.98 76.6 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 122.225 0.21 . . . . 0.0 111.456 -176.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.401 ' O ' HG23 ' A' ' 180' ' ' VAL . 51.5 m-80 -69.82 -40.36 75.95 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.161 0.584 . . . . 0.0 110.185 174.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -59.91 -40.44 88.82 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 124.084 0.865 . . . . 0.0 110.805 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 174' ' ' VAL . 67.5 mt -68.2 -38.86 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.352 0.661 . . . . 0.0 109.671 177.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.36 -35.29 91.44 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 116.003 -0.544 . . . . 0.0 113.612 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 176' ' ' ASN . 76.2 t -76.09 -38.67 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.112 0.565 . . . . 0.0 110.194 177.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.463 ' HA ' HD11 ' A' ' 119' ' ' ILE . 30.1 tp -57.01 -48.09 79.31 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.354 0.661 . . . . 0.0 110.276 173.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.414 ' O ' ' HG2' ' A' ' 186' ' ' GLU . 47.6 mt -60.82 -48.9 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.82 0.848 . . . . 0.0 110.492 176.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -55.93 -44.61 87.64 Favored Glycine 0 C--N 1.347 1.154 0 O-C-N 123.796 0.685 . . . . 0.0 113.438 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -66.79 -28.57 73.83 Favored Glycine 0 C--N 1.35 1.343 0 O-C-N 123.959 0.446 . . . . 0.0 113.676 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 33.9 mt -83.21 -33.27 26.16 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.296 1.038 . . . . 0.0 111.711 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 52.3 mm-40 -68.62 -39.3 80.88 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.541 0.737 . . . . 0.0 110.873 -177.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -73.8 -16.47 61.15 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.894 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.486 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 8.1 m-20 -77.09 -15.44 59.57 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.386 0.674 . . . . 0.0 111.743 169.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 66.72 64.31 0.48 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.408 1.083 . . . . 0.0 110.138 -172.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -137.06 154.6 50.3 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.755 167.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 20.7 m -98.95 105.98 18.18 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.744 0.818 . . . . 0.0 109.483 -169.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 13.7 m -97.93 150.3 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-O 121.714 0.769 . . . . 0.0 112.095 -178.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 19.6 tpp85 -133.37 139.1 46.61 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.9 t -98.69 146.77 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -178.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 27.9 t -55.08 145.54 20.53 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.286 0.634 . . . . 0.0 111.943 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -51.86 -37.8 53.52 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.005 0.922 . . . . 0.0 111.284 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 53.3 p -73.2 -51.86 16.22 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.726 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 62.2 mt -57.02 -39.02 73.98 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.09 0.556 . . . . 0.0 111.241 -177.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.452 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 46.7 mt-30 -58.81 -39.4 81.06 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.958 0.903 . . . . 0.0 112.246 -176.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.01 -32.54 10.9 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -176.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.479 ' O ' HD11 ' A' ' 171' ' ' ILE . 35.0 m-85 -74.97 -52.29 11.52 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 117.951 0.341 . . . . 0.0 111.25 -175.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.519 ' HB2' HD13 ' A' ' 141' ' ' LEU . . . -109.63 -50.62 2.96 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.056 0.542 . . . . 0.0 111.346 -172.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.452 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 70.7 t-105 -66.61 -44.33 82.37 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.369 1.068 . . . . 0.0 111.156 -170.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.36 -15.84 77.46 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 115.622 -0.717 . . . . 0.0 113.466 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 23.0 t -62.84 116.75 5.54 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.658 0.783 . . . . 0.0 109.1 178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 46.8 m -145.07 176.01 9.82 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.915 0.886 . . . . 0.0 110.381 -173.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 63.3 33.94 13.62 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.065 0.946 . . . . 0.0 111.495 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -97.7 -145.55 0.31 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.752 1.221 . . . . 0.0 110.368 -176.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -155.69 -58.75 0.1 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.884 0.474 . . . . 0.0 110.662 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 126.98 -27.07 4.93 Favored Glycine 0 N--CA 1.471 1.031 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 -173.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 17.1 mtm180 50.46 85.16 0.19 Allowed Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 125.216 1.406 . . . . 0.0 110.689 -175.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -76.15 157.52 37.92 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 123.023 2.482 . . . . 0.0 111.901 -170.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -51.41 117.84 3.82 Favored 'Trans proline' 0 C--N 1.384 2.421 0 C-N-CA 122.898 2.399 . . . . 0.0 111.243 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 84.9 mt -65.04 107.09 1.41 Allowed 'General case' 0 C--O 1.241 0.621 0 O-C-N 123.379 0.424 . . . . 0.0 110.287 -174.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 16.3 p -67.42 141.75 56.92 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.387 -177.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.1 pp -137.9 -173.34 3.48 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 124.225 1.01 . . . . 0.0 110.512 -172.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.556 1.21 0 C-N-CA 124.262 1.025 . . . . 0.0 108.623 -175.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 12.6 tpt . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.402 ' HB2' HD11 ' A' ' 137' ' ' ILE . 0.9 OUTLIER -86.42 176.72 4.75 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.779 2.32 . . . . 0.0 111.197 168.027 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.87 101.77 0.53 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.992 0.517 . . . . 0.0 110.67 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.8 t -131.42 142.35 50.0 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.633 0.773 . . . . 0.0 109.929 -174.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -158.48 148.82 20.01 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.145 0.578 . . . . 0.0 109.997 -173.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -98.78 110.49 23.09 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 168.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.8 mm -77.47 118.7 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.608 0.763 . . . . 0.0 109.025 173.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 38.5 p -102.47 68.02 1.04 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.538 ' HB3' ' O ' ' A' ' 132' ' ' ALA . 32.4 t70 -72.77 -25.17 61.08 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 114.439 -1.255 . . . . 0.0 111.059 -175.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 60.7 mtm -92.92 136.98 32.77 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 162.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 77.0 p -67.37 163.82 19.92 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 167.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 29.8 mm -57.04 -36.06 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 173.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -58.94 -42.07 88.9 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.313 175.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -77.43 -35.94 53.58 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 122.873 0.469 . . . . 0.0 111.549 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.429 HD12 ' ND2' ' A' ' 133' ' ' ASN . 6.7 tt -64.03 -40.23 95.85 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.974 1.31 . . . . 0.0 109.826 -177.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.0 t -113.34 22.05 14.61 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.348 1.059 . . . . 0.0 109.91 -176.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -66.33 137.5 56.96 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.481 0.712 . . . . 0.0 111.14 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -79.03 136.14 37.1 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 175.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.433 ' CG ' ' HB ' ' A' ' 156' ' ' ILE . 38.3 p-90 -156.06 164.86 37.9 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.932 0.893 . . . . 0.0 110.33 176.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -136.93 149.58 47.67 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.763 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.43 ' HG3' ' HG3' ' A' ' 107' ' ' PRO . 13.2 ptm -129.78 129.66 44.37 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 173.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.546 ' H ' HD23 ' A' ' 105' ' ' LEU . 0.9 OUTLIER -94.75 -19.41 20.39 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.297 0.639 . . . . 0.0 110.857 -173.169 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 94.1 mmm -127.37 72.44 77.33 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.187 0.995 . . . . 0.0 109.375 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.43 ' HG3' ' HG3' ' A' ' 104' ' ' MET . 12.3 Cg_exo -71.03 110.39 2.8 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 122.63 2.22 . . . . 0.0 111.741 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.491 ' HB3' ' HB ' ' A' ' 119' ' ' ILE . 57.7 tptt -82.83 117.07 22.44 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 173.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 20.6 tm0? -77.3 102.24 6.65 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.486 ' HA ' ' HE3' ' A' ' 110' ' ' LYS . 0.1 OUTLIER -137.09 130.63 31.55 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.383 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 91.0 t -134.43 138.01 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 173.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -123.61 102.96 8.14 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.154 0.582 . . . . 0.0 109.44 175.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.17 -125.18 26.71 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.007 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -86.31 13.79 2.63 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 123.397 2.732 . . . . 0.0 113.289 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.493 HD23 ' HA ' ' A' ' 162' ' ' PRO . 86.7 mt -130.97 130.85 43.93 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.567 0.747 . . . . 0.0 110.381 -175.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 53.3 t -83.83 137.27 33.78 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.502 0.721 . . . . 0.0 110.266 173.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.3 mm -106.08 151.93 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 C-N-CA 123.924 0.89 . . . . 0.0 108.763 175.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -130.79 124.29 31.04 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 173.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.616 HD13 ' HA3' ' A' ' 184' ' ' GLY . 55.3 mt -132.3 122.69 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.513 ' HB3' ' HB ' ' A' ' 157' ' ' VAL . 23.7 t70 -93.85 121.42 35.28 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.454 ' HA ' ' ND2' ' A' ' 188' ' ' ASN . 22.3 mt-30 -84.29 -7.83 59.21 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -174.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.83 -47.45 11.09 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 118.287 0.494 . . . . 0.0 110.4 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.523 HG23 ' HG3' ' A' ' 126' ' ' LYS . 1.7 mp -71.74 102.47 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-O 122.32 1.057 . . . . 0.0 109.499 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 38.6 mtt -124.55 170.14 11.2 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-N 113.613 -1.63 . . . . 0.0 109.773 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 70.47 11.67 7.38 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 124.762 1.225 . . . . 0.0 112.573 173.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.523 ' HG3' HG23 ' A' ' 123' ' ' ILE . 74.7 mmtt -100.64 156.67 17.18 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.708 0.803 . . . . 0.0 112.227 -171.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.437 ' HB2' ' HG2' ' A' ' 152' ' ' GLU . 90.4 m-20 -89.77 108.91 19.97 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 166.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.562 ' HB ' HG12 ' A' ' 192' ' ' VAL . 64.4 mt -112.55 137.33 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.261 0.624 . . . . 0.0 110.355 -176.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.508 ' HG3' ' HG2' ' A' ' 131' ' ' LYS . 37.2 tpp -113.84 132.81 55.75 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.912 1.285 . . . . 0.0 109.774 -175.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.524 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 2.4 mm? -93.18 102.49 14.79 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.583 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 9.1 mmpt? -105.53 143.2 34.03 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 175.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.538 ' O ' ' HB3' ' A' ' 92' ' ' ASP . . . -145.58 136.58 24.65 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.429 ' ND2' HD12 ' A' ' 98' ' ' LEU . 4.9 m-20 -89.62 118.68 29.42 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 163.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -148.58 157.5 43.5 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.094 0.558 . . . . 0.0 110.728 -174.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.5 t -86.43 160.19 19.11 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.756 174.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.6 t -134.41 143.92 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.371 1.068 . . . . 0.0 109.071 -176.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.402 HD11 ' HB2' ' A' ' 85' ' ' PRO . 10.4 tp -150.26 140.9 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 168.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 58.02 31.75 21.07 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 175.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 64.34 24.02 13.16 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.448 1.099 . . . . 0.0 112.589 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.482 ' HB2' HD12 ' A' ' 171' ' ' ILE . 2.9 ptp180 -133.09 165.53 24.55 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 173.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.59 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 10.3 tt -65.84 126.23 27.83 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 176.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -81.7 -74.05 0.35 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.3 m -139.17 125.68 20.49 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -175.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.4 HD22 HG13 ' A' ' 174' ' ' VAL . 60.0 tp -70.49 132.98 46.37 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.411 0.685 . . . . 0.0 110.167 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.5 mp -89.15 -52.38 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 173.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 40.4 tp -164.6 142.42 6.62 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.655 0.782 . . . . 0.0 109.142 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.591 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 9.3 tt -130.72 139.58 50.3 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 176.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 61.3 mtp85 -141.69 132.8 26.22 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.382 1.073 . . . . 0.0 109.117 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -116.71 126.69 53.54 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.881 1.272 . . . . 0.0 108.829 -173.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.583 ' CZ ' ' HG3' ' A' ' 131' ' ' LYS . 3.7 p90 -143.75 166.81 23.85 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.28 0.562 . . . . 0.0 111.852 -173.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 68.0 p -82.29 175.35 10.34 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.373 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.437 ' HG2' ' HB2' ' A' ' 127' ' ' ASN . 35.9 mm-40 -57.42 -29.51 64.2 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 121.198 0.523 . . . . 0.0 111.125 171.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -74.04 -16.86 61.03 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.155 0.982 . . . . 0.0 111.052 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 92.01 5.41 66.08 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 116.327 -0.397 . . . . 0.0 112.521 -177.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.63 102.72 6.26 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -178.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.542 HG12 ' HB3' ' A' ' 150' ' ' PHE . 16.8 mt -72.19 122.54 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -177.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.513 ' HB ' ' HB3' ' A' ' 120' ' ' ASP . 27.4 m -130.08 6.09 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.228 1.011 . . . . 0.0 110.592 -175.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -150.81 156.95 26.95 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -165.75 145.55 6.48 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.854 0.462 . . . . 0.0 110.078 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 63.7 mt -124.92 106.32 16.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 168.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 88.0 p -115.59 134.97 22.57 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.493 ' HA ' HD23 ' A' ' 115' ' ' LEU . 52.3 Cg_exo -53.85 140.99 67.45 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 122.743 2.295 . . . . 0.0 111.873 172.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.424 ' HB2' ' HB2' ' A' ' 166' ' ' PHE . 80.0 mt -63.6 143.81 97.88 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -59.7 -26.21 81.45 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 122.569 2.179 . . . . 0.0 112.778 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 79.0 p -93.64 -6.04 47.3 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.372 0.669 . . . . 0.0 111.747 177.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.424 ' HB2' ' HB2' ' A' ' 163' ' ' LEU . 96.6 m-85 -132.84 77.11 69.48 Favored Pre-proline 0 N--CA 1.485 1.293 0 C-N-CA 123.586 0.754 . . . . 0.0 110.408 176.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.75 -32.06 7.84 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.182 1.922 . . . . 0.0 111.896 173.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -96.82 125.59 8.52 Favored Glycine 0 C--N 1.347 1.183 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 -152.09 164.13 37.9 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.97 0.908 . . . . 0.0 110.291 178.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 22.7 m -96.66 158.34 15.48 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 123.898 0.879 . . . . 0.0 109.395 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.59 ' HB ' ' O ' ' A' ' 141' ' ' LEU . 4.7 tt -48.52 -38.61 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 125.378 1.471 . . . . 0.0 112.836 174.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.424 ' HG3' ' HB3' ' A' ' 208' ' ' GLU . 55.3 mm-40 -62.21 -40.36 95.86 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.846 0.858 . . . . 0.0 111.517 -175.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -62.85 -41.1 99.23 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.984 0.914 . . . . 0.0 110.005 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 178' ' ' ILE . 44.3 t -63.24 -54.46 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 O-C-N 124.398 1.061 . . . . 0.0 111.603 -177.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -61.3 -35.09 76.38 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 124.05 0.844 . . . . 0.0 110.991 -175.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.44 ' O ' HG23 ' A' ' 180' ' ' VAL . 76.9 m-20 -69.69 -41.88 74.83 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.9 -36.28 82.8 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.163 0.914 . . . . 0.0 111.036 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 174' ' ' VAL . 66.6 mt -65.68 -39.18 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 175.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -71.06 -24.64 76.89 Favored Glycine 0 C--N 1.341 0.852 0 O-C-N 123.668 0.605 . . . . 0.0 113.551 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 176' ' ' ASN . 71.1 t -76.04 -43.15 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.441 0.697 . . . . 0.0 109.711 175.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 19.9 tp -60.92 -46.59 90.07 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.43 0.692 . . . . 0.0 110.473 173.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.457 ' O ' ' HG2' ' A' ' 186' ' ' GLU . 57.5 mt -60.56 -50.07 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 123.967 0.907 . . . . 0.0 110.254 175.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -60.9 -33.15 82.39 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 123.447 0.467 . . . . 0.0 113.639 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.616 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -67.79 -43.81 82.56 Favored Glycine 0 C--N 1.347 1.19 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 171.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.439 HD22 HD12 ' A' ' 128' ' ' ILE . 53.4 mt -68.7 -23.9 64.43 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.521 1.129 . . . . 0.0 111.705 177.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 52.4 mm-40 -74.73 -41.9 59.28 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.947 0.499 . . . . 0.0 109.947 178.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -64.23 -41.72 96.88 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.128 171.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.454 ' ND2' ' HA ' ' A' ' 121' ' ' GLN . 6.2 m-20 -68.05 -10.66 55.51 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.552 0.741 . . . . 0.0 111.39 173.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 16.6 t70 63.52 64.49 0.8 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.475 1.11 . . . . 0.0 110.031 174.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -126.22 134.17 51.3 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.8 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 127' ' ' ASN . 59.2 m -80.92 99.25 8.27 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.562 HG12 ' HB ' ' A' ' 128' ' ' ILE . 24.5 m -104.87 148.38 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.668 0.747 . . . . 0.0 111.553 -172.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 44.0 ttt180 -137.76 135.48 36.39 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 114.25 -1.341 . . . . 0.0 107.937 173.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.524 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 4.1 t -87.33 155.27 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -178.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.543 ' HB3' ' HE2' ' A' ' 131' ' ' LYS . 88.6 p -62.45 149.15 43.46 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.446 0.566 . . . . 0.0 111.083 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -55.35 -34.68 64.47 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.188 0.995 . . . . 0.0 110.448 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 52.1 p -64.08 -58.65 6.03 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.436 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.434 ' HB2' HG12 ' A' ' 194' ' ' VAL . 69.7 mt -62.72 -37.45 86.58 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.148 0.579 . . . . 0.0 110.912 -174.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -55.79 -37.54 68.75 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.712 0.805 . . . . 0.0 112.085 -176.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -102.22 -25.33 13.73 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -82.73 -54.32 5.22 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 118.403 0.547 . . . . 0.0 111.519 -176.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.433 ' HB2' HD13 ' A' ' 141' ' ' LEU . . . -102.56 -56.72 2.19 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.811 0.844 . . . . 0.0 110.694 -171.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 44.3 t-105 -61.67 -42.21 98.61 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.383 1.473 . . . . 0.0 109.601 -177.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.24 174.73 19.22 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.365 169.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 23.2 m 60.83 24.44 14.39 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.779 1.231 . . . . 0.0 112.335 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 17.9 p -114.5 138.22 50.88 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.205 1.002 . . . . 0.0 109.93 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -140.85 80.63 1.76 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.443 0.697 . . . . 0.0 110.85 -174.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.424 ' HB3' ' HG3' ' A' ' 172' ' ' GLU . 7.2 pt-20 -79.74 112.21 16.8 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 167.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -83.46 86.57 7.06 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -177.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -76.1 85.04 0.91 Allowed Glycine 0 C--N 1.347 1.172 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.089 -175.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -86.25 143.93 37.63 Favored Pre-proline 0 C--O 1.241 0.629 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 172.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.99 123.87 14.18 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.375 2.05 . . . . 0.0 111.12 167.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -56.88 124.42 16.2 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 122.685 2.256 . . . . 0.0 111.304 -176.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 94.2 mt -66.1 95.52 0.28 Allowed 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.809 0.844 . . . . 0.0 110.732 -173.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 72.0 p -72.52 138.45 46.95 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.935 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.483 ' H ' HD23 ' A' ' 216' ' ' LEU . 0.7 OUTLIER -103.28 161.52 13.75 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.714 1.206 . . . . 0.0 108.575 175.356 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 . . . . . 0 CA--C 1.557 1.223 0 CA-C-O 118.83 -0.605 . . . . 0.0 109.684 178.299 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 62.6 ttp . . . . . 0 N--CA 1.476 0.852 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -68.55 136.78 37.39 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 122.289 1.992 . . . . 0.0 110.951 168.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.74 102.76 0.49 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.962 0.505 . . . . 0.0 111.257 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.5 t -80.56 144.87 32.1 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 170.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.519 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 8.1 ttm180 -151.65 152.87 33.41 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -167.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -121.74 101.42 7.57 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 172.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.9 mm -81.76 132.89 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 123.617 0.767 . . . . 0.0 109.787 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 34.2 p -121.96 83.55 2.11 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 171.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -70.19 -31.37 68.8 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.174 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -111.07 141.92 43.92 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 174.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 81.6 p -65.4 152.97 42.6 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.091 0.472 . . . . 0.0 110.569 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.52 -29.34 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.951 173.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -65.97 -49.61 67.25 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.644 1.177 . . . . 0.0 111.946 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.517 ' HA ' ' HB2' ' A' ' 100' ' ' ARG . 12.5 pt-20 -75.58 -22.32 57.07 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 120.801 0.334 . . . . 0.0 110.334 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.502 ' HG ' HD23 ' A' ' 146' ' ' LEU . 9.2 tt -69.15 -33.73 73.9 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.885 0.874 . . . . 0.0 109.542 170.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.3 t -103.12 13.75 33.4 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.7 0.8 . . . . 0.0 110.983 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.517 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 71.2 ttt180 -65.39 150.16 48.79 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.661 0.784 . . . . 0.0 111.723 -174.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -80.45 125.41 29.9 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 170.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -154.14 173.21 16.38 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.66 0.784 . . . . 0.0 110.488 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -138.78 146.74 41.73 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.158 0.583 . . . . 0.0 110.714 175.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.538 ' SD ' ' HB3' ' A' ' 107' ' ' PRO . 14.3 ptp -99.76 108.43 20.75 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 167.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 48.0 tp -71.58 -38.16 70.94 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.032 0.533 . . . . 0.0 110.552 -175.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 24.9 mmt -121.12 84.81 40.42 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 123.779 0.832 . . . . 0.0 109.088 173.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.538 ' HB3' ' SD ' ' A' ' 104' ' ' MET . 56.5 Cg_endo -67.81 117.86 5.19 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.144 2.563 . . . . 0.0 113.088 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -118.66 131.98 56.17 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 167.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -122.84 120.84 34.71 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 176.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.79 106.6 9.8 Favored 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 124.676 1.19 . . . . 0.0 107.997 176.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.443 HG13 HD11 ' A' ' 163' ' ' LEU . 79.3 t -75.35 128.54 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -122.57 85.24 2.38 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 124.864 1.266 . . . . 0.0 108.363 -176.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 68.01 -113.13 5.2 Favored Glycine 0 CA--C 1.539 1.531 0 CA-C-N 114.966 -1.016 . . . . 0.0 113.239 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -89.97 9.21 3.39 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 123.624 2.883 . . . . 0.0 113.227 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.1 mt -129.95 158.27 40.02 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -175.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 23.7 p -125.51 119.04 27.11 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 176.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.0 mm -86.72 140.94 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.378 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -122.36 129.97 52.65 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 170.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.605 HD13 ' HA3' ' A' ' 184' ' ' GLY . 60.4 mt -128.08 122.86 59.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -178.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -94.28 114.72 26.85 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 174.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -82.72 -10.49 58.88 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.097 0.959 . . . . 0.0 111.51 -175.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.71 -41.57 53.25 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.019 0.527 . . . . 0.0 111.881 -174.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.85 113.14 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.866 0.841 . . . . 0.0 109.834 -176.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 44.8 mtt -131.2 166.16 21.75 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.321 -1.309 . . . . 0.0 109.501 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.5 t70 57.69 32.72 22.29 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.828 0.851 . . . . 0.0 111.313 177.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -120.71 153.94 36.27 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.878 0.871 . . . . 0.0 110.507 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -90.78 106.97 18.88 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 173.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.617 HG12 HG22 ' A' ' 151' ' ' THR . 48.2 mt -108.14 130.77 60.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 123.478 0.711 . . . . 0.0 110.315 -173.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 52.1 tpp -110.0 126.47 53.98 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.28 1.032 . . . . 0.0 108.752 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 25.1 mt -87.77 103.0 15.22 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -110.55 132.39 54.23 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.313 1.045 . . . . 0.0 109.988 -172.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.563 ' HB2' ' HG ' ' A' ' 147' ' ' LEU . . . -136.99 154.93 50.29 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -175.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -112.84 128.44 56.45 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 167.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.456 ' HA ' HD13 ' A' ' 145' ' ' ILE . 33.0 p90 -157.37 163.57 38.46 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.351 0.596 . . . . 0.0 112.393 -170.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 46.6 t -85.14 156.99 20.79 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.425 -1.261 . . . . 0.0 109.417 173.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.519 ' HB ' ' HB3' ' A' ' 88' ' ' ARG . 79.1 t -140.27 142.96 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.378 1.071 . . . . 0.0 109.935 -174.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.428 ' O ' ' HG2' ' A' ' 140' ' ' ARG . 11.3 tp -150.3 145.6 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 168.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 60.62 22.8 12.61 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 123.632 0.773 . . . . 0.0 112.119 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 58.77 39.61 23.98 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.316 1.046 . . . . 0.0 111.658 -172.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 137' ' ' ILE . 5.8 ptp180 -144.85 163.35 34.35 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.509 0.724 . . . . 0.0 109.694 172.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.477 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 10.5 tt -63.85 117.25 6.68 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.952 0.501 . . . . 0.0 110.08 -176.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -79.8 -60.63 2.27 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.839 0.856 . . . . 0.0 109.121 175.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 80.5 m -147.75 132.13 17.59 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.632 0.773 . . . . 0.0 109.366 177.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.434 HD21 ' HB2' ' A' ' 147' ' ' LEU . 51.3 tp -76.7 131.59 38.87 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.557 0.743 . . . . 0.0 110.156 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.456 HD13 ' HA ' ' A' ' 134' ' ' PHE . 1.9 mp -87.15 -46.88 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 173.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.502 HD23 ' HG ' ' A' ' 98' ' ' LEU . 57.7 tp -167.94 149.08 5.22 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.573 0.749 . . . . 0.0 109.585 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.652 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 6.6 tt -134.19 140.08 46.27 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 177.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 58.7 mtp85 -145.48 147.63 32.38 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.32 1.048 . . . . 0.0 108.991 -175.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.01 109.2 21.1 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.009 0.923 . . . . 0.0 109.269 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -106.29 124.15 49.15 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.424 0.69 . . . . 0.0 110.187 -175.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.617 HG22 HG12 ' A' ' 128' ' ' ILE . 33.7 p -73.0 -174.45 1.51 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.372 0.669 . . . . 0.0 110.955 169.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.95 -25.51 63.68 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 122.257 -0.277 . . . . 0.0 111.243 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -83.85 -8.1 59.29 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.748 0.819 . . . . 0.0 110.381 173.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 78.99 23.02 64.63 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 116.331 -0.395 . . . . 0.0 113.391 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.26 127.62 32.57 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.7 mp -81.8 101.39 6.58 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.9 m -111.16 24.33 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.305 1.042 . . . . 0.0 109.991 -172.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 176.05 151.28 8.66 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 114.119 -1.401 . . . . 0.0 110.28 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -158.39 130.55 6.89 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.069 0.935 . . . . 0.0 111.047 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.652 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 67.3 mt -107.43 102.99 14.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 173.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 27.7 t -104.17 120.73 49.97 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 123.427 0.691 . . . . 0.0 109.37 -177.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -54.22 123.79 14.43 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.666 2.244 . . . . 0.0 112.492 172.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.443 HD11 HG13 ' A' ' 111' ' ' VAL . 67.2 mt -67.18 127.3 93.45 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 123.268 0.627 . . . . 0.0 111.261 -177.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 163' ' ' LEU . 31.2 Cg_exo -63.72 -16.1 52.75 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 123.578 2.852 . . . . 0.0 113.775 177.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.4 m -87.76 1.31 54.18 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.921 0.488 . . . . 0.0 111.804 175.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -131.32 83.1 60.51 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.7 89.57 0.98 Allowed 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.738 2.292 . . . . 0.0 112.138 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 104.41 131.19 7.07 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.228 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 34.9 p-80 -140.0 165.55 27.03 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.187 0.995 . . . . 0.0 109.762 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 27.3 m -93.03 159.01 15.49 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.363 0.665 . . . . 0.0 109.866 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 141' ' ' LEU . 7.6 tt -50.99 -37.77 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.728 1.211 . . . . 0.0 111.997 173.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -64.24 -35.41 80.72 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.417 1.087 . . . . 0.0 111.445 -175.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -64.38 -38.83 92.4 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.89 0.876 . . . . 0.0 110.488 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.45 ' O ' HG13 ' A' ' 178' ' ' ILE . 43.7 t -67.79 -37.11 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.297 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -62.14 -40.28 95.42 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.034 0.534 . . . . 0.0 110.747 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.424 ' O ' HG23 ' A' ' 180' ' ' VAL . 79.6 m-20 -61.0 -48.04 83.64 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 123.906 0.754 . . . . 0.0 109.568 174.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.55 -48.64 78.62 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 114.066 -1.424 . . . . 0.0 112.681 -173.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 174' ' ' VAL . 69.8 mt -59.66 -41.8 86.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -61.18 -34.37 87.79 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 115.301 -0.863 . . . . 0.0 114.005 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 176' ' ' ASN . 93.1 t -70.77 -44.08 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 122.956 0.502 . . . . 0.0 110.307 177.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 32.3 tp -59.91 -43.81 94.65 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.822 176.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.536 HG23 HG21 ' A' ' 192' ' ' VAL . 86.6 mt -59.83 -51.58 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.575 0.75 . . . . 0.0 110.267 175.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.22 -42.38 97.21 Favored Glycine 0 C--N 1.344 1.006 0 O-C-N 123.804 0.69 . . . . 0.0 113.779 -176.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.605 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -68.9 -24.81 75.62 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 115.502 -0.349 . . . . 0.0 113.116 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.444 HD22 HD12 ' A' ' 128' ' ' ILE . 32.6 mt -86.54 -25.69 24.92 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.878 0.871 . . . . 0.0 111.564 176.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 182' ' ' ILE . 50.2 mt-10 -70.78 -31.26 67.97 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 122.084 -0.385 . . . . 0.0 110.789 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -81.09 -20.66 41.04 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.161 0.585 . . . . 0.0 111.092 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -65.53 -20.82 66.49 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.011 0.525 . . . . 0.0 110.466 165.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 33.6 t70 63.4 67.47 0.65 Allowed 'General case' 0 C--N 1.355 0.833 0 C-N-CA 124.418 1.087 . . . . 0.0 110.195 -178.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -138.01 178.65 6.96 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.125 175.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 85.3 m -102.51 103.52 13.88 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -174.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.536 HG21 HG23 ' A' ' 182' ' ' ILE . 35.5 m -101.47 146.54 9.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 C-N-CA 123.388 0.675 . . . . 0.0 110.897 -178.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -143.84 145.37 32.28 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.522 171.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 4.6 t -89.9 137.6 21.11 Favored 'Isoleucine or valine' 0 C--O 1.245 0.818 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 173.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 78.9 p -56.96 148.29 21.62 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 118.819 0.736 . . . . 0.0 111.045 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -57.06 -27.03 61.34 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.545 0.738 . . . . 0.0 111.808 -177.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 65.1 p -70.49 -54.25 13.02 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 123.387 0.675 . . . . 0.0 109.847 174.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 33.5 mt -63.45 -26.98 68.98 Favored 'General case' 0 C--O 1.208 -1.079 0 CA-C-O 119.004 -0.522 . . . . 0.0 111.577 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -67.76 -49.71 61.03 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.886 0.474 . . . . 0.0 110.856 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -77.27 -36.54 54.23 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.341 0.401 . . . . 0.0 111.62 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -85.41 -54.94 4.26 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 122.257 -0.277 . . . . 0.0 111.152 -171.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -95.08 -60.37 1.7 Allowed 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.185 0.517 . . . . 0.0 111.447 -170.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 43.5 t-105 -63.92 -33.32 75.45 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.026 1.73 . . . . 0.0 111.039 -169.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -134.56 -153.29 6.84 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 170.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 65.2 m -132.22 124.93 29.95 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 29.0 t -62.74 98.0 0.11 Allowed 'General case' 0 C--N 1.351 0.669 0 O-C-N 123.745 0.653 . . . . 0.0 109.512 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -96.4 26.84 4.09 Favored 'General case' 0 CA--C 1.558 1.279 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -88.87 65.69 7.69 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 125.226 1.41 . . . . 0.0 108.143 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -90.96 -176.43 4.64 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.638 -168.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 177.2 -123.25 0.88 Allowed Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -165.62 145.84 5.63 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 123.829 0.852 . . . . 0.0 109.156 176.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -46.77 120.13 3.82 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.774 2.316 . . . . 0.0 112.232 168.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -52.8 118.25 4.55 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 123.101 2.534 . . . . 0.0 112.175 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 58.2 mt -69.57 93.39 0.69 Allowed 'General case' 0 CA--C 1.537 0.443 0 O-C-N 123.941 0.776 . . . . 0.0 109.63 -175.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 75.8 p -60.87 144.17 53.36 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.419 -175.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 55.9 mt -74.4 142.64 45.01 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.417 0.687 . . . . 0.0 110.685 -173.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 . . . . . 0 CA--C 1.558 1.283 0 C-N-CA 123.437 0.695 . . . . 0.0 109.378 176.662 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.474 ' HB2' HD11 ' A' ' 137' ' ' ILE . 32.4 Cg_endo -60.97 132.69 43.35 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 123.371 2.714 . . . . 0.0 112.809 -178.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.31 119.96 27.14 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.398 0.679 . . . . 0.0 110.275 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.1 p -108.08 140.19 41.62 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.08 0.952 . . . . 0.0 109.347 174.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -155.63 152.45 28.72 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.93 0.492 . . . . 0.0 110.014 -173.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -115.38 111.11 20.34 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 171.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.4 mm -81.83 130.42 35.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 123.597 0.759 . . . . 0.0 109.382 175.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.7 p -117.51 81.91 1.73 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -76.89 -13.46 59.99 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.582 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.533 ' HB3' ' HG3' ' A' ' 97' ' ' GLU . 63.2 mtm -114.97 143.94 44.37 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.139 1.376 . . . . 0.0 107.321 161.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 69.3 p -72.29 152.21 42.29 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 167.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 57.0 mt -57.41 -27.68 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 122.606 0.362 . . . . 0.0 111.13 178.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -54.67 -62.36 1.71 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.07 0.948 . . . . 0.0 111.801 170.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.533 ' HG3' ' HB3' ' A' ' 93' ' ' MET . 11.0 pt-20 -73.54 -22.07 60.2 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 122.924 0.49 . . . . 0.0 112.152 -177.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.586 ' HG ' HD23 ' A' ' 146' ' ' LEU . 10.0 tt -63.19 -36.44 83.65 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.007 0.923 . . . . 0.0 109.32 171.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.3 m -109.47 16.91 21.94 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.659 0.784 . . . . 0.0 111.601 -177.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.443 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 62.0 ttt180 -75.03 140.01 43.27 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.671 0.788 . . . . 0.0 110.828 -177.152 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -75.22 136.52 40.97 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.564 0.745 . . . . 0.0 111.248 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 28.0 p-90 -161.14 171.54 18.34 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.654 1.182 . . . . 0.0 109.666 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -141.0 165.08 28.54 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.244 0.618 . . . . 0.0 111.171 -175.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.408 ' SD ' ' HD2' ' A' ' 118' ' ' ARG . 63.6 mtp -118.11 131.08 56.46 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.046 0.939 . . . . 0.0 108.466 172.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.519 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.5 pt? -109.29 -29.21 8.59 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.289 0.636 . . . . 0.0 110.829 -175.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 7.7 mmt -123.24 70.31 42.51 Favored Pre-proline 0 N--CA 1.486 1.375 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 166.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.9 145.09 35.54 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 122.243 1.962 . . . . 0.0 113.014 -170.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.45 ' HB3' ' HB ' ' A' ' 119' ' ' ILE . 25.0 ttmm -134.94 120.31 19.06 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 168.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -96.81 100.04 11.59 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -178.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.552 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 17.7 tppt? -96.66 148.78 22.52 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 174.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 68.6 t -128.03 133.62 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 175.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -137.3 95.32 3.06 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 68.37 -131.25 27.0 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.289 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.402 ' HB2' ' HB3' ' A' ' 169' ' ' HIS . 6.2 Cg_exo -82.19 18.21 1.45 Allowed 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 123.356 2.704 . . . . 0.0 113.421 177.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -134.42 170.66 15.41 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.8 0.84 . . . . 0.0 109.655 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.411 ' HB3' HD21 ' A' ' 163' ' ' LEU . 17.9 p -136.33 143.61 44.22 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.033 0.933 . . . . 0.0 109.341 177.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.552 ' HB ' ' HB3' ' A' ' 110' ' ' LYS . 9.3 mm -111.09 147.35 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 124.371 1.069 . . . . 0.0 109.681 -173.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.542 ' HG3' ' HB3' ' A' ' 159' ' ' GLU . 36.3 mmt180 -109.87 118.52 36.7 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 173.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.554 HD12 ' HA3' ' A' ' 184' ' ' GLY . 46.1 mm -119.81 122.29 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 175.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -115.05 118.98 34.93 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -80.23 -9.18 59.72 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.695 0.798 . . . . 0.0 112.789 -170.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -79.66 -36.01 38.39 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 120.654 0.264 . . . . 0.0 110.787 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.6 mp -80.12 99.62 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 45.3 mtt -131.66 156.7 45.39 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-N 114.132 -1.395 . . . . 0.0 109.249 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.3 t70 72.03 2.17 4.2 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 124.384 1.074 . . . . 0.0 112.718 175.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -85.95 148.65 25.67 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 121.635 -0.665 . . . . 0.0 112.087 -173.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -91.16 105.38 17.77 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 172.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.667 ' HB ' HG12 ' A' ' 192' ' ' VAL . 56.8 mt -115.39 146.37 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 123.71 0.804 . . . . 0.0 110.257 -172.124 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.449 ' SD ' ' HB3' ' A' ' 193' ' ' ARG . 15.7 tpt -129.23 128.63 43.67 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 125.481 1.512 . . . . 0.0 107.781 177.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 35.7 mt -81.39 145.6 30.73 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -142.55 133.96 26.36 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 173.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.551 ' HB2' ' HG ' ' A' ' 147' ' ' LEU . . . -141.45 142.94 33.63 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -170.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -101.9 133.6 46.42 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 171.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.518 ' HA ' HD13 ' A' ' 145' ' ' ILE . 37.3 p90 -161.1 161.62 31.27 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 123.79 0.681 . . . . 0.0 111.057 -175.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.1 p -86.35 161.32 18.77 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.099 0.96 . . . . 0.0 109.41 172.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 53.9 t -139.25 139.39 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.258 1.423 . . . . 0.0 108.467 -175.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.474 HD11 ' HB2' ' A' ' 85' ' ' PRO . 9.8 tp -130.87 132.85 63.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 169.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 62.4 -84.59 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.914 1.286 . . . . 0.0 110.459 -173.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -158.98 23.42 0.21 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.13 0.972 . . . . 0.0 109.897 -176.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.506 ' HB2' HD12 ' A' ' 171' ' ' ILE . 11.1 ptp180 -127.47 163.06 24.92 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.584 0.754 . . . . 0.0 109.797 176.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.474 HD22 ' HA ' ' A' ' 171' ' ' ILE . 9.0 tt -67.7 125.41 26.13 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 171.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -81.35 -59.7 2.54 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 123.876 0.87 . . . . 0.0 108.811 174.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 95.6 m -149.71 136.68 19.58 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.98 0.912 . . . . 0.0 109.293 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.512 HD21 ' HB2' ' A' ' 147' ' ' LEU . 50.1 tp -77.73 121.47 24.08 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.518 HD13 ' HA ' ' A' ' 134' ' ' PHE . 1.6 mp -77.14 -52.14 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.516 0.727 . . . . 0.0 109.161 176.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.586 HD23 ' HG ' ' A' ' 98' ' ' LEU . 39.3 tp -165.69 150.2 8.47 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.735 0.814 . . . . 0.0 109.358 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.681 HD13 HD12 ' A' ' 160' ' ' ILE . 7.4 tt -133.16 145.85 51.02 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.479 ' HD3' HD13 ' A' ' 156' ' ' ILE . 45.5 mtt-85 -141.28 148.3 39.59 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.906 0.882 . . . . 0.0 110.189 176.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.1 110.35 22.25 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.468 1.107 . . . . 0.0 108.441 176.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -104.45 127.95 52.24 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.555 0.742 . . . . 0.0 109.347 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.462 HG22 HG12 ' A' ' 128' ' ' ILE . 41.6 p -70.97 -175.81 1.22 Allowed 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.267 0.556 . . . . 0.0 111.191 176.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -27.13 68.71 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.55 0.74 . . . . 0.0 111.971 173.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -83.26 -4.08 58.08 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.451 0.7 . . . . 0.0 111.243 171.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 77.45 27.07 60.07 Favored Glycine 0 C--N 1.348 1.241 0 CA-C-N 116.441 -0.345 . . . . 0.0 112.944 178.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -92.66 129.45 38.59 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.013 0.525 . . . . 0.0 110.221 -176.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.479 HD13 ' HD3' ' A' ' 148' ' ' ARG . 17.0 mt -72.59 102.93 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.463 0.705 . . . . 0.0 109.141 177.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.9 m -113.83 -2.14 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.287 1.035 . . . . 0.0 111.514 -176.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -157.18 167.43 33.88 Favored Glycine 0 C--N 1.338 0.648 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.542 ' HB3' ' HG3' ' A' ' 118' ' ' ARG . 27.2 tt0 -166.61 149.03 6.6 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.256 0.622 . . . . 0.0 109.627 -174.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.681 HD12 HD13 ' A' ' 147' ' ' LEU . 71.6 mt -130.06 117.69 41.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 169.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.0 t -128.0 138.04 32.09 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.77 139.96 83.21 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 122.951 2.434 . . . . 0.0 111.644 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.411 HD21 ' HB3' ' A' ' 116' ' ' CYS . 88.1 mt -60.77 138.07 93.34 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 123.0 0.52 . . . . 0.0 110.781 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -67.14 -22.2 47.55 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.83 2.353 . . . . 0.0 112.574 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 18.0 m -78.23 -14.47 59.43 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.937 0.895 . . . . 0.0 111.514 175.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -121.1 92.58 48.59 Favored Pre-proline 0 N--CA 1.477 0.912 0 C-N-CA 124.418 1.087 . . . . 0.0 109.366 -175.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -90.48 31.62 0.35 Allowed 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 123.316 2.677 . . . . 0.0 112.237 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -169.44 119.17 0.81 Allowed Glycine 0 C--N 1.342 0.915 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.007 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.402 ' HB3' ' HB2' ' A' ' 114' ' ' PRO . 31.2 p-80 -147.59 154.0 40.12 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.836 0.855 . . . . 0.0 109.683 171.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.624 HG22 HG22 ' A' ' 171' ' ' ILE . 4.9 m -99.35 171.73 7.79 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.915 0.886 . . . . 0.0 109.789 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.624 HG22 HG22 ' A' ' 170' ' ' THR . 11.2 tt -48.6 -41.84 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 125.84 1.656 . . . . 0.0 113.754 176.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -56.7 -35.83 68.94 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.187 1.395 . . . . 0.0 111.961 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -73.0 -38.02 66.75 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.26 0.624 . . . . 0.0 111.581 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.498 HG13 HD22 ' A' ' 144' ' ' LEU . 58.1 t -65.19 -51.4 65.86 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.88 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.931 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.27 -24.43 67.86 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 123.826 0.704 . . . . 0.0 112.026 -175.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.41 ' O ' HG23 ' A' ' 180' ' ' VAL . 91.1 m-20 -70.77 -50.67 33.43 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.992 0.517 . . . . 0.0 109.624 169.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.21 -40.29 81.25 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.236 1.014 . . . . 0.0 111.817 -177.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 174' ' ' VAL . 61.5 mt -60.5 -46.33 95.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.716 0.806 . . . . 0.0 109.478 178.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.05 -25.67 72.18 Favored Glycine 0 C--N 1.343 0.934 0 CA-C-N 115.293 -0.867 . . . . 0.0 113.427 -177.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 176' ' ' ASN . 91.8 t -74.67 -43.53 47.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.04 0.536 . . . . 0.0 110.135 176.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.411 ' HB2' HD11 ' A' ' 160' ' ' ILE . 57.0 tp -59.35 -47.13 86.59 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.861 0.464 . . . . 0.0 110.453 175.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.477 HD11 HG22 ' A' ' 194' ' ' VAL . 93.3 mt -59.01 -48.5 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.817 0.847 . . . . 0.0 110.167 177.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -62.24 -30.55 76.25 Favored Glycine 0 C--N 1.348 1.248 0 O-C-N 123.578 0.549 . . . . 0.0 113.385 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.554 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -75.76 -27.36 63.03 Favored Glycine 0 C--N 1.348 1.22 0 N-CA-C 112.345 -0.302 . . . . 0.0 112.345 175.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.559 ' HB3' HG11 ' A' ' 192' ' ' VAL . 61.0 mt -80.97 -31.54 34.76 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.239 1.015 . . . . 0.0 110.842 176.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 182' ' ' ILE . 49.2 mt-10 -72.05 -40.58 68.25 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.866 0.866 . . . . 0.0 110.765 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -70.07 -32.49 70.6 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.836 0.454 . . . . 0.0 110.46 176.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -76.35 -1.77 28.47 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.231 0.613 . . . . 0.0 111.394 170.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 23.4 t70 64.11 49.38 2.71 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.436 1.094 . . . . 0.0 111.011 170.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -109.95 140.36 44.03 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.622 1.169 . . . . 0.0 109.145 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 29.4 m -84.46 100.85 11.6 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.667 HG12 ' HB ' ' A' ' 128' ' ' ILE . 33.2 m -116.83 152.4 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-O 121.703 0.763 . . . . 0.0 112.822 -168.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.449 ' HB3' ' SD ' ' A' ' 129' ' ' MET . 63.4 ttt180 -134.99 142.96 46.58 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 114.043 -1.435 . . . . 0.0 108.307 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.477 HG22 HD11 ' A' ' 182' ' ' ILE . 13.2 t -82.37 154.38 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 5.4 m -50.53 132.48 25.38 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.423 0.689 . . . . 0.0 111.537 178.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -53.43 -30.74 42.03 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 124.218 1.007 . . . . 0.0 111.704 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 68.7 p -79.47 -47.06 16.28 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.983 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 90.6 mt -68.21 -33.68 74.87 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.948 0.499 . . . . 0.0 110.759 -177.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -51.06 -30.46 15.79 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.456 1.102 . . . . 0.0 112.624 -176.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -102.49 -47.92 4.31 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 171.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -67.89 -44.42 77.03 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -166.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -113.72 -54.26 2.62 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.33 0.652 . . . . 0.0 111.173 -175.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -68.77 -55.88 9.82 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.114 1.366 . . . . 0.0 111.511 -172.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -70.32 -26.24 74.49 Favored Glycine 0 N--CA 1.472 1.089 0 CA-C-N 116.168 -0.469 . . . . 0.0 113.203 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 20.6 t -69.27 110.15 4.47 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.657 0.783 . . . . 0.0 109.875 177.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 34.0 m -69.53 103.09 1.97 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.035 0.934 . . . . 0.0 110.523 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -126.22 128.34 47.07 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.697 0.799 . . . . 0.0 109.493 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -118.43 141.3 48.69 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.144 0.978 . . . . 0.0 110.357 -175.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 41.1 p30 -151.6 -157.13 0.78 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.626 1.171 . . . . 0.0 108.502 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 142.09 -115.36 0.96 Allowed Glycine 0 C--N 1.345 1.039 0 CA-C-O 119.411 -0.661 . . . . 0.0 111.791 170.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -61.18 113.04 6.84 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.18 0.992 . . . . 0.0 110.559 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -63.74 150.65 87.95 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.649 2.233 . . . . 0.0 111.596 173.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.52 115.14 2.47 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.67 2.247 . . . . 0.0 110.482 174.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 85.5 mt -65.67 130.97 45.18 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 123.738 0.649 . . . . 0.0 110.557 -176.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 74.3 p -71.58 177.36 4.11 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.617 0.767 . . . . 0.0 112.176 -175.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 94.5 mt -67.05 173.52 3.66 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.542 0.737 . . . . 0.0 111.557 177.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 . . . . . 0 C--O 1.251 1.173 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.164 -177.982 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.482 1.135 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -69.54 129.76 18.4 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 123.181 2.587 . . . . 0.0 113.061 -172.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -139.12 127.14 22.35 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.806 0.842 . . . . 0.0 109.587 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.9 t -66.6 100.03 0.64 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.696 0.798 . . . . 0.0 110.144 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 66.9 ttt180 -109.73 130.42 55.52 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.307 0.643 . . . . 0.0 110.391 -177.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -92.36 97.73 11.05 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.699 0.8 . . . . 0.0 109.401 -178.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.9 mm -81.84 122.66 37.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.968 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.9 p -117.18 97.38 5.89 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.93 0.892 . . . . 0.0 110.292 -174.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -79.34 -27.74 42.03 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.828 0.851 . . . . 0.0 111.002 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.456 ' HB2' ' HG3' ' A' ' 97' ' ' GLU . 24.4 ptt? -119.02 141.43 48.7 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.776 0.83 . . . . 0.0 109.188 -177.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.8 m -68.69 160.23 30.64 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.067 0.947 . . . . 0.0 110.599 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 61.1 mt -62.43 -31.84 53.14 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 C-N-CA 122.809 0.443 . . . . 0.0 111.47 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.23 -54.14 49.29 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.511 0.324 . . . . 0.0 111.328 175.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.667 ' HA ' ' HB2' ' A' ' 100' ' ' ARG . 14.8 pt-20 -77.19 -18.31 57.85 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.029 0.531 . . . . 0.0 111.874 -177.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.521 HD12 HD22 ' A' ' 133' ' ' ASN . 6.0 tt -59.92 -43.75 94.73 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.37 1.068 . . . . 0.0 108.89 167.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.1 t -105.76 21.11 17.81 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.745 -176.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.667 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 30.8 tpt180 -67.45 133.1 48.91 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.802 0.441 . . . . 0.0 110.639 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -72.1 136.99 46.75 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 123.692 0.62 . . . . 0.0 109.8 174.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 20.4 p-90 -157.59 166.3 33.25 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.837 0.855 . . . . 0.0 109.485 176.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -142.62 144.02 32.63 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 123.547 0.739 . . . . 0.0 109.033 -176.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.534 ' SD ' ' HD2' ' A' ' 118' ' ' ARG . 67.4 mtp -85.48 105.51 16.15 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.2 tp -62.51 -36.36 82.3 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.192 0.997 . . . . 0.0 110.331 177.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.478 ' HG2' ' HB2' ' A' ' 122' ' ' ALA . 20.7 mmt -134.38 92.48 20.62 Favored Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 123.736 0.814 . . . . 0.0 109.153 168.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.24 112.95 2.69 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 123.165 2.577 . . . . 0.0 114.394 -176.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 119' ' ' ILE . 55.5 tptt -109.54 117.96 35.35 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 161.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -107.72 113.44 26.71 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -125.88 103.31 7.71 Favored 'General case' 0 C--O 1.214 -0.767 0 C-N-CA 123.485 0.714 . . . . 0.0 109.516 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . 84.8 t -75.6 137.89 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 174.009 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -133.25 93.13 3.11 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-O 120.993 0.425 . . . . 0.0 109.963 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.15 -128.71 37.01 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.743 176.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -72.05 1.36 6.01 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 123.37 2.713 . . . . 0.0 114.126 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 4.3 mp -127.04 175.49 8.06 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.795 0.838 . . . . 0.0 109.411 -178.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.487 ' SG ' ' NH1' ' A' ' 118' ' ' ARG . 49.6 t -136.53 146.47 46.24 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 174.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.8 mm -116.22 147.32 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.309 1.044 . . . . 0.0 109.394 -174.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.534 ' HD2' ' SD ' ' A' ' 104' ' ' MET . 68.7 mmt-85 -119.54 127.31 52.88 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.049 0.939 . . . . 0.0 108.688 172.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.469 HD11 ' HA ' ' A' ' 181' ' ' LEU . 41.6 mm -122.84 125.59 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 173.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -93.45 116.86 29.4 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.411 ' HA ' HD21 ' A' ' 188' ' ' ASN . 80.3 mt-30 -78.51 -13.45 59.82 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.383 0.673 . . . . 0.0 112.257 -174.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.478 ' HB2' ' HG2' ' A' ' 106' ' ' MET . . . -82.86 -49.4 9.71 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.099 0.56 . . . . 0.0 110.791 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.424 HG12 HG11 ' A' ' 157' ' ' VAL . 1.8 mp -69.91 108.81 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-O 122.01 0.91 . . . . 0.0 109.731 -174.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.434 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 50.0 mtt -132.23 156.8 45.84 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 113.192 -1.822 . . . . 0.0 109.624 -177.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.0 t70 63.19 29.07 16.06 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.463 1.105 . . . . 0.0 111.801 173.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -115.0 149.56 37.21 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.569 0.748 . . . . 0.0 111.408 -179.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 152' ' ' GLU . 43.9 m-80 -83.52 107.29 15.9 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.542 HD12 HD22 ' A' ' 185' ' ' LEU . 50.2 mt -112.44 123.84 68.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-O 121.943 0.878 . . . . 0.0 111.105 -174.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 5.6 tpt -102.61 119.24 38.49 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 126.926 2.09 . . . . 0.0 108.905 -176.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 20.4 mt -95.25 104.9 16.8 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -115.43 144.8 43.27 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.192 0.597 . . . . 0.0 109.834 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -138.76 156.55 47.28 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.6 0.714 . . . . 0.0 112.479 -175.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.521 HD22 HD12 ' A' ' 98' ' ' LEU . 70.7 m-20 -113.6 119.38 37.28 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 165.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -153.1 157.96 41.18 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.416 0.686 . . . . 0.0 110.403 -167.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.0 p -89.66 156.8 18.32 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.345 0.658 . . . . 0.0 109.425 175.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.9 t -131.44 129.0 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.569 1.148 . . . . 0.0 109.325 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.5 tp -133.69 140.27 46.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 175.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 63.23 25.83 14.94 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.077 0.951 . . . . 0.0 111.604 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 66.13 15.73 10.19 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 124.986 1.314 . . . . 0.0 112.398 -176.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.424 HH21 HD13 ' A' ' 171' ' ' ILE . 9.7 ptm180 -127.27 171.19 11.69 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.481 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 7.0 tt -68.83 128.79 37.92 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -175.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -85.58 -69.61 0.65 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.757 0.823 . . . . 0.0 110.481 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 63.6 m -147.91 136.68 21.85 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.761 0.824 . . . . 0.0 109.05 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.459 HD22 HG13 ' A' ' 174' ' ' VAL . 47.6 tp -82.63 114.99 21.39 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.269 0.627 . . . . 0.0 109.58 177.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.0 mp -74.57 -50.8 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 175.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 49.4 tp -161.03 144.46 13.07 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.252 0.621 . . . . 0.0 109.464 178.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.61 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 7.6 tt -135.17 142.44 46.11 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 173.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.428 ' HB2' ' CE1' ' A' ' 150' ' ' PHE . 44.3 mtp85 -138.74 139.46 38.34 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -177.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.472 ' HB2' HD21 ' A' ' 181' ' ' LEU . . . -97.18 100.61 12.08 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -177.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.428 ' CE1' ' HB2' ' A' ' 148' ' ' ARG . 87.6 m-85 -96.56 124.55 40.58 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -177.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.485 HG22 HG12 ' A' ' 128' ' ' ILE . 58.6 p -67.5 178.84 1.47 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.266 0.555 . . . . 0.0 110.752 173.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 127' ' ' ASN . 10.3 pt-20 -60.84 -22.21 63.99 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.371 1.068 . . . . 0.0 112.076 174.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -91.23 -1.35 57.71 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.075 0.95 . . . . 0.0 111.327 176.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 79.79 9.69 86.51 Favored Glycine 0 C--N 1.348 1.222 0 O-C-N 123.375 0.422 . . . . 0.0 113.148 -177.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -87.25 120.8 28.91 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.69 0.796 . . . . 0.0 109.51 -174.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 16.1 mt -77.95 121.89 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -175.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.424 HG11 HG12 ' A' ' 123' ' ' ILE . 33.7 m -123.56 5.9 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.979 0.912 . . . . 0.0 110.948 -177.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -164.12 163.12 35.79 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -178.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -160.36 144.76 14.32 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.61 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 53.9 mt -123.71 115.54 45.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 172.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 18.4 p -138.84 132.34 16.1 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 122.902 0.481 . . . . 0.0 110.434 -175.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 31.1 Cg_endo -62.12 133.75 45.63 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.577 2.184 . . . . 0.0 111.875 176.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.2 mt -59.22 147.71 74.38 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 123.699 0.8 . . . . 0.0 111.256 177.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -64.04 -22.25 68.0 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.882 2.388 . . . . 0.0 112.439 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 39.8 m -78.52 -5.53 52.92 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.8 0.84 . . . . 0.0 111.936 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -131.93 94.91 23.45 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 124.146 0.978 . . . . 0.0 109.029 178.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -57.07 -32.98 94.85 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 123.56 2.84 . . . . 0.0 112.815 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.44 168.92 29.08 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.19 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -152.77 175.8 12.47 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.298 1.039 . . . . 0.0 109.867 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 6.3 m -96.15 162.33 13.58 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.533 0.733 . . . . 0.0 109.218 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 141' ' ' LEU . 9.2 tt -50.15 -33.74 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 124.606 1.162 . . . . 0.0 112.13 171.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -52.73 -48.25 66.81 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.48 1.112 . . . . 0.0 111.458 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -69.16 -36.33 77.26 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.741 -176.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.459 HG13 HD22 ' A' ' 144' ' ' LEU . 46.0 t -64.12 -48.88 83.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 O-C-N 123.948 0.78 . . . . 0.0 111.002 178.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -59.81 -40.72 89.34 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.638 0.775 . . . . 0.0 110.982 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.469 ' O ' HG23 ' A' ' 180' ' ' VAL . 89.4 m-20 -64.04 -46.26 85.21 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.871 176.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -61.76 -40.8 96.42 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.717 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 174' ' ' VAL . 66.6 mt -68.05 -37.5 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -65.72 -26.61 72.12 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 116.046 -0.524 . . . . 0.0 113.447 177.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 176' ' ' ASN . 98.3 t -75.59 -45.96 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.209 0.604 . . . . 0.0 109.916 175.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.472 HD21 ' HB2' ' A' ' 149' ' ' ALA . 42.6 tp -55.93 -52.5 63.92 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.342 0.657 . . . . 0.0 110.816 176.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.409 HG23 HG21 ' A' ' 192' ' ' VAL . 79.8 mt -60.13 -46.65 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.79 0.836 . . . . 0.0 110.595 176.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -52.65 -45.71 59.86 Favored Glycine 0 C--N 1.345 1.045 0 O-C-N 124.097 0.873 . . . . 0.0 114.156 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -68.14 -38.11 87.74 Favored Glycine 0 C--N 1.347 1.14 0 O-C-N 123.917 0.422 . . . . 0.0 112.538 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.542 HD22 HD12 ' A' ' 128' ' ' ILE . 97.5 mt -67.29 -34.12 76.73 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.484 0.713 . . . . 0.0 111.226 178.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -69.12 -38.81 79.07 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.59 0.756 . . . . 0.0 110.407 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -61.56 -41.35 97.24 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.191 174.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.434 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 6.7 m-20 -80.19 -2.86 46.64 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.965 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 61.68 57.03 2.33 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.054 0.941 . . . . 0.0 111.298 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -111.81 143.37 42.86 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.756 0.822 . . . . 0.0 109.146 174.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 96.0 m -78.64 102.84 8.2 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.409 HG21 HG23 ' A' ' 182' ' ' ILE . 26.7 m -86.7 143.0 12.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.418 -173.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -147.7 129.72 15.4 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 171.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 3.7 t -96.99 146.35 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 31.2 t -57.53 139.15 54.15 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 118.913 -0.565 . . . . 0.0 110.072 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -54.89 -37.89 66.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 123.497 0.498 . . . . 0.0 110.609 -177.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 41.1 p -62.02 -52.55 63.53 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.596 0.758 . . . . 0.0 109.541 176.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 68.9 mt -58.71 -28.09 65.49 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.61 0.764 . . . . 0.0 111.489 177.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.55 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 49.3 mt-30 -73.46 -42.74 61.56 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 119.021 -0.514 . . . . 0.0 112.191 -176.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.33 -20.78 20.05 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 119.541 1.064 . . . . 0.0 111.574 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -80.51 -41.78 23.65 Favored 'General case' 0 C--N 1.35 0.602 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.475 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -114.4 -60.59 1.87 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.059 0.543 . . . . 0.0 111.617 -176.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.55 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 46.1 t-105 -71.65 -15.77 62.24 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -161.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 153.49 -112.7 0.54 Allowed Glycine 0 C--N 1.339 0.723 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -178.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 58.2 m -149.73 96.5 2.48 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.43 0.692 . . . . 0.0 109.786 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 55.6 p -89.42 79.21 7.02 Favored 'General case' 0 C--N 1.351 0.657 0 CA-C-O 121.738 0.78 . . . . 0.0 108.933 171.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -139.11 91.31 2.5 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 174.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -67.66 83.13 0.18 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.852 0.861 . . . . 0.0 109.988 -173.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -79.04 116.0 19.07 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.383 -174.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -145.93 -118.42 1.14 Allowed Glycine 0 C--O 1.239 0.41 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 176.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 34.2 mtm-85 -120.16 139.44 28.45 Favored Pre-proline 0 C--O 1.243 0.732 0 C-N-CA 123.662 0.785 . . . . 0.0 109.416 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -61.0 127.56 22.66 Favored 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.542 2.162 . . . . 0.0 110.768 172.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -62.4 147.15 95.37 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.364 2.043 . . . . 0.0 111.525 173.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 78.8 mt -62.85 137.6 58.31 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 45.6 p -57.1 149.21 19.88 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.548 0.739 . . . . 0.0 112.11 -175.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 84.4 mt -67.25 95.44 0.42 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.573 0.749 . . . . 0.0 110.793 -175.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 . . . . . 0 C--O 1.251 1.17 0 CA-C-N 114.871 -1.058 . . . . 0.0 111.017 178.834 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 23.7 ptp . . . . . 0 N--CA 1.482 1.15 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.93 133.62 59.14 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 122.023 1.816 . . . . 0.0 110.987 166.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.72 98.0 0.09 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.817 0.847 . . . . 0.0 109.877 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 40.7 p -68.03 127.44 32.87 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.689 0.796 . . . . 0.0 110.482 -175.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -116.07 136.72 52.77 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.148 0.579 . . . . 0.0 110.523 -174.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -85.58 105.58 16.26 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 169.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.0 mm -77.6 120.45 28.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 175.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.4 p -100.85 66.54 1.18 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.416 ' HB3' ' O ' ' A' ' 132' ' ' ALA . 22.6 t70 -67.84 -29.15 68.22 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.755 176.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.743 ' HG3' ' HG3' ' A' ' 97' ' ' GLU . 32.7 ttp -104.84 129.42 53.16 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.724 1.61 . . . . 0.0 107.141 170.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 48.0 p -67.1 156.16 36.85 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 121.309 -0.87 . . . . 0.0 109.94 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -59.64 -35.3 58.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -57.87 -58.29 9.02 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.01 0.924 . . . . 0.0 112.175 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.743 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 12.5 pt-20 -71.15 -27.09 63.3 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 122.703 0.401 . . . . 0.0 111.05 -178.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.567 ' HG ' HD23 ' A' ' 146' ' ' LEU . 9.5 tt -60.71 -39.91 90.31 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.207 1.003 . . . . 0.0 110.201 171.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 81.1 p -107.07 19.96 19.69 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.277 0.631 . . . . 0.0 111.219 -177.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.545 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 2.5 tpm_? -69.78 140.15 53.34 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.879 0.871 . . . . 0.0 111.203 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -78.89 128.26 33.1 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 173.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 40.2 p-90 -150.65 168.13 25.25 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.064 0.946 . . . . 0.0 110.088 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -126.85 136.51 52.44 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.39 0.676 . . . . 0.0 109.795 178.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.508 ' HG3' ' HB2' ' A' ' 120' ' ' ASP . 43.7 ttp -94.31 93.06 7.51 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 167.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.2 tp -55.62 -53.73 52.93 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.718 1.207 . . . . 0.0 111.367 -168.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 27.5 mmt -101.95 93.75 3.97 Favored Pre-proline 0 C--O 1.244 0.779 0 C-N-CA 124.145 0.978 . . . . 0.0 108.581 171.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.501 ' HA ' ' HG2' ' A' ' 104' ' ' MET . 7.0 Cg_exo -73.02 111.73 3.35 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 122.573 2.182 . . . . 0.0 112.345 -172.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -114.63 112.32 22.71 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 171.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -94.92 101.5 13.29 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -177.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.471 ' HE2' HG11 ' A' ' 180' ' ' VAL . 55.2 tptt -101.93 146.23 28.15 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 170.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 93.2 t -131.01 129.29 63.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 167.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -123.78 95.11 4.44 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.35 -137.12 21.42 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.549 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -82.08 20.4 1.1 Allowed 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 123.705 2.937 . . . . 0.0 113.075 173.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.496 HD11 HG22 ' A' ' 174' ' ' VAL . 87.5 mt -127.86 122.69 33.24 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.358 0.663 . . . . 0.0 109.618 -175.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 49.4 t -85.44 115.41 23.15 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.038 0.935 . . . . 0.0 110.099 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.6 mm -100.47 121.88 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.588 0.755 . . . . 0.0 109.363 -175.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 51.3 mtt-85 -103.09 119.84 39.58 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 34.9 mm -114.56 122.04 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.508 ' HB2' ' HG3' ' A' ' 104' ' ' MET . 18.8 t70 -97.04 113.09 24.61 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 170.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -77.25 -11.56 59.84 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.716 0.806 . . . . 0.0 112.127 -175.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.66 -62.51 1.56 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.321 0.649 . . . . 0.0 111.765 -174.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.7 mp -71.23 115.0 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-O 122.014 0.911 . . . . 0.0 110.883 -174.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 59.1 mtt -133.11 167.25 20.67 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 113.83 -1.532 . . . . 0.0 109.879 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.9 t70 55.17 42.15 30.88 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.636 1.174 . . . . 0.0 111.374 177.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 190' ' ' ASN . 45.5 mmtm -124.75 153.39 42.49 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.209 1.004 . . . . 0.0 110.145 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -88.3 106.36 18.17 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 172.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.493 HG12 HG22 ' A' ' 151' ' ' THR . 56.0 mt -107.88 136.08 44.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 124.702 1.201 . . . . 0.0 110.031 -174.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 11.8 tpt -115.41 138.16 51.29 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.422 1.089 . . . . 0.0 110.057 -175.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.556 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 3.4 mm? -92.64 117.71 30.26 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.975 0.91 . . . . 0.0 108.92 177.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 93' ' ' MET . 73.5 mmtt -123.6 125.47 44.9 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.668 1.187 . . . . 0.0 109.211 176.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.548 ' HB2' ' HG ' ' A' ' 147' ' ' LEU . . . -137.49 144.43 42.22 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -175.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -106.29 130.77 54.08 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 169.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.425 ' HA ' HD13 ' A' ' 145' ' ' ILE . 4.9 p90 -162.87 157.46 21.32 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 124.15 0.906 . . . . 0.0 109.38 -172.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 22.2 p -85.65 152.1 23.36 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 172.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 87.6 t -121.84 138.51 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.847 0.859 . . . . 0.0 109.738 -177.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.0 tp -145.05 142.43 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 170.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 60.39 17.87 7.58 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.714 0.806 . . . . 0.0 112.757 177.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 73.87 21.08 2.75 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 126.566 1.947 . . . . 0.0 112.155 -177.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.419 ' HB2' HD12 ' A' ' 171' ' ' ILE . 10.8 ptp180 -125.39 172.19 9.82 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.938 0.895 . . . . 0.0 109.863 175.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.2 tt -69.32 119.56 13.78 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.365 0.666 . . . . 0.0 109.669 174.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -83.41 -65.93 0.95 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.319 1.047 . . . . 0.0 108.947 176.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 69.4 m -141.55 130.94 23.7 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.608 0.763 . . . . 0.0 109.028 175.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.431 HD21 ' HB2' ' A' ' 147' ' ' LEU . 52.9 tp -77.6 121.31 23.76 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.993 0.917 . . . . 0.0 109.812 174.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 134' ' ' PHE . 1.7 mp -81.94 -44.49 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.579 0.752 . . . . 0.0 109.458 176.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.567 HD23 ' HG ' ' A' ' 98' ' ' LEU . 34.0 tp -167.72 148.89 5.37 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.943 0.897 . . . . 0.0 108.714 173.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.71 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 8.3 tt -129.17 150.13 50.68 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 174.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.745 HH11 HG21 ' A' ' 156' ' ' ILE . 44.0 ttm-85 -143.1 143.57 31.89 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.379 0.672 . . . . 0.0 110.8 -173.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -124.22 118.8 27.65 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.437 1.095 . . . . 0.0 108.308 174.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -145.92 144.66 30.31 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.198 0.523 . . . . 0.0 111.018 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.493 HG22 HG12 ' A' ' 128' ' ' ILE . 55.3 p -65.41 171.51 3.9 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.616 -1.174 . . . . 0.0 112.197 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -65.3 -23.22 66.96 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.003 0.521 . . . . 0.0 110.821 172.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -66.12 -30.04 70.46 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.226 1.01 . . . . 0.0 110.234 174.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 107.3 -5.36 35.74 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.039 -174.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -70.26 105.14 2.87 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.434 0.694 . . . . 0.0 110.681 -175.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.745 HG21 HH11 ' A' ' 148' ' ' ARG . 33.3 mt -73.92 118.9 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.45 ' HB ' ' HB3' ' A' ' 120' ' ' ASP . 35.6 m -130.98 15.3 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.833 0.853 . . . . 0.0 110.648 -175.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -164.39 151.78 21.14 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -163.54 141.58 7.68 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.71 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 69.1 mt -113.13 102.74 14.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 170.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 20.7 t -98.93 108.49 49.4 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.135 0.974 . . . . 0.0 108.85 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.19 134.55 62.53 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.514 2.143 . . . . 0.0 111.318 175.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.9 mt -69.88 122.92 87.53 Favored Pre-proline 0 CA--C 1.551 1.001 0 O-C-N 123.531 0.52 . . . . 0.0 109.859 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -61.14 -17.84 54.69 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 123.785 2.99 . . . . 0.0 113.676 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 25.5 p -72.29 -14.22 61.7 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 124.076 0.95 . . . . 0.0 112.277 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -120.69 100.8 46.38 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 124.568 1.147 . . . . 0.0 108.271 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.42 -49.03 17.47 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.229 2.619 . . . . 0.0 113.145 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -125.25 155.35 18.72 Favored Glycine 0 C--N 1.35 1.321 0 CA-C-N 116.45 -0.341 . . . . 0.0 112.684 -175.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -150.63 154.79 38.15 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.496 1.118 . . . . 0.0 109.558 176.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.413 ' O ' HG23 ' A' ' 174' ' ' VAL . 80.7 p -87.69 151.4 22.96 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.064 0.546 . . . . 0.0 110.385 -174.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.443 ' O ' ' HG3' ' A' ' 175' ' ' LYS . 8.3 tt -58.52 -38.76 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 O-C-N 123.99 0.806 . . . . 0.0 111.129 175.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 47.2 mp0 -55.54 -41.57 73.4 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.086 0.955 . . . . 0.0 110.461 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -67.38 -47.19 71.08 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.556 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.496 HG22 HD11 ' A' ' 115' ' ' LEU . 57.4 t -61.53 -34.28 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 122.974 0.509 . . . . 0.0 110.959 -176.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 171' ' ' ILE . 39.2 mtpt -61.05 -34.7 75.3 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.247 0.619 . . . . 0.0 111.781 177.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -68.0 -47.65 67.94 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.35 -45.11 84.68 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 124.374 1.046 . . . . 0.0 112.249 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.5 ' HB ' ' HZ3' ' A' ' 203' ' ' TRP . 23.2 mt -72.06 -37.57 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -64.8 -27.47 72.12 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 116.126 -0.488 . . . . 0.0 113.003 177.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.471 HG11 ' HE2' ' A' ' 110' ' ' LYS . 54.1 t -83.15 -39.91 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.746 0.818 . . . . 0.0 110.203 177.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.483 HD22 HG13 ' A' ' 160' ' ' ILE . 58.7 tp -58.52 -53.03 62.95 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.084 0.554 . . . . 0.0 110.406 174.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.634 HG23 HG21 ' A' ' 192' ' ' VAL . 70.4 mt -59.28 -43.48 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.44 1.096 . . . . 0.0 110.278 173.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -58.53 -35.0 78.16 Favored Glycine 0 CA--C 1.533 1.203 0 O-C-N 123.886 0.741 . . . . 0.0 113.83 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -72.39 -35.49 59.91 Favored Glycine 0 C--N 1.349 1.292 0 N-CA-C 111.847 -0.501 . . . . 0.0 111.847 175.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.412 HD22 HD12 ' A' ' 128' ' ' ILE . 75.3 mt -71.06 -25.25 62.56 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 124.297 1.039 . . . . 0.0 111.252 175.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 26.9 mm-40 -70.85 -37.78 73.13 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.713 0.805 . . . . 0.0 110.06 174.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -73.83 -31.68 63.33 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.293 177.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -72.6 -14.72 61.68 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.088 169.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 15.6 t70 57.3 64.85 1.5 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.629 1.172 . . . . 0.0 110.313 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 10.5 p30 -131.84 165.73 23.18 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.671 174.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 42.3 m -87.78 106.39 18.04 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.507 -172.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.634 HG21 HG23 ' A' ' 182' ' ' ILE . 34.3 m -94.81 141.98 14.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.763 0 C-N-CA 122.918 0.487 . . . . 0.0 110.689 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -144.76 131.3 19.87 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.233 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.556 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 5.2 t -95.69 149.51 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.413 ' HB2' ' HG ' ' A' ' 198' ' ' LEU . 69.9 m -67.44 144.59 55.66 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 118.95 0.795 . . . . 0.0 110.947 177.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -60.22 -26.29 66.28 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.079 0.952 . . . . 0.0 111.797 -177.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.0 p -67.68 -53.18 29.74 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 172.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.51 ' HB2' HG12 ' A' ' 194' ' ' VAL . 68.1 mt -62.91 -25.61 68.41 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.881 0.873 . . . . 0.0 111.506 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.595 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 78.3 mt-30 -69.24 -44.12 72.65 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.224 0.61 . . . . 0.0 110.824 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.08 -30.0 20.22 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.662 -175.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -83.3 -57.89 3.07 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.548 0.339 . . . . 0.0 110.803 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -98.73 -37.37 9.51 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.16 0.584 . . . . 0.0 111.703 -165.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.595 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 43.4 t-105 -101.24 19.09 18.3 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.275 1.03 . . . . 0.0 109.415 -170.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -70.33 163.44 52.87 Favored Glycine 0 C--N 1.356 1.668 0 CA-C-N 115.96 -0.564 . . . . 0.0 113.336 -176.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 24.2 t -58.66 113.32 1.97 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.838 0.855 . . . . 0.0 111.26 -175.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 37.3 t -143.78 -178.43 5.91 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.266 1.026 . . . . 0.0 109.439 -173.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -72.7 103.0 3.48 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 165.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -69.79 86.84 0.51 Allowed 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.94 0.896 . . . . 0.0 109.189 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -61.74 122.84 16.35 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.907 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -161.57 122.69 1.13 Allowed Glycine 0 C--N 1.334 0.425 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -177.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.9 155.7 80.01 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 123.874 0.87 . . . . 0.0 109.686 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.426 ' HA ' ' HD3' ' A' ' 213' ' ' PRO . 23.7 Cg_exo -64.42 134.7 42.82 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.437 2.092 . . . . 0.0 111.466 -178.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 212' ' ' PRO . 38.4 Cg_exo -61.48 151.62 78.6 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.772 2.315 . . . . 0.0 112.385 179.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 65.0 mt -69.48 96.38 0.9 Allowed 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.855 0.862 . . . . 0.0 109.709 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 51.0 p -70.83 148.85 47.43 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.091 0.557 . . . . 0.0 111.049 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 34.3 mt -86.14 143.05 28.22 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.448 0.699 . . . . 0.0 109.665 -175.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 . . . . . 0 CA--C 1.556 1.194 0 C-N-CA 123.688 0.795 . . . . 0.0 108.869 -179.245 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 49.8 tpp . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.42 ' HB3' ' H ' ' A' ' 138' ' ' PHE . 17.9 Cg_exo -68.64 130.62 21.12 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 122.665 2.244 . . . . 0.0 111.394 175.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.93 93.61 0.09 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.012 0.925 . . . . 0.0 111.414 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 34.3 t -79.42 72.3 6.03 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 171.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -128.27 133.67 48.81 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.465 -168.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -86.47 105.03 16.49 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 175.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 49.9 mm -78.73 125.89 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 62.4 p -114.26 91.42 3.62 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.641 -176.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -75.51 -17.84 59.99 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.182 0.593 . . . . 0.0 110.703 177.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.508 ' SD ' ' HB3' ' A' ' 148' ' ' ARG . 61.1 mtm -117.22 128.72 55.38 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.456 1.103 . . . . 0.0 108.943 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.4 m -77.82 162.15 27.11 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 171.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -48.55 -35.41 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 124.402 1.081 . . . . 0.0 111.763 -177.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -51.58 -71.14 0.07 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.211 1.404 . . . . 0.0 112.207 177.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -69.11 -29.84 67.99 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.528 0.731 . . . . 0.0 111.744 -176.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.8 tt -62.5 -43.1 99.63 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.235 1.014 . . . . 0.0 109.263 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.2 m -105.23 15.18 27.85 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.738 0.815 . . . . 0.0 111.815 -175.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -80.88 135.47 35.92 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.159 0.583 . . . . 0.0 110.222 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -88.22 144.87 26.19 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.776 0.83 . . . . 0.0 109.306 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 18.5 p-90 -152.42 154.29 35.26 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.192 0.997 . . . . 0.0 110.465 -173.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -96.42 160.47 14.39 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.538 0.735 . . . . 0.0 110.791 -177.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 65.9 mtp -128.74 116.88 20.21 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 170.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.3 tt -70.71 -54.78 10.51 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 21.5 mmt -119.22 86.56 33.03 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 124.126 0.97 . . . . 0.0 109.378 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -76.67 113.61 3.69 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 122.837 2.358 . . . . 0.0 112.493 -175.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.55 ' HE3' ' HB2' ' A' ' 110' ' ' LYS . 51.4 tptt -90.59 106.69 18.68 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 169.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 51.2 tp60 -90.92 107.27 19.09 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.146 -0.933 . . . . 0.0 108.698 176.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.55 ' HB2' ' HE3' ' A' ' 108' ' ' LYS . 58.7 tttm -140.12 143.44 36.23 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.992 172.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 68.0 t -105.67 147.24 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 169.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -134.66 90.75 2.69 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 174.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.3 -136.37 21.21 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 114.823 -1.08 . . . . 0.0 112.687 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -81.43 17.9 1.42 Allowed 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 123.687 2.925 . . . . 0.0 113.148 176.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 4.3 mp -134.87 136.42 42.39 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.745 0.818 . . . . 0.0 108.91 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 26.4 p -100.82 138.83 37.35 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.105 0.562 . . . . 0.0 110.085 177.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.2 mm -106.72 133.94 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.326 1.05 . . . . 0.0 110.637 -171.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -108.84 118.18 36.12 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 173.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.496 ' HB ' ' HB3' ' A' ' 108' ' ' LYS . 87.0 mt -126.97 125.63 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -97.03 117.73 31.85 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 118.78 0.718 . . . . 0.0 109.331 173.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -78.5 -8.31 58.41 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.303 1.041 . . . . 0.0 112.506 -172.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.41 -26.33 23.36 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.676 0.39 . . . . 0.0 110.292 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 41.2 mm -81.89 102.15 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 121.997 0.904 . . . . 0.0 110.995 -173.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.527 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 52.1 mtt -134.09 160.47 37.67 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 114.253 -1.34 . . . . 0.0 108.763 -178.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.8 t70 65.34 24.56 12.1 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.719 0.771 . . . . 0.0 111.64 174.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 190' ' ' ASN . 74.9 mmtt -117.45 148.61 41.65 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.236 1.014 . . . . 0.0 110.66 -179.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -86.8 106.48 17.73 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 171.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.533 HD12 HD22 ' A' ' 185' ' ' LEU . 50.1 mt -102.28 128.63 54.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.893 0.877 . . . . 0.0 111.25 -174.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.558 ' HG3' ' HG3' ' A' ' 131' ' ' LYS . 4.0 tpt -98.99 116.38 31.1 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.064 1.746 . . . . 0.0 109.636 -176.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -98.57 104.7 16.76 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.558 ' HG3' ' HG3' ' A' ' 129' ' ' MET . 47.3 mtmt -127.17 149.58 49.91 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.166 0.586 . . . . 0.0 110.975 -177.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.485 ' HB3' HD21 ' A' ' 198' ' ' LEU . . . -141.4 149.93 41.7 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -173.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -100.25 118.88 37.46 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 163.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -151.91 159.18 43.89 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.157 0.583 . . . . 0.0 110.964 -171.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.8 m -86.36 150.52 24.27 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.787 1.235 . . . . 0.0 109.703 177.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 98.2 t -122.4 145.62 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 175.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.465 HG22 ' HB2' ' A' ' 142' ' ' GLU . 9.7 tp -162.67 145.48 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 167.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.42 ' H ' ' HB3' ' A' ' 85' ' ' PRO . 44.7 m-85 56.29 25.68 9.61 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 124.043 0.937 . . . . 0.0 112.606 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 69.72 25.52 5.12 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 125.781 1.632 . . . . 0.0 112.487 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.575 ' HB2' HD12 ' A' ' 171' ' ' ILE . 1.2 ptp85 -132.56 171.65 13.54 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.325 0.65 . . . . 0.0 110.902 175.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.7 tt -74.44 114.07 12.41 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 114.904 -1.043 . . . . 0.0 108.662 172.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.465 ' HB2' HG22 ' A' ' 137' ' ' ILE . 9.4 tp10 -73.45 -61.84 1.69 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.902 0.881 . . . . 0.0 110.247 175.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 65.4 m -146.32 127.53 14.76 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.99 0.916 . . . . 0.0 109.438 -175.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.452 HD11 ' HB1' ' A' ' 132' ' ' ALA . 36.7 tp -74.06 125.23 27.84 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 172.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.9 mp -83.35 -48.51 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 172.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.548 HD21 ' NH2' ' A' ' 148' ' ' ARG . 46.5 tp -165.26 147.42 7.8 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.687 0.795 . . . . 0.0 109.626 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.638 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 8.9 tt -129.62 156.75 43.7 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 171.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.793 ' HD3' HD13 ' A' ' 156' ' ' ILE . 48.4 ttm-85 -154.07 141.16 19.39 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.082 0.553 . . . . 0.0 110.733 -175.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.98 121.14 44.51 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.627 1.171 . . . . 0.0 109.411 -177.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -110.99 155.94 21.98 Favored 'General case' 0 C--O 1.208 -1.087 0 C-N-CA 124.74 1.216 . . . . 0.0 108.541 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 24.9 p -100.18 168.3 9.9 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 118.852 0.751 . . . . 0.0 109.833 168.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.8 -21.17 62.51 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 172.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -61.7 -30.27 70.64 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.103 0.961 . . . . 0.0 111.422 169.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 99.21 14.31 36.36 Favored Glycine 0 C--N 1.346 1.116 0 O-C-N 123.714 0.634 . . . . 0.0 112.84 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -101.1 135.11 43.09 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.41 0.684 . . . . 0.0 109.957 176.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.793 HD13 ' HD3' ' A' ' 148' ' ' ARG . 47.1 mt -78.93 127.13 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 174.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.6 m -127.01 1.41 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.636 0.774 . . . . 0.0 112.435 -171.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -164.81 170.03 39.73 Favored Glycine 0 C--N 1.344 0.973 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 34.6 tt0 -167.67 153.75 7.63 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.04 0.936 . . . . 0.0 109.139 -177.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.638 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 70.6 mt -129.4 104.23 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 167.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 5.4 p -109.95 121.84 40.71 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 123.85 0.86 . . . . 0.0 109.627 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 37.1 Cg_exo -62.53 140.11 79.81 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.752 2.301 . . . . 0.0 111.824 175.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 96.6 mt -72.72 123.25 89.33 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 123.744 0.818 . . . . 0.0 110.543 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.54 -10.48 29.16 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 123.361 2.707 . . . . 0.0 112.75 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 27.4 p -81.39 -1.87 47.23 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 124.06 0.944 . . . . 0.0 111.557 173.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -129.54 99.04 21.4 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 124.75 1.22 . . . . 0.0 108.567 177.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -71.71 79.16 1.61 Allowed 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 123.155 2.57 . . . . 0.0 112.688 177.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 108.16 156.47 18.88 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 115.959 -0.564 . . . . 0.0 113.925 173.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -151.4 172.13 16.42 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.069 1.348 . . . . 0.0 109.781 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 59.1 p -98.23 166.08 11.57 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 123.31 0.644 . . . . 0.0 110.268 174.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.626 HD11 ' HA ' ' A' ' 202' ' ' ALA . 12.7 tt -52.78 -35.84 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 124.189 0.996 . . . . 0.0 110.882 170.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -59.72 -44.71 93.61 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.55 1.14 . . . . 0.0 111.469 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -63.34 -43.69 97.01 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 124.105 0.878 . . . . 0.0 111.093 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.478 ' O ' HG13 ' A' ' 178' ' ' ILE . 67.3 t -64.07 -42.91 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.944 -178.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -62.14 -36.84 83.03 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.028 0.531 . . . . 0.0 111.634 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -66.29 -43.99 84.77 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 175.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -59.33 -44.69 92.58 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.232 1.013 . . . . 0.0 111.719 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 174' ' ' VAL . 51.3 mt -70.38 -35.99 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.27 0.628 . . . . 0.0 109.661 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.96 -27.17 73.31 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 116.22 -0.445 . . . . 0.0 113.723 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 45.5 t -75.2 -47.03 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.499 0.72 . . . . 0.0 110.614 175.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 30.0 tp -60.89 -52.76 63.66 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 123.748 0.655 . . . . 0.0 110.573 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.43 HG23 HG11 ' A' ' 192' ' ' VAL . 65.3 mt -65.85 -46.8 87.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.77 0.828 . . . . 0.0 111.149 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -58.13 -34.48 73.35 Favored Glycine 0 C--N 1.345 1.075 0 O-C-N 123.599 0.562 . . . . 0.0 113.396 177.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.5 -47.04 92.35 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 172.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.533 HD22 HD12 ' A' ' 128' ' ' ILE . 93.8 mt -64.54 -29.25 70.28 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.787 1.235 . . . . 0.0 111.92 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -69.68 -41.55 75.29 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.519 0.728 . . . . 0.0 110.493 177.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 20.6 mtm180 -74.53 -26.88 60.26 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.891 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.527 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 16.0 m120 -71.99 -20.07 61.78 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.237 0.615 . . . . 0.0 111.152 172.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 65.66 66.3 0.52 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.528 1.131 . . . . 0.0 110.831 -173.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 11.6 p30 -136.57 158.26 44.86 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.156 168.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 86.2 m -83.65 105.93 14.96 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.616 0.766 . . . . 0.0 110.588 -170.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.43 HG11 HG23 ' A' ' 182' ' ' ILE . 33.0 m -83.18 145.41 8.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 C-N-CA 123.153 0.581 . . . . 0.0 110.308 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -146.16 125.13 12.76 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 170.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 3.0 t -93.46 149.16 4.37 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -177.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 43.0 t -59.7 141.45 55.1 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.736 0.414 . . . . 0.0 110.235 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -52.61 -38.66 60.59 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.06 0.944 . . . . 0.0 111.443 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 68.6 p -67.54 -49.73 61.92 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.331 1.052 . . . . 0.0 110.647 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.485 HD21 ' HB3' ' A' ' 132' ' ' ALA . 71.5 mt -59.67 -34.81 73.33 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.714 0.805 . . . . 0.0 110.922 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.592 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 53.3 mt-30 -63.65 -54.53 34.26 Favored 'General case' 0 C--N 1.348 0.543 0 O-C-N 123.88 0.737 . . . . 0.0 110.974 178.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.39 -12.81 53.77 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -172.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -96.0 -40.43 9.27 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 118.058 0.39 . . . . 0.0 111.764 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.626 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -121.82 -61.49 1.5 Allowed 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -172.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.592 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 60.3 t-105 -64.3 -32.63 74.31 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.378 1.071 . . . . 0.0 112.323 -164.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -110.84 -53.44 0.55 Allowed Glycine 0 C--N 1.341 0.825 0 C-N-CA 123.709 0.671 . . . . 0.0 111.629 -173.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 47.8 m -94.93 112.74 24.42 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 69.5 m -150.9 82.96 1.33 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.98 1.312 . . . . 0.0 108.288 169.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -133.31 103.6 6.05 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.436 ' HB3' ' NH2' ' A' ' 140' ' ' ARG . 0.1 OUTLIER -147.3 136.5 22.47 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.264 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -165.07 85.25 0.4 Allowed 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -175.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -79.92 -53.24 4.31 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.942 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 52.7 mtm180 64.86 118.28 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.398 0 C-N-CA 125.554 1.542 . . . . 0.0 112.096 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -69.05 152.38 72.99 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.585 2.19 . . . . 0.0 111.274 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.31 113.84 1.67 Allowed 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.693 2.262 . . . . 0.0 111.567 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 66.3 mt -63.82 101.65 0.39 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.641 0.777 . . . . 0.0 109.996 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 71.6 p -74.64 144.0 44.05 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.19 0.519 . . . . 0.0 111.356 -174.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 30.6 mt -108.98 -179.5 3.87 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.039 0.935 . . . . 0.0 109.944 -175.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 . . . . . 0 C--O 1.249 1.037 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.965 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 61.7 mtt . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -63.71 162.75 27.05 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 123.507 2.805 . . . . 0.0 112.949 179.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.47 111.71 6.22 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 175.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.2 p -68.54 124.04 22.49 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.347 0.659 . . . . 0.0 110.07 177.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 45.0 ttm180 -118.66 140.1 50.47 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.076 0.55 . . . . 0.0 111.134 -173.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -96.85 111.05 23.41 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 170.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 133' ' ' ASN . 48.2 mm -83.05 117.69 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 170.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 37.7 p -113.5 88.49 2.85 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.017 0.927 . . . . 0.0 109.06 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -68.81 -31.06 69.78 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.456 177.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -121.31 142.88 49.53 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.816 0.847 . . . . 0.0 108.934 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 68.5 p -78.96 163.07 25.53 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.767 0.318 . . . . 0.0 110.297 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.46 -31.42 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.291 0 C-N-CA 124.863 1.265 . . . . 0.0 111.995 -176.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -54.34 -69.58 0.12 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.269 1.027 . . . . 0.0 112.363 178.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.9 pm0 -69.02 -25.19 64.37 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.007 0.523 . . . . 0.0 111.758 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.442 HD12 ' ND2' ' A' ' 133' ' ' ASN . 6.4 tt -59.67 -48.79 80.27 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.479 0.712 . . . . 0.0 109.386 176.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.8 t -106.77 19.24 20.76 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.203 0.601 . . . . 0.0 111.202 -175.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -77.58 140.59 39.71 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.689 0.796 . . . . 0.0 110.242 174.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -91.67 145.72 24.36 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.545 0.738 . . . . 0.0 110.459 174.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.552 ' HH2' ' HG2' ' A' ' 118' ' ' ARG . 42.3 p-90 -158.41 179.77 8.83 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.929 1.292 . . . . 0.0 109.78 -172.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -139.72 158.36 44.23 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.333 0.653 . . . . 0.0 110.513 177.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.541 ' HE3' ' HA ' ' A' ' 107' ' ' PRO . 71.0 mtm -105.99 145.62 31.12 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.741 0.816 . . . . 0.0 109.334 171.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.9 tp -82.2 -40.15 22.11 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.189 0.596 . . . . 0.0 110.177 -175.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 19.7 mmt -122.68 88.74 49.95 Favored Pre-proline 0 N--CA 1.484 1.236 0 C-N-CA 124.562 1.145 . . . . 0.0 108.666 169.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.541 ' HA ' ' HE3' ' A' ' 104' ' ' MET . 17.4 Cg_exo -68.27 131.96 24.69 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.622 2.215 . . . . 0.0 113.307 -178.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -135.57 135.91 40.69 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.404 1.082 . . . . 0.0 108.372 171.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -112.82 124.15 51.93 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.11 0.564 . . . . 0.0 110.144 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -125.53 150.06 47.76 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 168.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 12.9 t -126.81 142.51 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 172.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -138.68 98.12 3.5 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 68.69 -127.25 22.56 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 119.351 -0.694 . . . . 0.0 112.162 -177.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -89.45 14.75 2.12 Favored 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 123.483 2.789 . . . . 0.0 112.803 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.494 HD23 ' HA ' ' A' ' 162' ' ' PRO . 93.9 mt -128.03 122.44 32.21 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.931 0.492 . . . . 0.0 110.096 -172.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 40.2 t -83.05 116.9 22.5 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.345 1.058 . . . . 0.0 109.702 177.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 10.4 mm -90.81 115.96 31.09 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 C-N-CA 123.777 0.831 . . . . 0.0 109.287 -177.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.552 ' HG2' ' HH2' ' A' ' 102' ' ' TRP . 7.9 tpt180 -94.7 118.53 31.88 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 43.9 mm -123.3 134.39 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.531 0.732 . . . . 0.0 109.509 -176.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -117.97 120.87 39.13 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.445 0.698 . . . . 0.0 109.153 174.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -82.98 -1.24 52.0 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.949 0.9 . . . . 0.0 112.893 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.13 -56.92 3.12 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 117.934 0.334 . . . . 0.0 111.455 -173.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.474 HG23 ' HG3' ' A' ' 126' ' ' LYS . 2.0 mp -70.14 104.07 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-O 121.938 0.875 . . . . 0.0 110.314 -175.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.9 mtt -126.56 159.42 33.53 Favored 'General case' 0 C--N 1.348 0.508 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.964 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.71 33.84 21.94 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.608 0.763 . . . . 0.0 112.294 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.474 ' HG3' HG23 ' A' ' 123' ' ' ILE . 74.1 mmtt -114.49 155.23 26.79 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.461 0.705 . . . . 0.0 110.594 176.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.455 ' HB2' ' HB3' ' A' ' 152' ' ' GLU . 2.7 m-20 -89.73 101.63 14.32 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 170.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.506 ' HB ' HG12 ' A' ' 192' ' ' VAL . 66.5 mt -101.77 139.73 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.535 0.734 . . . . 0.0 109.431 -172.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 14.2 tpt -123.0 127.03 48.24 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.822 0.849 . . . . 0.0 109.649 -175.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 22.8 mt -99.15 104.59 16.58 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -176.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.419 ' HB2' ' HE1' ' A' ' 150' ' ' PHE . 2.8 mtpm? -117.23 130.72 56.76 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -175.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -133.52 152.69 51.94 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 122.016 0.912 . . . . 0.0 112.782 -170.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.442 ' ND2' HD12 ' A' ' 98' ' ' LEU . 5.2 m-20 -108.22 125.35 51.55 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 168.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -155.48 159.09 39.51 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.297 0.639 . . . . 0.0 111.083 -172.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.508 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . 37.9 m -90.12 161.69 15.66 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.985 0.914 . . . . 0.0 110.94 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 70.9 t -139.88 130.81 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 124.263 1.025 . . . . 0.0 110.075 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.618 HG22 ' HG2' ' A' ' 142' ' ' GLU . 9.1 tp -146.89 144.7 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 170.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 57.55 24.69 10.66 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.622 0.769 . . . . 0.0 111.628 -178.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 63.4 30.36 15.46 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.824 1.25 . . . . 0.0 112.28 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -131.9 165.45 23.86 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.615 0.766 . . . . 0.0 109.458 171.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.482 HD13 ' HB2' ' A' ' 202' ' ' ALA . 9.8 tt -70.9 129.39 38.91 Favored 'General case' 0 CA--C 1.554 1.096 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.618 ' HG2' HG22 ' A' ' 137' ' ' ILE . 31.8 mt-10 -83.88 -67.52 0.79 Allowed 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.698 0.761 . . . . 0.0 109.736 173.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 27.6 m -144.85 138.75 27.24 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.9 -170.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.449 HD22 HG13 ' A' ' 174' ' ' VAL . 56.5 tp -84.2 112.36 20.2 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.077 0.551 . . . . 0.0 109.577 175.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.13 -51.42 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 174.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.406 HD21 ' NH2' ' A' ' 148' ' ' ARG . 35.2 tp -170.6 149.13 3.15 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.321 177.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.538 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 10.0 tt -124.0 150.97 44.24 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 172.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.489 ' HD3' HD13 ' A' ' 156' ' ' ILE . 32.5 ttm-85 -143.31 135.09 26.61 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 122.671 0.388 . . . . 0.0 110.265 -178.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.06 113.73 27.44 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.419 ' HE1' ' HB2' ' A' ' 131' ' ' LYS . 17.4 m-85 -103.62 166.0 10.69 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 57.6 p -93.98 -179.44 4.97 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 120.949 0.404 . . . . 0.0 110.125 166.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 127' ' ' ASN . 13.3 pt-20 -61.94 -26.64 68.31 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.343 1.057 . . . . 0.0 110.913 172.11 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -77.57 -29.42 52.08 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.854 1.262 . . . . 0.0 110.815 174.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 103.96 11.03 33.29 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.908 -178.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.32 124.35 27.38 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.143 0.577 . . . . 0.0 109.503 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.489 HD13 ' HD3' ' A' ' 148' ' ' ARG . 54.9 mt -75.47 107.18 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -178.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.6 m -117.21 4.01 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.303 1.041 . . . . 0.0 111.869 -173.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -168.45 172.34 42.94 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-N 116.509 -0.314 . . . . 0.0 112.453 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -166.78 153.58 8.84 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.738 0.815 . . . . 0.0 109.394 -175.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.584 HD11 ' HB2' ' A' ' 181' ' ' LEU . 40.3 mm -124.95 103.58 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 164.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 55.9 p -102.68 126.95 31.35 Favored Pre-proline 0 N--CA 1.474 0.733 0 C-N-CA 123.146 0.578 . . . . 0.0 110.545 -177.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.494 ' HA ' HD23 ' A' ' 115' ' ' LEU . 56.4 Cg_endo -67.3 150.01 81.21 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 122.163 1.908 . . . . 0.0 112.015 175.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 77.0 mt -76.22 145.4 76.56 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.12 -27.54 78.98 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.906 2.404 . . . . 0.0 112.487 -176.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 24.2 m -74.32 -24.67 59.24 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.547 0.739 . . . . 0.0 111.567 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -131.8 71.47 80.58 Favored Pre-proline 0 N--CA 1.488 1.445 0 C-N-CA 123.23 0.612 . . . . 0.0 111.171 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -84.47 -6.09 10.01 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.657 2.238 . . . . 0.0 111.823 174.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -125.45 66.18 0.54 Allowed Glycine 0 C--N 1.347 1.151 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.445 ' CE1' HD21 ' A' ' 115' ' ' LEU . 27.2 p-80 -90.62 -175.68 4.5 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.857 0.863 . . . . 0.0 109.763 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 42.6 m -110.99 161.83 15.47 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.596 0.758 . . . . 0.0 110.315 -174.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' A' ' 141' ' ' LEU . 6.8 tt -45.94 -39.14 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.996 1.318 . . . . 0.0 112.498 173.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.594 ' HA ' ' NZ ' ' A' ' 175' ' ' LYS . 22.9 mm-40 -53.41 -48.87 68.32 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.262 1.025 . . . . 0.0 112.085 -176.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -61.11 -40.24 93.01 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 124.653 1.221 . . . . 0.0 110.813 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.449 HG13 HD22 ' A' ' 144' ' ' LEU . 41.1 t -66.8 -40.13 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.242 -175.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.594 ' NZ ' ' HA ' ' A' ' 172' ' ' GLU . 25.9 mtmm -60.39 -42.02 95.01 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 120.984 0.421 . . . . 0.0 110.009 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.498 ' O ' HG23 ' A' ' 180' ' ' VAL . 23.3 m-80 -62.92 -48.51 78.64 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.653 175.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -59.68 -48.01 83.36 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.997 0.811 . . . . 0.0 112.616 -173.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.8 mt -63.57 -37.8 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.283 175.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.44 -30.82 77.22 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 115.578 -0.737 . . . . 0.0 114.432 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 176' ' ' ASN . 44.9 t -76.03 -43.15 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 117.79 0.795 . . . . 0.0 108.994 176.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.584 ' HB2' HD11 ' A' ' 160' ' ' ILE . 37.8 tp -53.38 -53.19 54.75 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.339 176.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.423 HD12 ' CH2' ' A' ' 203' ' ' TRP . 43.1 mt -64.1 -39.76 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.898 0.879 . . . . 0.0 110.716 174.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -53.12 -35.56 49.62 Favored Glycine 0 CA--C 1.533 1.214 0 O-C-N 123.466 0.478 . . . . 0.0 114.088 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -83.43 -39.45 9.8 Favored Glycine 0 C--N 1.348 1.235 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 175.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 46.1 mt -66.21 -31.67 72.65 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.168 0.987 . . . . 0.0 112.437 -176.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -69.57 -33.58 72.94 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.743 0.417 . . . . 0.0 110.329 176.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -71.32 -32.83 69.07 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.181 176.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -63.31 -16.99 62.04 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.141 0.576 . . . . 0.0 111.767 171.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 63.5 65.78 0.73 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.976 0.91 . . . . 0.0 110.136 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.411 ' HB2' ' H ' ' A' ' 126' ' ' LYS . 4.0 p30 -141.0 175.9 9.24 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.069 176.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 90.9 m -109.91 101.91 10.71 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.106 0.563 . . . . 0.0 109.582 -173.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.506 HG12 ' HB ' ' A' ' 128' ' ' ILE . 12.7 m -99.82 153.87 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 121.535 0.683 . . . . 0.0 111.357 -177.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -136.56 143.91 43.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.174 -1.375 . . . . 0.0 108.305 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 3.3 t -111.06 145.88 16.79 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 47.4 m -57.93 140.66 51.62 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 118.014 0.37 . . . . 0.0 111.043 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -57.94 -29.91 65.53 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.291 0.636 . . . . 0.0 110.802 177.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 41.3 p -67.98 -52.64 33.52 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.784 0.834 . . . . 0.0 109.561 176.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 32.5 mt -54.58 -38.29 66.52 Favored 'General case' 0 C--O 1.208 -1.106 0 C-N-CA 123.871 0.868 . . . . 0.0 111.057 176.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.652 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 56.2 mt-30 -71.14 -39.74 71.8 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.258 0.623 . . . . 0.0 111.962 -176.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.29 -12.03 44.74 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -177.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -101.59 -42.53 6.19 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 178.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.482 ' HB2' HD13 ' A' ' 141' ' ' LEU . . . -123.42 -61.58 1.39 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.159 0.584 . . . . 0.0 112.243 -172.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.652 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 52.6 t-105 -70.49 79.39 0.57 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.841 1.257 . . . . 0.0 111.084 -171.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -112.09 -50.76 0.57 Allowed Glycine 0 C--O 1.242 0.652 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 170.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 31.5 m -141.86 87.52 2.05 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.604 0.762 . . . . 0.0 108.967 173.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.533 ' HA ' ' HB3' ' A' ' 175' ' ' LYS . 68.9 p -59.01 -46.28 88.57 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.678 0.791 . . . . 0.0 110.262 177.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 16.6 m120 61.75 19.36 10.48 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.412 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -96.46 84.07 3.64 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -87.17 86.36 7.28 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.578 -175.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -72.11 76.33 0.74 Allowed Glycine 0 C--N 1.348 1.231 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 171.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -79.98 156.69 74.47 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.095 0.958 . . . . 0.0 111.763 -166.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -81.76 125.07 4.75 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.022 1.814 . . . . 0.0 110.853 167.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -69.33 172.03 12.95 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 122.474 2.116 . . . . 0.0 111.587 171.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 91.1 mt -71.35 84.71 0.8 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 169.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 35.9 p -79.51 134.87 36.52 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.864 -173.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.5 pp -65.0 155.39 34.78 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.95 0.9 . . . . 0.0 112.446 -175.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 . . . . . 0 C--O 1.252 1.225 0 C-N-CA 123.952 0.901 . . . . 0.0 109.619 -179.314 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.522 ' HG3' ' HB2' ' A' ' 87' ' ' SER . 1.5 pmm? . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.15 -35.23 33.95 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.116 1.877 . . . . 0.0 111.197 172.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -167.28 144.55 4.58 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.866 1.266 . . . . 0.0 108.525 174.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.522 ' HB2' ' HG3' ' A' ' 84' ' ' MET . 40.4 t -139.85 147.44 40.68 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.245 1.018 . . . . 0.0 108.432 176.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.475 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 22.4 ttm-85 -102.2 118.22 36.42 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -174.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -92.76 101.97 14.36 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.942 0.897 . . . . 0.0 108.68 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.7 mm -78.96 114.33 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.491 0.716 . . . . 0.0 109.979 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.7 p -100.2 67.4 1.37 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 122.424 1.107 . . . . 0.0 108.752 174.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.455 ' HB3' ' O ' ' A' ' 132' ' ' ALA . 11.4 t70 -83.37 -33.31 25.84 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.76 -176.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 34.4 ttp -99.46 131.36 45.52 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 170.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.8 m -70.63 153.15 43.14 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 120.81 0.338 . . . . 0.0 110.4 177.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.43 -34.8 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.561 1.144 . . . . 0.0 110.406 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -54.44 -41.4 69.37 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.882 0.873 . . . . 0.0 111.627 174.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -80.69 -41.95 22.83 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.646 0.778 . . . . 0.0 110.451 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.572 ' HG ' HD23 ' A' ' 146' ' ' LEU . 10.4 tt -58.58 -46.65 86.48 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.565 1.146 . . . . 0.0 110.556 -176.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.5 t -100.22 19.28 16.8 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.764 0.826 . . . . 0.0 110.986 -175.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -84.74 128.11 34.44 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.033 0.533 . . . . 0.0 110.186 176.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -91.84 149.03 21.79 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.842 0.857 . . . . 0.0 108.949 174.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 24.2 p-90 -159.58 162.49 35.33 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.91 0.884 . . . . 0.0 110.463 -169.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -113.38 152.38 30.08 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.268 0.627 . . . . 0.0 109.974 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 66.2 mtp -104.79 123.2 47.25 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 175.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 42.7 tp -76.03 -40.28 53.8 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.502 0.721 . . . . 0.0 110.082 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 21.8 mmt -129.7 81.08 70.33 Favored Pre-proline 0 N--CA 1.482 1.173 0 C-N-CA 123.871 0.869 . . . . 0.0 108.926 171.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.81 113.39 3.19 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.7 2.266 . . . . 0.0 112.716 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.539 ' HB3' ' HB ' ' A' ' 119' ' ' ILE . 60.5 tttm -100.4 103.56 14.94 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 163.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.0 104.06 15.26 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -171.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.467 ' HG2' HG11 ' A' ' 180' ' ' VAL . 22.7 tptm -114.24 142.06 46.76 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.638 0.775 . . . . 0.0 109.451 177.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 97.6 t -125.82 126.4 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 170.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -115.06 83.96 2.0 Allowed 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 62.11 -114.95 7.3 Favored Glycine 0 CA--C 1.539 1.558 0 CA-C-N 114.875 -1.057 . . . . 0.0 113.468 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -84.93 5.93 5.99 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 123.702 2.935 . . . . 0.0 113.546 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 162' ' ' PRO . 35.2 mt -133.93 111.91 10.82 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -173.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 44.5 t -84.19 127.96 34.26 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.201 0.6 . . . . 0.0 110.063 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.5 mm -102.91 137.22 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.353 0.661 . . . . 0.0 110.126 -174.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.508 ' HG3' ' HB3' ' A' ' 159' ' ' GLU . 29.1 mmt180 -107.56 116.83 32.65 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 173.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.539 ' HB ' ' HB3' ' A' ' 108' ' ' LYS . 43.3 mm -113.87 120.01 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 172.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -103.01 116.29 32.24 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 174.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -75.75 -22.15 56.77 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.066 0.947 . . . . 0.0 111.848 -174.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.27 -46.99 37.88 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.062 0.545 . . . . 0.0 111.477 -175.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.499 HG21 HG11 ' A' ' 157' ' ' VAL . 1.9 mp -71.25 108.52 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-O 121.928 0.87 . . . . 0.0 110.08 -177.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.475 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 45.9 mtt -130.56 160.67 33.47 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.415 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.4 t70 63.73 38.6 9.16 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 124.338 1.055 . . . . 0.0 112.126 172.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -123.61 151.38 43.05 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.266 0.626 . . . . 0.0 110.774 177.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -85.03 103.05 13.71 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 169.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.527 HD13 HG21 ' A' ' 157' ' ' VAL . 48.0 mt -107.64 129.97 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.65 0.738 . . . . 0.0 110.515 -172.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.492 ' HG3' ' HG3' ' A' ' 131' ' ' LYS . 2.4 tpt -97.51 123.29 41.32 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 125.47 1.508 . . . . 0.0 109.644 -174.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.503 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 3.5 mm? -94.73 103.75 15.66 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.492 ' HG3' ' HG3' ' A' ' 129' ' ' MET . 62.5 mttm -124.44 153.32 42.12 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.054 0.542 . . . . 0.0 111.242 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.541 ' HB2' ' HG ' ' A' ' 147' ' ' LEU . . . -147.07 160.67 42.12 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.549 -176.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -112.13 131.63 55.34 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 163.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.4 ' HA ' HD13 ' A' ' 145' ' ' ILE . 28.0 p90 -160.25 154.7 23.7 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.752 0.658 . . . . 0.0 110.931 -172.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.7 t -86.11 153.67 21.92 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.375 1.07 . . . . 0.0 108.325 175.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 88' ' ' ARG . 79.6 t -134.88 139.73 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.516 0.726 . . . . 0.0 110.432 -175.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.9 tp -143.89 139.28 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 172.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 61.48 27.61 17.12 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 124.394 1.078 . . . . 0.0 112.354 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 61.14 29.96 19.11 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.669 1.187 . . . . 0.0 111.866 -177.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 7.5 ppt_? -135.3 158.22 44.91 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 173.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.6 tt -61.55 113.97 2.99 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.244 0.618 . . . . 0.0 110.288 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -75.28 -61.74 1.8 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.447 0.699 . . . . 0.0 110.462 176.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 40.5 m -147.09 129.03 15.41 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.516 0.726 . . . . 0.0 109.304 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.443 HD21 ' HB2' ' A' ' 147' ' ' LEU . 57.3 tp -78.11 120.6 23.15 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.894 0.878 . . . . 0.0 109.51 176.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 134' ' ' PHE . 1.8 mp -77.91 -47.54 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 175.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.572 HD23 ' HG ' ' A' ' 98' ' ' LEU . 55.2 tp -167.22 147.41 5.43 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.007 0.923 . . . . 0.0 109.079 175.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.738 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 6.6 tt -127.09 154.02 45.25 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 175.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.524 HH11 HG21 ' A' ' 156' ' ' ILE . 39.2 ttm-85 -150.58 143.82 24.89 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.094 0.558 . . . . 0.0 111.316 -171.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.403 ' HB2' HD21 ' A' ' 181' ' ' LEU . . . -117.27 111.84 19.94 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.765 1.226 . . . . 0.0 107.878 173.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.465 ' HZ ' ' HD2' ' A' ' 131' ' ' LYS . 46.5 p90 -131.55 142.58 49.95 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 72.3 p -62.95 169.4 3.31 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.524 0.729 . . . . 0.0 112.133 -177.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -51.9 -28.63 16.91 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.965 1.306 . . . . 0.0 112.317 174.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -84.18 -29.49 26.59 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.009 0.924 . . . . 0.0 111.313 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 114.03 8.37 17.77 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 116.482 -0.327 . . . . 0.0 113.593 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -79.92 114.29 18.73 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.524 HG21 HH11 ' A' ' 148' ' ' ARG . 23.9 mt -71.29 124.14 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 122.626 0.37 . . . . 0.0 110.188 -177.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.527 HG21 HD13 ' A' ' 128' ' ' ILE . 26.6 m -124.8 -5.67 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.243 1.017 . . . . 0.0 111.236 -176.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -158.97 164.96 34.0 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -178.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.508 ' HB3' ' HG3' ' A' ' 118' ' ' ARG . 26.2 tt0 -168.28 150.52 5.29 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.257 0.623 . . . . 0.0 109.346 -176.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.738 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 83.7 mt -121.75 104.13 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 168.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 35.3 t -96.08 107.96 38.1 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 123.933 0.893 . . . . 0.0 110.233 -177.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.426 ' HA ' HD23 ' A' ' 115' ' ' LEU . 51.5 Cg_exo -58.47 113.65 1.64 Allowed 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.526 2.151 . . . . 0.0 111.681 172.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.25 122.9 87.76 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 124.11 0.964 . . . . 0.0 111.377 -174.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -67.49 -12.69 36.6 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.975 2.45 . . . . 0.0 112.688 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 28.0 m -65.09 -24.74 67.53 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.063 0.945 . . . . 0.0 111.172 173.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -110.55 116.29 52.77 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 124.66 1.184 . . . . 0.0 108.618 -176.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -83.18 36.0 0.59 Allowed 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 123.067 2.511 . . . . 0.0 113.507 -176.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 160.52 157.86 8.93 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 116.696 -0.229 . . . . 0.0 113.058 174.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 -152.13 140.44 20.47 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.927 1.291 . . . . 0.0 108.556 173.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 14.7 m -88.31 152.4 21.96 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 6.7 tt -59.12 -35.91 59.9 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 124.933 1.293 . . . . 0.0 112.029 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.22 -31.91 73.3 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.753 0.821 . . . . 0.0 110.413 177.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -83.6 -30.01 27.3 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.712 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.507 ' O ' HG13 ' A' ' 178' ' ' ILE . 79.5 t -62.14 -38.82 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 171.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -52.0 -43.23 63.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 124.079 0.862 . . . . 0.0 110.85 173.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.444 ' O ' HG23 ' A' ' 180' ' ' VAL . 9.1 m120 -66.18 -45.29 81.37 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.989 0.805 . . . . 0.0 109.996 -177.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.5 -46.38 88.71 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.751 0.82 . . . . 0.0 111.908 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 174' ' ' VAL . 40.8 mt -63.37 -36.33 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 177.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.49 -35.52 91.86 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 115.433 -0.803 . . . . 0.0 113.403 176.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.467 HG11 ' HG2' ' A' ' 110' ' ' LYS . 60.2 t -68.39 -48.88 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.59 HD22 HG13 ' A' ' 160' ' ' ILE . 24.4 tp -59.77 -50.37 74.08 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.256 -178.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 70.4 mt -62.11 -47.47 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.48 0.712 . . . . 0.0 110.757 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -58.51 -35.15 78.72 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 123.938 0.774 . . . . 0.0 114.128 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.477 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -69.37 -38.21 80.48 Favored Glycine 0 C--N 1.347 1.156 0 C-N-CA 122.947 0.308 . . . . 0.0 112.488 176.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.442 HD13 ' O ' ' A' ' 181' ' ' LEU . 8.9 mp -71.37 -32.58 68.66 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.679 0.792 . . . . 0.0 111.702 178.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -69.83 -38.24 76.46 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.1 0.56 . . . . 0.0 111.896 -177.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -79.02 -16.6 56.64 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.71 0.404 . . . . 0.0 111.406 177.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.475 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 7.0 m-20 -76.32 -11.49 59.91 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.062 0.545 . . . . 0.0 110.876 165.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 25.5 t70 65.43 59.87 0.77 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.483 1.113 . . . . 0.0 109.424 -176.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -110.57 151.29 27.79 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.349 169.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 49.9 m -83.43 102.67 12.22 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 171.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 35.4 m -88.3 140.79 15.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 123.701 0.8 . . . . 0.0 109.351 -175.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 24.7 ttm-85 -145.09 127.32 15.75 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.51 175.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.503 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 2.6 t -87.85 143.02 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 26.5 t -63.76 147.8 50.82 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 118.519 0.599 . . . . 0.0 111.035 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -54.19 -35.59 62.51 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.031 0.932 . . . . 0.0 111.591 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 60.9 p -65.38 -53.15 47.58 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.945 0.898 . . . . 0.0 110.029 176.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.445 HD21 ' HB3' ' A' ' 132' ' ' ALA . 73.9 mt -62.93 -26.41 68.8 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.261 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.556 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 49.2 mt-30 -75.48 -46.68 30.93 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.29 0.636 . . . . 0.0 110.702 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.21 -12.29 47.25 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -175.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -106.5 -45.3 4.29 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 122.932 0.493 . . . . 0.0 112.283 178.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -114.87 -36.24 4.54 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -164.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.556 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 72.5 t-105 -98.37 -37.86 9.46 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.826 0.851 . . . . 0.0 110.551 -167.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.19 171.35 55.17 Favored Glycine 0 C--N 1.341 0.835 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.253 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 23.3 m 57.7 29.07 16.74 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.058 0.943 . . . . 0.0 110.35 -171.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 47.0 t -66.03 -41.21 91.21 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.244 1.017 . . . . 0.0 110.37 -175.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -73.72 158.05 35.37 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.064 173.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.57 135.31 54.92 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -153.15 165.46 35.58 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.145 0.578 . . . . 0.0 110.303 -172.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -75.18 159.97 52.12 Favored Glycine 0 C--N 1.341 0.85 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.076 175.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -151.48 157.71 34.68 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 123.889 0.876 . . . . 0.0 109.472 -177.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -59.72 158.61 27.69 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 123.024 2.482 . . . . 0.0 112.798 176.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.11 114.42 1.8 Allowed 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 122.902 2.401 . . . . 0.0 111.3 173.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 82.5 mt -73.29 120.76 19.35 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.114 0.565 . . . . 0.0 111.272 -170.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 10.3 m -76.43 108.35 9.34 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.924 0.889 . . . . 0.0 108.851 174.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 63.5 mt -130.41 144.88 51.67 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.899 0.48 . . . . 0.0 111.096 -170.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 C--O 1.252 1.188 0 C-N-CA 124.255 1.022 . . . . 0.0 110.232 178.948 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 19.7 ptp . . . . . 0 CA--C 1.55 0.976 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.32 175.44 11.09 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.948 2.432 . . . . 0.0 112.341 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.94 109.53 3.48 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.696 0.798 . . . . 0.0 110.696 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.1 m -125.02 132.32 53.25 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 124.374 1.07 . . . . 0.0 109.031 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -156.49 158.0 36.44 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.107 0.563 . . . . 0.0 109.967 -174.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -123.91 105.83 9.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.597 0.759 . . . . 0.0 109.656 174.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 50.6 mm -79.91 139.86 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 174.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.8 p -137.64 93.05 2.75 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.555 0.742 . . . . 0.0 109.546 176.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -80.93 -21.06 40.77 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.157 0.583 . . . . 0.0 111.106 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -100.67 126.82 47.22 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 175.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.61 177.28 8.78 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.88 0.872 . . . . 0.0 109.295 173.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -63.43 -43.16 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 123.88 0.872 . . . . 0.0 112.116 -167.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -62.46 -49.17 76.46 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.997 0.519 . . . . 0.0 111.931 -178.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.656 ' HA ' ' HB2' ' A' ' 100' ' ' ARG . 14.7 pt-20 -74.85 -19.82 60.01 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 123.475 0.485 . . . . 0.0 111.469 -178.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.8 tp -68.2 -32.3 72.43 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.29 1.036 . . . . 0.0 110.212 172.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.2 t -117.07 18.25 14.66 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.417 1.087 . . . . 0.0 110.849 -178.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.656 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 26.5 tpt180 -66.79 142.88 57.21 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.749 0.419 . . . . 0.0 112.107 -174.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -77.62 121.16 23.57 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.741 174.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 6.3 p-90 -140.12 149.25 42.82 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.402 1.081 . . . . 0.0 109.933 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -134.16 135.51 43.15 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.922 0.889 . . . . 0.0 109.179 178.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 92.1 mtp -101.69 112.45 25.03 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.63 0.772 . . . . 0.0 109.324 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 45.4 tp -65.93 -39.12 90.22 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.675 0.79 . . . . 0.0 110.206 -178.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 11.3 mmt -124.25 86.41 54.53 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 124.322 1.049 . . . . 0.0 108.407 173.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.37 131.36 24.64 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.253 1.969 . . . . 0.0 111.663 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.502 ' HB3' ' HB ' ' A' ' 119' ' ' ILE . 60.4 tptt -131.75 119.96 22.04 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 173.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.423 ' NE2' ' HB2' ' A' ' 116' ' ' CYS . 58.9 tp60 -108.63 106.06 15.95 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -176.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.51 97.96 5.9 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 123.677 0.791 . . . . 0.0 109.006 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.495 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . 55.9 t -78.75 124.79 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -122.45 94.33 4.26 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.8 -127.11 30.48 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.259 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -86.07 21.32 1.09 Allowed 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 123.054 2.503 . . . . 0.0 112.615 175.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.591 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 4.3 mp -129.63 167.57 17.77 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.973 0.909 . . . . 0.0 109.002 174.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 20.3 p -140.23 130.74 25.49 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 176.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 17.6 mm -105.83 132.63 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.285 1.034 . . . . 0.0 109.87 -170.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 15.9 mmt85 -99.99 122.93 43.65 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.76 1.224 . . . . 0.0 108.917 172.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.502 ' HB ' ' HB3' ' A' ' 108' ' ' LYS . 42.5 mm -122.69 121.59 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 172.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -95.5 111.83 23.66 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 168.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -78.86 -3.43 44.59 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.254 -174.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.3 -27.81 20.29 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.138 0.575 . . . . 0.0 110.505 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.408 HG21 HG11 ' A' ' 157' ' ' VAL . 39.5 mm -79.49 101.69 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-O 121.667 0.746 . . . . 0.0 111.145 -172.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.471 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 36.4 mtt -129.48 147.11 51.26 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.898 -174.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.0 t70 62.23 42.11 9.79 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.128 0.971 . . . . 0.0 111.765 175.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -119.76 147.91 44.06 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.195 0.998 . . . . 0.0 110.371 176.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.439 ' HA ' ' HB ' ' A' ' 191' ' ' THR . 44.2 m-80 -83.56 110.0 17.87 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 171.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 61.6 mt -117.54 134.13 62.12 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 123.382 0.673 . . . . 0.0 111.23 -171.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 37.7 tpp -111.59 125.61 54.12 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.513 1.925 . . . . 0.0 108.763 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.472 ' HB3' HD21 ' A' ' 147' ' ' LEU . 18.5 mt -97.23 102.59 14.39 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -98.5 149.18 22.99 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.667 0.787 . . . . 0.0 109.365 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -142.56 144.44 32.9 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 122.239 1.018 . . . . 0.0 113.723 175.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -99.52 122.51 42.69 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 163.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.537 ' HB3' HD12 ' A' ' 144' ' ' LEU . 49.7 p90 -153.15 159.78 42.77 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.268 0.556 . . . . 0.0 111.763 -175.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.7 t -90.94 156.36 18.04 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.982 177.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 72.0 t -130.72 136.03 59.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.906 1.282 . . . . 0.0 108.575 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.3 tp -145.19 144.09 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 170.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 62.39 24.18 14.38 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.661 0.785 . . . . 0.0 111.348 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.5 t70 71.03 5.46 5.49 Favored 'General case' 0 CA--C 1.564 1.511 0 C-N-CA 124.931 1.292 . . . . 0.0 111.954 -176.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -114.58 172.2 7.17 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.343 -0.848 . . . . 0.0 109.78 176.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.599 ' HB2' ' HB3' ' A' ' 201' ' ' PHE . 6.8 tt -69.39 125.49 26.84 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -83.7 -66.61 0.87 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.299 0.64 . . . . 0.0 110.247 177.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 65.9 m -149.88 131.12 14.56 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.808 1.243 . . . . 0.0 108.49 -173.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.537 HD12 ' HB3' ' A' ' 134' ' ' PHE . 44.7 tp -71.96 131.91 43.58 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 175.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.38 -50.06 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 172.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 54.4 tp -164.95 151.25 10.29 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.016 0.926 . . . . 0.0 109.358 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.709 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 7.2 tt -136.62 145.82 45.32 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 172.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.504 ' HE ' HD13 ' A' ' 156' ' ' ILE . 17.5 mtp180 -141.32 144.23 34.48 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.697 0.799 . . . . 0.0 109.599 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.11 111.86 24.77 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.399 1.08 . . . . 0.0 108.927 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.413 ' CE1' ' HB2' ' A' ' 148' ' ' ARG . 65.0 m-85 -106.6 137.2 45.04 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.191 0.996 . . . . 0.0 109.207 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 47.2 p -76.01 -179.9 5.2 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-O 121.286 0.565 . . . . 0.0 110.142 172.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -61.71 -20.44 63.49 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.515 0.726 . . . . 0.0 111.048 169.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -88.51 -1.75 58.22 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.962 1.305 . . . . 0.0 111.604 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 74.33 15.08 80.34 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-N 116.448 -0.342 . . . . 0.0 112.971 -178.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -86.01 125.0 33.08 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.426 0.69 . . . . 0.0 109.852 -176.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.504 HD13 ' HE ' ' A' ' 148' ' ' ARG . 22.6 mt -78.84 100.99 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -177.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.408 HG11 HG21 ' A' ' 123' ' ' ILE . 33.2 m -105.36 -0.16 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.138 0.975 . . . . 0.0 111.433 -173.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -162.96 167.07 37.19 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.329 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -163.47 153.36 15.28 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.709 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 63.1 mt -128.88 102.92 8.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 170.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.405 ' HA ' ' HD2' ' A' ' 162' ' ' PRO . 3.1 p -112.83 110.05 52.28 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 123.901 0.881 . . . . 0.0 109.605 -177.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.591 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 20.7 Cg_endo -60.04 127.85 24.62 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.641 2.227 . . . . 0.0 111.515 171.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.1 mt -64.12 120.43 64.23 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.812 0.845 . . . . 0.0 110.366 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -65.98 162.03 37.09 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.874 2.383 . . . . 0.0 111.733 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 13.6 t 71.24 20.11 5.17 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 125.206 1.402 . . . . 0.0 111.359 -175.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -126.95 90.27 49.95 Favored Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 123.979 0.912 . . . . 0.0 109.212 177.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.13 -23.23 39.87 Favored 'Trans proline' 0 C--N 1.381 2.288 0 C-N-CA 122.976 2.45 . . . . 0.0 112.419 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -71.39 90.21 0.44 Allowed Glycine 0 C--N 1.351 1.408 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 176.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -152.08 125.55 8.84 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 35.8 p -126.91 171.08 11.59 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.022 0.929 . . . . 0.0 110.36 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.46 ' O ' ' HG3' ' A' ' 175' ' ' LYS . 15.1 tt -50.69 -37.14 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.406 170.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -52.32 -51.29 59.53 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.338 1.455 . . . . 0.0 111.019 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -59.33 -41.1 88.34 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.949 0.9 . . . . 0.0 111.851 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.468 ' O ' HG13 ' A' ' 178' ' ' ILE . 25.9 t -64.07 -40.72 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 O-C-N 124.117 0.885 . . . . 0.0 110.52 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 171' ' ' ILE . 56.5 mtpt -61.66 -42.52 99.02 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.746 0.818 . . . . 0.0 111.165 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.47 ' O ' HG23 ' A' ' 180' ' ' VAL . 24.4 m120 -66.68 -43.24 84.97 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 123.591 0.557 . . . . 0.0 109.645 176.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -60.9 -45.08 96.03 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 124.584 1.177 . . . . 0.0 112.279 -175.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 174' ' ' VAL . 25.8 mt -69.27 -32.83 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.96 -30.64 78.31 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.433 174.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 176' ' ' ASN . 61.3 t -74.84 -51.08 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 122.813 0.445 . . . . 0.0 109.819 175.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.499 ' HA ' HD11 ' A' ' 119' ' ' ILE . 47.9 tp -54.18 -51.13 65.33 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 123.933 0.77 . . . . 0.0 111.26 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.491 ' O ' ' HG3' ' A' ' 186' ' ' GLU . 10.4 tt -62.27 -37.2 78.0 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.934 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.613 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -62.19 -42.53 99.72 Favored Glycine 0 C--N 1.351 1.366 0 O-C-N 123.287 0.367 . . . . 0.0 113.903 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -65.98 -35.85 91.23 Favored Glycine 0 C--N 1.348 1.208 0 O-C-N 123.843 0.378 . . . . 0.0 112.294 175.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 86.4 mt -68.33 -42.25 79.58 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.17 0.988 . . . . 0.0 111.49 177.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 182' ' ' ILE . 49.3 mt-10 -67.72 -38.41 83.53 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.494 0.718 . . . . 0.0 110.269 -176.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.11 -24.32 59.44 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.351 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.471 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 97.6 m-20 -68.93 -18.87 64.16 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 122.667 0.387 . . . . 0.0 111.059 170.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 35.9 t70 65.9 65.69 0.52 Allowed 'General case' 0 C--N 1.354 0.784 0 C-N-CA 124.116 0.967 . . . . 0.0 109.662 -174.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -131.14 169.09 16.38 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.694 173.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.439 ' HB ' ' HA ' ' A' ' 127' ' ' ASN . 89.5 m -84.17 114.72 22.0 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 30.0 m -97.52 136.37 28.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -145.04 128.09 16.56 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 176.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 4.8 t -103.07 150.58 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -175.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 45.8 t -60.91 141.07 57.51 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.86 -28.02 63.76 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.825 0.85 . . . . 0.0 112.249 -177.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 37.6 p -70.95 -45.25 64.48 Favored 'General case' 0 C--N 1.348 0.516 0 C-N-CA 123.544 0.738 . . . . 0.0 109.903 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 78.7 mt -65.1 -39.97 93.89 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.174 0.59 . . . . 0.0 110.52 176.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.647 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 52.5 mt-30 -60.06 -31.33 69.89 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.807 0.843 . . . . 0.0 111.101 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -83.87 -61.04 1.92 Allowed 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 123.887 0.875 . . . . 0.0 110.717 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.599 ' HB3' ' HB2' ' A' ' 141' ' ' LEU . 61.5 m-85 -71.44 -47.1 57.93 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.178 0.991 . . . . 0.0 112.84 -167.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.533 ' HB2' HD13 ' A' ' 141' ' ' LEU . . . -109.25 -58.15 2.07 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 122.944 0.497 . . . . 0.0 110.771 -170.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.647 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 40.4 t-105 -62.76 -25.81 68.39 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.751 1.221 . . . . 0.0 111.532 -175.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -72.96 -116.47 0.06 OUTLIER Glycine 0 CA--C 1.531 1.05 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 165.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 33.1 t 52.13 37.36 21.46 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.181 0.993 . . . . 0.0 112.758 172.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 14.1 m -74.87 83.16 2.17 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -143.47 149.17 37.17 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.066 -177.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -115.43 163.26 15.98 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.77 0.828 . . . . 0.0 109.179 170.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -83.53 114.87 21.81 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.509 0.724 . . . . 0.0 109.826 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -70.06 114.89 5.79 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 165.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 72.73 156.59 0.16 Allowed Pre-proline 0 N--CA 1.493 1.725 0 C-N-CA 124.696 1.198 . . . . 0.0 111.2 -171.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -58.76 149.62 76.17 Favored 'Trans proline' 0 C--N 1.388 2.627 0 C-N-CA 122.988 2.459 . . . . 0.0 113.136 -178.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -59.32 104.73 0.22 Allowed 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 122.898 2.398 . . . . 0.0 111.212 175.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 86.9 mt -71.58 90.62 1.03 Allowed 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 35.2 p -91.78 170.58 9.78 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.869 0.868 . . . . 0.0 110.664 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.484 ' H ' HD12 ' A' ' 216' ' ' LEU . 4.1 mp -69.33 111.03 4.96 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.598 0.759 . . . . 0.0 110.406 -168.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 . . . . . 0 C--O 1.249 1.039 0 C-N-CA 123.435 0.694 . . . . 0.0 110.236 -178.306 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.421 ' HB3' ' HB3' ' A' ' 87' ' ' SER . 61.0 mtt . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.79 116.45 4.01 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 123.071 2.514 . . . . 0.0 111.814 -176.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 64.01 9.97 5.02 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.323 1.049 . . . . 0.0 112.528 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 17.0 t -93.62 106.98 18.9 Favored 'General case' 0 C--N 1.345 0.392 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -127.57 148.56 50.35 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.848 0.859 . . . . 0.0 110.159 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -90.2 108.99 20.09 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 174.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.0 mm -77.25 117.72 22.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 176.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.2 p -98.0 75.31 2.34 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -73.51 -32.02 64.03 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 113.726 -1.579 . . . . 0.0 109.966 -178.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.43 ' HB3' ' HB3' ' A' ' 131' ' ' LYS . 21.2 ptt? -109.74 138.67 45.77 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 165.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 66.7 p -65.3 157.32 29.39 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.726 0.41 . . . . 0.0 110.128 177.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.9 mp -58.07 -35.85 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -56.56 -60.3 3.73 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.092 1.357 . . . . 0.0 112.481 176.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.415 ' HG3' ' HB2' ' A' ' 93' ' ' MET . 11.9 pt-20 -70.71 -24.99 62.75 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 122.631 0.372 . . . . 0.0 111.18 -176.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.525 ' HA ' ' HE ' ' A' ' 148' ' ' ARG . 7.8 tt -65.36 -48.26 73.58 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.818 0.847 . . . . 0.0 109.622 172.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 90.5 p -84.3 -3.08 58.01 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.192 0.597 . . . . 0.0 112.389 -173.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.1 tpt85 -61.51 126.89 28.96 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.584 0.754 . . . . 0.0 110.915 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -82.42 155.07 24.86 Favored 'General case' 0 C--O 1.239 0.535 0 O-C-N 123.976 0.797 . . . . 0.0 109.801 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -161.3 169.05 22.85 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.65 0.78 . . . . 0.0 110.84 -173.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -125.89 151.82 46.38 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.201 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 72.9 mtp -109.86 105.05 14.1 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 171.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.9 tt -62.64 -44.1 97.12 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 80.4 mmm -119.58 88.37 38.8 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 123.904 0.882 . . . . 0.0 109.416 171.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.71 124.54 9.34 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.69 2.26 . . . . 0.0 112.355 -178.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -123.15 124.76 43.78 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.39 101.31 7.1 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -102.82 129.11 49.38 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.103 0.961 . . . . 0.0 108.815 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 72.7 t -86.76 133.8 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 173.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -128.36 85.3 2.32 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 62.31 -121.43 25.37 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.666 176.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.496 ' HB2' ' HB3' ' A' ' 169' ' ' HIS . 3.7 Cg_exo -78.92 8.48 3.75 Favored 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 123.728 2.952 . . . . 0.0 114.199 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 4.5 mp -133.62 163.5 29.28 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.375 0.67 . . . . 0.0 109.506 -178.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.486 ' SG ' ' HB2' ' A' ' 161' ' ' SER . 31.5 p -126.86 136.02 51.78 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 10.2 mm -110.43 124.91 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.304 1.042 . . . . 0.0 109.542 -169.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -108.65 121.99 46.18 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.428 1.091 . . . . 0.0 108.347 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.579 HD13 ' HA3' ' A' ' 184' ' ' GLY . 53.0 mt -131.29 121.92 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.437 ' HB3' ' HB ' ' A' ' 157' ' ' VAL . 23.8 t70 -94.49 115.28 27.42 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 175.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -81.22 -10.64 59.57 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.715 0.806 . . . . 0.0 112.016 -174.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.2 -41.68 63.53 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.266 0.626 . . . . 0.0 110.963 -176.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.6 mp -76.91 115.83 19.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.882 177.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 48.6 mtt -132.89 154.97 49.88 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.567 1.147 . . . . 0.0 110.102 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.7 t70 62.34 23.95 14.23 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.354 1.062 . . . . 0.0 112.105 176.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 190' ' ' ASN . 73.9 mmtt -105.76 149.95 25.98 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.202 0.601 . . . . 0.0 110.079 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.559 ' HB2' ' HG2' ' A' ' 152' ' ' GLU . 75.8 m-20 -83.06 106.56 14.97 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 173.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 80.5 mt -106.29 121.86 59.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 123.39 0.676 . . . . 0.0 110.147 -174.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 36.7 tpp -96.33 130.44 43.44 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.879 1.272 . . . . 0.0 109.322 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 19.2 mt -100.07 104.27 15.83 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 93' ' ' MET . 32.7 mmtp -98.8 155.4 17.38 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.998 0.919 . . . . 0.0 109.507 173.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.566 ' HB3' HD21 ' A' ' 198' ' ' LEU . . . -155.49 145.69 21.73 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 168.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -108.18 134.35 51.15 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 172.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.461 ' HA ' HD13 ' A' ' 145' ' ' ILE . 37.9 p90 -160.01 160.62 33.5 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.735 0.814 . . . . 0.0 110.589 -169.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 43.7 p -85.47 155.24 21.32 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.866 0.866 . . . . 0.0 108.81 171.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 87' ' ' SER . 91.0 t -116.5 154.05 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.959 0.904 . . . . 0.0 110.308 -177.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.474 ' O ' ' HG3' ' A' ' 140' ' ' ARG . 11.0 tp -156.09 134.44 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 164.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 58.14 24.76 11.66 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.961 0.904 . . . . 0.0 113.024 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.549 ' HB3' HH22 ' A' ' 200' ' ' ARG . 1.6 m-20 65.5 35.03 7.52 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.869 1.268 . . . . 0.0 111.832 -176.389 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 137' ' ' ILE . 7.6 ppt_? -136.24 162.93 31.61 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.679 0.792 . . . . 0.0 109.048 169.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.458 ' HB3' HG13 ' A' ' 171' ' ' ILE . 9.7 tt -68.14 110.05 3.81 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.658 0.783 . . . . 0.0 109.765 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -70.78 -64.87 0.82 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.893 0.877 . . . . 0.0 109.558 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 53.1 m -142.54 131.31 22.78 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.549 HD21 ' HB2' ' A' ' 147' ' ' LEU . 53.6 tp -73.07 129.22 37.6 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.391 0.676 . . . . 0.0 109.455 173.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.461 HD13 ' HA ' ' A' ' 134' ' ' PHE . 1.6 mp -84.9 -52.86 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 174.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 39.9 tp -162.04 148.6 13.63 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.028 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.688 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 8.9 tt -125.76 149.13 48.81 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 174.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.617 HH11 HG21 ' A' ' 156' ' ' ILE . 21.7 ttm-85 -141.93 139.75 32.61 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.025 0.93 . . . . 0.0 110.583 -176.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.492 ' HB3' ' HA3' ' A' ' 158' ' ' GLY . . . -123.87 122.46 38.05 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.487 1.115 . . . . 0.0 108.023 176.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -142.05 166.36 24.92 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.241 0.616 . . . . 0.0 110.861 -177.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 82.4 p -85.67 179.0 7.17 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.735 0.814 . . . . 0.0 110.301 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.559 ' HG2' ' HB2' ' A' ' 127' ' ' ASN . 24.3 mm-40 -63.44 -21.84 66.54 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 122.16 -0.338 . . . . 0.0 111.889 172.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -78.78 -13.7 59.67 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.014 0.525 . . . . 0.0 111.059 176.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 88.84 -2.72 84.51 Favored Glycine 0 C--N 1.349 1.254 0 N-CA-C 112.044 -0.422 . . . . 0.0 112.044 -173.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.92 108.18 2.93 Favored 'General case' 0 C--N 1.353 0.721 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -178.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.617 HG21 HH11 ' A' ' 148' ' ' ARG . 23.6 mt -77.91 128.43 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 O-C-N 123.56 0.538 . . . . 0.0 110.415 -170.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 120' ' ' ASP . 34.6 m -130.62 8.06 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 123.883 0.873 . . . . 0.0 111.228 -174.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.492 ' HA3' ' HB3' ' A' ' 149' ' ' ALA . . . -161.23 157.53 29.13 Favored Glycine 0 C--N 1.339 0.703 0 N-CA-C 111.856 -0.498 . . . . 0.0 111.856 -177.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -168.35 140.96 2.96 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.562 0.745 . . . . 0.0 109.765 -178.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.688 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 70.9 mt -123.7 112.66 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 175.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.486 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 20.3 m -112.53 118.32 45.51 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.094 0.958 . . . . 0.0 109.919 -177.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 38.8 Cg_exo -63.94 124.55 13.74 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 122.855 2.37 . . . . 0.0 112.59 176.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 96.5 mt -64.43 129.75 94.33 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 124.343 1.057 . . . . 0.0 112.207 -177.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -67.33 -9.26 24.63 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.955 2.437 . . . . 0.0 112.803 169.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.9 m -65.26 -24.29 67.28 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.85 0.86 . . . . 0.0 111.29 169.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -132.53 90.67 32.68 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 124.134 0.974 . . . . 0.0 108.841 -178.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.78 90.68 1.25 Allowed 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.768 2.312 . . . . 0.0 112.567 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 114.22 96.83 2.18 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.845 174.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 114' ' ' PRO . 20.2 p-80 -102.44 162.71 12.7 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.873 0.869 . . . . 0.0 109.785 178.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 76.5 p -84.27 160.44 20.75 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 173.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.505 HD11 ' HA ' ' A' ' 202' ' ' ALA . 9.4 tt -54.64 -32.96 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 123.215 0.606 . . . . 0.0 110.712 168.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.676 ' HA ' ' HE2' ' A' ' 175' ' ' LYS . 35.6 mt-10 -64.71 -33.47 76.03 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.108 -178.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -70.62 -33.16 70.71 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.408 0.683 . . . . 0.0 111.55 175.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 56.4 t -69.76 -36.04 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 122.493 0.317 . . . . 0.0 110.33 174.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.676 ' HE2' ' HA ' ' A' ' 172' ' ' GLU . 48.6 mtmt -62.3 -38.04 87.89 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 120.77 0.319 . . . . 0.0 110.389 175.104 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -64.02 -44.23 93.2 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.221 174.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.87 -51.09 68.34 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.742 -175.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 49.5 mt -64.46 -33.37 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.15 0.58 . . . . 0.0 109.821 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -59.4 -39.72 95.16 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-N 115.653 -0.703 . . . . 0.0 113.649 175.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 97.2 t -72.42 -44.02 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 122.767 0.427 . . . . 0.0 110.395 176.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.464 HD12 HG12 ' A' ' 119' ' ' ILE . 59.5 tp -52.59 -57.3 10.43 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.802 0.841 . . . . 0.0 111.309 177.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.592 HG23 HG21 ' A' ' 192' ' ' VAL . 50.6 mt -58.88 -45.27 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 O-C-N 124.013 0.821 . . . . 0.0 110.598 174.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -53.54 -38.13 57.6 Favored Glycine 0 C--N 1.346 1.122 0 O-C-N 123.949 0.78 . . . . 0.0 114.066 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.579 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -81.0 -28.81 44.12 Favored Glycine 0 C--N 1.348 1.195 0 N-CA-C 112.577 -0.209 . . . . 0.0 112.577 176.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 68.6 mt -71.83 -21.45 61.68 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.237 0.615 . . . . 0.0 110.715 174.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 19.5 mm-40 -68.76 -36.56 78.5 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.354 0.662 . . . . 0.0 110.853 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -76.97 -24.77 52.27 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 122.939 0.149 . . . . 0.0 110.824 176.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -63.95 -22.55 66.97 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.57 0.348 . . . . 0.0 110.437 167.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 13.4 t70 53.19 67.33 1.01 Allowed 'General case' 0 C--N 1.356 0.85 0 C-N-CA 124.893 1.277 . . . . 0.0 111.252 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 3.0 p-10 -124.5 -161.31 1.0 Allowed 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.825 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 31.9 m -120.07 101.49 7.88 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.592 HG21 HG23 ' A' ' 182' ' ' ILE . 26.7 m -93.28 147.28 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 121.145 0.497 . . . . 0.0 110.386 -177.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 40.1 ttt180 -142.22 132.96 25.54 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.13 172.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.463 HG22 HD11 ' A' ' 182' ' ' ILE . 3.2 t -90.41 134.26 29.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 N-CA-C 104.802 -2.295 . . . . 0.0 104.802 175.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 27.9 t -60.35 151.74 27.04 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.142 0.428 . . . . 0.0 111.654 -173.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -51.44 -40.15 58.8 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.755 1.222 . . . . 0.0 112.241 -175.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 75.8 p -68.82 -49.29 59.7 Favored 'General case' 0 C--N 1.345 0.393 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.566 HD21 ' HB3' ' A' ' 132' ' ' ALA . 41.1 mt -61.22 -29.96 70.14 Favored 'General case' 0 C--O 1.21 -0.976 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.151 -177.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.617 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 53.3 mt-30 -68.17 -57.03 6.69 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.487 0.715 . . . . 0.0 110.956 178.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.549 HH22 ' HB3' ' A' ' 139' ' ' ASP . 0.0 OUTLIER -72.75 -21.55 61.0 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -176.196 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -83.99 -59.79 2.3 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.13 0.572 . . . . 0.0 111.034 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.505 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -114.39 -60.66 1.86 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.255 0.622 . . . . 0.0 111.546 -165.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.617 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 67.8 t-105 -66.89 -10.82 52.61 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.479 1.112 . . . . 0.0 112.685 -168.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -70.63 72.02 0.66 Allowed Glycine 0 C--N 1.346 1.091 0 N-CA-C 111.929 -0.468 . . . . 0.0 111.929 175.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 47.2 t -161.87 99.48 1.11 Allowed 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.547 1.139 . . . . 0.0 108.757 -173.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 51.1 p -69.47 -33.22 72.58 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.412 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 8.2 t30 61.22 22.73 13.03 Favored 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 124.377 1.071 . . . . 0.0 109.798 -176.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -63.77 -51.9 62.78 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 124.836 1.254 . . . . 0.0 110.766 -169.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -87.67 53.14 2.68 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-O 121.969 0.89 . . . . 0.0 109.393 173.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -155.77 48.89 0.48 Allowed Glycine 0 C--N 1.343 0.966 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.301 -177.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -96.16 148.93 35.27 Favored Pre-proline 0 N--CA 1.482 1.132 0 C-N-CA 123.553 0.741 . . . . 0.0 109.921 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.74 125.69 13.59 Favored 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.469 2.112 . . . . 0.0 110.943 173.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.92 143.62 85.94 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.452 2.101 . . . . 0.0 111.949 175.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 86.5 mt -68.53 93.85 0.53 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.131 0.573 . . . . 0.0 110.504 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 32.4 p -81.23 143.92 31.96 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.881 0.873 . . . . 0.0 111.046 -176.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.1 pp -105.1 156.81 17.73 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.905 0.882 . . . . 0.0 111.859 -175.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 . . . . . 0 C--O 1.254 1.338 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 171.678 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 21.2 ptp . . . . . 0 CA--C 1.56 1.346 0 N-CA-C 110.527 -0.175 . . . . 0.0 110.527 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -70.93 -164.8 0.16 Allowed 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 123.491 2.794 . . . . 0.0 112.917 175.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.88 79.97 0.46 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.633 0.773 . . . . 0.0 110.738 177.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.4 p -93.22 89.66 6.51 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.897 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -118.9 145.71 45.51 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.628 0.371 . . . . 0.0 110.738 -175.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 19.3 m-85 -96.3 108.95 21.52 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.641 0.776 . . . . 0.0 109.166 175.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 50.0 mm -78.31 116.43 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 174.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 36.8 p -98.35 72.96 2.12 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.53 ' HB3' ' O ' ' A' ' 132' ' ' ALA . 31.0 t70 -72.8 -30.76 64.33 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.056 -174.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.565 ' SD ' ' HB3' ' A' ' 148' ' ' ARG . 59.5 mtm -98.12 151.15 20.69 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 166.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 64.6 p -69.93 158.84 34.84 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 173.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 69.1 mt -59.23 -31.39 46.01 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 173.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -57.87 -55.98 27.87 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.434 171.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -61.41 -38.67 87.94 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.012 0.525 . . . . 0.0 111.311 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.9 tt -63.89 -38.91 92.85 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.128 0.971 . . . . 0.0 109.378 -177.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.8 t -108.9 20.38 18.52 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 123.875 0.87 . . . . 0.0 111.066 -176.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.544 ' HD3' HD11 ' A' ' 156' ' ' ILE . 76.8 ttt180 -78.3 142.57 37.68 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.762 0.825 . . . . 0.0 111.696 -174.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -82.73 138.02 34.21 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.939 0.895 . . . . 0.0 110.524 176.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.512 ' CZ3' ' SD ' ' A' ' 104' ' ' MET . 11.3 p-90 -157.33 160.28 38.36 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.842 1.257 . . . . 0.0 109.825 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -110.89 159.65 17.5 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.431 0.692 . . . . 0.0 111.693 -173.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.512 ' SD ' ' CZ3' ' A' ' 102' ' ' TRP . 99.2 mmm -120.65 93.06 3.91 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.237 1.015 . . . . 0.0 108.758 172.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.439 HD23 ' HB1' ' A' ' 122' ' ' ALA . 50.4 tp -71.8 -43.34 65.81 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.3 mmt -129.17 81.41 70.6 Favored Pre-proline 0 N--CA 1.479 1.002 0 C-N-CA 123.94 0.896 . . . . 0.0 109.353 175.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.75 145.56 46.46 Favored 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 122.104 1.869 . . . . 0.0 111.652 177.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -124.93 120.89 32.91 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 172.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -80.36 104.64 11.04 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.459 0.704 . . . . 0.0 109.624 -174.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -132.73 135.83 46.0 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.992 0.917 . . . . 0.0 109.467 172.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.2 t -125.4 142.79 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 166.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -123.34 91.6 3.51 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 176.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.37 -112.76 5.26 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.999 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -91.75 8.36 3.07 Favored 'Trans proline' 0 C--N 1.368 1.593 0 C-N-CA 123.27 2.647 . . . . 0.0 113.273 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 162' ' ' PRO . 61.4 mt -130.44 116.45 18.25 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.516 0.727 . . . . 0.0 109.656 -170.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 41.9 t -83.34 127.23 33.49 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.231 0.612 . . . . 0.0 110.256 -177.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.8 mm -106.94 110.03 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.232 0 C-N-CA 124.034 0.933 . . . . 0.0 110.58 -173.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -92.81 125.89 37.63 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.487 0.715 . . . . 0.0 109.858 173.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.574 HD13 ' HA3' ' A' ' 184' ' ' GLY . 73.2 mt -131.89 123.73 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.237 1.015 . . . . 0.0 108.561 176.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -99.49 120.76 40.14 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.44 0.696 . . . . 0.0 109.498 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.404 ' HA ' ' ND2' ' A' ' 188' ' ' ASN . 17.2 mt-30 -84.99 -14.96 45.82 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.619 1.168 . . . . 0.0 111.734 -174.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.439 ' HB1' HD23 ' A' ' 105' ' ' LEU . . . -68.57 -38.4 80.68 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.01 0.524 . . . . 0.0 111.106 -176.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.485 HG23 ' HG3' ' A' ' 126' ' ' LYS . 1.8 mp -87.07 112.79 23.63 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 CA-C-O 121.969 0.89 . . . . 0.0 109.7 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 48.0 mtt -129.23 159.5 35.9 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.859 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.8 t70 76.21 12.14 2.78 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 124.667 1.187 . . . . 0.0 112.365 172.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.485 ' HG3' HG23 ' A' ' 123' ' ' ILE . 75.1 mmtt -99.79 151.99 20.63 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.48 0.712 . . . . 0.0 111.976 -173.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -90.38 112.19 23.7 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 168.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.464 HD12 HD22 ' A' ' 185' ' ' LEU . 65.3 mt -114.01 135.23 54.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.965 0.888 . . . . 0.0 111.325 -171.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.536 ' HG3' ' HG3' ' A' ' 131' ' ' LYS . 8.0 tpt -102.81 121.65 42.92 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.203 1.801 . . . . 0.0 109.643 -172.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.46 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 3.7 mm? -96.25 104.75 16.73 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.536 ' HG3' ' HG3' ' A' ' 129' ' ' MET . 90.8 mttt -125.58 149.4 48.4 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.455 0.702 . . . . 0.0 110.497 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.616 ' HB3' HD21 ' A' ' 198' ' ' LEU . . . -149.37 152.99 36.72 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -174.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -102.77 128.44 49.5 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 169.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -154.97 155.44 34.22 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.544 0.738 . . . . 0.0 109.871 -170.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 58.1 p -87.48 169.58 12.09 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.246 0.618 . . . . 0.0 109.775 172.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 79.5 t -132.15 136.3 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 123.564 0.746 . . . . 0.0 110.595 -173.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 7.5 tp -146.18 139.6 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 169.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 60.94 33.11 19.93 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 124.195 0.998 . . . . 0.0 111.936 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.3 t70 65.75 18.66 11.22 Favored 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 125.341 1.456 . . . . 0.0 111.644 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -132.54 172.9 11.9 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.815 -0.553 . . . . 0.0 109.643 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.468 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 10.3 tt -64.63 126.77 28.94 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -88.99 -77.8 0.37 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.991 0.516 . . . . 0.0 109.951 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.1 m -125.64 137.62 53.88 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.773 0.829 . . . . 0.0 109.321 -173.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 50.3 tp -82.96 126.64 32.74 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 174.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.43 -51.7 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 172.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 50.9 tp -164.19 146.73 9.13 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.833 0.853 . . . . 0.0 109.121 177.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.723 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 8.0 tt -125.5 154.75 41.63 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.702 HH11 HG21 ' A' ' 156' ' ' ILE . 47.3 ttm-85 -150.18 138.75 20.66 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 123.131 0.573 . . . . 0.0 110.971 -173.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -115.57 115.58 26.68 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 175.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.408 ' HD1' ' HG2' ' A' ' 148' ' ' ARG . 31.6 p90 -136.08 145.98 46.53 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.543 0.737 . . . . 0.0 109.59 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 54.5 p -69.32 175.84 3.71 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.79 0.836 . . . . 0.0 111.01 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -54.69 -32.38 59.36 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.687 0.795 . . . . 0.0 111.617 172.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -70.98 -29.24 65.16 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.944 1.298 . . . . 0.0 110.801 179.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 100.05 8.57 50.55 Favored Glycine 0 C--N 1.345 1.064 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.565 -173.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -73.16 104.56 4.26 Favored 'General case' 0 C--N 1.352 0.713 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 177.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.702 HG21 HH11 ' A' ' 148' ' ' ARG . 24.1 mt -75.93 122.72 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -175.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.404 HG11 HG21 ' A' ' 123' ' ' ILE . 30.4 m -130.74 9.53 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.636 0.774 . . . . 0.0 111.065 -175.052 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -159.89 159.26 30.51 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.428 -178.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -165.67 150.99 8.92 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.353 0.661 . . . . 0.0 109.457 -177.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.723 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 71.0 mt -131.4 106.85 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 170.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 78.9 p -109.18 119.05 49.7 Favored Pre-proline 0 C--O 1.24 0.556 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.46 ' HA ' HD23 ' A' ' 115' ' ' LEU . 11.1 Cg_endo -55.48 134.78 65.88 Favored 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 122.254 1.969 . . . . 0.0 111.384 168.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.463 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 90.0 mt -73.59 127.62 88.38 Favored Pre-proline 0 CA--C 1.546 0.803 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 175.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 163' ' ' LEU . 32.5 Cg_exo -60.08 -28.14 86.4 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 123.562 2.842 . . . . 0.0 113.57 -177.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.1 m -71.36 -10.76 60.28 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.679 0.791 . . . . 0.0 111.89 175.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -123.12 77.11 51.65 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 123.856 0.862 . . . . 0.0 109.089 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -80.13 1.47 9.22 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 123.125 2.55 . . . . 0.0 112.982 -177.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -122.5 83.02 0.35 Allowed Glycine 0 C--N 1.345 1.066 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -120.23 132.74 55.47 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 169.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 57.9 p -82.48 173.15 12.26 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.64 0.376 . . . . 0.0 110.902 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.477 HD11 ' HA ' ' A' ' 202' ' ' ALA . 7.7 tt -51.67 -40.84 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.088 171.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -65.12 -36.57 84.68 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.842 0.857 . . . . 0.0 111.216 -173.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -62.74 -42.08 99.5 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 123.694 0.621 . . . . 0.0 110.604 174.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.526 ' O ' HG13 ' A' ' 178' ' ' ILE . 40.6 t -63.17 -41.9 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 123.829 0.706 . . . . 0.0 109.921 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 171' ' ' ILE . 57.7 mtpt -57.55 -42.69 83.47 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.815 0.846 . . . . 0.0 111.206 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.452 ' O ' HG23 ' A' ' 180' ' ' VAL . 63.0 m-80 -66.15 -47.44 74.05 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.993 0.517 . . . . 0.0 110.123 176.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.42 -42.28 86.9 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.462 1.101 . . . . 0.0 112.053 -175.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.526 HG13 ' O ' ' A' ' 174' ' ' VAL . 53.1 mt -60.75 -41.45 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 177.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -68.05 -26.68 73.94 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.66 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 176' ' ' ASN . 69.5 t -72.56 -50.06 37.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 123.414 0.686 . . . . 0.0 109.926 176.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 15.7 tp -59.41 -46.08 89.7 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.708 177.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.531 HD11 HG22 ' A' ' 194' ' ' VAL . 32.2 mt -56.76 -49.17 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.588 1.155 . . . . 0.0 111.299 174.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.43 ' O ' ' HG3' ' A' ' 187' ' ' ARG . . . -55.28 -42.14 81.63 Favored Glycine 0 C--N 1.343 0.923 0 O-C-N 124.149 0.905 . . . . 0.0 113.618 -178.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.574 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -71.29 -34.84 63.89 Favored Glycine 0 C--N 1.347 1.189 0 O-C-N 123.787 0.345 . . . . 0.0 113.084 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.464 HD22 HD12 ' A' ' 128' ' ' ILE . 95.0 mt -64.02 -40.74 97.0 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.372 0.669 . . . . 0.0 110.556 175.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -63.37 -35.34 80.08 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.607 0.763 . . . . 0.0 111.012 178.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 183' ' ' GLY . 83.0 mtp180 -64.99 -39.0 92.82 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.302 0.641 . . . . 0.0 110.451 175.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.404 ' ND2' ' HA ' ' A' ' 121' ' ' GLN . 5.7 m-20 -70.92 -3.92 21.79 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.987 0.915 . . . . 0.0 112.082 175.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.9 t70 65.95 46.39 2.24 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 122.646 1.212 . . . . 0.0 109.089 -176.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -111.08 138.37 47.59 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.088 177.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 26.6 m -79.79 114.02 18.39 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -177.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.412 HG21 HG23 ' A' ' 182' ' ' ILE . 27.3 m -92.65 139.01 18.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.612 -174.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -149.18 146.38 27.61 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.948 171.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.531 HG22 HD11 ' A' ' 182' ' ' ILE . 2.8 t -109.06 147.27 13.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 -175.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 27.2 t -61.0 152.3 28.24 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 118.158 0.435 . . . . 0.0 111.292 -174.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.37 -41.05 62.76 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 124.297 0.998 . . . . 0.0 110.988 179.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 57.9 p -70.49 -52.2 23.64 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.083 0.953 . . . . 0.0 110.01 178.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.616 HD21 ' HB3' ' A' ' 132' ' ' ALA . 34.9 mt -58.9 -29.68 67.22 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.751 0.82 . . . . 0.0 112.128 -176.042 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.572 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 47.5 mt-30 -72.09 -54.65 9.14 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.26 0.624 . . . . 0.0 110.554 177.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.81 -9.22 59.38 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -174.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -100.82 -50.46 3.84 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.008 0.523 . . . . 0.0 111.556 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.477 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -113.6 -62.47 1.59 Allowed 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -168.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.572 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 65.9 t-105 -59.29 -57.37 13.32 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.891 1.276 . . . . 0.0 111.246 -165.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -82.25 134.85 13.43 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 165.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 21.2 m -78.48 80.12 4.88 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.301 0.64 . . . . 0.0 111.306 -174.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 42.5 t -81.68 68.33 8.0 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 123.59 0.756 . . . . 0.0 109.32 172.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 7.2 p30 175.34 145.4 0.07 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.383 1.473 . . . . 0.0 108.065 -175.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -155.23 149.39 25.86 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.114 0.483 . . . . 0.0 110.681 175.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -117.97 75.85 1.03 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 168.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -61.53 -47.88 88.0 Favored Glycine 0 C--N 1.355 1.596 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 172.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 58.9 mtm-85 -113.24 133.55 22.06 Favored Pre-proline 0 C--O 1.244 0.81 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 165.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.14 146.76 94.42 Favored 'Trans proline' 0 C--N 1.366 1.496 0 C-N-CA 121.657 1.571 . . . . 0.0 110.898 170.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.17 164.66 19.11 Favored 'Trans proline' 0 C--N 1.368 1.585 0 C-N-CA 121.815 1.676 . . . . 0.0 110.909 167.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 84.7 mt -57.22 103.72 0.13 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 61.1 p -60.43 146.07 45.88 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.204 -173.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 79.4 mt -66.96 88.31 0.15 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.647 0.779 . . . . 0.0 111.759 -169.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.353 0 C-N-CA 124.308 1.043 . . . . 0.0 111.462 178.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.448 ' SD ' ' N ' ' A' ' 84' ' ' MET . 0.7 OUTLIER . . . . . 0 CA--C 1.557 1.237 0 CA-C-O 118.351 -0.833 . . . . 0.0 111.101 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.435 ' HD3' ' HB2' ' A' ' 84' ' ' MET . 14.0 Cg_exo -71.69 148.3 52.63 Favored 'Trans proline' 0 C--N 1.392 2.861 0 C-N-CA 121.706 1.604 . . . . 0.0 111.247 168.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.4 104.97 2.43 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 122.818 0.447 . . . . 0.0 110.124 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 37.9 p -56.41 109.94 0.69 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.628 0.771 . . . . 0.0 110.866 -178.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.9 ttp180 -102.4 159.59 15.29 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.622 1.169 . . . . 0.0 109.616 -170.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -123.21 109.12 13.58 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.122 0.969 . . . . 0.0 109.322 173.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 36.1 mm -82.35 133.95 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 171.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 37.8 p -126.96 93.43 3.76 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.104 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -77.9 -25.88 48.76 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.73 177.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.659 ' SD ' ' HG2' ' A' ' 148' ' ' ARG . 40.1 mtm -104.83 129.16 53.18 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 124.199 0.999 . . . . 0.0 108.495 178.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 69.9 p -87.61 175.16 8.03 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 170.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 83.5 mt -56.43 -32.36 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 123.709 0.804 . . . . 0.0 111.116 -177.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 100' ' ' ARG . 39.4 mt-10 -48.76 -55.5 11.32 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.152 1.381 . . . . 0.0 113.547 177.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -95.66 -25.73 16.01 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 118.039 0.382 . . . . 0.0 111.009 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.5 tt -66.72 -49.49 65.85 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -176.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.7 m -95.63 16.25 17.76 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.824 0.849 . . . . 0.0 110.86 -177.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 96' ' ' GLU . 73.9 ttt180 -82.28 126.84 32.59 Favored 'General case' 0 C--N 1.35 0.604 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -80.43 128.17 33.26 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 169.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -137.18 164.82 27.57 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.261 0.624 . . . . 0.0 110.293 -174.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -134.84 149.99 50.42 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.286 0.634 . . . . 0.0 109.676 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 10.8 ptm -126.0 128.57 47.66 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.4 tp -69.88 -41.22 75.06 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.719 0.807 . . . . 0.0 111.316 -170.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.413 ' O ' ' HA ' ' A' ' 120' ' ' ASP . 4.0 mmt -116.67 88.1 23.66 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 123.792 0.837 . . . . 0.0 109.864 173.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -74.8 137.58 22.4 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.678 2.252 . . . . 0.0 113.201 -177.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -130.67 135.43 47.83 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.058 0.943 . . . . 0.0 108.469 166.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -121.82 123.75 42.51 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 173.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -144.24 121.53 11.59 Favored 'General case' 0 C--O 1.217 -0.623 0 C-N-CA 123.374 0.669 . . . . 0.0 109.241 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 97.1 t -79.23 137.67 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.029 0.531 . . . . 0.0 110.501 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -125.12 85.42 2.41 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 171.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.89 -119.42 6.41 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.279 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -89.74 16.73 1.69 Allowed 'Trans proline' 0 CA--C 1.552 1.411 0 C-N-CA 123.531 2.821 . . . . 0.0 113.044 177.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.52 HD23 ' HA ' ' A' ' 162' ' ' PRO . 96.1 mt -128.85 151.91 49.09 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.844 0.858 . . . . 0.0 109.965 -176.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 36.1 t -115.28 131.2 57.0 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.177 0.991 . . . . 0.0 108.897 177.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.4 mm -106.34 139.6 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.562 0.745 . . . . 0.0 109.219 -177.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -119.29 119.73 34.9 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 175.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.436 HD13 ' HA3' ' A' ' 184' ' ' GLY . 69.9 mt -126.05 124.08 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -178.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' A' ' 106' ' ' MET . 24.4 t70 -97.59 123.27 41.42 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.837 0.455 . . . . 0.0 110.24 174.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.46 ' HA ' HD21 ' A' ' 188' ' ' ASN . 77.6 mt-30 -88.35 -11.2 46.94 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.21 -50.32 14.81 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.156 0.503 . . . . 0.0 111.454 -174.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.8 mp -72.34 112.67 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.706 1.202 . . . . 0.0 109.523 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.2 mtt -130.3 162.71 28.4 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.481 1.112 . . . . 0.0 109.974 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 73.78 18.96 3.28 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 125.037 1.335 . . . . 0.0 112.915 176.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -111.43 149.58 31.05 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.449 0.7 . . . . 0.0 111.716 -173.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -87.99 102.78 15.07 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 171.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.489 HG12 HG22 ' A' ' 151' ' ' THR . 54.8 mt -106.56 131.14 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.003 0.521 . . . . 0.0 109.92 -173.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 14.7 tpt -106.08 127.1 52.95 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.209 1.004 . . . . 0.0 109.688 -172.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.453 HD12 HG22 ' A' ' 194' ' ' VAL . 25.7 mt -99.16 105.08 17.11 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -177.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -130.42 145.56 51.84 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.42 0.688 . . . . 0.0 111.13 -175.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.49 155.43 46.66 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -170.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -109.02 122.19 46.72 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 166.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -155.84 161.07 40.67 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.692 0.797 . . . . 0.0 110.546 -170.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.7 p -86.56 163.77 17.28 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.688 173.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 90.0 t -139.04 137.26 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.667 1.187 . . . . 0.0 109.109 -174.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.2 tp -152.04 144.17 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 172.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 57.99 26.5 13.54 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 124.248 1.019 . . . . 0.0 111.767 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 57.63 44.32 20.98 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.655 1.182 . . . . 0.0 111.345 -174.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -146.74 166.79 25.55 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.162 169.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.507 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 9.6 tt -64.21 123.55 19.38 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.042 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -79.38 -70.28 0.52 Allowed 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 175.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 99.8 m -143.71 135.4 26.27 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.064 0.946 . . . . 0.0 109.185 177.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.475 ' HB3' ' NE2' ' A' ' 169' ' ' HIS . 62.7 tp -77.98 126.67 31.18 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.828 0.851 . . . . 0.0 109.716 178.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.58 -49.96 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 174.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.425 HD21 ' NH2' ' A' ' 148' ' ' ARG . 51.0 tp -162.66 147.59 12.03 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.408 0.683 . . . . 0.0 109.664 -178.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.62 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 8.8 tt -138.88 154.67 48.41 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.659 ' HG2' ' SD ' ' A' ' 93' ' ' MET . 10.8 ptp180 -153.7 158.33 40.87 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.78 0.8 . . . . 0.0 111.738 173.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.528 ' HB2' HD21 ' A' ' 181' ' ' LEU . . . -111.29 116.1 30.43 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.294 1.438 . . . . 0.0 107.748 176.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.476 ' HD1' ' HG3' ' A' ' 148' ' ' ARG . 44.6 p90 -134.69 136.78 43.0 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.067 0.547 . . . . 0.0 110.333 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.489 HG22 HG12 ' A' ' 128' ' ' ILE . 52.7 p -63.96 177.49 0.77 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.484 1.114 . . . . 0.0 112.364 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -64.99 -17.55 64.52 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.479 0.712 . . . . 0.0 112.384 173.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -81.7 -24.04 36.44 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 122.819 0.448 . . . . 0.0 109.826 172.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 101.23 3.56 54.01 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.576 -175.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -68.7 103.38 1.72 Allowed 'General case' 0 C--N 1.352 0.717 0 C-N-CA 123.489 0.716 . . . . 0.0 109.776 -178.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.588 HD13 HH11 ' A' ' 148' ' ' ARG . 14.5 mt -73.14 116.72 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -178.213 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.3 m -123.08 3.48 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.167 0.987 . . . . 0.0 111.17 -176.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -154.84 161.69 30.42 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.609 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 38.8 tt0 -166.0 144.65 5.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 122.687 0.395 . . . . 0.0 110.267 -177.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.62 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 68.8 mt -126.77 116.38 44.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 173.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 19.3 m -126.4 141.52 40.23 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 123.465 0.706 . . . . 0.0 109.954 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.52 ' HA ' HD23 ' A' ' 115' ' ' LEU . 32.0 Cg_exo -58.87 147.22 90.21 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.672 2.248 . . . . 0.0 112.171 173.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 76.3 mt -67.99 145.86 97.96 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 122.777 0.431 . . . . 0.0 110.454 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.2 -33.45 64.73 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 123.212 2.608 . . . . 0.0 113.23 170.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 40.9 m -82.22 -26.62 33.13 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.321 0.648 . . . . 0.0 111.602 177.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -134.42 74.07 67.21 Favored Pre-proline 0 N--CA 1.488 1.426 0 C-N-CA 123.079 0.552 . . . . 0.0 111.306 -175.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -72.1 -33.37 9.61 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.587 2.192 . . . . 0.0 112.028 174.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -94.47 119.2 6.0 Favored Glycine 0 C--N 1.345 1.048 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -175.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.475 ' NE2' ' HB3' ' A' ' 144' ' ' LEU . 51.6 p-80 -149.75 174.5 12.54 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.454 0.702 . . . . 0.0 110.484 -175.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 14.8 m -107.95 162.92 13.58 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.284 1.033 . . . . 0.0 109.692 -177.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.589 HD11 ' HA ' ' A' ' 202' ' ' ALA . 14.9 tt -54.63 -35.08 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 125.743 1.617 . . . . 0.0 113.465 178.213 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -63.12 -29.43 70.79 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.377 0.671 . . . . 0.0 111.331 -176.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -71.6 -38.86 70.8 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.159 0.584 . . . . 0.0 110.295 175.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 44.7 t -67.4 -41.72 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 124.067 0.854 . . . . 0.0 111.373 -175.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -65.32 -33.58 76.31 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 122.949 0.155 . . . . 0.0 110.854 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -70.23 -39.91 74.79 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.911 0.484 . . . . 0.0 109.719 175.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.58 -47.59 80.87 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.338 1.055 . . . . 0.0 111.353 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 73.2 mt -63.44 -35.05 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.532 0.733 . . . . 0.0 109.477 176.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -60.77 -36.3 91.58 Favored Glycine 0 C--N 1.349 1.278 0 O-C-N 123.586 0.554 . . . . 0.0 113.986 176.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 98.8 t -72.04 -45.99 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.135 0.574 . . . . 0.0 110.015 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.528 HD21 ' HB2' ' A' ' 149' ' ' ALA . 41.0 tp -58.23 -45.2 88.14 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.725 0.81 . . . . 0.0 111.168 178.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.485 ' O ' ' HG2' ' A' ' 186' ' ' GLU . 49.0 mt -62.05 -50.86 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.996 0.918 . . . . 0.0 110.169 175.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.413 ' O ' ' HG2' ' A' ' 187' ' ' ARG . . . -53.69 -37.81 57.66 Favored Glycine 0 C--N 1.346 1.089 0 O-C-N 124.067 0.854 . . . . 0.0 113.964 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.436 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -71.64 -38.43 61.38 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 123.676 0.28 . . . . 0.0 112.937 175.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.473 HD22 HD12 ' A' ' 128' ' ' ILE . 95.0 mt -72.36 -21.75 61.26 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.427 0.691 . . . . 0.0 111.469 176.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 11.6 mm-40 -74.76 -32.48 62.08 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.291 0.636 . . . . 0.0 109.64 176.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 183' ' ' GLY . 17.8 mmt180 -63.55 -39.12 93.59 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.375 172.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.46 HD21 ' HA ' ' A' ' 121' ' ' GLN . 4.6 m-20 -75.47 -5.6 45.9 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.582 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 26.9 t70 63.6 21.86 12.9 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 123.977 0.911 . . . . 0.0 110.748 -177.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -80.95 138.15 36.11 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.129 0.972 . . . . 0.0 110.412 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 41.1 m -79.78 103.04 9.41 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.462 HG21 HG23 ' A' ' 182' ' ' ILE . 25.5 m -85.17 143.81 10.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.023 -177.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -143.87 127.32 16.88 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 168.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.453 HG22 HD12 ' A' ' 130' ' ' LEU . 7.8 t -88.27 146.53 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 27.7 t -57.32 144.32 36.33 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 118.429 0.558 . . . . 0.0 111.02 -176.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -55.76 -31.52 62.63 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.209 0.603 . . . . 0.0 111.11 -178.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 37.7 p -67.65 -57.53 6.24 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.808 172.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 56.3 mt -59.47 -25.32 64.31 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.07 0.948 . . . . 0.0 112.02 -174.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.615 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 57.1 mt-30 -74.63 -55.22 6.13 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.093 0.557 . . . . 0.0 110.242 178.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.82 -24.34 60.89 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 116.81 -0.177 . . . . 0.0 111.379 -174.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -84.56 -52.19 6.31 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.322 0.649 . . . . 0.0 110.764 177.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.589 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -114.64 -42.8 3.22 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -165.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.615 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 27.9 t-105 -94.62 9.35 39.07 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.908 0.483 . . . . 0.0 111.972 -168.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -63.21 -64.17 3.98 Favored Glycine 0 N--CA 1.479 1.527 0 N-CA-C 112.331 -0.307 . . . . 0.0 112.331 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 25.4 m -85.2 84.08 7.8 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 169.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 31.8 t -131.27 154.85 48.06 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.73 0.812 . . . . 0.0 109.501 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -150.2 157.54 43.2 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.813 0.845 . . . . 0.0 109.039 -176.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -149.99 124.99 9.95 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.839 0.855 . . . . 0.0 109.096 177.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -96.81 106.39 18.69 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 174.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -77.39 79.73 1.34 Allowed Glycine 0 C--N 1.345 1.044 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 171.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.41 ' HA ' ' HD3' ' A' ' 212' ' ' PRO . 10.5 ptp180 -63.09 127.84 91.45 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 123.087 0.555 . . . . 0.0 111.261 -174.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 211' ' ' ARG . 27.5 Cg_exo -62.61 134.21 46.43 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.611 2.207 . . . . 0.0 111.472 178.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -56.05 123.13 13.09 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 123.071 2.514 . . . . 0.0 111.753 -176.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 88.6 mt -58.98 133.28 55.95 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.235 0.614 . . . . 0.0 112.21 -174.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 49.0 p -62.65 130.58 45.65 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.221 1.009 . . . . 0.0 111.107 -176.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.2 pp -73.38 -176.22 2.18 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.396 0.679 . . . . 0.0 111.656 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.558 1.263 0 CA-C-O 118.831 -0.604 . . . . 0.0 111.343 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.574 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 74.7 ttt180 . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -121.96 121.17 36.47 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 175.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.429 HG22 ' HB2' ' A' ' 92' ' ' ASP . 49.0 mm -91.25 112.9 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.5 p -98.75 65.54 1.56 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 170.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 132' ' ' ALA . 27.5 t70 -67.61 -41.07 84.6 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 113.489 -1.687 . . . . 0.0 110.361 -177.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -109.84 151.02 27.55 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 173.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.5 m -86.82 154.23 21.05 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.593 0.357 . . . . 0.0 111.126 -170.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 49.8 mm -63.13 -35.91 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 123.157 0.583 . . . . 0.0 110.424 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -47.66 -46.64 29.27 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.859 1.264 . . . . 0.0 112.743 174.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.38 -20.11 20.02 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.204 -175.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.489 ' HG ' HD23 ' A' ' 146' ' ' LEU . 8.7 tt -69.03 -35.77 76.98 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.739 0.815 . . . . 0.0 109.812 174.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.8 m -97.84 12.01 35.38 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.84 0.856 . . . . 0.0 110.753 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -79.41 131.58 36.13 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.533 0.733 . . . . 0.0 109.868 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -81.47 140.64 34.48 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 38.4 p-90 -158.7 176.22 12.64 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.086 0.954 . . . . 0.0 109.044 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -151.88 166.68 30.69 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.636 0.775 . . . . 0.0 109.259 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 74.4 mtm -102.07 127.8 48.81 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.066 0.546 . . . . 0.0 109.788 170.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.518 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.2 pt? -78.31 -33.3 49.43 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.11 0.564 . . . . 0.0 110.638 178.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 23.5 mmt -120.0 80.7 26.65 Favored Pre-proline 0 N--CA 1.485 1.287 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 168.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -73.23 129.23 13.75 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.669 2.246 . . . . 0.0 112.579 -173.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -134.81 121.84 21.23 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 174.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -109.65 110.24 21.23 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -174.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.461 ' HG2' HG11 ' A' ' 180' ' ' VAL . 22.1 tptm -100.79 133.6 45.02 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 169.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.8 t -103.61 126.92 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 171.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -131.46 88.65 2.61 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.29 -124.16 13.1 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.315 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -91.07 13.55 2.11 Favored 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 123.113 2.542 . . . . 0.0 112.476 176.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.1 mt -128.83 114.84 17.04 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.695 0.798 . . . . 0.0 108.916 -171.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.638 ' SG ' ' HB2' ' A' ' 161' ' ' SER . 25.6 p -89.8 114.14 25.82 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.062 0.458 . . . . 0.0 110.364 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.416 ' HB ' ' HB3' ' A' ' 110' ' ' LYS . 12.0 mm -86.07 121.0 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 124.812 1.245 . . . . 0.0 110.607 -175.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -94.18 118.44 31.57 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 33.1 mm -118.26 121.84 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -102.41 114.33 28.43 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 169.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -71.01 -16.8 62.64 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -176.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.13 -26.04 25.43 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 118.169 0.441 . . . . 0.0 111.954 -174.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.555 HG13 ' HB ' ' A' ' 157' ' ' VAL . 29.2 mm -70.55 104.08 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 122.493 0.317 . . . . 0.0 110.46 -176.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 48.1 mtt -134.41 152.38 51.76 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.376 1.07 . . . . 0.0 109.702 -176.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.3 t70 71.89 7.84 5.92 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.608 1.163 . . . . 0.0 112.129 174.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -93.03 151.27 19.98 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.778 0.831 . . . . 0.0 110.532 -175.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -95.22 108.64 20.78 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 171.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.613 ' HB ' HG12 ' A' ' 192' ' ' VAL . 66.5 mt -115.52 149.15 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.405 0.682 . . . . 0.0 110.167 -170.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 55.8 tpp -125.31 134.36 52.28 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.149 0.979 . . . . 0.0 109.504 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -94.3 103.38 15.39 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.477 ' HG3' ' CE1' ' A' ' 150' ' ' PHE . 25.1 mmmt -114.52 149.94 35.66 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.62 1.168 . . . . 0.0 109.229 -173.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.536 ' HB2' ' HG ' ' A' ' 147' ' ' LEU . . . -153.49 144.12 22.57 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -104.92 133.68 49.31 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 167.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.481 ' HA ' HG13 ' A' ' 145' ' ' ILE . 28.4 p90 -162.16 164.19 28.02 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.182 0.515 . . . . 0.0 111.569 -172.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.1 t -88.53 157.4 18.63 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.614 172.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' A' ' 88' ' ' ARG . 74.1 t -136.31 140.01 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.303 1.041 . . . . 0.0 109.028 -174.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 7.9 tp -145.95 140.55 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 172.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 58.82 26.96 15.44 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.753 0.821 . . . . 0.0 112.34 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.0 t70 72.29 14.41 5.48 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.338 1.455 . . . . 0.0 111.895 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -123.54 160.71 26.42 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.12 0.568 . . . . 0.0 109.764 175.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.434 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 8.7 tt -62.87 119.04 8.61 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 177.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -82.67 -69.38 0.63 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.158 0.983 . . . . 0.0 109.135 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 93.8 m -137.17 129.71 30.01 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.647 0.779 . . . . 0.0 109.271 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.492 HD21 ' HB2' ' A' ' 147' ' ' LEU . 52.2 tp -73.13 123.51 23.74 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.641 0.776 . . . . 0.0 109.449 176.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.481 HG13 ' HA ' ' A' ' 134' ' ' PHE . 69.0 mt -83.79 -48.56 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.489 HD23 ' HG ' ' A' ' 98' ' ' LEU . 49.2 tp -161.98 149.57 14.42 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.899 0.88 . . . . 0.0 109.503 172.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.715 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 7.7 tt -126.52 142.74 51.44 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 172.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.559 HH11 HG21 ' A' ' 156' ' ' ILE . 46.6 ttm-85 -135.0 137.57 43.15 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.772 1.229 . . . . 0.0 110.53 -177.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.567 ' HB2' HD21 ' A' ' 181' ' ' LEU . . . -111.67 118.6 36.1 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 171.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.477 ' CE1' ' HG3' ' A' ' 131' ' ' LYS . 29.2 p90 -143.39 160.41 40.6 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 40.8 p -80.83 170.82 15.79 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.003 -174.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.27 -11.39 60.87 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 120.735 0.302 . . . . 0.0 111.11 171.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -71.03 -30.19 66.32 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.852 0.861 . . . . 0.0 110.066 168.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 106.6 -4.93 37.24 Favored Glycine 0 C--N 1.352 1.447 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.443 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -77.66 122.34 25.19 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.388 0.675 . . . . 0.0 110.493 -174.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.559 HG21 HH11 ' A' ' 148' ' ' ARG . 39.3 mt -76.53 103.99 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.212 0.605 . . . . 0.0 110.651 -175.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.555 ' HB ' HG13 ' A' ' 123' ' ' ILE . 27.2 m -99.27 -9.49 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 123.74 0.816 . . . . 0.0 112.061 -172.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -167.79 173.03 42.75 Favored Glycine 0 C--N 1.34 0.785 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 147' ' ' LEU . 37.5 tt0 -164.08 157.79 18.64 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.715 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 93.6 mt -123.53 103.87 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 167.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.638 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 2.7 m -93.7 109.47 41.41 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.563 -177.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -64.34 119.11 6.06 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.624 2.216 . . . . 0.0 111.307 172.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 CA--C 1.545 0.751 0 O-C-N 124.051 0.844 . . . . 0.0 110.411 178.858 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 16.0 p-80 . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 5.0 m -102.17 162.25 13.06 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.618 0.767 . . . . 0.0 110.199 -173.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.437 HD11 ' HA ' ' A' ' 202' ' ' ALA . 17.8 tt -56.78 -28.98 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 C-N-CA 124.95 1.3 . . . . 0.0 111.819 173.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -54.86 -42.79 72.44 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.721 1.208 . . . . 0.0 111.607 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.01 -44.0 90.64 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.809 0.844 . . . . 0.0 110.482 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.484 ' O ' HG13 ' A' ' 178' ' ' ILE . 50.9 t -65.58 -48.66 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.633 -172.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -58.15 -36.08 72.47 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.595 0.758 . . . . 0.0 111.757 -175.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.429 ' O ' HG23 ' A' ' 180' ' ' VAL . 16.2 m120 -74.02 -43.09 59.14 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.618 0.767 . . . . 0.0 110.142 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -59.56 -42.15 91.77 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.185 0.928 . . . . 0.0 111.562 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 174' ' ' VAL . 62.0 mt -57.71 -42.8 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 123.734 0.813 . . . . 0.0 109.171 177.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -76.9 -22.43 71.79 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-N 114.662 -1.154 . . . . 0.0 114.431 -175.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.461 HG11 ' HG2' ' A' ' 110' ' ' LYS . 97.6 t -73.5 -43.43 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 172.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.641 HD22 HG13 ' A' ' 160' ' ' ILE . 33.0 tp -58.97 -48.85 80.06 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.656 173.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.51 ' O ' ' HG2' ' A' ' 186' ' ' GLU . 70.0 mt -60.46 -44.66 96.81 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.997 0 C-N-CA 123.856 0.862 . . . . 0.0 110.61 176.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.449 ' O ' ' HG3' ' A' ' 187' ' ' ARG . . . -56.67 -39.31 85.89 Favored Glycine 0 C--N 1.342 0.869 0 O-C-N 123.512 0.508 . . . . 0.0 113.268 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -67.01 -41.21 93.3 Favored Glycine 0 C--N 1.353 1.489 0 N-CA-C 112.058 -0.417 . . . . 0.0 112.058 174.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 182' ' ' ILE . 76.9 mt -62.96 -34.32 77.26 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.012 0.925 . . . . 0.0 111.043 176.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 31.1 mm-40 -68.41 -42.63 78.71 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 123.922 0.889 . . . . 0.0 109.827 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 183' ' ' GLY . 74.0 mtp180 -60.35 -38.38 83.62 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.299 0.64 . . . . 0.0 110.65 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -72.72 -14.21 61.51 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.951 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 36.6 t70 64.12 67.22 0.6 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.977 0.911 . . . . 0.0 110.819 -177.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -104.63 -162.82 0.91 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 170.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.1 m -135.0 101.0 4.74 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 169.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.613 HG12 ' HB ' ' A' ' 128' ' ' ILE . 8.2 m -111.02 153.26 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 121.784 0.802 . . . . 0.0 111.02 -172.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 52.2 ttm-85 -139.58 142.23 37.14 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.032 -1.44 . . . . 0.0 107.895 174.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.41 HG22 HD11 ' A' ' 182' ' ' ILE . 3.4 t -88.14 145.65 7.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 34.3 t -57.68 144.32 38.3 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.581 0.352 . . . . 0.0 111.272 178.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -45.8 -37.78 6.45 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 124.429 1.081 . . . . 0.0 112.062 174.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 70.5 p -69.29 -55.54 10.18 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 123.525 0.73 . . . . 0.0 110.271 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.44 HD21 ' HB3' ' A' ' 132' ' ' ALA . 73.3 mt -62.17 -31.99 72.55 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.261 0.624 . . . . 0.0 111.413 -175.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.569 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 49.7 mt-30 -62.1 -50.38 72.15 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.496 0.718 . . . . 0.0 111.131 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.25 -20.11 35.13 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -175.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -87.38 -62.31 1.53 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.8 0.44 . . . . 0.0 111.285 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.437 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -111.05 -51.95 2.82 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.315 0.646 . . . . 0.0 111.679 -162.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.569 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 57.5 t-105 . . . . . 0 CA--C 1.554 1.116 0 C-N-CA 125.37 1.468 . . . . 0.0 110.675 -173.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.405 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 41.3 ttm180 . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -119.36 109.95 16.39 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.781 0.833 . . . . 0.0 108.928 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.8 mm -87.09 131.69 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 123.457 0.703 . . . . 0.0 109.413 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.492 ' HA ' HD22 ' A' ' 133' ' ' ASN . 50.9 p -118.48 81.06 1.62 Allowed 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 172.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -74.56 -27.45 60.51 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.606 -174.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.489 ' HB2' ' HG3' ' A' ' 97' ' ' GLU . 23.4 ptt? -102.89 134.14 46.81 Favored 'General case' 0 C--O 1.245 0.86 0 C-N-CA 123.361 0.664 . . . . 0.0 109.553 174.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.434 ' O ' ' HB2' ' A' ' 98' ' ' LEU . 9.8 t -81.84 171.72 14.17 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.337 0.655 . . . . 0.0 110.908 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -55.7 -43.02 71.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 126.024 1.73 . . . . 0.0 111.384 -176.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.44 ' O ' ' HB2' ' A' ' 100' ' ' ARG . 27.0 mm-40 -52.38 -40.64 62.3 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.126 0.97 . . . . 0.0 113.454 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.489 ' HG3' ' HB2' ' A' ' 93' ' ' MET . 12.7 pt-20 -97.73 -22.1 16.61 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.22 0.608 . . . . 0.0 111.291 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 94' ' ' THR . 2.2 tt -73.91 -59.93 2.49 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.634 0.773 . . . . 0.0 109.077 -176.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 39.7 m -80.67 -7.5 59.33 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.378 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 96' ' ' GLU . 9.2 tpm_? -58.81 122.33 13.31 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 123.416 0.687 . . . . 0.0 110.501 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -92.9 145.9 24.04 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 173.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . 0.416 ' HE1' ' NH1' ' A' ' 148' ' ' ARG . 30.7 p-90 -154.16 178.65 9.75 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.828 0.851 . . . . 0.0 109.921 -166.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -136.84 151.17 48.82 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.093 0.957 . . . . 0.0 109.618 -177.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 65.6 mtp -93.17 95.16 9.23 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 172.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -57.14 -37.95 72.78 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.54 0.525 . . . . 0.0 111.312 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.604 ' HB3' ' HB2' ' A' ' 121' ' ' GLN . 8.7 mmt -124.77 97.06 39.41 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 168.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -82.82 127.06 4.71 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.965 2.444 . . . . 0.0 114.202 -170.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.534 ' HB3' ' HB ' ' A' ' 119' ' ' ILE . 87.5 tttt -123.19 116.29 23.17 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 162.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.489 ' NE2' ' SG ' ' A' ' 116' ' ' CYS . 50.8 tp60 -106.91 111.59 24.16 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -176.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.445 ' HG2' HG11 ' A' ' 180' ' ' VAL . 50.5 tptt -117.12 135.83 53.46 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 124.858 1.263 . . . . 0.0 108.58 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.1 t -112.06 118.67 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 170.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -110.15 88.52 2.78 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.79 -115.96 7.77 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.343 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -85.49 -1.43 9.07 Favored 'Trans proline' 0 C--N 1.367 1.52 0 C-N-CA 122.898 2.398 . . . . 0.0 113.694 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.475 HD12 ' HB2' ' A' ' 177' ' ' ALA . 45.0 mt -116.23 152.07 34.5 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.187 0.595 . . . . 0.0 110.743 -171.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.489 ' SG ' ' NE2' ' A' ' 109' ' ' GLN . 37.9 t -106.55 110.79 23.09 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.234 1.014 . . . . 0.0 109.824 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.8 mm -95.92 142.5 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.803 0.841 . . . . 0.0 109.317 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -128.52 121.76 29.57 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.534 ' HB ' ' HB3' ' A' ' 108' ' ' LYS . 37.3 mm -116.8 127.18 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.43 1.092 . . . . 0.0 109.762 -176.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -79.55 141.02 37.02 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 170.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.604 ' HB2' ' HB3' ' A' ' 106' ' ' MET . 58.8 mt-30 -103.4 3.19 34.82 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.919 172.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -108.14 -46.41 3.75 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -170.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.439 HG13 HG12 ' A' ' 157' ' ' VAL . 30.1 mm -81.98 106.63 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 121.295 0.569 . . . . 0.0 109.99 -163.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 63.0 mtt -127.82 161.45 28.98 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.527 1.131 . . . . 0.0 109.76 -172.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 66.43 6.39 4.31 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 124.311 1.045 . . . . 0.0 112.822 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -103.91 153.61 20.59 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.594 0.757 . . . . 0.0 110.393 -171.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -88.14 107.62 18.86 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 172.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.621 HD13 HG21 ' A' ' 157' ' ' VAL . 47.5 mt -105.62 117.9 52.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.625 0.726 . . . . 0.0 109.251 -175.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 13.4 tpt -102.47 133.86 46.73 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.423 -173.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 15.2 mt -108.36 104.04 13.32 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -176.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.414 ' HA ' ' OG ' ' A' ' 195' ' ' SER . 68.2 mttm -116.7 149.78 39.27 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.329 0.652 . . . . 0.0 110.501 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -141.08 161.94 36.66 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 122.146 0.974 . . . . 0.0 113.02 -174.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.492 HD22 ' HA ' ' A' ' 91' ' ' THR . 8.8 m120 -108.47 133.24 52.9 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 160.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -160.53 160.85 32.4 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.254 0.55 . . . . 0.0 111.6 -177.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.0 m -87.82 154.72 20.32 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.428 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.405 ' HB ' ' HB3' ' A' ' 88' ' ' ARG . 79.4 t -128.7 131.35 68.63 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 C-N-CA 123.938 0.895 . . . . 0.0 109.427 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 6.7 tp -142.99 141.51 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 171.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 58.2 37.92 26.23 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.832 0.853 . . . . 0.0 112.115 176.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 63.18 16.62 9.54 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 125.036 1.335 . . . . 0.0 112.446 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 16.1 ptt-85 -132.6 167.22 20.42 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.15 0.58 . . . . 0.0 110.856 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.6 tt -67.81 115.85 7.82 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -78.21 -61.9 1.85 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 122.789 0.436 . . . . 0.0 110.468 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 97.3 m -147.2 125.89 12.58 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.569 0.748 . . . . 0.0 110.12 -171.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.444 HD11 ' HB2' ' A' ' 147' ' ' LEU . 47.9 tp -73.51 129.53 38.18 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.191 0.596 . . . . 0.0 109.784 176.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 85.3 mt -88.27 -51.05 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.699 0.8 . . . . 0.0 109.283 174.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 54.3 tp -162.23 148.06 13.02 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 175.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.609 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 7.7 tt -137.28 149.45 47.11 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 175.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.486 ' HD3' HD13 ' A' ' 156' ' ' ILE . 46.8 mtt-85 -133.87 145.52 49.74 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.491 0.717 . . . . 0.0 110.729 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.556 ' HB2' HD21 ' A' ' 181' ' ' LEU . . . -109.76 123.52 49.68 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 168.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.528 ' HB3' ' HA ' ' A' ' 156' ' ' ILE . 18.8 p90 -150.22 168.51 23.79 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.64 0.776 . . . . 0.0 110.186 -176.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 79.1 p -85.69 165.87 16.61 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 173.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.05 -9.46 39.5 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 120.691 0.282 . . . . 0.0 111.675 174.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -79.83 -23.7 41.85 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.018 1.327 . . . . 0.0 110.973 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 106.18 -1.48 37.84 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-N 115.637 -0.711 . . . . 0.0 113.003 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.24 106.9 6.1 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.216 0.606 . . . . 0.0 109.911 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.528 ' HA ' ' HB3' ' A' ' 150' ' ' PHE . 25.6 mt -77.46 118.51 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -177.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.621 HG21 HD13 ' A' ' 128' ' ' ILE . 18.9 m -106.89 -15.31 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 124.595 1.158 . . . . 0.0 111.994 -170.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -165.25 177.23 40.72 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 111.826 -0.51 . . . . 0.0 111.826 -172.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -166.17 153.94 10.28 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.739 0.416 . . . . 0.0 111.046 -173.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.609 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 67.9 mt -127.61 116.49 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 166.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 33.4 t -128.03 118.74 20.84 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.108 0.563 . . . . 0.0 109.898 -174.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -62.14 121.45 9.49 Favored 'Trans proline' 0 C--N 1.382 2.328 0 C-N-CA 122.798 2.332 . . . . 0.0 111.91 176.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.4 mt . . . . . 0 CA--C 1.548 0.903 0 C-N-CA 122.862 0.465 . . . . 0.0 110.217 -178.92 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 10.1 p80 . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.0 m -107.27 161.86 14.41 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.269 1.027 . . . . 0.0 110.82 -169.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.603 HD11 ' HA ' ' A' ' 202' ' ' ALA . 14.8 tt -56.05 -29.99 28.06 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.308 0 C-N-CA 124.235 1.014 . . . . 0.0 112.307 172.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -56.21 -52.65 63.65 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.059 0.944 . . . . 0.0 111.835 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -73.63 -25.2 60.19 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.978 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 178' ' ' ILE . 63.4 t -65.78 -40.92 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 122.643 0.377 . . . . 0.0 110.185 172.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -72.1 -30.7 65.36 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.477 0.311 . . . . 0.0 111.005 178.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.441 ' O ' HG23 ' A' ' 180' ' ' VAL . 94.8 m-20 -62.79 -46.16 89.27 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 169.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.475 ' HB2' HD12 ' A' ' 115' ' ' LEU . . . -61.87 -48.21 81.53 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.766 1.226 . . . . 0.0 112.339 -174.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 174' ' ' VAL . 45.6 mt -68.32 -32.36 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -65.31 -38.74 95.39 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-N 116.086 -0.506 . . . . 0.0 113.364 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.445 HG11 ' HG2' ' A' ' 110' ' ' LYS . 95.8 t -72.45 -42.81 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.066 0.546 . . . . 0.0 109.847 177.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.556 HD21 ' HB2' ' A' ' 149' ' ' ALA . 35.4 tp -54.15 -55.97 22.69 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.027 0.931 . . . . 0.0 110.536 176.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.496 ' O ' ' HG2' ' A' ' 186' ' ' GLU . 24.7 mt -55.0 -45.27 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 124.152 0.907 . . . . 0.0 110.74 172.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -55.24 -41.86 80.45 Favored Glycine 0 CA--C 1.533 1.189 0 O-C-N 123.793 0.683 . . . . 0.0 114.268 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.35 -33.26 64.53 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-O 121.302 0.39 . . . . 0.0 112.134 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.428 ' HB3' ' OD1' ' A' ' 190' ' ' ASN . 88.9 mt -72.2 -28.82 63.44 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 124.618 1.167 . . . . 0.0 111.403 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 18.2 mm-40 -60.55 -38.45 84.56 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.703 0.801 . . . . 0.0 110.044 175.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 67.4 mtp85 -69.42 -30.83 68.86 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.24 -1.345 . . . . 0.0 110.821 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -83.09 4.81 24.76 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.516 0.727 . . . . 0.0 112.652 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 36.9 t70 59.33 26.96 15.92 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.986 0.898 . . . . 0.0 111.124 173.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.428 ' OD1' ' HB3' ' A' ' 185' ' ' LEU . 28.8 p30 -105.09 161.48 14.2 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -177.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 35.4 m -91.27 113.79 26.15 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.28 0.632 . . . . 0.0 109.827 -172.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.493 HG21 HG23 ' A' ' 182' ' ' ILE . 35.2 m -89.83 134.43 28.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-O 121.324 0.583 . . . . 0.0 109.986 -177.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -140.76 129.78 23.33 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.755 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 4.7 t -105.34 152.62 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.414 ' OG ' ' HA ' ' A' ' 131' ' ' LYS . 63.5 m -59.06 145.84 40.64 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 118.222 0.464 . . . . 0.0 111.037 176.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . 0.411 ' O ' ' HG3' ' A' ' 200' ' ' ARG . 0.2 OUTLIER -69.26 -28.08 66.0 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.294 0.371 . . . . 0.0 110.222 -178.216 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 62.6 p -67.34 -50.15 61.12 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 171.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 33.6 mt -58.58 -30.61 67.32 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.464 0.705 . . . . 0.0 111.26 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.673 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 45.6 mt-30 -70.58 -55.18 9.43 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.161 0.585 . . . . 0.0 110.897 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 196' ' ' LYS . 0.0 OUTLIER -81.61 -11.78 58.99 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -173.213 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -97.37 -39.51 9.17 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.038 0.535 . . . . 0.0 111.13 175.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.603 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -121.67 -61.55 1.5 Allowed 'General case' 0 N--CA 1.479 0.993 0 O-C-N 122.15 -0.344 . . . . 0.0 111.287 -172.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.673 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 51.2 t-105 . . . . . 0 CA--C 1.545 0.757 0 C-N-CA 124.584 1.153 . . . . 0.0 110.445 -165.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 120.5 0.19 . . . . 0.0 110.625 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -99.1 98.73 9.71 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.954 0.901 . . . . 0.0 109.197 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.8 mm -77.22 137.44 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.994 0.918 . . . . 0.0 109.018 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.2 p -127.35 85.92 2.43 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.107 0.563 . . . . 0.0 109.534 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -72.55 -25.52 61.39 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 122.824 0.45 . . . . 0.0 111.319 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.534 ' HB2' ' HG3' ' A' ' 97' ' ' GLU . 9.1 ptp -106.04 131.7 53.01 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 172.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 77.1 p -70.05 169.24 13.81 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.415 0.686 . . . . 0.0 109.946 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 45.0 mm -62.16 -35.66 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 122.593 0.357 . . . . 0.0 110.582 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 100' ' ' ARG . 43.2 mt-10 -53.72 -44.13 69.61 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.803 0.841 . . . . 0.0 112.294 176.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.534 ' HG3' ' HB2' ' A' ' 93' ' ' MET . 13.7 pt-20 -96.7 -13.23 22.89 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.076 0.55 . . . . 0.0 110.996 -177.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.565 HD12 HD23 ' A' ' 146' ' ' LEU . 53.2 tp -68.9 -50.21 51.5 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.919 0.888 . . . . 0.0 110.768 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.1 p -103.42 14.33 31.63 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.659 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 96' ' ' GLU . 59.5 ttt85 -72.15 141.38 49.11 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.237 0.615 . . . . 0.0 111.279 -174.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -84.28 152.28 24.26 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.344 0.592 . . . . 0.0 109.812 173.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . 0.55 ' HE1' HH12 ' A' ' 148' ' ' ARG . 7.9 p-90 -149.6 167.51 26.14 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.389 1.076 . . . . 0.0 109.396 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -129.19 145.08 51.4 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.685 0.794 . . . . 0.0 109.605 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.548 ' SD ' ' HD2' ' A' ' 118' ' ' ARG . 69.7 mtp -116.9 150.92 37.68 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.662 0.785 . . . . 0.0 109.886 178.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.446 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.9 pt? -126.93 -23.73 3.6 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.672 0.789 . . . . 0.0 110.552 -177.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 25.6 mmt -130.12 72.72 81.83 Favored Pre-proline 0 N--CA 1.49 1.563 0 C-N-CA 123.119 0.568 . . . . 0.0 109.627 167.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.93 135.66 35.85 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.867 2.378 . . . . 0.0 113.61 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.45 ' HD2' HE21 ' A' ' 121' ' ' GLN . 56.6 tttm -129.88 118.9 22.44 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.032 0.933 . . . . 0.0 109.133 173.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.413 ' NE2' ' SG ' ' A' ' 116' ' ' CYS . 0.0 OUTLIER -108.33 103.8 13.04 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.715 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.7 tptt -120.79 126.36 49.91 Favored 'General case' 0 C--O 1.206 -1.207 0 C-N-CA 124.957 1.303 . . . . 0.0 107.911 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 81.3 t -96.4 133.85 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 173.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -126.12 92.65 3.62 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 175.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.61 -133.25 25.3 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.909 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -75.65 3.78 5.64 Favored 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 123.716 2.944 . . . . 0.0 113.697 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.639 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 5.3 mp -125.23 156.67 38.14 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.267 0.627 . . . . 0.0 109.71 -177.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.413 ' SG ' ' NE2' ' A' ' 109' ' ' GLN . 42.6 t -116.87 132.75 56.62 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.002 0.921 . . . . 0.0 108.825 -177.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.419 HD11 ' HB1' ' A' ' 177' ' ' ALA . 12.6 mm -106.03 143.71 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.472 1.109 . . . . 0.0 109.184 -176.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.618 ' HB3' ' HB3' ' A' ' 159' ' ' GLU . 71.3 ttp85 -129.3 120.64 25.99 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 176.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.595 HD13 ' HA3' ' A' ' 184' ' ' GLY . 44.2 mt -128.68 139.17 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -176.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -107.86 121.92 45.73 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 171.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.46 ' HA ' ' ND2' ' A' ' 188' ' ' ASN . 70.2 mt-30 -82.96 -9.29 59.36 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -173.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.27 -32.18 26.53 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.798 0.439 . . . . 0.0 111.5 178.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.442 HG12 ' CG1' ' A' ' 157' ' ' VAL . 1.8 mp -71.02 108.57 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.758 0.789 . . . . 0.0 109.117 -178.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.439 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 58.4 mtt -132.08 163.19 29.01 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 113.684 -1.598 . . . . 0.0 108.988 -175.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 71.35 5.33 5.39 Favored 'General case' 0 N--CA 1.502 2.126 0 C-N-CA 124.543 1.137 . . . . 0.0 112.998 171.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -97.08 151.13 20.06 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.653 0.781 . . . . 0.0 112.143 -170.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -91.98 108.33 19.85 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 164.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.548 HG12 HG22 ' A' ' 151' ' ' THR . 34.0 mt -110.92 147.91 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 123.598 0.759 . . . . 0.0 110.397 -172.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 15.4 tpt -130.67 120.76 24.39 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.544 1.138 . . . . 0.0 109.768 -169.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -88.21 103.63 15.95 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -117.25 138.14 51.92 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.487 0.715 . . . . 0.0 109.26 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -134.8 147.03 49.86 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.512 0.931 . . . . 0.0 113.512 -171.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.458 ' OD1' ' HG2' ' A' ' 93' ' ' MET . 5.2 m-20 -102.07 122.92 45.03 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 165.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -159.73 158.7 31.78 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 122.901 0.48 . . . . 0.0 111.645 -171.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.9 t -88.02 155.11 19.99 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.008 0.923 . . . . 0.0 109.914 173.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.9 t -130.5 145.6 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 124.901 1.281 . . . . 0.0 109.297 -177.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.544 HG22 ' HB2' ' A' ' 142' ' ' GLU . 11.0 tp -157.95 144.01 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 171.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 55.5 27.59 10.49 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 123.64 0.776 . . . . 0.0 112.858 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 66.18 23.19 10.95 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.97 1.308 . . . . 0.0 112.661 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.452 ' HG2' ' O ' ' A' ' 137' ' ' ILE . 28.8 ptt180 -117.66 160.96 20.44 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.945 0.498 . . . . 0.0 109.78 175.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.8 tt -71.2 112.99 7.78 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 166.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.544 ' HB2' HG22 ' A' ' 137' ' ' ILE . 11.9 tp10 -81.43 -58.46 3.02 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.67 0.388 . . . . 0.0 110.186 177.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 96.4 m -141.78 120.94 12.97 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.249 0.22 . . . . 0.0 110.808 -174.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 43.6 tp -77.2 119.3 20.69 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.057 0.543 . . . . 0.0 109.577 172.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 72.0 mt -80.56 -53.68 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 174.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.565 HD23 HD12 ' A' ' 98' ' ' LEU . 65.0 tp -156.61 146.09 20.66 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.888 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.564 HD13 HD12 ' A' ' 160' ' ' ILE . 8.2 tt -133.2 145.59 50.72 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 171.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.681 HH11 HG21 ' A' ' 156' ' ' ILE . 84.4 mtt-85 -140.52 143.69 35.54 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.227 1.011 . . . . 0.0 108.845 178.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -101.61 112.43 24.99 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 176.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -106.58 125.31 50.84 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.382 1.073 . . . . 0.0 109.74 -175.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.548 HG22 HG12 ' A' ' 128' ' ' ILE . 43.7 p -71.64 -174.07 1.06 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.034 0.534 . . . . 0.0 111.583 175.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -19.2 65.5 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.462 0.705 . . . . 0.0 112.833 175.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -98.3 -1.2 42.37 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.728 0.811 . . . . 0.0 111.358 172.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 76.38 26.3 63.91 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 116.396 -0.365 . . . . 0.0 113.343 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -77.7 131.63 37.79 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.681 HG21 HH11 ' A' ' 148' ' ' ARG . 22.9 mt -83.02 86.86 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 121.649 0.738 . . . . 0.0 109.181 -177.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.442 ' CG1' HG12 ' A' ' 123' ' ' ILE . 19.3 m -100.09 -12.89 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.519 1.128 . . . . 0.0 111.185 -169.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.44 ' HA3' HD11 ' A' ' 181' ' ' LEU . . . -142.84 164.76 27.05 Favored Glycine 0 C--O 1.245 0.836 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.618 ' HB3' ' HB3' ' A' ' 118' ' ' ARG . 32.8 tt0 -167.89 150.05 5.56 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 117.437 0.618 . . . . 0.0 110.428 -173.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.564 HD12 HD13 ' A' ' 147' ' ' LEU . 57.6 mt -136.0 125.67 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 170.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 14.4 m -138.46 122.88 11.7 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.639 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 88.1 Cg_exo -48.51 142.44 17.78 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 123.257 2.638 . . . . 0.0 113.175 173.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 90.4 mt . . . . . 0 CA--C 1.559 1.307 0 C-N-CA 123.623 0.769 . . . . 0.0 111.09 178.873 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.8 m -122.51 154.96 37.15 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.465 HD11 ' HA ' ' A' ' 202' ' ' ALA . 10.7 tt -51.88 -34.96 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 C-N-CA 124.726 1.21 . . . . 0.0 113.001 177.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -61.97 -44.15 97.35 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.221 1.008 . . . . 0.0 112.784 -177.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -82.75 -25.62 32.67 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.647 0.379 . . . . 0.0 111.276 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.453 ' O ' HG13 ' A' ' 178' ' ' ILE . 91.4 t -64.49 -48.64 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 122.809 0.444 . . . . 0.0 110.858 172.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -65.96 -28.22 68.74 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.61 0.364 . . . . 0.0 110.905 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.426 ' O ' HG23 ' A' ' 180' ' ' VAL . 13.7 m120 -68.53 -43.56 76.48 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 123.144 0.578 . . . . 0.0 109.495 171.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.419 ' HB1' HD11 ' A' ' 117' ' ' ILE . . . -61.3 -40.52 94.46 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.842 0.857 . . . . 0.0 111.36 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 174' ' ' VAL . 57.6 mt -65.0 -39.91 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.19 -36.98 94.16 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.476 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 176' ' ' ASN . 80.9 t -66.2 -47.59 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.218 0.607 . . . . 0.0 110.613 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.44 HD11 ' HA3' ' A' ' 158' ' ' GLY . 32.7 tp -59.46 -46.76 87.85 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.879 0.737 . . . . 0.0 110.344 178.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.8 HG23 HG21 ' A' ' 192' ' ' VAL . 47.8 mt -57.12 -46.19 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.37 1.068 . . . . 0.0 111.447 176.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -63.41 -34.58 90.34 Favored Glycine 0 C--N 1.341 0.841 0 O-C-N 123.675 0.609 . . . . 0.0 113.104 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.595 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -71.12 -27.61 71.67 Favored Glycine 0 C--N 1.35 1.343 0 O-C-N 123.751 0.324 . . . . 0.0 113.0 177.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.411 HD22 ' CD1' ' A' ' 128' ' ' ILE . 64.2 mt -77.28 -47.35 20.29 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.832 0.853 . . . . 0.0 110.076 175.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -67.14 -34.11 76.89 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.316 0.646 . . . . 0.0 112.417 -174.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -66.89 -29.05 68.85 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 122.432 0.293 . . . . 0.0 111.365 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.46 ' ND2' ' HA ' ' A' ' 121' ' ' GLN . 49.5 m-20 -80.38 8.19 8.11 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.207 0.603 . . . . 0.0 110.86 174.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 34.4 t70 65.49 64.2 0.6 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.776 1.23 . . . . 0.0 110.207 177.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.408 HD21 ' HA ' ' A' ' 124' ' ' MET . 35.7 m-80 -124.46 172.96 8.76 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.153 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 70.2 m -122.93 102.55 8.08 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.8 HG21 HG23 ' A' ' 182' ' ' ILE . 31.8 m -89.99 150.97 3.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 CA-C-O 121.898 0.856 . . . . 0.0 111.574 -174.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -141.22 131.23 24.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 113.8 -1.545 . . . . 0.0 107.701 173.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 5.8 t -89.75 152.7 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 38.6 t -62.95 141.6 58.66 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 118.179 0.445 . . . . 0.0 109.929 176.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -57.94 -33.73 69.13 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.258 0.623 . . . . 0.0 111.888 -177.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 15.0 p -66.79 -49.6 65.34 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.433 0.458 . . . . 0.0 110.242 174.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 72.5 mt -58.63 -34.65 71.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 122.697 0.399 . . . . 0.0 110.775 178.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.58 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 75.5 mt-30 -61.35 -41.53 97.21 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.092 0.957 . . . . 0.0 112.666 -175.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.26 -21.09 14.41 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -178.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -79.49 -48.69 13.47 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 118.745 0.702 . . . . 0.0 111.107 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.465 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -114.82 -50.89 2.76 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.498 0.666 . . . . 0.0 111.221 -174.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.58 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 35.4 t-105 . . . . . 0 CA--C 1.555 1.136 0 C-N-CA 124.97 1.308 . . . . 0.0 111.391 -171.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -116.4 113.54 23.02 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.888 0.875 . . . . 0.0 109.345 174.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 32.5 mm -78.38 132.85 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 36.1 p -128.25 87.93 2.67 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.923 0.889 . . . . 0.0 109.305 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -71.33 -22.9 61.86 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 173.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.419 ' SD ' ' HB2' ' A' ' 148' ' ' ARG . 56.9 mtm -119.63 139.89 51.47 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 125.15 1.38 . . . . 0.0 109.027 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 72.2 p -88.88 165.67 14.48 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 172.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.482 ' HA ' HD12 ' A' ' 98' ' ' LEU . 2.2 mp -53.93 -30.73 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 124.609 1.164 . . . . 0.0 111.736 -171.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -53.33 -62.69 1.49 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.355 1.062 . . . . 0.0 111.984 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.719 ' HA ' ' HB2' ' A' ' 100' ' ' ARG . 14.9 pm0 -77.21 -22.56 52.14 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.834 0.453 . . . . 0.0 111.74 -177.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.633 HD11 ' ND2' ' A' ' 133' ' ' ASN . 32.7 mt -58.53 -39.17 79.4 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.089 0.556 . . . . 0.0 110.491 169.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.3 m -108.32 20.96 17.98 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.278 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.719 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 6.5 tpt180 -71.29 143.05 50.46 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.75 0.42 . . . . 0.0 110.861 -174.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -96.12 104.99 16.98 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.113 0.965 . . . . 0.0 109.563 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . 0.431 ' HE1' ' NH1' ' A' ' 148' ' ' ARG . 46.0 p-90 -137.04 172.66 12.67 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.216 1.006 . . . . 0.0 110.496 -177.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -138.38 166.22 24.8 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.611 0.764 . . . . 0.0 110.657 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.413 ' HG2' ' HB2' ' A' ' 120' ' ' ASP . 55.9 mtm -122.16 129.19 52.08 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.286 1.034 . . . . 0.0 109.105 172.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 56.3 tp -71.38 -40.62 70.45 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.023 0.929 . . . . 0.0 110.034 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.425 ' HG2' ' HB2' ' A' ' 122' ' ' ALA . 24.1 mmt -125.0 77.97 66.48 Favored Pre-proline 0 N--CA 1.483 1.194 0 C-N-CA 124.404 1.082 . . . . 0.0 109.451 174.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.43 111.93 3.43 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.627 2.218 . . . . 0.0 112.352 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.427 ' HD2' HE21 ' A' ' 121' ' ' GLN . 53.4 tttm -87.04 111.2 20.65 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 172.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -89.21 116.8 27.72 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.547 0.339 . . . . 0.0 110.271 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.422 ' HG2' HG11 ' A' ' 180' ' ' VAL . 14.4 tppt? -127.47 140.23 52.29 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.983 1.313 . . . . 0.0 109.332 174.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.559 HG13 HD11 ' A' ' 163' ' ' LEU . 79.5 t -123.24 99.5 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 166.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.48 ' HG2' HG21 ' A' ' 180' ' ' VAL . 9.1 tp10 -104.3 95.56 6.04 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -175.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.16 -125.91 19.19 Favored Glycine 0 CA--C 1.536 1.362 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.39 -176.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -85.75 6.38 5.59 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 123.246 2.63 . . . . 0.0 112.875 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.407 HD12 ' HB2' ' A' ' 177' ' ' ALA . 73.6 mt -123.51 144.32 49.62 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.345 0.658 . . . . 0.0 109.666 -171.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 46.4 t -107.66 115.58 30.4 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.322 0.649 . . . . 0.0 109.458 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.0 mm -99.72 133.71 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.2 mtm180 -134.42 120.98 20.47 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.66 0.784 . . . . 0.0 108.946 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.551 HG12 HD12 ' A' ' 181' ' ' LEU . 49.6 mt -126.06 132.47 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.391 1.077 . . . . 0.0 108.988 -173.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.426 ' OD2' HG12 ' A' ' 123' ' ' ILE . 16.7 t70 -89.29 120.09 30.34 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 118.064 0.393 . . . . 0.0 109.958 176.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.457 ' HA ' ' ND2' ' A' ' 188' ' ' ASN . 82.2 mt-30 -91.35 2.21 56.56 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.74 0.816 . . . . 0.0 113.118 -175.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.425 ' HB2' ' HG2' ' A' ' 106' ' ' MET . . . -94.11 -27.82 16.04 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 174.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.426 HG12 ' OD2' ' A' ' 120' ' ' ASP . 22.5 mm -78.49 95.03 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.685 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 37.4 mtt -122.74 149.33 44.24 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.045 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.0 t70 65.55 52.1 1.41 Allowed 'General case' 0 N--CA 1.484 1.23 0 O-C-N 124.529 1.143 . . . . 0.0 110.928 175.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -130.03 156.1 45.05 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.068 0.947 . . . . 0.0 110.691 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -95.64 108.27 20.54 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 170.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.545 ' HB ' HG12 ' A' ' 192' ' ' VAL . 58.7 mt -113.66 143.56 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.761 0.824 . . . . 0.0 111.186 -171.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 12.4 tpt -118.41 122.85 43.79 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.324 1.05 . . . . 0.0 108.912 -177.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.434 HD12 HG22 ' A' ' 194' ' ' VAL . 12.1 mt -94.79 103.87 15.77 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -175.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.406 ' HA ' ' HB2' ' A' ' 195' ' ' SER . 53.4 mtpt -118.37 140.74 49.37 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.948 0.899 . . . . 0.0 109.974 -170.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -135.6 154.12 51.44 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 122.581 1.181 . . . . 0.0 114.141 -171.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.633 ' ND2' HD11 ' A' ' 98' ' ' LEU . 3.3 m-20 -108.06 127.63 53.96 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 162.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -156.21 159.6 39.09 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.682 0.614 . . . . 0.0 110.556 -176.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.2 t -86.3 162.85 18.04 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 173.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.8 t -135.02 133.87 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.625 1.17 . . . . 0.0 109.132 -174.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.6 tp -148.88 145.81 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 172.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 59.21 30.47 20.24 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.741 0.816 . . . . 0.0 111.3 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 64.06 17.74 10.81 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.057 1.343 . . . . 0.0 112.096 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -127.36 175.39 8.23 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.899 0.88 . . . . 0.0 110.0 176.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.467 HD22 ' HA ' ' A' ' 171' ' ' ILE . 9.1 tt -67.33 123.46 20.42 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.545 0.738 . . . . 0.0 109.119 175.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -82.99 -70.19 0.57 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.137 0.575 . . . . 0.0 109.886 174.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 61.4 m -147.92 129.34 14.85 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.88 0.872 . . . . 0.0 109.656 -174.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 59.3 tp -72.3 134.55 45.59 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.768 0.827 . . . . 0.0 110.46 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 66.1 mt -96.16 -43.48 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.924 0.89 . . . . 0.0 110.102 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.439 HD21 ' NH2' ' A' ' 148' ' ' ARG . 40.9 tp -169.5 149.12 3.9 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.922 0.889 . . . . 0.0 109.253 174.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.666 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 7.5 tt -136.0 144.93 45.59 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.717 ' HD3' HD13 ' A' ' 156' ' ' ILE . 71.7 mtt-85 -142.54 146.75 34.98 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.224 1.01 . . . . 0.0 109.939 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.73 118.72 37.47 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.239 1.016 . . . . 0.0 108.844 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -110.25 128.94 55.77 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.277 1.031 . . . . 0.0 110.397 -174.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 31.4 p -76.8 179.27 6.21 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.022 0.529 . . . . 0.0 111.022 172.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -61.97 -21.02 64.48 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.884 0.874 . . . . 0.0 112.02 174.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -83.04 -1.54 52.98 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.801 1.24 . . . . 0.0 111.569 176.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 69.0 18.23 72.51 Favored Glycine 0 C--N 1.357 1.709 0 CA-C-N 116.456 -0.338 . . . . 0.0 112.847 -173.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -92.57 129.47 38.49 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.383 0.673 . . . . 0.0 109.419 -174.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.717 HD13 ' HD3' ' A' ' 148' ' ' ARG . 24.4 mt -79.97 109.26 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.1 m -117.08 -0.55 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.974 0.91 . . . . 0.0 111.397 -173.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -150.22 164.47 29.71 Favored Glycine 0 C--N 1.34 0.76 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -165.57 144.39 6.23 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 117.149 0.475 . . . . 0.0 110.595 -174.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.666 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 73.8 mt -127.05 102.84 10.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.1 t -106.79 112.62 63.39 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 123.366 0.666 . . . . 0.0 109.579 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -58.96 128.26 27.26 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.749 2.299 . . . . 0.0 111.983 174.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.559 HD11 HG13 ' A' ' 111' ' ' VAL . 88.8 mt . . . . . 0 CA--C 1.548 0.873 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.202 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.401 ' CE1' HD21 ' A' ' 115' ' ' LEU . 42.3 p-80 . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 120.993 0.425 . . . . 0.0 110.551 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 19.2 m -106.56 158.16 17.14 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.269 1.027 . . . . 0.0 110.064 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.467 ' HA ' HD22 ' A' ' 141' ' ' LEU . 2.8 tt -48.22 -39.78 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 125.563 1.545 . . . . 0.0 113.024 174.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -63.54 -34.17 77.21 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.55 0.74 . . . . 0.0 111.687 -174.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -65.98 -37.05 84.96 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.861 0.864 . . . . 0.0 110.546 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 25.5 t -68.63 -34.95 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 123.865 0.728 . . . . 0.0 110.611 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -64.24 -38.27 90.47 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 120.486 0.184 . . . . 0.0 110.707 176.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -63.16 -47.21 83.64 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 123.992 0.808 . . . . 0.0 109.568 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.407 ' HB2' HD12 ' A' ' 115' ' ' LEU . . . -60.41 -48.78 80.27 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 114.29 -1.323 . . . . 0.0 112.2 -175.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 68.5 mt -67.42 -38.73 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 123.779 0.674 . . . . 0.0 109.418 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.26 -30.07 76.42 Favored Glycine 0 CA--C 1.536 1.372 0 O-C-N 123.328 0.392 . . . . 0.0 113.677 176.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.48 HG21 ' HG2' ' A' ' 112' ' ' GLU . 43.2 t -76.45 -43.73 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.663 0.785 . . . . 0.0 110.32 175.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.551 HD12 HG12 ' A' ' 119' ' ' ILE . 36.6 tp -56.53 -49.04 75.92 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.727 0.811 . . . . 0.0 110.509 175.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.461 ' O ' ' HG2' ' A' ' 186' ' ' GLU . 77.3 mt -61.54 -52.18 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.14 0.976 . . . . 0.0 110.272 174.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -54.99 -36.26 60.41 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 124.153 0.908 . . . . 0.0 114.141 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.13 -41.34 47.69 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 112.235 -0.346 . . . . 0.0 112.235 174.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.492 HD13 HG11 ' A' ' 192' ' ' VAL . 35.5 mt -69.79 -16.49 63.3 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.304 1.042 . . . . 0.0 111.944 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 20.5 mm-40 -70.81 -39.27 73.18 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 171.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -77.83 -34.48 51.89 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.451 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.457 ' ND2' ' HA ' ' A' ' 121' ' ' GLN . 7.9 m-20 -72.59 -13.63 61.43 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.692 170.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 38.6 t70 57.57 67.63 0.95 Allowed 'General case' 0 C--N 1.355 0.842 0 C-N-CA 125.556 1.542 . . . . 0.0 111.367 176.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -124.92 139.2 54.05 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.484 -1.235 . . . . 0.0 107.843 175.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 86.7 m -79.54 102.44 8.84 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.545 HG12 ' HB ' ' A' ' 128' ' ' ILE . 34.0 m -107.57 147.58 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 121.505 0.669 . . . . 0.0 110.983 -173.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -135.79 139.93 43.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 113.957 -1.474 . . . . 0.0 107.779 175.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.434 HG22 HD12 ' A' ' 130' ' ' LEU . 16.5 t -89.42 155.96 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.406 ' HB2' ' HA ' ' A' ' 131' ' ' LYS . 28.8 t -56.1 151.75 11.68 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.186 0.595 . . . . 0.0 112.172 -178.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . 0.4 ' H ' ' HD2' ' A' ' 196' ' ' LYS . 0.2 OUTLIER -56.78 -44.73 82.15 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 124.04 0.838 . . . . 0.0 109.861 179.757 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 63.7 p -65.83 -49.3 68.69 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 113.93 -1.486 . . . . 0.0 110.516 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 54.9 mt -62.56 -35.06 78.28 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.321 0.649 . . . . 0.0 110.868 -177.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.548 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 42.0 mt-30 -62.39 -34.06 75.98 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.775 0.83 . . . . 0.0 111.775 -176.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.417 ' HE ' ' HB2' ' A' ' 200' ' ' ARG . 0.0 OUTLIER -104.16 -30.54 10.14 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -76.48 -33.42 58.67 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.218 0.607 . . . . 0.0 111.562 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.42 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -121.13 -58.18 1.81 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.174 0.59 . . . . 0.0 110.643 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.548 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 27.7 t-105 . . . . . 0 CA--C 1.555 1.167 0 C-N-CA 125.026 1.33 . . . . 0.0 111.225 -166.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -100.82 100.98 11.71 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.536 0.734 . . . . 0.0 109.658 -175.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 50.8 mm -78.41 120.5 29.45 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.088 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 174.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 62.2 p -114.49 97.38 6.27 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -88.84 -25.56 22.12 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.513 0.325 . . . . 0.0 110.301 -178.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.513 ' HB3' ' HG3' ' A' ' 97' ' ' GLU . 2.7 mpp? -101.44 144.24 30.47 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.897 0.879 . . . . 0.0 108.945 172.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.3 m -72.94 161.05 31.17 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.328 0.651 . . . . 0.0 109.533 171.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.41 ' H ' HD12 ' A' ' 95' ' ' ILE . 3.0 mp -55.69 -39.26 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.612 0.765 . . . . 0.0 111.373 -177.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -65.37 -52.37 54.09 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.446 0.699 . . . . 0.0 111.699 -175.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.513 ' HG3' ' HB3' ' A' ' 93' ' ' MET . 11.3 pt-20 -70.25 -26.73 63.97 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 122.903 0.481 . . . . 0.0 111.532 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.406 ' HG ' HD23 ' A' ' 146' ' ' LEU . 9.1 tt -66.56 -44.29 82.73 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.732 0.813 . . . . 0.0 109.787 174.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 39.1 t -99.66 20.63 13.68 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.95 0.9 . . . . 0.0 110.734 -177.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.447 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 20.4 tpt180 -80.09 136.46 36.55 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.532 0.733 . . . . 0.0 111.657 -176.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -84.94 136.15 33.74 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 170.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 16.6 p-90 -144.14 137.74 27.68 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.229 1.012 . . . . 0.0 109.52 -175.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -94.73 138.19 32.86 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 18.1 ptm -123.97 124.11 41.86 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 173.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.53 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.6 pt? -82.55 -25.21 33.55 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.114 0.566 . . . . 0.0 111.571 -171.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 23.4 mmt -123.23 80.87 52.3 Favored Pre-proline 0 N--CA 1.475 0.816 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 175.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -76.04 110.66 3.12 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.493 2.129 . . . . 0.0 112.12 -177.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -95.96 112.28 24.05 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 165.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.499 ' NE2' ' SG ' ' A' ' 116' ' ' CYS . 0.0 OUTLIER -91.95 98.82 11.81 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 179.068 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.543 ' HG2' HG11 ' A' ' 180' ' ' VAL . 51.2 tptt -107.65 147.2 31.0 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.243 1.017 . . . . 0.0 108.906 177.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 51.5 t -130.68 129.18 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 172.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -135.88 104.83 5.87 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.43 -148.62 42.49 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 119.507 -0.607 . . . . 0.0 111.958 -175.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -73.89 13.11 0.84 Allowed 'Trans proline' 0 CA--C 1.555 1.552 0 C-N-CA 123.37 2.713 . . . . 0.0 114.097 173.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 4.2 mp -125.35 152.28 44.96 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.754 0.822 . . . . 0.0 108.802 -176.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.499 ' SG ' ' NE2' ' A' ' 109' ' ' GLN . 23.5 t -109.07 140.45 42.6 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.328 0.651 . . . . 0.0 110.029 175.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.7 mm -111.34 147.57 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.625 0.77 . . . . 0.0 109.518 178.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -124.86 119.98 30.38 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 27.6 mm -116.05 123.9 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -90.96 116.68 28.95 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 168.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.445 ' HA ' HD21 ' A' ' 188' ' ' ASN . 75.5 mt-30 -75.18 -16.63 60.49 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.552 0.741 . . . . 0.0 112.484 -173.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.44 -35.58 19.6 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.428 0.691 . . . . 0.0 112.128 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.85 109.95 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-O 121.994 0.902 . . . . 0.0 109.304 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.45 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 51.2 mtt -135.17 156.22 49.37 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 113.908 -1.496 . . . . 0.0 109.602 -177.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.3 t70 61.61 24.08 14.26 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 124.713 1.205 . . . . 0.0 112.228 174.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 54.3 mmtt -104.55 146.13 29.33 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 121.657 -0.652 . . . . 0.0 111.466 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.554 ' HA ' ' HB ' ' A' ' 191' ' ' THR . 0.8 OUTLIER -83.96 102.41 12.42 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 174.586 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.495 HD12 HD22 ' A' ' 185' ' ' LEU . 59.4 mt -114.95 141.07 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 123.681 0.793 . . . . 0.0 110.496 -172.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 14.0 tpt -117.59 131.42 56.68 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.304 1.042 . . . . 0.0 109.326 -174.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.517 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 2.9 mm? -91.4 104.4 16.92 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -118.45 136.1 53.98 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.365 1.066 . . . . 0.0 109.613 -171.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.464 ' HB2' ' HG ' ' A' ' 147' ' ' LEU . . . -142.22 152.52 43.16 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 -177.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -110.79 131.11 55.32 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 114.138 -1.392 . . . . 0.0 107.267 167.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.467 ' HA ' HG13 ' A' ' 145' ' ' ILE . 44.1 p90 -161.93 164.69 28.34 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.13 0.572 . . . . 0.0 111.4 -171.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.6 p -92.91 161.27 14.54 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.852 0.861 . . . . 0.0 109.667 173.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 54.8 t -128.27 133.36 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 124.288 1.035 . . . . 0.0 109.854 -176.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 8.7 tp -143.83 144.98 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 60.34 32.77 20.78 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.003 0.921 . . . . 0.0 112.447 174.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.7 t70 76.41 -0.07 3.13 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 124.555 1.142 . . . . 0.0 111.982 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -126.73 179.94 5.11 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.377 1.071 . . . . 0.0 110.136 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.515 ' HB3' HG13 ' A' ' 171' ' ' ILE . 9.9 tt -70.09 136.3 50.09 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.853 0.461 . . . . 0.0 109.877 177.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -91.48 -66.72 0.9 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.736 0.814 . . . . 0.0 110.517 174.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 75.9 m -145.96 130.0 17.41 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.513 0.725 . . . . 0.0 109.713 -174.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.487 HD21 ' HB2' ' A' ' 147' ' ' LEU . 40.6 tp -72.34 129.83 39.3 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 173.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.467 HG13 ' HA ' ' A' ' 134' ' ' PHE . 66.1 mt -87.14 -51.1 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 174.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.406 HD23 ' HG ' ' A' ' 98' ' ' LEU . 59.0 tp -163.77 147.42 10.11 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.225 1.01 . . . . 0.0 109.227 175.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.659 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 7.0 tt -131.8 148.15 52.54 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 173.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.509 HH11 HG21 ' A' ' 156' ' ' ILE . 55.2 mtt-85 -142.92 148.23 36.58 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.18 0.992 . . . . 0.0 109.857 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.436 ' HB2' HD21 ' A' ' 181' ' ' LEU . . . -105.63 112.39 25.45 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.354 1.062 . . . . 0.0 108.499 175.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -106.2 130.16 54.12 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.403 0.681 . . . . 0.0 110.347 -177.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 28.3 p -71.29 174.01 7.03 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.069 0.548 . . . . 0.0 110.991 170.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.42 -18.26 64.4 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.433 0.693 . . . . 0.0 111.349 171.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -64.08 -29.7 70.82 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.952 0.901 . . . . 0.0 110.76 168.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 91.91 20.6 36.1 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.747 -173.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -103.31 134.48 46.62 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.815 0.846 . . . . 0.0 110.668 -175.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.509 HG21 HH11 ' A' ' 148' ' ' ARG . 16.2 mt -73.87 116.03 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.43 -1.06 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.685 0.794 . . . . 0.0 110.787 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -157.13 161.86 31.42 Favored Glycine 0 C--N 1.334 0.417 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -162.0 150.46 15.11 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 117.482 0.641 . . . . 0.0 109.968 -172.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.659 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 67.5 mt -129.34 103.71 9.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 167.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.5 t -107.34 106.45 58.4 Favored Pre-proline 0 C--O 1.243 0.757 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 51.1 Cg_exo -57.45 117.59 4.31 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.997 2.465 . . . . 0.0 112.258 175.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.7 mt . . . . . 0 CA--C 1.548 0.879 0 C-N-CA 123.738 0.815 . . . . 0.0 111.985 -173.029 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 . . . . . 0 C--O 1.243 0.747 0 CA-C-O 121.377 0.608 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 27.9 m -99.58 164.46 12.06 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.279 1.031 . . . . 0.0 109.385 174.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.515 HG13 ' HB3' ' A' ' 141' ' ' LEU . 7.7 tt -49.83 -36.41 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 124.613 1.165 . . . . 0.0 112.051 174.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -60.59 -39.63 88.81 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.348 1.059 . . . . 0.0 111.308 -177.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -66.31 -36.6 83.36 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.461 0.705 . . . . 0.0 110.969 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 178' ' ' ILE . 46.3 t -65.19 -39.68 86.27 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.687 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.245 175.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.441 ' HE2' ' O ' ' A' ' 202' ' ' ALA . 88.1 mttt -58.79 -45.54 89.63 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.117 0.567 . . . . 0.0 110.775 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.486 ' O ' HG23 ' A' ' 180' ' ' VAL . 53.6 m-80 -64.15 -43.29 95.66 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.182 177.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.2 -50.27 74.11 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.209 0.943 . . . . 0.0 111.568 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 174' ' ' VAL . 39.9 mt -62.84 -40.27 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -58.69 -32.99 70.66 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 115.474 -0.785 . . . . 0.0 113.88 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.543 HG11 ' HG2' ' A' ' 110' ' ' LYS . 41.0 t -73.09 -46.38 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 117.041 0.421 . . . . 0.0 110.039 177.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.473 HD22 HG13 ' A' ' 160' ' ' ILE . 21.7 tp -61.77 -46.37 89.87 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 123.79 0.682 . . . . 0.0 110.825 -177.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 75.4 mt -61.41 -50.39 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.547 0.739 . . . . 0.0 110.078 175.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.45 ' O ' ' HG2' ' A' ' 187' ' ' ARG . . . -53.99 -47.85 64.87 Favored Glycine 0 C--N 1.346 1.13 0 O-C-N 124.201 0.938 . . . . 0.0 113.629 -177.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.19 -40.86 99.16 Favored Glycine 0 C--N 1.344 0.974 0 C-N-CA 123.164 0.411 . . . . 0.0 112.23 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.495 HD22 HD12 ' A' ' 128' ' ' ILE . 96.7 mt -63.7 -39.58 94.66 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.421 0.688 . . . . 0.0 111.084 176.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -67.75 -35.29 78.46 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.487 0.715 . . . . 0.0 110.984 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 183' ' ' GLY . 12.6 mmp_? -75.04 -27.48 60.05 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.81 0.444 . . . . 0.0 110.63 177.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.45 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 6.1 m-20 -81.02 -7.12 59.49 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.304 0.641 . . . . 0.0 110.898 170.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 38.7 t70 63.33 67.18 0.67 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.051 1.341 . . . . 0.0 111.328 -176.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -119.0 145.95 45.42 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.847 0.859 . . . . 0.0 109.074 175.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.554 ' HB ' ' HA ' ' A' ' 127' ' ' ASN . 28.2 m -76.99 107.51 9.39 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -178.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 18.0 m -101.85 134.85 41.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 121.265 0.555 . . . . 0.0 110.865 -172.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -143.9 133.87 24.06 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.321 1.048 . . . . 0.0 108.273 169.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.517 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 5.2 t -90.87 151.51 3.49 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 48.0 t -59.06 139.14 57.16 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 175.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -62.44 -25.29 67.89 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.985 0.514 . . . . 0.0 111.19 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 67.0 p -76.33 -44.59 36.02 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.213 0.605 . . . . 0.0 109.378 175.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.422 HD21 ' HB3' ' A' ' 132' ' ' ALA . 28.4 mt -58.65 -33.37 70.01 Favored 'General case' 0 C--O 1.2 -1.524 0 C-N-CA 122.713 0.405 . . . . 0.0 111.493 172.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.502 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 50.6 mt-30 -76.92 -41.2 44.44 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.999 0.52 . . . . 0.0 110.412 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 41.6 tpt85 -62.73 -43.23 99.35 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.282 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -100.72 -49.07 4.29 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.446 -169.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.461 ' HB2' HD13 ' A' ' 141' ' ' LEU . . . -97.19 -57.4 2.27 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -167.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.502 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 49.4 t-105 . . . . . 0 N--CA 1.48 1.042 0 C-N-CA 124.621 1.168 . . . . 0.0 112.271 -164.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 . . . . . 0 N--CA 1.473 0.692 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -104.71 101.71 11.32 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 177.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 133' ' ' ASN . 38.5 mm -75.93 129.59 36.93 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 68.6 p -122.14 80.7 1.74 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.844 0.858 . . . . 0.0 108.783 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.456 ' HB2' ' HB3' ' A' ' 131' ' ' LYS . 37.8 m-20 -69.84 -31.25 69.0 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 121.855 0.836 . . . . 0.0 109.55 172.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.609 ' HG3' ' HG3' ' A' ' 97' ' ' GLU . 25.1 ttp -102.69 121.81 43.17 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.142 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.4 m -72.97 155.65 39.63 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.832 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.8 mp -53.59 -34.3 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 C-N-CA 123.958 0.903 . . . . 0.0 111.084 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -50.9 -68.39 0.17 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.878 1.271 . . . . 0.0 112.108 173.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.609 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 9.9 pt-20 -71.13 -22.64 62.05 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.329 1.052 . . . . 0.0 112.063 -178.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.539 ' HG ' HD23 ' A' ' 146' ' ' LEU . 9.8 tt -66.72 -45.37 78.92 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.221 1.008 . . . . 0.0 110.347 174.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.9 t -98.94 1.63 45.76 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.39 0.676 . . . . 0.0 111.323 -175.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -61.01 140.88 57.72 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.554 0.742 . . . . 0.0 111.121 175.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -86.24 142.27 28.69 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.125 0.57 . . . . 0.0 109.751 171.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 28.7 p-90 -152.85 156.83 39.75 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.34 -170.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -111.26 155.24 23.3 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.265 1.026 . . . . 0.0 110.579 -175.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 93.8 mtp -128.43 109.23 11.22 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.113 0.965 . . . . 0.0 108.464 166.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.4 tp -67.92 -49.5 61.51 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.637 0.775 . . . . 0.0 110.261 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.502 ' HG2' ' HB2' ' A' ' 122' ' ' ALA . 97.7 mmm -119.95 82.19 28.19 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 124.151 0.98 . . . . 0.0 109.54 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -71.9 125.72 11.26 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.506 2.138 . . . . 0.0 112.675 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -95.76 110.18 22.37 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 166.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 20.4 tm0? -80.43 106.08 12.17 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 176.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.471 ' HG2' HG11 ' A' ' 180' ' ' VAL . 22.7 tptm -130.01 143.99 51.09 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.817 0.847 . . . . 0.0 108.745 170.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.451 HG11 HD11 ' A' ' 163' ' ' LEU . 63.1 t -131.72 122.16 49.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 168.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -109.18 97.56 7.15 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.29 -126.14 8.07 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 119.083 -0.843 . . . . 0.0 111.724 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.619 ' HG2' ' HB3' ' A' ' 169' ' ' HIS . 42.3 Cg_endo -98.26 31.88 0.13 Allowed 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 123.408 2.739 . . . . 0.0 111.74 172.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 162' ' ' PRO . 90.4 mt -131.17 123.97 29.67 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.177 0.991 . . . . 0.0 109.448 -178.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 16.6 p -83.78 122.69 29.01 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.445 0.698 . . . . 0.0 109.92 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.4 mm -103.11 106.65 20.48 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 C-N-CA 123.69 0.796 . . . . 0.0 109.3 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.618 ' HD2' ' HB3' ' A' ' 159' ' ' GLU . 77.2 mtt85 -95.93 119.92 35.29 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.76 0.824 . . . . 0.0 108.834 176.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.517 HD13 ' HA3' ' A' ' 184' ' ' GLY . 82.3 mt -129.76 123.79 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 124.401 1.08 . . . . 0.0 108.307 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -92.65 128.37 38.48 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.322 0.582 . . . . 0.0 110.029 177.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.482 ' HA ' ' ND2' ' A' ' 188' ' ' ASN . 75.1 mt-30 -91.13 -11.45 38.49 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.233 -174.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.502 ' HB2' ' HG2' ' A' ' 106' ' ' MET . . . -79.41 -49.43 12.35 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 120.997 0.427 . . . . 0.0 110.589 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.544 HG12 HG11 ' A' ' 157' ' ' VAL . 1.7 mp -71.34 109.73 3.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.288 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 50.3 mtt -131.61 159.2 38.97 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 113.693 -1.594 . . . . 0.0 109.554 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.4 t70 67.97 18.36 9.53 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 125.288 1.435 . . . . 0.0 112.295 174.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -103.61 151.99 22.28 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.585 0.754 . . . . 0.0 111.162 -176.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -84.31 102.2 12.51 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 168.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.507 HD12 HD22 ' A' ' 185' ' ' LEU . 44.3 mt -103.28 124.12 57.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -176.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.528 ' HG3' ' HG3' ' A' ' 131' ' ' LYS . 14.0 tpt -98.61 126.65 44.27 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.435 1.094 . . . . 0.0 109.069 -175.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.455 HD12 HG22 ' A' ' 194' ' ' VAL . 12.4 mt -105.79 103.43 12.93 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -174.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.528 ' HG3' ' HG3' ' A' ' 129' ' ' MET . 45.1 mtmt -126.5 150.95 48.44 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.037 0.535 . . . . 0.0 109.981 -176.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -136.91 153.68 50.67 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.907 0.86 . . . . 0.0 112.304 -174.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.52 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 4.6 m-20 -107.5 120.77 43.11 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 162.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -156.4 160.18 39.4 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.264 0.626 . . . . 0.0 111.02 -170.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 53.5 p -86.28 151.22 23.78 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.749 0.819 . . . . 0.0 109.226 174.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.0 t -130.55 132.75 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.381 1.073 . . . . 0.0 108.477 -177.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.3 tp -140.78 140.68 33.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 174.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 58.19 31.04 20.29 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.933 0.893 . . . . 0.0 111.946 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 63.31 30.88 15.59 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 124.97 1.308 . . . . 0.0 112.338 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 7.8 ppt_? -143.65 165.68 26.95 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.226 0.61 . . . . 0.0 109.687 173.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.472 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 10.5 tt -66.48 121.56 15.59 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.313 0.645 . . . . 0.0 109.742 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -82.31 -67.14 0.81 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.257 0.623 . . . . 0.0 110.281 173.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 62.2 m -141.96 127.4 18.87 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.885 0.474 . . . . 0.0 109.843 -173.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.647 HD11 ' HB2' ' A' ' 147' ' ' LEU . 51.9 tp -77.37 114.56 16.33 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.716 0.807 . . . . 0.0 109.545 178.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 57.1 mt -77.82 -52.65 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 175.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.539 HD23 ' HG ' ' A' ' 98' ' ' LEU . 50.2 tp -158.82 145.12 16.92 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.452 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.647 ' HB2' HD11 ' A' ' 144' ' ' LEU . 8.2 tt -139.26 152.25 47.13 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 176.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.738 HH11 HG21 ' A' ' 156' ' ' ILE . 6.8 ptp180 -150.73 157.44 42.96 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 122.046 0.927 . . . . 0.0 112.503 174.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.684 ' HB2' HD21 ' A' ' 181' ' ' LEU . . . -117.55 117.78 30.36 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 113.346 -1.752 . . . . 0.0 107.317 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -145.64 145.1 30.8 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.049 0.452 . . . . 0.0 111.709 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 80.5 p -65.13 163.28 15.29 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.457 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -64.82 -19.6 65.94 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -84.59 -1.46 55.98 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.164 0.586 . . . . 0.0 111.4 176.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 97.45 -5.25 62.5 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-O 119.931 -0.372 . . . . 0.0 114.005 172.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.99 105.97 6.26 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.991 0.395 . . . . 0.0 110.085 -175.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.738 HG21 HH11 ' A' ' 148' ' ' ARG . 13.8 mt -79.51 126.65 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.544 HG11 HG12 ' A' ' 123' ' ' ILE . 24.2 m -134.63 5.41 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 123.902 0.881 . . . . 0.0 110.964 -174.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -153.27 156.06 26.52 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.618 ' HB3' ' HD2' ' A' ' 118' ' ' ARG . 40.5 tt0 -164.83 141.64 6.01 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.802 0.441 . . . . 0.0 110.368 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.498 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 72.2 mt -120.62 121.64 65.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 172.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 15.5 m -137.52 148.13 60.32 Favored Pre-proline 0 N--CA 1.469 0.509 0 C-N-CA 123.272 0.629 . . . . 0.0 109.898 -177.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.403 ' HA ' HD23 ' A' ' 115' ' ' LEU . 18.1 Cg_endo -61.01 134.46 53.19 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 121.864 1.709 . . . . 0.0 110.302 165.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.451 HD11 HG11 ' A' ' 111' ' ' VAL . 66.2 mt . . . . . 0 CA--C 1.548 0.901 0 C-N-CA 123.266 0.626 . . . . 0.0 110.886 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.619 ' HB3' ' HG2' ' A' ' 114' ' ' PRO . 25.4 p-80 . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 121.181 0.515 . . . . 0.0 110.663 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 65.2 p -98.43 -178.62 4.08 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.471 169.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.472 ' HB ' ' O ' ' A' ' 141' ' ' LEU . 5.8 tt -54.6 -41.85 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.152 171.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.546 ' HA ' ' HD3' ' A' ' 175' ' ' LYS . 14.7 mm-40 -56.91 -41.35 77.99 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.366 1.066 . . . . 0.0 111.613 -176.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -64.05 -40.17 95.7 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.372 0.669 . . . . 0.0 111.018 178.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 46.2 t -68.1 -32.65 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.175 0.59 . . . . 0.0 110.604 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.546 ' HD3' ' HA ' ' A' ' 172' ' ' GLU . 27.3 mtpp -62.08 -42.92 99.7 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.564 0.745 . . . . 0.0 110.684 176.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.497 ' O ' HG23 ' A' ' 180' ' ' VAL . 60.7 m-80 -68.58 -41.27 79.9 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.143 175.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.99 -53.28 60.01 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 124.416 1.073 . . . . 0.0 112.008 -175.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 49.9 mt -63.19 -35.43 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 O-C-N 123.604 0.565 . . . . 0.0 109.756 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.19 -32.09 81.15 Favored Glycine 0 C--N 1.347 1.155 0 CA-C-N 116.159 -0.473 . . . . 0.0 114.082 177.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 176' ' ' ASN . 98.0 t -73.0 -44.66 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.684 HD21 ' HB2' ' A' ' 149' ' ' ALA . 48.9 tp -54.44 -49.76 69.27 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.261 1.025 . . . . 0.0 110.674 176.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.468 HD12 ' CH2' ' A' ' 203' ' ' TRP . 17.8 mt -63.88 -45.66 96.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.929 0.891 . . . . 0.0 110.979 176.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -55.1 -36.87 62.15 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 123.893 0.746 . . . . 0.0 113.811 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.517 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -70.07 -48.75 38.0 Favored Glycine 0 C--N 1.347 1.142 0 N-CA-C 111.793 -0.523 . . . . 0.0 111.793 174.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.507 HD22 HD12 ' A' ' 128' ' ' ILE . 97.7 mt -64.19 -31.97 73.37 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.985 0.914 . . . . 0.0 112.419 -176.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -66.24 -41.99 89.23 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.419 0.688 . . . . 0.0 111.121 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -74.84 -34.65 62.34 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.216 0.607 . . . . 0.0 110.417 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.482 ' ND2' ' HA ' ' A' ' 121' ' ' GLN . 6.0 m-20 -67.28 -15.14 63.52 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.344 0.657 . . . . 0.0 110.297 169.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 21.9 t70 64.49 65.99 0.62 Allowed 'General case' 0 C--N 1.349 0.577 0 C-N-CA 125.799 1.64 . . . . 0.0 110.223 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -121.95 139.69 53.36 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 175.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 74.0 m -78.46 104.81 9.3 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 23.9 m -80.77 130.23 36.24 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.591 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -133.36 123.07 24.74 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 173.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.455 HG22 HD12 ' A' ' 130' ' ' LEU . 4.3 t -101.82 150.05 6.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 -175.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 34.0 t -58.68 143.48 46.54 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.867 0.467 . . . . 0.0 111.146 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -57.01 -32.96 66.67 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.939 0.896 . . . . 0.0 111.25 -178.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 67.8 p -72.02 -48.49 44.24 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.582 175.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 58.3 mt -62.67 -36.45 82.92 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.107 0.563 . . . . 0.0 110.389 -177.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.499 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 42.2 mt-30 -55.51 -33.79 64.05 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.596 1.159 . . . . 0.0 112.426 -177.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -101.25 -39.53 7.58 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -73.97 -38.03 64.3 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -168.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.435 ' O ' ' HG2' ' A' ' 175' ' ' LYS . . . -120.64 -57.7 1.88 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.896 0.478 . . . . 0.0 110.074 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.499 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 69.5 t-105 . . . . . 0 CA--C 1.556 1.188 0 C-N-CA 125.272 1.429 . . . . 0.0 114.057 -168.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 29.8 ttp-105 . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -99.65 109.52 22.0 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.834 0.853 . . . . 0.0 109.945 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.7 mm -78.85 121.68 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 123.783 0.833 . . . . 0.0 109.352 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.1 p -108.38 66.19 0.64 Allowed 'General case' 0 C--O 1.244 0.781 0 CA-C-O 122.672 1.225 . . . . 0.0 108.112 173.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.543 ' HB3' ' O ' ' A' ' 132' ' ' ALA . 19.1 t70 -68.95 -35.54 76.88 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 112.91 -1.95 . . . . 0.0 110.963 -177.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.582 ' HB3' ' HB3' ' A' ' 131' ' ' LYS . 26.2 ptt? -110.93 146.24 36.92 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 171.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.1 m -91.85 158.02 16.55 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.308 0.643 . . . . 0.0 111.069 -167.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.2 mp -58.53 -34.97 52.54 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 C-N-CA 124.122 0.969 . . . . 0.0 110.385 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -48.91 -43.02 38.94 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.358 1.063 . . . . 0.0 113.094 176.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.52 -24.45 15.56 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 122.847 0.459 . . . . 0.0 111.102 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.476 ' HA ' HH21 ' A' ' 148' ' ' ARG . 9.0 tt -67.46 -45.81 74.89 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.616 0.766 . . . . 0.0 110.128 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 26.4 t -96.32 10.93 36.46 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.561 1.144 . . . . 0.0 110.316 -175.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -74.23 136.02 42.72 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.049 0.54 . . . . 0.0 110.517 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -77.42 133.56 38.62 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 174.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 17.9 p-90 -150.76 171.35 17.33 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.661 0.784 . . . . 0.0 110.406 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -148.2 165.33 31.24 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.728 1.211 . . . . 0.0 108.665 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 62.3 mtp -110.37 127.77 55.24 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 36.2 tp -73.39 -40.84 64.01 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.411 0.684 . . . . 0.0 109.642 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.521 ' HG2' ' HB2' ' A' ' 122' ' ' ALA . 23.8 mmt -124.77 88.96 53.11 Favored Pre-proline 0 N--CA 1.482 1.134 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 169.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.18 112.38 2.74 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 122.995 2.464 . . . . 0.0 112.236 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.44 ' HB2' ' NE2' ' A' ' 121' ' ' GLN . 58.7 tptt -115.61 118.39 32.99 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 169.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -100.96 115.37 30.29 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.46 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 16.7 tppt? -120.9 159.84 24.7 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.429 1.092 . . . . 0.0 108.377 175.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.5 t -137.68 140.8 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -122.84 84.7 2.3 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 171.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.5 -116.71 7.2 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.883 175.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -85.25 8.84 4.39 Favored 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 123.227 2.618 . . . . 0.0 112.739 -177.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.8 mt -131.87 121.95 24.89 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.977 0.911 . . . . 0.0 109.021 -171.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.573 ' SG ' HD21 ' A' ' 163' ' ' LEU . 90.0 m -90.51 120.61 31.75 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.964 0.506 . . . . 0.0 111.252 -178.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.46 ' HB ' ' HB3' ' A' ' 110' ' ' LYS . 17.2 mm -86.64 155.3 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.358 0 C-N-CA 124.298 1.039 . . . . 0.0 110.034 -176.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -134.66 121.27 20.61 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.438 HD12 ' HA3' ' A' ' 184' ' ' GLY . 50.5 mm -123.7 122.85 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 123.416 0.686 . . . . 0.0 109.686 -177.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -98.64 115.45 28.7 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 172.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.477 ' HA ' HD21 ' A' ' 188' ' ' ASN . 44.4 mt-30 -84.08 -6.91 59.49 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.02 0.928 . . . . 0.0 113.327 -174.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.521 ' HB2' ' HG2' ' A' ' 106' ' ' MET . . . -87.7 -45.45 10.35 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.963 0.505 . . . . 0.0 110.301 177.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.467 HG12 HG11 ' A' ' 157' ' ' VAL . 1.8 mp -70.67 110.7 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-O 122.038 0.923 . . . . 0.0 110.006 -177.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.585 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 51.3 mtt -131.72 158.43 41.19 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.224 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.5 t70 67.82 13.47 9.2 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.757 1.223 . . . . 0.0 112.739 174.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -97.55 146.82 24.9 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.43 -0.793 . . . . 0.0 110.611 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.563 ' HB2' ' HB3' ' A' ' 152' ' ' GLU . 39.4 m-80 -82.73 97.74 8.72 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 174.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.444 HD12 HD22 ' A' ' 185' ' ' LEU . 53.4 mt -105.82 130.12 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.462 0.705 . . . . 0.0 110.111 -171.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 12.2 tpt -105.12 134.11 48.77 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.163 0.985 . . . . 0.0 110.026 -175.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.425 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 2.2 mm? -100.2 109.15 21.4 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.582 ' HB3' ' HB3' ' A' ' 93' ' ' MET . 40.9 mttm -127.56 152.0 48.18 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.049 0.939 . . . . 0.0 110.682 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.698 ' HB3' HD21 ' A' ' 198' ' ' LEU . . . -146.63 149.42 33.47 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -105.5 132.69 51.36 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 165.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.471 ' HA ' HG13 ' A' ' 145' ' ' ILE . 39.6 p90 -158.79 159.27 34.95 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.761 0.824 . . . . 0.0 109.979 -171.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.8 p -86.57 160.69 18.86 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.391 0.676 . . . . 0.0 109.695 173.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 77.7 t -128.0 135.79 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.36 1.064 . . . . 0.0 109.135 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' A' ' 137' ' ' ILE . 8.2 tp -142.08 139.46 30.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 170.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 57.25 33.8 23.84 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.776 0.83 . . . . 0.0 111.72 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 36.0 t70 67.35 8.82 6.54 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.892 1.277 . . . . 0.0 112.636 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 44.5 ptt85 -116.57 165.25 13.46 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.647 0.779 . . . . 0.0 110.033 176.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.404 ' HB3' HG13 ' A' ' 171' ' ' ILE . 8.5 tt -64.26 108.63 1.64 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.507 0.723 . . . . 0.0 109.204 175.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -68.18 -68.73 0.37 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.341 0.656 . . . . 0.0 110.334 177.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.6 m -143.68 130.56 20.44 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.418 -175.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.7 tp -73.16 124.88 26.46 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 175.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.471 HG13 ' HA ' ' A' ' 134' ' ' PHE . 70.1 mt -84.54 -49.86 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 176.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 48.2 tp -164.8 147.53 8.48 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.75 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.774 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 6.7 tt -134.06 153.52 51.75 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 176.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.494 ' N ' HD23 ' A' ' 147' ' ' LEU . 45.1 ttm-85 -143.23 147.25 34.54 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.546 0.738 . . . . 0.0 111.284 -173.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.595 ' HB2' HD21 ' A' ' 181' ' ' LEU . . . -120.69 111.3 17.44 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.791 1.237 . . . . 0.0 107.856 169.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 40.5 p90 -127.67 157.27 40.74 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.166 0.986 . . . . 0.0 108.756 -178.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 63.0 p -86.02 176.65 7.91 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.39 0.614 . . . . 0.0 111.122 -174.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 127' ' ' ASN . 11.0 pt-20 -54.38 -35.78 63.19 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.912 1.285 . . . . 0.0 112.144 174.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.418 ' HG2' ' H ' ' A' ' 153' ' ' GLU . 8.5 pt-20 -88.32 -9.22 53.52 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.115 0.966 . . . . 0.0 111.618 -177.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 100.63 -3.36 56.17 Favored Glycine 0 C--N 1.352 1.43 0 CA-C-O 120.016 -0.324 . . . . 0.0 113.471 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.82 104.9 2.59 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.437 HD13 ' HD3' ' A' ' 148' ' ' ARG . 26.3 mt -69.87 124.28 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.178 0.591 . . . . 0.0 109.53 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.467 HG11 HG12 ' A' ' 123' ' ' ILE . 35.0 m -126.41 -3.68 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.737 0.815 . . . . 0.0 111.382 -174.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -155.31 164.96 32.19 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.651 -175.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -167.43 153.86 8.05 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.245 0.618 . . . . 0.0 109.528 -176.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.774 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 78.6 mt -125.75 102.99 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 165.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 84.0 p -99.0 110.42 57.66 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 123.61 0.764 . . . . 0.0 110.014 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.06 123.95 14.59 Favored 'Trans proline' 0 C--N 1.367 1.513 0 C-N-CA 122.921 2.414 . . . . 0.0 112.921 174.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.573 HD21 ' SG ' ' A' ' 116' ' ' CYS . 89.5 mt . . . . . 0 CA--C 1.544 0.723 0 C-N-CA 123.789 0.836 . . . . 0.0 110.714 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 44.5 p -84.57 160.58 20.43 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.493 0.663 . . . . 0.0 112.081 -174.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.428 HD11 ' O ' ' A' ' 201' ' ' PHE . 11.4 tt -57.58 -32.1 41.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.648 170.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -72.85 -30.54 64.09 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.539 0.736 . . . . 0.0 111.353 -177.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -60.76 -39.72 89.82 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 122.843 0.457 . . . . 0.0 110.499 173.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 178' ' ' ILE . 38.5 t -64.88 -39.13 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 O-C-N 124.471 1.107 . . . . 0.0 110.2 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -59.26 -48.76 80.43 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.525 0.73 . . . . 0.0 111.459 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.465 ' O ' HG23 ' A' ' 180' ' ' VAL . 65.0 m-80 -65.71 -38.86 90.37 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.935 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.4 -43.4 97.65 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 124.137 0.898 . . . . 0.0 111.451 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 174' ' ' VAL . 60.5 mt -67.52 -34.1 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.9 -33.38 87.09 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 116.625 -0.262 . . . . 0.0 113.596 176.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 176' ' ' ASN . 97.8 t -78.71 -43.25 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.48 0.712 . . . . 0.0 110.353 177.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.595 HD21 ' HB2' ' A' ' 149' ' ' ALA . 38.6 tp -57.34 -54.79 42.81 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.819 0.848 . . . . 0.0 111.035 176.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.614 HG23 HG21 ' A' ' 192' ' ' VAL . 61.8 mt -58.06 -40.12 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 123.821 0.848 . . . . 0.0 110.225 170.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.4 -21.82 54.88 Favored Glycine 0 N--CA 1.475 1.28 0 N-CA-C 115.151 0.82 . . . . 0.0 115.151 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.438 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -95.74 -16.11 40.45 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 117.004 0.402 . . . . 0.0 112.751 173.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.444 HD22 HD12 ' A' ' 128' ' ' ILE . 81.9 mt -91.76 -32.66 15.31 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.408 1.083 . . . . 0.0 111.825 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 182' ' ' ILE . 0.4 OUTLIER -77.84 -31.8 51.76 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.136 0.574 . . . . 0.0 111.132 -173.439 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 8.7 ptm85 -70.23 -24.77 63.15 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.669 0.787 . . . . 0.0 110.942 173.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.585 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 4.2 m-20 -81.48 -10.88 59.39 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.79 0.836 . . . . 0.0 110.293 172.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 19.5 t70 57.63 65.79 1.26 Allowed 'General case' 0 C--N 1.358 0.975 0 C-N-CA 125.414 1.486 . . . . 0.0 110.2 -171.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -107.57 145.71 32.85 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.635 169.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.1 m -83.47 100.31 10.66 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.614 HG21 HG23 ' A' ' 182' ' ' ILE . 18.7 m -99.27 134.63 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 123.645 0.778 . . . . 0.0 110.571 -171.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -135.66 129.82 33.35 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.425 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 2.9 t -90.01 143.03 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 23.2 t -69.11 156.58 38.44 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -172.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -50.23 -49.5 52.73 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.312 1.045 . . . . 0.0 111.812 -176.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 38.1 p -61.18 -50.84 71.52 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 123.967 0.792 . . . . 0.0 110.19 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.698 HD21 ' HB3' ' A' ' 132' ' ' ALA . 62.9 mt -60.07 -36.47 77.43 Favored 'General case' 0 C--O 1.215 -0.735 0 O-C-N 123.882 0.739 . . . . 0.0 111.752 -176.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.495 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 48.3 mt-30 -66.0 -51.7 55.99 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.472 0.709 . . . . 0.0 110.776 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.26 -24.79 51.08 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -175.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.428 ' O ' HD11 ' A' ' 171' ' ' ILE . 25.3 m-85 -82.04 -57.37 3.43 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.819 0.448 . . . . 0.0 110.698 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -116.82 -57.77 2.14 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.24 0.616 . . . . 0.0 110.408 -166.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.495 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 51.4 t-105 . . . . . 0 CA--C 1.546 0.826 0 C-N-CA 124.857 1.263 . . . . 0.0 111.103 -168.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 . . . . . 0 N--CA 1.476 0.832 0 CA-C-O 120.897 0.379 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -97.54 111.74 23.89 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 168.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.6 mm -77.42 140.43 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.749 0.82 . . . . 0.0 109.76 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.6 p -141.34 61.12 1.49 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.183 0.993 . . . . 0.0 109.326 -173.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.9 -15.01 60.27 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.493 172.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 69.2 mtm -110.66 133.71 53.09 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 165.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 74.8 p -71.6 159.65 34.05 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 167.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.72 -34.76 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 123.195 0.598 . . . . 0.0 110.249 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -56.6 -61.51 2.37 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.375 1.07 . . . . 0.0 112.053 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -73.51 -26.5 60.91 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -176.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.402 ' HG ' HD23 ' A' ' 146' ' ' LEU . 7.8 tt -63.18 -51.98 64.2 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.62 0.768 . . . . 0.0 109.785 176.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.9 t -91.94 2.28 56.64 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.583 -174.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -69.71 132.46 46.16 Favored 'General case' 0 C--N 1.356 0.858 0 C-N-CA 122.717 0.407 . . . . 0.0 111.262 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -89.15 148.77 23.48 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.665 0.786 . . . . 0.0 109.729 176.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . 0.464 ' HE1' ' NH1' ' A' ' 148' ' ' ARG . 12.2 p-90 -151.93 164.45 37.12 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 124.337 1.055 . . . . 0.0 110.373 -171.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -115.19 158.17 22.63 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.526 1.13 . . . . 0.0 110.135 -176.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.484 ' SD ' ' HD2' ' A' ' 118' ' ' ARG . 70.2 mtp -122.02 145.53 48.05 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.386 0.674 . . . . 0.0 110.454 178.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.7 tp -91.97 -42.49 9.97 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.856 0.862 . . . . 0.0 109.926 177.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 24.9 mmt -126.49 85.69 59.79 Favored Pre-proline 0 N--CA 1.482 1.159 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 173.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -70.47 113.27 3.44 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 123.125 2.55 . . . . 0.0 111.676 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.487 ' HD3' ' NE2' ' A' ' 121' ' ' GLN . 55.9 tptt -98.23 118.49 34.99 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 172.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -82.76 105.68 13.98 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 170.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -125.98 145.49 50.27 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.907 0.883 . . . . 0.0 108.91 174.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.0 t -136.77 139.53 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 173.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -126.82 86.08 2.46 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 174.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.38 -121.52 8.22 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.48 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -89.54 15.96 1.86 Allowed 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 123.339 2.693 . . . . 0.0 113.225 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.667 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 5.4 mp -129.11 137.4 51.2 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.658 0.783 . . . . 0.0 108.976 176.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 53.5 t -92.03 130.46 37.77 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 173.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.1 mm -100.76 155.9 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.962 0.905 . . . . 0.0 108.802 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.484 ' HD2' ' SD ' ' A' ' 104' ' ' MET . 20.2 tpp180 -138.61 120.54 15.48 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.463 HD11 ' HA ' ' A' ' 181' ' ' LEU . 38.8 mm -123.56 134.84 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.555 1.142 . . . . 0.0 108.703 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -101.65 115.19 29.97 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 169.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.487 ' NE2' ' HD3' ' A' ' 108' ' ' LYS . 85.5 mt-30 -78.73 -2.07 37.61 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.557 0.743 . . . . 0.0 112.912 -172.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.59 -32.75 10.94 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.359 0.664 . . . . 0.0 110.395 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 31.2 mm -71.23 110.88 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 121.468 0.651 . . . . 0.0 110.739 -176.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.486 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 57.9 mtt -136.34 161.91 34.48 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.218 -173.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 62.62 19.66 11.47 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.739 1.215 . . . . 0.0 113.351 171.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -102.3 149.94 23.83 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.336 0.654 . . . . 0.0 110.016 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -87.23 102.87 14.9 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 167.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 57.3 mt -104.2 142.31 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 123.607 0.763 . . . . 0.0 109.038 -172.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 11.4 tpt -126.65 125.13 41.36 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.274 1.029 . . . . 0.0 108.636 -173.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 14.6 mt -90.46 102.73 15.47 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -176.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.481 ' HD3' ' CD1' ' A' ' 150' ' ' PHE . 25.0 mtpp -113.71 129.84 56.51 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.528 1.131 . . . . 0.0 108.771 -171.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.491 ' HB2' ' HG ' ' A' ' 147' ' ' LEU . . . -134.67 154.98 51.29 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.797 0.808 . . . . 0.0 113.017 -172.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -116.48 134.9 54.32 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 114.061 -1.427 . . . . 0.0 107.774 165.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.507 ' HA ' HG13 ' A' ' 145' ' ' ILE . 37.6 p90 -162.96 165.05 25.46 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.508 0.505 . . . . 0.0 111.581 -176.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 44.7 p -85.98 148.76 25.6 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.462 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 90.1 t -126.44 151.81 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.252 1.021 . . . . 0.0 109.148 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.3 tp -158.4 144.87 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 170.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 57.41 26.52 12.64 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 176.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 67.83 15.03 9.57 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 124.758 1.223 . . . . 0.0 112.701 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -120.82 160.7 22.87 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.715 0.806 . . . . 0.0 109.457 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.519 HD13 ' HB2' ' A' ' 202' ' ' ALA . 9.8 tt -66.6 123.27 19.62 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 174.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -78.93 -69.38 0.57 Allowed 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 176.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 99.0 m -145.8 129.5 17.13 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.368 0.667 . . . . 0.0 109.418 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.567 HD22 HG13 ' A' ' 174' ' ' VAL . 53.3 tp -71.52 115.83 11.15 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 123.894 0.746 . . . . 0.0 109.966 176.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.507 HG13 ' HA ' ' A' ' 134' ' ' PHE . 73.5 mt -74.29 -53.83 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.402 HD23 ' HG ' ' A' ' 98' ' ' LEU . 57.7 tp -160.18 149.74 17.81 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.134 177.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.633 HD13 HD12 ' A' ' 160' ' ' ILE . 7.1 tt -134.51 148.78 50.6 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 174.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.464 ' NH1' ' HE1' ' A' ' 102' ' ' TRP . 43.5 mtt-85 -141.95 159.48 42.14 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.994 0.918 . . . . 0.0 110.329 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -115.77 112.15 21.59 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.121 0.968 . . . . 0.0 109.166 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.481 ' CD1' ' HD3' ' A' ' 131' ' ' LYS . 56.9 m-85 -107.99 136.01 48.4 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.232 1.013 . . . . 0.0 109.93 -177.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 66.9 p -81.43 -172.93 4.08 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.955 0.502 . . . . 0.0 110.648 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -53.76 -37.56 63.53 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.446 0.698 . . . . 0.0 111.882 170.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -80.5 -5.5 56.76 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.121 0.968 . . . . 0.0 111.91 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 75.46 23.05 74.39 Favored Glycine 0 C--N 1.347 1.19 0 N-CA-C 112.102 -0.399 . . . . 0.0 112.102 -174.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -82.69 121.25 26.61 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.417 HD13 ' HD3' ' A' ' 148' ' ' ARG . 12.2 mt -75.6 110.3 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.6 m -120.41 1.86 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.337 1.055 . . . . 0.0 111.047 -175.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -157.23 166.59 33.69 Favored Glycine 0 C--O 1.242 0.634 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -165.26 150.17 9.09 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -174.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.633 HD12 HD13 ' A' ' 147' ' ' LEU . 63.9 mt -128.43 102.69 8.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 164.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 48.1 t -112.06 113.35 52.07 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.667 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 19.0 Cg_endo -57.79 136.21 73.95 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.291 1.994 . . . . 0.0 111.787 178.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 83.2 mt . . . . . 0 CA--C 1.552 1.036 0 C-N-CA 123.968 0.907 . . . . 0.0 112.402 -171.741 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 . . . . . 0 C--O 1.245 0.839 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 34.5 p -83.94 156.26 22.43 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.479 HD11 ' O ' ' A' ' 201' ' ' PHE . 7.2 tt -58.37 -31.89 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 124.178 0.991 . . . . 0.0 110.593 171.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -67.15 -38.08 84.9 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.474 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -62.71 -33.93 76.12 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.834 0.454 . . . . 0.0 110.833 176.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.567 HG13 HD22 ' A' ' 144' ' ' LEU . 60.9 t -66.56 -52.53 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 124.009 0.818 . . . . 0.0 111.618 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -63.04 -33.98 76.6 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 122.225 0.21 . . . . 0.0 111.456 -176.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.401 ' O ' HG23 ' A' ' 180' ' ' VAL . 17.3 m120 -69.82 -40.36 75.95 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.161 0.584 . . . . 0.0 110.185 174.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -59.91 -40.44 88.82 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 124.084 0.865 . . . . 0.0 110.805 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 174' ' ' VAL . 67.5 mt -68.2 -38.86 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.352 0.661 . . . . 0.0 109.671 177.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.36 -35.29 91.44 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 116.003 -0.544 . . . . 0.0 113.612 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 176' ' ' ASN . 76.2 t -76.09 -38.67 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.112 0.565 . . . . 0.0 110.194 177.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.463 ' HA ' HD11 ' A' ' 119' ' ' ILE . 30.1 tp -57.01 -48.09 79.31 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.354 0.661 . . . . 0.0 110.276 173.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.414 ' O ' ' HG2' ' A' ' 186' ' ' GLU . 47.6 mt -60.82 -48.9 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.82 0.848 . . . . 0.0 110.492 176.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -55.93 -44.61 87.64 Favored Glycine 0 C--N 1.347 1.154 0 O-C-N 123.796 0.685 . . . . 0.0 113.438 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -66.79 -28.57 73.83 Favored Glycine 0 C--N 1.35 1.343 0 O-C-N 123.959 0.446 . . . . 0.0 113.676 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 33.9 mt -83.21 -33.27 26.16 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.296 1.038 . . . . 0.0 111.711 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 52.3 mm-40 -68.62 -39.3 80.88 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.541 0.737 . . . . 0.0 110.873 -177.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -73.8 -16.47 61.15 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.894 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.486 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 8.1 m-20 -77.09 -15.44 59.57 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.386 0.674 . . . . 0.0 111.743 169.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 66.72 64.31 0.48 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.408 1.083 . . . . 0.0 110.138 -172.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -137.06 154.6 50.3 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.755 167.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 20.7 m -98.95 105.98 18.18 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.744 0.818 . . . . 0.0 109.483 -169.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 13.7 m -97.93 150.3 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-O 121.714 0.769 . . . . 0.0 112.095 -178.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 19.6 tpp85 -133.37 139.1 46.61 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.9 t -98.69 146.77 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -178.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 27.9 t -55.08 145.54 20.53 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.286 0.634 . . . . 0.0 111.943 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -51.86 -37.8 53.52 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.005 0.922 . . . . 0.0 111.284 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 53.3 p -73.2 -51.86 16.22 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.726 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 62.2 mt -57.02 -39.02 73.98 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.09 0.556 . . . . 0.0 111.241 -177.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.452 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 46.7 mt-30 -58.81 -39.4 81.06 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.958 0.903 . . . . 0.0 112.246 -176.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.01 -32.54 10.9 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -176.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.479 ' O ' HD11 ' A' ' 171' ' ' ILE . 35.0 m-85 -74.97 -52.29 11.52 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 117.951 0.341 . . . . 0.0 111.25 -175.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.519 ' HB2' HD13 ' A' ' 141' ' ' LEU . . . -109.63 -50.62 2.96 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.056 0.542 . . . . 0.0 111.346 -172.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.452 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 70.7 t-105 . . . . . 0 N--CA 1.477 0.924 0 C-N-CA 124.369 1.068 . . . . 0.0 111.156 -170.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -98.78 110.49 23.09 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 168.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.8 mm -77.47 118.7 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.608 0.763 . . . . 0.0 109.025 173.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 38.5 p -102.47 68.02 1.04 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.538 ' HB3' ' O ' ' A' ' 132' ' ' ALA . 32.4 t70 -72.77 -25.17 61.08 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 114.439 -1.255 . . . . 0.0 111.059 -175.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 60.7 mtm -92.92 136.98 32.77 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 162.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 77.0 p -67.37 163.82 19.92 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 167.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 29.8 mm -57.04 -36.06 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 173.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -58.94 -42.07 88.9 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.313 175.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -77.43 -35.94 53.58 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 122.873 0.469 . . . . 0.0 111.549 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.429 HD12 ' ND2' ' A' ' 133' ' ' ASN . 6.7 tt -64.03 -40.23 95.85 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.974 1.31 . . . . 0.0 109.826 -177.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.0 t -113.34 22.05 14.61 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.348 1.059 . . . . 0.0 109.91 -176.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -66.33 137.5 56.96 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.481 0.712 . . . . 0.0 111.14 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -79.03 136.14 37.1 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 175.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . 0.433 ' CG ' ' HB ' ' A' ' 156' ' ' ILE . 38.3 p-90 -156.06 164.86 37.9 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.932 0.893 . . . . 0.0 110.33 176.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -136.93 149.58 47.67 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.763 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.43 ' HG3' ' HG3' ' A' ' 107' ' ' PRO . 13.2 ptm -129.78 129.66 44.37 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 173.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.546 ' H ' HD23 ' A' ' 105' ' ' LEU . 0.9 OUTLIER -94.75 -19.41 20.39 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.297 0.639 . . . . 0.0 110.857 -173.169 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 94.1 mmm -127.37 72.44 77.33 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.187 0.995 . . . . 0.0 109.375 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.43 ' HG3' ' HG3' ' A' ' 104' ' ' MET . 12.3 Cg_exo -71.03 110.39 2.8 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 122.63 2.22 . . . . 0.0 111.741 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.491 ' HB3' ' HB ' ' A' ' 119' ' ' ILE . 57.7 tptt -82.83 117.07 22.44 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 173.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 20.6 tm0? -77.3 102.24 6.65 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.486 ' HA ' ' HE3' ' A' ' 110' ' ' LYS . 0.1 OUTLIER -137.09 130.63 31.55 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.383 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 91.0 t -134.43 138.01 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 173.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -123.61 102.96 8.14 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.154 0.582 . . . . 0.0 109.44 175.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.17 -125.18 26.71 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.007 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -86.31 13.79 2.63 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 123.397 2.732 . . . . 0.0 113.289 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.493 HD23 ' HA ' ' A' ' 162' ' ' PRO . 86.7 mt -130.97 130.85 43.93 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.567 0.747 . . . . 0.0 110.381 -175.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 53.3 t -83.83 137.27 33.78 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.502 0.721 . . . . 0.0 110.266 173.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.3 mm -106.08 151.93 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 C-N-CA 123.924 0.89 . . . . 0.0 108.763 175.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -130.79 124.29 31.04 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 173.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.616 HD13 ' HA3' ' A' ' 184' ' ' GLY . 55.3 mt -132.3 122.69 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.513 ' HB3' ' HB ' ' A' ' 157' ' ' VAL . 23.7 t70 -93.85 121.42 35.28 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.454 ' HA ' ' ND2' ' A' ' 188' ' ' ASN . 81.9 mt-30 -84.29 -7.83 59.21 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -174.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.83 -47.45 11.09 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 118.287 0.494 . . . . 0.0 110.4 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.523 HG23 ' HG3' ' A' ' 126' ' ' LYS . 1.7 mp -71.74 102.47 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-O 122.32 1.057 . . . . 0.0 109.499 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 38.6 mtt -124.55 170.14 11.2 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-N 113.613 -1.63 . . . . 0.0 109.773 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 70.47 11.67 7.38 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 124.762 1.225 . . . . 0.0 112.573 173.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.523 ' HG3' HG23 ' A' ' 123' ' ' ILE . 74.7 mmtt -100.64 156.67 17.18 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.708 0.803 . . . . 0.0 112.227 -171.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.437 ' HB2' ' HG2' ' A' ' 152' ' ' GLU . 90.4 m-20 -89.77 108.91 19.97 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 166.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.562 ' HB ' HG12 ' A' ' 192' ' ' VAL . 64.4 mt -112.55 137.33 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.261 0.624 . . . . 0.0 110.355 -176.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.508 ' HG3' ' HG2' ' A' ' 131' ' ' LYS . 37.2 tpp -113.84 132.81 55.75 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.912 1.285 . . . . 0.0 109.774 -175.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.524 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 2.4 mm? -93.18 102.49 14.79 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.583 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 9.1 mmpt? -105.53 143.2 34.03 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 175.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.538 ' O ' ' HB3' ' A' ' 92' ' ' ASP . . . -145.58 136.58 24.65 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.429 ' ND2' HD12 ' A' ' 98' ' ' LEU . 4.9 m-20 -89.62 118.68 29.42 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 163.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -148.58 157.5 43.5 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.094 0.558 . . . . 0.0 110.728 -174.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.5 t -86.43 160.19 19.11 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.756 174.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.6 t -134.41 143.92 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.371 1.068 . . . . 0.0 109.071 -176.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.4 tp -150.26 140.9 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 168.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 58.02 31.75 21.07 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 175.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 64.34 24.02 13.16 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.448 1.099 . . . . 0.0 112.589 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.482 ' HB2' HD12 ' A' ' 171' ' ' ILE . 2.9 ptp180 -133.09 165.53 24.55 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 173.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.59 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 10.3 tt -65.84 126.23 27.83 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 176.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -81.7 -74.05 0.35 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.3 m -139.17 125.68 20.49 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -175.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.4 HD22 HG13 ' A' ' 174' ' ' VAL . 60.0 tp -70.49 132.98 46.37 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.411 0.685 . . . . 0.0 110.167 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.5 mp -89.15 -52.38 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 173.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 40.4 tp -164.6 142.42 6.62 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.655 0.782 . . . . 0.0 109.142 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.591 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 9.3 tt -130.72 139.58 50.3 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 176.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 61.3 mtp85 -141.69 132.8 26.22 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.382 1.073 . . . . 0.0 109.117 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -116.71 126.69 53.54 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.881 1.272 . . . . 0.0 108.829 -173.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.583 ' CZ ' ' HG3' ' A' ' 131' ' ' LYS . 3.7 p90 -143.75 166.81 23.85 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.28 0.562 . . . . 0.0 111.852 -173.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 68.0 p -82.29 175.35 10.34 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.373 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.437 ' HG2' ' HB2' ' A' ' 127' ' ' ASN . 35.9 mm-40 -57.42 -29.51 64.2 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 121.198 0.523 . . . . 0.0 111.125 171.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -74.04 -16.86 61.03 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.155 0.982 . . . . 0.0 111.052 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 92.01 5.41 66.08 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 116.327 -0.397 . . . . 0.0 112.521 -177.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.63 102.72 6.26 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -178.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.542 HG12 ' HB3' ' A' ' 150' ' ' PHE . 16.8 mt -72.19 122.54 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -177.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.513 ' HB ' ' HB3' ' A' ' 120' ' ' ASP . 27.4 m -130.08 6.09 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.228 1.011 . . . . 0.0 110.592 -175.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -150.81 156.95 26.95 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -165.75 145.55 6.48 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.854 0.462 . . . . 0.0 110.078 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 63.7 mt -124.92 106.32 16.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 168.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 88.0 p -115.59 134.97 22.57 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.493 ' HA ' HD23 ' A' ' 115' ' ' LEU . 52.3 Cg_exo -53.85 140.99 67.45 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 122.743 2.295 . . . . 0.0 111.873 172.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 80.0 mt . . . . . 0 CA--C 1.547 0.859 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.765 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 . . . . . 0 N--CA 1.476 0.83 0 CA-C-O 120.747 0.308 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 22.7 m -96.66 158.34 15.48 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 123.898 0.879 . . . . 0.0 109.395 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.59 ' HB ' ' O ' ' A' ' 141' ' ' LEU . 4.7 tt -48.52 -38.61 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 125.378 1.471 . . . . 0.0 112.836 174.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -62.21 -40.36 95.86 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.846 0.858 . . . . 0.0 111.517 -175.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -62.85 -41.1 99.23 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.984 0.914 . . . . 0.0 110.005 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 178' ' ' ILE . 44.3 t -63.24 -54.46 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 O-C-N 124.398 1.061 . . . . 0.0 111.603 -177.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -61.3 -35.09 76.38 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 124.05 0.844 . . . . 0.0 110.991 -175.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.44 ' O ' HG23 ' A' ' 180' ' ' VAL . 76.9 m-20 -69.69 -41.88 74.83 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.9 -36.28 82.8 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.163 0.914 . . . . 0.0 111.036 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 174' ' ' VAL . 66.6 mt -65.68 -39.18 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 175.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -71.06 -24.64 76.89 Favored Glycine 0 C--N 1.341 0.852 0 O-C-N 123.668 0.605 . . . . 0.0 113.551 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 176' ' ' ASN . 71.1 t -76.04 -43.15 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.441 0.697 . . . . 0.0 109.711 175.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 19.9 tp -60.92 -46.59 90.07 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.43 0.692 . . . . 0.0 110.473 173.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.457 ' O ' ' HG2' ' A' ' 186' ' ' GLU . 57.5 mt -60.56 -50.07 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 123.967 0.907 . . . . 0.0 110.254 175.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -60.9 -33.15 82.39 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 123.447 0.467 . . . . 0.0 113.639 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.616 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -67.79 -43.81 82.56 Favored Glycine 0 C--N 1.347 1.19 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 171.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.439 HD22 HD12 ' A' ' 128' ' ' ILE . 53.4 mt -68.7 -23.9 64.43 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.521 1.129 . . . . 0.0 111.705 177.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 52.4 mm-40 -74.73 -41.9 59.28 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.947 0.499 . . . . 0.0 109.947 178.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -64.23 -41.72 96.88 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.128 171.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.454 ' ND2' ' HA ' ' A' ' 121' ' ' GLN . 6.2 m-20 -68.05 -10.66 55.51 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.552 0.741 . . . . 0.0 111.39 173.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 16.6 t70 63.52 64.49 0.8 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.475 1.11 . . . . 0.0 110.031 174.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -126.22 134.17 51.3 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.8 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 127' ' ' ASN . 59.2 m -80.92 99.25 8.27 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.562 HG12 ' HB ' ' A' ' 128' ' ' ILE . 24.5 m -104.87 148.38 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.668 0.747 . . . . 0.0 111.553 -172.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 44.0 ttt180 -137.76 135.48 36.39 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 114.25 -1.341 . . . . 0.0 107.937 173.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.524 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 4.1 t -87.33 155.27 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -178.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.543 ' HB3' ' HE2' ' A' ' 131' ' ' LYS . 88.6 p -62.45 149.15 43.46 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.446 0.566 . . . . 0.0 111.083 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -55.35 -34.68 64.47 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.188 0.995 . . . . 0.0 110.448 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 52.1 p -64.08 -58.65 6.03 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.436 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.434 ' HB2' HG12 ' A' ' 194' ' ' VAL . 69.7 mt -62.72 -37.45 86.58 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.148 0.579 . . . . 0.0 110.912 -174.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -55.79 -37.54 68.75 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.712 0.805 . . . . 0.0 112.085 -176.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -102.22 -25.33 13.73 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -82.73 -54.32 5.22 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 118.403 0.547 . . . . 0.0 111.519 -176.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.433 ' HB2' HD13 ' A' ' 141' ' ' LEU . . . -102.56 -56.72 2.19 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.811 0.844 . . . . 0.0 110.694 -171.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 44.3 t-105 . . . . . 0 N--CA 1.476 0.842 0 C-N-CA 125.383 1.473 . . . . 0.0 109.601 -177.303 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.519 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 8.1 ttm180 . . . . . 0 N--CA 1.473 0.698 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -121.74 101.42 7.57 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 172.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.9 mm -81.76 132.89 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 123.617 0.767 . . . . 0.0 109.787 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 34.2 p -121.96 83.55 2.11 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 171.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -70.19 -31.37 68.8 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.174 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -111.07 141.92 43.92 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 174.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 81.6 p -65.4 152.97 42.6 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.091 0.472 . . . . 0.0 110.569 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.52 -29.34 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.951 173.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -65.97 -49.61 67.25 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.644 1.177 . . . . 0.0 111.946 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.517 ' HA ' ' HB2' ' A' ' 100' ' ' ARG . 12.5 pt-20 -75.58 -22.32 57.07 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 120.801 0.334 . . . . 0.0 110.334 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.502 ' HG ' HD23 ' A' ' 146' ' ' LEU . 9.2 tt -69.15 -33.73 73.9 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.885 0.874 . . . . 0.0 109.542 170.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.3 t -103.12 13.75 33.4 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.7 0.8 . . . . 0.0 110.983 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.517 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 71.2 ttt180 -65.39 150.16 48.79 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.661 0.784 . . . . 0.0 111.723 -174.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -80.45 125.41 29.9 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 170.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -154.14 173.21 16.38 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.66 0.784 . . . . 0.0 110.488 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -138.78 146.74 41.73 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.158 0.583 . . . . 0.0 110.714 175.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.538 ' SD ' ' HB3' ' A' ' 107' ' ' PRO . 14.3 ptp -99.76 108.43 20.75 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 167.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 48.0 tp -71.58 -38.16 70.94 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.032 0.533 . . . . 0.0 110.552 -175.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 24.9 mmt -121.12 84.81 40.42 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 123.779 0.832 . . . . 0.0 109.088 173.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.538 ' HB3' ' SD ' ' A' ' 104' ' ' MET . 56.5 Cg_endo -67.81 117.86 5.19 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.144 2.563 . . . . 0.0 113.088 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.484 ' HD2' HE21 ' A' ' 121' ' ' GLN . 61.6 tttp -118.66 131.98 56.17 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 167.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -122.84 120.84 34.71 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 176.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.79 106.6 9.8 Favored 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 124.676 1.19 . . . . 0.0 107.997 176.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.443 HG13 HD11 ' A' ' 163' ' ' LEU . 79.3 t -75.35 128.54 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -122.57 85.24 2.38 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 124.864 1.266 . . . . 0.0 108.363 -176.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 68.01 -113.13 5.2 Favored Glycine 0 CA--C 1.539 1.531 0 CA-C-N 114.966 -1.016 . . . . 0.0 113.239 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -89.97 9.21 3.39 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 123.624 2.883 . . . . 0.0 113.227 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.1 mt -129.95 158.27 40.02 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -175.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 23.7 p -125.51 119.04 27.11 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 176.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.0 mm -86.72 140.94 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.378 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -122.36 129.97 52.65 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 170.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.605 HD13 ' HA3' ' A' ' 184' ' ' GLY . 60.4 mt -128.08 122.86 59.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -178.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -94.28 114.72 26.85 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 174.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.484 HE21 ' HD2' ' A' ' 108' ' ' LYS . 76.2 mt-30 -82.72 -10.49 58.88 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.097 0.959 . . . . 0.0 111.51 -175.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.71 -41.57 53.25 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.019 0.527 . . . . 0.0 111.881 -174.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.85 113.14 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.866 0.841 . . . . 0.0 109.834 -176.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 44.8 mtt -131.2 166.16 21.75 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.321 -1.309 . . . . 0.0 109.501 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.5 t70 57.69 32.72 22.29 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.828 0.851 . . . . 0.0 111.313 177.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -120.71 153.94 36.27 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.878 0.871 . . . . 0.0 110.507 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -90.78 106.97 18.88 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 173.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.617 HG12 HG22 ' A' ' 151' ' ' THR . 48.2 mt -108.14 130.77 60.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 123.478 0.711 . . . . 0.0 110.315 -173.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 52.1 tpp -110.0 126.47 53.98 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.28 1.032 . . . . 0.0 108.752 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 25.1 mt -87.77 103.0 15.22 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -110.55 132.39 54.23 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.313 1.045 . . . . 0.0 109.988 -172.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.563 ' HB2' ' HG ' ' A' ' 147' ' ' LEU . . . -136.99 154.93 50.29 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -175.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -112.84 128.44 56.45 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 167.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.456 ' HA ' HD13 ' A' ' 145' ' ' ILE . 33.0 p90 -157.37 163.57 38.46 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.351 0.596 . . . . 0.0 112.393 -170.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 46.6 t -85.14 156.99 20.79 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.425 -1.261 . . . . 0.0 109.417 173.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.519 ' HB ' ' HB3' ' A' ' 88' ' ' ARG . 79.1 t -140.27 142.96 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.378 1.071 . . . . 0.0 109.935 -174.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.428 ' O ' ' HG2' ' A' ' 140' ' ' ARG . 11.3 tp -150.3 145.6 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 168.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 60.62 22.8 12.61 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 123.632 0.773 . . . . 0.0 112.119 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 58.77 39.61 23.98 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.316 1.046 . . . . 0.0 111.658 -172.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 137' ' ' ILE . 5.8 ptp180 -144.85 163.35 34.35 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.509 0.724 . . . . 0.0 109.694 172.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.477 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 10.5 tt -63.85 117.25 6.68 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.952 0.501 . . . . 0.0 110.08 -176.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -79.8 -60.63 2.27 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.839 0.856 . . . . 0.0 109.121 175.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 80.5 m -147.75 132.13 17.59 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.632 0.773 . . . . 0.0 109.366 177.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.434 HD21 ' HB2' ' A' ' 147' ' ' LEU . 51.3 tp -76.7 131.59 38.87 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.557 0.743 . . . . 0.0 110.156 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.456 HD13 ' HA ' ' A' ' 134' ' ' PHE . 1.9 mp -87.15 -46.88 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 173.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.502 HD23 ' HG ' ' A' ' 98' ' ' LEU . 57.7 tp -167.94 149.08 5.22 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.573 0.749 . . . . 0.0 109.585 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.652 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 6.6 tt -134.19 140.08 46.27 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 177.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 58.7 mtp85 -145.48 147.63 32.38 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.32 1.048 . . . . 0.0 108.991 -175.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.01 109.2 21.1 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.009 0.923 . . . . 0.0 109.269 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -106.29 124.15 49.15 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.424 0.69 . . . . 0.0 110.187 -175.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.617 HG22 HG12 ' A' ' 128' ' ' ILE . 33.7 p -73.0 -174.45 1.51 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.372 0.669 . . . . 0.0 110.955 169.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.95 -25.51 63.68 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 122.257 -0.277 . . . . 0.0 111.243 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -83.85 -8.1 59.29 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.748 0.819 . . . . 0.0 110.381 173.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 78.99 23.02 64.63 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 116.331 -0.395 . . . . 0.0 113.391 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.26 127.62 32.57 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.7 mp -81.8 101.39 6.58 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.9 m -111.16 24.33 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.305 1.042 . . . . 0.0 109.991 -172.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 176.05 151.28 8.66 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 114.119 -1.401 . . . . 0.0 110.28 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -158.39 130.55 6.89 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.069 0.935 . . . . 0.0 111.047 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.652 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 67.3 mt -107.43 102.99 14.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 173.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 27.7 t -104.17 120.73 49.97 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 123.427 0.691 . . . . 0.0 109.37 -177.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -54.22 123.79 14.43 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.666 2.244 . . . . 0.0 112.492 172.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.443 HD11 HG13 ' A' ' 111' ' ' VAL . 67.2 mt . . . . . 0 CA--C 1.55 0.961 0 C-N-CA 123.268 0.627 . . . . 0.0 111.261 -177.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 34.9 p-80 . . . . . 0 N--CA 1.476 0.871 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 27.3 m -93.03 159.01 15.49 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.363 0.665 . . . . 0.0 109.866 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 141' ' ' LEU . 7.6 tt -50.99 -37.77 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.728 1.211 . . . . 0.0 111.997 173.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -64.24 -35.41 80.72 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.417 1.087 . . . . 0.0 111.445 -175.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -64.38 -38.83 92.4 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.89 0.876 . . . . 0.0 110.488 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.45 ' O ' HG13 ' A' ' 178' ' ' ILE . 43.7 t -67.79 -37.11 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.297 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -62.14 -40.28 95.42 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.034 0.534 . . . . 0.0 110.747 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.424 ' O ' HG23 ' A' ' 180' ' ' VAL . 79.6 m-20 -61.0 -48.04 83.64 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 123.906 0.754 . . . . 0.0 109.568 174.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.55 -48.64 78.62 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 114.066 -1.424 . . . . 0.0 112.681 -173.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 174' ' ' VAL . 69.8 mt -59.66 -41.8 86.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -61.18 -34.37 87.79 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 115.301 -0.863 . . . . 0.0 114.005 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 176' ' ' ASN . 93.1 t -70.77 -44.08 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 122.956 0.502 . . . . 0.0 110.307 177.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 32.3 tp -59.91 -43.81 94.65 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.822 176.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.536 HG23 HG21 ' A' ' 192' ' ' VAL . 86.6 mt -59.83 -51.58 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.575 0.75 . . . . 0.0 110.267 175.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.22 -42.38 97.21 Favored Glycine 0 C--N 1.344 1.006 0 O-C-N 123.804 0.69 . . . . 0.0 113.779 -176.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.605 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -68.9 -24.81 75.62 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 115.502 -0.349 . . . . 0.0 113.116 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.444 HD22 HD12 ' A' ' 128' ' ' ILE . 32.6 mt -86.54 -25.69 24.92 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.878 0.871 . . . . 0.0 111.564 176.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 182' ' ' ILE . 50.2 mt-10 -70.78 -31.26 67.97 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 122.084 -0.385 . . . . 0.0 110.789 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -81.09 -20.66 41.04 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.161 0.585 . . . . 0.0 111.092 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -65.53 -20.82 66.49 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.011 0.525 . . . . 0.0 110.466 165.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 33.6 t70 63.4 67.47 0.65 Allowed 'General case' 0 C--N 1.355 0.833 0 C-N-CA 124.418 1.087 . . . . 0.0 110.195 -178.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -138.01 178.65 6.96 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.125 175.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 85.3 m -102.51 103.52 13.88 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -174.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.536 HG21 HG23 ' A' ' 182' ' ' ILE . 35.5 m -101.47 146.54 9.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 C-N-CA 123.388 0.675 . . . . 0.0 110.897 -178.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -143.84 145.37 32.28 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.522 171.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 4.6 t -89.9 137.6 21.11 Favored 'Isoleucine or valine' 0 C--O 1.245 0.818 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 173.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 78.9 p -56.96 148.29 21.62 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 118.819 0.736 . . . . 0.0 111.045 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -57.06 -27.03 61.34 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.545 0.738 . . . . 0.0 111.808 -177.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 65.1 p -70.49 -54.25 13.02 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 123.387 0.675 . . . . 0.0 109.847 174.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 33.5 mt -63.45 -26.98 68.98 Favored 'General case' 0 C--O 1.208 -1.079 0 CA-C-O 119.004 -0.522 . . . . 0.0 111.577 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -67.76 -49.71 61.03 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.886 0.474 . . . . 0.0 110.856 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -77.27 -36.54 54.23 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.341 0.401 . . . . 0.0 111.62 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -85.41 -54.94 4.26 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 122.257 -0.277 . . . . 0.0 111.152 -171.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -95.08 -60.37 1.7 Allowed 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.185 0.517 . . . . 0.0 111.447 -170.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 43.5 t-105 . . . . . 0 N--CA 1.475 0.814 0 C-N-CA 126.026 1.73 . . . . 0.0 111.039 -169.967 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -115.38 111.11 20.34 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 171.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.4 mm -81.83 130.42 35.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 123.597 0.759 . . . . 0.0 109.382 175.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.7 p -117.51 81.91 1.73 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -76.89 -13.46 59.99 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.582 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.533 ' HB3' ' HG3' ' A' ' 97' ' ' GLU . 63.2 mtm -114.97 143.94 44.37 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.139 1.376 . . . . 0.0 107.321 161.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 69.3 p -72.29 152.21 42.29 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 167.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 57.0 mt -57.41 -27.68 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 122.606 0.362 . . . . 0.0 111.13 178.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -54.67 -62.36 1.71 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.07 0.948 . . . . 0.0 111.801 170.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.533 ' HG3' ' HB3' ' A' ' 93' ' ' MET . 11.0 pt-20 -73.54 -22.07 60.2 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 122.924 0.49 . . . . 0.0 112.152 -177.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.586 ' HG ' HD23 ' A' ' 146' ' ' LEU . 10.0 tt -63.19 -36.44 83.65 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.007 0.923 . . . . 0.0 109.32 171.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.3 m -109.47 16.91 21.94 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.659 0.784 . . . . 0.0 111.601 -177.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.443 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 62.0 ttt180 -75.03 140.01 43.27 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.671 0.788 . . . . 0.0 110.828 -177.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -75.22 136.52 40.97 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.564 0.745 . . . . 0.0 111.248 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 28.0 p-90 -161.14 171.54 18.34 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.654 1.182 . . . . 0.0 109.666 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -141.0 165.08 28.54 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.244 0.618 . . . . 0.0 111.171 -175.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.408 ' SD ' ' HD2' ' A' ' 118' ' ' ARG . 63.6 mtp -118.11 131.08 56.46 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.046 0.939 . . . . 0.0 108.466 172.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.519 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.5 pt? -109.29 -29.21 8.59 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.289 0.636 . . . . 0.0 110.829 -175.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 7.7 mmt -123.24 70.31 42.51 Favored Pre-proline 0 N--CA 1.486 1.375 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 166.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.9 145.09 35.54 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 122.243 1.962 . . . . 0.0 113.014 -170.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.45 ' HB3' ' HB ' ' A' ' 119' ' ' ILE . 25.0 ttmm -134.94 120.31 19.06 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 168.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -96.81 100.04 11.59 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -178.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.552 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 17.7 tppt? -96.66 148.78 22.52 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 174.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 68.6 t -128.03 133.62 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 175.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -137.3 95.32 3.06 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 68.37 -131.25 27.0 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.289 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.402 ' HB2' ' HB3' ' A' ' 169' ' ' HIS . 6.2 Cg_exo -82.19 18.21 1.45 Allowed 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 123.356 2.704 . . . . 0.0 113.421 177.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -134.42 170.66 15.41 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.8 0.84 . . . . 0.0 109.655 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.411 ' HB3' HD21 ' A' ' 163' ' ' LEU . 17.9 p -136.33 143.61 44.22 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.033 0.933 . . . . 0.0 109.341 177.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.552 ' HB ' ' HB3' ' A' ' 110' ' ' LYS . 9.3 mm -111.09 147.35 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 124.371 1.069 . . . . 0.0 109.681 -173.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.542 ' HG3' ' HB3' ' A' ' 159' ' ' GLU . 36.3 mmt180 -109.87 118.52 36.7 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 173.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.554 HD12 ' HA3' ' A' ' 184' ' ' GLY . 46.1 mm -119.81 122.29 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 175.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -115.05 118.98 34.93 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -80.23 -9.18 59.72 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.695 0.798 . . . . 0.0 112.789 -170.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -79.66 -36.01 38.39 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 120.654 0.264 . . . . 0.0 110.787 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.6 mp -80.12 99.62 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 45.3 mtt -131.66 156.7 45.39 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-N 114.132 -1.395 . . . . 0.0 109.249 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.3 t70 72.03 2.17 4.2 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 124.384 1.074 . . . . 0.0 112.718 175.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -85.95 148.65 25.67 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 121.635 -0.665 . . . . 0.0 112.087 -173.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -91.16 105.38 17.77 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 172.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.667 ' HB ' HG12 ' A' ' 192' ' ' VAL . 56.8 mt -115.39 146.37 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 123.71 0.804 . . . . 0.0 110.257 -172.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.449 ' SD ' ' HB3' ' A' ' 193' ' ' ARG . 15.7 tpt -129.23 128.63 43.67 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 125.481 1.512 . . . . 0.0 107.781 177.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 35.7 mt -81.39 145.6 30.73 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -142.55 133.96 26.36 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 173.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.551 ' HB2' ' HG ' ' A' ' 147' ' ' LEU . . . -141.45 142.94 33.63 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -170.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -101.9 133.6 46.42 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 171.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.518 ' HA ' HD13 ' A' ' 145' ' ' ILE . 37.3 p90 -161.1 161.62 31.27 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 123.79 0.681 . . . . 0.0 111.057 -175.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.1 p -86.35 161.32 18.77 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.099 0.96 . . . . 0.0 109.41 172.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 53.9 t -139.25 139.39 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.258 1.423 . . . . 0.0 108.467 -175.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 9.8 tp -130.87 132.85 63.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 169.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 62.4 -84.59 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.914 1.286 . . . . 0.0 110.459 -173.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -158.98 23.42 0.21 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.13 0.972 . . . . 0.0 109.897 -176.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.506 ' HB2' HD12 ' A' ' 171' ' ' ILE . 11.1 ptp180 -127.47 163.06 24.92 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.584 0.754 . . . . 0.0 109.797 176.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.474 HD22 ' HA ' ' A' ' 171' ' ' ILE . 9.0 tt -67.7 125.41 26.13 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 171.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -81.35 -59.7 2.54 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 123.876 0.87 . . . . 0.0 108.811 174.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 95.6 m -149.71 136.68 19.58 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.98 0.912 . . . . 0.0 109.293 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.512 HD21 ' HB2' ' A' ' 147' ' ' LEU . 50.1 tp -77.73 121.47 24.08 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.518 HD13 ' HA ' ' A' ' 134' ' ' PHE . 1.6 mp -77.14 -52.14 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.516 0.727 . . . . 0.0 109.161 176.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.586 HD23 ' HG ' ' A' ' 98' ' ' LEU . 39.3 tp -165.69 150.2 8.47 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.735 0.814 . . . . 0.0 109.358 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.681 HD13 HD12 ' A' ' 160' ' ' ILE . 7.4 tt -133.16 145.85 51.02 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.479 ' HD3' HD13 ' A' ' 156' ' ' ILE . 45.5 mtt-85 -141.28 148.3 39.59 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.906 0.882 . . . . 0.0 110.189 176.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.1 110.35 22.25 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.468 1.107 . . . . 0.0 108.441 176.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -104.45 127.95 52.24 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.555 0.742 . . . . 0.0 109.347 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.462 HG22 HG12 ' A' ' 128' ' ' ILE . 41.6 p -70.97 -175.81 1.22 Allowed 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.267 0.556 . . . . 0.0 111.191 176.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -27.13 68.71 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.55 0.74 . . . . 0.0 111.971 173.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -83.26 -4.08 58.08 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.451 0.7 . . . . 0.0 111.243 171.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 77.45 27.07 60.07 Favored Glycine 0 C--N 1.348 1.241 0 CA-C-N 116.441 -0.345 . . . . 0.0 112.944 178.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -92.66 129.45 38.59 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.013 0.525 . . . . 0.0 110.221 -176.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.479 HD13 ' HD3' ' A' ' 148' ' ' ARG . 17.0 mt -72.59 102.93 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.463 0.705 . . . . 0.0 109.141 177.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.9 m -113.83 -2.14 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.287 1.035 . . . . 0.0 111.514 -176.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -157.18 167.43 33.88 Favored Glycine 0 C--N 1.338 0.648 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.542 ' HB3' ' HG3' ' A' ' 118' ' ' ARG . 27.2 tt0 -166.61 149.03 6.6 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.256 0.622 . . . . 0.0 109.627 -174.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.681 HD12 HD13 ' A' ' 147' ' ' LEU . 71.6 mt -130.06 117.69 41.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 169.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.0 t -128.0 138.04 32.09 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.77 139.96 83.21 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 122.951 2.434 . . . . 0.0 111.644 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.411 HD21 ' HB3' ' A' ' 116' ' ' CYS . 88.1 mt . . . . . 0 CA--C 1.548 0.899 0 C-N-CA 123.0 0.52 . . . . 0.0 110.781 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.402 ' HB3' ' HB2' ' A' ' 114' ' ' PRO . 31.2 p-80 . . . . . 0 N--CA 1.473 0.692 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.624 HG22 HG22 ' A' ' 171' ' ' ILE . 4.9 m -99.35 171.73 7.79 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.915 0.886 . . . . 0.0 109.789 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.624 HG22 HG22 ' A' ' 170' ' ' THR . 11.2 tt -48.6 -41.84 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 125.84 1.656 . . . . 0.0 113.754 176.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -56.7 -35.83 68.94 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.187 1.395 . . . . 0.0 111.961 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -73.0 -38.02 66.75 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.26 0.624 . . . . 0.0 111.581 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.498 HG13 HD22 ' A' ' 144' ' ' LEU . 58.1 t -65.19 -51.4 65.86 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.88 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.931 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.27 -24.43 67.86 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 123.826 0.704 . . . . 0.0 112.026 -175.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.41 ' O ' HG23 ' A' ' 180' ' ' VAL . 15.4 m120 -70.77 -50.67 33.43 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.992 0.517 . . . . 0.0 109.624 169.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.21 -40.29 81.25 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.236 1.014 . . . . 0.0 111.817 -177.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 174' ' ' VAL . 61.5 mt -60.5 -46.33 95.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.716 0.806 . . . . 0.0 109.478 178.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.05 -25.67 72.18 Favored Glycine 0 C--N 1.343 0.934 0 CA-C-N 115.293 -0.867 . . . . 0.0 113.427 -177.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 176' ' ' ASN . 91.8 t -74.67 -43.53 47.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.04 0.536 . . . . 0.0 110.135 176.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.411 ' HB2' HD11 ' A' ' 160' ' ' ILE . 57.0 tp -59.35 -47.13 86.59 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.861 0.464 . . . . 0.0 110.453 175.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.477 HD11 HG22 ' A' ' 194' ' ' VAL . 93.3 mt -59.01 -48.5 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.817 0.847 . . . . 0.0 110.167 177.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -62.24 -30.55 76.25 Favored Glycine 0 C--N 1.348 1.248 0 O-C-N 123.578 0.549 . . . . 0.0 113.385 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.554 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -75.76 -27.36 63.03 Favored Glycine 0 C--N 1.348 1.22 0 N-CA-C 112.345 -0.302 . . . . 0.0 112.345 175.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.559 ' HB3' HG11 ' A' ' 192' ' ' VAL . 61.0 mt -80.97 -31.54 34.76 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.239 1.015 . . . . 0.0 110.842 176.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 182' ' ' ILE . 49.2 mt-10 -72.05 -40.58 68.25 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.866 0.866 . . . . 0.0 110.765 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -70.07 -32.49 70.6 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.836 0.454 . . . . 0.0 110.46 176.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -76.35 -1.77 28.47 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.231 0.613 . . . . 0.0 111.394 170.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 23.4 t70 64.11 49.38 2.71 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.436 1.094 . . . . 0.0 111.011 170.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -109.95 140.36 44.03 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.622 1.169 . . . . 0.0 109.145 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 29.4 m -84.46 100.85 11.6 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.667 HG12 ' HB ' ' A' ' 128' ' ' ILE . 33.2 m -116.83 152.4 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-O 121.703 0.763 . . . . 0.0 112.822 -168.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.449 ' HB3' ' SD ' ' A' ' 129' ' ' MET . 63.4 ttt180 -134.99 142.96 46.58 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 114.043 -1.435 . . . . 0.0 108.307 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.477 HG22 HD11 ' A' ' 182' ' ' ILE . 13.2 t -82.37 154.38 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 5.4 m -50.53 132.48 25.38 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.423 0.689 . . . . 0.0 111.537 178.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -53.43 -30.74 42.03 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 124.218 1.007 . . . . 0.0 111.704 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 68.7 p -79.47 -47.06 16.28 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.983 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 90.6 mt -68.21 -33.68 74.87 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.948 0.499 . . . . 0.0 110.759 -177.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -51.06 -30.46 15.79 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.456 1.102 . . . . 0.0 112.624 -176.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -102.49 -47.92 4.31 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 171.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -67.89 -44.42 77.03 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -166.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -113.72 -54.26 2.62 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.33 0.652 . . . . 0.0 111.173 -175.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 . . . . . 0 CA--C 1.544 0.732 0 C-N-CA 125.114 1.366 . . . . 0.0 111.511 -172.637 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 66.9 ttt180 . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -92.36 97.73 11.05 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.699 0.8 . . . . 0.0 109.401 -178.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.9 mm -81.84 122.66 37.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.968 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.9 p -117.18 97.38 5.89 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.93 0.892 . . . . 0.0 110.292 -174.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -79.34 -27.74 42.03 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.828 0.851 . . . . 0.0 111.002 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.456 ' HB2' ' HG3' ' A' ' 97' ' ' GLU . 24.4 ptt? -119.02 141.43 48.7 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.776 0.83 . . . . 0.0 109.188 -177.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.8 m -68.69 160.23 30.64 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.067 0.947 . . . . 0.0 110.599 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 61.1 mt -62.43 -31.84 53.14 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 C-N-CA 122.809 0.443 . . . . 0.0 111.47 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.23 -54.14 49.29 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.511 0.324 . . . . 0.0 111.328 175.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.667 ' HA ' ' HB2' ' A' ' 100' ' ' ARG . 14.8 pt-20 -77.19 -18.31 57.85 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.029 0.531 . . . . 0.0 111.874 -177.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.521 HD12 HD22 ' A' ' 133' ' ' ASN . 6.0 tt -59.92 -43.75 94.73 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.37 1.068 . . . . 0.0 108.89 167.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.1 t -105.76 21.11 17.81 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.745 -176.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.667 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 30.8 tpt180 -67.45 133.1 48.91 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.802 0.441 . . . . 0.0 110.639 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -72.1 136.99 46.75 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 123.692 0.62 . . . . 0.0 109.8 174.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 20.4 p-90 -157.59 166.3 33.25 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.837 0.855 . . . . 0.0 109.485 176.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -142.62 144.02 32.63 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 123.547 0.739 . . . . 0.0 109.033 -176.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.534 ' SD ' ' HD2' ' A' ' 118' ' ' ARG . 67.4 mtp -85.48 105.51 16.15 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.2 tp -62.51 -36.36 82.3 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.192 0.997 . . . . 0.0 110.331 177.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.478 ' HG2' ' HB2' ' A' ' 122' ' ' ALA . 20.7 mmt -134.38 92.48 20.62 Favored Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 123.736 0.814 . . . . 0.0 109.153 168.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.24 112.95 2.69 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 123.165 2.577 . . . . 0.0 114.394 -176.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 119' ' ' ILE . 55.5 tptt -109.54 117.96 35.35 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 161.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -107.72 113.44 26.71 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -125.88 103.31 7.71 Favored 'General case' 0 C--O 1.214 -0.767 0 C-N-CA 123.485 0.714 . . . . 0.0 109.516 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . 84.8 t -75.6 137.89 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 174.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -133.25 93.13 3.11 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-O 120.993 0.425 . . . . 0.0 109.963 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.15 -128.71 37.01 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.743 176.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -72.05 1.36 6.01 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 123.37 2.713 . . . . 0.0 114.126 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 4.3 mp -127.04 175.49 8.06 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.795 0.838 . . . . 0.0 109.411 -178.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.487 ' SG ' ' NH1' ' A' ' 118' ' ' ARG . 49.6 t -136.53 146.47 46.24 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 174.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.8 mm -116.22 147.32 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.309 1.044 . . . . 0.0 109.394 -174.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.534 ' HD2' ' SD ' ' A' ' 104' ' ' MET . 68.7 mmt-85 -119.54 127.31 52.88 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.049 0.939 . . . . 0.0 108.688 172.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.469 HD11 ' HA ' ' A' ' 181' ' ' LEU . 41.6 mm -122.84 125.59 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 173.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -93.45 116.86 29.4 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.411 ' HA ' HD21 ' A' ' 188' ' ' ASN . 80.3 mt-30 -78.51 -13.45 59.82 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.383 0.673 . . . . 0.0 112.257 -174.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.478 ' HB2' ' HG2' ' A' ' 106' ' ' MET . . . -82.86 -49.4 9.71 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.099 0.56 . . . . 0.0 110.791 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.424 HG12 HG11 ' A' ' 157' ' ' VAL . 1.8 mp -69.91 108.81 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-O 122.01 0.91 . . . . 0.0 109.731 -174.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.434 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 50.0 mtt -132.23 156.8 45.84 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 113.192 -1.822 . . . . 0.0 109.624 -177.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.0 t70 63.19 29.07 16.06 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.463 1.105 . . . . 0.0 111.801 173.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -115.0 149.56 37.21 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.569 0.748 . . . . 0.0 111.408 -179.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 152' ' ' GLU . 43.9 m-80 -83.52 107.29 15.9 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.542 HD12 HD22 ' A' ' 185' ' ' LEU . 50.2 mt -112.44 123.84 68.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-O 121.943 0.878 . . . . 0.0 111.105 -174.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 5.6 tpt -102.61 119.24 38.49 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 126.926 2.09 . . . . 0.0 108.905 -176.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 20.4 mt -95.25 104.9 16.8 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -115.43 144.8 43.27 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.192 0.597 . . . . 0.0 109.834 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -138.76 156.55 47.28 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.6 0.714 . . . . 0.0 112.479 -175.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.521 HD22 HD12 ' A' ' 98' ' ' LEU . 70.7 m-20 -113.6 119.38 37.28 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 165.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -153.1 157.96 41.18 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.416 0.686 . . . . 0.0 110.403 -167.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.0 p -89.66 156.8 18.32 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.345 0.658 . . . . 0.0 109.425 175.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.9 t -131.44 129.0 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.569 1.148 . . . . 0.0 109.325 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.5 tp -133.69 140.27 46.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 175.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 63.23 25.83 14.94 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.077 0.951 . . . . 0.0 111.604 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 66.13 15.73 10.19 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 124.986 1.314 . . . . 0.0 112.398 -176.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.424 HH21 HD13 ' A' ' 171' ' ' ILE . 9.7 ptm180 -127.27 171.19 11.69 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.481 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 7.0 tt -68.83 128.79 37.92 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -175.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -85.58 -69.61 0.65 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.757 0.823 . . . . 0.0 110.481 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 63.6 m -147.91 136.68 21.85 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.761 0.824 . . . . 0.0 109.05 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.459 HD22 HG13 ' A' ' 174' ' ' VAL . 47.6 tp -82.63 114.99 21.39 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.269 0.627 . . . . 0.0 109.58 177.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.0 mp -74.57 -50.8 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 175.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 49.4 tp -161.03 144.46 13.07 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.252 0.621 . . . . 0.0 109.464 178.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.61 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 7.6 tt -135.17 142.44 46.11 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 173.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.428 ' HB2' ' CE1' ' A' ' 150' ' ' PHE . 44.3 mtp85 -138.74 139.46 38.34 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -177.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.472 ' HB2' HD21 ' A' ' 181' ' ' LEU . . . -97.18 100.61 12.08 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -177.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.428 ' CE1' ' HB2' ' A' ' 148' ' ' ARG . 87.6 m-85 -96.56 124.55 40.58 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -177.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.485 HG22 HG12 ' A' ' 128' ' ' ILE . 58.6 p -67.5 178.84 1.47 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.266 0.555 . . . . 0.0 110.752 173.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 127' ' ' ASN . 10.3 pt-20 -60.84 -22.21 63.99 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.371 1.068 . . . . 0.0 112.076 174.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -91.23 -1.35 57.71 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.075 0.95 . . . . 0.0 111.327 176.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 79.79 9.69 86.51 Favored Glycine 0 C--N 1.348 1.222 0 O-C-N 123.375 0.422 . . . . 0.0 113.148 -177.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -87.25 120.8 28.91 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.69 0.796 . . . . 0.0 109.51 -174.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 16.1 mt -77.95 121.89 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -175.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.424 HG11 HG12 ' A' ' 123' ' ' ILE . 33.7 m -123.56 5.9 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.979 0.912 . . . . 0.0 110.948 -177.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -164.12 163.12 35.79 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -178.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -160.36 144.76 14.32 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.61 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 53.9 mt -123.71 115.54 45.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 172.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 18.4 p -138.84 132.34 16.1 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 122.902 0.481 . . . . 0.0 110.434 -175.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 31.1 Cg_endo -62.12 133.75 45.63 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.577 2.184 . . . . 0.0 111.875 176.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.2 mt . . . . . 0 CA--C 1.549 0.925 0 C-N-CA 123.699 0.8 . . . . 0.0 111.256 177.553 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 6.3 m -96.15 162.33 13.58 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.533 0.733 . . . . 0.0 109.218 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 141' ' ' LEU . 9.2 tt -50.15 -33.74 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 124.606 1.162 . . . . 0.0 112.13 171.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -52.73 -48.25 66.81 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.48 1.112 . . . . 0.0 111.458 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -69.16 -36.33 77.26 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.741 -176.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.459 HG13 HD22 ' A' ' 144' ' ' LEU . 46.0 t -64.12 -48.88 83.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 O-C-N 123.948 0.78 . . . . 0.0 111.002 178.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -59.81 -40.72 89.34 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.638 0.775 . . . . 0.0 110.982 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.469 ' O ' HG23 ' A' ' 180' ' ' VAL . 89.4 m-20 -64.04 -46.26 85.21 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.871 176.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -61.76 -40.8 96.42 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.717 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 174' ' ' VAL . 66.6 mt -68.05 -37.5 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -65.72 -26.61 72.12 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 116.046 -0.524 . . . . 0.0 113.447 177.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 176' ' ' ASN . 98.3 t -75.59 -45.96 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.209 0.604 . . . . 0.0 109.916 175.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.472 HD21 ' HB2' ' A' ' 149' ' ' ALA . 42.6 tp -55.93 -52.5 63.92 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.342 0.657 . . . . 0.0 110.816 176.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.409 HG23 HG21 ' A' ' 192' ' ' VAL . 79.8 mt -60.13 -46.65 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.79 0.836 . . . . 0.0 110.595 176.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -52.65 -45.71 59.86 Favored Glycine 0 C--N 1.345 1.045 0 O-C-N 124.097 0.873 . . . . 0.0 114.156 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -68.14 -38.11 87.74 Favored Glycine 0 C--N 1.347 1.14 0 O-C-N 123.917 0.422 . . . . 0.0 112.538 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.542 HD22 HD12 ' A' ' 128' ' ' ILE . 97.5 mt -67.29 -34.12 76.73 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.484 0.713 . . . . 0.0 111.226 178.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -69.12 -38.81 79.07 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.59 0.756 . . . . 0.0 110.407 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -61.56 -41.35 97.24 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.191 174.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.434 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 6.7 m-20 -80.19 -2.86 46.64 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.965 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 61.68 57.03 2.33 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.054 0.941 . . . . 0.0 111.298 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -111.81 143.37 42.86 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.756 0.822 . . . . 0.0 109.146 174.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 96.0 m -78.64 102.84 8.2 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.409 HG21 HG23 ' A' ' 182' ' ' ILE . 26.7 m -86.7 143.0 12.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.418 -173.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -147.7 129.72 15.4 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 171.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 3.7 t -96.99 146.35 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 31.2 t -57.53 139.15 54.15 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 118.913 -0.565 . . . . 0.0 110.072 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -54.89 -37.89 66.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 123.497 0.498 . . . . 0.0 110.609 -177.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 41.1 p -62.02 -52.55 63.53 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.596 0.758 . . . . 0.0 109.541 176.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 68.9 mt -58.71 -28.09 65.49 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.61 0.764 . . . . 0.0 111.489 177.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.55 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 46.5 mt-30 -73.46 -42.74 61.56 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 119.021 -0.514 . . . . 0.0 112.191 -176.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.33 -20.78 20.05 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 119.541 1.064 . . . . 0.0 111.574 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -80.51 -41.78 23.65 Favored 'General case' 0 C--N 1.35 0.602 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.475 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -114.4 -60.59 1.87 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.059 0.543 . . . . 0.0 111.617 -176.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.55 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 46.1 t-105 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -161.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 110.523 -0.177 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -85.58 105.58 16.26 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 169.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.0 mm -77.6 120.45 28.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 175.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.4 p -100.85 66.54 1.18 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.416 ' HB3' ' O ' ' A' ' 132' ' ' ALA . 22.6 t70 -67.84 -29.15 68.22 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.755 176.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.743 ' HG3' ' HG3' ' A' ' 97' ' ' GLU . 32.7 ttp -104.84 129.42 53.16 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.724 1.61 . . . . 0.0 107.141 170.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 48.0 p -67.1 156.16 36.85 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 121.309 -0.87 . . . . 0.0 109.94 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -59.64 -35.3 58.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -57.87 -58.29 9.02 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.01 0.924 . . . . 0.0 112.175 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.743 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 12.5 pt-20 -71.15 -27.09 63.3 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 122.703 0.401 . . . . 0.0 111.05 -178.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.567 ' HG ' HD23 ' A' ' 146' ' ' LEU . 9.5 tt -60.71 -39.91 90.31 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.207 1.003 . . . . 0.0 110.201 171.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 81.1 p -107.07 19.96 19.69 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.277 0.631 . . . . 0.0 111.219 -177.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.545 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 2.5 tpm_? -69.78 140.15 53.34 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.879 0.871 . . . . 0.0 111.203 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -78.89 128.26 33.1 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 173.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 40.2 p-90 -150.65 168.13 25.25 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.064 0.946 . . . . 0.0 110.088 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -126.85 136.51 52.44 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.39 0.676 . . . . 0.0 109.795 178.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.508 ' HG3' ' HB2' ' A' ' 120' ' ' ASP . 43.7 ttp -94.31 93.06 7.51 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 167.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.2 tp -55.62 -53.73 52.93 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.718 1.207 . . . . 0.0 111.367 -168.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 27.5 mmt -101.95 93.75 3.97 Favored Pre-proline 0 C--O 1.244 0.779 0 C-N-CA 124.145 0.978 . . . . 0.0 108.581 171.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.501 ' HA ' ' HG2' ' A' ' 104' ' ' MET . 7.0 Cg_exo -73.02 111.73 3.35 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 122.573 2.182 . . . . 0.0 112.345 -172.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -114.63 112.32 22.71 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 171.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -94.92 101.5 13.29 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -177.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.471 ' HE2' HG11 ' A' ' 180' ' ' VAL . 55.2 tptt -101.93 146.23 28.15 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 170.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 93.2 t -131.01 129.29 63.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 167.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -123.78 95.11 4.44 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.35 -137.12 21.42 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.549 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -82.08 20.4 1.1 Allowed 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 123.705 2.937 . . . . 0.0 113.075 173.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.496 HD11 HG22 ' A' ' 174' ' ' VAL . 87.5 mt -127.86 122.69 33.24 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.358 0.663 . . . . 0.0 109.618 -175.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 49.4 t -85.44 115.41 23.15 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.038 0.935 . . . . 0.0 110.099 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.6 mm -100.47 121.88 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.588 0.755 . . . . 0.0 109.363 -175.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 51.3 mtt-85 -103.09 119.84 39.58 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 34.9 mm -114.56 122.04 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.508 ' HB2' ' HG3' ' A' ' 104' ' ' MET . 18.8 t70 -97.04 113.09 24.61 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 170.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -77.25 -11.56 59.84 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.716 0.806 . . . . 0.0 112.127 -175.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.66 -62.51 1.56 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.321 0.649 . . . . 0.0 111.765 -174.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.7 mp -71.23 115.0 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-O 122.014 0.911 . . . . 0.0 110.883 -174.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 59.1 mtt -133.11 167.25 20.67 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 113.83 -1.532 . . . . 0.0 109.879 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.9 t70 55.17 42.15 30.88 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.636 1.174 . . . . 0.0 111.374 177.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 190' ' ' ASN . 45.5 mmtm -124.75 153.39 42.49 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.209 1.004 . . . . 0.0 110.145 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -88.3 106.36 18.17 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 172.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.493 HG12 HG22 ' A' ' 151' ' ' THR . 56.0 mt -107.88 136.08 44.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 124.702 1.201 . . . . 0.0 110.031 -174.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 11.8 tpt -115.41 138.16 51.29 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.422 1.089 . . . . 0.0 110.057 -175.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.556 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 3.4 mm? -92.64 117.71 30.26 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.975 0.91 . . . . 0.0 108.92 177.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 93' ' ' MET . 73.5 mmtt -123.6 125.47 44.9 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.668 1.187 . . . . 0.0 109.211 176.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.548 ' HB2' ' HG ' ' A' ' 147' ' ' LEU . . . -137.49 144.43 42.22 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -175.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -106.29 130.77 54.08 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 169.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.425 ' HA ' HD13 ' A' ' 145' ' ' ILE . 4.9 p90 -162.87 157.46 21.32 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 124.15 0.906 . . . . 0.0 109.38 -172.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 22.2 p -85.65 152.1 23.36 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 172.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 87.6 t -121.84 138.51 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.847 0.859 . . . . 0.0 109.738 -177.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.0 tp -145.05 142.43 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 170.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 60.39 17.87 7.58 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.714 0.806 . . . . 0.0 112.757 177.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 73.87 21.08 2.75 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 126.566 1.947 . . . . 0.0 112.155 -177.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.419 ' HB2' HD12 ' A' ' 171' ' ' ILE . 10.8 ptp180 -125.39 172.19 9.82 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.938 0.895 . . . . 0.0 109.863 175.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.2 tt -69.32 119.56 13.78 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.365 0.666 . . . . 0.0 109.669 174.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -83.41 -65.93 0.95 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.319 1.047 . . . . 0.0 108.947 176.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 69.4 m -141.55 130.94 23.7 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.608 0.763 . . . . 0.0 109.028 175.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.431 HD21 ' HB2' ' A' ' 147' ' ' LEU . 52.9 tp -77.6 121.31 23.76 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.993 0.917 . . . . 0.0 109.812 174.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 134' ' ' PHE . 1.7 mp -81.94 -44.49 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.579 0.752 . . . . 0.0 109.458 176.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.567 HD23 ' HG ' ' A' ' 98' ' ' LEU . 34.0 tp -167.72 148.89 5.37 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.943 0.897 . . . . 0.0 108.714 173.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.71 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 8.3 tt -129.17 150.13 50.68 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 174.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.745 HH11 HG21 ' A' ' 156' ' ' ILE . 44.0 ttm-85 -143.1 143.57 31.89 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.379 0.672 . . . . 0.0 110.8 -173.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -124.22 118.8 27.65 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.437 1.095 . . . . 0.0 108.308 174.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -145.92 144.66 30.31 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.198 0.523 . . . . 0.0 111.018 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.493 HG22 HG12 ' A' ' 128' ' ' ILE . 55.3 p -65.41 171.51 3.9 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.616 -1.174 . . . . 0.0 112.197 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -65.3 -23.22 66.96 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.003 0.521 . . . . 0.0 110.821 172.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -66.12 -30.04 70.46 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.226 1.01 . . . . 0.0 110.234 174.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 107.3 -5.36 35.74 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.039 -174.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -70.26 105.14 2.87 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.434 0.694 . . . . 0.0 110.681 -175.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.745 HG21 HH11 ' A' ' 148' ' ' ARG . 33.3 mt -73.92 118.9 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.45 ' HB ' ' HB3' ' A' ' 120' ' ' ASP . 35.6 m -130.98 15.3 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.833 0.853 . . . . 0.0 110.648 -175.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -164.39 151.78 21.14 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -163.54 141.58 7.68 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.71 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 69.1 mt -113.13 102.74 14.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 170.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 20.7 t -98.93 108.49 49.4 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.135 0.974 . . . . 0.0 108.85 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.19 134.55 62.53 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.514 2.143 . . . . 0.0 111.318 175.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 CA--C 1.551 1.001 0 O-C-N 123.531 0.52 . . . . 0.0 109.859 -179.614 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.413 ' O ' HG23 ' A' ' 174' ' ' VAL . 80.7 p -87.69 151.4 22.96 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.064 0.546 . . . . 0.0 110.385 -174.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.443 ' O ' ' HG3' ' A' ' 175' ' ' LYS . 8.3 tt -58.52 -38.76 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 O-C-N 123.99 0.806 . . . . 0.0 111.129 175.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 47.2 mp0 -55.54 -41.57 73.4 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.086 0.955 . . . . 0.0 110.461 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -67.38 -47.19 71.08 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.556 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.496 HG22 HD11 ' A' ' 115' ' ' LEU . 57.4 t -61.53 -34.28 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 122.974 0.509 . . . . 0.0 110.959 -176.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 171' ' ' ILE . 39.2 mtpt -61.05 -34.7 75.3 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.247 0.619 . . . . 0.0 111.781 177.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -68.0 -47.65 67.94 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.35 -45.11 84.68 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 124.374 1.046 . . . . 0.0 112.249 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.5 ' HB ' ' HZ3' ' A' ' 203' ' ' TRP . 23.2 mt -72.06 -37.57 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -64.8 -27.47 72.12 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 116.126 -0.488 . . . . 0.0 113.003 177.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.471 HG11 ' HE2' ' A' ' 110' ' ' LYS . 54.1 t -83.15 -39.91 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.746 0.818 . . . . 0.0 110.203 177.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.483 HD22 HG13 ' A' ' 160' ' ' ILE . 58.7 tp -58.52 -53.03 62.95 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.084 0.554 . . . . 0.0 110.406 174.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.634 HG23 HG21 ' A' ' 192' ' ' VAL . 70.4 mt -59.28 -43.48 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.44 1.096 . . . . 0.0 110.278 173.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -58.53 -35.0 78.16 Favored Glycine 0 CA--C 1.533 1.203 0 O-C-N 123.886 0.741 . . . . 0.0 113.83 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -72.39 -35.49 59.91 Favored Glycine 0 C--N 1.349 1.292 0 N-CA-C 111.847 -0.501 . . . . 0.0 111.847 175.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.412 HD22 HD12 ' A' ' 128' ' ' ILE . 75.3 mt -71.06 -25.25 62.56 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 124.297 1.039 . . . . 0.0 111.252 175.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 26.9 mm-40 -70.85 -37.78 73.13 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.713 0.805 . . . . 0.0 110.06 174.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -73.83 -31.68 63.33 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.293 177.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -72.6 -14.72 61.68 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.088 169.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 15.6 t70 57.3 64.85 1.5 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.629 1.172 . . . . 0.0 110.313 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 10.5 p30 -131.84 165.73 23.18 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.671 174.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 42.3 m -87.78 106.39 18.04 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.507 -172.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.634 HG21 HG23 ' A' ' 182' ' ' ILE . 34.3 m -94.81 141.98 14.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.763 0 C-N-CA 122.918 0.487 . . . . 0.0 110.689 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -144.76 131.3 19.87 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.233 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.556 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 5.2 t -95.69 149.51 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.413 ' HB2' ' HG ' ' A' ' 198' ' ' LEU . 69.9 m -67.44 144.59 55.66 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 118.95 0.795 . . . . 0.0 110.947 177.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -60.22 -26.29 66.28 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.079 0.952 . . . . 0.0 111.797 -177.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.0 p -67.68 -53.18 29.74 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 172.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.51 ' HB2' HG12 ' A' ' 194' ' ' VAL . 68.1 mt -62.91 -25.61 68.41 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.881 0.873 . . . . 0.0 111.506 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.595 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 78.3 mt-30 -69.24 -44.12 72.65 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.224 0.61 . . . . 0.0 110.824 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.08 -30.0 20.22 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.662 -175.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -83.3 -57.89 3.07 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.548 0.339 . . . . 0.0 110.803 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -98.73 -37.37 9.51 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.16 0.584 . . . . 0.0 111.703 -165.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.595 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 43.4 t-105 . . . . . 0 N--CA 1.481 1.103 0 C-N-CA 124.275 1.03 . . . . 0.0 109.415 -170.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 . . . . . 0 N--CA 1.47 0.526 0 CA-C-O 120.76 0.314 . . . . 0.0 111.465 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -86.47 105.03 16.49 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 175.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 49.9 mm -78.73 125.89 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 62.4 p -114.26 91.42 3.62 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.641 -176.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -75.51 -17.84 59.99 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.182 0.593 . . . . 0.0 110.703 177.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.508 ' SD ' ' HB3' ' A' ' 148' ' ' ARG . 61.1 mtm -117.22 128.72 55.38 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.456 1.103 . . . . 0.0 108.943 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.4 m -77.82 162.15 27.11 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 171.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -48.55 -35.41 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 124.402 1.081 . . . . 0.0 111.763 -177.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -51.58 -71.14 0.07 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.211 1.404 . . . . 0.0 112.207 177.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -69.11 -29.84 67.99 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.528 0.731 . . . . 0.0 111.744 -176.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.8 tt -62.5 -43.1 99.63 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.235 1.014 . . . . 0.0 109.263 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.2 m -105.23 15.18 27.85 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.738 0.815 . . . . 0.0 111.815 -175.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -80.88 135.47 35.92 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.159 0.583 . . . . 0.0 110.222 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -88.22 144.87 26.19 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.776 0.83 . . . . 0.0 109.306 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 18.5 p-90 -152.42 154.29 35.26 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.192 0.997 . . . . 0.0 110.465 -173.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -96.42 160.47 14.39 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.538 0.735 . . . . 0.0 110.791 -177.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 65.9 mtp -128.74 116.88 20.21 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 170.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.3 tt -70.71 -54.78 10.51 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 21.5 mmt -119.22 86.56 33.03 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 124.126 0.97 . . . . 0.0 109.378 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -76.67 113.61 3.69 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 122.837 2.358 . . . . 0.0 112.493 -175.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.55 ' HE3' ' HB2' ' A' ' 110' ' ' LYS . 51.4 tptt -90.59 106.69 18.68 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 169.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 51.2 tp60 -90.92 107.27 19.09 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.146 -0.933 . . . . 0.0 108.698 176.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.55 ' HB2' ' HE3' ' A' ' 108' ' ' LYS . 58.7 tttm -140.12 143.44 36.23 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.992 172.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 68.0 t -105.67 147.24 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 169.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -134.66 90.75 2.69 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 174.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.3 -136.37 21.21 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 114.823 -1.08 . . . . 0.0 112.687 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -81.43 17.9 1.42 Allowed 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 123.687 2.925 . . . . 0.0 113.148 176.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 4.3 mp -134.87 136.42 42.39 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.745 0.818 . . . . 0.0 108.91 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 26.4 p -100.82 138.83 37.35 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.105 0.562 . . . . 0.0 110.085 177.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.2 mm -106.72 133.94 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.326 1.05 . . . . 0.0 110.637 -171.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -108.84 118.18 36.12 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 173.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.496 ' HB ' ' HB3' ' A' ' 108' ' ' LYS . 87.0 mt -126.97 125.63 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -97.03 117.73 31.85 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 118.78 0.718 . . . . 0.0 109.331 173.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -78.5 -8.31 58.41 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.303 1.041 . . . . 0.0 112.506 -172.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.41 -26.33 23.36 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.676 0.39 . . . . 0.0 110.292 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 41.2 mm -81.89 102.15 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 121.997 0.904 . . . . 0.0 110.995 -173.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.527 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 52.1 mtt -134.09 160.47 37.67 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 114.253 -1.34 . . . . 0.0 108.763 -178.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.8 t70 65.34 24.56 12.1 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.719 0.771 . . . . 0.0 111.64 174.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 190' ' ' ASN . 74.9 mmtt -117.45 148.61 41.65 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.236 1.014 . . . . 0.0 110.66 -179.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.408 HD22 ' N ' ' A' ' 127' ' ' ASN . 0.8 OUTLIER -86.8 106.48 17.73 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 171.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.533 HD12 HD22 ' A' ' 185' ' ' LEU . 50.1 mt -102.28 128.63 54.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.893 0.877 . . . . 0.0 111.25 -174.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.558 ' HG3' ' HG3' ' A' ' 131' ' ' LYS . 4.0 tpt -98.99 116.38 31.1 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.064 1.746 . . . . 0.0 109.636 -176.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -98.57 104.7 16.76 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.558 ' HG3' ' HG3' ' A' ' 129' ' ' MET . 47.3 mtmt -127.17 149.58 49.91 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.166 0.586 . . . . 0.0 110.975 -177.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.485 ' HB3' HD21 ' A' ' 198' ' ' LEU . . . -141.4 149.93 41.7 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -173.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -100.25 118.88 37.46 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 163.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -151.91 159.18 43.89 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.157 0.583 . . . . 0.0 110.964 -171.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.8 m -86.36 150.52 24.27 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.787 1.235 . . . . 0.0 109.703 177.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 98.2 t -122.4 145.62 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 175.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.465 HG22 ' HB2' ' A' ' 142' ' ' GLU . 9.7 tp -162.67 145.48 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 167.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 56.29 25.68 9.61 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 124.043 0.937 . . . . 0.0 112.606 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 69.72 25.52 5.12 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 125.781 1.632 . . . . 0.0 112.487 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.575 ' HB2' HD12 ' A' ' 171' ' ' ILE . 1.2 ptp85 -132.56 171.65 13.54 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.325 0.65 . . . . 0.0 110.902 175.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.7 tt -74.44 114.07 12.41 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 114.904 -1.043 . . . . 0.0 108.662 172.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.465 ' HB2' HG22 ' A' ' 137' ' ' ILE . 9.4 tp10 -73.45 -61.84 1.69 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.902 0.881 . . . . 0.0 110.247 175.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 65.4 m -146.32 127.53 14.76 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.99 0.916 . . . . 0.0 109.438 -175.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.452 HD11 ' HB1' ' A' ' 132' ' ' ALA . 36.7 tp -74.06 125.23 27.84 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 172.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.9 mp -83.35 -48.51 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 172.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.548 HD21 ' NH2' ' A' ' 148' ' ' ARG . 46.5 tp -165.26 147.42 7.8 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.687 0.795 . . . . 0.0 109.626 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.638 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 8.9 tt -129.62 156.75 43.7 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 171.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.793 ' HD3' HD13 ' A' ' 156' ' ' ILE . 48.4 ttm-85 -154.07 141.16 19.39 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.082 0.553 . . . . 0.0 110.733 -175.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.98 121.14 44.51 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.627 1.171 . . . . 0.0 109.411 -177.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -110.99 155.94 21.98 Favored 'General case' 0 C--O 1.208 -1.087 0 C-N-CA 124.74 1.216 . . . . 0.0 108.541 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 24.9 p -100.18 168.3 9.9 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 118.852 0.751 . . . . 0.0 109.833 168.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.8 -21.17 62.51 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 172.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -61.7 -30.27 70.64 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.103 0.961 . . . . 0.0 111.422 169.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 99.21 14.31 36.36 Favored Glycine 0 C--N 1.346 1.116 0 O-C-N 123.714 0.634 . . . . 0.0 112.84 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -101.1 135.11 43.09 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.41 0.684 . . . . 0.0 109.957 176.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.793 HD13 ' HD3' ' A' ' 148' ' ' ARG . 47.1 mt -78.93 127.13 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 174.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.6 m -127.01 1.41 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.636 0.774 . . . . 0.0 112.435 -171.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -164.81 170.03 39.73 Favored Glycine 0 C--N 1.344 0.973 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 34.6 tt0 -167.67 153.75 7.63 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.04 0.936 . . . . 0.0 109.139 -177.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.638 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 70.6 mt -129.4 104.23 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 167.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 5.4 p -109.95 121.84 40.71 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 123.85 0.86 . . . . 0.0 109.627 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 37.1 Cg_exo -62.53 140.11 79.81 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.752 2.301 . . . . 0.0 111.824 175.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 CA--C 1.548 0.874 0 C-N-CA 123.744 0.818 . . . . 0.0 110.543 179.297 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 59.1 p -98.23 166.08 11.57 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 123.31 0.644 . . . . 0.0 110.268 174.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.626 HD11 ' HA ' ' A' ' 202' ' ' ALA . 12.7 tt -52.78 -35.84 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 124.189 0.996 . . . . 0.0 110.882 170.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -59.72 -44.71 93.61 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.55 1.14 . . . . 0.0 111.469 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -63.34 -43.69 97.01 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 124.105 0.878 . . . . 0.0 111.093 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.478 ' O ' HG13 ' A' ' 178' ' ' ILE . 67.3 t -64.07 -42.91 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.944 -178.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -62.14 -36.84 83.03 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.028 0.531 . . . . 0.0 111.634 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -66.29 -43.99 84.77 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 175.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -59.33 -44.69 92.58 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.232 1.013 . . . . 0.0 111.719 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 174' ' ' VAL . 51.3 mt -70.38 -35.99 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.27 0.628 . . . . 0.0 109.661 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.96 -27.17 73.31 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 116.22 -0.445 . . . . 0.0 113.723 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 45.5 t -75.2 -47.03 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.499 0.72 . . . . 0.0 110.614 175.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 30.0 tp -60.89 -52.76 63.66 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 123.748 0.655 . . . . 0.0 110.573 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.43 HG23 HG11 ' A' ' 192' ' ' VAL . 65.3 mt -65.85 -46.8 87.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.77 0.828 . . . . 0.0 111.149 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -58.13 -34.48 73.35 Favored Glycine 0 C--N 1.345 1.075 0 O-C-N 123.599 0.562 . . . . 0.0 113.396 177.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.5 -47.04 92.35 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 172.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.533 HD22 HD12 ' A' ' 128' ' ' ILE . 93.8 mt -64.54 -29.25 70.28 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.787 1.235 . . . . 0.0 111.92 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -69.68 -41.55 75.29 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.519 0.728 . . . . 0.0 110.493 177.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 20.6 mtm180 -74.53 -26.88 60.26 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.891 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.527 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 16.0 m120 -71.99 -20.07 61.78 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.237 0.615 . . . . 0.0 111.152 172.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 65.66 66.3 0.52 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.528 1.131 . . . . 0.0 110.831 -173.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 11.6 p30 -136.57 158.26 44.86 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.156 168.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 86.2 m -83.65 105.93 14.96 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.616 0.766 . . . . 0.0 110.588 -170.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.43 HG11 HG23 ' A' ' 182' ' ' ILE . 33.0 m -83.18 145.41 8.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 C-N-CA 123.153 0.581 . . . . 0.0 110.308 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -146.16 125.13 12.76 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 170.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 3.0 t -93.46 149.16 4.37 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -177.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 43.0 t -59.7 141.45 55.1 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.736 0.414 . . . . 0.0 110.235 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -52.61 -38.66 60.59 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.06 0.944 . . . . 0.0 111.443 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 68.6 p -67.54 -49.73 61.92 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.331 1.052 . . . . 0.0 110.647 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.485 HD21 ' HB3' ' A' ' 132' ' ' ALA . 71.5 mt -59.67 -34.81 73.33 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.714 0.805 . . . . 0.0 110.922 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.592 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 50.5 mt-30 -63.65 -54.53 34.26 Favored 'General case' 0 C--N 1.348 0.543 0 O-C-N 123.88 0.737 . . . . 0.0 110.974 178.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.39 -12.81 53.77 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -172.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -96.0 -40.43 9.27 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 118.058 0.39 . . . . 0.0 111.764 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.626 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -121.82 -61.49 1.5 Allowed 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -172.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.592 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 60.3 t-105 . . . . . 0 N--CA 1.484 1.226 0 C-N-CA 124.378 1.071 . . . . 0.0 112.323 -164.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 45.0 ttm180 . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 120.97 0.414 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -96.85 111.05 23.41 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 170.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 133' ' ' ASN . 48.2 mm -83.05 117.69 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 170.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 37.7 p -113.5 88.49 2.85 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.017 0.927 . . . . 0.0 109.06 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -68.81 -31.06 69.78 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.456 177.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -121.31 142.88 49.53 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.816 0.847 . . . . 0.0 108.934 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 68.5 p -78.96 163.07 25.53 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.767 0.318 . . . . 0.0 110.297 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.46 -31.42 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.291 0 C-N-CA 124.863 1.265 . . . . 0.0 111.995 -176.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -54.34 -69.58 0.12 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.269 1.027 . . . . 0.0 112.363 178.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.9 pm0 -69.02 -25.19 64.37 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.007 0.523 . . . . 0.0 111.758 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.442 HD12 ' ND2' ' A' ' 133' ' ' ASN . 6.4 tt -59.67 -48.79 80.27 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.479 0.712 . . . . 0.0 109.386 176.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.8 t -106.77 19.24 20.76 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.203 0.601 . . . . 0.0 111.202 -175.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -77.58 140.59 39.71 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.689 0.796 . . . . 0.0 110.242 174.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -91.67 145.72 24.36 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.545 0.738 . . . . 0.0 110.459 174.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . 0.552 ' HH2' ' HG2' ' A' ' 118' ' ' ARG . 42.3 p-90 -158.41 179.77 8.83 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.929 1.292 . . . . 0.0 109.78 -172.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -139.72 158.36 44.23 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.333 0.653 . . . . 0.0 110.513 177.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.541 ' HE3' ' HA ' ' A' ' 107' ' ' PRO . 71.0 mtm -105.99 145.62 31.12 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.741 0.816 . . . . 0.0 109.334 171.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.9 tp -82.2 -40.15 22.11 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.189 0.596 . . . . 0.0 110.177 -175.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 19.7 mmt -122.68 88.74 49.95 Favored Pre-proline 0 N--CA 1.484 1.236 0 C-N-CA 124.562 1.145 . . . . 0.0 108.666 169.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.541 ' HA ' ' HE3' ' A' ' 104' ' ' MET . 17.4 Cg_exo -68.27 131.96 24.69 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.622 2.215 . . . . 0.0 113.307 -178.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.54 ' HD2' HE21 ' A' ' 121' ' ' GLN . 86.9 tttt -135.57 135.91 40.69 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.404 1.082 . . . . 0.0 108.372 171.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -112.82 124.15 51.93 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.11 0.564 . . . . 0.0 110.144 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -125.53 150.06 47.76 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 168.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 12.9 t -126.81 142.51 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 172.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -138.68 98.12 3.5 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 68.69 -127.25 22.56 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 119.351 -0.694 . . . . 0.0 112.162 -177.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -89.45 14.75 2.12 Favored 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 123.483 2.789 . . . . 0.0 112.803 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.494 HD23 ' HA ' ' A' ' 162' ' ' PRO . 93.9 mt -128.03 122.44 32.21 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.931 0.492 . . . . 0.0 110.096 -172.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 40.2 t -83.05 116.9 22.5 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.345 1.058 . . . . 0.0 109.702 177.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 10.4 mm -90.81 115.96 31.09 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 C-N-CA 123.777 0.831 . . . . 0.0 109.287 -177.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.552 ' HG2' ' HH2' ' A' ' 102' ' ' TRP . 7.9 tpt180 -94.7 118.53 31.88 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 43.9 mm -123.3 134.39 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.531 0.732 . . . . 0.0 109.509 -176.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -117.97 120.87 39.13 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.445 0.698 . . . . 0.0 109.153 174.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.54 HE21 ' HD2' ' A' ' 108' ' ' LYS . 82.4 mt-30 -82.98 -1.24 52.0 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.949 0.9 . . . . 0.0 112.893 -177.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.13 -56.92 3.12 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 117.934 0.334 . . . . 0.0 111.455 -173.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.474 HG23 ' HG3' ' A' ' 126' ' ' LYS . 2.0 mp -70.14 104.07 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-O 121.938 0.875 . . . . 0.0 110.314 -175.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.9 mtt -126.56 159.42 33.53 Favored 'General case' 0 C--N 1.348 0.508 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.964 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.71 33.84 21.94 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.608 0.763 . . . . 0.0 112.294 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.474 ' HG3' HG23 ' A' ' 123' ' ' ILE . 74.1 mmtt -114.49 155.23 26.79 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.461 0.705 . . . . 0.0 110.594 176.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.455 ' HB2' ' HB3' ' A' ' 152' ' ' GLU . 0.8 OUTLIER -89.73 101.63 14.32 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 170.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.506 ' HB ' HG12 ' A' ' 192' ' ' VAL . 66.5 mt -101.77 139.73 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.535 0.734 . . . . 0.0 109.431 -172.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 14.2 tpt -123.0 127.03 48.24 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.822 0.849 . . . . 0.0 109.649 -175.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 22.8 mt -99.15 104.59 16.58 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -176.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.419 ' HB2' ' HE1' ' A' ' 150' ' ' PHE . 2.8 mtpm? -117.23 130.72 56.76 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -175.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -133.52 152.69 51.94 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 122.016 0.912 . . . . 0.0 112.782 -170.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.442 ' ND2' HD12 ' A' ' 98' ' ' LEU . 5.2 m-20 -108.22 125.35 51.55 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 168.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -155.48 159.09 39.51 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.297 0.639 . . . . 0.0 111.083 -172.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.508 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . 37.9 m -90.12 161.69 15.66 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.985 0.914 . . . . 0.0 110.94 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 70.9 t -139.88 130.81 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 124.263 1.025 . . . . 0.0 110.075 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.618 HG22 ' HG2' ' A' ' 142' ' ' GLU . 9.1 tp -146.89 144.7 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 170.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 57.55 24.69 10.66 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.622 0.769 . . . . 0.0 111.628 -178.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 63.4 30.36 15.46 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.824 1.25 . . . . 0.0 112.28 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -131.9 165.45 23.86 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.615 0.766 . . . . 0.0 109.458 171.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.482 HD13 ' HB2' ' A' ' 202' ' ' ALA . 9.8 tt -70.9 129.39 38.91 Favored 'General case' 0 CA--C 1.554 1.096 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.618 ' HG2' HG22 ' A' ' 137' ' ' ILE . 31.8 mt-10 -83.88 -67.52 0.79 Allowed 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.698 0.761 . . . . 0.0 109.736 173.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 27.6 m -144.85 138.75 27.24 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.9 -170.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.449 HD22 HG13 ' A' ' 174' ' ' VAL . 56.5 tp -84.2 112.36 20.2 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.077 0.551 . . . . 0.0 109.577 175.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.13 -51.42 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 174.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.406 HD21 ' NH2' ' A' ' 148' ' ' ARG . 35.2 tp -170.6 149.13 3.15 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.321 177.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.538 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 10.0 tt -124.0 150.97 44.24 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 172.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.489 ' HD3' HD13 ' A' ' 156' ' ' ILE . 32.5 ttm-85 -143.31 135.09 26.61 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 122.671 0.388 . . . . 0.0 110.265 -178.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.06 113.73 27.44 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.419 ' HE1' ' HB2' ' A' ' 131' ' ' LYS . 17.4 m-85 -103.62 166.0 10.69 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 57.6 p -93.98 -179.44 4.97 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 120.949 0.404 . . . . 0.0 110.125 166.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 127' ' ' ASN . 13.3 pt-20 -61.94 -26.64 68.31 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.343 1.057 . . . . 0.0 110.913 172.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -77.57 -29.42 52.08 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.854 1.262 . . . . 0.0 110.815 174.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 103.96 11.03 33.29 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.908 -178.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.32 124.35 27.38 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.143 0.577 . . . . 0.0 109.503 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.489 HD13 ' HD3' ' A' ' 148' ' ' ARG . 54.9 mt -75.47 107.18 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -178.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.6 m -117.21 4.01 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.303 1.041 . . . . 0.0 111.869 -173.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -168.45 172.34 42.94 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-N 116.509 -0.314 . . . . 0.0 112.453 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -166.78 153.58 8.84 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.738 0.815 . . . . 0.0 109.394 -175.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.584 HD11 ' HB2' ' A' ' 181' ' ' LEU . 40.3 mm -124.95 103.58 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 164.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 55.9 p -102.68 126.95 31.35 Favored Pre-proline 0 N--CA 1.474 0.733 0 C-N-CA 123.146 0.578 . . . . 0.0 110.545 -177.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.494 ' HA ' HD23 ' A' ' 115' ' ' LEU . 56.4 Cg_endo -67.3 150.01 81.21 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 122.163 1.908 . . . . 0.0 112.015 175.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 77.0 mt . . . . . 0 CA--C 1.543 0.686 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.547 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.445 ' CE1' HD21 ' A' ' 115' ' ' LEU . 27.2 p-80 . . . . . 0 N--CA 1.477 0.908 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 42.6 m -110.99 161.83 15.47 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.596 0.758 . . . . 0.0 110.315 -174.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' A' ' 141' ' ' LEU . 6.8 tt -45.94 -39.14 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.996 1.318 . . . . 0.0 112.498 173.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.594 ' HA ' ' NZ ' ' A' ' 175' ' ' LYS . 22.9 mm-40 -53.41 -48.87 68.32 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.262 1.025 . . . . 0.0 112.085 -176.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -61.11 -40.24 93.01 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 124.653 1.221 . . . . 0.0 110.813 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.449 HG13 HD22 ' A' ' 144' ' ' LEU . 41.1 t -66.8 -40.13 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.242 -175.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.594 ' NZ ' ' HA ' ' A' ' 172' ' ' GLU . 25.9 mtmm -60.39 -42.02 95.01 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 120.984 0.421 . . . . 0.0 110.009 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.498 ' O ' HG23 ' A' ' 180' ' ' VAL . 13.4 m120 -62.92 -48.51 78.64 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.653 175.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -59.68 -48.01 83.36 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.997 0.811 . . . . 0.0 112.616 -173.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.8 mt -63.57 -37.8 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.283 175.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.44 -30.82 77.22 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 115.578 -0.737 . . . . 0.0 114.432 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 176' ' ' ASN . 44.9 t -76.03 -43.15 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 117.79 0.795 . . . . 0.0 108.994 176.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.584 ' HB2' HD11 ' A' ' 160' ' ' ILE . 37.8 tp -53.38 -53.19 54.75 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.339 176.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.423 HD12 ' CH2' ' A' ' 203' ' ' TRP . 43.1 mt -64.1 -39.76 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.898 0.879 . . . . 0.0 110.716 174.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -53.12 -35.56 49.62 Favored Glycine 0 CA--C 1.533 1.214 0 O-C-N 123.466 0.478 . . . . 0.0 114.088 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -83.43 -39.45 9.8 Favored Glycine 0 C--N 1.348 1.235 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 175.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 46.1 mt -66.21 -31.67 72.65 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.168 0.987 . . . . 0.0 112.437 -176.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -69.57 -33.58 72.94 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.743 0.417 . . . . 0.0 110.329 176.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -71.32 -32.83 69.07 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.181 176.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -63.31 -16.99 62.04 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.141 0.576 . . . . 0.0 111.767 171.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 63.5 65.78 0.73 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.976 0.91 . . . . 0.0 110.136 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.411 ' HB2' ' H ' ' A' ' 126' ' ' LYS . 4.0 p30 -141.0 175.9 9.24 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.069 176.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 90.9 m -109.91 101.91 10.71 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.106 0.563 . . . . 0.0 109.582 -173.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.506 HG12 ' HB ' ' A' ' 128' ' ' ILE . 12.7 m -99.82 153.87 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 121.535 0.683 . . . . 0.0 111.357 -177.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -136.56 143.91 43.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.174 -1.375 . . . . 0.0 108.305 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 3.3 t -111.06 145.88 16.79 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 47.4 m -57.93 140.66 51.62 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 118.014 0.37 . . . . 0.0 111.043 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -57.94 -29.91 65.53 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.291 0.636 . . . . 0.0 110.802 177.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 41.3 p -67.98 -52.64 33.52 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.784 0.834 . . . . 0.0 109.561 176.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 32.5 mt -54.58 -38.29 66.52 Favored 'General case' 0 C--O 1.208 -1.106 0 C-N-CA 123.871 0.868 . . . . 0.0 111.057 176.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.652 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 49.4 mt-30 -71.14 -39.74 71.8 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.258 0.623 . . . . 0.0 111.962 -176.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.29 -12.03 44.74 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -177.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -101.59 -42.53 6.19 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 178.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.482 ' HB2' HD13 ' A' ' 141' ' ' LEU . . . -123.42 -61.58 1.39 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.159 0.584 . . . . 0.0 112.243 -172.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.652 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 52.6 t-105 . . . . . 0 N--CA 1.475 0.804 0 C-N-CA 124.841 1.257 . . . . 0.0 111.084 -171.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.475 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 22.4 ttm-85 . . . . . 0 N--CA 1.471 0.6 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -92.76 101.97 14.36 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.942 0.897 . . . . 0.0 108.68 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.7 mm -78.96 114.33 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.491 0.716 . . . . 0.0 109.979 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.7 p -100.2 67.4 1.37 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 122.424 1.107 . . . . 0.0 108.752 174.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.455 ' HB3' ' O ' ' A' ' 132' ' ' ALA . 11.4 t70 -83.37 -33.31 25.84 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.76 -176.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 34.4 ttp -99.46 131.36 45.52 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 170.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.8 m -70.63 153.15 43.14 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 120.81 0.338 . . . . 0.0 110.4 177.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.43 -34.8 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.561 1.144 . . . . 0.0 110.406 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -54.44 -41.4 69.37 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.882 0.873 . . . . 0.0 111.627 174.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -80.69 -41.95 22.83 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.646 0.778 . . . . 0.0 110.451 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.572 ' HG ' HD23 ' A' ' 146' ' ' LEU . 10.4 tt -58.58 -46.65 86.48 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.565 1.146 . . . . 0.0 110.556 -176.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.5 t -100.22 19.28 16.8 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.764 0.826 . . . . 0.0 110.986 -175.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -84.74 128.11 34.44 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.033 0.533 . . . . 0.0 110.186 176.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -91.84 149.03 21.79 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.842 0.857 . . . . 0.0 108.949 174.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 24.2 p-90 -159.58 162.49 35.33 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.91 0.884 . . . . 0.0 110.463 -169.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -113.38 152.38 30.08 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.268 0.627 . . . . 0.0 109.974 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 66.2 mtp -104.79 123.2 47.25 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 175.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 42.7 tp -76.03 -40.28 53.8 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.502 0.721 . . . . 0.0 110.082 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 21.8 mmt -129.7 81.08 70.33 Favored Pre-proline 0 N--CA 1.482 1.173 0 C-N-CA 123.871 0.869 . . . . 0.0 108.926 171.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.81 113.39 3.19 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.7 2.266 . . . . 0.0 112.716 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.539 ' HB3' ' HB ' ' A' ' 119' ' ' ILE . 60.5 tttm -100.4 103.56 14.94 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 163.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.0 104.06 15.26 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -171.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.467 ' HG2' HG11 ' A' ' 180' ' ' VAL . 22.7 tptm -114.24 142.06 46.76 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.638 0.775 . . . . 0.0 109.451 177.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 97.6 t -125.82 126.4 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 170.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -115.06 83.96 2.0 Allowed 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 62.11 -114.95 7.3 Favored Glycine 0 CA--C 1.539 1.558 0 CA-C-N 114.875 -1.057 . . . . 0.0 113.468 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -84.93 5.93 5.99 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 123.702 2.935 . . . . 0.0 113.546 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 162' ' ' PRO . 35.2 mt -133.93 111.91 10.82 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -173.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 44.5 t -84.19 127.96 34.26 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.201 0.6 . . . . 0.0 110.063 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.5 mm -102.91 137.22 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.353 0.661 . . . . 0.0 110.126 -174.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.508 ' HG3' ' HB3' ' A' ' 159' ' ' GLU . 29.1 mmt180 -107.56 116.83 32.65 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 173.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.539 ' HB ' ' HB3' ' A' ' 108' ' ' LYS . 43.3 mm -113.87 120.01 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 172.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -103.01 116.29 32.24 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 174.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -75.75 -22.15 56.77 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.066 0.947 . . . . 0.0 111.848 -174.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.27 -46.99 37.88 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.062 0.545 . . . . 0.0 111.477 -175.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.499 HG21 HG11 ' A' ' 157' ' ' VAL . 1.9 mp -71.25 108.52 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-O 121.928 0.87 . . . . 0.0 110.08 -177.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.475 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 45.9 mtt -130.56 160.67 33.47 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.415 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.4 t70 63.73 38.6 9.16 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 124.338 1.055 . . . . 0.0 112.126 172.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -123.61 151.38 43.05 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.266 0.626 . . . . 0.0 110.774 177.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -85.03 103.05 13.71 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 169.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.527 HD13 HG21 ' A' ' 157' ' ' VAL . 48.0 mt -107.64 129.97 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.65 0.738 . . . . 0.0 110.515 -172.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.492 ' HG3' ' HG3' ' A' ' 131' ' ' LYS . 2.4 tpt -97.51 123.29 41.32 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 125.47 1.508 . . . . 0.0 109.644 -174.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.503 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 3.5 mm? -94.73 103.75 15.66 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.492 ' HG3' ' HG3' ' A' ' 129' ' ' MET . 62.5 mttm -124.44 153.32 42.12 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.054 0.542 . . . . 0.0 111.242 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.541 ' HB2' ' HG ' ' A' ' 147' ' ' LEU . . . -147.07 160.67 42.12 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.549 -176.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -112.13 131.63 55.34 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 163.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.4 ' HA ' HD13 ' A' ' 145' ' ' ILE . 28.0 p90 -160.25 154.7 23.7 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.752 0.658 . . . . 0.0 110.931 -172.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.7 t -86.11 153.67 21.92 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.375 1.07 . . . . 0.0 108.325 175.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 88' ' ' ARG . 79.6 t -134.88 139.73 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.516 0.726 . . . . 0.0 110.432 -175.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.9 tp -143.89 139.28 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 172.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 61.48 27.61 17.12 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 124.394 1.078 . . . . 0.0 112.354 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 61.14 29.96 19.11 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.669 1.187 . . . . 0.0 111.866 -177.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 7.5 ppt_? -135.3 158.22 44.91 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 173.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.6 tt -61.55 113.97 2.99 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.244 0.618 . . . . 0.0 110.288 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -75.28 -61.74 1.8 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.447 0.699 . . . . 0.0 110.462 176.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 40.5 m -147.09 129.03 15.41 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.516 0.726 . . . . 0.0 109.304 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.443 HD21 ' HB2' ' A' ' 147' ' ' LEU . 57.3 tp -78.11 120.6 23.15 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.894 0.878 . . . . 0.0 109.51 176.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 134' ' ' PHE . 1.8 mp -77.91 -47.54 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 175.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.572 HD23 ' HG ' ' A' ' 98' ' ' LEU . 55.2 tp -167.22 147.41 5.43 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.007 0.923 . . . . 0.0 109.079 175.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.738 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 6.6 tt -127.09 154.02 45.25 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 175.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.524 HH11 HG21 ' A' ' 156' ' ' ILE . 39.2 ttm-85 -150.58 143.82 24.89 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.094 0.558 . . . . 0.0 111.316 -171.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.403 ' HB2' HD21 ' A' ' 181' ' ' LEU . . . -117.27 111.84 19.94 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.765 1.226 . . . . 0.0 107.878 173.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.465 ' HZ ' ' HD2' ' A' ' 131' ' ' LYS . 46.5 p90 -131.55 142.58 49.95 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 72.3 p -62.95 169.4 3.31 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.524 0.729 . . . . 0.0 112.133 -177.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -51.9 -28.63 16.91 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.965 1.306 . . . . 0.0 112.317 174.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -84.18 -29.49 26.59 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.009 0.924 . . . . 0.0 111.313 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 114.03 8.37 17.77 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 116.482 -0.327 . . . . 0.0 113.593 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -79.92 114.29 18.73 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.524 HG21 HH11 ' A' ' 148' ' ' ARG . 23.9 mt -71.29 124.14 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 122.626 0.37 . . . . 0.0 110.188 -177.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.527 HG21 HD13 ' A' ' 128' ' ' ILE . 26.6 m -124.8 -5.67 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.243 1.017 . . . . 0.0 111.236 -176.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -158.97 164.96 34.0 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -178.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.508 ' HB3' ' HG3' ' A' ' 118' ' ' ARG . 26.2 tt0 -168.28 150.52 5.29 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.257 0.623 . . . . 0.0 109.346 -176.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.738 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 83.7 mt -121.75 104.13 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 168.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 35.3 t -96.08 107.96 38.1 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 123.933 0.893 . . . . 0.0 110.233 -177.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.426 ' HA ' HD23 ' A' ' 115' ' ' LEU . 51.5 Cg_exo -58.47 113.65 1.64 Allowed 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.526 2.151 . . . . 0.0 111.681 172.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 CA--C 1.542 0.65 0 C-N-CA 124.11 0.964 . . . . 0.0 111.377 -174.114 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 . . . . . 0 C--O 1.242 0.69 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 14.7 m -88.31 152.4 21.96 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 6.7 tt -59.12 -35.91 59.9 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 124.933 1.293 . . . . 0.0 112.029 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.22 -31.91 73.3 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.753 0.821 . . . . 0.0 110.413 177.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.435 ' HA ' ' ND2' ' A' ' 176' ' ' ASN . 18.4 t70 -83.6 -30.01 27.3 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.712 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.507 ' O ' HG13 ' A' ' 178' ' ' ILE . 79.5 t -62.14 -38.82 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 171.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -52.0 -43.23 63.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 124.079 0.862 . . . . 0.0 110.85 173.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.444 ' O ' HG23 ' A' ' 180' ' ' VAL . 53.5 m-20 -66.18 -45.29 81.37 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.989 0.805 . . . . 0.0 109.996 -177.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.5 -46.38 88.71 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.751 0.82 . . . . 0.0 111.908 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 174' ' ' VAL . 40.8 mt -63.37 -36.33 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 177.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.49 -35.52 91.86 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 115.433 -0.803 . . . . 0.0 113.403 176.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.467 HG11 ' HG2' ' A' ' 110' ' ' LYS . 60.2 t -68.39 -48.88 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.59 HD22 HG13 ' A' ' 160' ' ' ILE . 24.4 tp -59.77 -50.37 74.08 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.256 -178.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 70.4 mt -62.11 -47.47 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.48 0.712 . . . . 0.0 110.757 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -58.51 -35.15 78.72 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 123.938 0.774 . . . . 0.0 114.128 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.477 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -69.37 -38.21 80.48 Favored Glycine 0 C--N 1.347 1.156 0 C-N-CA 122.947 0.308 . . . . 0.0 112.488 176.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.442 HD13 ' O ' ' A' ' 181' ' ' LEU . 8.9 mp -71.37 -32.58 68.66 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.679 0.792 . . . . 0.0 111.702 178.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -69.83 -38.24 76.46 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.1 0.56 . . . . 0.0 111.896 -177.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -79.02 -16.6 56.64 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.71 0.404 . . . . 0.0 111.406 177.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.475 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 7.0 m-20 -76.32 -11.49 59.91 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.062 0.545 . . . . 0.0 110.876 165.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 25.5 t70 65.43 59.87 0.77 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.483 1.113 . . . . 0.0 109.424 -176.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -110.57 151.29 27.79 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.349 169.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 49.9 m -83.43 102.67 12.22 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 171.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 35.4 m -88.3 140.79 15.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 123.701 0.8 . . . . 0.0 109.351 -175.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 24.7 ttm-85 -145.09 127.32 15.75 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.51 175.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.503 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 2.6 t -87.85 143.02 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 26.5 t -63.76 147.8 50.82 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 118.519 0.599 . . . . 0.0 111.035 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -54.19 -35.59 62.51 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.031 0.932 . . . . 0.0 111.591 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 60.9 p -65.38 -53.15 47.58 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.945 0.898 . . . . 0.0 110.029 176.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.445 HD21 ' HB3' ' A' ' 132' ' ' ALA . 73.9 mt -62.93 -26.41 68.8 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.261 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.556 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 49.2 mt-30 -75.48 -46.68 30.93 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.29 0.636 . . . . 0.0 110.702 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.21 -12.29 47.25 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -175.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -106.5 -45.3 4.29 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 122.932 0.493 . . . . 0.0 112.283 178.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -114.87 -36.24 4.54 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -164.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.556 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 72.5 t-105 . . . . . 0 N--CA 1.486 1.33 0 C-N-CA 123.826 0.851 . . . . 0.0 110.551 -167.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -123.91 105.83 9.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.597 0.759 . . . . 0.0 109.656 174.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 50.6 mm -79.91 139.86 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 174.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.8 p -137.64 93.05 2.75 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.555 0.742 . . . . 0.0 109.546 176.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -80.93 -21.06 40.77 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.157 0.583 . . . . 0.0 111.106 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -100.67 126.82 47.22 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 175.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.61 177.28 8.78 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.88 0.872 . . . . 0.0 109.295 173.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -63.43 -43.16 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 123.88 0.872 . . . . 0.0 112.116 -167.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -62.46 -49.17 76.46 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.997 0.519 . . . . 0.0 111.931 -178.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.656 ' HA ' ' HB2' ' A' ' 100' ' ' ARG . 14.7 pt-20 -74.85 -19.82 60.01 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 123.475 0.485 . . . . 0.0 111.469 -178.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.8 tp -68.2 -32.3 72.43 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.29 1.036 . . . . 0.0 110.212 172.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.2 t -117.07 18.25 14.66 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.417 1.087 . . . . 0.0 110.849 -178.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.656 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 26.5 tpt180 -66.79 142.88 57.21 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.749 0.419 . . . . 0.0 112.107 -174.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -77.62 121.16 23.57 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.741 174.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 6.3 p-90 -140.12 149.25 42.82 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.402 1.081 . . . . 0.0 109.933 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -134.16 135.51 43.15 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.922 0.889 . . . . 0.0 109.179 178.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 92.1 mtp -101.69 112.45 25.03 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.63 0.772 . . . . 0.0 109.324 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 45.4 tp -65.93 -39.12 90.22 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.675 0.79 . . . . 0.0 110.206 -178.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 11.3 mmt -124.25 86.41 54.53 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 124.322 1.049 . . . . 0.0 108.407 173.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.37 131.36 24.64 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.253 1.969 . . . . 0.0 111.663 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.502 ' HB3' ' HB ' ' A' ' 119' ' ' ILE . 60.4 tptt -131.75 119.96 22.04 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 173.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.423 ' NE2' ' HB2' ' A' ' 116' ' ' CYS . 58.9 tp60 -108.63 106.06 15.95 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -176.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.51 97.96 5.9 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 123.677 0.791 . . . . 0.0 109.006 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.495 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . 55.9 t -78.75 124.79 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -122.45 94.33 4.26 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.8 -127.11 30.48 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.259 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -86.07 21.32 1.09 Allowed 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 123.054 2.503 . . . . 0.0 112.615 175.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.591 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 4.3 mp -129.63 167.57 17.77 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.973 0.909 . . . . 0.0 109.002 174.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 20.3 p -140.23 130.74 25.49 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 176.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 17.6 mm -105.83 132.63 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.285 1.034 . . . . 0.0 109.87 -170.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 15.9 mmt85 -99.99 122.93 43.65 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.76 1.224 . . . . 0.0 108.917 172.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.502 ' HB ' ' HB3' ' A' ' 108' ' ' LYS . 42.5 mm -122.69 121.59 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 172.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -95.5 111.83 23.66 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 168.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -78.86 -3.43 44.59 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.254 -174.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.3 -27.81 20.29 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.138 0.575 . . . . 0.0 110.505 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.408 HG21 HG11 ' A' ' 157' ' ' VAL . 39.5 mm -79.49 101.69 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-O 121.667 0.746 . . . . 0.0 111.145 -172.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.471 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 36.4 mtt -129.48 147.11 51.26 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.898 -174.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.0 t70 62.23 42.11 9.79 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.128 0.971 . . . . 0.0 111.765 175.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -119.76 147.91 44.06 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.195 0.998 . . . . 0.0 110.371 176.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.439 ' HA ' ' HB ' ' A' ' 191' ' ' THR . 44.2 m-80 -83.56 110.0 17.87 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 171.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 61.6 mt -117.54 134.13 62.12 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 123.382 0.673 . . . . 0.0 111.23 -171.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 37.7 tpp -111.59 125.61 54.12 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.513 1.925 . . . . 0.0 108.763 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.472 ' HB3' HD21 ' A' ' 147' ' ' LEU . 18.5 mt -97.23 102.59 14.39 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -98.5 149.18 22.99 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.667 0.787 . . . . 0.0 109.365 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -142.56 144.44 32.9 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 122.239 1.018 . . . . 0.0 113.723 175.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -99.52 122.51 42.69 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 163.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.537 ' HB3' HD12 ' A' ' 144' ' ' LEU . 49.7 p90 -153.15 159.78 42.77 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.268 0.556 . . . . 0.0 111.763 -175.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.7 t -90.94 156.36 18.04 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.982 177.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 72.0 t -130.72 136.03 59.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.906 1.282 . . . . 0.0 108.575 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.3 tp -145.19 144.09 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 170.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 62.39 24.18 14.38 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.661 0.785 . . . . 0.0 111.348 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.5 t70 71.03 5.46 5.49 Favored 'General case' 0 CA--C 1.564 1.511 0 C-N-CA 124.931 1.292 . . . . 0.0 111.954 -176.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -114.58 172.2 7.17 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.343 -0.848 . . . . 0.0 109.78 176.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.599 ' HB2' ' HB3' ' A' ' 201' ' ' PHE . 6.8 tt -69.39 125.49 26.84 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -83.7 -66.61 0.87 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.299 0.64 . . . . 0.0 110.247 177.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 65.9 m -149.88 131.12 14.56 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.808 1.243 . . . . 0.0 108.49 -173.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.537 HD12 ' HB3' ' A' ' 134' ' ' PHE . 44.7 tp -71.96 131.91 43.58 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 175.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.38 -50.06 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 172.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 54.4 tp -164.95 151.25 10.29 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.016 0.926 . . . . 0.0 109.358 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.709 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 7.2 tt -136.62 145.82 45.32 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 172.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.504 ' HE ' HD13 ' A' ' 156' ' ' ILE . 17.5 mtp180 -141.32 144.23 34.48 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.697 0.799 . . . . 0.0 109.599 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.11 111.86 24.77 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.399 1.08 . . . . 0.0 108.927 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.413 ' CE1' ' HB2' ' A' ' 148' ' ' ARG . 65.0 m-85 -106.6 137.2 45.04 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.191 0.996 . . . . 0.0 109.207 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 47.2 p -76.01 -179.9 5.2 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-O 121.286 0.565 . . . . 0.0 110.142 172.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -61.71 -20.44 63.49 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.515 0.726 . . . . 0.0 111.048 169.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -88.51 -1.75 58.22 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.962 1.305 . . . . 0.0 111.604 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 74.33 15.08 80.34 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-N 116.448 -0.342 . . . . 0.0 112.971 -178.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -86.01 125.0 33.08 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.426 0.69 . . . . 0.0 109.852 -176.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.504 HD13 ' HE ' ' A' ' 148' ' ' ARG . 22.6 mt -78.84 100.99 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -177.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.408 HG11 HG21 ' A' ' 123' ' ' ILE . 33.2 m -105.36 -0.16 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.138 0.975 . . . . 0.0 111.433 -173.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -162.96 167.07 37.19 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.329 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -163.47 153.36 15.28 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.709 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 63.1 mt -128.88 102.92 8.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 170.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.405 ' HA ' ' HD2' ' A' ' 162' ' ' PRO . 3.1 p -112.83 110.05 52.28 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 123.901 0.881 . . . . 0.0 109.605 -177.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.591 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 20.7 Cg_endo -60.04 127.85 24.62 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.641 2.227 . . . . 0.0 111.515 171.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.1 mt . . . . . 0 CA--C 1.55 0.943 0 C-N-CA 123.812 0.845 . . . . 0.0 110.366 177.195 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 . . . . . 0 CA--C 1.541 0.631 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 35.8 p -126.91 171.08 11.59 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.022 0.929 . . . . 0.0 110.36 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.46 ' O ' ' HG3' ' A' ' 175' ' ' LYS . 15.1 tt -50.69 -37.14 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.406 170.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -52.32 -51.29 59.53 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.338 1.455 . . . . 0.0 111.019 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -59.33 -41.1 88.34 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.949 0.9 . . . . 0.0 111.851 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.468 ' O ' HG13 ' A' ' 178' ' ' ILE . 25.9 t -64.07 -40.72 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 O-C-N 124.117 0.885 . . . . 0.0 110.52 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 171' ' ' ILE . 56.5 mtpt -61.66 -42.52 99.02 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.746 0.818 . . . . 0.0 111.165 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.47 ' O ' HG23 ' A' ' 180' ' ' VAL . 24.4 m120 -66.68 -43.24 84.97 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 123.591 0.557 . . . . 0.0 109.645 176.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -60.9 -45.08 96.03 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 124.584 1.177 . . . . 0.0 112.279 -175.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 174' ' ' VAL . 25.8 mt -69.27 -32.83 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.96 -30.64 78.31 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.433 174.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 176' ' ' ASN . 61.3 t -74.84 -51.08 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 122.813 0.445 . . . . 0.0 109.819 175.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.499 ' HA ' HD11 ' A' ' 119' ' ' ILE . 47.9 tp -54.18 -51.13 65.33 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 123.933 0.77 . . . . 0.0 111.26 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.491 ' O ' ' HG3' ' A' ' 186' ' ' GLU . 10.4 tt -62.27 -37.2 78.0 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.934 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.613 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -62.19 -42.53 99.72 Favored Glycine 0 C--N 1.351 1.366 0 O-C-N 123.287 0.367 . . . . 0.0 113.903 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -65.98 -35.85 91.23 Favored Glycine 0 C--N 1.348 1.208 0 O-C-N 123.843 0.378 . . . . 0.0 112.294 175.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 86.4 mt -68.33 -42.25 79.58 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.17 0.988 . . . . 0.0 111.49 177.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 182' ' ' ILE . 49.3 mt-10 -67.72 -38.41 83.53 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.494 0.718 . . . . 0.0 110.269 -176.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.11 -24.32 59.44 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.351 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.471 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 97.6 m-20 -68.93 -18.87 64.16 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 122.667 0.387 . . . . 0.0 111.059 170.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 35.9 t70 65.9 65.69 0.52 Allowed 'General case' 0 C--N 1.354 0.784 0 C-N-CA 124.116 0.967 . . . . 0.0 109.662 -174.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -131.14 169.09 16.38 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.694 173.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.439 ' HB ' ' HA ' ' A' ' 127' ' ' ASN . 89.5 m -84.17 114.72 22.0 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 30.0 m -97.52 136.37 28.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -145.04 128.09 16.56 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 176.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 4.8 t -103.07 150.58 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -175.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 45.8 t -60.91 141.07 57.51 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.86 -28.02 63.76 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.825 0.85 . . . . 0.0 112.249 -177.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 37.6 p -70.95 -45.25 64.48 Favored 'General case' 0 C--N 1.348 0.516 0 C-N-CA 123.544 0.738 . . . . 0.0 109.903 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 78.7 mt -65.1 -39.97 93.89 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.174 0.59 . . . . 0.0 110.52 176.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.647 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 49.5 mt-30 -60.06 -31.33 69.89 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.807 0.843 . . . . 0.0 111.101 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -83.87 -61.04 1.92 Allowed 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 123.887 0.875 . . . . 0.0 110.717 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.599 ' HB3' ' HB2' ' A' ' 141' ' ' LEU . 61.5 m-85 -71.44 -47.1 57.93 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.178 0.991 . . . . 0.0 112.84 -167.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.533 ' HB2' HD13 ' A' ' 141' ' ' LEU . . . -109.25 -58.15 2.07 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 122.944 0.497 . . . . 0.0 110.771 -170.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.647 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 40.4 t-105 . . . . . 0 N--CA 1.479 1.025 0 C-N-CA 124.751 1.221 . . . . 0.0 111.532 -175.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -90.2 108.99 20.09 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 174.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.0 mm -77.25 117.72 22.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 176.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.2 p -98.0 75.31 2.34 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -73.51 -32.02 64.03 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 113.726 -1.579 . . . . 0.0 109.966 -178.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.43 ' HB3' ' HB3' ' A' ' 131' ' ' LYS . 21.2 ptt? -109.74 138.67 45.77 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 165.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 66.7 p -65.3 157.32 29.39 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.726 0.41 . . . . 0.0 110.128 177.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.9 mp -58.07 -35.85 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -56.56 -60.3 3.73 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.092 1.357 . . . . 0.0 112.481 176.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.415 ' HG3' ' HB2' ' A' ' 93' ' ' MET . 11.9 pt-20 -70.71 -24.99 62.75 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 122.631 0.372 . . . . 0.0 111.18 -176.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.525 ' HA ' ' HE ' ' A' ' 148' ' ' ARG . 7.8 tt -65.36 -48.26 73.58 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.818 0.847 . . . . 0.0 109.622 172.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 90.5 p -84.3 -3.08 58.01 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.192 0.597 . . . . 0.0 112.389 -173.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.1 tpt85 -61.51 126.89 28.96 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.584 0.754 . . . . 0.0 110.915 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -82.42 155.07 24.86 Favored 'General case' 0 C--O 1.239 0.535 0 O-C-N 123.976 0.797 . . . . 0.0 109.801 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -161.3 169.05 22.85 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.65 0.78 . . . . 0.0 110.84 -173.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -125.89 151.82 46.38 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.201 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 72.9 mtp -109.86 105.05 14.1 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 171.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.9 tt -62.64 -44.1 97.12 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 80.4 mmm -119.58 88.37 38.8 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 123.904 0.882 . . . . 0.0 109.416 171.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.71 124.54 9.34 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.69 2.26 . . . . 0.0 112.355 -178.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.467 ' HD2' HE21 ' A' ' 121' ' ' GLN . 59.5 tttp -123.15 124.76 43.78 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.39 101.31 7.1 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -102.82 129.11 49.38 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.103 0.961 . . . . 0.0 108.815 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 72.7 t -86.76 133.8 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 173.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -128.36 85.3 2.32 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 62.31 -121.43 25.37 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.666 176.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.496 ' HB2' ' HB3' ' A' ' 169' ' ' HIS . 3.7 Cg_exo -78.92 8.48 3.75 Favored 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 123.728 2.952 . . . . 0.0 114.199 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 4.5 mp -133.62 163.5 29.28 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.375 0.67 . . . . 0.0 109.506 -178.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.486 ' SG ' ' HB2' ' A' ' 161' ' ' SER . 31.5 p -126.86 136.02 51.78 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 10.2 mm -110.43 124.91 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.304 1.042 . . . . 0.0 109.542 -169.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -108.65 121.99 46.18 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.428 1.091 . . . . 0.0 108.347 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.579 HD13 ' HA3' ' A' ' 184' ' ' GLY . 53.0 mt -131.29 121.92 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.437 ' HB3' ' HB ' ' A' ' 157' ' ' VAL . 23.8 t70 -94.49 115.28 27.42 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 175.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.467 HE21 ' HD2' ' A' ' 108' ' ' LYS . 83.6 mt-30 -81.22 -10.64 59.57 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.715 0.806 . . . . 0.0 112.016 -174.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.2 -41.68 63.53 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.266 0.626 . . . . 0.0 110.963 -176.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.6 mp -76.91 115.83 19.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.882 177.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 48.6 mtt -132.89 154.97 49.88 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.567 1.147 . . . . 0.0 110.102 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.7 t70 62.34 23.95 14.23 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.354 1.062 . . . . 0.0 112.105 176.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 190' ' ' ASN . 73.9 mmtt -105.76 149.95 25.98 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.202 0.601 . . . . 0.0 110.079 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.559 ' HB2' ' HG2' ' A' ' 152' ' ' GLU . 75.8 m-20 -83.06 106.56 14.97 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 173.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 80.5 mt -106.29 121.86 59.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 123.39 0.676 . . . . 0.0 110.147 -174.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 36.7 tpp -96.33 130.44 43.44 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.879 1.272 . . . . 0.0 109.322 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 19.2 mt -100.07 104.27 15.83 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 93' ' ' MET . 32.7 mmtp -98.8 155.4 17.38 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.998 0.919 . . . . 0.0 109.507 173.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.566 ' HB3' HD21 ' A' ' 198' ' ' LEU . . . -155.49 145.69 21.73 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 168.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -108.18 134.35 51.15 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 172.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.461 ' HA ' HD13 ' A' ' 145' ' ' ILE . 37.9 p90 -160.01 160.62 33.5 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.735 0.814 . . . . 0.0 110.589 -169.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 43.7 p -85.47 155.24 21.32 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.866 0.866 . . . . 0.0 108.81 171.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 91.0 t -116.5 154.05 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.959 0.904 . . . . 0.0 110.308 -177.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.474 ' O ' ' HG3' ' A' ' 140' ' ' ARG . 11.0 tp -156.09 134.44 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 164.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 58.14 24.76 11.66 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.961 0.904 . . . . 0.0 113.024 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.549 ' HB3' HH22 ' A' ' 200' ' ' ARG . 1.6 m-20 65.5 35.03 7.52 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.869 1.268 . . . . 0.0 111.832 -176.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 137' ' ' ILE . 7.6 ppt_? -136.24 162.93 31.61 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.679 0.792 . . . . 0.0 109.048 169.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.458 ' HB3' HG13 ' A' ' 171' ' ' ILE . 9.7 tt -68.14 110.05 3.81 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.658 0.783 . . . . 0.0 109.765 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -70.78 -64.87 0.82 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.893 0.877 . . . . 0.0 109.558 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 53.1 m -142.54 131.31 22.78 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.549 HD21 ' HB2' ' A' ' 147' ' ' LEU . 53.6 tp -73.07 129.22 37.6 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.391 0.676 . . . . 0.0 109.455 173.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.461 HD13 ' HA ' ' A' ' 134' ' ' PHE . 1.6 mp -84.9 -52.86 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 174.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 39.9 tp -162.04 148.6 13.63 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.028 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.688 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 8.9 tt -125.76 149.13 48.81 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 174.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.617 HH11 HG21 ' A' ' 156' ' ' ILE . 21.7 ttm-85 -141.93 139.75 32.61 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.025 0.93 . . . . 0.0 110.583 -176.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.492 ' HB3' ' HA3' ' A' ' 158' ' ' GLY . . . -123.87 122.46 38.05 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.487 1.115 . . . . 0.0 108.023 176.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -142.05 166.36 24.92 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.241 0.616 . . . . 0.0 110.861 -177.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 82.4 p -85.67 179.0 7.17 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.735 0.814 . . . . 0.0 110.301 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.559 ' HG2' ' HB2' ' A' ' 127' ' ' ASN . 24.3 mm-40 -63.44 -21.84 66.54 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 122.16 -0.338 . . . . 0.0 111.889 172.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -78.78 -13.7 59.67 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.014 0.525 . . . . 0.0 111.059 176.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 88.84 -2.72 84.51 Favored Glycine 0 C--N 1.349 1.254 0 N-CA-C 112.044 -0.422 . . . . 0.0 112.044 -173.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.92 108.18 2.93 Favored 'General case' 0 C--N 1.353 0.721 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -178.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.617 HG21 HH11 ' A' ' 148' ' ' ARG . 23.6 mt -77.91 128.43 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 O-C-N 123.56 0.538 . . . . 0.0 110.415 -170.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 120' ' ' ASP . 34.6 m -130.62 8.06 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 123.883 0.873 . . . . 0.0 111.228 -174.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.492 ' HA3' ' HB3' ' A' ' 149' ' ' ALA . . . -161.23 157.53 29.13 Favored Glycine 0 C--N 1.339 0.703 0 N-CA-C 111.856 -0.498 . . . . 0.0 111.856 -177.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -168.35 140.96 2.96 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.562 0.745 . . . . 0.0 109.765 -178.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.688 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 70.9 mt -123.7 112.66 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 175.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.486 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 20.3 m -112.53 118.32 45.51 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.094 0.958 . . . . 0.0 109.919 -177.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 38.8 Cg_exo -63.94 124.55 13.74 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 122.855 2.37 . . . . 0.0 112.59 176.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 CA--C 1.549 0.936 0 C-N-CA 124.343 1.057 . . . . 0.0 112.207 -177.121 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 114' ' ' PRO . 20.2 p-80 . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 76.5 p -84.27 160.44 20.75 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 173.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.505 HD11 ' HA ' ' A' ' 202' ' ' ALA . 9.4 tt -54.64 -32.96 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 123.215 0.606 . . . . 0.0 110.712 168.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.676 ' HA ' ' HE2' ' A' ' 175' ' ' LYS . 35.6 mt-10 -64.71 -33.47 76.03 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.108 -178.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -70.62 -33.16 70.71 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.408 0.683 . . . . 0.0 111.55 175.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 56.4 t -69.76 -36.04 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 122.493 0.317 . . . . 0.0 110.33 174.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.676 ' HE2' ' HA ' ' A' ' 172' ' ' GLU . 48.6 mtmt -62.3 -38.04 87.89 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 120.77 0.319 . . . . 0.0 110.389 175.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -64.02 -44.23 93.2 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.221 174.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.87 -51.09 68.34 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.742 -175.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 49.5 mt -64.46 -33.37 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.15 0.58 . . . . 0.0 109.821 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -59.4 -39.72 95.16 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-N 115.653 -0.703 . . . . 0.0 113.649 175.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 97.2 t -72.42 -44.02 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 122.767 0.427 . . . . 0.0 110.395 176.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.464 HD12 HG12 ' A' ' 119' ' ' ILE . 59.5 tp -52.59 -57.3 10.43 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.802 0.841 . . . . 0.0 111.309 177.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.592 HG23 HG21 ' A' ' 192' ' ' VAL . 50.6 mt -58.88 -45.27 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 O-C-N 124.013 0.821 . . . . 0.0 110.598 174.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -53.54 -38.13 57.6 Favored Glycine 0 C--N 1.346 1.122 0 O-C-N 123.949 0.78 . . . . 0.0 114.066 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.579 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -81.0 -28.81 44.12 Favored Glycine 0 C--N 1.348 1.195 0 N-CA-C 112.577 -0.209 . . . . 0.0 112.577 176.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.5 ' HB3' HD21 ' A' ' 190' ' ' ASN . 68.6 mt -71.83 -21.45 61.68 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.237 0.615 . . . . 0.0 110.715 174.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 19.5 mm-40 -68.76 -36.56 78.5 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.354 0.662 . . . . 0.0 110.853 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -76.97 -24.77 52.27 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 122.939 0.149 . . . . 0.0 110.824 176.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -63.95 -22.55 66.97 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.57 0.348 . . . . 0.0 110.437 167.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 13.4 t70 53.19 67.33 1.01 Allowed 'General case' 0 C--N 1.356 0.85 0 C-N-CA 124.893 1.277 . . . . 0.0 111.252 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.5 HD21 ' HB3' ' A' ' 185' ' ' LEU . 8.5 p30 -124.5 -161.31 1.0 Allowed 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.825 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 31.9 m -120.07 101.49 7.88 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.592 HG21 HG23 ' A' ' 182' ' ' ILE . 26.7 m -93.28 147.28 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 121.145 0.497 . . . . 0.0 110.386 -177.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 40.1 ttt180 -142.22 132.96 25.54 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.13 172.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.463 HG22 HD11 ' A' ' 182' ' ' ILE . 3.2 t -90.41 134.26 29.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 N-CA-C 104.802 -2.295 . . . . 0.0 104.802 175.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 27.9 t -60.35 151.74 27.04 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.142 0.428 . . . . 0.0 111.654 -173.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -51.44 -40.15 58.8 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.755 1.222 . . . . 0.0 112.241 -175.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 75.8 p -68.82 -49.29 59.7 Favored 'General case' 0 C--N 1.345 0.393 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.566 HD21 ' HB3' ' A' ' 132' ' ' ALA . 41.1 mt -61.22 -29.96 70.14 Favored 'General case' 0 C--O 1.21 -0.976 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.151 -177.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.617 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 48.9 mt-30 -68.17 -57.03 6.69 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.487 0.715 . . . . 0.0 110.956 178.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.549 HH22 ' HB3' ' A' ' 139' ' ' ASP . 0.0 OUTLIER -72.75 -21.55 61.0 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -176.196 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -83.99 -59.79 2.3 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.13 0.572 . . . . 0.0 111.034 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.505 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -114.39 -60.66 1.86 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.255 0.622 . . . . 0.0 111.546 -165.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.617 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 67.8 t-105 . . . . . 0 N--CA 1.483 1.217 0 C-N-CA 124.479 1.112 . . . . 0.0 112.685 -168.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 . . . . . 0 N--CA 1.477 0.885 0 CA-C-O 120.517 0.198 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 19.3 m-85 -96.3 108.95 21.52 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.641 0.776 . . . . 0.0 109.166 175.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 50.0 mm -78.31 116.43 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 174.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 36.8 p -98.35 72.96 2.12 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.53 ' HB3' ' O ' ' A' ' 132' ' ' ALA . 31.0 t70 -72.8 -30.76 64.33 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.056 -174.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.565 ' SD ' ' HB3' ' A' ' 148' ' ' ARG . 59.5 mtm -98.12 151.15 20.69 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 166.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 64.6 p -69.93 158.84 34.84 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 173.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 69.1 mt -59.23 -31.39 46.01 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 173.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -57.87 -55.98 27.87 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.434 171.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -61.41 -38.67 87.94 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.012 0.525 . . . . 0.0 111.311 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.9 tt -63.89 -38.91 92.85 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.128 0.971 . . . . 0.0 109.378 -177.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.8 t -108.9 20.38 18.52 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 123.875 0.87 . . . . 0.0 111.066 -176.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.544 ' HD3' HD11 ' A' ' 156' ' ' ILE . 76.8 ttt180 -78.3 142.57 37.68 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.762 0.825 . . . . 0.0 111.696 -174.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -82.73 138.02 34.21 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.939 0.895 . . . . 0.0 110.524 176.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . 0.512 ' CZ3' ' SD ' ' A' ' 104' ' ' MET . 11.3 p-90 -157.33 160.28 38.36 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.842 1.257 . . . . 0.0 109.825 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -110.89 159.65 17.5 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.431 0.692 . . . . 0.0 111.693 -173.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.512 ' SD ' ' CZ3' ' A' ' 102' ' ' TRP . 99.2 mmm -120.65 93.06 3.91 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.237 1.015 . . . . 0.0 108.758 172.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.439 HD23 ' HB1' ' A' ' 122' ' ' ALA . 50.4 tp -71.8 -43.34 65.81 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.3 mmt -129.17 81.41 70.6 Favored Pre-proline 0 N--CA 1.479 1.002 0 C-N-CA 123.94 0.896 . . . . 0.0 109.353 175.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.75 145.56 46.46 Favored 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 122.104 1.869 . . . . 0.0 111.652 177.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.441 ' HD3' HE21 ' A' ' 121' ' ' GLN . 20.6 ttpp -124.93 120.89 32.91 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 172.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.36 104.64 11.04 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.459 0.704 . . . . 0.0 109.624 -174.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -132.73 135.83 46.0 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.992 0.917 . . . . 0.0 109.467 172.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.2 t -125.4 142.79 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 166.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -123.34 91.6 3.51 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 176.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.37 -112.76 5.26 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.999 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -91.75 8.36 3.07 Favored 'Trans proline' 0 C--N 1.368 1.593 0 C-N-CA 123.27 2.647 . . . . 0.0 113.273 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 162' ' ' PRO . 61.4 mt -130.44 116.45 18.25 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.516 0.727 . . . . 0.0 109.656 -170.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 41.9 t -83.34 127.23 33.49 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.231 0.612 . . . . 0.0 110.256 -177.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.8 mm -106.94 110.03 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.232 0 C-N-CA 124.034 0.933 . . . . 0.0 110.58 -173.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -92.81 125.89 37.63 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.487 0.715 . . . . 0.0 109.858 173.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.574 HD13 ' HA3' ' A' ' 184' ' ' GLY . 73.2 mt -131.89 123.73 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.237 1.015 . . . . 0.0 108.561 176.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -99.49 120.76 40.14 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.44 0.696 . . . . 0.0 109.498 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.441 HE21 ' HD3' ' A' ' 108' ' ' LYS . 80.5 mt-30 -84.99 -14.96 45.82 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.619 1.168 . . . . 0.0 111.734 -174.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.439 ' HB1' HD23 ' A' ' 105' ' ' LEU . . . -68.57 -38.4 80.68 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.01 0.524 . . . . 0.0 111.106 -176.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.485 HG23 ' HG3' ' A' ' 126' ' ' LYS . 1.8 mp -87.07 112.79 23.63 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 CA-C-O 121.969 0.89 . . . . 0.0 109.7 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 48.0 mtt -129.23 159.5 35.9 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.859 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.8 t70 76.21 12.14 2.78 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 124.667 1.187 . . . . 0.0 112.365 172.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.485 ' HG3' HG23 ' A' ' 123' ' ' ILE . 75.1 mmtt -99.79 151.99 20.63 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.48 0.712 . . . . 0.0 111.976 -173.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -90.38 112.19 23.7 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 168.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.464 HD12 HD22 ' A' ' 185' ' ' LEU . 65.3 mt -114.01 135.23 54.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.965 0.888 . . . . 0.0 111.325 -171.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.536 ' HG3' ' HG3' ' A' ' 131' ' ' LYS . 8.0 tpt -102.81 121.65 42.92 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.203 1.801 . . . . 0.0 109.643 -172.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.46 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 3.7 mm? -96.25 104.75 16.73 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.536 ' HG3' ' HG3' ' A' ' 129' ' ' MET . 90.8 mttt -125.58 149.4 48.4 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.455 0.702 . . . . 0.0 110.497 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.616 ' HB3' HD21 ' A' ' 198' ' ' LEU . . . -149.37 152.99 36.72 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -174.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -102.77 128.44 49.5 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 169.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -154.97 155.44 34.22 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.544 0.738 . . . . 0.0 109.871 -170.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 58.1 p -87.48 169.58 12.09 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.246 0.618 . . . . 0.0 109.775 172.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 79.5 t -132.15 136.3 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 123.564 0.746 . . . . 0.0 110.595 -173.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 7.5 tp -146.18 139.6 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 169.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 60.94 33.11 19.93 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 124.195 0.998 . . . . 0.0 111.936 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.3 t70 65.75 18.66 11.22 Favored 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 125.341 1.456 . . . . 0.0 111.644 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -132.54 172.9 11.9 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.815 -0.553 . . . . 0.0 109.643 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.468 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 10.3 tt -64.63 126.77 28.94 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -88.99 -77.8 0.37 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.991 0.516 . . . . 0.0 109.951 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.1 m -125.64 137.62 53.88 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.773 0.829 . . . . 0.0 109.321 -173.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 50.3 tp -82.96 126.64 32.74 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 174.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.43 -51.7 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 172.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 50.9 tp -164.19 146.73 9.13 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.833 0.853 . . . . 0.0 109.121 177.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.723 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 8.0 tt -125.5 154.75 41.63 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.702 HH11 HG21 ' A' ' 156' ' ' ILE . 47.3 ttm-85 -150.18 138.75 20.66 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 123.131 0.573 . . . . 0.0 110.971 -173.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -115.57 115.58 26.68 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 175.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.408 ' HD1' ' HG2' ' A' ' 148' ' ' ARG . 31.6 p90 -136.08 145.98 46.53 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.543 0.737 . . . . 0.0 109.59 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 54.5 p -69.32 175.84 3.71 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.79 0.836 . . . . 0.0 111.01 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -54.69 -32.38 59.36 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.687 0.795 . . . . 0.0 111.617 172.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -70.98 -29.24 65.16 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.944 1.298 . . . . 0.0 110.801 179.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 100.05 8.57 50.55 Favored Glycine 0 C--N 1.345 1.064 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.565 -173.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -73.16 104.56 4.26 Favored 'General case' 0 C--N 1.352 0.713 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 177.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.702 HG21 HH11 ' A' ' 148' ' ' ARG . 24.1 mt -75.93 122.72 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -175.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.404 HG11 HG21 ' A' ' 123' ' ' ILE . 30.4 m -130.74 9.53 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.636 0.774 . . . . 0.0 111.065 -175.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -159.89 159.26 30.51 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.428 -178.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -165.67 150.99 8.92 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.353 0.661 . . . . 0.0 109.457 -177.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.723 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 71.0 mt -131.4 106.85 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 170.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 78.9 p -109.18 119.05 49.7 Favored Pre-proline 0 C--O 1.24 0.556 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.46 ' HA ' HD23 ' A' ' 115' ' ' LEU . 11.1 Cg_endo -55.48 134.78 65.88 Favored 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 122.254 1.969 . . . . 0.0 111.384 168.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 90.0 mt . . . . . 0 CA--C 1.546 0.803 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 175.303 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 57.9 p -82.48 173.15 12.26 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.64 0.376 . . . . 0.0 110.902 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.477 HD11 ' HA ' ' A' ' 202' ' ' ALA . 7.7 tt -51.67 -40.84 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.088 171.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -65.12 -36.57 84.68 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.842 0.857 . . . . 0.0 111.216 -173.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -62.74 -42.08 99.5 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 123.694 0.621 . . . . 0.0 110.604 174.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.526 ' O ' HG13 ' A' ' 178' ' ' ILE . 40.6 t -63.17 -41.9 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 123.829 0.706 . . . . 0.0 109.921 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 171' ' ' ILE . 57.7 mtpt -57.55 -42.69 83.47 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.815 0.846 . . . . 0.0 111.206 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.452 ' O ' HG23 ' A' ' 180' ' ' VAL . 63.0 m-80 -66.15 -47.44 74.05 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.993 0.517 . . . . 0.0 110.123 176.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.42 -42.28 86.9 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.462 1.101 . . . . 0.0 112.053 -175.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.526 HG13 ' O ' ' A' ' 174' ' ' VAL . 53.1 mt -60.75 -41.45 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 177.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -68.05 -26.68 73.94 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.66 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 176' ' ' ASN . 69.5 t -72.56 -50.06 37.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 123.414 0.686 . . . . 0.0 109.926 176.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 15.7 tp -59.41 -46.08 89.7 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.708 177.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.531 HD11 HG22 ' A' ' 194' ' ' VAL . 32.2 mt -56.76 -49.17 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.588 1.155 . . . . 0.0 111.299 174.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.43 ' O ' ' HG3' ' A' ' 187' ' ' ARG . . . -55.28 -42.14 81.63 Favored Glycine 0 C--N 1.343 0.923 0 O-C-N 124.149 0.905 . . . . 0.0 113.618 -178.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.574 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -71.29 -34.84 63.89 Favored Glycine 0 C--N 1.347 1.189 0 O-C-N 123.787 0.345 . . . . 0.0 113.084 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.464 HD22 HD12 ' A' ' 128' ' ' ILE . 95.0 mt -64.02 -40.74 97.0 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.372 0.669 . . . . 0.0 110.556 175.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -63.37 -35.34 80.08 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.607 0.763 . . . . 0.0 111.012 178.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 183' ' ' GLY . 83.0 mtp180 -64.99 -39.0 92.82 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.302 0.641 . . . . 0.0 110.451 175.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.404 ' ND2' ' HA ' ' A' ' 121' ' ' GLN . 5.7 m-20 -70.92 -3.92 21.79 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.987 0.915 . . . . 0.0 112.082 175.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.9 t70 65.95 46.39 2.24 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 122.646 1.212 . . . . 0.0 109.089 -176.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -111.08 138.37 47.59 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.088 177.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 26.6 m -79.79 114.02 18.39 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -177.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.412 HG21 HG23 ' A' ' 182' ' ' ILE . 27.3 m -92.65 139.01 18.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.612 -174.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -149.18 146.38 27.61 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.948 171.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.531 HG22 HD11 ' A' ' 182' ' ' ILE . 2.8 t -109.06 147.27 13.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 -175.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 27.2 t -61.0 152.3 28.24 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 118.158 0.435 . . . . 0.0 111.292 -174.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.37 -41.05 62.76 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 124.297 0.998 . . . . 0.0 110.988 179.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 57.9 p -70.49 -52.2 23.64 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.083 0.953 . . . . 0.0 110.01 178.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.616 HD21 ' HB3' ' A' ' 132' ' ' ALA . 34.9 mt -58.9 -29.68 67.22 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.751 0.82 . . . . 0.0 112.128 -176.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.572 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 47.5 mt-30 -72.09 -54.65 9.14 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.26 0.624 . . . . 0.0 110.554 177.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.81 -9.22 59.38 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -174.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -100.82 -50.46 3.84 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.008 0.523 . . . . 0.0 111.556 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.477 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -113.6 -62.47 1.59 Allowed 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -168.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.572 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 65.9 t-105 . . . . . 0 N--CA 1.481 1.08 0 C-N-CA 124.891 1.276 . . . . 0.0 111.246 -165.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.9 ttp180 . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -123.21 109.12 13.58 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.122 0.969 . . . . 0.0 109.322 173.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 36.1 mm -82.35 133.95 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 171.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 37.8 p -126.96 93.43 3.76 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.104 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -77.9 -25.88 48.76 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.73 177.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.659 ' SD ' ' HG2' ' A' ' 148' ' ' ARG . 40.1 mtm -104.83 129.16 53.18 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 124.199 0.999 . . . . 0.0 108.495 178.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 69.9 p -87.61 175.16 8.03 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 170.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 83.5 mt -56.43 -32.36 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 123.709 0.804 . . . . 0.0 111.116 -177.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 100' ' ' ARG . 39.4 mt-10 -48.76 -55.5 11.32 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.152 1.381 . . . . 0.0 113.547 177.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -95.66 -25.73 16.01 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 118.039 0.382 . . . . 0.0 111.009 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.5 tt -66.72 -49.49 65.85 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -176.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.7 m -95.63 16.25 17.76 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.824 0.849 . . . . 0.0 110.86 -177.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 96' ' ' GLU . 73.9 ttt180 -82.28 126.84 32.59 Favored 'General case' 0 C--N 1.35 0.604 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -80.43 128.17 33.26 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 169.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -137.18 164.82 27.57 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.261 0.624 . . . . 0.0 110.293 -174.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -134.84 149.99 50.42 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.286 0.634 . . . . 0.0 109.676 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 10.8 ptm -126.0 128.57 47.66 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.4 tp -69.88 -41.22 75.06 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.719 0.807 . . . . 0.0 111.316 -170.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.413 ' O ' ' HA ' ' A' ' 120' ' ' ASP . 4.0 mmt -116.67 88.1 23.66 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 123.792 0.837 . . . . 0.0 109.864 173.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -74.8 137.58 22.4 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.678 2.252 . . . . 0.0 113.201 -177.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -130.67 135.43 47.83 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.058 0.943 . . . . 0.0 108.469 166.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -121.82 123.75 42.51 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 173.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -144.24 121.53 11.59 Favored 'General case' 0 C--O 1.217 -0.623 0 C-N-CA 123.374 0.669 . . . . 0.0 109.241 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 97.1 t -79.23 137.67 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.029 0.531 . . . . 0.0 110.501 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -125.12 85.42 2.41 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 171.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.89 -119.42 6.41 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.279 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -89.74 16.73 1.69 Allowed 'Trans proline' 0 CA--C 1.552 1.411 0 C-N-CA 123.531 2.821 . . . . 0.0 113.044 177.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.52 HD23 ' HA ' ' A' ' 162' ' ' PRO . 96.1 mt -128.85 151.91 49.09 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.844 0.858 . . . . 0.0 109.965 -176.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 36.1 t -115.28 131.2 57.0 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.177 0.991 . . . . 0.0 108.897 177.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.4 mm -106.34 139.6 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.562 0.745 . . . . 0.0 109.219 -177.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -119.29 119.73 34.9 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 175.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.436 HD13 ' HA3' ' A' ' 184' ' ' GLY . 69.9 mt -126.05 124.08 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -178.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' A' ' 106' ' ' MET . 24.4 t70 -97.59 123.27 41.42 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.837 0.455 . . . . 0.0 110.24 174.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.46 ' HA ' HD21 ' A' ' 188' ' ' ASN . 77.6 mt-30 -88.35 -11.2 46.94 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.21 -50.32 14.81 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.156 0.503 . . . . 0.0 111.454 -174.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.8 mp -72.34 112.67 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.706 1.202 . . . . 0.0 109.523 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.2 mtt -130.3 162.71 28.4 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.481 1.112 . . . . 0.0 109.974 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 73.78 18.96 3.28 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 125.037 1.335 . . . . 0.0 112.915 176.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -111.43 149.58 31.05 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.449 0.7 . . . . 0.0 111.716 -173.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -87.99 102.78 15.07 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 171.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.489 HG12 HG22 ' A' ' 151' ' ' THR . 54.8 mt -106.56 131.14 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.003 0.521 . . . . 0.0 109.92 -173.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 14.7 tpt -106.08 127.1 52.95 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.209 1.004 . . . . 0.0 109.688 -172.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.453 HD12 HG22 ' A' ' 194' ' ' VAL . 25.7 mt -99.16 105.08 17.11 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -177.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -130.42 145.56 51.84 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.42 0.688 . . . . 0.0 111.13 -175.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.49 155.43 46.66 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -170.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -109.02 122.19 46.72 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 166.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -155.84 161.07 40.67 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.692 0.797 . . . . 0.0 110.546 -170.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.7 p -86.56 163.77 17.28 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.688 173.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 90.0 t -139.04 137.26 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.667 1.187 . . . . 0.0 109.109 -174.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.2 tp -152.04 144.17 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 172.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 57.99 26.5 13.54 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 124.248 1.019 . . . . 0.0 111.767 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 57.63 44.32 20.98 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.655 1.182 . . . . 0.0 111.345 -174.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -146.74 166.79 25.55 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.162 169.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.507 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 9.6 tt -64.21 123.55 19.38 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -79.38 -70.28 0.52 Allowed 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 175.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 99.8 m -143.71 135.4 26.27 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.064 0.946 . . . . 0.0 109.185 177.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.475 ' HB3' ' NE2' ' A' ' 169' ' ' HIS . 62.7 tp -77.98 126.67 31.18 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.828 0.851 . . . . 0.0 109.716 178.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.58 -49.96 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 174.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.425 HD21 ' NH2' ' A' ' 148' ' ' ARG . 51.0 tp -162.66 147.59 12.03 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.408 0.683 . . . . 0.0 109.664 -178.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.62 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 8.8 tt -138.88 154.67 48.41 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.659 ' HG2' ' SD ' ' A' ' 93' ' ' MET . 10.8 ptp180 -153.7 158.33 40.87 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.78 0.8 . . . . 0.0 111.738 173.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.528 ' HB2' HD21 ' A' ' 181' ' ' LEU . . . -111.29 116.1 30.43 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.294 1.438 . . . . 0.0 107.748 176.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.476 ' HD1' ' HG3' ' A' ' 148' ' ' ARG . 44.6 p90 -134.69 136.78 43.0 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.067 0.547 . . . . 0.0 110.333 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.489 HG22 HG12 ' A' ' 128' ' ' ILE . 52.7 p -63.96 177.49 0.77 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.484 1.114 . . . . 0.0 112.364 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -64.99 -17.55 64.52 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.479 0.712 . . . . 0.0 112.384 173.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -81.7 -24.04 36.44 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 122.819 0.448 . . . . 0.0 109.826 172.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 101.23 3.56 54.01 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.576 -175.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -68.7 103.38 1.72 Allowed 'General case' 0 C--N 1.352 0.717 0 C-N-CA 123.489 0.716 . . . . 0.0 109.776 -178.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.588 HD13 HH11 ' A' ' 148' ' ' ARG . 14.5 mt -73.14 116.72 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -178.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.3 m -123.08 3.48 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.167 0.987 . . . . 0.0 111.17 -176.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -154.84 161.69 30.42 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.609 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 38.8 tt0 -166.0 144.65 5.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 122.687 0.395 . . . . 0.0 110.267 -177.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.62 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 68.8 mt -126.77 116.38 44.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 173.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 19.3 m -126.4 141.52 40.23 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 123.465 0.706 . . . . 0.0 109.954 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.52 ' HA ' HD23 ' A' ' 115' ' ' LEU . 32.0 Cg_exo -58.87 147.22 90.21 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.672 2.248 . . . . 0.0 112.171 173.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 76.3 mt . . . . . 0 CA--C 1.546 0.804 0 C-N-CA 122.777 0.431 . . . . 0.0 110.454 179.559 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.475 ' NE2' ' HB3' ' A' ' 144' ' ' LEU . 51.6 p-80 . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 121.073 0.463 . . . . 0.0 110.484 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 14.8 m -107.95 162.92 13.58 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.284 1.033 . . . . 0.0 109.692 -177.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.589 HD11 ' HA ' ' A' ' 202' ' ' ALA . 14.9 tt -54.63 -35.08 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 125.743 1.617 . . . . 0.0 113.465 178.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -63.12 -29.43 70.79 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.377 0.671 . . . . 0.0 111.331 -176.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -71.6 -38.86 70.8 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.159 0.584 . . . . 0.0 110.295 175.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 44.7 t -67.4 -41.72 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 124.067 0.854 . . . . 0.0 111.373 -175.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -65.32 -33.58 76.31 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 122.949 0.155 . . . . 0.0 110.854 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -70.23 -39.91 74.79 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.911 0.484 . . . . 0.0 109.719 175.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.58 -47.59 80.87 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.338 1.055 . . . . 0.0 111.353 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 73.2 mt -63.44 -35.05 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.532 0.733 . . . . 0.0 109.477 176.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -60.77 -36.3 91.58 Favored Glycine 0 C--N 1.349 1.278 0 O-C-N 123.586 0.554 . . . . 0.0 113.986 176.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 98.8 t -72.04 -45.99 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.135 0.574 . . . . 0.0 110.015 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.528 HD21 ' HB2' ' A' ' 149' ' ' ALA . 41.0 tp -58.23 -45.2 88.14 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.725 0.81 . . . . 0.0 111.168 178.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.485 ' O ' ' HG2' ' A' ' 186' ' ' GLU . 49.0 mt -62.05 -50.86 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.996 0.918 . . . . 0.0 110.169 175.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.413 ' O ' ' HG2' ' A' ' 187' ' ' ARG . . . -53.69 -37.81 57.66 Favored Glycine 0 C--N 1.346 1.089 0 O-C-N 124.067 0.854 . . . . 0.0 113.964 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.436 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -71.64 -38.43 61.38 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 123.676 0.28 . . . . 0.0 112.937 175.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.473 HD22 HD12 ' A' ' 128' ' ' ILE . 95.0 mt -72.36 -21.75 61.26 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.427 0.691 . . . . 0.0 111.469 176.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 11.6 mm-40 -74.76 -32.48 62.08 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.291 0.636 . . . . 0.0 109.64 176.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 183' ' ' GLY . 17.8 mmt180 -63.55 -39.12 93.59 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.375 172.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.46 HD21 ' HA ' ' A' ' 121' ' ' GLN . 4.6 m-20 -75.47 -5.6 45.9 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.582 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 26.9 t70 63.6 21.86 12.9 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 123.977 0.911 . . . . 0.0 110.748 -177.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -80.95 138.15 36.11 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.129 0.972 . . . . 0.0 110.412 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 41.1 m -79.78 103.04 9.41 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.462 HG21 HG23 ' A' ' 182' ' ' ILE . 25.5 m -85.17 143.81 10.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.023 -177.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -143.87 127.32 16.88 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 168.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.453 HG22 HD12 ' A' ' 130' ' ' LEU . 7.8 t -88.27 146.53 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 27.7 t -57.32 144.32 36.33 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 118.429 0.558 . . . . 0.0 111.02 -176.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -55.76 -31.52 62.63 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.209 0.603 . . . . 0.0 111.11 -178.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 37.7 p -67.65 -57.53 6.24 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.808 172.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 56.3 mt -59.47 -25.32 64.31 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.07 0.948 . . . . 0.0 112.02 -174.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.615 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 49.9 mt-30 -74.63 -55.22 6.13 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.093 0.557 . . . . 0.0 110.242 178.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.82 -24.34 60.89 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 116.81 -0.177 . . . . 0.0 111.379 -174.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -84.56 -52.19 6.31 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.322 0.649 . . . . 0.0 110.764 177.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.589 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -114.64 -42.8 3.22 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -165.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.615 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 27.9 t-105 . . . . . 0 N--CA 1.488 1.437 0 C-N-CA 122.908 0.483 . . . . 0.0 111.972 -168.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 26.3 ttt . . . . . 0 N--CA 1.477 0.878 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.506 ' HG2' HD11 ' A' ' 137' ' ' ILE . 34.0 Cg_endo -63.96 151.47 85.09 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.287 1.991 . . . . 0.0 111.077 168.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.89 124.22 20.18 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.587 0.755 . . . . 0.0 111.239 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 55.8 p -88.31 126.63 35.28 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.451 0.7 . . . . 0.0 109.413 175.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.574 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 74.7 ttt180 -95.93 153.33 17.82 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.544 0.737 . . . . 0.0 109.21 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -121.96 121.17 36.47 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 175.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.429 HG22 ' HB2' ' A' ' 92' ' ' ASP . 49.0 mm -91.25 112.9 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.5 p -98.75 65.54 1.56 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 170.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 132' ' ' ALA . 27.5 t70 -67.61 -41.07 84.6 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 113.489 -1.687 . . . . 0.0 110.361 -177.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -109.84 151.02 27.55 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 173.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.5 m -86.82 154.23 21.05 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.593 0.357 . . . . 0.0 111.126 -170.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 49.8 mm -63.13 -35.91 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 123.157 0.583 . . . . 0.0 110.424 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -47.66 -46.64 29.27 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.859 1.264 . . . . 0.0 112.743 174.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.38 -20.11 20.02 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.204 -175.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.489 ' HG ' HD23 ' A' ' 146' ' ' LEU . 8.7 tt -69.03 -35.77 76.98 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.739 0.815 . . . . 0.0 109.812 174.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.8 m -97.84 12.01 35.38 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.84 0.856 . . . . 0.0 110.753 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -79.41 131.58 36.13 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.533 0.733 . . . . 0.0 109.868 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -81.47 140.64 34.48 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 38.4 p-90 -158.7 176.22 12.64 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.086 0.954 . . . . 0.0 109.044 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -151.88 166.68 30.69 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.636 0.775 . . . . 0.0 109.259 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 74.4 mtm -102.07 127.8 48.81 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.066 0.546 . . . . 0.0 109.788 170.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.518 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.2 pt? -78.31 -33.3 49.43 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.11 0.564 . . . . 0.0 110.638 178.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 23.5 mmt -120.0 80.7 26.65 Favored Pre-proline 0 N--CA 1.485 1.287 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 168.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -73.23 129.23 13.75 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.669 2.246 . . . . 0.0 112.579 -173.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -134.81 121.84 21.23 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 174.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -109.65 110.24 21.23 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -174.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.461 ' HG2' HG11 ' A' ' 180' ' ' VAL . 22.1 tptm -100.79 133.6 45.02 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 169.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.8 t -103.61 126.92 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 171.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -131.46 88.65 2.61 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.29 -124.16 13.1 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.315 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -91.07 13.55 2.11 Favored 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 123.113 2.542 . . . . 0.0 112.476 176.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.1 mt -128.83 114.84 17.04 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.695 0.798 . . . . 0.0 108.916 -171.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.638 ' SG ' ' HB2' ' A' ' 161' ' ' SER . 25.6 p -89.8 114.14 25.82 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.062 0.458 . . . . 0.0 110.364 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.416 ' HB ' ' HB3' ' A' ' 110' ' ' LYS . 12.0 mm -86.07 121.0 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 124.812 1.245 . . . . 0.0 110.607 -175.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -94.18 118.44 31.57 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 33.1 mm -118.26 121.84 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -102.41 114.33 28.43 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 169.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -71.01 -16.8 62.64 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -176.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.13 -26.04 25.43 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 118.169 0.441 . . . . 0.0 111.954 -174.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.555 HG13 ' HB ' ' A' ' 157' ' ' VAL . 29.2 mm -70.55 104.08 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 122.493 0.317 . . . . 0.0 110.46 -176.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 48.1 mtt -134.41 152.38 51.76 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.376 1.07 . . . . 0.0 109.702 -176.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.3 t70 71.89 7.84 5.92 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.608 1.163 . . . . 0.0 112.129 174.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -93.03 151.27 19.98 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.778 0.831 . . . . 0.0 110.532 -175.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -95.22 108.64 20.78 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 171.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.613 ' HB ' HG12 ' A' ' 192' ' ' VAL . 66.5 mt -115.52 149.15 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.405 0.682 . . . . 0.0 110.167 -170.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 55.8 tpp -125.31 134.36 52.28 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.149 0.979 . . . . 0.0 109.504 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -94.3 103.38 15.39 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.477 ' HG3' ' CE1' ' A' ' 150' ' ' PHE . 25.1 mmmt -114.52 149.94 35.66 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.62 1.168 . . . . 0.0 109.229 -173.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.536 ' HB2' ' HG ' ' A' ' 147' ' ' LEU . . . -153.49 144.12 22.57 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -104.92 133.68 49.31 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 167.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.481 ' HA ' HG13 ' A' ' 145' ' ' ILE . 28.4 p90 -162.16 164.19 28.02 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.182 0.515 . . . . 0.0 111.569 -172.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.1 t -88.53 157.4 18.63 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.614 172.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' A' ' 88' ' ' ARG . 74.1 t -136.31 140.01 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.303 1.041 . . . . 0.0 109.028 -174.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.506 HD11 ' HG2' ' A' ' 85' ' ' PRO . 7.9 tp -145.95 140.55 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 172.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 58.82 26.96 15.44 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.753 0.821 . . . . 0.0 112.34 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.0 t70 72.29 14.41 5.48 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.338 1.455 . . . . 0.0 111.895 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -123.54 160.71 26.42 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.12 0.568 . . . . 0.0 109.764 175.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.434 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 8.7 tt -62.87 119.04 8.61 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 177.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -82.67 -69.38 0.63 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.158 0.983 . . . . 0.0 109.135 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 93.8 m -137.17 129.71 30.01 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.647 0.779 . . . . 0.0 109.271 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.492 HD21 ' HB2' ' A' ' 147' ' ' LEU . 52.2 tp -73.13 123.51 23.74 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.641 0.776 . . . . 0.0 109.449 176.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.481 HG13 ' HA ' ' A' ' 134' ' ' PHE . 69.0 mt -83.79 -48.56 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.489 HD23 ' HG ' ' A' ' 98' ' ' LEU . 49.2 tp -161.98 149.57 14.42 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.899 0.88 . . . . 0.0 109.503 172.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.715 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 7.7 tt -126.52 142.74 51.44 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 172.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.559 HH11 HG21 ' A' ' 156' ' ' ILE . 46.6 ttm-85 -135.0 137.57 43.15 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.772 1.229 . . . . 0.0 110.53 -177.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.567 ' HB2' HD21 ' A' ' 181' ' ' LEU . . . -111.67 118.6 36.1 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 171.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.477 ' CE1' ' HG3' ' A' ' 131' ' ' LYS . 29.2 p90 -143.39 160.41 40.6 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 40.8 p -80.83 170.82 15.79 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.003 -174.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.27 -11.39 60.87 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 120.735 0.302 . . . . 0.0 111.11 171.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -71.03 -30.19 66.32 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.852 0.861 . . . . 0.0 110.066 168.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 106.6 -4.93 37.24 Favored Glycine 0 C--N 1.352 1.447 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.443 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -77.66 122.34 25.19 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.388 0.675 . . . . 0.0 110.493 -174.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.559 HG21 HH11 ' A' ' 148' ' ' ARG . 39.3 mt -76.53 103.99 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.212 0.605 . . . . 0.0 110.651 -175.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.555 ' HB ' HG13 ' A' ' 123' ' ' ILE . 27.2 m -99.27 -9.49 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 123.74 0.816 . . . . 0.0 112.061 -172.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -167.79 173.03 42.75 Favored Glycine 0 C--N 1.34 0.785 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 147' ' ' LEU . 37.5 tt0 -164.08 157.79 18.64 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.715 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 93.6 mt -123.53 103.87 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 167.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.638 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 2.7 m -93.7 109.47 41.41 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.563 -177.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -64.34 119.11 6.06 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.624 2.216 . . . . 0.0 111.307 172.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.472 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 94.7 mt -58.36 124.51 71.57 Favored Pre-proline 0 CA--C 1.545 0.751 0 O-C-N 124.051 0.844 . . . . 0.0 110.411 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 163' ' ' LEU . 16.8 Cg_exo -66.31 -24.18 50.81 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 123.397 2.732 . . . . 0.0 112.045 -172.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 77.7 p -74.05 -4.21 34.05 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.981 0.913 . . . . 0.0 111.809 177.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -123.96 81.39 56.51 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 124.251 1.02 . . . . 0.0 109.332 176.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -85.92 -6.05 8.65 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.329 2.019 . . . . 0.0 112.716 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -121.63 63.71 0.51 Allowed Glycine 0 C--N 1.344 0.984 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -175.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 16.0 p-80 -108.0 157.62 18.08 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 175.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 5.0 m -102.17 162.25 13.06 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.618 0.767 . . . . 0.0 110.199 -173.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.437 HD11 ' HA ' ' A' ' 202' ' ' ALA . 17.8 tt -56.78 -28.98 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 C-N-CA 124.95 1.3 . . . . 0.0 111.819 173.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -54.86 -42.79 72.44 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.721 1.208 . . . . 0.0 111.607 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.01 -44.0 90.64 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.809 0.844 . . . . 0.0 110.482 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.484 ' O ' HG13 ' A' ' 178' ' ' ILE . 50.9 t -65.58 -48.66 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.633 -172.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -58.15 -36.08 72.47 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.595 0.758 . . . . 0.0 111.757 -175.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.429 ' O ' HG23 ' A' ' 180' ' ' VAL . 16.2 m120 -74.02 -43.09 59.14 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.618 0.767 . . . . 0.0 110.142 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -59.56 -42.15 91.77 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.185 0.928 . . . . 0.0 111.562 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 174' ' ' VAL . 62.0 mt -57.71 -42.8 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 123.734 0.813 . . . . 0.0 109.171 177.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.66 ' HA3' ' HB2' ' A' ' 208' ' ' GLU . . . -76.9 -22.43 71.79 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-N 114.662 -1.154 . . . . 0.0 114.431 -175.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.461 HG11 ' HG2' ' A' ' 110' ' ' LYS . 97.6 t -73.5 -43.43 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 172.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.641 HD22 HG13 ' A' ' 160' ' ' ILE . 33.0 tp -58.97 -48.85 80.06 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.656 173.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.51 ' O ' ' HG2' ' A' ' 186' ' ' GLU . 70.0 mt -60.46 -44.66 96.81 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.997 0 C-N-CA 123.856 0.862 . . . . 0.0 110.61 176.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.449 ' O ' ' HG3' ' A' ' 187' ' ' ARG . . . -56.67 -39.31 85.89 Favored Glycine 0 C--N 1.342 0.869 0 O-C-N 123.512 0.508 . . . . 0.0 113.268 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -67.01 -41.21 93.3 Favored Glycine 0 C--N 1.353 1.489 0 N-CA-C 112.058 -0.417 . . . . 0.0 112.058 174.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 182' ' ' ILE . 76.9 mt -62.96 -34.32 77.26 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.012 0.925 . . . . 0.0 111.043 176.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 31.1 mm-40 -68.41 -42.63 78.71 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 123.922 0.889 . . . . 0.0 109.827 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 183' ' ' GLY . 74.0 mtp180 -60.35 -38.38 83.62 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.299 0.64 . . . . 0.0 110.65 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -72.72 -14.21 61.51 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.951 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 36.6 t70 64.12 67.22 0.6 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.977 0.911 . . . . 0.0 110.819 -177.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -104.63 -162.82 0.91 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 170.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.1 m -135.0 101.0 4.74 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 169.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.613 HG12 ' HB ' ' A' ' 128' ' ' ILE . 8.2 m -111.02 153.26 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 121.784 0.802 . . . . 0.0 111.02 -172.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 52.2 ttm-85 -139.58 142.23 37.14 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.032 -1.44 . . . . 0.0 107.895 174.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.41 HG22 HD11 ' A' ' 182' ' ' ILE . 3.4 t -88.14 145.65 7.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 34.3 t -57.68 144.32 38.3 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.581 0.352 . . . . 0.0 111.272 178.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -45.8 -37.78 6.45 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 124.429 1.081 . . . . 0.0 112.062 174.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 70.5 p -69.29 -55.54 10.18 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 123.525 0.73 . . . . 0.0 110.271 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.44 HD21 ' HB3' ' A' ' 132' ' ' ALA . 73.3 mt -62.17 -31.99 72.55 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.261 0.624 . . . . 0.0 111.413 -175.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.569 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 49.7 mt-30 -62.1 -50.38 72.15 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.496 0.718 . . . . 0.0 111.131 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.25 -20.11 35.13 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -175.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -87.38 -62.31 1.53 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.8 0.44 . . . . 0.0 111.285 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.437 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -111.05 -51.95 2.82 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.315 0.646 . . . . 0.0 111.679 -162.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.569 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 57.5 t-105 -61.38 -79.62 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.37 1.468 . . . . 0.0 110.675 -173.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 50.71 -125.68 23.43 Favored Glycine 0 C--N 1.35 1.353 0 C-N-CA 123.834 0.73 . . . . 0.0 114.847 171.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 30.4 t -74.53 -39.68 62.2 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.645 0.778 . . . . 0.0 110.126 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 27.5 p -86.21 75.43 9.87 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.527 0.731 . . . . 0.0 110.405 -177.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -110.52 135.45 51.16 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.055 -176.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.66 ' HB2' ' HA3' ' A' ' 179' ' ' GLY . 8.6 mm-40 -79.21 143.09 35.69 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.422 0.689 . . . . 0.0 109.639 175.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -145.92 148.89 33.29 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.055 0.542 . . . . 0.0 109.828 -176.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 132.83 145.82 5.49 Favored Glycine 0 C--N 1.344 1.002 0 O-C-N 123.281 0.363 . . . . 0.0 112.626 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.492 ' HB3' ' HB3' ' A' ' 186' ' ' GLU . 0.1 OUTLIER -147.53 101.85 3.74 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.817 0.847 . . . . 0.0 109.56 177.66 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -62.29 113.9 2.11 Favored 'Trans proline' 0 CA--C 1.555 1.535 0 C-N-CA 122.173 1.915 . . . . 0.0 110.552 165.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -61.05 133.02 44.75 Favored 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 122.308 2.005 . . . . 0.0 111.715 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.4 102.22 0.52 Allowed 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 18.9 p -74.45 155.5 37.96 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.34 1.056 . . . . 0.0 111.851 -174.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.5 pp -109.37 166.1 11.13 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.497 0.719 . . . . 0.0 110.163 177.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 . . . . . 0 C--O 1.251 1.163 0 C-N-CA 123.592 0.757 . . . . 0.0 109.302 -179.461 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.5 166.24 27.71 Favored 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.37 2.047 . . . . 0.0 111.537 176.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.13 115.27 7.42 Favored 'General case' 0 C--O 1.239 0.533 0 O-C-N 123.833 0.708 . . . . 0.0 109.949 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.9 p -60.73 106.74 0.6 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.262 1.025 . . . . 0.0 110.188 178.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.405 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 41.3 ttm180 -100.97 145.28 28.87 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -175.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -119.36 109.95 16.39 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.781 0.833 . . . . 0.0 108.928 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.8 mm -87.09 131.69 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 123.457 0.703 . . . . 0.0 109.413 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.492 ' HA ' HD22 ' A' ' 133' ' ' ASN . 50.9 p -118.48 81.06 1.62 Allowed 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 172.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -74.56 -27.45 60.51 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.606 -174.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.489 ' HB2' ' HG3' ' A' ' 97' ' ' GLU . 23.4 ptt? -102.89 134.14 46.81 Favored 'General case' 0 C--O 1.245 0.86 0 C-N-CA 123.361 0.664 . . . . 0.0 109.553 174.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.434 ' O ' ' HB2' ' A' ' 98' ' ' LEU . 9.8 t -81.84 171.72 14.17 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.337 0.655 . . . . 0.0 110.908 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -55.7 -43.02 71.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 126.024 1.73 . . . . 0.0 111.384 -176.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.44 ' O ' ' HB2' ' A' ' 100' ' ' ARG . 27.0 mm-40 -52.38 -40.64 62.3 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.126 0.97 . . . . 0.0 113.454 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.489 ' HG3' ' HB2' ' A' ' 93' ' ' MET . 12.7 pt-20 -97.73 -22.1 16.61 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.22 0.608 . . . . 0.0 111.291 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 94' ' ' THR . 2.2 tt -73.91 -59.93 2.49 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.634 0.773 . . . . 0.0 109.077 -176.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 39.7 m -80.67 -7.5 59.33 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.378 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 96' ' ' GLU . 9.2 tpm_? -58.81 122.33 13.31 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 123.416 0.687 . . . . 0.0 110.501 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -92.9 145.9 24.04 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 173.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.416 ' HE1' ' NH1' ' A' ' 148' ' ' ARG . 30.7 p-90 -154.16 178.65 9.75 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.828 0.851 . . . . 0.0 109.921 -166.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -136.84 151.17 48.82 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.093 0.957 . . . . 0.0 109.618 -177.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 65.6 mtp -93.17 95.16 9.23 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 172.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -57.14 -37.95 72.78 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.54 0.525 . . . . 0.0 111.312 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.604 ' HB3' ' HB2' ' A' ' 121' ' ' GLN . 8.7 mmt -124.77 97.06 39.41 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 168.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -82.82 127.06 4.71 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.965 2.444 . . . . 0.0 114.202 -170.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.534 ' HB3' ' HB ' ' A' ' 119' ' ' ILE . 87.5 tttt -123.19 116.29 23.17 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 162.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.489 ' NE2' ' SG ' ' A' ' 116' ' ' CYS . 50.8 tp60 -106.91 111.59 24.16 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -176.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.445 ' HG2' HG11 ' A' ' 180' ' ' VAL . 50.5 tptt -117.12 135.83 53.46 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 124.858 1.263 . . . . 0.0 108.58 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.1 t -112.06 118.67 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 170.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -110.15 88.52 2.78 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.79 -115.96 7.77 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.343 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -85.49 -1.43 9.07 Favored 'Trans proline' 0 C--N 1.367 1.52 0 C-N-CA 122.898 2.398 . . . . 0.0 113.694 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.475 HD12 ' HB2' ' A' ' 177' ' ' ALA . 45.0 mt -116.23 152.07 34.5 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.187 0.595 . . . . 0.0 110.743 -171.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.489 ' SG ' ' NE2' ' A' ' 109' ' ' GLN . 37.9 t -106.55 110.79 23.09 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.234 1.014 . . . . 0.0 109.824 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.8 mm -95.92 142.5 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.803 0.841 . . . . 0.0 109.317 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -128.52 121.76 29.57 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.534 ' HB ' ' HB3' ' A' ' 108' ' ' LYS . 37.3 mm -116.8 127.18 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.43 1.092 . . . . 0.0 109.762 -176.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -79.55 141.02 37.02 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 170.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.604 ' HB2' ' HB3' ' A' ' 106' ' ' MET . 58.8 mt-30 -103.4 3.19 34.82 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.919 172.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -108.14 -46.41 3.75 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -170.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.439 HG13 HG12 ' A' ' 157' ' ' VAL . 30.1 mm -81.98 106.63 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 121.295 0.569 . . . . 0.0 109.99 -163.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 63.0 mtt -127.82 161.45 28.98 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.527 1.131 . . . . 0.0 109.76 -172.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 66.43 6.39 4.31 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 124.311 1.045 . . . . 0.0 112.822 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -103.91 153.61 20.59 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.594 0.757 . . . . 0.0 110.393 -171.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -88.14 107.62 18.86 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 172.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.621 HD13 HG21 ' A' ' 157' ' ' VAL . 47.5 mt -105.62 117.9 52.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.625 0.726 . . . . 0.0 109.251 -175.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 13.4 tpt -102.47 133.86 46.73 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.423 -173.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 15.2 mt -108.36 104.04 13.32 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -176.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.414 ' HA ' ' OG ' ' A' ' 195' ' ' SER . 68.2 mttm -116.7 149.78 39.27 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.329 0.652 . . . . 0.0 110.501 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -141.08 161.94 36.66 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 122.146 0.974 . . . . 0.0 113.02 -174.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.492 HD22 ' HA ' ' A' ' 91' ' ' THR . 8.8 m120 -108.47 133.24 52.9 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 160.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -160.53 160.85 32.4 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.254 0.55 . . . . 0.0 111.6 -177.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.0 m -87.82 154.72 20.32 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.428 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.405 ' HB ' ' HB3' ' A' ' 88' ' ' ARG . 79.4 t -128.7 131.35 68.63 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 C-N-CA 123.938 0.895 . . . . 0.0 109.427 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 6.7 tp -142.99 141.51 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 171.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 58.2 37.92 26.23 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.832 0.853 . . . . 0.0 112.115 176.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 63.18 16.62 9.54 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 125.036 1.335 . . . . 0.0 112.446 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 16.1 ptt-85 -132.6 167.22 20.42 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.15 0.58 . . . . 0.0 110.856 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.6 tt -67.81 115.85 7.82 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -78.21 -61.9 1.85 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 122.789 0.436 . . . . 0.0 110.468 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 97.3 m -147.2 125.89 12.58 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.569 0.748 . . . . 0.0 110.12 -171.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.444 HD11 ' HB2' ' A' ' 147' ' ' LEU . 47.9 tp -73.51 129.53 38.18 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.191 0.596 . . . . 0.0 109.784 176.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 85.3 mt -88.27 -51.05 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.699 0.8 . . . . 0.0 109.283 174.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 54.3 tp -162.23 148.06 13.02 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 175.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.609 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 7.7 tt -137.28 149.45 47.11 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 175.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.486 ' HD3' HD13 ' A' ' 156' ' ' ILE . 46.8 mtt-85 -133.87 145.52 49.74 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.491 0.717 . . . . 0.0 110.729 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.556 ' HB2' HD21 ' A' ' 181' ' ' LEU . . . -109.76 123.52 49.68 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 168.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.528 ' HB3' ' HA ' ' A' ' 156' ' ' ILE . 18.8 p90 -150.22 168.51 23.79 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.64 0.776 . . . . 0.0 110.186 -176.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 79.1 p -85.69 165.87 16.61 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 173.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.05 -9.46 39.5 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 120.691 0.282 . . . . 0.0 111.675 174.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -79.83 -23.7 41.85 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.018 1.327 . . . . 0.0 110.973 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 106.18 -1.48 37.84 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-N 115.637 -0.711 . . . . 0.0 113.003 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.24 106.9 6.1 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.216 0.606 . . . . 0.0 109.911 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.528 ' HA ' ' HB3' ' A' ' 150' ' ' PHE . 25.6 mt -77.46 118.51 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -177.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.621 HG21 HD13 ' A' ' 128' ' ' ILE . 18.9 m -106.89 -15.31 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 124.595 1.158 . . . . 0.0 111.994 -170.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -165.25 177.23 40.72 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 111.826 -0.51 . . . . 0.0 111.826 -172.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -166.17 153.94 10.28 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.739 0.416 . . . . 0.0 111.046 -173.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.609 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 67.9 mt -127.61 116.49 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 166.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 33.4 t -128.03 118.74 20.84 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.108 0.563 . . . . 0.0 109.898 -174.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -62.14 121.45 9.49 Favored 'Trans proline' 0 C--N 1.382 2.328 0 C-N-CA 122.798 2.332 . . . . 0.0 111.91 176.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.4 mt -72.19 128.29 89.22 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 122.862 0.465 . . . . 0.0 110.217 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -60.78 -15.92 40.82 Favored 'Trans proline' 0 C--N 1.382 2.297 0 C-N-CA 124.098 3.199 . . . . 0.0 114.513 -177.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 19.5 m -64.13 -17.09 63.13 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.245 0.618 . . . . 0.0 111.559 172.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -123.9 90.71 50.41 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -68.26 -32.07 27.44 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 122.62 2.213 . . . . 0.0 112.556 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -119.41 97.64 0.69 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -177.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -113.16 157.32 21.81 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.159 0.584 . . . . 0.0 109.684 172.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.0 m -107.27 161.86 14.41 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.269 1.027 . . . . 0.0 110.82 -169.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.603 HD11 ' HA ' ' A' ' 202' ' ' ALA . 14.8 tt -56.05 -29.99 28.06 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.308 0 C-N-CA 124.235 1.014 . . . . 0.0 112.307 172.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -56.21 -52.65 63.65 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.059 0.944 . . . . 0.0 111.835 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -73.63 -25.2 60.19 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.978 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 178' ' ' ILE . 63.4 t -65.78 -40.92 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 122.643 0.377 . . . . 0.0 110.185 172.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -72.1 -30.7 65.36 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.477 0.311 . . . . 0.0 111.005 178.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.441 ' O ' HG23 ' A' ' 180' ' ' VAL . 94.8 m-20 -62.79 -46.16 89.27 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 169.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.475 ' HB2' HD12 ' A' ' 115' ' ' LEU . . . -61.87 -48.21 81.53 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.766 1.226 . . . . 0.0 112.339 -174.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 174' ' ' VAL . 45.6 mt -68.32 -32.36 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -65.31 -38.74 95.39 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-N 116.086 -0.506 . . . . 0.0 113.364 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.445 HG11 ' HG2' ' A' ' 110' ' ' LYS . 95.8 t -72.45 -42.81 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.066 0.546 . . . . 0.0 109.847 177.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.556 HD21 ' HB2' ' A' ' 149' ' ' ALA . 35.4 tp -54.15 -55.97 22.69 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.027 0.931 . . . . 0.0 110.536 176.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.496 ' O ' ' HG2' ' A' ' 186' ' ' GLU . 24.7 mt -55.0 -45.27 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 124.152 0.907 . . . . 0.0 110.74 172.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -55.24 -41.86 80.45 Favored Glycine 0 CA--C 1.533 1.189 0 O-C-N 123.793 0.683 . . . . 0.0 114.268 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.35 -33.26 64.53 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-O 121.302 0.39 . . . . 0.0 112.134 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.428 ' HB3' ' OD1' ' A' ' 190' ' ' ASN . 88.9 mt -72.2 -28.82 63.44 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 124.618 1.167 . . . . 0.0 111.403 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 18.2 mm-40 -60.55 -38.45 84.56 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.703 0.801 . . . . 0.0 110.044 175.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 67.4 mtp85 -69.42 -30.83 68.86 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.24 -1.345 . . . . 0.0 110.821 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -83.09 4.81 24.76 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.516 0.727 . . . . 0.0 112.652 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 36.9 t70 59.33 26.96 15.92 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.986 0.898 . . . . 0.0 111.124 173.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.428 ' OD1' ' HB3' ' A' ' 185' ' ' LEU . 28.8 p30 -105.09 161.48 14.2 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -177.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 35.4 m -91.27 113.79 26.15 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.28 0.632 . . . . 0.0 109.827 -172.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.493 HG21 HG23 ' A' ' 182' ' ' ILE . 35.2 m -89.83 134.43 28.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-O 121.324 0.583 . . . . 0.0 109.986 -177.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -140.76 129.78 23.33 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.755 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 4.7 t -105.34 152.62 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.414 ' OG ' ' HA ' ' A' ' 131' ' ' LYS . 63.5 m -59.06 145.84 40.64 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 118.222 0.464 . . . . 0.0 111.037 176.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.411 ' O ' ' HG3' ' A' ' 200' ' ' ARG . 0.2 OUTLIER -69.26 -28.08 66.0 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.294 0.371 . . . . 0.0 110.222 -178.216 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 62.6 p -67.34 -50.15 61.12 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 171.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 33.6 mt -58.58 -30.61 67.32 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.464 0.705 . . . . 0.0 111.26 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.673 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 45.6 mt-30 -70.58 -55.18 9.43 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.161 0.585 . . . . 0.0 110.897 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 196' ' ' LYS . 0.0 OUTLIER -81.61 -11.78 58.99 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -173.213 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -97.37 -39.51 9.17 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.038 0.535 . . . . 0.0 111.13 175.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.603 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -121.67 -61.55 1.5 Allowed 'General case' 0 N--CA 1.479 0.993 0 O-C-N 122.15 -0.344 . . . . 0.0 111.287 -172.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.673 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 51.2 t-105 -74.29 79.15 1.83 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.584 1.153 . . . . 0.0 110.445 -165.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 177.7 -136.39 3.04 Favored Glycine 0 C--O 1.239 0.466 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 74.4 p -87.72 12.84 11.78 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.391 0.676 . . . . 0.0 112.117 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 23.4 m -74.36 89.25 2.09 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 123.455 0.702 . . . . 0.0 111.056 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -116.21 140.05 49.71 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.427 0.691 . . . . 0.0 110.397 178.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -96.39 129.18 43.8 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.044 0.938 . . . . 0.0 110.172 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -98.57 79.37 2.46 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.384 0.673 . . . . 0.0 109.189 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -94.8 122.24 7.1 Favored Glycine 0 C--N 1.34 0.792 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 42.6 ptt85 -86.62 145.8 40.12 Favored Pre-proline 0 CA--C 1.55 0.959 0 CA-C-N 117.256 0.528 . . . . 0.0 110.088 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 213' ' ' PRO . 31.7 Cg_exo -61.42 137.35 69.41 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.751 2.301 . . . . 0.0 111.872 173.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 212' ' ' PRO . 8.9 Cg_exo -69.94 110.16 2.52 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.309 2.006 . . . . 0.0 110.447 176.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 71.1 mt -92.36 51.22 1.73 Allowed 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 47.0 p -82.23 144.28 30.78 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.563 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.01 158.82 35.93 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.38 1.072 . . . . 0.0 109.375 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 C--O 1.251 1.135 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -177.601 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.83 114.38 2.39 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.832 2.355 . . . . 0.0 111.638 174.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.33 134.39 33.83 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.705 0.802 . . . . 0.0 109.524 176.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 30.2 p -63.8 105.46 0.83 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.111 0.964 . . . . 0.0 110.009 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -110.71 135.1 51.82 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.329 0.652 . . . . 0.0 110.625 -170.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -99.1 98.73 9.71 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.954 0.901 . . . . 0.0 109.197 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.8 mm -77.22 137.44 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.994 0.918 . . . . 0.0 109.018 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.2 p -127.35 85.92 2.43 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.107 0.563 . . . . 0.0 109.534 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -72.55 -25.52 61.39 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 122.824 0.45 . . . . 0.0 111.319 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.534 ' HB2' ' HG3' ' A' ' 97' ' ' GLU . 9.1 ptp -106.04 131.7 53.01 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 172.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 77.1 p -70.05 169.24 13.81 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.415 0.686 . . . . 0.0 109.946 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 45.0 mm -62.16 -35.66 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 122.593 0.357 . . . . 0.0 110.582 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 100' ' ' ARG . 43.2 mt-10 -53.72 -44.13 69.61 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.803 0.841 . . . . 0.0 112.294 176.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.534 ' HG3' ' HB2' ' A' ' 93' ' ' MET . 13.7 pt-20 -96.7 -13.23 22.89 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.076 0.55 . . . . 0.0 110.996 -177.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.565 HD12 HD23 ' A' ' 146' ' ' LEU . 53.2 tp -68.9 -50.21 51.5 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.919 0.888 . . . . 0.0 110.768 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.1 p -103.42 14.33 31.63 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.659 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 96' ' ' GLU . 59.5 ttt85 -72.15 141.38 49.11 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.237 0.615 . . . . 0.0 111.279 -174.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -84.28 152.28 24.26 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.344 0.592 . . . . 0.0 109.812 173.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.55 ' HE1' HH12 ' A' ' 148' ' ' ARG . 7.9 p-90 -149.6 167.51 26.14 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.389 1.076 . . . . 0.0 109.396 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -129.19 145.08 51.4 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.685 0.794 . . . . 0.0 109.605 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.548 ' SD ' ' HD2' ' A' ' 118' ' ' ARG . 69.7 mtp -116.9 150.92 37.68 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.662 0.785 . . . . 0.0 109.886 178.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.446 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.9 pt? -126.93 -23.73 3.6 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.672 0.789 . . . . 0.0 110.552 -177.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 25.6 mmt -130.12 72.72 81.83 Favored Pre-proline 0 N--CA 1.49 1.563 0 C-N-CA 123.119 0.568 . . . . 0.0 109.627 167.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.93 135.66 35.85 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.867 2.378 . . . . 0.0 113.61 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.45 ' HD2' HE21 ' A' ' 121' ' ' GLN . 56.6 tttm -129.88 118.9 22.44 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.032 0.933 . . . . 0.0 109.133 173.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.413 ' NE2' ' SG ' ' A' ' 116' ' ' CYS . 0.0 OUTLIER -108.33 103.8 13.04 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.715 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.7 tptt -120.79 126.36 49.91 Favored 'General case' 0 C--O 1.206 -1.207 0 C-N-CA 124.957 1.303 . . . . 0.0 107.911 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 81.3 t -96.4 133.85 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 173.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -126.12 92.65 3.62 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 175.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.61 -133.25 25.3 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.909 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -75.65 3.78 5.64 Favored 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 123.716 2.944 . . . . 0.0 113.697 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.639 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 5.3 mp -125.23 156.67 38.14 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.267 0.627 . . . . 0.0 109.71 -177.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.413 ' SG ' ' NE2' ' A' ' 109' ' ' GLN . 42.6 t -116.87 132.75 56.62 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.002 0.921 . . . . 0.0 108.825 -177.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.419 HD11 ' HB1' ' A' ' 177' ' ' ALA . 12.6 mm -106.03 143.71 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.472 1.109 . . . . 0.0 109.184 -176.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.618 ' HB3' ' HB3' ' A' ' 159' ' ' GLU . 71.3 ttp85 -129.3 120.64 25.99 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 176.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.595 HD13 ' HA3' ' A' ' 184' ' ' GLY . 44.2 mt -128.68 139.17 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -176.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -107.86 121.92 45.73 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 171.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.46 ' HA ' ' ND2' ' A' ' 188' ' ' ASN . 70.2 mt-30 -82.96 -9.29 59.36 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -173.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.27 -32.18 26.53 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.798 0.439 . . . . 0.0 111.5 178.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.442 HG12 ' CG1' ' A' ' 157' ' ' VAL . 1.8 mp -71.02 108.57 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.758 0.789 . . . . 0.0 109.117 -178.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.439 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 58.4 mtt -132.08 163.19 29.01 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 113.684 -1.598 . . . . 0.0 108.988 -175.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 71.35 5.33 5.39 Favored 'General case' 0 N--CA 1.502 2.126 0 C-N-CA 124.543 1.137 . . . . 0.0 112.998 171.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -97.08 151.13 20.06 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.653 0.781 . . . . 0.0 112.143 -170.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -91.98 108.33 19.85 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 164.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.548 HG12 HG22 ' A' ' 151' ' ' THR . 34.0 mt -110.92 147.91 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 123.598 0.759 . . . . 0.0 110.397 -172.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 15.4 tpt -130.67 120.76 24.39 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.544 1.138 . . . . 0.0 109.768 -169.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -88.21 103.63 15.95 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -117.25 138.14 51.92 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.487 0.715 . . . . 0.0 109.26 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -134.8 147.03 49.86 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.512 0.931 . . . . 0.0 113.512 -171.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.458 ' OD1' ' HG2' ' A' ' 93' ' ' MET . 5.2 m-20 -102.07 122.92 45.03 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 165.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -159.73 158.7 31.78 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 122.901 0.48 . . . . 0.0 111.645 -171.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.9 t -88.02 155.11 19.99 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.008 0.923 . . . . 0.0 109.914 173.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 87' ' ' SER . 45.9 t -130.5 145.6 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 124.901 1.281 . . . . 0.0 109.297 -177.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.544 HG22 ' HB2' ' A' ' 142' ' ' GLU . 11.0 tp -157.95 144.01 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 171.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 55.5 27.59 10.49 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 123.64 0.776 . . . . 0.0 112.858 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 66.18 23.19 10.95 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.97 1.308 . . . . 0.0 112.661 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.452 ' HG2' ' O ' ' A' ' 137' ' ' ILE . 28.8 ptt180 -117.66 160.96 20.44 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.945 0.498 . . . . 0.0 109.78 175.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.8 tt -71.2 112.99 7.78 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 166.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.544 ' HB2' HG22 ' A' ' 137' ' ' ILE . 11.9 tp10 -81.43 -58.46 3.02 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.67 0.388 . . . . 0.0 110.186 177.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 96.4 m -141.78 120.94 12.97 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.249 0.22 . . . . 0.0 110.808 -174.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 43.6 tp -77.2 119.3 20.69 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.057 0.543 . . . . 0.0 109.577 172.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 72.0 mt -80.56 -53.68 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 174.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.565 HD23 HD12 ' A' ' 98' ' ' LEU . 65.0 tp -156.61 146.09 20.66 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.888 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.564 HD13 HD12 ' A' ' 160' ' ' ILE . 8.2 tt -133.2 145.59 50.72 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 171.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.681 HH11 HG21 ' A' ' 156' ' ' ILE . 84.4 mtt-85 -140.52 143.69 35.54 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.227 1.011 . . . . 0.0 108.845 178.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -101.61 112.43 24.99 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 176.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -106.58 125.31 50.84 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.382 1.073 . . . . 0.0 109.74 -175.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.548 HG22 HG12 ' A' ' 128' ' ' ILE . 43.7 p -71.64 -174.07 1.06 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.034 0.534 . . . . 0.0 111.583 175.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -19.2 65.5 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.462 0.705 . . . . 0.0 112.833 175.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -98.3 -1.2 42.37 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.728 0.811 . . . . 0.0 111.358 172.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 76.38 26.3 63.91 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 116.396 -0.365 . . . . 0.0 113.343 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -77.7 131.63 37.79 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.681 HG21 HH11 ' A' ' 148' ' ' ARG . 22.9 mt -83.02 86.86 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 121.649 0.738 . . . . 0.0 109.181 -177.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.442 ' CG1' HG12 ' A' ' 123' ' ' ILE . 19.3 m -100.09 -12.89 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.519 1.128 . . . . 0.0 111.185 -169.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.44 ' HA3' HD11 ' A' ' 181' ' ' LEU . . . -142.84 164.76 27.05 Favored Glycine 0 C--O 1.245 0.836 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.618 ' HB3' ' HB3' ' A' ' 118' ' ' ARG . 32.8 tt0 -167.89 150.05 5.56 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 117.437 0.618 . . . . 0.0 110.428 -173.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.564 HD12 HD13 ' A' ' 147' ' ' LEU . 57.6 mt -136.0 125.67 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 170.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 14.4 m -138.46 122.88 11.7 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.639 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 88.1 Cg_exo -48.51 142.44 17.78 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 123.257 2.638 . . . . 0.0 113.175 173.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 90.4 mt -61.06 135.7 93.43 Favored Pre-proline 0 CA--C 1.559 1.307 0 C-N-CA 123.623 0.769 . . . . 0.0 111.09 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.87 72.2 3.94 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 123.21 2.607 . . . . 0.0 111.916 176.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 32.6 t 173.28 -18.59 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 126.411 1.884 . . . . 0.0 108.883 -175.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -115.39 84.14 11.46 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 124.944 1.298 . . . . 0.0 109.492 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.58 -24.94 5.85 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 122.647 2.231 . . . . 0.0 113.461 -177.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -122.45 87.6 0.4 Allowed Glycine 0 C--N 1.349 1.278 0 N-CA-C 111.681 -0.568 . . . . 0.0 111.681 -172.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -98.26 177.58 5.33 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.769 0.827 . . . . 0.0 110.26 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.8 m -122.51 154.96 37.15 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.465 HD11 ' HA ' ' A' ' 202' ' ' ALA . 10.7 tt -51.88 -34.96 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 C-N-CA 124.726 1.21 . . . . 0.0 113.001 177.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -61.97 -44.15 97.35 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.221 1.008 . . . . 0.0 112.784 -177.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -82.75 -25.62 32.67 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.647 0.379 . . . . 0.0 111.276 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.453 ' O ' HG13 ' A' ' 178' ' ' ILE . 91.4 t -64.49 -48.64 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 122.809 0.444 . . . . 0.0 110.858 172.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -65.96 -28.22 68.74 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.61 0.364 . . . . 0.0 110.905 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.426 ' O ' HG23 ' A' ' 180' ' ' VAL . 13.7 m120 -68.53 -43.56 76.48 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 123.144 0.578 . . . . 0.0 109.495 171.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.419 ' HB1' HD11 ' A' ' 117' ' ' ILE . . . -61.3 -40.52 94.46 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.842 0.857 . . . . 0.0 111.36 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 174' ' ' VAL . 57.6 mt -65.0 -39.91 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.19 -36.98 94.16 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.476 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 176' ' ' ASN . 80.9 t -66.2 -47.59 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.218 0.607 . . . . 0.0 110.613 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.44 HD11 ' HA3' ' A' ' 158' ' ' GLY . 32.7 tp -59.46 -46.76 87.85 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.879 0.737 . . . . 0.0 110.344 178.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.8 HG23 HG21 ' A' ' 192' ' ' VAL . 47.8 mt -57.12 -46.19 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.37 1.068 . . . . 0.0 111.447 176.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -63.41 -34.58 90.34 Favored Glycine 0 C--N 1.341 0.841 0 O-C-N 123.675 0.609 . . . . 0.0 113.104 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.595 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -71.12 -27.61 71.67 Favored Glycine 0 C--N 1.35 1.343 0 O-C-N 123.751 0.324 . . . . 0.0 113.0 177.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.411 HD22 ' CD1' ' A' ' 128' ' ' ILE . 64.2 mt -77.28 -47.35 20.29 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.832 0.853 . . . . 0.0 110.076 175.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -67.14 -34.11 76.89 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.316 0.646 . . . . 0.0 112.417 -174.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -66.89 -29.05 68.85 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 122.432 0.293 . . . . 0.0 111.365 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.46 ' ND2' ' HA ' ' A' ' 121' ' ' GLN . 49.5 m-20 -80.38 8.19 8.11 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.207 0.603 . . . . 0.0 110.86 174.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 34.4 t70 65.49 64.2 0.6 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.776 1.23 . . . . 0.0 110.207 177.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.408 HD21 ' HA ' ' A' ' 124' ' ' MET . 35.7 m-80 -124.46 172.96 8.76 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.153 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 70.2 m -122.93 102.55 8.08 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.8 HG21 HG23 ' A' ' 182' ' ' ILE . 31.8 m -89.99 150.97 3.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 CA-C-O 121.898 0.856 . . . . 0.0 111.574 -174.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -141.22 131.23 24.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 113.8 -1.545 . . . . 0.0 107.701 173.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 5.8 t -89.75 152.7 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 38.6 t -62.95 141.6 58.66 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 118.179 0.445 . . . . 0.0 109.929 176.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -57.94 -33.73 69.13 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.258 0.623 . . . . 0.0 111.888 -177.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 15.0 p -66.79 -49.6 65.34 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.433 0.458 . . . . 0.0 110.242 174.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 72.5 mt -58.63 -34.65 71.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 122.697 0.399 . . . . 0.0 110.775 178.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.58 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 75.5 mt-30 -61.35 -41.53 97.21 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.092 0.957 . . . . 0.0 112.666 -175.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.26 -21.09 14.41 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -178.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -79.49 -48.69 13.47 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 118.745 0.702 . . . . 0.0 111.107 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.465 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -114.82 -50.89 2.76 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.498 0.666 . . . . 0.0 111.221 -174.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.58 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 35.4 t-105 -79.18 4.58 14.44 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 124.97 1.308 . . . . 0.0 111.391 -171.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -58.79 -20.27 46.99 Favored Glycine 0 C--N 1.362 2.003 0 C-N-CA 123.08 0.371 . . . . 0.0 113.731 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 19.6 m -68.14 100.18 0.98 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.767 0.827 . . . . 0.0 110.072 170.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 49.5 m -87.55 75.78 9.05 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.868 0.842 . . . . 0.0 109.296 176.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -108.4 2.11 22.2 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.725 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -152.46 143.12 22.82 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.968 0.907 . . . . 0.0 109.317 -176.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -100.25 121.23 41.13 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 172.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -77.06 -97.38 0.18 Allowed Glycine 0 C--N 1.346 1.124 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 175.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.423 ' HA ' ' HD3' ' A' ' 212' ' ' PRO . 5.8 ptm180 -176.42 137.54 0.46 Allowed Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 124.151 0.98 . . . . 0.0 110.091 171.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 211' ' ' ARG . 1.6 Cg_endo -81.7 120.49 3.51 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.926 2.418 . . . . 0.0 110.229 174.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -58.26 103.0 0.14 Allowed 'Trans proline' 0 C--N 1.383 2.342 0 C-N-CA 123.069 2.513 . . . . 0.0 111.207 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 89.9 mt -71.89 91.0 1.15 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.971 -173.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 41.9 p -83.07 141.28 32.13 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.833 175.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.8 pp -71.68 161.65 30.66 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.418 0.687 . . . . 0.0 111.696 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 C--O 1.252 1.237 0 CA-C-O 118.75 -0.643 . . . . 0.0 109.581 -173.09 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.432 ' SD ' ' N ' ' A' ' 84' ' ' MET . 0.5 OUTLIER . . . . . 0 CA--C 1.553 1.069 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.43 ' HB3' ' HA ' ' A' ' 138' ' ' PHE . 53.1 Cg_endo -67.4 121.06 8.14 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.939 2.426 . . . . 0.0 112.038 178.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.1 126.21 41.17 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.729 0.811 . . . . 0.0 109.679 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.5 p -76.44 83.09 3.16 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 170.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -114.77 153.6 30.06 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.606 -173.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -116.4 113.54 23.02 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.888 0.875 . . . . 0.0 109.345 174.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 32.5 mm -78.38 132.85 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 36.1 p -128.25 87.93 2.67 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.923 0.889 . . . . 0.0 109.305 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -71.33 -22.9 61.86 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 173.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.419 ' SD ' ' HB2' ' A' ' 148' ' ' ARG . 56.9 mtm -119.63 139.89 51.47 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 125.15 1.38 . . . . 0.0 109.027 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 72.2 p -88.88 165.67 14.48 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 172.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.482 ' HA ' HD12 ' A' ' 98' ' ' LEU . 2.2 mp -53.93 -30.73 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 124.609 1.164 . . . . 0.0 111.736 -171.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -53.33 -62.69 1.49 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.355 1.062 . . . . 0.0 111.984 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.719 ' HA ' ' HB2' ' A' ' 100' ' ' ARG . 14.9 pm0 -77.21 -22.56 52.14 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.834 0.453 . . . . 0.0 111.74 -177.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.633 HD11 ' ND2' ' A' ' 133' ' ' ASN . 32.7 mt -58.53 -39.17 79.4 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.089 0.556 . . . . 0.0 110.491 169.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.3 m -108.32 20.96 17.98 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.278 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.719 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 6.5 tpt180 -71.29 143.05 50.46 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.75 0.42 . . . . 0.0 110.861 -174.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -96.12 104.99 16.98 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.113 0.965 . . . . 0.0 109.563 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.431 ' HE1' ' NH1' ' A' ' 148' ' ' ARG . 46.0 p-90 -137.04 172.66 12.67 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.216 1.006 . . . . 0.0 110.496 -177.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -138.38 166.22 24.8 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.611 0.764 . . . . 0.0 110.657 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.413 ' HG2' ' HB2' ' A' ' 120' ' ' ASP . 55.9 mtm -122.16 129.19 52.08 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.286 1.034 . . . . 0.0 109.105 172.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 56.3 tp -71.38 -40.62 70.45 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.023 0.929 . . . . 0.0 110.034 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.425 ' HG2' ' HB2' ' A' ' 122' ' ' ALA . 24.1 mmt -125.0 77.97 66.48 Favored Pre-proline 0 N--CA 1.483 1.194 0 C-N-CA 124.404 1.082 . . . . 0.0 109.451 174.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.43 111.93 3.43 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.627 2.218 . . . . 0.0 112.352 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.427 ' HD2' HE21 ' A' ' 121' ' ' GLN . 53.4 tttm -87.04 111.2 20.65 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 172.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -89.21 116.8 27.72 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.547 0.339 . . . . 0.0 110.271 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.422 ' HG2' HG11 ' A' ' 180' ' ' VAL . 14.4 tppt? -127.47 140.23 52.29 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.983 1.313 . . . . 0.0 109.332 174.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.559 HG13 HD11 ' A' ' 163' ' ' LEU . 79.5 t -123.24 99.5 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 166.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.48 ' HG2' HG21 ' A' ' 180' ' ' VAL . 9.1 tp10 -104.3 95.56 6.04 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -175.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.16 -125.91 19.19 Favored Glycine 0 CA--C 1.536 1.362 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.39 -176.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -85.75 6.38 5.59 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 123.246 2.63 . . . . 0.0 112.875 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.407 HD12 ' HB2' ' A' ' 177' ' ' ALA . 73.6 mt -123.51 144.32 49.62 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.345 0.658 . . . . 0.0 109.666 -171.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 46.4 t -107.66 115.58 30.4 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.322 0.649 . . . . 0.0 109.458 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.0 mm -99.72 133.71 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.2 mtm180 -134.42 120.98 20.47 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.66 0.784 . . . . 0.0 108.946 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.551 HG12 HD12 ' A' ' 181' ' ' LEU . 49.6 mt -126.06 132.47 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.391 1.077 . . . . 0.0 108.988 -173.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.426 ' OD2' HG12 ' A' ' 123' ' ' ILE . 16.7 t70 -89.29 120.09 30.34 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 118.064 0.393 . . . . 0.0 109.958 176.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.457 ' HA ' ' ND2' ' A' ' 188' ' ' ASN . 82.2 mt-30 -91.35 2.21 56.56 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.74 0.816 . . . . 0.0 113.118 -175.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.425 ' HB2' ' HG2' ' A' ' 106' ' ' MET . . . -94.11 -27.82 16.04 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 174.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.426 HG12 ' OD2' ' A' ' 120' ' ' ASP . 22.5 mm -78.49 95.03 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.685 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 37.4 mtt -122.74 149.33 44.24 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.045 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.0 t70 65.55 52.1 1.41 Allowed 'General case' 0 N--CA 1.484 1.23 0 O-C-N 124.529 1.143 . . . . 0.0 110.928 175.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -130.03 156.1 45.05 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.068 0.947 . . . . 0.0 110.691 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -95.64 108.27 20.54 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 170.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.545 ' HB ' HG12 ' A' ' 192' ' ' VAL . 58.7 mt -113.66 143.56 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.761 0.824 . . . . 0.0 111.186 -171.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 12.4 tpt -118.41 122.85 43.79 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.324 1.05 . . . . 0.0 108.912 -177.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.434 HD12 HG22 ' A' ' 194' ' ' VAL . 12.1 mt -94.79 103.87 15.77 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -175.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.406 ' HA ' ' HB2' ' A' ' 195' ' ' SER . 53.4 mtpt -118.37 140.74 49.37 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.948 0.899 . . . . 0.0 109.974 -170.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -135.6 154.12 51.44 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 122.581 1.181 . . . . 0.0 114.141 -171.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.633 ' ND2' HD11 ' A' ' 98' ' ' LEU . 3.3 m-20 -108.06 127.63 53.96 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 162.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -156.21 159.6 39.09 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.682 0.614 . . . . 0.0 110.556 -176.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.2 t -86.3 162.85 18.04 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 173.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.8 t -135.02 133.87 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.625 1.17 . . . . 0.0 109.132 -174.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.6 tp -148.88 145.81 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 172.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.43 ' HA ' ' HB3' ' A' ' 85' ' ' PRO . 38.7 m-85 59.21 30.47 20.24 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.741 0.816 . . . . 0.0 111.3 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 64.06 17.74 10.81 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.057 1.343 . . . . 0.0 112.096 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -127.36 175.39 8.23 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.899 0.88 . . . . 0.0 110.0 176.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.467 HD22 ' HA ' ' A' ' 171' ' ' ILE . 9.1 tt -67.33 123.46 20.42 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.545 0.738 . . . . 0.0 109.119 175.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -82.99 -70.19 0.57 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.137 0.575 . . . . 0.0 109.886 174.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 61.4 m -147.92 129.34 14.85 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.88 0.872 . . . . 0.0 109.656 -174.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 59.3 tp -72.3 134.55 45.59 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.768 0.827 . . . . 0.0 110.46 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 66.1 mt -96.16 -43.48 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.924 0.89 . . . . 0.0 110.102 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.439 HD21 ' NH2' ' A' ' 148' ' ' ARG . 40.9 tp -169.5 149.12 3.9 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.922 0.889 . . . . 0.0 109.253 174.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.666 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 7.5 tt -136.0 144.93 45.59 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.717 ' HD3' HD13 ' A' ' 156' ' ' ILE . 71.7 mtt-85 -142.54 146.75 34.98 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.224 1.01 . . . . 0.0 109.939 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.73 118.72 37.47 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.239 1.016 . . . . 0.0 108.844 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -110.25 128.94 55.77 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.277 1.031 . . . . 0.0 110.397 -174.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 31.4 p -76.8 179.27 6.21 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.022 0.529 . . . . 0.0 111.022 172.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -61.97 -21.02 64.48 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.884 0.874 . . . . 0.0 112.02 174.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -83.04 -1.54 52.98 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.801 1.24 . . . . 0.0 111.569 176.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 69.0 18.23 72.51 Favored Glycine 0 C--N 1.357 1.709 0 CA-C-N 116.456 -0.338 . . . . 0.0 112.847 -173.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -92.57 129.47 38.49 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.383 0.673 . . . . 0.0 109.419 -174.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.717 HD13 ' HD3' ' A' ' 148' ' ' ARG . 24.4 mt -79.97 109.26 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.1 m -117.08 -0.55 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.974 0.91 . . . . 0.0 111.397 -173.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -150.22 164.47 29.71 Favored Glycine 0 C--N 1.34 0.76 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -165.57 144.39 6.23 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 117.149 0.475 . . . . 0.0 110.595 -174.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.666 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 73.8 mt -127.05 102.84 10.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.1 t -106.79 112.62 63.39 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 123.366 0.666 . . . . 0.0 109.579 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -58.96 128.26 27.26 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.749 2.299 . . . . 0.0 111.983 174.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.559 HD11 HG13 ' A' ' 111' ' ' VAL . 88.8 mt -65.83 128.0 93.5 Favored Pre-proline 0 CA--C 1.548 0.873 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.202 -177.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.44 -9.02 25.14 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 123.185 2.59 . . . . 0.0 113.013 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 25.3 p -71.89 -13.18 61.59 Favored 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 123.738 0.815 . . . . 0.0 111.255 169.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -121.88 113.13 31.7 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 125.01 1.324 . . . . 0.0 107.698 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.63 -34.51 90.52 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.39 2.727 . . . . 0.0 113.792 -177.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -163.41 -179.29 37.75 Favored Glycine 0 N--CA 1.467 0.73 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.401 ' CE1' HD21 ' A' ' 115' ' ' LEU . 42.3 p-80 -153.05 -175.7 5.45 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.477 0.711 . . . . 0.0 110.551 175.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 19.2 m -106.56 158.16 17.14 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.269 1.027 . . . . 0.0 110.064 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.467 ' HA ' HD22 ' A' ' 141' ' ' LEU . 2.8 tt -48.22 -39.78 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 125.563 1.545 . . . . 0.0 113.024 174.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -63.54 -34.17 77.21 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.55 0.74 . . . . 0.0 111.687 -174.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -65.98 -37.05 84.96 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.861 0.864 . . . . 0.0 110.546 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 25.5 t -68.63 -34.95 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 123.865 0.728 . . . . 0.0 110.611 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -64.24 -38.27 90.47 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 120.486 0.184 . . . . 0.0 110.707 176.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -63.16 -47.21 83.64 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 123.992 0.808 . . . . 0.0 109.568 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.407 ' HB2' HD12 ' A' ' 115' ' ' LEU . . . -60.41 -48.78 80.27 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 114.29 -1.323 . . . . 0.0 112.2 -175.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 68.5 mt -67.42 -38.73 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 123.779 0.674 . . . . 0.0 109.418 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.26 -30.07 76.42 Favored Glycine 0 CA--C 1.536 1.372 0 O-C-N 123.328 0.392 . . . . 0.0 113.677 176.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.48 HG21 ' HG2' ' A' ' 112' ' ' GLU . 43.2 t -76.45 -43.73 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.663 0.785 . . . . 0.0 110.32 175.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.551 HD12 HG12 ' A' ' 119' ' ' ILE . 36.6 tp -56.53 -49.04 75.92 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.727 0.811 . . . . 0.0 110.509 175.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.461 ' O ' ' HG2' ' A' ' 186' ' ' GLU . 77.3 mt -61.54 -52.18 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.14 0.976 . . . . 0.0 110.272 174.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -54.99 -36.26 60.41 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 124.153 0.908 . . . . 0.0 114.141 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.13 -41.34 47.69 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 112.235 -0.346 . . . . 0.0 112.235 174.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.492 HD13 HG11 ' A' ' 192' ' ' VAL . 35.5 mt -69.79 -16.49 63.3 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.304 1.042 . . . . 0.0 111.944 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 20.5 mm-40 -70.81 -39.27 73.18 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 171.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -77.83 -34.48 51.89 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.451 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.457 ' ND2' ' HA ' ' A' ' 121' ' ' GLN . 7.9 m-20 -72.59 -13.63 61.43 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.692 170.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 38.6 t70 57.57 67.63 0.95 Allowed 'General case' 0 C--N 1.355 0.842 0 C-N-CA 125.556 1.542 . . . . 0.0 111.367 176.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -124.92 139.2 54.05 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.484 -1.235 . . . . 0.0 107.843 175.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 86.7 m -79.54 102.44 8.84 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.545 HG12 ' HB ' ' A' ' 128' ' ' ILE . 34.0 m -107.57 147.58 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 121.505 0.669 . . . . 0.0 110.983 -173.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -135.79 139.93 43.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 113.957 -1.474 . . . . 0.0 107.779 175.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.434 HG22 HD12 ' A' ' 130' ' ' LEU . 16.5 t -89.42 155.96 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.406 ' HB2' ' HA ' ' A' ' 131' ' ' LYS . 28.8 t -56.1 151.75 11.68 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.186 0.595 . . . . 0.0 112.172 -178.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.4 ' H ' ' HD2' ' A' ' 196' ' ' LYS . 0.2 OUTLIER -56.78 -44.73 82.15 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 124.04 0.838 . . . . 0.0 109.861 179.757 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 63.7 p -65.83 -49.3 68.69 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 113.93 -1.486 . . . . 0.0 110.516 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 54.9 mt -62.56 -35.06 78.28 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.321 0.649 . . . . 0.0 110.868 -177.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.548 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 42.0 mt-30 -62.39 -34.06 75.98 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.775 0.83 . . . . 0.0 111.775 -176.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.417 ' HE ' ' HB2' ' A' ' 200' ' ' ARG . 0.0 OUTLIER -104.16 -30.54 10.14 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -76.48 -33.42 58.67 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.218 0.607 . . . . 0.0 111.562 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.42 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -121.13 -58.18 1.81 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.174 0.59 . . . . 0.0 110.643 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.548 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 27.7 t-105 -77.06 -6.74 53.91 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 125.026 1.33 . . . . 0.0 111.225 -166.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -143.9 41.44 1.12 Allowed Glycine 0 C--N 1.347 1.17 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 177.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 33.4 t -128.51 -27.69 2.6 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.693 0.797 . . . . 0.0 111.995 -172.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 27.9 p -146.94 -55.23 0.24 Allowed 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -174.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 62.08 20.78 11.9 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 124.961 1.305 . . . . 0.0 112.775 169.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -123.02 -176.5 3.43 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 123.407 0.683 . . . . 0.0 110.978 -175.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -60.39 -30.82 69.83 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.906 0.882 . . . . 0.0 111.645 174.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 113.67 20.48 6.11 Favored Glycine 0 CA--C 1.502 -0.748 0 CA-C-O 119.416 -0.658 . . . . 0.0 113.72 173.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 64.93 107.55 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.647 1.179 . . . . 0.0 111.514 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -62.39 111.66 1.36 Allowed 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.105 1.87 . . . . 0.0 108.929 169.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -57.25 98.37 0.08 OUTLIER 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 123.073 2.515 . . . . 0.0 112.72 -171.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 84.4 mt -73.56 88.33 1.65 Allowed 'General case' 0 C--O 1.24 0.585 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 65.6 p -89.49 125.75 35.31 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.603 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.8 pp -73.24 -172.87 1.2 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.24 0.616 . . . . 0.0 111.487 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 . . . . . 0 CA--C 1.554 1.096 0 C-N-CA 123.361 0.665 . . . . 0.0 109.569 -178.973 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.44 148.3 23.4 Favored 'Trans proline' 0 C--N 1.365 1.434 0 C-N-CA 122.215 1.944 . . . . 0.0 110.663 165.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.24 116.05 17.54 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 27.2 p -56.85 109.02 0.57 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.464 0.706 . . . . 0.0 111.222 -177.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -101.1 138.62 37.9 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.519 0.728 . . . . 0.0 109.635 -171.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -100.82 100.98 11.71 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.536 0.734 . . . . 0.0 109.658 -175.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 50.8 mm -78.41 120.5 29.45 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.088 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 174.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 62.2 p -114.49 97.38 6.27 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -88.84 -25.56 22.12 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.513 0.325 . . . . 0.0 110.301 -178.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.513 ' HB3' ' HG3' ' A' ' 97' ' ' GLU . 2.7 mpp? -101.44 144.24 30.47 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.897 0.879 . . . . 0.0 108.945 172.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.3 m -72.94 161.05 31.17 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.328 0.651 . . . . 0.0 109.533 171.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.41 ' H ' HD12 ' A' ' 95' ' ' ILE . 3.0 mp -55.69 -39.26 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.612 0.765 . . . . 0.0 111.373 -177.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -65.37 -52.37 54.09 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.446 0.699 . . . . 0.0 111.699 -175.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.513 ' HG3' ' HB3' ' A' ' 93' ' ' MET . 11.3 pt-20 -70.25 -26.73 63.97 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 122.903 0.481 . . . . 0.0 111.532 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.406 ' HG ' HD23 ' A' ' 146' ' ' LEU . 9.1 tt -66.56 -44.29 82.73 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.732 0.813 . . . . 0.0 109.787 174.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 39.1 t -99.66 20.63 13.68 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.95 0.9 . . . . 0.0 110.734 -177.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.447 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 20.4 tpt180 -80.09 136.46 36.55 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.532 0.733 . . . . 0.0 111.657 -176.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -84.94 136.15 33.74 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 170.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 16.6 p-90 -144.14 137.74 27.68 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.229 1.012 . . . . 0.0 109.52 -175.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -94.73 138.19 32.86 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 18.1 ptm -123.97 124.11 41.86 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 173.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.53 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.6 pt? -82.55 -25.21 33.55 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.114 0.566 . . . . 0.0 111.571 -171.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 23.4 mmt -123.23 80.87 52.3 Favored Pre-proline 0 N--CA 1.475 0.816 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 175.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -76.04 110.66 3.12 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.493 2.129 . . . . 0.0 112.12 -177.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -95.96 112.28 24.05 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 165.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.499 ' NE2' ' SG ' ' A' ' 116' ' ' CYS . 0.0 OUTLIER -91.95 98.82 11.81 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 179.068 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.543 ' HG2' HG11 ' A' ' 180' ' ' VAL . 51.2 tptt -107.65 147.2 31.0 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.243 1.017 . . . . 0.0 108.906 177.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 51.5 t -130.68 129.18 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 172.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -135.88 104.83 5.87 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.43 -148.62 42.49 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 119.507 -0.607 . . . . 0.0 111.958 -175.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -73.89 13.11 0.84 Allowed 'Trans proline' 0 CA--C 1.555 1.552 0 C-N-CA 123.37 2.713 . . . . 0.0 114.097 173.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 4.2 mp -125.35 152.28 44.96 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.754 0.822 . . . . 0.0 108.802 -176.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.499 ' SG ' ' NE2' ' A' ' 109' ' ' GLN . 23.5 t -109.07 140.45 42.6 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.328 0.651 . . . . 0.0 110.029 175.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.7 mm -111.34 147.57 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.625 0.77 . . . . 0.0 109.518 178.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -124.86 119.98 30.38 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 27.6 mm -116.05 123.9 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -90.96 116.68 28.95 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 168.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.445 ' HA ' HD21 ' A' ' 188' ' ' ASN . 75.5 mt-30 -75.18 -16.63 60.49 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.552 0.741 . . . . 0.0 112.484 -173.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.44 -35.58 19.6 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.428 0.691 . . . . 0.0 112.128 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.85 109.95 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-O 121.994 0.902 . . . . 0.0 109.304 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.45 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 51.2 mtt -135.17 156.22 49.37 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 113.908 -1.496 . . . . 0.0 109.602 -177.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.3 t70 61.61 24.08 14.26 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 124.713 1.205 . . . . 0.0 112.228 174.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 54.3 mmtt -104.55 146.13 29.33 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 121.657 -0.652 . . . . 0.0 111.466 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.554 ' HA ' ' HB ' ' A' ' 191' ' ' THR . 0.8 OUTLIER -83.96 102.41 12.42 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 174.586 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.495 HD12 HD22 ' A' ' 185' ' ' LEU . 59.4 mt -114.95 141.07 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 123.681 0.793 . . . . 0.0 110.496 -172.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 14.0 tpt -117.59 131.42 56.68 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.304 1.042 . . . . 0.0 109.326 -174.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.517 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 2.9 mm? -91.4 104.4 16.92 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -118.45 136.1 53.98 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.365 1.066 . . . . 0.0 109.613 -171.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.464 ' HB2' ' HG ' ' A' ' 147' ' ' LEU . . . -142.22 152.52 43.16 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 -177.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -110.79 131.11 55.32 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 114.138 -1.392 . . . . 0.0 107.267 167.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.467 ' HA ' HG13 ' A' ' 145' ' ' ILE . 44.1 p90 -161.93 164.69 28.34 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.13 0.572 . . . . 0.0 111.4 -171.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.6 p -92.91 161.27 14.54 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.852 0.861 . . . . 0.0 109.667 173.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 87' ' ' SER . 54.8 t -128.27 133.36 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 124.288 1.035 . . . . 0.0 109.854 -176.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 8.7 tp -143.83 144.98 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 60.34 32.77 20.78 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.003 0.921 . . . . 0.0 112.447 174.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.7 t70 76.41 -0.07 3.13 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 124.555 1.142 . . . . 0.0 111.982 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -126.73 179.94 5.11 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.377 1.071 . . . . 0.0 110.136 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.515 ' HB3' HG13 ' A' ' 171' ' ' ILE . 9.9 tt -70.09 136.3 50.09 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.853 0.461 . . . . 0.0 109.877 177.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -91.48 -66.72 0.9 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.736 0.814 . . . . 0.0 110.517 174.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 75.9 m -145.96 130.0 17.41 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.513 0.725 . . . . 0.0 109.713 -174.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.487 HD21 ' HB2' ' A' ' 147' ' ' LEU . 40.6 tp -72.34 129.83 39.3 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 173.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.467 HG13 ' HA ' ' A' ' 134' ' ' PHE . 66.1 mt -87.14 -51.1 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 174.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.406 HD23 ' HG ' ' A' ' 98' ' ' LEU . 59.0 tp -163.77 147.42 10.11 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.225 1.01 . . . . 0.0 109.227 175.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.659 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 7.0 tt -131.8 148.15 52.54 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 173.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.509 HH11 HG21 ' A' ' 156' ' ' ILE . 55.2 mtt-85 -142.92 148.23 36.58 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.18 0.992 . . . . 0.0 109.857 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.436 ' HB2' HD21 ' A' ' 181' ' ' LEU . . . -105.63 112.39 25.45 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.354 1.062 . . . . 0.0 108.499 175.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -106.2 130.16 54.12 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.403 0.681 . . . . 0.0 110.347 -177.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 28.3 p -71.29 174.01 7.03 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.069 0.548 . . . . 0.0 110.991 170.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.42 -18.26 64.4 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.433 0.693 . . . . 0.0 111.349 171.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -64.08 -29.7 70.82 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.952 0.901 . . . . 0.0 110.76 168.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 91.91 20.6 36.1 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.747 -173.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -103.31 134.48 46.62 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.815 0.846 . . . . 0.0 110.668 -175.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.509 HG21 HH11 ' A' ' 148' ' ' ARG . 16.2 mt -73.87 116.03 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.43 -1.06 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.685 0.794 . . . . 0.0 110.787 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -157.13 161.86 31.42 Favored Glycine 0 C--N 1.334 0.417 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -162.0 150.46 15.11 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 117.482 0.641 . . . . 0.0 109.968 -172.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.659 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 67.5 mt -129.34 103.71 9.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 167.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.5 t -107.34 106.45 58.4 Favored Pre-proline 0 C--O 1.243 0.757 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 51.1 Cg_exo -57.45 117.59 4.31 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.997 2.465 . . . . 0.0 112.258 175.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.7 mt -72.68 123.42 89.53 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 123.738 0.815 . . . . 0.0 111.985 -173.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.9 -7.46 20.79 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.999 2.466 . . . . 0.0 112.342 173.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 16.5 m -60.48 -25.25 65.92 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.321 1.048 . . . . 0.0 111.759 173.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -118.79 129.31 25.46 Favored Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -176.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -44.19 -52.66 5.47 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 124.419 3.413 . . . . 0.0 114.533 -170.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -162.3 -174.45 32.21 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.181 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -147.19 163.07 37.51 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-O 121.377 0.608 . . . . 0.0 110.754 176.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 27.9 m -99.58 164.46 12.06 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.279 1.031 . . . . 0.0 109.385 174.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.515 HG13 ' HB3' ' A' ' 141' ' ' LEU . 7.7 tt -49.83 -36.41 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 124.613 1.165 . . . . 0.0 112.051 174.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -60.59 -39.63 88.81 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.348 1.059 . . . . 0.0 111.308 -177.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -66.31 -36.6 83.36 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.461 0.705 . . . . 0.0 110.969 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 178' ' ' ILE . 46.3 t -65.19 -39.68 86.27 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.687 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.245 175.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.441 ' HE2' ' O ' ' A' ' 202' ' ' ALA . 88.1 mttt -58.79 -45.54 89.63 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.117 0.567 . . . . 0.0 110.775 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.486 ' O ' HG23 ' A' ' 180' ' ' VAL . 53.6 m-80 -64.15 -43.29 95.66 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.182 177.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.2 -50.27 74.11 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.209 0.943 . . . . 0.0 111.568 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 174' ' ' VAL . 39.9 mt -62.84 -40.27 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -58.69 -32.99 70.66 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 115.474 -0.785 . . . . 0.0 113.88 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.543 HG11 ' HG2' ' A' ' 110' ' ' LYS . 41.0 t -73.09 -46.38 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 117.041 0.421 . . . . 0.0 110.039 177.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.473 HD22 HG13 ' A' ' 160' ' ' ILE . 21.7 tp -61.77 -46.37 89.87 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 123.79 0.682 . . . . 0.0 110.825 -177.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 75.4 mt -61.41 -50.39 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.547 0.739 . . . . 0.0 110.078 175.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.45 ' O ' ' HG2' ' A' ' 187' ' ' ARG . . . -53.99 -47.85 64.87 Favored Glycine 0 C--N 1.346 1.13 0 O-C-N 124.201 0.938 . . . . 0.0 113.629 -177.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.19 -40.86 99.16 Favored Glycine 0 C--N 1.344 0.974 0 C-N-CA 123.164 0.411 . . . . 0.0 112.23 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.495 HD22 HD12 ' A' ' 128' ' ' ILE . 96.7 mt -63.7 -39.58 94.66 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.421 0.688 . . . . 0.0 111.084 176.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -67.75 -35.29 78.46 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.487 0.715 . . . . 0.0 110.984 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 183' ' ' GLY . 12.6 mmp_? -75.04 -27.48 60.05 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.81 0.444 . . . . 0.0 110.63 177.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.45 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 6.1 m-20 -81.02 -7.12 59.49 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.304 0.641 . . . . 0.0 110.898 170.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 38.7 t70 63.33 67.18 0.67 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.051 1.341 . . . . 0.0 111.328 -176.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -119.0 145.95 45.42 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.847 0.859 . . . . 0.0 109.074 175.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.554 ' HB ' ' HA ' ' A' ' 127' ' ' ASN . 28.2 m -76.99 107.51 9.39 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -178.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 18.0 m -101.85 134.85 41.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 121.265 0.555 . . . . 0.0 110.865 -172.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -143.9 133.87 24.06 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.321 1.048 . . . . 0.0 108.273 169.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.517 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 5.2 t -90.87 151.51 3.49 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 48.0 t -59.06 139.14 57.16 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 175.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -62.44 -25.29 67.89 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.985 0.514 . . . . 0.0 111.19 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 67.0 p -76.33 -44.59 36.02 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.213 0.605 . . . . 0.0 109.378 175.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.422 HD21 ' HB3' ' A' ' 132' ' ' ALA . 28.4 mt -58.65 -33.37 70.01 Favored 'General case' 0 C--O 1.2 -1.524 0 C-N-CA 122.713 0.405 . . . . 0.0 111.493 172.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.502 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 50.6 mt-30 -76.92 -41.2 44.44 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.999 0.52 . . . . 0.0 110.412 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 41.6 tpt85 -62.73 -43.23 99.35 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.282 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -100.72 -49.07 4.29 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.446 -169.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.461 ' HB2' HD13 ' A' ' 141' ' ' LEU . . . -97.19 -57.4 2.27 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -167.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.502 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 49.4 t-105 -68.78 -13.03 62.14 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.621 1.168 . . . . 0.0 112.271 -164.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -57.11 115.28 6.33 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 169.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 21.2 m -55.71 138.8 46.8 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.608 1.163 . . . . 0.0 113.214 -169.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 18.9 m -64.85 -26.59 68.4 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.893 0.877 . . . . 0.0 112.044 -177.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -66.6 93.52 0.25 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.009 0.924 . . . . 0.0 110.36 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -140.01 90.25 2.37 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -80.95 77.69 7.82 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.56 0.744 . . . . 0.0 110.789 -172.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 50.0 47.55 40.22 Favored Glycine 0 C--N 1.349 1.294 0 O-C-N 123.965 0.791 . . . . 0.0 113.398 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -69.28 115.77 35.65 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 122.613 0.365 . . . . 0.0 110.692 -172.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -75.74 160.88 37.29 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.605 2.203 . . . . 0.0 111.459 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.16 129.02 25.64 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.049 1.833 . . . . 0.0 110.581 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 94.9 mt -68.59 90.15 0.38 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.293 0.568 . . . . 0.0 110.399 -176.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 33.3 p -80.68 151.03 29.15 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-N 114.799 -1.092 . . . . 0.0 110.735 -176.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.2 pp -140.39 163.13 33.63 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.792 0.837 . . . . 0.0 109.485 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 . . . . . 0 CA--C 1.555 1.144 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -177.72 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 23.0 mmt . . . . . 0 N--CA 1.48 1.045 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.43 -33.29 97.78 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.579 2.186 . . . . 0.0 113.314 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -164.83 86.19 0.43 Allowed 'General case' 0 C--N 1.353 0.745 0 C-N-CA 123.255 0.622 . . . . 0.0 110.528 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 22.5 p -94.41 115.21 27.37 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.982 0.513 . . . . 0.0 110.095 177.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -104.82 139.42 39.61 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 176.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -104.71 101.71 11.32 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 177.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 133' ' ' ASN . 38.5 mm -75.93 129.59 36.93 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 68.6 p -122.14 80.7 1.74 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.844 0.858 . . . . 0.0 108.783 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.456 ' HB2' ' HB3' ' A' ' 131' ' ' LYS . 37.8 m-20 -69.84 -31.25 69.0 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 121.855 0.836 . . . . 0.0 109.55 172.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.609 ' HG3' ' HG3' ' A' ' 97' ' ' GLU . 25.1 ttp -102.69 121.81 43.17 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.142 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.4 m -72.97 155.65 39.63 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.832 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.8 mp -53.59 -34.3 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 C-N-CA 123.958 0.903 . . . . 0.0 111.084 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -50.9 -68.39 0.17 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.878 1.271 . . . . 0.0 112.108 173.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.609 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 9.9 pt-20 -71.13 -22.64 62.05 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.329 1.052 . . . . 0.0 112.063 -178.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.539 ' HG ' HD23 ' A' ' 146' ' ' LEU . 9.8 tt -66.72 -45.37 78.92 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.221 1.008 . . . . 0.0 110.347 174.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.9 t -98.94 1.63 45.76 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.39 0.676 . . . . 0.0 111.323 -175.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -61.01 140.88 57.72 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.554 0.742 . . . . 0.0 111.121 175.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -86.24 142.27 28.69 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.125 0.57 . . . . 0.0 109.751 171.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 28.7 p-90 -152.85 156.83 39.75 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.34 -170.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -111.26 155.24 23.3 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.265 1.026 . . . . 0.0 110.579 -175.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 93.8 mtp -128.43 109.23 11.22 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.113 0.965 . . . . 0.0 108.464 166.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.4 tp -67.92 -49.5 61.51 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.637 0.775 . . . . 0.0 110.261 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.502 ' HG2' ' HB2' ' A' ' 122' ' ' ALA . 97.7 mmm -119.95 82.19 28.19 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 124.151 0.98 . . . . 0.0 109.54 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -71.9 125.72 11.26 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.506 2.138 . . . . 0.0 112.675 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -95.76 110.18 22.37 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 166.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 20.4 tm0? -80.43 106.08 12.17 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 176.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.471 ' HG2' HG11 ' A' ' 180' ' ' VAL . 22.7 tptm -130.01 143.99 51.09 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.817 0.847 . . . . 0.0 108.745 170.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.451 HG11 HD11 ' A' ' 163' ' ' LEU . 63.1 t -131.72 122.16 49.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 168.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -109.18 97.56 7.15 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.29 -126.14 8.07 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 119.083 -0.843 . . . . 0.0 111.724 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.619 ' HG2' ' HB3' ' A' ' 169' ' ' HIS . 42.3 Cg_endo -98.26 31.88 0.13 Allowed 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 123.408 2.739 . . . . 0.0 111.74 172.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 162' ' ' PRO . 90.4 mt -131.17 123.97 29.67 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.177 0.991 . . . . 0.0 109.448 -178.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 16.6 p -83.78 122.69 29.01 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.445 0.698 . . . . 0.0 109.92 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.4 mm -103.11 106.65 20.48 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 C-N-CA 123.69 0.796 . . . . 0.0 109.3 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.618 ' HD2' ' HB3' ' A' ' 159' ' ' GLU . 77.2 mtt85 -95.93 119.92 35.29 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.76 0.824 . . . . 0.0 108.834 176.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.517 HD13 ' HA3' ' A' ' 184' ' ' GLY . 82.3 mt -129.76 123.79 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 124.401 1.08 . . . . 0.0 108.307 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -92.65 128.37 38.48 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.322 0.582 . . . . 0.0 110.029 177.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.482 ' HA ' ' ND2' ' A' ' 188' ' ' ASN . 75.1 mt-30 -91.13 -11.45 38.49 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.233 -174.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.502 ' HB2' ' HG2' ' A' ' 106' ' ' MET . . . -79.41 -49.43 12.35 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 120.997 0.427 . . . . 0.0 110.589 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.544 HG12 HG11 ' A' ' 157' ' ' VAL . 1.7 mp -71.34 109.73 3.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.288 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 50.3 mtt -131.61 159.2 38.97 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 113.693 -1.594 . . . . 0.0 109.554 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.4 t70 67.97 18.36 9.53 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 125.288 1.435 . . . . 0.0 112.295 174.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -103.61 151.99 22.28 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.585 0.754 . . . . 0.0 111.162 -176.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -84.31 102.2 12.51 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 168.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.507 HD12 HD22 ' A' ' 185' ' ' LEU . 44.3 mt -103.28 124.12 57.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -176.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.528 ' HG3' ' HG3' ' A' ' 131' ' ' LYS . 14.0 tpt -98.61 126.65 44.27 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.435 1.094 . . . . 0.0 109.069 -175.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.455 HD12 HG22 ' A' ' 194' ' ' VAL . 12.4 mt -105.79 103.43 12.93 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -174.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.528 ' HG3' ' HG3' ' A' ' 129' ' ' MET . 45.1 mtmt -126.5 150.95 48.44 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.037 0.535 . . . . 0.0 109.981 -176.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -136.91 153.68 50.67 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.907 0.86 . . . . 0.0 112.304 -174.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.52 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 4.6 m-20 -107.5 120.77 43.11 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 162.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -156.4 160.18 39.4 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.264 0.626 . . . . 0.0 111.02 -170.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 53.5 p -86.28 151.22 23.78 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.749 0.819 . . . . 0.0 109.226 174.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 87' ' ' SER . 60.0 t -130.55 132.75 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.381 1.073 . . . . 0.0 108.477 -177.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.3 tp -140.78 140.68 33.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 174.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 58.19 31.04 20.29 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.933 0.893 . . . . 0.0 111.946 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 63.31 30.88 15.59 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 124.97 1.308 . . . . 0.0 112.338 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 7.8 ppt_? -143.65 165.68 26.95 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.226 0.61 . . . . 0.0 109.687 173.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.472 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 10.5 tt -66.48 121.56 15.59 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.313 0.645 . . . . 0.0 109.742 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -82.31 -67.14 0.81 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.257 0.623 . . . . 0.0 110.281 173.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 62.2 m -141.96 127.4 18.87 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.885 0.474 . . . . 0.0 109.843 -173.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.647 HD11 ' HB2' ' A' ' 147' ' ' LEU . 51.9 tp -77.37 114.56 16.33 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.716 0.807 . . . . 0.0 109.545 178.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 57.1 mt -77.82 -52.65 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 175.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.539 HD23 ' HG ' ' A' ' 98' ' ' LEU . 50.2 tp -158.82 145.12 16.92 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.452 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.647 ' HB2' HD11 ' A' ' 144' ' ' LEU . 8.2 tt -139.26 152.25 47.13 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 176.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.738 HH11 HG21 ' A' ' 156' ' ' ILE . 6.8 ptp180 -150.73 157.44 42.96 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 122.046 0.927 . . . . 0.0 112.503 174.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.684 ' HB2' HD21 ' A' ' 181' ' ' LEU . . . -117.55 117.78 30.36 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 113.346 -1.752 . . . . 0.0 107.317 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -145.64 145.1 30.8 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.049 0.452 . . . . 0.0 111.709 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 80.5 p -65.13 163.28 15.29 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.457 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -64.82 -19.6 65.94 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -84.59 -1.46 55.98 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.164 0.586 . . . . 0.0 111.4 176.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 97.45 -5.25 62.5 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-O 119.931 -0.372 . . . . 0.0 114.005 172.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.99 105.97 6.26 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.991 0.395 . . . . 0.0 110.085 -175.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.738 HG21 HH11 ' A' ' 148' ' ' ARG . 13.8 mt -79.51 126.65 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.544 HG11 HG12 ' A' ' 123' ' ' ILE . 24.2 m -134.63 5.41 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 123.902 0.881 . . . . 0.0 110.964 -174.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -153.27 156.06 26.52 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.618 ' HB3' ' HD2' ' A' ' 118' ' ' ARG . 40.5 tt0 -164.83 141.64 6.01 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.802 0.441 . . . . 0.0 110.368 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.498 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 72.2 mt -120.62 121.64 65.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 172.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 15.5 m -137.52 148.13 60.32 Favored Pre-proline 0 N--CA 1.469 0.509 0 C-N-CA 123.272 0.629 . . . . 0.0 109.898 -177.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.403 ' HA ' HD23 ' A' ' 115' ' ' LEU . 18.1 Cg_endo -61.01 134.46 53.19 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 121.864 1.709 . . . . 0.0 110.302 165.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.586 ' HB2' ' HB2' ' A' ' 166' ' ' PHE . 66.2 mt -62.22 145.37 93.87 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.266 0.626 . . . . 0.0 110.886 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -59.01 127.22 23.49 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.53 2.154 . . . . 0.0 110.879 172.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 30.1 m 73.92 10.15 4.65 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.649 1.579 . . . . 0.0 112.519 -175.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.586 ' HB2' ' HB2' ' A' ' 163' ' ' LEU . 90.9 m-85 -132.51 73.41 76.83 Favored Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 123.702 0.801 . . . . 0.0 110.255 175.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -97.68 43.7 0.1 OUTLIER 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 123.612 2.875 . . . . 0.0 111.22 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -129.48 69.22 0.53 Allowed Glycine 0 C--N 1.345 1.04 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.792 -174.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.619 ' HB3' ' HG2' ' A' ' 114' ' ' PRO . 25.4 p-80 -122.66 150.08 43.17 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.474 0.71 . . . . 0.0 110.663 172.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 65.2 p -98.43 -178.62 4.08 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.471 169.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.472 ' HB ' ' O ' ' A' ' 141' ' ' LEU . 5.8 tt -54.6 -41.85 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.152 171.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.546 ' HA ' ' HD3' ' A' ' 175' ' ' LYS . 14.7 mm-40 -56.91 -41.35 77.99 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.366 1.066 . . . . 0.0 111.613 -176.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -64.05 -40.17 95.7 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.372 0.669 . . . . 0.0 111.018 178.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 46.2 t -68.1 -32.65 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.175 0.59 . . . . 0.0 110.604 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.546 ' HD3' ' HA ' ' A' ' 172' ' ' GLU . 27.3 mtpp -62.08 -42.92 99.7 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.564 0.745 . . . . 0.0 110.684 176.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.497 ' O ' HG23 ' A' ' 180' ' ' VAL . 60.7 m-80 -68.58 -41.27 79.9 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.143 175.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.99 -53.28 60.01 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 124.416 1.073 . . . . 0.0 112.008 -175.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 49.9 mt -63.19 -35.43 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 O-C-N 123.604 0.565 . . . . 0.0 109.756 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.19 -32.09 81.15 Favored Glycine 0 C--N 1.347 1.155 0 CA-C-N 116.159 -0.473 . . . . 0.0 114.082 177.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 176' ' ' ASN . 98.0 t -73.0 -44.66 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.684 HD21 ' HB2' ' A' ' 149' ' ' ALA . 48.9 tp -54.44 -49.76 69.27 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.261 1.025 . . . . 0.0 110.674 176.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.468 HD12 ' CH2' ' A' ' 203' ' ' TRP . 17.8 mt -63.88 -45.66 96.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.929 0.891 . . . . 0.0 110.979 176.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -55.1 -36.87 62.15 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 123.893 0.746 . . . . 0.0 113.811 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.517 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -70.07 -48.75 38.0 Favored Glycine 0 C--N 1.347 1.142 0 N-CA-C 111.793 -0.523 . . . . 0.0 111.793 174.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.507 HD22 HD12 ' A' ' 128' ' ' ILE . 97.7 mt -64.19 -31.97 73.37 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.985 0.914 . . . . 0.0 112.419 -176.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -66.24 -41.99 89.23 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.419 0.688 . . . . 0.0 111.121 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -74.84 -34.65 62.34 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.216 0.607 . . . . 0.0 110.417 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.482 ' ND2' ' HA ' ' A' ' 121' ' ' GLN . 6.0 m-20 -67.28 -15.14 63.52 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.344 0.657 . . . . 0.0 110.297 169.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 21.9 t70 64.49 65.99 0.62 Allowed 'General case' 0 C--N 1.349 0.577 0 C-N-CA 125.799 1.64 . . . . 0.0 110.223 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -121.95 139.69 53.36 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 175.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 74.0 m -78.46 104.81 9.3 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 23.9 m -80.77 130.23 36.24 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.591 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -133.36 123.07 24.74 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 173.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.455 HG22 HD12 ' A' ' 130' ' ' LEU . 4.3 t -101.82 150.05 6.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 -175.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 34.0 t -58.68 143.48 46.54 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.867 0.467 . . . . 0.0 111.146 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -57.01 -32.96 66.67 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.939 0.896 . . . . 0.0 111.25 -178.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 67.8 p -72.02 -48.49 44.24 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.582 175.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 58.3 mt -62.67 -36.45 82.92 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.107 0.563 . . . . 0.0 110.389 -177.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.541 ' HB3' ' HB3' ' A' ' 206' ' ' SER . 42.2 mt-30 -55.51 -33.79 64.05 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.596 1.159 . . . . 0.0 112.426 -177.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -101.25 -39.53 7.58 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -73.97 -38.03 64.3 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -168.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.435 ' O ' ' HG2' ' A' ' 175' ' ' LYS . . . -120.64 -57.7 1.88 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.896 0.478 . . . . 0.0 110.074 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.499 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 69.5 t-105 -58.36 -21.54 50.26 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 125.272 1.429 . . . . 0.0 114.057 -168.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 132.59 -127.38 4.81 Favored Glycine 0 N--CA 1.471 1.014 0 CA-C-O 119.75 -0.472 . . . . 0.0 112.184 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 31.2 t -109.59 112.59 24.77 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 123.554 0.742 . . . . 0.0 109.395 -177.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.541 ' HB3' ' HB3' ' A' ' 199' ' ' GLN . 32.1 t -155.28 101.67 2.23 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -76.17 87.15 3.02 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.514 0.725 . . . . 0.0 109.162 178.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.85 160.83 31.89 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.503 178.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -142.88 88.7 2.07 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.169 0.588 . . . . 0.0 110.102 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -69.87 115.9 6.49 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 171.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -60.83 148.74 82.35 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 123.387 0.675 . . . . 0.0 111.391 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -53.13 134.5 56.45 Favored 'Trans proline' 0 C--N 1.383 2.358 0 C-N-CA 123.109 2.54 . . . . 0.0 112.162 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -64.85 85.19 0.17 Allowed 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.916 2.411 . . . . 0.0 112.07 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 72.6 mt -139.41 149.44 44.08 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.139 1.375 . . . . 0.0 108.096 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.451 HG22 ' HG ' ' A' ' 216' ' ' LEU . 33.0 m -133.94 -78.97 0.47 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.451 ' HG ' HG22 ' A' ' 215' ' ' THR . 71.3 mt -140.95 163.66 32.36 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.522 1.129 . . . . 0.0 109.067 -176.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 . . . . . 0 CA--C 1.555 1.166 0 CA-C-O 118.5 -0.762 . . . . 0.0 109.195 176.145 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 N--CA 1.482 1.145 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.559 ' HB2' HD11 ' A' ' 137' ' ' ILE . 45.5 Cg_endo -64.71 115.54 3.29 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.607 2.204 . . . . 0.0 112.376 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -89.15 141.4 28.55 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.566 0.746 . . . . 0.0 110.597 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 50.4 m -99.63 128.29 45.74 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.396 0.678 . . . . 0.0 110.276 178.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 29.8 ttp-105 -115.59 140.87 48.78 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.617 0.767 . . . . 0.0 109.956 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -99.65 109.52 22.0 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.834 0.853 . . . . 0.0 109.945 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.7 mm -78.85 121.68 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 123.783 0.833 . . . . 0.0 109.352 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.1 p -108.38 66.19 0.64 Allowed 'General case' 0 C--O 1.244 0.781 0 CA-C-O 122.672 1.225 . . . . 0.0 108.112 173.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.543 ' HB3' ' O ' ' A' ' 132' ' ' ALA . 19.1 t70 -68.95 -35.54 76.88 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 112.91 -1.95 . . . . 0.0 110.963 -177.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.582 ' HB3' ' HB3' ' A' ' 131' ' ' LYS . 26.2 ptt? -110.93 146.24 36.92 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 171.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.1 m -91.85 158.02 16.55 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.308 0.643 . . . . 0.0 111.069 -167.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.2 mp -58.53 -34.97 52.54 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 C-N-CA 124.122 0.969 . . . . 0.0 110.385 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -48.91 -43.02 38.94 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.358 1.063 . . . . 0.0 113.094 176.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.52 -24.45 15.56 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 122.847 0.459 . . . . 0.0 111.102 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.476 ' HA ' HH21 ' A' ' 148' ' ' ARG . 9.0 tt -67.46 -45.81 74.89 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.616 0.766 . . . . 0.0 110.128 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 26.4 t -96.32 10.93 36.46 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.561 1.144 . . . . 0.0 110.316 -175.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -74.23 136.02 42.72 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.049 0.54 . . . . 0.0 110.517 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -77.42 133.56 38.62 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 174.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 17.9 p-90 -150.76 171.35 17.33 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.661 0.784 . . . . 0.0 110.406 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -148.2 165.33 31.24 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.728 1.211 . . . . 0.0 108.665 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 62.3 mtp -110.37 127.77 55.24 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 36.2 tp -73.39 -40.84 64.01 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.411 0.684 . . . . 0.0 109.642 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.521 ' HG2' ' HB2' ' A' ' 122' ' ' ALA . 23.8 mmt -124.77 88.96 53.11 Favored Pre-proline 0 N--CA 1.482 1.134 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 169.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.18 112.38 2.74 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 122.995 2.464 . . . . 0.0 112.236 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.44 ' HB2' ' NE2' ' A' ' 121' ' ' GLN . 58.7 tptt -115.61 118.39 32.99 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 169.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -100.96 115.37 30.29 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.46 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 16.7 tppt? -120.9 159.84 24.7 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.429 1.092 . . . . 0.0 108.377 175.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.5 t -137.68 140.8 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -122.84 84.7 2.3 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 171.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.5 -116.71 7.2 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.883 175.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -85.25 8.84 4.39 Favored 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 123.227 2.618 . . . . 0.0 112.739 -177.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.8 mt -131.87 121.95 24.89 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.977 0.911 . . . . 0.0 109.021 -171.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.573 ' SG ' HD21 ' A' ' 163' ' ' LEU . 90.0 m -90.51 120.61 31.75 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.964 0.506 . . . . 0.0 111.252 -178.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.46 ' HB ' ' HB3' ' A' ' 110' ' ' LYS . 17.2 mm -86.64 155.3 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.358 0 C-N-CA 124.298 1.039 . . . . 0.0 110.034 -176.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -134.66 121.27 20.61 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.438 HD12 ' HA3' ' A' ' 184' ' ' GLY . 50.5 mm -123.7 122.85 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 123.416 0.686 . . . . 0.0 109.686 -177.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -98.64 115.45 28.7 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 172.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.477 ' HA ' HD21 ' A' ' 188' ' ' ASN . 44.4 mt-30 -84.08 -6.91 59.49 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.02 0.928 . . . . 0.0 113.327 -174.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.521 ' HB2' ' HG2' ' A' ' 106' ' ' MET . . . -87.7 -45.45 10.35 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.963 0.505 . . . . 0.0 110.301 177.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.467 HG12 HG11 ' A' ' 157' ' ' VAL . 1.8 mp -70.67 110.7 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-O 122.038 0.923 . . . . 0.0 110.006 -177.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.585 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 51.3 mtt -131.72 158.43 41.19 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.224 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.5 t70 67.82 13.47 9.2 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.757 1.223 . . . . 0.0 112.739 174.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -97.55 146.82 24.9 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.43 -0.793 . . . . 0.0 110.611 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.563 ' HB2' ' HB3' ' A' ' 152' ' ' GLU . 39.4 m-80 -82.73 97.74 8.72 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 174.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.444 HD12 HD22 ' A' ' 185' ' ' LEU . 53.4 mt -105.82 130.12 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.462 0.705 . . . . 0.0 110.111 -171.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 12.2 tpt -105.12 134.11 48.77 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.163 0.985 . . . . 0.0 110.026 -175.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.425 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 2.2 mm? -100.2 109.15 21.4 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.582 ' HB3' ' HB3' ' A' ' 93' ' ' MET . 40.9 mttm -127.56 152.0 48.18 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.049 0.939 . . . . 0.0 110.682 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.698 ' HB3' HD21 ' A' ' 198' ' ' LEU . . . -146.63 149.42 33.47 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -105.5 132.69 51.36 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 165.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.471 ' HA ' HG13 ' A' ' 145' ' ' ILE . 39.6 p90 -158.79 159.27 34.95 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.761 0.824 . . . . 0.0 109.979 -171.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.8 p -86.57 160.69 18.86 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.391 0.676 . . . . 0.0 109.695 173.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 87' ' ' SER . 77.7 t -128.0 135.79 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.36 1.064 . . . . 0.0 109.135 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.559 HD11 ' HB2' ' A' ' 85' ' ' PRO . 8.2 tp -142.08 139.46 30.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 170.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 57.25 33.8 23.84 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.776 0.83 . . . . 0.0 111.72 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 36.0 t70 67.35 8.82 6.54 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.892 1.277 . . . . 0.0 112.636 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 44.5 ptt85 -116.57 165.25 13.46 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.647 0.779 . . . . 0.0 110.033 176.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.404 ' HB3' HG13 ' A' ' 171' ' ' ILE . 8.5 tt -64.26 108.63 1.64 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.507 0.723 . . . . 0.0 109.204 175.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -68.18 -68.73 0.37 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.341 0.656 . . . . 0.0 110.334 177.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.6 m -143.68 130.56 20.44 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.418 -175.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.7 tp -73.16 124.88 26.46 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 175.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.471 HG13 ' HA ' ' A' ' 134' ' ' PHE . 70.1 mt -84.54 -49.86 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 176.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 48.2 tp -164.8 147.53 8.48 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.75 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.774 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 6.7 tt -134.06 153.52 51.75 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 176.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.494 ' N ' HD23 ' A' ' 147' ' ' LEU . 45.1 ttm-85 -143.23 147.25 34.54 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.546 0.738 . . . . 0.0 111.284 -173.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.595 ' HB2' HD21 ' A' ' 181' ' ' LEU . . . -120.69 111.3 17.44 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.791 1.237 . . . . 0.0 107.856 169.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 40.5 p90 -127.67 157.27 40.74 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.166 0.986 . . . . 0.0 108.756 -178.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 63.0 p -86.02 176.65 7.91 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.39 0.614 . . . . 0.0 111.122 -174.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 127' ' ' ASN . 11.0 pt-20 -54.38 -35.78 63.19 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.912 1.285 . . . . 0.0 112.144 174.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.418 ' HG2' ' H ' ' A' ' 153' ' ' GLU . 8.5 pt-20 -88.32 -9.22 53.52 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.115 0.966 . . . . 0.0 111.618 -177.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 100.63 -3.36 56.17 Favored Glycine 0 C--N 1.352 1.43 0 CA-C-O 120.016 -0.324 . . . . 0.0 113.471 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.82 104.9 2.59 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.437 HD13 ' HD3' ' A' ' 148' ' ' ARG . 26.3 mt -69.87 124.28 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.178 0.591 . . . . 0.0 109.53 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.467 HG11 HG12 ' A' ' 123' ' ' ILE . 35.0 m -126.41 -3.68 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.737 0.815 . . . . 0.0 111.382 -174.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -155.31 164.96 32.19 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.651 -175.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -167.43 153.86 8.05 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.245 0.618 . . . . 0.0 109.528 -176.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.774 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 78.6 mt -125.75 102.99 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 165.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 84.0 p -99.0 110.42 57.66 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 123.61 0.764 . . . . 0.0 110.014 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.06 123.95 14.59 Favored 'Trans proline' 0 C--N 1.367 1.513 0 C-N-CA 122.921 2.414 . . . . 0.0 112.921 174.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.573 HD21 ' SG ' ' A' ' 116' ' ' CYS . 89.5 mt -62.13 129.18 91.88 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 123.789 0.836 . . . . 0.0 110.714 177.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 163' ' ' LEU . 15.3 Cg_exo -68.71 -21.1 39.37 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 123.267 2.645 . . . . 0.0 111.951 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 48.0 p -69.99 -18.09 63.31 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.804 0.842 . . . . 0.0 111.414 173.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -128.67 75.74 79.44 Favored Pre-proline 0 N--CA 1.479 0.98 0 C-N-CA 123.642 0.777 . . . . 0.0 110.109 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.25 -31.42 7.57 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.283 1.989 . . . . 0.0 112.087 175.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -92.79 68.73 1.74 Allowed Glycine 0 C--N 1.345 1.082 0 N-CA-C 111.781 -0.527 . . . . 0.0 111.781 -176.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -108.75 151.94 25.53 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.36 0.664 . . . . 0.0 110.097 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 44.5 p -84.57 160.58 20.43 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.493 0.663 . . . . 0.0 112.081 -174.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.428 HD11 ' O ' ' A' ' 201' ' ' PHE . 11.4 tt -57.58 -32.1 41.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.648 170.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -72.85 -30.54 64.09 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.539 0.736 . . . . 0.0 111.353 -177.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -60.76 -39.72 89.82 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 122.843 0.457 . . . . 0.0 110.499 173.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 178' ' ' ILE . 38.5 t -64.88 -39.13 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 O-C-N 124.471 1.107 . . . . 0.0 110.2 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -59.26 -48.76 80.43 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.525 0.73 . . . . 0.0 111.459 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.465 ' O ' HG23 ' A' ' 180' ' ' VAL . 65.0 m-80 -65.71 -38.86 90.37 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.935 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.4 -43.4 97.65 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 124.137 0.898 . . . . 0.0 111.451 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 174' ' ' VAL . 60.5 mt -67.52 -34.1 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.9 -33.38 87.09 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 116.625 -0.262 . . . . 0.0 113.596 176.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 176' ' ' ASN . 97.8 t -78.71 -43.25 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.48 0.712 . . . . 0.0 110.353 177.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.595 HD21 ' HB2' ' A' ' 149' ' ' ALA . 38.6 tp -57.34 -54.79 42.81 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.819 0.848 . . . . 0.0 111.035 176.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.614 HG23 HG21 ' A' ' 192' ' ' VAL . 61.8 mt -58.06 -40.12 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 123.821 0.848 . . . . 0.0 110.225 170.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.4 -21.82 54.88 Favored Glycine 0 N--CA 1.475 1.28 0 N-CA-C 115.151 0.82 . . . . 0.0 115.151 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.438 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -95.74 -16.11 40.45 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 117.004 0.402 . . . . 0.0 112.751 173.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.444 HD22 HD12 ' A' ' 128' ' ' ILE . 81.9 mt -91.76 -32.66 15.31 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.408 1.083 . . . . 0.0 111.825 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.517 ' O ' ' HD3' ' A' ' 212' ' ' PRO . 0.4 OUTLIER -77.84 -31.8 51.76 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.136 0.574 . . . . 0.0 111.132 -173.439 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 8.7 ptm85 -70.23 -24.77 63.15 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.669 0.787 . . . . 0.0 110.942 173.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.585 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 4.2 m-20 -81.48 -10.88 59.39 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.79 0.836 . . . . 0.0 110.293 172.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 19.5 t70 57.63 65.79 1.26 Allowed 'General case' 0 C--N 1.358 0.975 0 C-N-CA 125.414 1.486 . . . . 0.0 110.2 -171.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -107.57 145.71 32.85 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.635 169.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.1 m -83.47 100.31 10.66 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.614 HG21 HG23 ' A' ' 182' ' ' ILE . 18.7 m -99.27 134.63 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 123.645 0.778 . . . . 0.0 110.571 -171.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -135.66 129.82 33.35 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.425 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 2.9 t -90.01 143.03 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 23.2 t -69.11 156.58 38.44 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -172.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -50.23 -49.5 52.73 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.312 1.045 . . . . 0.0 111.812 -176.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 38.1 p -61.18 -50.84 71.52 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 123.967 0.792 . . . . 0.0 110.19 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.698 HD21 ' HB3' ' A' ' 132' ' ' ALA . 62.9 mt -60.07 -36.47 77.43 Favored 'General case' 0 C--O 1.215 -0.735 0 O-C-N 123.882 0.739 . . . . 0.0 111.752 -176.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.495 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 48.3 mt-30 -66.0 -51.7 55.99 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.472 0.709 . . . . 0.0 110.776 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.26 -24.79 51.08 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -175.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.428 ' O ' HD11 ' A' ' 171' ' ' ILE . 25.3 m-85 -82.04 -57.37 3.43 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.819 0.448 . . . . 0.0 110.698 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -116.82 -57.77 2.14 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.24 0.616 . . . . 0.0 110.408 -166.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.495 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 51.4 t-105 -79.65 73.98 6.33 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.857 1.263 . . . . 0.0 111.103 -168.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -102.2 20.7 44.18 Favored Glycine 0 N--CA 1.469 0.853 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 172.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 37.0 p -146.69 93.85 2.35 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.276 1.03 . . . . 0.0 109.128 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 15.4 p -81.07 95.7 6.92 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.507 0.723 . . . . 0.0 109.21 174.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -118.17 6.97 12.03 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.307 0.643 . . . . 0.0 112.542 -168.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.439 ' HG3' ' HG2' ' A' ' 186' ' ' GLU . 8.7 tp10 -138.54 101.67 4.41 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.285 0.564 . . . . 0.0 111.807 -176.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -149.66 30.42 0.74 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 125.813 1.645 . . . . 0.0 108.661 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -63.29 -41.91 99.39 Favored Glycine 0 C--N 1.351 1.378 0 CA-C-N 115.84 -0.618 . . . . 0.0 113.898 -170.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 66.15 156.39 0.13 Allowed Pre-proline 0 N--CA 1.493 1.69 0 C-N-CA 125.438 1.495 . . . . 0.0 112.623 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.517 ' HD3' ' O ' ' A' ' 186' ' ' GLU . 85.2 Cg_endo -77.02 130.52 11.34 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 122.174 1.916 . . . . 0.0 110.649 178.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -47.74 123.28 8.11 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 123.769 2.979 . . . . 0.0 112.223 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 73.2 mt -72.42 83.22 1.08 Allowed 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.271 0.558 . . . . 0.0 109.888 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 71.6 p -73.09 142.59 47.56 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.823 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.4 pp -66.53 146.77 54.16 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 123.237 0.336 . . . . 0.0 110.662 -175.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 . . . . . 0 CA--C 1.55 0.977 0 C-N-CA 123.801 0.84 . . . . 0.0 109.317 179.257 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.405 ' SD ' ' N ' ' A' ' 84' ' ' MET . 1.4 pmm? . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.17 -13.92 40.66 Favored 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 123.124 2.549 . . . . 0.0 112.923 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 69.09 39.26 1.78 Allowed 'General case' 0 C--N 1.353 0.743 0 C-N-CA 124.689 1.195 . . . . 0.0 110.846 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.4 t -96.31 130.16 43.47 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.529 177.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -156.86 147.39 21.44 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.146 0.578 . . . . 0.0 110.823 -174.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -97.54 111.74 23.89 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 168.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.6 mm -77.42 140.43 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.749 0.82 . . . . 0.0 109.76 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.6 p -141.34 61.12 1.49 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.183 0.993 . . . . 0.0 109.326 -173.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.9 -15.01 60.27 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.493 172.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 69.2 mtm -110.66 133.71 53.09 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 165.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 74.8 p -71.6 159.65 34.05 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 167.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.72 -34.76 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 123.195 0.598 . . . . 0.0 110.249 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -56.6 -61.51 2.37 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.375 1.07 . . . . 0.0 112.053 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -73.51 -26.5 60.91 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -176.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.402 ' HG ' HD23 ' A' ' 146' ' ' LEU . 7.8 tt -63.18 -51.98 64.2 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.62 0.768 . . . . 0.0 109.785 176.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.9 t -91.94 2.28 56.64 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.583 -174.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -69.71 132.46 46.16 Favored 'General case' 0 C--N 1.356 0.858 0 C-N-CA 122.717 0.407 . . . . 0.0 111.262 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -89.15 148.77 23.48 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.665 0.786 . . . . 0.0 109.729 176.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.464 ' HE1' ' NH1' ' A' ' 148' ' ' ARG . 12.2 p-90 -151.93 164.45 37.12 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 124.337 1.055 . . . . 0.0 110.373 -171.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -115.19 158.17 22.63 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.526 1.13 . . . . 0.0 110.135 -176.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.484 ' SD ' ' HD2' ' A' ' 118' ' ' ARG . 70.2 mtp -122.02 145.53 48.05 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.386 0.674 . . . . 0.0 110.454 178.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.7 tp -91.97 -42.49 9.97 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.856 0.862 . . . . 0.0 109.926 177.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 24.9 mmt -126.49 85.69 59.79 Favored Pre-proline 0 N--CA 1.482 1.159 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 173.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -70.47 113.27 3.44 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 123.125 2.55 . . . . 0.0 111.676 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.487 ' HD3' ' NE2' ' A' ' 121' ' ' GLN . 55.9 tptt -98.23 118.49 34.99 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 172.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -82.76 105.68 13.98 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 170.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -125.98 145.49 50.27 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.907 0.883 . . . . 0.0 108.91 174.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.0 t -136.77 139.53 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 173.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -126.82 86.08 2.46 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 174.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.38 -121.52 8.22 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.48 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -89.54 15.96 1.86 Allowed 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 123.339 2.693 . . . . 0.0 113.225 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.667 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 5.4 mp -129.11 137.4 51.2 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.658 0.783 . . . . 0.0 108.976 176.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 53.5 t -92.03 130.46 37.77 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 173.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.1 mm -100.76 155.9 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.962 0.905 . . . . 0.0 108.802 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.484 ' HD2' ' SD ' ' A' ' 104' ' ' MET . 20.2 tpp180 -138.61 120.54 15.48 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.463 HD11 ' HA ' ' A' ' 181' ' ' LEU . 38.8 mm -123.56 134.84 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.555 1.142 . . . . 0.0 108.703 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -101.65 115.19 29.97 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 169.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.487 ' NE2' ' HD3' ' A' ' 108' ' ' LYS . 85.5 mt-30 -78.73 -2.07 37.61 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.557 0.743 . . . . 0.0 112.912 -172.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.59 -32.75 10.94 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.359 0.664 . . . . 0.0 110.395 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 31.2 mm -71.23 110.88 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 121.468 0.651 . . . . 0.0 110.739 -176.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.486 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 57.9 mtt -136.34 161.91 34.48 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.218 -173.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 62.62 19.66 11.47 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.739 1.215 . . . . 0.0 113.351 171.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -102.3 149.94 23.83 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.336 0.654 . . . . 0.0 110.016 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -87.23 102.87 14.9 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 167.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 57.3 mt -104.2 142.31 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 123.607 0.763 . . . . 0.0 109.038 -172.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 11.4 tpt -126.65 125.13 41.36 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.274 1.029 . . . . 0.0 108.636 -173.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 14.6 mt -90.46 102.73 15.47 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -176.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.481 ' HD3' ' CD1' ' A' ' 150' ' ' PHE . 25.0 mtpp -113.71 129.84 56.51 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.528 1.131 . . . . 0.0 108.771 -171.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.491 ' HB2' ' HG ' ' A' ' 147' ' ' LEU . . . -134.67 154.98 51.29 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.797 0.808 . . . . 0.0 113.017 -172.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -116.48 134.9 54.32 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 114.061 -1.427 . . . . 0.0 107.774 165.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.507 ' HA ' HG13 ' A' ' 145' ' ' ILE . 37.6 p90 -162.96 165.05 25.46 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.508 0.505 . . . . 0.0 111.581 -176.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 44.7 p -85.98 148.76 25.6 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.462 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 90.1 t -126.44 151.81 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.252 1.021 . . . . 0.0 109.148 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.3 tp -158.4 144.87 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 170.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 57.41 26.52 12.64 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 176.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 67.83 15.03 9.57 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 124.758 1.223 . . . . 0.0 112.701 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -120.82 160.7 22.87 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.715 0.806 . . . . 0.0 109.457 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.519 HD13 ' HB2' ' A' ' 202' ' ' ALA . 9.8 tt -66.6 123.27 19.62 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 174.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -78.93 -69.38 0.57 Allowed 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 176.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 99.0 m -145.8 129.5 17.13 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.368 0.667 . . . . 0.0 109.418 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.567 HD22 HG13 ' A' ' 174' ' ' VAL . 53.3 tp -71.52 115.83 11.15 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 123.894 0.746 . . . . 0.0 109.966 176.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.507 HG13 ' HA ' ' A' ' 134' ' ' PHE . 73.5 mt -74.29 -53.83 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.402 HD23 ' HG ' ' A' ' 98' ' ' LEU . 57.7 tp -160.18 149.74 17.81 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.134 177.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.633 HD13 HD12 ' A' ' 160' ' ' ILE . 7.1 tt -134.51 148.78 50.6 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 174.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.464 ' NH1' ' HE1' ' A' ' 102' ' ' TRP . 43.5 mtt-85 -141.95 159.48 42.14 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.994 0.918 . . . . 0.0 110.329 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -115.77 112.15 21.59 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.121 0.968 . . . . 0.0 109.166 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.481 ' CD1' ' HD3' ' A' ' 131' ' ' LYS . 56.9 m-85 -107.99 136.01 48.4 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.232 1.013 . . . . 0.0 109.93 -177.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 66.9 p -81.43 -172.93 4.08 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.955 0.502 . . . . 0.0 110.648 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -53.76 -37.56 63.53 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.446 0.698 . . . . 0.0 111.882 170.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -80.5 -5.5 56.76 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.121 0.968 . . . . 0.0 111.91 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 75.46 23.05 74.39 Favored Glycine 0 C--N 1.347 1.19 0 N-CA-C 112.102 -0.399 . . . . 0.0 112.102 -174.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -82.69 121.25 26.61 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.417 HD13 ' HD3' ' A' ' 148' ' ' ARG . 12.2 mt -75.6 110.3 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.6 m -120.41 1.86 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.337 1.055 . . . . 0.0 111.047 -175.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -157.23 166.59 33.69 Favored Glycine 0 C--O 1.242 0.634 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -165.26 150.17 9.09 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -174.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.633 HD12 HD13 ' A' ' 147' ' ' LEU . 63.9 mt -128.43 102.69 8.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 164.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 48.1 t -112.06 113.35 52.07 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.667 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 19.0 Cg_endo -57.79 136.21 73.95 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.291 1.994 . . . . 0.0 111.787 178.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 83.2 mt -57.54 136.89 82.19 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 123.968 0.907 . . . . 0.0 112.402 -171.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.23 -31.65 84.83 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 123.521 2.814 . . . . 0.0 113.109 175.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 25.1 m -77.43 -6.64 54.16 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.99 0.916 . . . . 0.0 112.509 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -133.43 89.87 30.86 Favored Pre-proline 0 N--CA 1.479 0.982 0 C-N-CA 123.92 0.888 . . . . 0.0 109.143 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -76.32 3.04 6.62 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.333 2.689 . . . . 0.0 113.792 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -146.94 146.16 15.73 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 177.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -148.48 163.52 36.92 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 123.823 0.849 . . . . 0.0 109.553 175.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 34.5 p -83.94 156.26 22.43 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.479 HD11 ' O ' ' A' ' 201' ' ' PHE . 7.2 tt -58.37 -31.89 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 124.178 0.991 . . . . 0.0 110.593 171.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -67.15 -38.08 84.9 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.474 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -62.71 -33.93 76.12 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.834 0.454 . . . . 0.0 110.833 176.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.567 HG13 HD22 ' A' ' 144' ' ' LEU . 60.9 t -66.56 -52.53 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 124.009 0.818 . . . . 0.0 111.618 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -63.04 -33.98 76.6 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 122.225 0.21 . . . . 0.0 111.456 -176.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.401 ' O ' HG23 ' A' ' 180' ' ' VAL . 17.3 m120 -69.82 -40.36 75.95 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.161 0.584 . . . . 0.0 110.185 174.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -59.91 -40.44 88.82 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 124.084 0.865 . . . . 0.0 110.805 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 174' ' ' VAL . 67.5 mt -68.2 -38.86 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.352 0.661 . . . . 0.0 109.671 177.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.36 -35.29 91.44 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 116.003 -0.544 . . . . 0.0 113.612 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 176' ' ' ASN . 76.2 t -76.09 -38.67 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.112 0.565 . . . . 0.0 110.194 177.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.463 ' HA ' HD11 ' A' ' 119' ' ' ILE . 30.1 tp -57.01 -48.09 79.31 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.354 0.661 . . . . 0.0 110.276 173.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.414 ' O ' ' HG2' ' A' ' 186' ' ' GLU . 47.6 mt -60.82 -48.9 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.82 0.848 . . . . 0.0 110.492 176.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -55.93 -44.61 87.64 Favored Glycine 0 C--N 1.347 1.154 0 O-C-N 123.796 0.685 . . . . 0.0 113.438 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -66.79 -28.57 73.83 Favored Glycine 0 C--N 1.35 1.343 0 O-C-N 123.959 0.446 . . . . 0.0 113.676 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 33.9 mt -83.21 -33.27 26.16 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.296 1.038 . . . . 0.0 111.711 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 52.3 mm-40 -68.62 -39.3 80.88 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.541 0.737 . . . . 0.0 110.873 -177.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -73.8 -16.47 61.15 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.894 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.486 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 8.1 m-20 -77.09 -15.44 59.57 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.386 0.674 . . . . 0.0 111.743 169.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 66.72 64.31 0.48 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.408 1.083 . . . . 0.0 110.138 -172.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -137.06 154.6 50.3 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.755 167.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 20.7 m -98.95 105.98 18.18 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.744 0.818 . . . . 0.0 109.483 -169.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 13.7 m -97.93 150.3 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-O 121.714 0.769 . . . . 0.0 112.095 -178.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 19.6 tpp85 -133.37 139.1 46.61 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.9 t -98.69 146.77 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -178.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 27.9 t -55.08 145.54 20.53 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.286 0.634 . . . . 0.0 111.943 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -51.86 -37.8 53.52 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.005 0.922 . . . . 0.0 111.284 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 53.3 p -73.2 -51.86 16.22 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.726 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 62.2 mt -57.02 -39.02 73.98 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.09 0.556 . . . . 0.0 111.241 -177.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.452 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 46.7 mt-30 -58.81 -39.4 81.06 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.958 0.903 . . . . 0.0 112.246 -176.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.01 -32.54 10.9 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -176.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.479 ' O ' HD11 ' A' ' 171' ' ' ILE . 35.0 m-85 -74.97 -52.29 11.52 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 117.951 0.341 . . . . 0.0 111.25 -175.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.519 ' HB2' HD13 ' A' ' 141' ' ' LEU . . . -109.63 -50.62 2.96 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.056 0.542 . . . . 0.0 111.346 -172.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.452 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 70.7 t-105 -66.61 -44.33 82.37 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.369 1.068 . . . . 0.0 111.156 -170.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.36 -15.84 77.46 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 115.622 -0.717 . . . . 0.0 113.466 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 23.0 t -62.84 116.75 5.54 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.658 0.783 . . . . 0.0 109.1 178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 46.8 m -145.07 176.01 9.82 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.915 0.886 . . . . 0.0 110.381 -173.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 63.3 33.94 13.62 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.065 0.946 . . . . 0.0 111.495 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -97.7 -145.55 0.31 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.752 1.221 . . . . 0.0 110.368 -176.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -155.69 -58.75 0.1 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.884 0.474 . . . . 0.0 110.662 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 126.98 -27.07 4.93 Favored Glycine 0 N--CA 1.471 1.031 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 -173.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 17.1 mtm180 50.46 85.16 0.19 Allowed Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 125.216 1.406 . . . . 0.0 110.689 -175.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -76.15 157.52 37.92 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 123.023 2.482 . . . . 0.0 111.901 -170.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -51.41 117.84 3.82 Favored 'Trans proline' 0 C--N 1.384 2.421 0 C-N-CA 122.898 2.399 . . . . 0.0 111.243 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 84.9 mt -65.04 107.09 1.41 Allowed 'General case' 0 C--O 1.241 0.621 0 O-C-N 123.379 0.424 . . . . 0.0 110.287 -174.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 16.3 p -67.42 141.75 56.92 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.387 -177.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.1 pp -137.9 -173.34 3.48 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 124.225 1.01 . . . . 0.0 110.512 -172.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.556 1.21 0 C-N-CA 124.262 1.025 . . . . 0.0 108.623 -175.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 12.6 tpt . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.402 ' HB2' HD11 ' A' ' 137' ' ' ILE . 0.9 OUTLIER -86.42 176.72 4.75 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.779 2.32 . . . . 0.0 111.197 168.027 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.87 101.77 0.53 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.992 0.517 . . . . 0.0 110.67 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.8 t -131.42 142.35 50.0 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.633 0.773 . . . . 0.0 109.929 -174.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -158.48 148.82 20.01 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.145 0.578 . . . . 0.0 109.997 -173.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -98.78 110.49 23.09 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 168.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.8 mm -77.47 118.7 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.608 0.763 . . . . 0.0 109.025 173.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 38.5 p -102.47 68.02 1.04 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.538 ' HB3' ' O ' ' A' ' 132' ' ' ALA . 32.4 t70 -72.77 -25.17 61.08 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 114.439 -1.255 . . . . 0.0 111.059 -175.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 60.7 mtm -92.92 136.98 32.77 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 162.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 77.0 p -67.37 163.82 19.92 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 167.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 29.8 mm -57.04 -36.06 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 173.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -58.94 -42.07 88.9 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.313 175.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -77.43 -35.94 53.58 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 122.873 0.469 . . . . 0.0 111.549 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.429 HD12 ' ND2' ' A' ' 133' ' ' ASN . 6.7 tt -64.03 -40.23 95.85 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.974 1.31 . . . . 0.0 109.826 -177.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.0 t -113.34 22.05 14.61 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.348 1.059 . . . . 0.0 109.91 -176.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -66.33 137.5 56.96 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.481 0.712 . . . . 0.0 111.14 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -79.03 136.14 37.1 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 175.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.433 ' CG ' ' HB ' ' A' ' 156' ' ' ILE . 38.3 p-90 -156.06 164.86 37.9 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.932 0.893 . . . . 0.0 110.33 176.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -136.93 149.58 47.67 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.763 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.43 ' HG3' ' HG3' ' A' ' 107' ' ' PRO . 13.2 ptm -129.78 129.66 44.37 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 173.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.546 ' H ' HD23 ' A' ' 105' ' ' LEU . 0.9 OUTLIER -94.75 -19.41 20.39 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.297 0.639 . . . . 0.0 110.857 -173.169 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 94.1 mmm -127.37 72.44 77.33 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.187 0.995 . . . . 0.0 109.375 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.43 ' HG3' ' HG3' ' A' ' 104' ' ' MET . 12.3 Cg_exo -71.03 110.39 2.8 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 122.63 2.22 . . . . 0.0 111.741 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.491 ' HB3' ' HB ' ' A' ' 119' ' ' ILE . 57.7 tptt -82.83 117.07 22.44 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 173.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 20.6 tm0? -77.3 102.24 6.65 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.486 ' HA ' ' HE3' ' A' ' 110' ' ' LYS . 0.1 OUTLIER -137.09 130.63 31.55 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.383 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 91.0 t -134.43 138.01 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 173.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -123.61 102.96 8.14 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.154 0.582 . . . . 0.0 109.44 175.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.17 -125.18 26.71 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.007 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -86.31 13.79 2.63 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 123.397 2.732 . . . . 0.0 113.289 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.493 HD23 ' HA ' ' A' ' 162' ' ' PRO . 86.7 mt -130.97 130.85 43.93 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.567 0.747 . . . . 0.0 110.381 -175.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 53.3 t -83.83 137.27 33.78 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.502 0.721 . . . . 0.0 110.266 173.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.3 mm -106.08 151.93 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 C-N-CA 123.924 0.89 . . . . 0.0 108.763 175.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -130.79 124.29 31.04 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 173.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.616 HD13 ' HA3' ' A' ' 184' ' ' GLY . 55.3 mt -132.3 122.69 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.513 ' HB3' ' HB ' ' A' ' 157' ' ' VAL . 23.7 t70 -93.85 121.42 35.28 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.454 ' HA ' ' ND2' ' A' ' 188' ' ' ASN . 81.9 mt-30 -84.29 -7.83 59.21 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -174.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.83 -47.45 11.09 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 118.287 0.494 . . . . 0.0 110.4 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.523 HG23 ' HG3' ' A' ' 126' ' ' LYS . 1.7 mp -71.74 102.47 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-O 122.32 1.057 . . . . 0.0 109.499 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 38.6 mtt -124.55 170.14 11.2 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-N 113.613 -1.63 . . . . 0.0 109.773 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 70.47 11.67 7.38 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 124.762 1.225 . . . . 0.0 112.573 173.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.523 ' HG3' HG23 ' A' ' 123' ' ' ILE . 74.7 mmtt -100.64 156.67 17.18 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.708 0.803 . . . . 0.0 112.227 -171.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.437 ' HB2' ' HG2' ' A' ' 152' ' ' GLU . 90.4 m-20 -89.77 108.91 19.97 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 166.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.562 ' HB ' HG12 ' A' ' 192' ' ' VAL . 64.4 mt -112.55 137.33 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.261 0.624 . . . . 0.0 110.355 -176.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.508 ' HG3' ' HG2' ' A' ' 131' ' ' LYS . 37.2 tpp -113.84 132.81 55.75 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.912 1.285 . . . . 0.0 109.774 -175.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.524 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 2.4 mm? -93.18 102.49 14.79 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.583 ' HG3' ' CZ ' ' A' ' 150' ' ' PHE . 9.1 mmpt? -105.53 143.2 34.03 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 175.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.538 ' O ' ' HB3' ' A' ' 92' ' ' ASP . . . -145.58 136.58 24.65 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.429 ' ND2' HD12 ' A' ' 98' ' ' LEU . 4.9 m-20 -89.62 118.68 29.42 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 163.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -148.58 157.5 43.5 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.094 0.558 . . . . 0.0 110.728 -174.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.5 t -86.43 160.19 19.11 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.756 174.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.6 t -134.41 143.92 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.371 1.068 . . . . 0.0 109.071 -176.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.402 HD11 ' HB2' ' A' ' 85' ' ' PRO . 10.4 tp -150.26 140.9 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 168.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 58.02 31.75 21.07 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 175.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 64.34 24.02 13.16 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.448 1.099 . . . . 0.0 112.589 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.482 ' HB2' HD12 ' A' ' 171' ' ' ILE . 2.9 ptp180 -133.09 165.53 24.55 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 173.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.59 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 10.3 tt -65.84 126.23 27.83 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 176.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -81.7 -74.05 0.35 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.3 m -139.17 125.68 20.49 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -175.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.4 HD22 HG13 ' A' ' 174' ' ' VAL . 60.0 tp -70.49 132.98 46.37 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.411 0.685 . . . . 0.0 110.167 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.5 mp -89.15 -52.38 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 173.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 40.4 tp -164.6 142.42 6.62 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.655 0.782 . . . . 0.0 109.142 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.591 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 9.3 tt -130.72 139.58 50.3 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 176.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 61.3 mtp85 -141.69 132.8 26.22 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.382 1.073 . . . . 0.0 109.117 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -116.71 126.69 53.54 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.881 1.272 . . . . 0.0 108.829 -173.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.583 ' CZ ' ' HG3' ' A' ' 131' ' ' LYS . 3.7 p90 -143.75 166.81 23.85 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.28 0.562 . . . . 0.0 111.852 -173.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 68.0 p -82.29 175.35 10.34 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.373 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.437 ' HG2' ' HB2' ' A' ' 127' ' ' ASN . 35.9 mm-40 -57.42 -29.51 64.2 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 121.198 0.523 . . . . 0.0 111.125 171.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -74.04 -16.86 61.03 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.155 0.982 . . . . 0.0 111.052 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 92.01 5.41 66.08 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 116.327 -0.397 . . . . 0.0 112.521 -177.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.63 102.72 6.26 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -178.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.542 HG12 ' HB3' ' A' ' 150' ' ' PHE . 16.8 mt -72.19 122.54 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -177.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.513 ' HB ' ' HB3' ' A' ' 120' ' ' ASP . 27.4 m -130.08 6.09 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.228 1.011 . . . . 0.0 110.592 -175.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -150.81 156.95 26.95 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -165.75 145.55 6.48 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.854 0.462 . . . . 0.0 110.078 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 63.7 mt -124.92 106.32 16.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 168.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 88.0 p -115.59 134.97 22.57 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.493 ' HA ' HD23 ' A' ' 115' ' ' LEU . 52.3 Cg_exo -53.85 140.99 67.45 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 122.743 2.295 . . . . 0.0 111.873 172.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.424 ' HB2' ' HB2' ' A' ' 166' ' ' PHE . 80.0 mt -63.6 143.81 97.88 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -59.7 -26.21 81.45 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 122.569 2.179 . . . . 0.0 112.778 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 79.0 p -93.64 -6.04 47.3 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.372 0.669 . . . . 0.0 111.747 177.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.424 ' HB2' ' HB2' ' A' ' 163' ' ' LEU . 96.6 m-85 -132.84 77.11 69.48 Favored Pre-proline 0 N--CA 1.485 1.293 0 C-N-CA 123.586 0.754 . . . . 0.0 110.408 176.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.75 -32.06 7.84 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.182 1.922 . . . . 0.0 111.896 173.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -96.82 125.59 8.52 Favored Glycine 0 C--N 1.347 1.183 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 -152.09 164.13 37.9 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.97 0.908 . . . . 0.0 110.291 178.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 22.7 m -96.66 158.34 15.48 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 123.898 0.879 . . . . 0.0 109.395 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.59 ' HB ' ' O ' ' A' ' 141' ' ' LEU . 4.7 tt -48.52 -38.61 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 125.378 1.471 . . . . 0.0 112.836 174.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.424 ' HG3' ' HB3' ' A' ' 208' ' ' GLU . 55.3 mm-40 -62.21 -40.36 95.86 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.846 0.858 . . . . 0.0 111.517 -175.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -62.85 -41.1 99.23 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.984 0.914 . . . . 0.0 110.005 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 178' ' ' ILE . 44.3 t -63.24 -54.46 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 O-C-N 124.398 1.061 . . . . 0.0 111.603 -177.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -61.3 -35.09 76.38 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 124.05 0.844 . . . . 0.0 110.991 -175.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.44 ' O ' HG23 ' A' ' 180' ' ' VAL . 76.9 m-20 -69.69 -41.88 74.83 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.9 -36.28 82.8 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.163 0.914 . . . . 0.0 111.036 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 174' ' ' VAL . 66.6 mt -65.68 -39.18 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 175.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -71.06 -24.64 76.89 Favored Glycine 0 C--N 1.341 0.852 0 O-C-N 123.668 0.605 . . . . 0.0 113.551 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 176' ' ' ASN . 71.1 t -76.04 -43.15 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.441 0.697 . . . . 0.0 109.711 175.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 19.9 tp -60.92 -46.59 90.07 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.43 0.692 . . . . 0.0 110.473 173.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.457 ' O ' ' HG2' ' A' ' 186' ' ' GLU . 57.5 mt -60.56 -50.07 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 123.967 0.907 . . . . 0.0 110.254 175.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -60.9 -33.15 82.39 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 123.447 0.467 . . . . 0.0 113.639 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.616 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -67.79 -43.81 82.56 Favored Glycine 0 C--N 1.347 1.19 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 171.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.439 HD22 HD12 ' A' ' 128' ' ' ILE . 53.4 mt -68.7 -23.9 64.43 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.521 1.129 . . . . 0.0 111.705 177.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 52.4 mm-40 -74.73 -41.9 59.28 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.947 0.499 . . . . 0.0 109.947 178.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -64.23 -41.72 96.88 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.128 171.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.454 ' ND2' ' HA ' ' A' ' 121' ' ' GLN . 6.2 m-20 -68.05 -10.66 55.51 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.552 0.741 . . . . 0.0 111.39 173.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 16.6 t70 63.52 64.49 0.8 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.475 1.11 . . . . 0.0 110.031 174.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -126.22 134.17 51.3 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.8 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 127' ' ' ASN . 59.2 m -80.92 99.25 8.27 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.562 HG12 ' HB ' ' A' ' 128' ' ' ILE . 24.5 m -104.87 148.38 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.668 0.747 . . . . 0.0 111.553 -172.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 44.0 ttt180 -137.76 135.48 36.39 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 114.25 -1.341 . . . . 0.0 107.937 173.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.524 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 4.1 t -87.33 155.27 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -178.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.543 ' HB3' ' HE2' ' A' ' 131' ' ' LYS . 88.6 p -62.45 149.15 43.46 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.446 0.566 . . . . 0.0 111.083 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -55.35 -34.68 64.47 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.188 0.995 . . . . 0.0 110.448 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 52.1 p -64.08 -58.65 6.03 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.436 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.434 ' HB2' HG12 ' A' ' 194' ' ' VAL . 69.7 mt -62.72 -37.45 86.58 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.148 0.579 . . . . 0.0 110.912 -174.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -55.79 -37.54 68.75 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.712 0.805 . . . . 0.0 112.085 -176.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -102.22 -25.33 13.73 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -82.73 -54.32 5.22 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 118.403 0.547 . . . . 0.0 111.519 -176.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.433 ' HB2' HD13 ' A' ' 141' ' ' LEU . . . -102.56 -56.72 2.19 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.811 0.844 . . . . 0.0 110.694 -171.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 44.3 t-105 -61.67 -42.21 98.61 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.383 1.473 . . . . 0.0 109.601 -177.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.24 174.73 19.22 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.365 169.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 23.2 m 60.83 24.44 14.39 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.779 1.231 . . . . 0.0 112.335 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 17.9 p -114.5 138.22 50.88 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.205 1.002 . . . . 0.0 109.93 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -140.85 80.63 1.76 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.443 0.697 . . . . 0.0 110.85 -174.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.424 ' HB3' ' HG3' ' A' ' 172' ' ' GLU . 7.2 pt-20 -79.74 112.21 16.8 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 167.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -83.46 86.57 7.06 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -177.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -76.1 85.04 0.91 Allowed Glycine 0 C--N 1.347 1.172 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.089 -175.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -86.25 143.93 37.63 Favored Pre-proline 0 C--O 1.241 0.629 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 172.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.99 123.87 14.18 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.375 2.05 . . . . 0.0 111.12 167.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -56.88 124.42 16.2 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 122.685 2.256 . . . . 0.0 111.304 -176.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 94.2 mt -66.1 95.52 0.28 Allowed 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.809 0.844 . . . . 0.0 110.732 -173.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 72.0 p -72.52 138.45 46.95 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.935 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.483 ' H ' HD23 ' A' ' 216' ' ' LEU . 0.7 OUTLIER -103.28 161.52 13.75 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.714 1.206 . . . . 0.0 108.575 175.356 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 . . . . . 0 CA--C 1.557 1.223 0 CA-C-O 118.83 -0.605 . . . . 0.0 109.684 178.299 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 62.6 ttp . . . . . 0 N--CA 1.476 0.852 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -68.55 136.78 37.39 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 122.289 1.992 . . . . 0.0 110.951 168.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.74 102.76 0.49 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.962 0.505 . . . . 0.0 111.257 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.5 t -80.56 144.87 32.1 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 170.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.519 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 8.1 ttm180 -151.65 152.87 33.41 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -167.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -121.74 101.42 7.57 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 172.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.9 mm -81.76 132.89 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 123.617 0.767 . . . . 0.0 109.787 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 34.2 p -121.96 83.55 2.11 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 171.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -70.19 -31.37 68.8 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.174 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -111.07 141.92 43.92 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 174.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 81.6 p -65.4 152.97 42.6 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.091 0.472 . . . . 0.0 110.569 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.52 -29.34 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.951 173.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -65.97 -49.61 67.25 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.644 1.177 . . . . 0.0 111.946 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.517 ' HA ' ' HB2' ' A' ' 100' ' ' ARG . 12.5 pt-20 -75.58 -22.32 57.07 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 120.801 0.334 . . . . 0.0 110.334 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.502 ' HG ' HD23 ' A' ' 146' ' ' LEU . 9.2 tt -69.15 -33.73 73.9 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.885 0.874 . . . . 0.0 109.542 170.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.3 t -103.12 13.75 33.4 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.7 0.8 . . . . 0.0 110.983 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.517 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 71.2 ttt180 -65.39 150.16 48.79 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.661 0.784 . . . . 0.0 111.723 -174.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -80.45 125.41 29.9 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 170.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -154.14 173.21 16.38 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.66 0.784 . . . . 0.0 110.488 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -138.78 146.74 41.73 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.158 0.583 . . . . 0.0 110.714 175.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.538 ' SD ' ' HB3' ' A' ' 107' ' ' PRO . 14.3 ptp -99.76 108.43 20.75 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 167.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 48.0 tp -71.58 -38.16 70.94 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.032 0.533 . . . . 0.0 110.552 -175.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 24.9 mmt -121.12 84.81 40.42 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 123.779 0.832 . . . . 0.0 109.088 173.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.538 ' HB3' ' SD ' ' A' ' 104' ' ' MET . 56.5 Cg_endo -67.81 117.86 5.19 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.144 2.563 . . . . 0.0 113.088 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.484 ' HD2' HE21 ' A' ' 121' ' ' GLN . 61.6 tttp -118.66 131.98 56.17 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 167.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -122.84 120.84 34.71 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 176.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.79 106.6 9.8 Favored 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 124.676 1.19 . . . . 0.0 107.997 176.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.443 HG13 HD11 ' A' ' 163' ' ' LEU . 79.3 t -75.35 128.54 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -122.57 85.24 2.38 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 124.864 1.266 . . . . 0.0 108.363 -176.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 68.01 -113.13 5.2 Favored Glycine 0 CA--C 1.539 1.531 0 CA-C-N 114.966 -1.016 . . . . 0.0 113.239 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -89.97 9.21 3.39 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 123.624 2.883 . . . . 0.0 113.227 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.1 mt -129.95 158.27 40.02 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -175.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 23.7 p -125.51 119.04 27.11 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 176.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.0 mm -86.72 140.94 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.378 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -122.36 129.97 52.65 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 170.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.605 HD13 ' HA3' ' A' ' 184' ' ' GLY . 60.4 mt -128.08 122.86 59.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -178.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -94.28 114.72 26.85 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 174.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.484 HE21 ' HD2' ' A' ' 108' ' ' LYS . 76.2 mt-30 -82.72 -10.49 58.88 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.097 0.959 . . . . 0.0 111.51 -175.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.71 -41.57 53.25 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.019 0.527 . . . . 0.0 111.881 -174.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.85 113.14 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.866 0.841 . . . . 0.0 109.834 -176.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 44.8 mtt -131.2 166.16 21.75 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.321 -1.309 . . . . 0.0 109.501 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.5 t70 57.69 32.72 22.29 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.828 0.851 . . . . 0.0 111.313 177.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -120.71 153.94 36.27 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.878 0.871 . . . . 0.0 110.507 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -90.78 106.97 18.88 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 173.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.617 HG12 HG22 ' A' ' 151' ' ' THR . 48.2 mt -108.14 130.77 60.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 123.478 0.711 . . . . 0.0 110.315 -173.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 52.1 tpp -110.0 126.47 53.98 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.28 1.032 . . . . 0.0 108.752 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 25.1 mt -87.77 103.0 15.22 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -110.55 132.39 54.23 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.313 1.045 . . . . 0.0 109.988 -172.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.563 ' HB2' ' HG ' ' A' ' 147' ' ' LEU . . . -136.99 154.93 50.29 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -175.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -112.84 128.44 56.45 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 167.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.456 ' HA ' HD13 ' A' ' 145' ' ' ILE . 33.0 p90 -157.37 163.57 38.46 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.351 0.596 . . . . 0.0 112.393 -170.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 46.6 t -85.14 156.99 20.79 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.425 -1.261 . . . . 0.0 109.417 173.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.519 ' HB ' ' HB3' ' A' ' 88' ' ' ARG . 79.1 t -140.27 142.96 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.378 1.071 . . . . 0.0 109.935 -174.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.428 ' O ' ' HG2' ' A' ' 140' ' ' ARG . 11.3 tp -150.3 145.6 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 168.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 60.62 22.8 12.61 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 123.632 0.773 . . . . 0.0 112.119 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 58.77 39.61 23.98 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.316 1.046 . . . . 0.0 111.658 -172.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 137' ' ' ILE . 5.8 ptp180 -144.85 163.35 34.35 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.509 0.724 . . . . 0.0 109.694 172.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.477 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 10.5 tt -63.85 117.25 6.68 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.952 0.501 . . . . 0.0 110.08 -176.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -79.8 -60.63 2.27 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.839 0.856 . . . . 0.0 109.121 175.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 80.5 m -147.75 132.13 17.59 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.632 0.773 . . . . 0.0 109.366 177.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.434 HD21 ' HB2' ' A' ' 147' ' ' LEU . 51.3 tp -76.7 131.59 38.87 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.557 0.743 . . . . 0.0 110.156 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.456 HD13 ' HA ' ' A' ' 134' ' ' PHE . 1.9 mp -87.15 -46.88 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 173.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.502 HD23 ' HG ' ' A' ' 98' ' ' LEU . 57.7 tp -167.94 149.08 5.22 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.573 0.749 . . . . 0.0 109.585 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.652 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 6.6 tt -134.19 140.08 46.27 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 177.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 58.7 mtp85 -145.48 147.63 32.38 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.32 1.048 . . . . 0.0 108.991 -175.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.01 109.2 21.1 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.009 0.923 . . . . 0.0 109.269 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -106.29 124.15 49.15 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.424 0.69 . . . . 0.0 110.187 -175.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.617 HG22 HG12 ' A' ' 128' ' ' ILE . 33.7 p -73.0 -174.45 1.51 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.372 0.669 . . . . 0.0 110.955 169.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.95 -25.51 63.68 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 122.257 -0.277 . . . . 0.0 111.243 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -83.85 -8.1 59.29 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.748 0.819 . . . . 0.0 110.381 173.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 78.99 23.02 64.63 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 116.331 -0.395 . . . . 0.0 113.391 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.26 127.62 32.57 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.7 mp -81.8 101.39 6.58 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.9 m -111.16 24.33 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.305 1.042 . . . . 0.0 109.991 -172.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 176.05 151.28 8.66 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 114.119 -1.401 . . . . 0.0 110.28 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -158.39 130.55 6.89 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.069 0.935 . . . . 0.0 111.047 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.652 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 67.3 mt -107.43 102.99 14.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 173.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 27.7 t -104.17 120.73 49.97 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 123.427 0.691 . . . . 0.0 109.37 -177.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -54.22 123.79 14.43 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.666 2.244 . . . . 0.0 112.492 172.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.443 HD11 HG13 ' A' ' 111' ' ' VAL . 67.2 mt -67.18 127.3 93.45 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 123.268 0.627 . . . . 0.0 111.261 -177.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 163' ' ' LEU . 31.2 Cg_exo -63.72 -16.1 52.75 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 123.578 2.852 . . . . 0.0 113.775 177.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.4 m -87.76 1.31 54.18 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.921 0.488 . . . . 0.0 111.804 175.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -131.32 83.1 60.51 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.7 89.57 0.98 Allowed 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.738 2.292 . . . . 0.0 112.138 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 104.41 131.19 7.07 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.228 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 34.9 p-80 -140.0 165.55 27.03 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.187 0.995 . . . . 0.0 109.762 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 27.3 m -93.03 159.01 15.49 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.363 0.665 . . . . 0.0 109.866 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 141' ' ' LEU . 7.6 tt -50.99 -37.77 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.728 1.211 . . . . 0.0 111.997 173.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -64.24 -35.41 80.72 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.417 1.087 . . . . 0.0 111.445 -175.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -64.38 -38.83 92.4 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.89 0.876 . . . . 0.0 110.488 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.45 ' O ' HG13 ' A' ' 178' ' ' ILE . 43.7 t -67.79 -37.11 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.297 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -62.14 -40.28 95.42 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.034 0.534 . . . . 0.0 110.747 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.424 ' O ' HG23 ' A' ' 180' ' ' VAL . 79.6 m-20 -61.0 -48.04 83.64 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 123.906 0.754 . . . . 0.0 109.568 174.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.55 -48.64 78.62 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 114.066 -1.424 . . . . 0.0 112.681 -173.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 174' ' ' VAL . 69.8 mt -59.66 -41.8 86.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -61.18 -34.37 87.79 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 115.301 -0.863 . . . . 0.0 114.005 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 176' ' ' ASN . 93.1 t -70.77 -44.08 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 122.956 0.502 . . . . 0.0 110.307 177.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 32.3 tp -59.91 -43.81 94.65 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.822 176.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.536 HG23 HG21 ' A' ' 192' ' ' VAL . 86.6 mt -59.83 -51.58 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.575 0.75 . . . . 0.0 110.267 175.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.22 -42.38 97.21 Favored Glycine 0 C--N 1.344 1.006 0 O-C-N 123.804 0.69 . . . . 0.0 113.779 -176.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.605 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -68.9 -24.81 75.62 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 115.502 -0.349 . . . . 0.0 113.116 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.444 HD22 HD12 ' A' ' 128' ' ' ILE . 32.6 mt -86.54 -25.69 24.92 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.878 0.871 . . . . 0.0 111.564 176.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 182' ' ' ILE . 50.2 mt-10 -70.78 -31.26 67.97 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 122.084 -0.385 . . . . 0.0 110.789 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -81.09 -20.66 41.04 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.161 0.585 . . . . 0.0 111.092 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -65.53 -20.82 66.49 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.011 0.525 . . . . 0.0 110.466 165.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 33.6 t70 63.4 67.47 0.65 Allowed 'General case' 0 C--N 1.355 0.833 0 C-N-CA 124.418 1.087 . . . . 0.0 110.195 -178.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -138.01 178.65 6.96 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.125 175.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 85.3 m -102.51 103.52 13.88 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -174.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.536 HG21 HG23 ' A' ' 182' ' ' ILE . 35.5 m -101.47 146.54 9.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 C-N-CA 123.388 0.675 . . . . 0.0 110.897 -178.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -143.84 145.37 32.28 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.522 171.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 4.6 t -89.9 137.6 21.11 Favored 'Isoleucine or valine' 0 C--O 1.245 0.818 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 173.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 78.9 p -56.96 148.29 21.62 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 118.819 0.736 . . . . 0.0 111.045 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -57.06 -27.03 61.34 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.545 0.738 . . . . 0.0 111.808 -177.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 65.1 p -70.49 -54.25 13.02 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 123.387 0.675 . . . . 0.0 109.847 174.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 33.5 mt -63.45 -26.98 68.98 Favored 'General case' 0 C--O 1.208 -1.079 0 CA-C-O 119.004 -0.522 . . . . 0.0 111.577 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -67.76 -49.71 61.03 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.886 0.474 . . . . 0.0 110.856 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -77.27 -36.54 54.23 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.341 0.401 . . . . 0.0 111.62 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -85.41 -54.94 4.26 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 122.257 -0.277 . . . . 0.0 111.152 -171.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -95.08 -60.37 1.7 Allowed 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.185 0.517 . . . . 0.0 111.447 -170.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 43.5 t-105 -63.92 -33.32 75.45 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.026 1.73 . . . . 0.0 111.039 -169.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -134.56 -153.29 6.84 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 170.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 65.2 m -132.22 124.93 29.95 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 29.0 t -62.74 98.0 0.11 Allowed 'General case' 0 C--N 1.351 0.669 0 O-C-N 123.745 0.653 . . . . 0.0 109.512 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -96.4 26.84 4.09 Favored 'General case' 0 CA--C 1.558 1.279 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -88.87 65.69 7.69 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 125.226 1.41 . . . . 0.0 108.143 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -90.96 -176.43 4.64 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.638 -168.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 177.2 -123.25 0.88 Allowed Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -165.62 145.84 5.63 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 123.829 0.852 . . . . 0.0 109.156 176.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -46.77 120.13 3.82 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.774 2.316 . . . . 0.0 112.232 168.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -52.8 118.25 4.55 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 123.101 2.534 . . . . 0.0 112.175 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 58.2 mt -69.57 93.39 0.69 Allowed 'General case' 0 CA--C 1.537 0.443 0 O-C-N 123.941 0.776 . . . . 0.0 109.63 -175.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 75.8 p -60.87 144.17 53.36 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.419 -175.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 55.9 mt -74.4 142.64 45.01 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.417 0.687 . . . . 0.0 110.685 -173.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 . . . . . 0 CA--C 1.558 1.283 0 C-N-CA 123.437 0.695 . . . . 0.0 109.378 176.662 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.474 ' HB2' HD11 ' A' ' 137' ' ' ILE . 32.4 Cg_endo -60.97 132.69 43.35 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 123.371 2.714 . . . . 0.0 112.809 -178.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.31 119.96 27.14 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.398 0.679 . . . . 0.0 110.275 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.1 p -108.08 140.19 41.62 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.08 0.952 . . . . 0.0 109.347 174.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -155.63 152.45 28.72 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.93 0.492 . . . . 0.0 110.014 -173.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -115.38 111.11 20.34 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 171.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.4 mm -81.83 130.42 35.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 123.597 0.759 . . . . 0.0 109.382 175.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.7 p -117.51 81.91 1.73 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -76.89 -13.46 59.99 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.582 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.533 ' HB3' ' HG3' ' A' ' 97' ' ' GLU . 63.2 mtm -114.97 143.94 44.37 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.139 1.376 . . . . 0.0 107.321 161.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 69.3 p -72.29 152.21 42.29 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 167.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 57.0 mt -57.41 -27.68 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 122.606 0.362 . . . . 0.0 111.13 178.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -54.67 -62.36 1.71 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.07 0.948 . . . . 0.0 111.801 170.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.533 ' HG3' ' HB3' ' A' ' 93' ' ' MET . 11.0 pt-20 -73.54 -22.07 60.2 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 122.924 0.49 . . . . 0.0 112.152 -177.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.586 ' HG ' HD23 ' A' ' 146' ' ' LEU . 10.0 tt -63.19 -36.44 83.65 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.007 0.923 . . . . 0.0 109.32 171.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.3 m -109.47 16.91 21.94 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.659 0.784 . . . . 0.0 111.601 -177.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.443 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 62.0 ttt180 -75.03 140.01 43.27 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.671 0.788 . . . . 0.0 110.828 -177.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -75.22 136.52 40.97 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.564 0.745 . . . . 0.0 111.248 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 28.0 p-90 -161.14 171.54 18.34 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.654 1.182 . . . . 0.0 109.666 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -141.0 165.08 28.54 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.244 0.618 . . . . 0.0 111.171 -175.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.408 ' SD ' ' HD2' ' A' ' 118' ' ' ARG . 63.6 mtp -118.11 131.08 56.46 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.046 0.939 . . . . 0.0 108.466 172.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.519 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.5 pt? -109.29 -29.21 8.59 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.289 0.636 . . . . 0.0 110.829 -175.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 7.7 mmt -123.24 70.31 42.51 Favored Pre-proline 0 N--CA 1.486 1.375 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 166.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.9 145.09 35.54 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 122.243 1.962 . . . . 0.0 113.014 -170.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.45 ' HB3' ' HB ' ' A' ' 119' ' ' ILE . 25.0 ttmm -134.94 120.31 19.06 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 168.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -96.81 100.04 11.59 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -178.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.552 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 17.7 tppt? -96.66 148.78 22.52 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 174.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 68.6 t -128.03 133.62 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 175.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -137.3 95.32 3.06 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 68.37 -131.25 27.0 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.289 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.402 ' HB2' ' HB3' ' A' ' 169' ' ' HIS . 6.2 Cg_exo -82.19 18.21 1.45 Allowed 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 123.356 2.704 . . . . 0.0 113.421 177.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -134.42 170.66 15.41 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.8 0.84 . . . . 0.0 109.655 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.411 ' HB3' HD21 ' A' ' 163' ' ' LEU . 17.9 p -136.33 143.61 44.22 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.033 0.933 . . . . 0.0 109.341 177.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.552 ' HB ' ' HB3' ' A' ' 110' ' ' LYS . 9.3 mm -111.09 147.35 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 124.371 1.069 . . . . 0.0 109.681 -173.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.542 ' HG3' ' HB3' ' A' ' 159' ' ' GLU . 36.3 mmt180 -109.87 118.52 36.7 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 173.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.554 HD12 ' HA3' ' A' ' 184' ' ' GLY . 46.1 mm -119.81 122.29 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 175.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -115.05 118.98 34.93 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -80.23 -9.18 59.72 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.695 0.798 . . . . 0.0 112.789 -170.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -79.66 -36.01 38.39 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 120.654 0.264 . . . . 0.0 110.787 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.6 mp -80.12 99.62 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 45.3 mtt -131.66 156.7 45.39 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-N 114.132 -1.395 . . . . 0.0 109.249 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.3 t70 72.03 2.17 4.2 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 124.384 1.074 . . . . 0.0 112.718 175.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -85.95 148.65 25.67 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 121.635 -0.665 . . . . 0.0 112.087 -173.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -91.16 105.38 17.77 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 172.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.667 ' HB ' HG12 ' A' ' 192' ' ' VAL . 56.8 mt -115.39 146.37 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 123.71 0.804 . . . . 0.0 110.257 -172.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.449 ' SD ' ' HB3' ' A' ' 193' ' ' ARG . 15.7 tpt -129.23 128.63 43.67 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 125.481 1.512 . . . . 0.0 107.781 177.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 35.7 mt -81.39 145.6 30.73 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -142.55 133.96 26.36 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 173.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.551 ' HB2' ' HG ' ' A' ' 147' ' ' LEU . . . -141.45 142.94 33.63 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -170.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -101.9 133.6 46.42 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 171.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.518 ' HA ' HD13 ' A' ' 145' ' ' ILE . 37.3 p90 -161.1 161.62 31.27 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 123.79 0.681 . . . . 0.0 111.057 -175.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.1 p -86.35 161.32 18.77 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.099 0.96 . . . . 0.0 109.41 172.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 53.9 t -139.25 139.39 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.258 1.423 . . . . 0.0 108.467 -175.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.474 HD11 ' HB2' ' A' ' 85' ' ' PRO . 9.8 tp -130.87 132.85 63.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 169.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 62.4 -84.59 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.914 1.286 . . . . 0.0 110.459 -173.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -158.98 23.42 0.21 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.13 0.972 . . . . 0.0 109.897 -176.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.506 ' HB2' HD12 ' A' ' 171' ' ' ILE . 11.1 ptp180 -127.47 163.06 24.92 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.584 0.754 . . . . 0.0 109.797 176.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.474 HD22 ' HA ' ' A' ' 171' ' ' ILE . 9.0 tt -67.7 125.41 26.13 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 171.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -81.35 -59.7 2.54 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 123.876 0.87 . . . . 0.0 108.811 174.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 95.6 m -149.71 136.68 19.58 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.98 0.912 . . . . 0.0 109.293 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.512 HD21 ' HB2' ' A' ' 147' ' ' LEU . 50.1 tp -77.73 121.47 24.08 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.518 HD13 ' HA ' ' A' ' 134' ' ' PHE . 1.6 mp -77.14 -52.14 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.516 0.727 . . . . 0.0 109.161 176.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.586 HD23 ' HG ' ' A' ' 98' ' ' LEU . 39.3 tp -165.69 150.2 8.47 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.735 0.814 . . . . 0.0 109.358 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.681 HD13 HD12 ' A' ' 160' ' ' ILE . 7.4 tt -133.16 145.85 51.02 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.479 ' HD3' HD13 ' A' ' 156' ' ' ILE . 45.5 mtt-85 -141.28 148.3 39.59 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.906 0.882 . . . . 0.0 110.189 176.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.1 110.35 22.25 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.468 1.107 . . . . 0.0 108.441 176.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -104.45 127.95 52.24 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.555 0.742 . . . . 0.0 109.347 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.462 HG22 HG12 ' A' ' 128' ' ' ILE . 41.6 p -70.97 -175.81 1.22 Allowed 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.267 0.556 . . . . 0.0 111.191 176.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -27.13 68.71 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.55 0.74 . . . . 0.0 111.971 173.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -83.26 -4.08 58.08 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.451 0.7 . . . . 0.0 111.243 171.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 77.45 27.07 60.07 Favored Glycine 0 C--N 1.348 1.241 0 CA-C-N 116.441 -0.345 . . . . 0.0 112.944 178.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -92.66 129.45 38.59 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.013 0.525 . . . . 0.0 110.221 -176.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.479 HD13 ' HD3' ' A' ' 148' ' ' ARG . 17.0 mt -72.59 102.93 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.463 0.705 . . . . 0.0 109.141 177.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.9 m -113.83 -2.14 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.287 1.035 . . . . 0.0 111.514 -176.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -157.18 167.43 33.88 Favored Glycine 0 C--N 1.338 0.648 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.542 ' HB3' ' HG3' ' A' ' 118' ' ' ARG . 27.2 tt0 -166.61 149.03 6.6 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.256 0.622 . . . . 0.0 109.627 -174.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.681 HD12 HD13 ' A' ' 147' ' ' LEU . 71.6 mt -130.06 117.69 41.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 169.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.0 t -128.0 138.04 32.09 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.77 139.96 83.21 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 122.951 2.434 . . . . 0.0 111.644 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.411 HD21 ' HB3' ' A' ' 116' ' ' CYS . 88.1 mt -60.77 138.07 93.34 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 123.0 0.52 . . . . 0.0 110.781 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -67.14 -22.2 47.55 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.83 2.353 . . . . 0.0 112.574 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 18.0 m -78.23 -14.47 59.43 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.937 0.895 . . . . 0.0 111.514 175.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -121.1 92.58 48.59 Favored Pre-proline 0 N--CA 1.477 0.912 0 C-N-CA 124.418 1.087 . . . . 0.0 109.366 -175.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -90.48 31.62 0.35 Allowed 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 123.316 2.677 . . . . 0.0 112.237 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -169.44 119.17 0.81 Allowed Glycine 0 C--N 1.342 0.915 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.007 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.402 ' HB3' ' HB2' ' A' ' 114' ' ' PRO . 31.2 p-80 -147.59 154.0 40.12 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.836 0.855 . . . . 0.0 109.683 171.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.624 HG22 HG22 ' A' ' 171' ' ' ILE . 4.9 m -99.35 171.73 7.79 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.915 0.886 . . . . 0.0 109.789 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.624 HG22 HG22 ' A' ' 170' ' ' THR . 11.2 tt -48.6 -41.84 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 125.84 1.656 . . . . 0.0 113.754 176.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -56.7 -35.83 68.94 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.187 1.395 . . . . 0.0 111.961 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -73.0 -38.02 66.75 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.26 0.624 . . . . 0.0 111.581 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.498 HG13 HD22 ' A' ' 144' ' ' LEU . 58.1 t -65.19 -51.4 65.86 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.88 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.931 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.27 -24.43 67.86 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 123.826 0.704 . . . . 0.0 112.026 -175.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.41 ' O ' HG23 ' A' ' 180' ' ' VAL . 15.4 m120 -70.77 -50.67 33.43 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.992 0.517 . . . . 0.0 109.624 169.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.21 -40.29 81.25 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.236 1.014 . . . . 0.0 111.817 -177.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 174' ' ' VAL . 61.5 mt -60.5 -46.33 95.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.716 0.806 . . . . 0.0 109.478 178.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.05 -25.67 72.18 Favored Glycine 0 C--N 1.343 0.934 0 CA-C-N 115.293 -0.867 . . . . 0.0 113.427 -177.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 176' ' ' ASN . 91.8 t -74.67 -43.53 47.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.04 0.536 . . . . 0.0 110.135 176.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.411 ' HB2' HD11 ' A' ' 160' ' ' ILE . 57.0 tp -59.35 -47.13 86.59 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.861 0.464 . . . . 0.0 110.453 175.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.477 HD11 HG22 ' A' ' 194' ' ' VAL . 93.3 mt -59.01 -48.5 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.817 0.847 . . . . 0.0 110.167 177.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -62.24 -30.55 76.25 Favored Glycine 0 C--N 1.348 1.248 0 O-C-N 123.578 0.549 . . . . 0.0 113.385 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.554 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -75.76 -27.36 63.03 Favored Glycine 0 C--N 1.348 1.22 0 N-CA-C 112.345 -0.302 . . . . 0.0 112.345 175.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.559 ' HB3' HG11 ' A' ' 192' ' ' VAL . 61.0 mt -80.97 -31.54 34.76 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.239 1.015 . . . . 0.0 110.842 176.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 182' ' ' ILE . 49.2 mt-10 -72.05 -40.58 68.25 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.866 0.866 . . . . 0.0 110.765 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -70.07 -32.49 70.6 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.836 0.454 . . . . 0.0 110.46 176.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -76.35 -1.77 28.47 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.231 0.613 . . . . 0.0 111.394 170.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 23.4 t70 64.11 49.38 2.71 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.436 1.094 . . . . 0.0 111.011 170.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -109.95 140.36 44.03 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.622 1.169 . . . . 0.0 109.145 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 29.4 m -84.46 100.85 11.6 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.667 HG12 ' HB ' ' A' ' 128' ' ' ILE . 33.2 m -116.83 152.4 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-O 121.703 0.763 . . . . 0.0 112.822 -168.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.449 ' HB3' ' SD ' ' A' ' 129' ' ' MET . 63.4 ttt180 -134.99 142.96 46.58 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 114.043 -1.435 . . . . 0.0 108.307 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.477 HG22 HD11 ' A' ' 182' ' ' ILE . 13.2 t -82.37 154.38 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 5.4 m -50.53 132.48 25.38 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.423 0.689 . . . . 0.0 111.537 178.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -53.43 -30.74 42.03 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 124.218 1.007 . . . . 0.0 111.704 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 68.7 p -79.47 -47.06 16.28 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.983 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 90.6 mt -68.21 -33.68 74.87 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.948 0.499 . . . . 0.0 110.759 -177.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -51.06 -30.46 15.79 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.456 1.102 . . . . 0.0 112.624 -176.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -102.49 -47.92 4.31 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 171.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -67.89 -44.42 77.03 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -166.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -113.72 -54.26 2.62 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.33 0.652 . . . . 0.0 111.173 -175.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -68.77 -55.88 9.82 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.114 1.366 . . . . 0.0 111.511 -172.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -70.32 -26.24 74.49 Favored Glycine 0 N--CA 1.472 1.089 0 CA-C-N 116.168 -0.469 . . . . 0.0 113.203 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 20.6 t -69.27 110.15 4.47 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.657 0.783 . . . . 0.0 109.875 177.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 34.0 m -69.53 103.09 1.97 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.035 0.934 . . . . 0.0 110.523 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -126.22 128.34 47.07 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.697 0.799 . . . . 0.0 109.493 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -118.43 141.3 48.69 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.144 0.978 . . . . 0.0 110.357 -175.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 41.1 p30 -151.6 -157.13 0.78 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.626 1.171 . . . . 0.0 108.502 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 142.09 -115.36 0.96 Allowed Glycine 0 C--N 1.345 1.039 0 CA-C-O 119.411 -0.661 . . . . 0.0 111.791 170.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -61.18 113.04 6.84 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.18 0.992 . . . . 0.0 110.559 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -63.74 150.65 87.95 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.649 2.233 . . . . 0.0 111.596 173.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.52 115.14 2.47 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.67 2.247 . . . . 0.0 110.482 174.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 85.5 mt -65.67 130.97 45.18 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 123.738 0.649 . . . . 0.0 110.557 -176.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 74.3 p -71.58 177.36 4.11 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.617 0.767 . . . . 0.0 112.176 -175.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 94.5 mt -67.05 173.52 3.66 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.542 0.737 . . . . 0.0 111.557 177.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 . . . . . 0 C--O 1.251 1.173 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.164 -177.982 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.482 1.135 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -69.54 129.76 18.4 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 123.181 2.587 . . . . 0.0 113.061 -172.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -139.12 127.14 22.35 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.806 0.842 . . . . 0.0 109.587 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.9 t -66.6 100.03 0.64 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.696 0.798 . . . . 0.0 110.144 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 66.9 ttt180 -109.73 130.42 55.52 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.307 0.643 . . . . 0.0 110.391 -177.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -92.36 97.73 11.05 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.699 0.8 . . . . 0.0 109.401 -178.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.9 mm -81.84 122.66 37.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.968 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.9 p -117.18 97.38 5.89 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.93 0.892 . . . . 0.0 110.292 -174.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -79.34 -27.74 42.03 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.828 0.851 . . . . 0.0 111.002 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.456 ' HB2' ' HG3' ' A' ' 97' ' ' GLU . 24.4 ptt? -119.02 141.43 48.7 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.776 0.83 . . . . 0.0 109.188 -177.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.8 m -68.69 160.23 30.64 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.067 0.947 . . . . 0.0 110.599 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 61.1 mt -62.43 -31.84 53.14 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 C-N-CA 122.809 0.443 . . . . 0.0 111.47 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.23 -54.14 49.29 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.511 0.324 . . . . 0.0 111.328 175.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.667 ' HA ' ' HB2' ' A' ' 100' ' ' ARG . 14.8 pt-20 -77.19 -18.31 57.85 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.029 0.531 . . . . 0.0 111.874 -177.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.521 HD12 HD22 ' A' ' 133' ' ' ASN . 6.0 tt -59.92 -43.75 94.73 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.37 1.068 . . . . 0.0 108.89 167.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.1 t -105.76 21.11 17.81 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.745 -176.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.667 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 30.8 tpt180 -67.45 133.1 48.91 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.802 0.441 . . . . 0.0 110.639 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -72.1 136.99 46.75 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 123.692 0.62 . . . . 0.0 109.8 174.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 20.4 p-90 -157.59 166.3 33.25 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.837 0.855 . . . . 0.0 109.485 176.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -142.62 144.02 32.63 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 123.547 0.739 . . . . 0.0 109.033 -176.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.534 ' SD ' ' HD2' ' A' ' 118' ' ' ARG . 67.4 mtp -85.48 105.51 16.15 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.2 tp -62.51 -36.36 82.3 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.192 0.997 . . . . 0.0 110.331 177.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.478 ' HG2' ' HB2' ' A' ' 122' ' ' ALA . 20.7 mmt -134.38 92.48 20.62 Favored Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 123.736 0.814 . . . . 0.0 109.153 168.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.24 112.95 2.69 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 123.165 2.577 . . . . 0.0 114.394 -176.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 119' ' ' ILE . 55.5 tptt -109.54 117.96 35.35 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 161.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -107.72 113.44 26.71 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -125.88 103.31 7.71 Favored 'General case' 0 C--O 1.214 -0.767 0 C-N-CA 123.485 0.714 . . . . 0.0 109.516 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . 84.8 t -75.6 137.89 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 174.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -133.25 93.13 3.11 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-O 120.993 0.425 . . . . 0.0 109.963 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.15 -128.71 37.01 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.743 176.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -72.05 1.36 6.01 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 123.37 2.713 . . . . 0.0 114.126 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 4.3 mp -127.04 175.49 8.06 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.795 0.838 . . . . 0.0 109.411 -178.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.487 ' SG ' ' NH1' ' A' ' 118' ' ' ARG . 49.6 t -136.53 146.47 46.24 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 174.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.8 mm -116.22 147.32 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.309 1.044 . . . . 0.0 109.394 -174.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.534 ' HD2' ' SD ' ' A' ' 104' ' ' MET . 68.7 mmt-85 -119.54 127.31 52.88 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.049 0.939 . . . . 0.0 108.688 172.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.469 HD11 ' HA ' ' A' ' 181' ' ' LEU . 41.6 mm -122.84 125.59 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 173.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -93.45 116.86 29.4 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.411 ' HA ' HD21 ' A' ' 188' ' ' ASN . 80.3 mt-30 -78.51 -13.45 59.82 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.383 0.673 . . . . 0.0 112.257 -174.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.478 ' HB2' ' HG2' ' A' ' 106' ' ' MET . . . -82.86 -49.4 9.71 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.099 0.56 . . . . 0.0 110.791 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.424 HG12 HG11 ' A' ' 157' ' ' VAL . 1.8 mp -69.91 108.81 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-O 122.01 0.91 . . . . 0.0 109.731 -174.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.434 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 50.0 mtt -132.23 156.8 45.84 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 113.192 -1.822 . . . . 0.0 109.624 -177.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.0 t70 63.19 29.07 16.06 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.463 1.105 . . . . 0.0 111.801 173.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -115.0 149.56 37.21 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.569 0.748 . . . . 0.0 111.408 -179.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 152' ' ' GLU . 43.9 m-80 -83.52 107.29 15.9 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.542 HD12 HD22 ' A' ' 185' ' ' LEU . 50.2 mt -112.44 123.84 68.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-O 121.943 0.878 . . . . 0.0 111.105 -174.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 5.6 tpt -102.61 119.24 38.49 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 126.926 2.09 . . . . 0.0 108.905 -176.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 20.4 mt -95.25 104.9 16.8 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -115.43 144.8 43.27 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.192 0.597 . . . . 0.0 109.834 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -138.76 156.55 47.28 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.6 0.714 . . . . 0.0 112.479 -175.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.521 HD22 HD12 ' A' ' 98' ' ' LEU . 70.7 m-20 -113.6 119.38 37.28 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 165.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -153.1 157.96 41.18 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.416 0.686 . . . . 0.0 110.403 -167.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.0 p -89.66 156.8 18.32 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.345 0.658 . . . . 0.0 109.425 175.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.9 t -131.44 129.0 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.569 1.148 . . . . 0.0 109.325 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.5 tp -133.69 140.27 46.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 175.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 63.23 25.83 14.94 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.077 0.951 . . . . 0.0 111.604 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 66.13 15.73 10.19 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 124.986 1.314 . . . . 0.0 112.398 -176.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.424 HH21 HD13 ' A' ' 171' ' ' ILE . 9.7 ptm180 -127.27 171.19 11.69 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.481 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 7.0 tt -68.83 128.79 37.92 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -175.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -85.58 -69.61 0.65 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.757 0.823 . . . . 0.0 110.481 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 63.6 m -147.91 136.68 21.85 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.761 0.824 . . . . 0.0 109.05 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.459 HD22 HG13 ' A' ' 174' ' ' VAL . 47.6 tp -82.63 114.99 21.39 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.269 0.627 . . . . 0.0 109.58 177.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.0 mp -74.57 -50.8 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 175.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 49.4 tp -161.03 144.46 13.07 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.252 0.621 . . . . 0.0 109.464 178.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.61 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 7.6 tt -135.17 142.44 46.11 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 173.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.428 ' HB2' ' CE1' ' A' ' 150' ' ' PHE . 44.3 mtp85 -138.74 139.46 38.34 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -177.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.472 ' HB2' HD21 ' A' ' 181' ' ' LEU . . . -97.18 100.61 12.08 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -177.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.428 ' CE1' ' HB2' ' A' ' 148' ' ' ARG . 87.6 m-85 -96.56 124.55 40.58 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -177.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.485 HG22 HG12 ' A' ' 128' ' ' ILE . 58.6 p -67.5 178.84 1.47 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.266 0.555 . . . . 0.0 110.752 173.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 127' ' ' ASN . 10.3 pt-20 -60.84 -22.21 63.99 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.371 1.068 . . . . 0.0 112.076 174.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -91.23 -1.35 57.71 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.075 0.95 . . . . 0.0 111.327 176.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 79.79 9.69 86.51 Favored Glycine 0 C--N 1.348 1.222 0 O-C-N 123.375 0.422 . . . . 0.0 113.148 -177.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -87.25 120.8 28.91 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.69 0.796 . . . . 0.0 109.51 -174.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 16.1 mt -77.95 121.89 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -175.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.424 HG11 HG12 ' A' ' 123' ' ' ILE . 33.7 m -123.56 5.9 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.979 0.912 . . . . 0.0 110.948 -177.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -164.12 163.12 35.79 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -178.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -160.36 144.76 14.32 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.61 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 53.9 mt -123.71 115.54 45.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 172.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 18.4 p -138.84 132.34 16.1 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 122.902 0.481 . . . . 0.0 110.434 -175.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 31.1 Cg_endo -62.12 133.75 45.63 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.577 2.184 . . . . 0.0 111.875 176.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.2 mt -59.22 147.71 74.38 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 123.699 0.8 . . . . 0.0 111.256 177.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -64.04 -22.25 68.0 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.882 2.388 . . . . 0.0 112.439 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 39.8 m -78.52 -5.53 52.92 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.8 0.84 . . . . 0.0 111.936 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -131.93 94.91 23.45 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 124.146 0.978 . . . . 0.0 109.029 178.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -57.07 -32.98 94.85 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 123.56 2.84 . . . . 0.0 112.815 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.44 168.92 29.08 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.19 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -152.77 175.8 12.47 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.298 1.039 . . . . 0.0 109.867 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 6.3 m -96.15 162.33 13.58 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.533 0.733 . . . . 0.0 109.218 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 141' ' ' LEU . 9.2 tt -50.15 -33.74 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 124.606 1.162 . . . . 0.0 112.13 171.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -52.73 -48.25 66.81 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.48 1.112 . . . . 0.0 111.458 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -69.16 -36.33 77.26 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.741 -176.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.459 HG13 HD22 ' A' ' 144' ' ' LEU . 46.0 t -64.12 -48.88 83.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 O-C-N 123.948 0.78 . . . . 0.0 111.002 178.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -59.81 -40.72 89.34 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.638 0.775 . . . . 0.0 110.982 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.469 ' O ' HG23 ' A' ' 180' ' ' VAL . 89.4 m-20 -64.04 -46.26 85.21 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.871 176.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -61.76 -40.8 96.42 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.717 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 174' ' ' VAL . 66.6 mt -68.05 -37.5 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -65.72 -26.61 72.12 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 116.046 -0.524 . . . . 0.0 113.447 177.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 176' ' ' ASN . 98.3 t -75.59 -45.96 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.209 0.604 . . . . 0.0 109.916 175.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.472 HD21 ' HB2' ' A' ' 149' ' ' ALA . 42.6 tp -55.93 -52.5 63.92 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.342 0.657 . . . . 0.0 110.816 176.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.409 HG23 HG21 ' A' ' 192' ' ' VAL . 79.8 mt -60.13 -46.65 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.79 0.836 . . . . 0.0 110.595 176.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -52.65 -45.71 59.86 Favored Glycine 0 C--N 1.345 1.045 0 O-C-N 124.097 0.873 . . . . 0.0 114.156 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -68.14 -38.11 87.74 Favored Glycine 0 C--N 1.347 1.14 0 O-C-N 123.917 0.422 . . . . 0.0 112.538 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.542 HD22 HD12 ' A' ' 128' ' ' ILE . 97.5 mt -67.29 -34.12 76.73 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.484 0.713 . . . . 0.0 111.226 178.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -69.12 -38.81 79.07 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.59 0.756 . . . . 0.0 110.407 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -61.56 -41.35 97.24 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.191 174.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.434 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 6.7 m-20 -80.19 -2.86 46.64 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.965 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 61.68 57.03 2.33 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.054 0.941 . . . . 0.0 111.298 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -111.81 143.37 42.86 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.756 0.822 . . . . 0.0 109.146 174.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 96.0 m -78.64 102.84 8.2 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.409 HG21 HG23 ' A' ' 182' ' ' ILE . 26.7 m -86.7 143.0 12.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.418 -173.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -147.7 129.72 15.4 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 171.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 3.7 t -96.99 146.35 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 31.2 t -57.53 139.15 54.15 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 118.913 -0.565 . . . . 0.0 110.072 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -54.89 -37.89 66.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 123.497 0.498 . . . . 0.0 110.609 -177.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 41.1 p -62.02 -52.55 63.53 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.596 0.758 . . . . 0.0 109.541 176.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 68.9 mt -58.71 -28.09 65.49 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.61 0.764 . . . . 0.0 111.489 177.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.55 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 46.5 mt-30 -73.46 -42.74 61.56 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 119.021 -0.514 . . . . 0.0 112.191 -176.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.33 -20.78 20.05 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 119.541 1.064 . . . . 0.0 111.574 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -80.51 -41.78 23.65 Favored 'General case' 0 C--N 1.35 0.602 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.475 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -114.4 -60.59 1.87 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.059 0.543 . . . . 0.0 111.617 -176.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.55 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 46.1 t-105 -71.65 -15.77 62.24 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -161.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 153.49 -112.7 0.54 Allowed Glycine 0 C--N 1.339 0.723 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -178.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 58.2 m -149.73 96.5 2.48 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.43 0.692 . . . . 0.0 109.786 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 55.6 p -89.42 79.21 7.02 Favored 'General case' 0 C--N 1.351 0.657 0 CA-C-O 121.738 0.78 . . . . 0.0 108.933 171.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -139.11 91.31 2.5 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 174.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -67.66 83.13 0.18 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.852 0.861 . . . . 0.0 109.988 -173.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -79.04 116.0 19.07 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.383 -174.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -145.93 -118.42 1.14 Allowed Glycine 0 C--O 1.239 0.41 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 176.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 34.2 mtm-85 -120.16 139.44 28.45 Favored Pre-proline 0 C--O 1.243 0.732 0 C-N-CA 123.662 0.785 . . . . 0.0 109.416 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -61.0 127.56 22.66 Favored 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.542 2.162 . . . . 0.0 110.768 172.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -62.4 147.15 95.37 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.364 2.043 . . . . 0.0 111.525 173.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 78.8 mt -62.85 137.6 58.31 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 45.6 p -57.1 149.21 19.88 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.548 0.739 . . . . 0.0 112.11 -175.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 84.4 mt -67.25 95.44 0.42 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.573 0.749 . . . . 0.0 110.793 -175.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 . . . . . 0 C--O 1.251 1.17 0 CA-C-N 114.871 -1.058 . . . . 0.0 111.017 178.834 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 23.7 ptp . . . . . 0 N--CA 1.482 1.15 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.93 133.62 59.14 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 122.023 1.816 . . . . 0.0 110.987 166.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.72 98.0 0.09 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.817 0.847 . . . . 0.0 109.877 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 40.7 p -68.03 127.44 32.87 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.689 0.796 . . . . 0.0 110.482 -175.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -116.07 136.72 52.77 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.148 0.579 . . . . 0.0 110.523 -174.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -85.58 105.58 16.26 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 169.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.0 mm -77.6 120.45 28.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 175.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.4 p -100.85 66.54 1.18 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.416 ' HB3' ' O ' ' A' ' 132' ' ' ALA . 22.6 t70 -67.84 -29.15 68.22 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.755 176.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.743 ' HG3' ' HG3' ' A' ' 97' ' ' GLU . 32.7 ttp -104.84 129.42 53.16 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.724 1.61 . . . . 0.0 107.141 170.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 48.0 p -67.1 156.16 36.85 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 121.309 -0.87 . . . . 0.0 109.94 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -59.64 -35.3 58.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -57.87 -58.29 9.02 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.01 0.924 . . . . 0.0 112.175 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.743 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 12.5 pt-20 -71.15 -27.09 63.3 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 122.703 0.401 . . . . 0.0 111.05 -178.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.567 ' HG ' HD23 ' A' ' 146' ' ' LEU . 9.5 tt -60.71 -39.91 90.31 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.207 1.003 . . . . 0.0 110.201 171.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 81.1 p -107.07 19.96 19.69 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.277 0.631 . . . . 0.0 111.219 -177.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.545 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 2.5 tpm_? -69.78 140.15 53.34 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.879 0.871 . . . . 0.0 111.203 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -78.89 128.26 33.1 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 173.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 40.2 p-90 -150.65 168.13 25.25 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.064 0.946 . . . . 0.0 110.088 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -126.85 136.51 52.44 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.39 0.676 . . . . 0.0 109.795 178.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.508 ' HG3' ' HB2' ' A' ' 120' ' ' ASP . 43.7 ttp -94.31 93.06 7.51 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 167.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.2 tp -55.62 -53.73 52.93 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.718 1.207 . . . . 0.0 111.367 -168.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 27.5 mmt -101.95 93.75 3.97 Favored Pre-proline 0 C--O 1.244 0.779 0 C-N-CA 124.145 0.978 . . . . 0.0 108.581 171.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.501 ' HA ' ' HG2' ' A' ' 104' ' ' MET . 7.0 Cg_exo -73.02 111.73 3.35 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 122.573 2.182 . . . . 0.0 112.345 -172.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -114.63 112.32 22.71 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 171.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -94.92 101.5 13.29 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -177.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.471 ' HE2' HG11 ' A' ' 180' ' ' VAL . 55.2 tptt -101.93 146.23 28.15 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 170.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 93.2 t -131.01 129.29 63.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 167.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -123.78 95.11 4.44 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.35 -137.12 21.42 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.549 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -82.08 20.4 1.1 Allowed 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 123.705 2.937 . . . . 0.0 113.075 173.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.496 HD11 HG22 ' A' ' 174' ' ' VAL . 87.5 mt -127.86 122.69 33.24 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.358 0.663 . . . . 0.0 109.618 -175.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 49.4 t -85.44 115.41 23.15 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.038 0.935 . . . . 0.0 110.099 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.6 mm -100.47 121.88 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.588 0.755 . . . . 0.0 109.363 -175.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 51.3 mtt-85 -103.09 119.84 39.58 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 34.9 mm -114.56 122.04 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.508 ' HB2' ' HG3' ' A' ' 104' ' ' MET . 18.8 t70 -97.04 113.09 24.61 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 170.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -77.25 -11.56 59.84 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.716 0.806 . . . . 0.0 112.127 -175.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.66 -62.51 1.56 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.321 0.649 . . . . 0.0 111.765 -174.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.7 mp -71.23 115.0 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-O 122.014 0.911 . . . . 0.0 110.883 -174.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 59.1 mtt -133.11 167.25 20.67 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 113.83 -1.532 . . . . 0.0 109.879 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.9 t70 55.17 42.15 30.88 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.636 1.174 . . . . 0.0 111.374 177.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 190' ' ' ASN . 45.5 mmtm -124.75 153.39 42.49 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.209 1.004 . . . . 0.0 110.145 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -88.3 106.36 18.17 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 172.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.493 HG12 HG22 ' A' ' 151' ' ' THR . 56.0 mt -107.88 136.08 44.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 124.702 1.201 . . . . 0.0 110.031 -174.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 11.8 tpt -115.41 138.16 51.29 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.422 1.089 . . . . 0.0 110.057 -175.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.556 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 3.4 mm? -92.64 117.71 30.26 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.975 0.91 . . . . 0.0 108.92 177.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 93' ' ' MET . 73.5 mmtt -123.6 125.47 44.9 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.668 1.187 . . . . 0.0 109.211 176.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.548 ' HB2' ' HG ' ' A' ' 147' ' ' LEU . . . -137.49 144.43 42.22 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -175.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -106.29 130.77 54.08 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 169.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.425 ' HA ' HD13 ' A' ' 145' ' ' ILE . 4.9 p90 -162.87 157.46 21.32 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 124.15 0.906 . . . . 0.0 109.38 -172.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 22.2 p -85.65 152.1 23.36 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 172.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 87.6 t -121.84 138.51 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.847 0.859 . . . . 0.0 109.738 -177.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.0 tp -145.05 142.43 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 170.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 60.39 17.87 7.58 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.714 0.806 . . . . 0.0 112.757 177.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 73.87 21.08 2.75 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 126.566 1.947 . . . . 0.0 112.155 -177.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.419 ' HB2' HD12 ' A' ' 171' ' ' ILE . 10.8 ptp180 -125.39 172.19 9.82 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.938 0.895 . . . . 0.0 109.863 175.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.2 tt -69.32 119.56 13.78 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.365 0.666 . . . . 0.0 109.669 174.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -83.41 -65.93 0.95 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.319 1.047 . . . . 0.0 108.947 176.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 69.4 m -141.55 130.94 23.7 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.608 0.763 . . . . 0.0 109.028 175.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.431 HD21 ' HB2' ' A' ' 147' ' ' LEU . 52.9 tp -77.6 121.31 23.76 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.993 0.917 . . . . 0.0 109.812 174.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 134' ' ' PHE . 1.7 mp -81.94 -44.49 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.579 0.752 . . . . 0.0 109.458 176.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.567 HD23 ' HG ' ' A' ' 98' ' ' LEU . 34.0 tp -167.72 148.89 5.37 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.943 0.897 . . . . 0.0 108.714 173.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.71 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 8.3 tt -129.17 150.13 50.68 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 174.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.745 HH11 HG21 ' A' ' 156' ' ' ILE . 44.0 ttm-85 -143.1 143.57 31.89 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.379 0.672 . . . . 0.0 110.8 -173.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -124.22 118.8 27.65 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.437 1.095 . . . . 0.0 108.308 174.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -145.92 144.66 30.31 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.198 0.523 . . . . 0.0 111.018 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.493 HG22 HG12 ' A' ' 128' ' ' ILE . 55.3 p -65.41 171.51 3.9 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.616 -1.174 . . . . 0.0 112.197 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -65.3 -23.22 66.96 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.003 0.521 . . . . 0.0 110.821 172.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -66.12 -30.04 70.46 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.226 1.01 . . . . 0.0 110.234 174.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 107.3 -5.36 35.74 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.039 -174.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -70.26 105.14 2.87 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.434 0.694 . . . . 0.0 110.681 -175.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.745 HG21 HH11 ' A' ' 148' ' ' ARG . 33.3 mt -73.92 118.9 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.45 ' HB ' ' HB3' ' A' ' 120' ' ' ASP . 35.6 m -130.98 15.3 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.833 0.853 . . . . 0.0 110.648 -175.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -164.39 151.78 21.14 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -163.54 141.58 7.68 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.71 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 69.1 mt -113.13 102.74 14.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 170.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 20.7 t -98.93 108.49 49.4 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.135 0.974 . . . . 0.0 108.85 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.19 134.55 62.53 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.514 2.143 . . . . 0.0 111.318 175.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.9 mt -69.88 122.92 87.53 Favored Pre-proline 0 CA--C 1.551 1.001 0 O-C-N 123.531 0.52 . . . . 0.0 109.859 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -61.14 -17.84 54.69 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 123.785 2.99 . . . . 0.0 113.676 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 25.5 p -72.29 -14.22 61.7 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 124.076 0.95 . . . . 0.0 112.277 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -120.69 100.8 46.38 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 124.568 1.147 . . . . 0.0 108.271 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.42 -49.03 17.47 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.229 2.619 . . . . 0.0 113.145 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -125.25 155.35 18.72 Favored Glycine 0 C--N 1.35 1.321 0 CA-C-N 116.45 -0.341 . . . . 0.0 112.684 -175.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -150.63 154.79 38.15 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.496 1.118 . . . . 0.0 109.558 176.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.413 ' O ' HG23 ' A' ' 174' ' ' VAL . 80.7 p -87.69 151.4 22.96 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.064 0.546 . . . . 0.0 110.385 -174.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.443 ' O ' ' HG3' ' A' ' 175' ' ' LYS . 8.3 tt -58.52 -38.76 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 O-C-N 123.99 0.806 . . . . 0.0 111.129 175.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 47.2 mp0 -55.54 -41.57 73.4 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.086 0.955 . . . . 0.0 110.461 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -67.38 -47.19 71.08 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.556 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.496 HG22 HD11 ' A' ' 115' ' ' LEU . 57.4 t -61.53 -34.28 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 122.974 0.509 . . . . 0.0 110.959 -176.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 171' ' ' ILE . 39.2 mtpt -61.05 -34.7 75.3 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.247 0.619 . . . . 0.0 111.781 177.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -68.0 -47.65 67.94 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.35 -45.11 84.68 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 124.374 1.046 . . . . 0.0 112.249 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.5 ' HB ' ' HZ3' ' A' ' 203' ' ' TRP . 23.2 mt -72.06 -37.57 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -64.8 -27.47 72.12 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 116.126 -0.488 . . . . 0.0 113.003 177.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.471 HG11 ' HE2' ' A' ' 110' ' ' LYS . 54.1 t -83.15 -39.91 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.746 0.818 . . . . 0.0 110.203 177.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.483 HD22 HG13 ' A' ' 160' ' ' ILE . 58.7 tp -58.52 -53.03 62.95 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.084 0.554 . . . . 0.0 110.406 174.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.634 HG23 HG21 ' A' ' 192' ' ' VAL . 70.4 mt -59.28 -43.48 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.44 1.096 . . . . 0.0 110.278 173.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -58.53 -35.0 78.16 Favored Glycine 0 CA--C 1.533 1.203 0 O-C-N 123.886 0.741 . . . . 0.0 113.83 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -72.39 -35.49 59.91 Favored Glycine 0 C--N 1.349 1.292 0 N-CA-C 111.847 -0.501 . . . . 0.0 111.847 175.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.412 HD22 HD12 ' A' ' 128' ' ' ILE . 75.3 mt -71.06 -25.25 62.56 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 124.297 1.039 . . . . 0.0 111.252 175.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 26.9 mm-40 -70.85 -37.78 73.13 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.713 0.805 . . . . 0.0 110.06 174.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -73.83 -31.68 63.33 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.293 177.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -72.6 -14.72 61.68 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.088 169.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 15.6 t70 57.3 64.85 1.5 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.629 1.172 . . . . 0.0 110.313 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 10.5 p30 -131.84 165.73 23.18 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.671 174.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 42.3 m -87.78 106.39 18.04 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.507 -172.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.634 HG21 HG23 ' A' ' 182' ' ' ILE . 34.3 m -94.81 141.98 14.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.763 0 C-N-CA 122.918 0.487 . . . . 0.0 110.689 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -144.76 131.3 19.87 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.233 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.556 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 5.2 t -95.69 149.51 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.413 ' HB2' ' HG ' ' A' ' 198' ' ' LEU . 69.9 m -67.44 144.59 55.66 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 118.95 0.795 . . . . 0.0 110.947 177.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -60.22 -26.29 66.28 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.079 0.952 . . . . 0.0 111.797 -177.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.0 p -67.68 -53.18 29.74 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 172.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.51 ' HB2' HG12 ' A' ' 194' ' ' VAL . 68.1 mt -62.91 -25.61 68.41 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.881 0.873 . . . . 0.0 111.506 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.595 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 78.3 mt-30 -69.24 -44.12 72.65 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.224 0.61 . . . . 0.0 110.824 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.08 -30.0 20.22 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.662 -175.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -83.3 -57.89 3.07 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.548 0.339 . . . . 0.0 110.803 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -98.73 -37.37 9.51 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.16 0.584 . . . . 0.0 111.703 -165.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.595 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 43.4 t-105 -101.24 19.09 18.3 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.275 1.03 . . . . 0.0 109.415 -170.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -70.33 163.44 52.87 Favored Glycine 0 C--N 1.356 1.668 0 CA-C-N 115.96 -0.564 . . . . 0.0 113.336 -176.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 24.2 t -58.66 113.32 1.97 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.838 0.855 . . . . 0.0 111.26 -175.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 37.3 t -143.78 -178.43 5.91 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.266 1.026 . . . . 0.0 109.439 -173.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -72.7 103.0 3.48 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 165.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -69.79 86.84 0.51 Allowed 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.94 0.896 . . . . 0.0 109.189 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -61.74 122.84 16.35 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.907 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -161.57 122.69 1.13 Allowed Glycine 0 C--N 1.334 0.425 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -177.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.9 155.7 80.01 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 123.874 0.87 . . . . 0.0 109.686 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.426 ' HA ' ' HD3' ' A' ' 213' ' ' PRO . 23.7 Cg_exo -64.42 134.7 42.82 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.437 2.092 . . . . 0.0 111.466 -178.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 212' ' ' PRO . 38.4 Cg_exo -61.48 151.62 78.6 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.772 2.315 . . . . 0.0 112.385 179.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 65.0 mt -69.48 96.38 0.9 Allowed 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.855 0.862 . . . . 0.0 109.709 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 51.0 p -70.83 148.85 47.43 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.091 0.557 . . . . 0.0 111.049 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 34.3 mt -86.14 143.05 28.22 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.448 0.699 . . . . 0.0 109.665 -175.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 . . . . . 0 CA--C 1.556 1.194 0 C-N-CA 123.688 0.795 . . . . 0.0 108.869 -179.245 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 49.8 tpp . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.42 ' HB3' ' H ' ' A' ' 138' ' ' PHE . 17.9 Cg_exo -68.64 130.62 21.12 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 122.665 2.244 . . . . 0.0 111.394 175.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.93 93.61 0.09 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.012 0.925 . . . . 0.0 111.414 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 34.3 t -79.42 72.3 6.03 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 171.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -128.27 133.67 48.81 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.465 -168.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -86.47 105.03 16.49 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 175.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 49.9 mm -78.73 125.89 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 62.4 p -114.26 91.42 3.62 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.641 -176.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -75.51 -17.84 59.99 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.182 0.593 . . . . 0.0 110.703 177.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.508 ' SD ' ' HB3' ' A' ' 148' ' ' ARG . 61.1 mtm -117.22 128.72 55.38 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.456 1.103 . . . . 0.0 108.943 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.4 m -77.82 162.15 27.11 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 171.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -48.55 -35.41 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 124.402 1.081 . . . . 0.0 111.763 -177.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -51.58 -71.14 0.07 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.211 1.404 . . . . 0.0 112.207 177.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -69.11 -29.84 67.99 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.528 0.731 . . . . 0.0 111.744 -176.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.8 tt -62.5 -43.1 99.63 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.235 1.014 . . . . 0.0 109.263 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.2 m -105.23 15.18 27.85 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.738 0.815 . . . . 0.0 111.815 -175.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -80.88 135.47 35.92 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.159 0.583 . . . . 0.0 110.222 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -88.22 144.87 26.19 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.776 0.83 . . . . 0.0 109.306 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 18.5 p-90 -152.42 154.29 35.26 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.192 0.997 . . . . 0.0 110.465 -173.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -96.42 160.47 14.39 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.538 0.735 . . . . 0.0 110.791 -177.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 65.9 mtp -128.74 116.88 20.21 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 170.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.3 tt -70.71 -54.78 10.51 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 21.5 mmt -119.22 86.56 33.03 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 124.126 0.97 . . . . 0.0 109.378 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -76.67 113.61 3.69 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 122.837 2.358 . . . . 0.0 112.493 -175.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.55 ' HE3' ' HB2' ' A' ' 110' ' ' LYS . 51.4 tptt -90.59 106.69 18.68 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 169.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 51.2 tp60 -90.92 107.27 19.09 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.146 -0.933 . . . . 0.0 108.698 176.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.55 ' HB2' ' HE3' ' A' ' 108' ' ' LYS . 58.7 tttm -140.12 143.44 36.23 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.992 172.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 68.0 t -105.67 147.24 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 169.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -134.66 90.75 2.69 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 174.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.3 -136.37 21.21 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 114.823 -1.08 . . . . 0.0 112.687 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -81.43 17.9 1.42 Allowed 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 123.687 2.925 . . . . 0.0 113.148 176.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 4.3 mp -134.87 136.42 42.39 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.745 0.818 . . . . 0.0 108.91 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 26.4 p -100.82 138.83 37.35 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.105 0.562 . . . . 0.0 110.085 177.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.2 mm -106.72 133.94 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.326 1.05 . . . . 0.0 110.637 -171.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -108.84 118.18 36.12 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 173.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.496 ' HB ' ' HB3' ' A' ' 108' ' ' LYS . 87.0 mt -126.97 125.63 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -97.03 117.73 31.85 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 118.78 0.718 . . . . 0.0 109.331 173.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -78.5 -8.31 58.41 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.303 1.041 . . . . 0.0 112.506 -172.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.41 -26.33 23.36 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.676 0.39 . . . . 0.0 110.292 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 41.2 mm -81.89 102.15 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 121.997 0.904 . . . . 0.0 110.995 -173.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.527 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 52.1 mtt -134.09 160.47 37.67 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 114.253 -1.34 . . . . 0.0 108.763 -178.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.8 t70 65.34 24.56 12.1 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.719 0.771 . . . . 0.0 111.64 174.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 190' ' ' ASN . 74.9 mmtt -117.45 148.61 41.65 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.236 1.014 . . . . 0.0 110.66 -179.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.408 HD22 ' N ' ' A' ' 127' ' ' ASN . 0.8 OUTLIER -86.8 106.48 17.73 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 171.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.533 HD12 HD22 ' A' ' 185' ' ' LEU . 50.1 mt -102.28 128.63 54.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.893 0.877 . . . . 0.0 111.25 -174.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.558 ' HG3' ' HG3' ' A' ' 131' ' ' LYS . 4.0 tpt -98.99 116.38 31.1 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.064 1.746 . . . . 0.0 109.636 -176.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -98.57 104.7 16.76 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.558 ' HG3' ' HG3' ' A' ' 129' ' ' MET . 47.3 mtmt -127.17 149.58 49.91 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.166 0.586 . . . . 0.0 110.975 -177.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.485 ' HB3' HD21 ' A' ' 198' ' ' LEU . . . -141.4 149.93 41.7 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -173.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -100.25 118.88 37.46 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 163.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -151.91 159.18 43.89 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.157 0.583 . . . . 0.0 110.964 -171.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.8 m -86.36 150.52 24.27 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.787 1.235 . . . . 0.0 109.703 177.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 98.2 t -122.4 145.62 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 175.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.465 HG22 ' HB2' ' A' ' 142' ' ' GLU . 9.7 tp -162.67 145.48 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 167.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.42 ' H ' ' HB3' ' A' ' 85' ' ' PRO . 44.7 m-85 56.29 25.68 9.61 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 124.043 0.937 . . . . 0.0 112.606 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 69.72 25.52 5.12 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 125.781 1.632 . . . . 0.0 112.487 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.575 ' HB2' HD12 ' A' ' 171' ' ' ILE . 1.2 ptp85 -132.56 171.65 13.54 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.325 0.65 . . . . 0.0 110.902 175.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.7 tt -74.44 114.07 12.41 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 114.904 -1.043 . . . . 0.0 108.662 172.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.465 ' HB2' HG22 ' A' ' 137' ' ' ILE . 9.4 tp10 -73.45 -61.84 1.69 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.902 0.881 . . . . 0.0 110.247 175.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 65.4 m -146.32 127.53 14.76 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.99 0.916 . . . . 0.0 109.438 -175.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.452 HD11 ' HB1' ' A' ' 132' ' ' ALA . 36.7 tp -74.06 125.23 27.84 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 172.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.9 mp -83.35 -48.51 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 172.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.548 HD21 ' NH2' ' A' ' 148' ' ' ARG . 46.5 tp -165.26 147.42 7.8 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.687 0.795 . . . . 0.0 109.626 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.638 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 8.9 tt -129.62 156.75 43.7 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 171.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.793 ' HD3' HD13 ' A' ' 156' ' ' ILE . 48.4 ttm-85 -154.07 141.16 19.39 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.082 0.553 . . . . 0.0 110.733 -175.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.98 121.14 44.51 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.627 1.171 . . . . 0.0 109.411 -177.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -110.99 155.94 21.98 Favored 'General case' 0 C--O 1.208 -1.087 0 C-N-CA 124.74 1.216 . . . . 0.0 108.541 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 24.9 p -100.18 168.3 9.9 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 118.852 0.751 . . . . 0.0 109.833 168.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.8 -21.17 62.51 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 172.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -61.7 -30.27 70.64 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.103 0.961 . . . . 0.0 111.422 169.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 99.21 14.31 36.36 Favored Glycine 0 C--N 1.346 1.116 0 O-C-N 123.714 0.634 . . . . 0.0 112.84 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -101.1 135.11 43.09 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.41 0.684 . . . . 0.0 109.957 176.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.793 HD13 ' HD3' ' A' ' 148' ' ' ARG . 47.1 mt -78.93 127.13 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 174.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.6 m -127.01 1.41 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.636 0.774 . . . . 0.0 112.435 -171.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -164.81 170.03 39.73 Favored Glycine 0 C--N 1.344 0.973 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 34.6 tt0 -167.67 153.75 7.63 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.04 0.936 . . . . 0.0 109.139 -177.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.638 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 70.6 mt -129.4 104.23 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 167.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 5.4 p -109.95 121.84 40.71 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 123.85 0.86 . . . . 0.0 109.627 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 37.1 Cg_exo -62.53 140.11 79.81 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.752 2.301 . . . . 0.0 111.824 175.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 96.6 mt -72.72 123.25 89.33 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 123.744 0.818 . . . . 0.0 110.543 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.54 -10.48 29.16 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 123.361 2.707 . . . . 0.0 112.75 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 27.4 p -81.39 -1.87 47.23 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 124.06 0.944 . . . . 0.0 111.557 173.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -129.54 99.04 21.4 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 124.75 1.22 . . . . 0.0 108.567 177.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -71.71 79.16 1.61 Allowed 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 123.155 2.57 . . . . 0.0 112.688 177.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 108.16 156.47 18.88 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 115.959 -0.564 . . . . 0.0 113.925 173.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -151.4 172.13 16.42 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.069 1.348 . . . . 0.0 109.781 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 59.1 p -98.23 166.08 11.57 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 123.31 0.644 . . . . 0.0 110.268 174.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.626 HD11 ' HA ' ' A' ' 202' ' ' ALA . 12.7 tt -52.78 -35.84 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 124.189 0.996 . . . . 0.0 110.882 170.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -59.72 -44.71 93.61 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.55 1.14 . . . . 0.0 111.469 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -63.34 -43.69 97.01 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 124.105 0.878 . . . . 0.0 111.093 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.478 ' O ' HG13 ' A' ' 178' ' ' ILE . 67.3 t -64.07 -42.91 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.944 -178.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -62.14 -36.84 83.03 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.028 0.531 . . . . 0.0 111.634 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -66.29 -43.99 84.77 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 175.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -59.33 -44.69 92.58 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.232 1.013 . . . . 0.0 111.719 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 174' ' ' VAL . 51.3 mt -70.38 -35.99 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.27 0.628 . . . . 0.0 109.661 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.96 -27.17 73.31 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 116.22 -0.445 . . . . 0.0 113.723 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 45.5 t -75.2 -47.03 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.499 0.72 . . . . 0.0 110.614 175.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 30.0 tp -60.89 -52.76 63.66 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 123.748 0.655 . . . . 0.0 110.573 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.43 HG23 HG11 ' A' ' 192' ' ' VAL . 65.3 mt -65.85 -46.8 87.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.77 0.828 . . . . 0.0 111.149 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -58.13 -34.48 73.35 Favored Glycine 0 C--N 1.345 1.075 0 O-C-N 123.599 0.562 . . . . 0.0 113.396 177.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.5 -47.04 92.35 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 172.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.533 HD22 HD12 ' A' ' 128' ' ' ILE . 93.8 mt -64.54 -29.25 70.28 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.787 1.235 . . . . 0.0 111.92 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -69.68 -41.55 75.29 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.519 0.728 . . . . 0.0 110.493 177.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 20.6 mtm180 -74.53 -26.88 60.26 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.891 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.527 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 16.0 m120 -71.99 -20.07 61.78 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.237 0.615 . . . . 0.0 111.152 172.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 65.66 66.3 0.52 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.528 1.131 . . . . 0.0 110.831 -173.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 11.6 p30 -136.57 158.26 44.86 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.156 168.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 86.2 m -83.65 105.93 14.96 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.616 0.766 . . . . 0.0 110.588 -170.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.43 HG11 HG23 ' A' ' 182' ' ' ILE . 33.0 m -83.18 145.41 8.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 C-N-CA 123.153 0.581 . . . . 0.0 110.308 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -146.16 125.13 12.76 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 170.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 3.0 t -93.46 149.16 4.37 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -177.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 43.0 t -59.7 141.45 55.1 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.736 0.414 . . . . 0.0 110.235 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -52.61 -38.66 60.59 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.06 0.944 . . . . 0.0 111.443 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 68.6 p -67.54 -49.73 61.92 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.331 1.052 . . . . 0.0 110.647 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.485 HD21 ' HB3' ' A' ' 132' ' ' ALA . 71.5 mt -59.67 -34.81 73.33 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.714 0.805 . . . . 0.0 110.922 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.592 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 50.5 mt-30 -63.65 -54.53 34.26 Favored 'General case' 0 C--N 1.348 0.543 0 O-C-N 123.88 0.737 . . . . 0.0 110.974 178.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.39 -12.81 53.77 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -172.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -96.0 -40.43 9.27 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 118.058 0.39 . . . . 0.0 111.764 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.626 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -121.82 -61.49 1.5 Allowed 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -172.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.592 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 60.3 t-105 -64.3 -32.63 74.31 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.378 1.071 . . . . 0.0 112.323 -164.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -110.84 -53.44 0.55 Allowed Glycine 0 C--N 1.341 0.825 0 C-N-CA 123.709 0.671 . . . . 0.0 111.629 -173.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 47.8 m -94.93 112.74 24.42 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 69.5 m -150.9 82.96 1.33 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.98 1.312 . . . . 0.0 108.288 169.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -133.31 103.6 6.05 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.436 ' HB3' ' NH2' ' A' ' 140' ' ' ARG . 0.1 OUTLIER -147.3 136.5 22.47 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.264 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -165.07 85.25 0.4 Allowed 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -175.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -79.92 -53.24 4.31 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.942 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 52.7 mtm180 64.86 118.28 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.398 0 C-N-CA 125.554 1.542 . . . . 0.0 112.096 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -69.05 152.38 72.99 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.585 2.19 . . . . 0.0 111.274 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.31 113.84 1.67 Allowed 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.693 2.262 . . . . 0.0 111.567 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 66.3 mt -63.82 101.65 0.39 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.641 0.777 . . . . 0.0 109.996 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 71.6 p -74.64 144.0 44.05 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.19 0.519 . . . . 0.0 111.356 -174.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 30.6 mt -108.98 -179.5 3.87 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.039 0.935 . . . . 0.0 109.944 -175.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 . . . . . 0 C--O 1.249 1.037 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.965 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 61.7 mtt . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -63.71 162.75 27.05 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 123.507 2.805 . . . . 0.0 112.949 179.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.47 111.71 6.22 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 175.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.2 p -68.54 124.04 22.49 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.347 0.659 . . . . 0.0 110.07 177.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 45.0 ttm180 -118.66 140.1 50.47 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.076 0.55 . . . . 0.0 111.134 -173.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -96.85 111.05 23.41 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 170.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 133' ' ' ASN . 48.2 mm -83.05 117.69 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 170.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 37.7 p -113.5 88.49 2.85 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.017 0.927 . . . . 0.0 109.06 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -68.81 -31.06 69.78 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.456 177.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -121.31 142.88 49.53 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.816 0.847 . . . . 0.0 108.934 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 68.5 p -78.96 163.07 25.53 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.767 0.318 . . . . 0.0 110.297 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.46 -31.42 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.291 0 C-N-CA 124.863 1.265 . . . . 0.0 111.995 -176.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -54.34 -69.58 0.12 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.269 1.027 . . . . 0.0 112.363 178.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.9 pm0 -69.02 -25.19 64.37 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.007 0.523 . . . . 0.0 111.758 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.442 HD12 ' ND2' ' A' ' 133' ' ' ASN . 6.4 tt -59.67 -48.79 80.27 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.479 0.712 . . . . 0.0 109.386 176.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.8 t -106.77 19.24 20.76 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.203 0.601 . . . . 0.0 111.202 -175.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -77.58 140.59 39.71 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.689 0.796 . . . . 0.0 110.242 174.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -91.67 145.72 24.36 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.545 0.738 . . . . 0.0 110.459 174.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.552 ' HH2' ' HG2' ' A' ' 118' ' ' ARG . 42.3 p-90 -158.41 179.77 8.83 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.929 1.292 . . . . 0.0 109.78 -172.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -139.72 158.36 44.23 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.333 0.653 . . . . 0.0 110.513 177.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.541 ' HE3' ' HA ' ' A' ' 107' ' ' PRO . 71.0 mtm -105.99 145.62 31.12 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.741 0.816 . . . . 0.0 109.334 171.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.9 tp -82.2 -40.15 22.11 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.189 0.596 . . . . 0.0 110.177 -175.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 19.7 mmt -122.68 88.74 49.95 Favored Pre-proline 0 N--CA 1.484 1.236 0 C-N-CA 124.562 1.145 . . . . 0.0 108.666 169.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.541 ' HA ' ' HE3' ' A' ' 104' ' ' MET . 17.4 Cg_exo -68.27 131.96 24.69 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.622 2.215 . . . . 0.0 113.307 -178.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.54 ' HD2' HE21 ' A' ' 121' ' ' GLN . 86.9 tttt -135.57 135.91 40.69 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.404 1.082 . . . . 0.0 108.372 171.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -112.82 124.15 51.93 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.11 0.564 . . . . 0.0 110.144 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -125.53 150.06 47.76 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 168.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 12.9 t -126.81 142.51 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 172.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -138.68 98.12 3.5 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 68.69 -127.25 22.56 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 119.351 -0.694 . . . . 0.0 112.162 -177.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -89.45 14.75 2.12 Favored 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 123.483 2.789 . . . . 0.0 112.803 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.494 HD23 ' HA ' ' A' ' 162' ' ' PRO . 93.9 mt -128.03 122.44 32.21 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.931 0.492 . . . . 0.0 110.096 -172.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 40.2 t -83.05 116.9 22.5 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.345 1.058 . . . . 0.0 109.702 177.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 10.4 mm -90.81 115.96 31.09 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 C-N-CA 123.777 0.831 . . . . 0.0 109.287 -177.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.552 ' HG2' ' HH2' ' A' ' 102' ' ' TRP . 7.9 tpt180 -94.7 118.53 31.88 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 43.9 mm -123.3 134.39 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.531 0.732 . . . . 0.0 109.509 -176.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -117.97 120.87 39.13 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.445 0.698 . . . . 0.0 109.153 174.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.54 HE21 ' HD2' ' A' ' 108' ' ' LYS . 82.4 mt-30 -82.98 -1.24 52.0 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.949 0.9 . . . . 0.0 112.893 -177.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.13 -56.92 3.12 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 117.934 0.334 . . . . 0.0 111.455 -173.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.474 HG23 ' HG3' ' A' ' 126' ' ' LYS . 2.0 mp -70.14 104.07 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-O 121.938 0.875 . . . . 0.0 110.314 -175.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.9 mtt -126.56 159.42 33.53 Favored 'General case' 0 C--N 1.348 0.508 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.964 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.71 33.84 21.94 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.608 0.763 . . . . 0.0 112.294 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.474 ' HG3' HG23 ' A' ' 123' ' ' ILE . 74.1 mmtt -114.49 155.23 26.79 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.461 0.705 . . . . 0.0 110.594 176.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.455 ' HB2' ' HB3' ' A' ' 152' ' ' GLU . 0.8 OUTLIER -89.73 101.63 14.32 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 170.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.506 ' HB ' HG12 ' A' ' 192' ' ' VAL . 66.5 mt -101.77 139.73 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.535 0.734 . . . . 0.0 109.431 -172.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 14.2 tpt -123.0 127.03 48.24 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.822 0.849 . . . . 0.0 109.649 -175.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 22.8 mt -99.15 104.59 16.58 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -176.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.419 ' HB2' ' HE1' ' A' ' 150' ' ' PHE . 2.8 mtpm? -117.23 130.72 56.76 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -175.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -133.52 152.69 51.94 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 122.016 0.912 . . . . 0.0 112.782 -170.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.442 ' ND2' HD12 ' A' ' 98' ' ' LEU . 5.2 m-20 -108.22 125.35 51.55 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 168.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -155.48 159.09 39.51 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.297 0.639 . . . . 0.0 111.083 -172.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.508 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . 37.9 m -90.12 161.69 15.66 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.985 0.914 . . . . 0.0 110.94 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 70.9 t -139.88 130.81 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 124.263 1.025 . . . . 0.0 110.075 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.618 HG22 ' HG2' ' A' ' 142' ' ' GLU . 9.1 tp -146.89 144.7 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 170.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 57.55 24.69 10.66 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.622 0.769 . . . . 0.0 111.628 -178.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 63.4 30.36 15.46 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.824 1.25 . . . . 0.0 112.28 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -131.9 165.45 23.86 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.615 0.766 . . . . 0.0 109.458 171.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.482 HD13 ' HB2' ' A' ' 202' ' ' ALA . 9.8 tt -70.9 129.39 38.91 Favored 'General case' 0 CA--C 1.554 1.096 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.618 ' HG2' HG22 ' A' ' 137' ' ' ILE . 31.8 mt-10 -83.88 -67.52 0.79 Allowed 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.698 0.761 . . . . 0.0 109.736 173.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 27.6 m -144.85 138.75 27.24 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.9 -170.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.449 HD22 HG13 ' A' ' 174' ' ' VAL . 56.5 tp -84.2 112.36 20.2 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.077 0.551 . . . . 0.0 109.577 175.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.13 -51.42 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 174.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.406 HD21 ' NH2' ' A' ' 148' ' ' ARG . 35.2 tp -170.6 149.13 3.15 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.321 177.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.538 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 10.0 tt -124.0 150.97 44.24 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 172.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.489 ' HD3' HD13 ' A' ' 156' ' ' ILE . 32.5 ttm-85 -143.31 135.09 26.61 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 122.671 0.388 . . . . 0.0 110.265 -178.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.06 113.73 27.44 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.419 ' HE1' ' HB2' ' A' ' 131' ' ' LYS . 17.4 m-85 -103.62 166.0 10.69 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 57.6 p -93.98 -179.44 4.97 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 120.949 0.404 . . . . 0.0 110.125 166.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 127' ' ' ASN . 13.3 pt-20 -61.94 -26.64 68.31 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.343 1.057 . . . . 0.0 110.913 172.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -77.57 -29.42 52.08 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.854 1.262 . . . . 0.0 110.815 174.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 103.96 11.03 33.29 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.908 -178.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.32 124.35 27.38 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.143 0.577 . . . . 0.0 109.503 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.489 HD13 ' HD3' ' A' ' 148' ' ' ARG . 54.9 mt -75.47 107.18 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -178.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.6 m -117.21 4.01 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.303 1.041 . . . . 0.0 111.869 -173.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -168.45 172.34 42.94 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-N 116.509 -0.314 . . . . 0.0 112.453 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -166.78 153.58 8.84 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.738 0.815 . . . . 0.0 109.394 -175.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.584 HD11 ' HB2' ' A' ' 181' ' ' LEU . 40.3 mm -124.95 103.58 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 164.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 55.9 p -102.68 126.95 31.35 Favored Pre-proline 0 N--CA 1.474 0.733 0 C-N-CA 123.146 0.578 . . . . 0.0 110.545 -177.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.494 ' HA ' HD23 ' A' ' 115' ' ' LEU . 56.4 Cg_endo -67.3 150.01 81.21 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 122.163 1.908 . . . . 0.0 112.015 175.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 77.0 mt -76.22 145.4 76.56 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.12 -27.54 78.98 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.906 2.404 . . . . 0.0 112.487 -176.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 24.2 m -74.32 -24.67 59.24 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.547 0.739 . . . . 0.0 111.567 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -131.8 71.47 80.58 Favored Pre-proline 0 N--CA 1.488 1.445 0 C-N-CA 123.23 0.612 . . . . 0.0 111.171 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -84.47 -6.09 10.01 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.657 2.238 . . . . 0.0 111.823 174.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -125.45 66.18 0.54 Allowed Glycine 0 C--N 1.347 1.151 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.445 ' CE1' HD21 ' A' ' 115' ' ' LEU . 27.2 p-80 -90.62 -175.68 4.5 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.857 0.863 . . . . 0.0 109.763 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 42.6 m -110.99 161.83 15.47 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.596 0.758 . . . . 0.0 110.315 -174.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' A' ' 141' ' ' LEU . 6.8 tt -45.94 -39.14 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.996 1.318 . . . . 0.0 112.498 173.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.594 ' HA ' ' NZ ' ' A' ' 175' ' ' LYS . 22.9 mm-40 -53.41 -48.87 68.32 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.262 1.025 . . . . 0.0 112.085 -176.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -61.11 -40.24 93.01 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 124.653 1.221 . . . . 0.0 110.813 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.449 HG13 HD22 ' A' ' 144' ' ' LEU . 41.1 t -66.8 -40.13 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.242 -175.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.594 ' NZ ' ' HA ' ' A' ' 172' ' ' GLU . 25.9 mtmm -60.39 -42.02 95.01 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 120.984 0.421 . . . . 0.0 110.009 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.498 ' O ' HG23 ' A' ' 180' ' ' VAL . 13.4 m120 -62.92 -48.51 78.64 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.653 175.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -59.68 -48.01 83.36 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.997 0.811 . . . . 0.0 112.616 -173.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.8 mt -63.57 -37.8 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.283 175.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.44 -30.82 77.22 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 115.578 -0.737 . . . . 0.0 114.432 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 176' ' ' ASN . 44.9 t -76.03 -43.15 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 117.79 0.795 . . . . 0.0 108.994 176.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.584 ' HB2' HD11 ' A' ' 160' ' ' ILE . 37.8 tp -53.38 -53.19 54.75 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.339 176.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.423 HD12 ' CH2' ' A' ' 203' ' ' TRP . 43.1 mt -64.1 -39.76 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.898 0.879 . . . . 0.0 110.716 174.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -53.12 -35.56 49.62 Favored Glycine 0 CA--C 1.533 1.214 0 O-C-N 123.466 0.478 . . . . 0.0 114.088 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -83.43 -39.45 9.8 Favored Glycine 0 C--N 1.348 1.235 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 175.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 46.1 mt -66.21 -31.67 72.65 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.168 0.987 . . . . 0.0 112.437 -176.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -69.57 -33.58 72.94 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.743 0.417 . . . . 0.0 110.329 176.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -71.32 -32.83 69.07 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.181 176.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -63.31 -16.99 62.04 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.141 0.576 . . . . 0.0 111.767 171.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 63.5 65.78 0.73 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.976 0.91 . . . . 0.0 110.136 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.411 ' HB2' ' H ' ' A' ' 126' ' ' LYS . 4.0 p30 -141.0 175.9 9.24 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.069 176.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 90.9 m -109.91 101.91 10.71 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.106 0.563 . . . . 0.0 109.582 -173.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.506 HG12 ' HB ' ' A' ' 128' ' ' ILE . 12.7 m -99.82 153.87 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 121.535 0.683 . . . . 0.0 111.357 -177.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -136.56 143.91 43.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.174 -1.375 . . . . 0.0 108.305 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 3.3 t -111.06 145.88 16.79 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 47.4 m -57.93 140.66 51.62 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 118.014 0.37 . . . . 0.0 111.043 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -57.94 -29.91 65.53 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.291 0.636 . . . . 0.0 110.802 177.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 41.3 p -67.98 -52.64 33.52 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.784 0.834 . . . . 0.0 109.561 176.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 32.5 mt -54.58 -38.29 66.52 Favored 'General case' 0 C--O 1.208 -1.106 0 C-N-CA 123.871 0.868 . . . . 0.0 111.057 176.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.652 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 49.4 mt-30 -71.14 -39.74 71.8 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.258 0.623 . . . . 0.0 111.962 -176.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.29 -12.03 44.74 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -177.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -101.59 -42.53 6.19 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 178.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.482 ' HB2' HD13 ' A' ' 141' ' ' LEU . . . -123.42 -61.58 1.39 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.159 0.584 . . . . 0.0 112.243 -172.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.652 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 52.6 t-105 -70.49 79.39 0.57 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.841 1.257 . . . . 0.0 111.084 -171.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -112.09 -50.76 0.57 Allowed Glycine 0 C--O 1.242 0.652 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 170.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 31.5 m -141.86 87.52 2.05 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.604 0.762 . . . . 0.0 108.967 173.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.533 ' HA ' ' HB3' ' A' ' 175' ' ' LYS . 68.9 p -59.01 -46.28 88.57 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.678 0.791 . . . . 0.0 110.262 177.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 16.6 m120 61.75 19.36 10.48 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.412 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -96.46 84.07 3.64 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -87.17 86.36 7.28 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.578 -175.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -72.11 76.33 0.74 Allowed Glycine 0 C--N 1.348 1.231 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 171.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -79.98 156.69 74.47 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.095 0.958 . . . . 0.0 111.763 -166.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -81.76 125.07 4.75 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.022 1.814 . . . . 0.0 110.853 167.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -69.33 172.03 12.95 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 122.474 2.116 . . . . 0.0 111.587 171.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 91.1 mt -71.35 84.71 0.8 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 169.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 35.9 p -79.51 134.87 36.52 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.864 -173.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.5 pp -65.0 155.39 34.78 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.95 0.9 . . . . 0.0 112.446 -175.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 . . . . . 0 C--O 1.252 1.225 0 C-N-CA 123.952 0.901 . . . . 0.0 109.619 -179.314 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.522 ' HG3' ' HB2' ' A' ' 87' ' ' SER . 1.5 pmm? . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.15 -35.23 33.95 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.116 1.877 . . . . 0.0 111.197 172.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -167.28 144.55 4.58 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.866 1.266 . . . . 0.0 108.525 174.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.522 ' HB2' ' HG3' ' A' ' 84' ' ' MET . 40.4 t -139.85 147.44 40.68 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.245 1.018 . . . . 0.0 108.432 176.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.475 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 22.4 ttm-85 -102.2 118.22 36.42 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -174.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -92.76 101.97 14.36 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.942 0.897 . . . . 0.0 108.68 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.7 mm -78.96 114.33 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.491 0.716 . . . . 0.0 109.979 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.7 p -100.2 67.4 1.37 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 122.424 1.107 . . . . 0.0 108.752 174.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.455 ' HB3' ' O ' ' A' ' 132' ' ' ALA . 11.4 t70 -83.37 -33.31 25.84 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.76 -176.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 34.4 ttp -99.46 131.36 45.52 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 170.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.8 m -70.63 153.15 43.14 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 120.81 0.338 . . . . 0.0 110.4 177.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.43 -34.8 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.561 1.144 . . . . 0.0 110.406 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -54.44 -41.4 69.37 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.882 0.873 . . . . 0.0 111.627 174.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -80.69 -41.95 22.83 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.646 0.778 . . . . 0.0 110.451 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.572 ' HG ' HD23 ' A' ' 146' ' ' LEU . 10.4 tt -58.58 -46.65 86.48 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.565 1.146 . . . . 0.0 110.556 -176.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.5 t -100.22 19.28 16.8 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.764 0.826 . . . . 0.0 110.986 -175.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -84.74 128.11 34.44 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.033 0.533 . . . . 0.0 110.186 176.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -91.84 149.03 21.79 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.842 0.857 . . . . 0.0 108.949 174.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 24.2 p-90 -159.58 162.49 35.33 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.91 0.884 . . . . 0.0 110.463 -169.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -113.38 152.38 30.08 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.268 0.627 . . . . 0.0 109.974 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 66.2 mtp -104.79 123.2 47.25 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 175.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 42.7 tp -76.03 -40.28 53.8 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.502 0.721 . . . . 0.0 110.082 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 21.8 mmt -129.7 81.08 70.33 Favored Pre-proline 0 N--CA 1.482 1.173 0 C-N-CA 123.871 0.869 . . . . 0.0 108.926 171.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.81 113.39 3.19 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.7 2.266 . . . . 0.0 112.716 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.539 ' HB3' ' HB ' ' A' ' 119' ' ' ILE . 60.5 tttm -100.4 103.56 14.94 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 163.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.0 104.06 15.26 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -171.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.467 ' HG2' HG11 ' A' ' 180' ' ' VAL . 22.7 tptm -114.24 142.06 46.76 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.638 0.775 . . . . 0.0 109.451 177.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 97.6 t -125.82 126.4 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 170.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -115.06 83.96 2.0 Allowed 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 62.11 -114.95 7.3 Favored Glycine 0 CA--C 1.539 1.558 0 CA-C-N 114.875 -1.057 . . . . 0.0 113.468 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -84.93 5.93 5.99 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 123.702 2.935 . . . . 0.0 113.546 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 162' ' ' PRO . 35.2 mt -133.93 111.91 10.82 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -173.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 44.5 t -84.19 127.96 34.26 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.201 0.6 . . . . 0.0 110.063 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.5 mm -102.91 137.22 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.353 0.661 . . . . 0.0 110.126 -174.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.508 ' HG3' ' HB3' ' A' ' 159' ' ' GLU . 29.1 mmt180 -107.56 116.83 32.65 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 173.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.539 ' HB ' ' HB3' ' A' ' 108' ' ' LYS . 43.3 mm -113.87 120.01 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 172.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -103.01 116.29 32.24 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 174.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -75.75 -22.15 56.77 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.066 0.947 . . . . 0.0 111.848 -174.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.27 -46.99 37.88 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.062 0.545 . . . . 0.0 111.477 -175.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.499 HG21 HG11 ' A' ' 157' ' ' VAL . 1.9 mp -71.25 108.52 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-O 121.928 0.87 . . . . 0.0 110.08 -177.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.475 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 45.9 mtt -130.56 160.67 33.47 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.415 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.4 t70 63.73 38.6 9.16 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 124.338 1.055 . . . . 0.0 112.126 172.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -123.61 151.38 43.05 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.266 0.626 . . . . 0.0 110.774 177.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -85.03 103.05 13.71 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 169.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.527 HD13 HG21 ' A' ' 157' ' ' VAL . 48.0 mt -107.64 129.97 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.65 0.738 . . . . 0.0 110.515 -172.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.492 ' HG3' ' HG3' ' A' ' 131' ' ' LYS . 2.4 tpt -97.51 123.29 41.32 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 125.47 1.508 . . . . 0.0 109.644 -174.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.503 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 3.5 mm? -94.73 103.75 15.66 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.492 ' HG3' ' HG3' ' A' ' 129' ' ' MET . 62.5 mttm -124.44 153.32 42.12 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.054 0.542 . . . . 0.0 111.242 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.541 ' HB2' ' HG ' ' A' ' 147' ' ' LEU . . . -147.07 160.67 42.12 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.549 -176.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -112.13 131.63 55.34 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 163.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.4 ' HA ' HD13 ' A' ' 145' ' ' ILE . 28.0 p90 -160.25 154.7 23.7 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.752 0.658 . . . . 0.0 110.931 -172.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.7 t -86.11 153.67 21.92 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.375 1.07 . . . . 0.0 108.325 175.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 88' ' ' ARG . 79.6 t -134.88 139.73 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.516 0.726 . . . . 0.0 110.432 -175.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.9 tp -143.89 139.28 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 172.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 61.48 27.61 17.12 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 124.394 1.078 . . . . 0.0 112.354 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 61.14 29.96 19.11 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.669 1.187 . . . . 0.0 111.866 -177.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 7.5 ppt_? -135.3 158.22 44.91 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 173.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.6 tt -61.55 113.97 2.99 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.244 0.618 . . . . 0.0 110.288 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -75.28 -61.74 1.8 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.447 0.699 . . . . 0.0 110.462 176.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 40.5 m -147.09 129.03 15.41 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.516 0.726 . . . . 0.0 109.304 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.443 HD21 ' HB2' ' A' ' 147' ' ' LEU . 57.3 tp -78.11 120.6 23.15 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.894 0.878 . . . . 0.0 109.51 176.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 134' ' ' PHE . 1.8 mp -77.91 -47.54 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 175.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.572 HD23 ' HG ' ' A' ' 98' ' ' LEU . 55.2 tp -167.22 147.41 5.43 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.007 0.923 . . . . 0.0 109.079 175.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.738 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 6.6 tt -127.09 154.02 45.25 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 175.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.524 HH11 HG21 ' A' ' 156' ' ' ILE . 39.2 ttm-85 -150.58 143.82 24.89 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.094 0.558 . . . . 0.0 111.316 -171.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.403 ' HB2' HD21 ' A' ' 181' ' ' LEU . . . -117.27 111.84 19.94 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.765 1.226 . . . . 0.0 107.878 173.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.465 ' HZ ' ' HD2' ' A' ' 131' ' ' LYS . 46.5 p90 -131.55 142.58 49.95 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 72.3 p -62.95 169.4 3.31 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.524 0.729 . . . . 0.0 112.133 -177.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -51.9 -28.63 16.91 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.965 1.306 . . . . 0.0 112.317 174.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -84.18 -29.49 26.59 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.009 0.924 . . . . 0.0 111.313 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 114.03 8.37 17.77 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 116.482 -0.327 . . . . 0.0 113.593 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -79.92 114.29 18.73 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.524 HG21 HH11 ' A' ' 148' ' ' ARG . 23.9 mt -71.29 124.14 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 122.626 0.37 . . . . 0.0 110.188 -177.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.527 HG21 HD13 ' A' ' 128' ' ' ILE . 26.6 m -124.8 -5.67 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.243 1.017 . . . . 0.0 111.236 -176.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -158.97 164.96 34.0 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -178.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.508 ' HB3' ' HG3' ' A' ' 118' ' ' ARG . 26.2 tt0 -168.28 150.52 5.29 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.257 0.623 . . . . 0.0 109.346 -176.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.738 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 83.7 mt -121.75 104.13 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 168.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 35.3 t -96.08 107.96 38.1 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 123.933 0.893 . . . . 0.0 110.233 -177.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.426 ' HA ' HD23 ' A' ' 115' ' ' LEU . 51.5 Cg_exo -58.47 113.65 1.64 Allowed 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.526 2.151 . . . . 0.0 111.681 172.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.25 122.9 87.76 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 124.11 0.964 . . . . 0.0 111.377 -174.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -67.49 -12.69 36.6 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.975 2.45 . . . . 0.0 112.688 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 28.0 m -65.09 -24.74 67.53 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.063 0.945 . . . . 0.0 111.172 173.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -110.55 116.29 52.77 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 124.66 1.184 . . . . 0.0 108.618 -176.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -83.18 36.0 0.59 Allowed 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 123.067 2.511 . . . . 0.0 113.507 -176.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 160.52 157.86 8.93 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 116.696 -0.229 . . . . 0.0 113.058 174.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 -152.13 140.44 20.47 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.927 1.291 . . . . 0.0 108.556 173.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 14.7 m -88.31 152.4 21.96 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 6.7 tt -59.12 -35.91 59.9 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 124.933 1.293 . . . . 0.0 112.029 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.22 -31.91 73.3 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.753 0.821 . . . . 0.0 110.413 177.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.435 ' HA ' ' ND2' ' A' ' 176' ' ' ASN . 18.4 t70 -83.6 -30.01 27.3 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.712 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.507 ' O ' HG13 ' A' ' 178' ' ' ILE . 79.5 t -62.14 -38.82 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 171.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -52.0 -43.23 63.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 124.079 0.862 . . . . 0.0 110.85 173.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.444 ' O ' HG23 ' A' ' 180' ' ' VAL . 53.5 m-20 -66.18 -45.29 81.37 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.989 0.805 . . . . 0.0 109.996 -177.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.5 -46.38 88.71 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.751 0.82 . . . . 0.0 111.908 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 174' ' ' VAL . 40.8 mt -63.37 -36.33 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 177.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.49 -35.52 91.86 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 115.433 -0.803 . . . . 0.0 113.403 176.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.467 HG11 ' HG2' ' A' ' 110' ' ' LYS . 60.2 t -68.39 -48.88 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.59 HD22 HG13 ' A' ' 160' ' ' ILE . 24.4 tp -59.77 -50.37 74.08 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.256 -178.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 70.4 mt -62.11 -47.47 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.48 0.712 . . . . 0.0 110.757 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -58.51 -35.15 78.72 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 123.938 0.774 . . . . 0.0 114.128 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.477 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -69.37 -38.21 80.48 Favored Glycine 0 C--N 1.347 1.156 0 C-N-CA 122.947 0.308 . . . . 0.0 112.488 176.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.442 HD13 ' O ' ' A' ' 181' ' ' LEU . 8.9 mp -71.37 -32.58 68.66 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.679 0.792 . . . . 0.0 111.702 178.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -69.83 -38.24 76.46 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.1 0.56 . . . . 0.0 111.896 -177.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -79.02 -16.6 56.64 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.71 0.404 . . . . 0.0 111.406 177.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.475 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 7.0 m-20 -76.32 -11.49 59.91 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.062 0.545 . . . . 0.0 110.876 165.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 25.5 t70 65.43 59.87 0.77 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.483 1.113 . . . . 0.0 109.424 -176.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -110.57 151.29 27.79 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.349 169.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 49.9 m -83.43 102.67 12.22 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 171.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 35.4 m -88.3 140.79 15.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 123.701 0.8 . . . . 0.0 109.351 -175.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 24.7 ttm-85 -145.09 127.32 15.75 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.51 175.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.503 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 2.6 t -87.85 143.02 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 26.5 t -63.76 147.8 50.82 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 118.519 0.599 . . . . 0.0 111.035 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -54.19 -35.59 62.51 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.031 0.932 . . . . 0.0 111.591 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 60.9 p -65.38 -53.15 47.58 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.945 0.898 . . . . 0.0 110.029 176.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.445 HD21 ' HB3' ' A' ' 132' ' ' ALA . 73.9 mt -62.93 -26.41 68.8 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.261 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.556 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 49.2 mt-30 -75.48 -46.68 30.93 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.29 0.636 . . . . 0.0 110.702 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.21 -12.29 47.25 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -175.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -106.5 -45.3 4.29 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 122.932 0.493 . . . . 0.0 112.283 178.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -114.87 -36.24 4.54 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -164.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.556 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 72.5 t-105 -98.37 -37.86 9.46 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.826 0.851 . . . . 0.0 110.551 -167.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.19 171.35 55.17 Favored Glycine 0 C--N 1.341 0.835 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.253 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 23.3 m 57.7 29.07 16.74 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.058 0.943 . . . . 0.0 110.35 -171.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 47.0 t -66.03 -41.21 91.21 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.244 1.017 . . . . 0.0 110.37 -175.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -73.72 158.05 35.37 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.064 173.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.57 135.31 54.92 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -153.15 165.46 35.58 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.145 0.578 . . . . 0.0 110.303 -172.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -75.18 159.97 52.12 Favored Glycine 0 C--N 1.341 0.85 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.076 175.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -151.48 157.71 34.68 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 123.889 0.876 . . . . 0.0 109.472 -177.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -59.72 158.61 27.69 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 123.024 2.482 . . . . 0.0 112.798 176.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.11 114.42 1.8 Allowed 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 122.902 2.401 . . . . 0.0 111.3 173.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 82.5 mt -73.29 120.76 19.35 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.114 0.565 . . . . 0.0 111.272 -170.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 10.3 m -76.43 108.35 9.34 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.924 0.889 . . . . 0.0 108.851 174.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 63.5 mt -130.41 144.88 51.67 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.899 0.48 . . . . 0.0 111.096 -170.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 C--O 1.252 1.188 0 C-N-CA 124.255 1.022 . . . . 0.0 110.232 178.948 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 19.7 ptp . . . . . 0 CA--C 1.55 0.976 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.32 175.44 11.09 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.948 2.432 . . . . 0.0 112.341 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.94 109.53 3.48 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.696 0.798 . . . . 0.0 110.696 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.1 m -125.02 132.32 53.25 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 124.374 1.07 . . . . 0.0 109.031 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -156.49 158.0 36.44 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.107 0.563 . . . . 0.0 109.967 -174.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -123.91 105.83 9.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.597 0.759 . . . . 0.0 109.656 174.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 50.6 mm -79.91 139.86 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 174.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.8 p -137.64 93.05 2.75 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.555 0.742 . . . . 0.0 109.546 176.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -80.93 -21.06 40.77 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.157 0.583 . . . . 0.0 111.106 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -100.67 126.82 47.22 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 175.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.61 177.28 8.78 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.88 0.872 . . . . 0.0 109.295 173.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -63.43 -43.16 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 123.88 0.872 . . . . 0.0 112.116 -167.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -62.46 -49.17 76.46 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.997 0.519 . . . . 0.0 111.931 -178.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.656 ' HA ' ' HB2' ' A' ' 100' ' ' ARG . 14.7 pt-20 -74.85 -19.82 60.01 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 123.475 0.485 . . . . 0.0 111.469 -178.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.8 tp -68.2 -32.3 72.43 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.29 1.036 . . . . 0.0 110.212 172.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.2 t -117.07 18.25 14.66 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.417 1.087 . . . . 0.0 110.849 -178.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.656 ' HB2' ' HA ' ' A' ' 97' ' ' GLU . 26.5 tpt180 -66.79 142.88 57.21 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.749 0.419 . . . . 0.0 112.107 -174.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -77.62 121.16 23.57 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.741 174.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 6.3 p-90 -140.12 149.25 42.82 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.402 1.081 . . . . 0.0 109.933 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -134.16 135.51 43.15 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.922 0.889 . . . . 0.0 109.179 178.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 92.1 mtp -101.69 112.45 25.03 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.63 0.772 . . . . 0.0 109.324 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 45.4 tp -65.93 -39.12 90.22 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.675 0.79 . . . . 0.0 110.206 -178.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 11.3 mmt -124.25 86.41 54.53 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 124.322 1.049 . . . . 0.0 108.407 173.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.37 131.36 24.64 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.253 1.969 . . . . 0.0 111.663 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.502 ' HB3' ' HB ' ' A' ' 119' ' ' ILE . 60.4 tptt -131.75 119.96 22.04 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 173.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.423 ' NE2' ' HB2' ' A' ' 116' ' ' CYS . 58.9 tp60 -108.63 106.06 15.95 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -176.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.51 97.96 5.9 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 123.677 0.791 . . . . 0.0 109.006 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.495 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . 55.9 t -78.75 124.79 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -122.45 94.33 4.26 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.8 -127.11 30.48 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.259 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -86.07 21.32 1.09 Allowed 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 123.054 2.503 . . . . 0.0 112.615 175.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.591 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 4.3 mp -129.63 167.57 17.77 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.973 0.909 . . . . 0.0 109.002 174.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 20.3 p -140.23 130.74 25.49 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 176.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 17.6 mm -105.83 132.63 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.285 1.034 . . . . 0.0 109.87 -170.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 15.9 mmt85 -99.99 122.93 43.65 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.76 1.224 . . . . 0.0 108.917 172.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.502 ' HB ' ' HB3' ' A' ' 108' ' ' LYS . 42.5 mm -122.69 121.59 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 172.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -95.5 111.83 23.66 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 168.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -78.86 -3.43 44.59 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.254 -174.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.3 -27.81 20.29 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.138 0.575 . . . . 0.0 110.505 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.408 HG21 HG11 ' A' ' 157' ' ' VAL . 39.5 mm -79.49 101.69 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-O 121.667 0.746 . . . . 0.0 111.145 -172.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.471 ' HG2' ' HB3' ' A' ' 188' ' ' ASN . 36.4 mtt -129.48 147.11 51.26 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.898 -174.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.0 t70 62.23 42.11 9.79 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.128 0.971 . . . . 0.0 111.765 175.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -119.76 147.91 44.06 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.195 0.998 . . . . 0.0 110.371 176.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.439 ' HA ' ' HB ' ' A' ' 191' ' ' THR . 44.2 m-80 -83.56 110.0 17.87 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 171.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 61.6 mt -117.54 134.13 62.12 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 123.382 0.673 . . . . 0.0 111.23 -171.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 37.7 tpp -111.59 125.61 54.12 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.513 1.925 . . . . 0.0 108.763 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.472 ' HB3' HD21 ' A' ' 147' ' ' LEU . 18.5 mt -97.23 102.59 14.39 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -98.5 149.18 22.99 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.667 0.787 . . . . 0.0 109.365 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -142.56 144.44 32.9 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 122.239 1.018 . . . . 0.0 113.723 175.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -99.52 122.51 42.69 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 163.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.537 ' HB3' HD12 ' A' ' 144' ' ' LEU . 49.7 p90 -153.15 159.78 42.77 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.268 0.556 . . . . 0.0 111.763 -175.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.7 t -90.94 156.36 18.04 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.982 177.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 72.0 t -130.72 136.03 59.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.906 1.282 . . . . 0.0 108.575 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.3 tp -145.19 144.09 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 170.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 62.39 24.18 14.38 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.661 0.785 . . . . 0.0 111.348 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.5 t70 71.03 5.46 5.49 Favored 'General case' 0 CA--C 1.564 1.511 0 C-N-CA 124.931 1.292 . . . . 0.0 111.954 -176.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -114.58 172.2 7.17 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.343 -0.848 . . . . 0.0 109.78 176.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.599 ' HB2' ' HB3' ' A' ' 201' ' ' PHE . 6.8 tt -69.39 125.49 26.84 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -83.7 -66.61 0.87 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.299 0.64 . . . . 0.0 110.247 177.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 65.9 m -149.88 131.12 14.56 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.808 1.243 . . . . 0.0 108.49 -173.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.537 HD12 ' HB3' ' A' ' 134' ' ' PHE . 44.7 tp -71.96 131.91 43.58 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 175.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.38 -50.06 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 172.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 54.4 tp -164.95 151.25 10.29 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.016 0.926 . . . . 0.0 109.358 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.709 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 7.2 tt -136.62 145.82 45.32 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 172.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.504 ' HE ' HD13 ' A' ' 156' ' ' ILE . 17.5 mtp180 -141.32 144.23 34.48 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.697 0.799 . . . . 0.0 109.599 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.11 111.86 24.77 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.399 1.08 . . . . 0.0 108.927 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.413 ' CE1' ' HB2' ' A' ' 148' ' ' ARG . 65.0 m-85 -106.6 137.2 45.04 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.191 0.996 . . . . 0.0 109.207 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 47.2 p -76.01 -179.9 5.2 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-O 121.286 0.565 . . . . 0.0 110.142 172.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -61.71 -20.44 63.49 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.515 0.726 . . . . 0.0 111.048 169.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -88.51 -1.75 58.22 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.962 1.305 . . . . 0.0 111.604 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 74.33 15.08 80.34 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-N 116.448 -0.342 . . . . 0.0 112.971 -178.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -86.01 125.0 33.08 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.426 0.69 . . . . 0.0 109.852 -176.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.504 HD13 ' HE ' ' A' ' 148' ' ' ARG . 22.6 mt -78.84 100.99 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -177.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.408 HG11 HG21 ' A' ' 123' ' ' ILE . 33.2 m -105.36 -0.16 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.138 0.975 . . . . 0.0 111.433 -173.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -162.96 167.07 37.19 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.329 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -163.47 153.36 15.28 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.709 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 63.1 mt -128.88 102.92 8.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 170.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.405 ' HA ' ' HD2' ' A' ' 162' ' ' PRO . 3.1 p -112.83 110.05 52.28 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 123.901 0.881 . . . . 0.0 109.605 -177.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.591 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 20.7 Cg_endo -60.04 127.85 24.62 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.641 2.227 . . . . 0.0 111.515 171.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.1 mt -64.12 120.43 64.23 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.812 0.845 . . . . 0.0 110.366 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -65.98 162.03 37.09 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.874 2.383 . . . . 0.0 111.733 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 13.6 t 71.24 20.11 5.17 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 125.206 1.402 . . . . 0.0 111.359 -175.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -126.95 90.27 49.95 Favored Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 123.979 0.912 . . . . 0.0 109.212 177.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.13 -23.23 39.87 Favored 'Trans proline' 0 C--N 1.381 2.288 0 C-N-CA 122.976 2.45 . . . . 0.0 112.419 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -71.39 90.21 0.44 Allowed Glycine 0 C--N 1.351 1.408 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 176.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -152.08 125.55 8.84 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 35.8 p -126.91 171.08 11.59 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.022 0.929 . . . . 0.0 110.36 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.46 ' O ' ' HG3' ' A' ' 175' ' ' LYS . 15.1 tt -50.69 -37.14 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.406 170.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -52.32 -51.29 59.53 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.338 1.455 . . . . 0.0 111.019 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -59.33 -41.1 88.34 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.949 0.9 . . . . 0.0 111.851 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.468 ' O ' HG13 ' A' ' 178' ' ' ILE . 25.9 t -64.07 -40.72 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 O-C-N 124.117 0.885 . . . . 0.0 110.52 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 171' ' ' ILE . 56.5 mtpt -61.66 -42.52 99.02 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.746 0.818 . . . . 0.0 111.165 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.47 ' O ' HG23 ' A' ' 180' ' ' VAL . 24.4 m120 -66.68 -43.24 84.97 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 123.591 0.557 . . . . 0.0 109.645 176.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -60.9 -45.08 96.03 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 124.584 1.177 . . . . 0.0 112.279 -175.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 174' ' ' VAL . 25.8 mt -69.27 -32.83 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.96 -30.64 78.31 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.433 174.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 176' ' ' ASN . 61.3 t -74.84 -51.08 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 122.813 0.445 . . . . 0.0 109.819 175.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.499 ' HA ' HD11 ' A' ' 119' ' ' ILE . 47.9 tp -54.18 -51.13 65.33 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 123.933 0.77 . . . . 0.0 111.26 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.491 ' O ' ' HG3' ' A' ' 186' ' ' GLU . 10.4 tt -62.27 -37.2 78.0 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.934 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.613 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -62.19 -42.53 99.72 Favored Glycine 0 C--N 1.351 1.366 0 O-C-N 123.287 0.367 . . . . 0.0 113.903 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -65.98 -35.85 91.23 Favored Glycine 0 C--N 1.348 1.208 0 O-C-N 123.843 0.378 . . . . 0.0 112.294 175.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 86.4 mt -68.33 -42.25 79.58 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.17 0.988 . . . . 0.0 111.49 177.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 182' ' ' ILE . 49.3 mt-10 -67.72 -38.41 83.53 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.494 0.718 . . . . 0.0 110.269 -176.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.11 -24.32 59.44 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.351 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.471 ' HB3' ' HG2' ' A' ' 124' ' ' MET . 97.6 m-20 -68.93 -18.87 64.16 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 122.667 0.387 . . . . 0.0 111.059 170.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 35.9 t70 65.9 65.69 0.52 Allowed 'General case' 0 C--N 1.354 0.784 0 C-N-CA 124.116 0.967 . . . . 0.0 109.662 -174.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -131.14 169.09 16.38 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.694 173.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.439 ' HB ' ' HA ' ' A' ' 127' ' ' ASN . 89.5 m -84.17 114.72 22.0 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 30.0 m -97.52 136.37 28.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -145.04 128.09 16.56 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 176.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 4.8 t -103.07 150.58 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -175.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 45.8 t -60.91 141.07 57.51 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.86 -28.02 63.76 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.825 0.85 . . . . 0.0 112.249 -177.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 37.6 p -70.95 -45.25 64.48 Favored 'General case' 0 C--N 1.348 0.516 0 C-N-CA 123.544 0.738 . . . . 0.0 109.903 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 78.7 mt -65.1 -39.97 93.89 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.174 0.59 . . . . 0.0 110.52 176.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.647 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 49.5 mt-30 -60.06 -31.33 69.89 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.807 0.843 . . . . 0.0 111.101 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -83.87 -61.04 1.92 Allowed 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 123.887 0.875 . . . . 0.0 110.717 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.599 ' HB3' ' HB2' ' A' ' 141' ' ' LEU . 61.5 m-85 -71.44 -47.1 57.93 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.178 0.991 . . . . 0.0 112.84 -167.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.533 ' HB2' HD13 ' A' ' 141' ' ' LEU . . . -109.25 -58.15 2.07 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 122.944 0.497 . . . . 0.0 110.771 -170.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.647 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 40.4 t-105 -62.76 -25.81 68.39 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.751 1.221 . . . . 0.0 111.532 -175.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -72.96 -116.47 0.06 OUTLIER Glycine 0 CA--C 1.531 1.05 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 165.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 33.1 t 52.13 37.36 21.46 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.181 0.993 . . . . 0.0 112.758 172.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 14.1 m -74.87 83.16 2.17 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -143.47 149.17 37.17 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.066 -177.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -115.43 163.26 15.98 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.77 0.828 . . . . 0.0 109.179 170.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -83.53 114.87 21.81 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.509 0.724 . . . . 0.0 109.826 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -70.06 114.89 5.79 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 165.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 72.73 156.59 0.16 Allowed Pre-proline 0 N--CA 1.493 1.725 0 C-N-CA 124.696 1.198 . . . . 0.0 111.2 -171.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -58.76 149.62 76.17 Favored 'Trans proline' 0 C--N 1.388 2.627 0 C-N-CA 122.988 2.459 . . . . 0.0 113.136 -178.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -59.32 104.73 0.22 Allowed 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 122.898 2.398 . . . . 0.0 111.212 175.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 86.9 mt -71.58 90.62 1.03 Allowed 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 35.2 p -91.78 170.58 9.78 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.869 0.868 . . . . 0.0 110.664 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.484 ' H ' HD12 ' A' ' 216' ' ' LEU . 4.1 mp -69.33 111.03 4.96 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.598 0.759 . . . . 0.0 110.406 -168.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 . . . . . 0 C--O 1.249 1.039 0 C-N-CA 123.435 0.694 . . . . 0.0 110.236 -178.306 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.421 ' HB3' ' HB3' ' A' ' 87' ' ' SER . 61.0 mtt . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.79 116.45 4.01 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 123.071 2.514 . . . . 0.0 111.814 -176.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 64.01 9.97 5.02 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.323 1.049 . . . . 0.0 112.528 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 17.0 t -93.62 106.98 18.9 Favored 'General case' 0 C--N 1.345 0.392 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -127.57 148.56 50.35 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.848 0.859 . . . . 0.0 110.159 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -90.2 108.99 20.09 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 174.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.0 mm -77.25 117.72 22.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 176.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.2 p -98.0 75.31 2.34 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -73.51 -32.02 64.03 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 113.726 -1.579 . . . . 0.0 109.966 -178.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.43 ' HB3' ' HB3' ' A' ' 131' ' ' LYS . 21.2 ptt? -109.74 138.67 45.77 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 165.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 66.7 p -65.3 157.32 29.39 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.726 0.41 . . . . 0.0 110.128 177.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.9 mp -58.07 -35.85 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -56.56 -60.3 3.73 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.092 1.357 . . . . 0.0 112.481 176.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.415 ' HG3' ' HB2' ' A' ' 93' ' ' MET . 11.9 pt-20 -70.71 -24.99 62.75 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 122.631 0.372 . . . . 0.0 111.18 -176.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.525 ' HA ' ' HE ' ' A' ' 148' ' ' ARG . 7.8 tt -65.36 -48.26 73.58 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.818 0.847 . . . . 0.0 109.622 172.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 90.5 p -84.3 -3.08 58.01 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.192 0.597 . . . . 0.0 112.389 -173.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.1 tpt85 -61.51 126.89 28.96 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.584 0.754 . . . . 0.0 110.915 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -82.42 155.07 24.86 Favored 'General case' 0 C--O 1.239 0.535 0 O-C-N 123.976 0.797 . . . . 0.0 109.801 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -161.3 169.05 22.85 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.65 0.78 . . . . 0.0 110.84 -173.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -125.89 151.82 46.38 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.201 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 72.9 mtp -109.86 105.05 14.1 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 171.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.9 tt -62.64 -44.1 97.12 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 80.4 mmm -119.58 88.37 38.8 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 123.904 0.882 . . . . 0.0 109.416 171.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.71 124.54 9.34 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.69 2.26 . . . . 0.0 112.355 -178.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.467 ' HD2' HE21 ' A' ' 121' ' ' GLN . 59.5 tttp -123.15 124.76 43.78 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.39 101.31 7.1 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -102.82 129.11 49.38 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.103 0.961 . . . . 0.0 108.815 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 72.7 t -86.76 133.8 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 173.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -128.36 85.3 2.32 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 62.31 -121.43 25.37 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.666 176.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.496 ' HB2' ' HB3' ' A' ' 169' ' ' HIS . 3.7 Cg_exo -78.92 8.48 3.75 Favored 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 123.728 2.952 . . . . 0.0 114.199 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 4.5 mp -133.62 163.5 29.28 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.375 0.67 . . . . 0.0 109.506 -178.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.486 ' SG ' ' HB2' ' A' ' 161' ' ' SER . 31.5 p -126.86 136.02 51.78 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 10.2 mm -110.43 124.91 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.304 1.042 . . . . 0.0 109.542 -169.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -108.65 121.99 46.18 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.428 1.091 . . . . 0.0 108.347 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.579 HD13 ' HA3' ' A' ' 184' ' ' GLY . 53.0 mt -131.29 121.92 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.437 ' HB3' ' HB ' ' A' ' 157' ' ' VAL . 23.8 t70 -94.49 115.28 27.42 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 175.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.467 HE21 ' HD2' ' A' ' 108' ' ' LYS . 83.6 mt-30 -81.22 -10.64 59.57 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.715 0.806 . . . . 0.0 112.016 -174.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.2 -41.68 63.53 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.266 0.626 . . . . 0.0 110.963 -176.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.6 mp -76.91 115.83 19.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.882 177.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 48.6 mtt -132.89 154.97 49.88 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.567 1.147 . . . . 0.0 110.102 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.7 t70 62.34 23.95 14.23 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.354 1.062 . . . . 0.0 112.105 176.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 190' ' ' ASN . 73.9 mmtt -105.76 149.95 25.98 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.202 0.601 . . . . 0.0 110.079 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.559 ' HB2' ' HG2' ' A' ' 152' ' ' GLU . 75.8 m-20 -83.06 106.56 14.97 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 173.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 80.5 mt -106.29 121.86 59.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 123.39 0.676 . . . . 0.0 110.147 -174.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 36.7 tpp -96.33 130.44 43.44 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.879 1.272 . . . . 0.0 109.322 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 19.2 mt -100.07 104.27 15.83 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 93' ' ' MET . 32.7 mmtp -98.8 155.4 17.38 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.998 0.919 . . . . 0.0 109.507 173.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.566 ' HB3' HD21 ' A' ' 198' ' ' LEU . . . -155.49 145.69 21.73 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 168.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -108.18 134.35 51.15 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 172.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.461 ' HA ' HD13 ' A' ' 145' ' ' ILE . 37.9 p90 -160.01 160.62 33.5 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.735 0.814 . . . . 0.0 110.589 -169.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 43.7 p -85.47 155.24 21.32 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.866 0.866 . . . . 0.0 108.81 171.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 87' ' ' SER . 91.0 t -116.5 154.05 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.959 0.904 . . . . 0.0 110.308 -177.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.474 ' O ' ' HG3' ' A' ' 140' ' ' ARG . 11.0 tp -156.09 134.44 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 164.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 58.14 24.76 11.66 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.961 0.904 . . . . 0.0 113.024 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.549 ' HB3' HH22 ' A' ' 200' ' ' ARG . 1.6 m-20 65.5 35.03 7.52 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.869 1.268 . . . . 0.0 111.832 -176.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 137' ' ' ILE . 7.6 ppt_? -136.24 162.93 31.61 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.679 0.792 . . . . 0.0 109.048 169.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.458 ' HB3' HG13 ' A' ' 171' ' ' ILE . 9.7 tt -68.14 110.05 3.81 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.658 0.783 . . . . 0.0 109.765 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -70.78 -64.87 0.82 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.893 0.877 . . . . 0.0 109.558 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 53.1 m -142.54 131.31 22.78 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.549 HD21 ' HB2' ' A' ' 147' ' ' LEU . 53.6 tp -73.07 129.22 37.6 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.391 0.676 . . . . 0.0 109.455 173.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.461 HD13 ' HA ' ' A' ' 134' ' ' PHE . 1.6 mp -84.9 -52.86 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 174.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 39.9 tp -162.04 148.6 13.63 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.028 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.688 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 8.9 tt -125.76 149.13 48.81 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 174.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.617 HH11 HG21 ' A' ' 156' ' ' ILE . 21.7 ttm-85 -141.93 139.75 32.61 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.025 0.93 . . . . 0.0 110.583 -176.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.492 ' HB3' ' HA3' ' A' ' 158' ' ' GLY . . . -123.87 122.46 38.05 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.487 1.115 . . . . 0.0 108.023 176.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -142.05 166.36 24.92 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.241 0.616 . . . . 0.0 110.861 -177.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 82.4 p -85.67 179.0 7.17 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.735 0.814 . . . . 0.0 110.301 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.559 ' HG2' ' HB2' ' A' ' 127' ' ' ASN . 24.3 mm-40 -63.44 -21.84 66.54 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 122.16 -0.338 . . . . 0.0 111.889 172.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -78.78 -13.7 59.67 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.014 0.525 . . . . 0.0 111.059 176.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 88.84 -2.72 84.51 Favored Glycine 0 C--N 1.349 1.254 0 N-CA-C 112.044 -0.422 . . . . 0.0 112.044 -173.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.92 108.18 2.93 Favored 'General case' 0 C--N 1.353 0.721 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -178.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.617 HG21 HH11 ' A' ' 148' ' ' ARG . 23.6 mt -77.91 128.43 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 O-C-N 123.56 0.538 . . . . 0.0 110.415 -170.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 120' ' ' ASP . 34.6 m -130.62 8.06 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 123.883 0.873 . . . . 0.0 111.228 -174.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.492 ' HA3' ' HB3' ' A' ' 149' ' ' ALA . . . -161.23 157.53 29.13 Favored Glycine 0 C--N 1.339 0.703 0 N-CA-C 111.856 -0.498 . . . . 0.0 111.856 -177.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -168.35 140.96 2.96 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.562 0.745 . . . . 0.0 109.765 -178.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.688 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 70.9 mt -123.7 112.66 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 175.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.486 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 20.3 m -112.53 118.32 45.51 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.094 0.958 . . . . 0.0 109.919 -177.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 38.8 Cg_exo -63.94 124.55 13.74 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 122.855 2.37 . . . . 0.0 112.59 176.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 96.5 mt -64.43 129.75 94.33 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 124.343 1.057 . . . . 0.0 112.207 -177.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -67.33 -9.26 24.63 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.955 2.437 . . . . 0.0 112.803 169.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.9 m -65.26 -24.29 67.28 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.85 0.86 . . . . 0.0 111.29 169.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -132.53 90.67 32.68 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 124.134 0.974 . . . . 0.0 108.841 -178.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.78 90.68 1.25 Allowed 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.768 2.312 . . . . 0.0 112.567 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 114.22 96.83 2.18 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.845 174.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 114' ' ' PRO . 20.2 p-80 -102.44 162.71 12.7 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.873 0.869 . . . . 0.0 109.785 178.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 76.5 p -84.27 160.44 20.75 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 173.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.505 HD11 ' HA ' ' A' ' 202' ' ' ALA . 9.4 tt -54.64 -32.96 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 123.215 0.606 . . . . 0.0 110.712 168.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.676 ' HA ' ' HE2' ' A' ' 175' ' ' LYS . 35.6 mt-10 -64.71 -33.47 76.03 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.108 -178.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -70.62 -33.16 70.71 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.408 0.683 . . . . 0.0 111.55 175.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 56.4 t -69.76 -36.04 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 122.493 0.317 . . . . 0.0 110.33 174.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.676 ' HE2' ' HA ' ' A' ' 172' ' ' GLU . 48.6 mtmt -62.3 -38.04 87.89 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 120.77 0.319 . . . . 0.0 110.389 175.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -64.02 -44.23 93.2 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.221 174.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.87 -51.09 68.34 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.742 -175.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 49.5 mt -64.46 -33.37 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.15 0.58 . . . . 0.0 109.821 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -59.4 -39.72 95.16 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-N 115.653 -0.703 . . . . 0.0 113.649 175.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 97.2 t -72.42 -44.02 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 122.767 0.427 . . . . 0.0 110.395 176.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.464 HD12 HG12 ' A' ' 119' ' ' ILE . 59.5 tp -52.59 -57.3 10.43 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.802 0.841 . . . . 0.0 111.309 177.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.592 HG23 HG21 ' A' ' 192' ' ' VAL . 50.6 mt -58.88 -45.27 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 O-C-N 124.013 0.821 . . . . 0.0 110.598 174.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -53.54 -38.13 57.6 Favored Glycine 0 C--N 1.346 1.122 0 O-C-N 123.949 0.78 . . . . 0.0 114.066 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.579 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -81.0 -28.81 44.12 Favored Glycine 0 C--N 1.348 1.195 0 N-CA-C 112.577 -0.209 . . . . 0.0 112.577 176.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.5 ' HB3' HD21 ' A' ' 190' ' ' ASN . 68.6 mt -71.83 -21.45 61.68 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.237 0.615 . . . . 0.0 110.715 174.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 19.5 mm-40 -68.76 -36.56 78.5 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.354 0.662 . . . . 0.0 110.853 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -76.97 -24.77 52.27 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 122.939 0.149 . . . . 0.0 110.824 176.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -63.95 -22.55 66.97 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.57 0.348 . . . . 0.0 110.437 167.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 13.4 t70 53.19 67.33 1.01 Allowed 'General case' 0 C--N 1.356 0.85 0 C-N-CA 124.893 1.277 . . . . 0.0 111.252 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.5 HD21 ' HB3' ' A' ' 185' ' ' LEU . 8.5 p30 -124.5 -161.31 1.0 Allowed 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.825 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 31.9 m -120.07 101.49 7.88 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.592 HG21 HG23 ' A' ' 182' ' ' ILE . 26.7 m -93.28 147.28 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 121.145 0.497 . . . . 0.0 110.386 -177.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 40.1 ttt180 -142.22 132.96 25.54 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.13 172.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.463 HG22 HD11 ' A' ' 182' ' ' ILE . 3.2 t -90.41 134.26 29.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 N-CA-C 104.802 -2.295 . . . . 0.0 104.802 175.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 27.9 t -60.35 151.74 27.04 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.142 0.428 . . . . 0.0 111.654 -173.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -51.44 -40.15 58.8 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.755 1.222 . . . . 0.0 112.241 -175.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 75.8 p -68.82 -49.29 59.7 Favored 'General case' 0 C--N 1.345 0.393 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.566 HD21 ' HB3' ' A' ' 132' ' ' ALA . 41.1 mt -61.22 -29.96 70.14 Favored 'General case' 0 C--O 1.21 -0.976 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.151 -177.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.617 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 48.9 mt-30 -68.17 -57.03 6.69 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.487 0.715 . . . . 0.0 110.956 178.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.549 HH22 ' HB3' ' A' ' 139' ' ' ASP . 0.0 OUTLIER -72.75 -21.55 61.0 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -176.196 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -83.99 -59.79 2.3 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.13 0.572 . . . . 0.0 111.034 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.505 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -114.39 -60.66 1.86 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.255 0.622 . . . . 0.0 111.546 -165.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.617 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 67.8 t-105 -66.89 -10.82 52.61 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.479 1.112 . . . . 0.0 112.685 -168.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -70.63 72.02 0.66 Allowed Glycine 0 C--N 1.346 1.091 0 N-CA-C 111.929 -0.468 . . . . 0.0 111.929 175.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 47.2 t -161.87 99.48 1.11 Allowed 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.547 1.139 . . . . 0.0 108.757 -173.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 51.1 p -69.47 -33.22 72.58 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.412 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 8.2 t30 61.22 22.73 13.03 Favored 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 124.377 1.071 . . . . 0.0 109.798 -176.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -63.77 -51.9 62.78 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 124.836 1.254 . . . . 0.0 110.766 -169.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -87.67 53.14 2.68 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-O 121.969 0.89 . . . . 0.0 109.393 173.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -155.77 48.89 0.48 Allowed Glycine 0 C--N 1.343 0.966 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.301 -177.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -96.16 148.93 35.27 Favored Pre-proline 0 N--CA 1.482 1.132 0 C-N-CA 123.553 0.741 . . . . 0.0 109.921 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.74 125.69 13.59 Favored 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.469 2.112 . . . . 0.0 110.943 173.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.92 143.62 85.94 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.452 2.101 . . . . 0.0 111.949 175.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 86.5 mt -68.53 93.85 0.53 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.131 0.573 . . . . 0.0 110.504 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 32.4 p -81.23 143.92 31.96 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.881 0.873 . . . . 0.0 111.046 -176.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.1 pp -105.1 156.81 17.73 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.905 0.882 . . . . 0.0 111.859 -175.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 . . . . . 0 C--O 1.254 1.338 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 171.678 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 21.2 ptp . . . . . 0 CA--C 1.56 1.346 0 N-CA-C 110.527 -0.175 . . . . 0.0 110.527 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -70.93 -164.8 0.16 Allowed 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 123.491 2.794 . . . . 0.0 112.917 175.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.88 79.97 0.46 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.633 0.773 . . . . 0.0 110.738 177.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.4 p -93.22 89.66 6.51 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.897 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -118.9 145.71 45.51 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.628 0.371 . . . . 0.0 110.738 -175.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 19.3 m-85 -96.3 108.95 21.52 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.641 0.776 . . . . 0.0 109.166 175.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 50.0 mm -78.31 116.43 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 174.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 36.8 p -98.35 72.96 2.12 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.53 ' HB3' ' O ' ' A' ' 132' ' ' ALA . 31.0 t70 -72.8 -30.76 64.33 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.056 -174.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.565 ' SD ' ' HB3' ' A' ' 148' ' ' ARG . 59.5 mtm -98.12 151.15 20.69 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 166.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 64.6 p -69.93 158.84 34.84 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 173.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 69.1 mt -59.23 -31.39 46.01 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 173.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -57.87 -55.98 27.87 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.434 171.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -61.41 -38.67 87.94 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.012 0.525 . . . . 0.0 111.311 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.9 tt -63.89 -38.91 92.85 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.128 0.971 . . . . 0.0 109.378 -177.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.8 t -108.9 20.38 18.52 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 123.875 0.87 . . . . 0.0 111.066 -176.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.544 ' HD3' HD11 ' A' ' 156' ' ' ILE . 76.8 ttt180 -78.3 142.57 37.68 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.762 0.825 . . . . 0.0 111.696 -174.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -82.73 138.02 34.21 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.939 0.895 . . . . 0.0 110.524 176.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.512 ' CZ3' ' SD ' ' A' ' 104' ' ' MET . 11.3 p-90 -157.33 160.28 38.36 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.842 1.257 . . . . 0.0 109.825 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -110.89 159.65 17.5 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.431 0.692 . . . . 0.0 111.693 -173.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.512 ' SD ' ' CZ3' ' A' ' 102' ' ' TRP . 99.2 mmm -120.65 93.06 3.91 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.237 1.015 . . . . 0.0 108.758 172.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.439 HD23 ' HB1' ' A' ' 122' ' ' ALA . 50.4 tp -71.8 -43.34 65.81 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.3 mmt -129.17 81.41 70.6 Favored Pre-proline 0 N--CA 1.479 1.002 0 C-N-CA 123.94 0.896 . . . . 0.0 109.353 175.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.75 145.56 46.46 Favored 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 122.104 1.869 . . . . 0.0 111.652 177.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.441 ' HD3' HE21 ' A' ' 121' ' ' GLN . 20.6 ttpp -124.93 120.89 32.91 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 172.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.36 104.64 11.04 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.459 0.704 . . . . 0.0 109.624 -174.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -132.73 135.83 46.0 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.992 0.917 . . . . 0.0 109.467 172.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.2 t -125.4 142.79 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 166.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -123.34 91.6 3.51 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 176.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.37 -112.76 5.26 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.999 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -91.75 8.36 3.07 Favored 'Trans proline' 0 C--N 1.368 1.593 0 C-N-CA 123.27 2.647 . . . . 0.0 113.273 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 162' ' ' PRO . 61.4 mt -130.44 116.45 18.25 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.516 0.727 . . . . 0.0 109.656 -170.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 41.9 t -83.34 127.23 33.49 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.231 0.612 . . . . 0.0 110.256 -177.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.8 mm -106.94 110.03 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.232 0 C-N-CA 124.034 0.933 . . . . 0.0 110.58 -173.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -92.81 125.89 37.63 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.487 0.715 . . . . 0.0 109.858 173.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.574 HD13 ' HA3' ' A' ' 184' ' ' GLY . 73.2 mt -131.89 123.73 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.237 1.015 . . . . 0.0 108.561 176.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -99.49 120.76 40.14 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.44 0.696 . . . . 0.0 109.498 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.441 HE21 ' HD3' ' A' ' 108' ' ' LYS . 80.5 mt-30 -84.99 -14.96 45.82 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.619 1.168 . . . . 0.0 111.734 -174.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.439 ' HB1' HD23 ' A' ' 105' ' ' LEU . . . -68.57 -38.4 80.68 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.01 0.524 . . . . 0.0 111.106 -176.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.485 HG23 ' HG3' ' A' ' 126' ' ' LYS . 1.8 mp -87.07 112.79 23.63 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 CA-C-O 121.969 0.89 . . . . 0.0 109.7 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 48.0 mtt -129.23 159.5 35.9 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.859 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.8 t70 76.21 12.14 2.78 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 124.667 1.187 . . . . 0.0 112.365 172.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.485 ' HG3' HG23 ' A' ' 123' ' ' ILE . 75.1 mmtt -99.79 151.99 20.63 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.48 0.712 . . . . 0.0 111.976 -173.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -90.38 112.19 23.7 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 168.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.464 HD12 HD22 ' A' ' 185' ' ' LEU . 65.3 mt -114.01 135.23 54.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.965 0.888 . . . . 0.0 111.325 -171.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.536 ' HG3' ' HG3' ' A' ' 131' ' ' LYS . 8.0 tpt -102.81 121.65 42.92 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.203 1.801 . . . . 0.0 109.643 -172.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.46 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 3.7 mm? -96.25 104.75 16.73 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.536 ' HG3' ' HG3' ' A' ' 129' ' ' MET . 90.8 mttt -125.58 149.4 48.4 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.455 0.702 . . . . 0.0 110.497 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.616 ' HB3' HD21 ' A' ' 198' ' ' LEU . . . -149.37 152.99 36.72 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -174.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -102.77 128.44 49.5 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 169.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -154.97 155.44 34.22 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.544 0.738 . . . . 0.0 109.871 -170.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 58.1 p -87.48 169.58 12.09 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.246 0.618 . . . . 0.0 109.775 172.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 79.5 t -132.15 136.3 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 123.564 0.746 . . . . 0.0 110.595 -173.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 7.5 tp -146.18 139.6 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 169.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 60.94 33.11 19.93 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 124.195 0.998 . . . . 0.0 111.936 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.3 t70 65.75 18.66 11.22 Favored 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 125.341 1.456 . . . . 0.0 111.644 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -132.54 172.9 11.9 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.815 -0.553 . . . . 0.0 109.643 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.468 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 10.3 tt -64.63 126.77 28.94 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -88.99 -77.8 0.37 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.991 0.516 . . . . 0.0 109.951 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.1 m -125.64 137.62 53.88 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.773 0.829 . . . . 0.0 109.321 -173.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 50.3 tp -82.96 126.64 32.74 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 174.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.43 -51.7 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 172.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 50.9 tp -164.19 146.73 9.13 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.833 0.853 . . . . 0.0 109.121 177.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.723 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 8.0 tt -125.5 154.75 41.63 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.702 HH11 HG21 ' A' ' 156' ' ' ILE . 47.3 ttm-85 -150.18 138.75 20.66 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 123.131 0.573 . . . . 0.0 110.971 -173.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -115.57 115.58 26.68 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 175.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.408 ' HD1' ' HG2' ' A' ' 148' ' ' ARG . 31.6 p90 -136.08 145.98 46.53 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.543 0.737 . . . . 0.0 109.59 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 54.5 p -69.32 175.84 3.71 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.79 0.836 . . . . 0.0 111.01 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -54.69 -32.38 59.36 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.687 0.795 . . . . 0.0 111.617 172.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -70.98 -29.24 65.16 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.944 1.298 . . . . 0.0 110.801 179.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 100.05 8.57 50.55 Favored Glycine 0 C--N 1.345 1.064 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.565 -173.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -73.16 104.56 4.26 Favored 'General case' 0 C--N 1.352 0.713 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 177.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.702 HG21 HH11 ' A' ' 148' ' ' ARG . 24.1 mt -75.93 122.72 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -175.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.404 HG11 HG21 ' A' ' 123' ' ' ILE . 30.4 m -130.74 9.53 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.636 0.774 . . . . 0.0 111.065 -175.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -159.89 159.26 30.51 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.428 -178.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -165.67 150.99 8.92 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.353 0.661 . . . . 0.0 109.457 -177.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.723 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 71.0 mt -131.4 106.85 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 170.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 78.9 p -109.18 119.05 49.7 Favored Pre-proline 0 C--O 1.24 0.556 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.46 ' HA ' HD23 ' A' ' 115' ' ' LEU . 11.1 Cg_endo -55.48 134.78 65.88 Favored 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 122.254 1.969 . . . . 0.0 111.384 168.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.463 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 90.0 mt -73.59 127.62 88.38 Favored Pre-proline 0 CA--C 1.546 0.803 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 175.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 163' ' ' LEU . 32.5 Cg_exo -60.08 -28.14 86.4 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 123.562 2.842 . . . . 0.0 113.57 -177.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.1 m -71.36 -10.76 60.28 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.679 0.791 . . . . 0.0 111.89 175.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -123.12 77.11 51.65 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 123.856 0.862 . . . . 0.0 109.089 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -80.13 1.47 9.22 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 123.125 2.55 . . . . 0.0 112.982 -177.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -122.5 83.02 0.35 Allowed Glycine 0 C--N 1.345 1.066 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -120.23 132.74 55.47 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 169.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 57.9 p -82.48 173.15 12.26 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.64 0.376 . . . . 0.0 110.902 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.477 HD11 ' HA ' ' A' ' 202' ' ' ALA . 7.7 tt -51.67 -40.84 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.088 171.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -65.12 -36.57 84.68 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.842 0.857 . . . . 0.0 111.216 -173.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -62.74 -42.08 99.5 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 123.694 0.621 . . . . 0.0 110.604 174.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.526 ' O ' HG13 ' A' ' 178' ' ' ILE . 40.6 t -63.17 -41.9 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 123.829 0.706 . . . . 0.0 109.921 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 171' ' ' ILE . 57.7 mtpt -57.55 -42.69 83.47 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.815 0.846 . . . . 0.0 111.206 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.452 ' O ' HG23 ' A' ' 180' ' ' VAL . 63.0 m-80 -66.15 -47.44 74.05 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.993 0.517 . . . . 0.0 110.123 176.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.42 -42.28 86.9 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.462 1.101 . . . . 0.0 112.053 -175.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.526 HG13 ' O ' ' A' ' 174' ' ' VAL . 53.1 mt -60.75 -41.45 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 177.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -68.05 -26.68 73.94 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.66 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 176' ' ' ASN . 69.5 t -72.56 -50.06 37.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 123.414 0.686 . . . . 0.0 109.926 176.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 15.7 tp -59.41 -46.08 89.7 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.708 177.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.531 HD11 HG22 ' A' ' 194' ' ' VAL . 32.2 mt -56.76 -49.17 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.588 1.155 . . . . 0.0 111.299 174.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.43 ' O ' ' HG3' ' A' ' 187' ' ' ARG . . . -55.28 -42.14 81.63 Favored Glycine 0 C--N 1.343 0.923 0 O-C-N 124.149 0.905 . . . . 0.0 113.618 -178.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.574 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -71.29 -34.84 63.89 Favored Glycine 0 C--N 1.347 1.189 0 O-C-N 123.787 0.345 . . . . 0.0 113.084 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.464 HD22 HD12 ' A' ' 128' ' ' ILE . 95.0 mt -64.02 -40.74 97.0 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.372 0.669 . . . . 0.0 110.556 175.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -63.37 -35.34 80.08 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.607 0.763 . . . . 0.0 111.012 178.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 183' ' ' GLY . 83.0 mtp180 -64.99 -39.0 92.82 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.302 0.641 . . . . 0.0 110.451 175.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.404 ' ND2' ' HA ' ' A' ' 121' ' ' GLN . 5.7 m-20 -70.92 -3.92 21.79 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.987 0.915 . . . . 0.0 112.082 175.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.9 t70 65.95 46.39 2.24 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 122.646 1.212 . . . . 0.0 109.089 -176.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -111.08 138.37 47.59 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.088 177.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 26.6 m -79.79 114.02 18.39 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -177.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.412 HG21 HG23 ' A' ' 182' ' ' ILE . 27.3 m -92.65 139.01 18.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.612 -174.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -149.18 146.38 27.61 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.948 171.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.531 HG22 HD11 ' A' ' 182' ' ' ILE . 2.8 t -109.06 147.27 13.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 -175.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 27.2 t -61.0 152.3 28.24 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 118.158 0.435 . . . . 0.0 111.292 -174.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.37 -41.05 62.76 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 124.297 0.998 . . . . 0.0 110.988 179.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 57.9 p -70.49 -52.2 23.64 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.083 0.953 . . . . 0.0 110.01 178.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.616 HD21 ' HB3' ' A' ' 132' ' ' ALA . 34.9 mt -58.9 -29.68 67.22 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.751 0.82 . . . . 0.0 112.128 -176.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.572 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 47.5 mt-30 -72.09 -54.65 9.14 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.26 0.624 . . . . 0.0 110.554 177.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.81 -9.22 59.38 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -174.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -100.82 -50.46 3.84 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.008 0.523 . . . . 0.0 111.556 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.477 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -113.6 -62.47 1.59 Allowed 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -168.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.572 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 65.9 t-105 -59.29 -57.37 13.32 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.891 1.276 . . . . 0.0 111.246 -165.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -82.25 134.85 13.43 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 165.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 21.2 m -78.48 80.12 4.88 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.301 0.64 . . . . 0.0 111.306 -174.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 42.5 t -81.68 68.33 8.0 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 123.59 0.756 . . . . 0.0 109.32 172.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 7.2 p30 175.34 145.4 0.07 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.383 1.473 . . . . 0.0 108.065 -175.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -155.23 149.39 25.86 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.114 0.483 . . . . 0.0 110.681 175.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -117.97 75.85 1.03 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 168.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -61.53 -47.88 88.0 Favored Glycine 0 C--N 1.355 1.596 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 172.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 58.9 mtm-85 -113.24 133.55 22.06 Favored Pre-proline 0 C--O 1.244 0.81 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 165.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.14 146.76 94.42 Favored 'Trans proline' 0 C--N 1.366 1.496 0 C-N-CA 121.657 1.571 . . . . 0.0 110.898 170.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.17 164.66 19.11 Favored 'Trans proline' 0 C--N 1.368 1.585 0 C-N-CA 121.815 1.676 . . . . 0.0 110.909 167.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 84.7 mt -57.22 103.72 0.13 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 61.1 p -60.43 146.07 45.88 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.204 -173.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 79.4 mt -66.96 88.31 0.15 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.647 0.779 . . . . 0.0 111.759 -169.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.353 0 C-N-CA 124.308 1.043 . . . . 0.0 111.462 178.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.448 ' SD ' ' N ' ' A' ' 84' ' ' MET . 0.7 OUTLIER . . . . . 0 CA--C 1.557 1.237 0 CA-C-O 118.351 -0.833 . . . . 0.0 111.101 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.435 ' HD3' ' HB2' ' A' ' 84' ' ' MET . 14.0 Cg_exo -71.69 148.3 52.63 Favored 'Trans proline' 0 C--N 1.392 2.861 0 C-N-CA 121.706 1.604 . . . . 0.0 111.247 168.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.4 104.97 2.43 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 122.818 0.447 . . . . 0.0 110.124 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 37.9 p -56.41 109.94 0.69 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.628 0.771 . . . . 0.0 110.866 -178.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.9 ttp180 -102.4 159.59 15.29 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.622 1.169 . . . . 0.0 109.616 -170.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -123.21 109.12 13.58 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.122 0.969 . . . . 0.0 109.322 173.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 36.1 mm -82.35 133.95 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 171.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 37.8 p -126.96 93.43 3.76 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.104 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -77.9 -25.88 48.76 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.73 177.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.659 ' SD ' ' HG2' ' A' ' 148' ' ' ARG . 40.1 mtm -104.83 129.16 53.18 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 124.199 0.999 . . . . 0.0 108.495 178.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 69.9 p -87.61 175.16 8.03 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 170.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 83.5 mt -56.43 -32.36 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 123.709 0.804 . . . . 0.0 111.116 -177.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 100' ' ' ARG . 39.4 mt-10 -48.76 -55.5 11.32 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.152 1.381 . . . . 0.0 113.547 177.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -95.66 -25.73 16.01 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 118.039 0.382 . . . . 0.0 111.009 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.5 tt -66.72 -49.49 65.85 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -176.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.7 m -95.63 16.25 17.76 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.824 0.849 . . . . 0.0 110.86 -177.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 96' ' ' GLU . 73.9 ttt180 -82.28 126.84 32.59 Favored 'General case' 0 C--N 1.35 0.604 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -80.43 128.17 33.26 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 169.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -137.18 164.82 27.57 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.261 0.624 . . . . 0.0 110.293 -174.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -134.84 149.99 50.42 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.286 0.634 . . . . 0.0 109.676 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 10.8 ptm -126.0 128.57 47.66 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.4 tp -69.88 -41.22 75.06 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.719 0.807 . . . . 0.0 111.316 -170.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.413 ' O ' ' HA ' ' A' ' 120' ' ' ASP . 4.0 mmt -116.67 88.1 23.66 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 123.792 0.837 . . . . 0.0 109.864 173.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -74.8 137.58 22.4 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.678 2.252 . . . . 0.0 113.201 -177.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -130.67 135.43 47.83 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.058 0.943 . . . . 0.0 108.469 166.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -121.82 123.75 42.51 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 173.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -144.24 121.53 11.59 Favored 'General case' 0 C--O 1.217 -0.623 0 C-N-CA 123.374 0.669 . . . . 0.0 109.241 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 97.1 t -79.23 137.67 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.029 0.531 . . . . 0.0 110.501 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -125.12 85.42 2.41 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 171.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.89 -119.42 6.41 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.279 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -89.74 16.73 1.69 Allowed 'Trans proline' 0 CA--C 1.552 1.411 0 C-N-CA 123.531 2.821 . . . . 0.0 113.044 177.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.52 HD23 ' HA ' ' A' ' 162' ' ' PRO . 96.1 mt -128.85 151.91 49.09 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.844 0.858 . . . . 0.0 109.965 -176.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 36.1 t -115.28 131.2 57.0 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.177 0.991 . . . . 0.0 108.897 177.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.4 mm -106.34 139.6 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.562 0.745 . . . . 0.0 109.219 -177.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -119.29 119.73 34.9 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 175.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.436 HD13 ' HA3' ' A' ' 184' ' ' GLY . 69.9 mt -126.05 124.08 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -178.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' A' ' 106' ' ' MET . 24.4 t70 -97.59 123.27 41.42 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.837 0.455 . . . . 0.0 110.24 174.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.46 ' HA ' HD21 ' A' ' 188' ' ' ASN . 77.6 mt-30 -88.35 -11.2 46.94 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.21 -50.32 14.81 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.156 0.503 . . . . 0.0 111.454 -174.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.8 mp -72.34 112.67 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.706 1.202 . . . . 0.0 109.523 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.2 mtt -130.3 162.71 28.4 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.481 1.112 . . . . 0.0 109.974 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 73.78 18.96 3.28 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 125.037 1.335 . . . . 0.0 112.915 176.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -111.43 149.58 31.05 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.449 0.7 . . . . 0.0 111.716 -173.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -87.99 102.78 15.07 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 171.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.489 HG12 HG22 ' A' ' 151' ' ' THR . 54.8 mt -106.56 131.14 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.003 0.521 . . . . 0.0 109.92 -173.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 14.7 tpt -106.08 127.1 52.95 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.209 1.004 . . . . 0.0 109.688 -172.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.453 HD12 HG22 ' A' ' 194' ' ' VAL . 25.7 mt -99.16 105.08 17.11 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -177.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -130.42 145.56 51.84 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.42 0.688 . . . . 0.0 111.13 -175.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.49 155.43 46.66 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -170.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -109.02 122.19 46.72 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 166.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -155.84 161.07 40.67 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.692 0.797 . . . . 0.0 110.546 -170.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.7 p -86.56 163.77 17.28 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.688 173.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 90.0 t -139.04 137.26 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.667 1.187 . . . . 0.0 109.109 -174.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.2 tp -152.04 144.17 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 172.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 57.99 26.5 13.54 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 124.248 1.019 . . . . 0.0 111.767 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 57.63 44.32 20.98 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.655 1.182 . . . . 0.0 111.345 -174.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -146.74 166.79 25.55 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.162 169.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.507 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 9.6 tt -64.21 123.55 19.38 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -79.38 -70.28 0.52 Allowed 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 175.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 99.8 m -143.71 135.4 26.27 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.064 0.946 . . . . 0.0 109.185 177.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.475 ' HB3' ' NE2' ' A' ' 169' ' ' HIS . 62.7 tp -77.98 126.67 31.18 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.828 0.851 . . . . 0.0 109.716 178.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.58 -49.96 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 174.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.425 HD21 ' NH2' ' A' ' 148' ' ' ARG . 51.0 tp -162.66 147.59 12.03 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.408 0.683 . . . . 0.0 109.664 -178.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.62 ' HB3' ' HB ' ' A' ' 160' ' ' ILE . 8.8 tt -138.88 154.67 48.41 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.659 ' HG2' ' SD ' ' A' ' 93' ' ' MET . 10.8 ptp180 -153.7 158.33 40.87 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.78 0.8 . . . . 0.0 111.738 173.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.528 ' HB2' HD21 ' A' ' 181' ' ' LEU . . . -111.29 116.1 30.43 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.294 1.438 . . . . 0.0 107.748 176.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.476 ' HD1' ' HG3' ' A' ' 148' ' ' ARG . 44.6 p90 -134.69 136.78 43.0 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.067 0.547 . . . . 0.0 110.333 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.489 HG22 HG12 ' A' ' 128' ' ' ILE . 52.7 p -63.96 177.49 0.77 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.484 1.114 . . . . 0.0 112.364 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -64.99 -17.55 64.52 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.479 0.712 . . . . 0.0 112.384 173.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -81.7 -24.04 36.44 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 122.819 0.448 . . . . 0.0 109.826 172.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 101.23 3.56 54.01 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.576 -175.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -68.7 103.38 1.72 Allowed 'General case' 0 C--N 1.352 0.717 0 C-N-CA 123.489 0.716 . . . . 0.0 109.776 -178.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.588 HD13 HH11 ' A' ' 148' ' ' ARG . 14.5 mt -73.14 116.72 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -178.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.3 m -123.08 3.48 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.167 0.987 . . . . 0.0 111.17 -176.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -154.84 161.69 30.42 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.609 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 38.8 tt0 -166.0 144.65 5.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 122.687 0.395 . . . . 0.0 110.267 -177.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.62 ' HB ' ' HB3' ' A' ' 147' ' ' LEU . 68.8 mt -126.77 116.38 44.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 173.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 19.3 m -126.4 141.52 40.23 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 123.465 0.706 . . . . 0.0 109.954 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.52 ' HA ' HD23 ' A' ' 115' ' ' LEU . 32.0 Cg_exo -58.87 147.22 90.21 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.672 2.248 . . . . 0.0 112.171 173.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 76.3 mt -67.99 145.86 97.96 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 122.777 0.431 . . . . 0.0 110.454 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.2 -33.45 64.73 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 123.212 2.608 . . . . 0.0 113.23 170.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 40.9 m -82.22 -26.62 33.13 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.321 0.648 . . . . 0.0 111.602 177.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -134.42 74.07 67.21 Favored Pre-proline 0 N--CA 1.488 1.426 0 C-N-CA 123.079 0.552 . . . . 0.0 111.306 -175.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -72.1 -33.37 9.61 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.587 2.192 . . . . 0.0 112.028 174.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -94.47 119.2 6.0 Favored Glycine 0 C--N 1.345 1.048 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -175.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.475 ' NE2' ' HB3' ' A' ' 144' ' ' LEU . 51.6 p-80 -149.75 174.5 12.54 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.454 0.702 . . . . 0.0 110.484 -175.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 14.8 m -107.95 162.92 13.58 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.284 1.033 . . . . 0.0 109.692 -177.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.589 HD11 ' HA ' ' A' ' 202' ' ' ALA . 14.9 tt -54.63 -35.08 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 125.743 1.617 . . . . 0.0 113.465 178.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -63.12 -29.43 70.79 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.377 0.671 . . . . 0.0 111.331 -176.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -71.6 -38.86 70.8 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.159 0.584 . . . . 0.0 110.295 175.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 44.7 t -67.4 -41.72 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 124.067 0.854 . . . . 0.0 111.373 -175.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -65.32 -33.58 76.31 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 122.949 0.155 . . . . 0.0 110.854 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -70.23 -39.91 74.79 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.911 0.484 . . . . 0.0 109.719 175.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.58 -47.59 80.87 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.338 1.055 . . . . 0.0 111.353 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 73.2 mt -63.44 -35.05 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.532 0.733 . . . . 0.0 109.477 176.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -60.77 -36.3 91.58 Favored Glycine 0 C--N 1.349 1.278 0 O-C-N 123.586 0.554 . . . . 0.0 113.986 176.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 98.8 t -72.04 -45.99 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.135 0.574 . . . . 0.0 110.015 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.528 HD21 ' HB2' ' A' ' 149' ' ' ALA . 41.0 tp -58.23 -45.2 88.14 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.725 0.81 . . . . 0.0 111.168 178.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.485 ' O ' ' HG2' ' A' ' 186' ' ' GLU . 49.0 mt -62.05 -50.86 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.996 0.918 . . . . 0.0 110.169 175.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.413 ' O ' ' HG2' ' A' ' 187' ' ' ARG . . . -53.69 -37.81 57.66 Favored Glycine 0 C--N 1.346 1.089 0 O-C-N 124.067 0.854 . . . . 0.0 113.964 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.436 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -71.64 -38.43 61.38 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 123.676 0.28 . . . . 0.0 112.937 175.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.473 HD22 HD12 ' A' ' 128' ' ' ILE . 95.0 mt -72.36 -21.75 61.26 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.427 0.691 . . . . 0.0 111.469 176.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 182' ' ' ILE . 11.6 mm-40 -74.76 -32.48 62.08 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.291 0.636 . . . . 0.0 109.64 176.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 183' ' ' GLY . 17.8 mmt180 -63.55 -39.12 93.59 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.375 172.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.46 HD21 ' HA ' ' A' ' 121' ' ' GLN . 4.6 m-20 -75.47 -5.6 45.9 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.582 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 26.9 t70 63.6 21.86 12.9 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 123.977 0.911 . . . . 0.0 110.748 -177.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -80.95 138.15 36.11 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.129 0.972 . . . . 0.0 110.412 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 41.1 m -79.78 103.04 9.41 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.462 HG21 HG23 ' A' ' 182' ' ' ILE . 25.5 m -85.17 143.81 10.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.023 -177.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -143.87 127.32 16.88 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 168.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.453 HG22 HD12 ' A' ' 130' ' ' LEU . 7.8 t -88.27 146.53 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 27.7 t -57.32 144.32 36.33 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 118.429 0.558 . . . . 0.0 111.02 -176.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -55.76 -31.52 62.63 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.209 0.603 . . . . 0.0 111.11 -178.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 37.7 p -67.65 -57.53 6.24 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.808 172.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 56.3 mt -59.47 -25.32 64.31 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.07 0.948 . . . . 0.0 112.02 -174.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.615 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 49.9 mt-30 -74.63 -55.22 6.13 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.093 0.557 . . . . 0.0 110.242 178.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.82 -24.34 60.89 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 116.81 -0.177 . . . . 0.0 111.379 -174.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -84.56 -52.19 6.31 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.322 0.649 . . . . 0.0 110.764 177.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.589 ' HA ' HD11 ' A' ' 171' ' ' ILE . . . -114.64 -42.8 3.22 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -165.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.615 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 27.9 t-105 -94.62 9.35 39.07 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.908 0.483 . . . . 0.0 111.972 -168.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -63.21 -64.17 3.98 Favored Glycine 0 N--CA 1.479 1.527 0 N-CA-C 112.331 -0.307 . . . . 0.0 112.331 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 25.4 m -85.2 84.08 7.8 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 169.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 31.8 t -131.27 154.85 48.06 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.73 0.812 . . . . 0.0 109.501 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -150.2 157.54 43.2 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.813 0.845 . . . . 0.0 109.039 -176.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -149.99 124.99 9.95 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.839 0.855 . . . . 0.0 109.096 177.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -96.81 106.39 18.69 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 174.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -77.39 79.73 1.34 Allowed Glycine 0 C--N 1.345 1.044 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 171.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.41 ' HA ' ' HD3' ' A' ' 212' ' ' PRO . 10.5 ptp180 -63.09 127.84 91.45 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 123.087 0.555 . . . . 0.0 111.261 -174.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 211' ' ' ARG . 27.5 Cg_exo -62.61 134.21 46.43 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.611 2.207 . . . . 0.0 111.472 178.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -56.05 123.13 13.09 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 123.071 2.514 . . . . 0.0 111.753 -176.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 88.6 mt -58.98 133.28 55.95 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.235 0.614 . . . . 0.0 112.21 -174.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 49.0 p -62.65 130.58 45.65 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.221 1.009 . . . . 0.0 111.107 -176.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.2 pp -73.38 -176.22 2.18 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.396 0.679 . . . . 0.0 111.656 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.558 1.263 0 CA-C-O 118.831 -0.604 . . . . 0.0 111.343 178.782 . . . . . . . . 1 1 . 1 stop_ save_